Citrus Sinensis ID: 044568
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 257 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.692 | 0.213 | 0.427 | 3e-40 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.723 | 0.224 | 0.391 | 4e-33 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.712 | 0.209 | 0.379 | 7e-32 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.719 | 0.232 | 0.38 | 9e-31 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.712 | 0.221 | 0.378 | 2e-29 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.649 | 0.203 | 0.401 | 3e-29 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.630 | 0.256 | 0.370 | 5e-28 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.715 | 0.275 | 0.364 | 5e-28 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.653 | 0.264 | 0.392 | 6e-28 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.715 | 0.211 | 0.355 | 1e-27 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 165 bits (417), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 82/192 (42%), Positives = 121/192 (63%), Gaps = 14/192 (7%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
G+L + +F P W R IA+ +A+GILYLH+EC I+HCDIKPQNIL+DE++T
Sbjct: 614 GTLANFLF--RRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTP 671
Query: 134 KILDFGLAK--LPNEDFVID--KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
+I DFGLAK L N+ + + + KGY+APE ++ +PI+ K DVY YG++LLE +CC+K
Sbjct: 672 RISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKK 731
Query: 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV---DKKNLENLVKVGLWCVQDEPA 246
++++ + +IL NW Y CF L L D + +E VK+ +WC+Q+E
Sbjct: 732 AVDLE----DNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHG 787
Query: 247 LRP-MKCAVMML 257
+RP M+ ML
Sbjct: 788 MRPNMRNVTQML 799
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (356), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 78/199 (39%), Positives = 113/199 (56%), Gaps = 13/199 (6%)
Query: 71 VRNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
+RNGSL + +F + + + W R IAL AKGI YLH+EC I+HCDIKP+NIL+D+
Sbjct: 559 MRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDD 618
Query: 130 FWTAKILDFGLAKLPNE-----DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184
+ AK+ DFGLAKL N + + +GY+APE PI+ K+DVY YG+VLLE
Sbjct: 619 NFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEL 678
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINREL-----NKLVRGTKVDKKNLENLVKVGLW 239
+ ++N ++ + K + W Y+ F +L VD + + +VK W
Sbjct: 679 VSGKRNFDV-SEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFW 737
Query: 240 CVQDEPALRP-MKCAVMML 257
C+Q++P RP M V ML
Sbjct: 738 CIQEQPLQRPTMGKVVQML 756
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (345), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 74/195 (37%), Positives = 115/195 (58%), Gaps = 12/195 (6%)
Query: 73 NGSLTDIIFCSAERNPY--WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
NGSL IF S + W R IA+ A+GI Y H++C I+HCDIKP+NIL+D+
Sbjct: 608 NGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDN 667
Query: 131 WTAKILDFGLAKLPNEDF----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ K+ DFGLAK+ + + + +GY+APE PI+VKADVY YG++LLE +
Sbjct: 668 FCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 727
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFIN----RELNKLVRGTKVDKKNLENLVKVGLWCVQ 242
R+N+++ + E+ W YK N + ++K ++G +++ ++ L KV WC+Q
Sbjct: 728 GRRNLDM-SYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKAL-KVAFWCIQ 785
Query: 243 DEPALRPMKCAVMML 257
DE ++RP V+ L
Sbjct: 786 DEVSMRPSMGEVVKL 800
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (336), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 76/200 (38%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
GSL+ + ++ + W R RIAL AKGI YLH+ C I+HCDIKP+NIL+D +
Sbjct: 539 QGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYN 598
Query: 133 AKILDFGLAKLPNEDF----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
AK+ DFGLAKL DF + GY+APE PI+ KADVY +G+ LLE I R
Sbjct: 599 AKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGR 658
Query: 189 KNMEIDA-------SKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK---VGL 238
+N+ +++ ++PE+ W + I ++ +V + N E + + V +
Sbjct: 659 RNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAI 718
Query: 239 WCVQDEPALRP-MKCAVMML 257
WC+QD +RP M V ML
Sbjct: 719 WCIQDNEEIRPAMGTVVKML 738
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 129 bits (324), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 75/198 (37%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 73 NGSLTDIIFCSAERNPY---WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
NGSL +F + W R +IAL A+G+ YLHDEC I+HCDIKP+NIL+D
Sbjct: 570 NGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDS 629
Query: 130 FWTAKILDFGLAKLPNEDF----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFGLAKL DF + +GY+APE I+ KADVY YG++L E +
Sbjct: 630 QFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELV 689
Query: 186 CCRKNMEIDASKPEEI-ILTNWVYKCFI-NRELNKLV----RGTKVDKKNLENLVKVGLW 239
R+N E S+ E++ +W + ++ LV G VD + + KV W
Sbjct: 690 SGRRNTE--QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACW 747
Query: 240 CVQDEPALRPMKCAVMML 257
C+QDE + RP V+ +
Sbjct: 748 CIQDEESHRPAMSQVVQI 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 129 bits (323), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 71/177 (40%), Positives = 103/177 (58%), Gaps = 10/177 (5%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147
W+ R IAL AKG+ YLH++C+ I+HCDIKP+NIL+D+ + AK+ DFGLAKL +
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648
Query: 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN 205
F + +GY+APE IS K+DVY YG+VLLE I RKN + + E+ +
Sbjct: 649 HVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYD-PSETSEKCHFPS 707
Query: 206 WVYKCFINRELNKLVRG----TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
+ +K +L +V G V + ++ +K LWC+Q++ RP M V ML
Sbjct: 708 FAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (312), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 67/181 (37%), Positives = 104/181 (57%), Gaps = 19/181 (10%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
W++R +IA+ A+G++YLH++C+P I+H D+K NIL+DE + A + DFGLAKL
Sbjct: 399 WSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL------ 452
Query: 150 IDKRDK----------GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPE 199
+D RD G++APE S K DV+G+GI+LLE I +K ++ S +
Sbjct: 453 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQ 512
Query: 200 EIILTNWVYKCFINRELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRPMKCAVMM 256
+ ++ +WV K +L +L+ K D+ LE +V+V L C Q P+ RP VM
Sbjct: 513 KGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMK 572
Query: 257 L 257
+
Sbjct: 573 M 573
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (312), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 70/192 (36%), Positives = 105/192 (54%), Gaps = 8/192 (4%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GSL ++ E++ W+QR +I DVA G+ YLH + I+H DIKP N+L+D+
Sbjct: 424 GSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNG 483
Query: 134 KILDFGLAKLPNEDFVIDKRDK----GYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
K+ DFGLAKL F + GY++PE + S +DV+ +GI++LE C R+
Sbjct: 484 KLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRR 543
Query: 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV----KVGLWCVQDEP 245
+ AS P E++LT+WV C+ + L + K D K LE V K+GL+C
Sbjct: 544 PVLPRASSPSEMVLTDWVLDCWEDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVA 603
Query: 246 ALRPMKCAVMML 257
A+RP +V+
Sbjct: 604 AVRPSMSSVIQF 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (311), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 69/176 (39%), Positives = 102/176 (57%), Gaps = 8/176 (4%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN-EDF 148
WN R +IA+ A+G+ YLH++C+P I+H D+K NIL+DE++ A + DFGLAKL N ED
Sbjct: 393 WNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDS 452
Query: 149 VID---KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN 205
+ + G++APE S K DV+G+GI+LLE I + +E S ++ +
Sbjct: 453 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLE 512
Query: 206 WVYKCFINRELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
WV K ++ +LV GT D+ + +++V L C Q PA RP M V ML
Sbjct: 513 WVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQML 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 1e-27, Method: Composition-based stats.
Identities = 75/211 (35%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ +GSL +F W +R IAL A+G+ YLH C+ I+HCD+KP+NIL+ +
Sbjct: 591 MNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDH 650
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ KI DFGL+KL N++ F + +GY+APE IS KADVY YG+VLLE +
Sbjct: 651 FQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVS 710
Query: 187 CRKNMEIDASKPEEIILTN-------------WVYKCFINRELNKLVR---------GTK 224
RKN S+ + N VY ++++ R +
Sbjct: 711 GRKNCSF-RSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGR 769
Query: 225 VDKKNLENLVKVGLWCVQDEPALRPMKCAVM 255
V + E LV++ L CV +EPALRP AV+
Sbjct: 770 VTSQEAEKLVRIALCCVHEEPALRPTMAAVV 800
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 257 | ||||||
| 359477046 | 798 | PREDICTED: G-type lectin S-receptor-like | 0.723 | 0.233 | 0.645 | 6e-66 | |
| 359477052 | 767 | PREDICTED: G-type lectin S-receptor-like | 0.723 | 0.242 | 0.635 | 8e-66 | |
| 225431565 | 791 | PREDICTED: G-type lectin S-receptor-like | 0.723 | 0.235 | 0.640 | 9e-66 | |
| 147867430 | 930 | hypothetical protein VITISV_038238 [Viti | 0.723 | 0.2 | 0.640 | 1e-65 | |
| 224116044 | 313 | predicted protein [Populus trichocarpa] | 0.715 | 0.587 | 0.610 | 8e-63 | |
| 224105693 | 313 | predicted protein [Populus trichocarpa] | 0.715 | 0.587 | 0.6 | 3e-62 | |
| 357478041 | 854 | Receptor like kinase [Medicago truncatul | 0.723 | 0.217 | 0.593 | 9e-61 | |
| 356546166 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.719 | 0.228 | 0.616 | 4e-60 | |
| 224093336 | 755 | predicted protein [Populus trichocarpa] | 0.723 | 0.246 | 0.595 | 1e-59 | |
| 359477048 | 792 | PREDICTED: G-type lectin S-receptor-like | 0.723 | 0.234 | 0.583 | 8e-59 |
| >gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 256 bits (654), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 124/192 (64%), Positives = 150/192 (78%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL +++F + R P+WN+RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMDEF
Sbjct: 591 MSNGSLANLLFNAGTR-PHWNERVRIALDVARGILYLHEECETPIIHCDIKPQNILMDEF 649
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
AKI DFGLAKL D F + +GY+APE + TPISVKAD+Y YGIVLLE +C
Sbjct: 650 LNAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQRNTPISVKADIYSYGIVLLEIVC 709
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CRKNME+ PEEIIL+NWVY+C ++REL+KLV DKK LE +VKVGLWC+QDEPA
Sbjct: 710 CRKNMEVQVKNPEEIILSNWVYQCMVSRELDKLVADEVADKKTLERMVKVGLWCIQDEPA 769
Query: 247 LRP-MKCAVMML 257
LRP MK V++L
Sbjct: 770 LRPSMKSVVLIL 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 8e-66, Method: Compositional matrix adjust.
Identities = 122/192 (63%), Positives = 154/192 (80%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ N SL DI+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+F
Sbjct: 560 MSNRSLADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDF 618
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
WTAKI DFGLAKL D F + +GY+APE + PISVKADVY YGIVLLE +C
Sbjct: 619 WTAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVC 678
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CR+N+E++ S+PEEI+L+NW YKCF+ EL+KL+ G +V++K+LE +VK+GLWC+QDEPA
Sbjct: 679 CRRNLEVNVSEPEEIVLSNWAYKCFVAGELHKLLGGEEVERKSLEQMVKLGLWCIQDEPA 738
Query: 247 LRP-MKCAVMML 257
LRP +K V+ML
Sbjct: 739 LRPSIKSIVLML 750
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 9e-66, Method: Compositional matrix adjust.
Identities = 123/192 (64%), Positives = 153/192 (79%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ N SL DI+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+F
Sbjct: 584 MSNRSLADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDF 642
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
WTAKI DFGLAKL D F + +GY+APE + PISVKADVY YGIVLLE +C
Sbjct: 643 WTAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVC 702
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CR+N+E++ SKPEEI+L+NW YKCF+ EL KL+ G +V++K+LE +VK+GLWC+QDEPA
Sbjct: 703 CRRNLEVNVSKPEEIVLSNWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPA 762
Query: 247 LRP-MKCAVMML 257
LRP +K V+ML
Sbjct: 763 LRPSIKSIVLML 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147867430|emb|CAN78998.1| hypothetical protein VITISV_038238 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 255 bits (652), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 123/192 (64%), Positives = 153/192 (79%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ N SL DI+F S R P W++RVRIALDVA+GILYLH+ECE PI+HCDIKPQNILMD+F
Sbjct: 723 MSNRSLADILFKSKTRPP-WDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDF 781
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
WTAKI DFGLAKL D F + +GY+APE + PISVKADVY YGIVLLE +C
Sbjct: 782 WTAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVC 841
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CR+N+E++ SKPEEI+L+NW YKCF+ EL KL+ G +V++K+LE +VK+GLWC+QDEPA
Sbjct: 842 CRRNLEVNVSKPEEIVLSNWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPA 901
Query: 247 LRP-MKCAVMML 257
LRP +K V+ML
Sbjct: 902 LRPSIKSIVLML 913
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116044|ref|XP_002332034.1| predicted protein [Populus trichocarpa] gi|222875259|gb|EEF12390.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 246 bits (627), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 116/190 (61%), Positives = 148/190 (77%), Gaps = 6/190 (3%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NGSL D++F ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+FW
Sbjct: 108 NGSLADLLF-RTERIPNWSHRVKIALDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWN 166
Query: 133 AKILDFGLAKL--PNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
AKI DFGLAKL P++ F I + +GY+APE +K TPISVKADVY YG++LLE + CR
Sbjct: 167 AKISDFGLAKLLVPDQTRTFTIVRGTRGYLAPEWHKNTPISVKADVYSYGVMLLEIVFCR 226
Query: 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248
+N+E + S+PEE+ L+NW Y+ + REL+KL G VD +NLE +V VG+WC+QDEP +R
Sbjct: 227 RNIETNVSRPEEVQLSNWAYELLVERELDKLDLGEDVDLQNLEKMVMVGIWCIQDEPGIR 286
Query: 249 P-MKCAVMML 257
P MK V+ML
Sbjct: 287 PSMKSVVLML 296
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105693|ref|XP_002333784.1| predicted protein [Populus trichocarpa] gi|222838485|gb|EEE76850.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 244 bits (622), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 114/190 (60%), Positives = 147/190 (77%), Gaps = 6/190 (3%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NGSL D++F ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+FW
Sbjct: 108 NGSLADLLF-RTERIPNWSHRVKIALDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWN 166
Query: 133 AKILDFGLAKL--PNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
AKI DFGLAKL P++ F + + +GY+APE +K TPISVKADVY YG++LLE + CR
Sbjct: 167 AKISDFGLAKLLVPDQTRTFTMVRGTRGYLAPEWHKNTPISVKADVYSYGVMLLEIVFCR 226
Query: 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248
+N+E + S+PEE+ L+NW Y+ + REL+KL G VD +N E +V VG+WC+QDEP +R
Sbjct: 227 RNIETNVSRPEEVQLSNWAYELLVERELDKLDLGEDVDLQNFEKMVMVGIWCIQDEPGIR 286
Query: 249 P-MKCAVMML 257
P MK V+ML
Sbjct: 287 PSMKSVVLML 296
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478041|ref|XP_003609306.1| Receptor like kinase [Medicago truncatula] gi|357478087|ref|XP_003609329.1| Receptor like kinase [Medicago truncatula] gi|355510361|gb|AES91503.1| Receptor like kinase [Medicago truncatula] gi|355510384|gb|AES91526.1| Receptor like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 239 bits (610), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 114/192 (59%), Positives = 145/192 (75%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL ++F +R P WN+RVRIALD+A+GILYLH+EC+ PI+HCD+KPQNILMD+F
Sbjct: 603 MSNGSLGKLLF-GDQRRPDWNERVRIALDIARGILYLHEECDAPIIHCDLKPQNILMDKF 661
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
WTAKI DFGLAKL D F + + +GYMAPE K ISVK DVY YGIVLLE +C
Sbjct: 662 WTAKISDFGLAKLLMPDQTRTFTMVRGTRGYMAPEWNKNVAISVKTDVYSYGIVLLEILC 721
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CR+N++++ +PEEI+L W YKCFI ++NKLV +DK +EN+VKV LWC+QD+P
Sbjct: 722 CRRNLDVNVLEPEEILLAGWTYKCFIAGDVNKLVPSEAIDKNVMENMVKVALWCIQDDPF 781
Query: 247 LRP-MKCAVMML 257
LRP MK V+ML
Sbjct: 782 LRPTMKGVVLML 793
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546166|ref|XP_003541502.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 237 bits (604), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 119/193 (61%), Positives = 149/193 (77%), Gaps = 8/193 (4%)
Query: 73 NGSLTDIIF-CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
NGSL ++IF ++R P W++RVRIAL++AKGILYLH+ECE PI+HCDIKPQNILMDEFW
Sbjct: 601 NGSLENLIFGAQSQRRPGWDERVRIALEIAKGILYLHEECEAPIIHCDIKPQNILMDEFW 660
Query: 132 TAKILDFGLAKL--PNEDFVID--KRDKGYMAPECYK-RTPISVKADVYGYGIVLLETIC 186
TAKI DFGLAKL P++ I + +GY+APE K PISVK DVY YGIVLLE +C
Sbjct: 661 TAKISDFGLAKLLMPDQTRTITGARGTRGYVAPEWDKLNIPISVKVDVYSYGIVLLEILC 720
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK-NLENLVKVGLWCVQDEP 245
CR+N+E+ S+PE +L+NW YKCF++ +LNKL VD K ++EN+VKV LWC+QDEP
Sbjct: 721 CRRNIEVHVSEPEAALLSNWAYKCFVSGQLNKLFLWESVDNKTSVENIVKVALWCIQDEP 780
Query: 246 ALRP-MKCAVMML 257
LRP MK V+ML
Sbjct: 781 FLRPTMKSVVLML 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093336|ref|XP_002309887.1| predicted protein [Populus trichocarpa] gi|222852790|gb|EEE90337.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 235 bits (600), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 115/193 (59%), Positives = 146/193 (75%), Gaps = 7/193 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL +++F ER P W+ RV+IALD+AKGILYLH+ECE PI+HCDIKPQNILMD+F
Sbjct: 547 MSNGSLANLLF-RNERIPDWSDRVKIALDIAKGILYLHEECEAPIMHCDIKPQNILMDDF 605
Query: 131 WTAKILDFGLAKL--PNED--FVIDKRDKGYMAPECYK-RTPISVKADVYGYGIVLLETI 185
WTAKI DFGLAKL P++ I + GYMAPE K TP SVK DVY YG+VLLE +
Sbjct: 606 WTAKISDFGLAKLLVPDQTRTLTIARGTPGYMAPEWTKISTPTSVKVDVYSYGVVLLEIV 665
Query: 186 CCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEP 245
CR+NM+I+ SKPEE++L+ W Y+ + REL++L G VD++ LE +V +G+WC+QDEP
Sbjct: 666 FCRRNMKINVSKPEEVLLSKWAYELLVARELDRLDLGEDVDRQKLEKMVMIGIWCIQDEP 725
Query: 246 ALRP-MKCAVMML 257
LRP MK VMML
Sbjct: 726 GLRPSMKTVVMML 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477048|ref|XP_002275811.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 233 bits (593), Expect = 8e-59, Method: Compositional matrix adjust.
Identities = 112/192 (58%), Positives = 150/192 (78%), Gaps = 6/192 (3%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+RNGSL D++F +AE+ W RVRIAL++A+GILYLH+ECE I+HCDIKPQNILMD+
Sbjct: 587 MRNGSLADLLF-NAEKRSIWKVRVRIALELARGILYLHEECESQIVHCDIKPQNILMDDA 645
Query: 131 WTAKILDFGLAKL--PNEDFVID--KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
WTAKI DFG +KL PN++ ++ + GY APE +K T ISVKAD+Y +G+VLLE +C
Sbjct: 646 WTAKISDFGFSKLLMPNQEGIVTGIRGTAGYSAPEWHKNTLISVKADIYSFGVVLLEIVC 705
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
CR+++E+ S +EIIL++WVY C + REL+KLV +V+ K+LE +VKVGLWCVQD+PA
Sbjct: 706 CRRSIEVKVSTADEIILSSWVYGCLVARELDKLVGDEQVEFKSLERMVKVGLWCVQDDPA 765
Query: 247 LRP-MKCAVMML 257
LRP MK ++ML
Sbjct: 766 LRPSMKNVILML 777
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 257 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.719 | 0.223 | 0.4 | 6.4e-31 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.712 | 0.221 | 0.383 | 1.5e-28 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.712 | 0.222 | 0.394 | 6.4e-28 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.719 | 0.216 | 0.396 | 7e-28 | |
| TAIR|locus:2033577 | 425 | AT1G70740 [Arabidopsis thalian | 0.723 | 0.437 | 0.369 | 8.2e-28 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.466 | 0.137 | 0.443 | 9.1e-28 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.653 | 0.371 | 0.395 | 7.1e-27 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.688 | 0.266 | 0.382 | 1.6e-26 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.692 | 0.490 | 0.403 | 1.9e-26 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.708 | 0.272 | 0.368 | 7.3e-26 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 350 (128.3 bits), Expect = 6.4e-31, P = 6.4e-31
Identities = 80/200 (40%), Positives = 118/200 (59%)
Query: 71 VRNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
+RNGSL + +F + + + W R IAL AKGI YLH+EC I+HCDIKP+NIL+D+
Sbjct: 559 MRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDD 618
Query: 130 FWTAKILDFGLAKLPN-EDFVID----KRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184
+ AK+ DFGLAKL N +D + + +GY+APE PI+ K+DVY YG+VLLE
Sbjct: 619 NFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEL 678
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK------VDKKNLENLVKVGL 238
+ ++N ++ + K + W Y+ F + K + T+ VD + + +VK
Sbjct: 679 VSGKRNFDV-SEKTNHKKFSIWAYEEF-EKGNTKAILDTRLSEDQTVDMEQVMRMVKTSF 736
Query: 239 WCVQDEPALRP-MKCAVMML 257
WC+Q++P RP M V ML
Sbjct: 737 WCIQEQPLQRPTMGKVVQML 756
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 1.5e-28, P = 1.5e-28
Identities = 76/198 (38%), Positives = 108/198 (54%)
Query: 73 NGSLTDIIFCSAERNPY---WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
NGSL +F + W R +IAL A+G+ YLHDEC I+HCDIKP+NIL+D
Sbjct: 570 NGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDS 629
Query: 130 FWTAKILDFGLAKLPNEDF--VID--KRDKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFGLAKL DF V+ + +GY+APE I+ KADVY YG++L E +
Sbjct: 630 QFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELV 689
Query: 186 CCRKNMEIDASKPEEI-ILTNWVYKCFI-NRELNKLV----RGTKVDKKNLENLVKVGLW 239
R+N E S+ E++ +W + ++ LV G VD + + KV W
Sbjct: 690 SGRRNTE--QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACW 747
Query: 240 CVQDEPALRPMKCAVMML 257
C+QDE + RP V+ +
Sbjct: 748 CIQDEESHRPAMSQVVQI 765
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 322 (118.4 bits), Expect = 6.4e-28, P = 6.4e-28
Identities = 77/195 (39%), Positives = 111/195 (56%)
Query: 74 GSLTDIIFCSAERNPY--WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL IF + + W+ R IAL AKG+ YLH++C+ I+HCDIKP+NIL+D+ +
Sbjct: 571 GSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNF 630
Query: 132 TAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC 187
AK+ DFGLAKL + F + +GY+APE IS K+DVY YG+VLLE I
Sbjct: 631 NAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGG 690
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVD--KKNLENLVKVGLWCVQD 243
RKN + + E+ ++ +K +L +V G VD + ++ +K LWC+Q+
Sbjct: 691 RKNYD-PSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQE 749
Query: 244 EPALRP-MKCAVMML 257
+ RP M V ML
Sbjct: 750 DMQTRPSMSKVVQML 764
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 322 (118.4 bits), Expect = 7.0e-28, P = 7.0e-28
Identities = 79/199 (39%), Positives = 113/199 (56%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NGSL I + W IA+ VA+G+ YLH+ C I+H DIKPQNIL+DE
Sbjct: 598 NGSLDKFISENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLC 657
Query: 133 AKILDFGLAKL--PNEDFV--IDKRDK-GYMAPECYKRT--PISVKADVYGYGIVLLETI 185
KI DFGLAKL E + +D R GY+APE + + +S K+DVY YG+V+LE I
Sbjct: 658 PKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMI 717
Query: 186 CCRKNMEIDASKPEE--IILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK----VGLW 239
K E++ S ++ + +WVY+ +E +L+ ++++ E +VK VGLW
Sbjct: 718 GATKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLW 777
Query: 240 CVQDEPALRP-MKCAVMML 257
C+Q P+ RP M+ V ML
Sbjct: 778 CIQTNPSDRPPMRKVVEML 796
|
|
| TAIR|locus:2033577 AT1G70740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 8.2e-28, P = 8.2e-28
Identities = 72/195 (36%), Positives = 108/195 (55%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
V N SL ++F S ++ W QR I +A+G+LYLH++ I+H DIK NIL+DE
Sbjct: 138 VVNESLDKVLFKSNRKSEIDWKQRFEIITGIARGLLYLHEDAPNCIIHRDIKAGNILLDE 197
Query: 130 FWTAKILDFGLAKLPNEDFV-IDKR---DKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
W KI DFG+A+L ED ++ R GYMAPE +SVKADV+ +G+++LE +
Sbjct: 198 KWVPKIADFGMARLYQEDVTHVNTRVAGTNGYMAPEYVMHGVLSVKADVFSFGVLVLELV 257
Query: 186 CCRKNMEIDASKPEEIILTNWVYKCFIN-RELNKLVR--GTKVDKKNLENLVKVGLWCVQ 242
+KN P++ +L W +K + R + L + D ++ V++GL CVQ
Sbjct: 258 SGQKNSSFSMRHPDQTLL-EWAFKLYKKGRTMEILDQDIAASADPDQVKLCVQIGLLCVQ 316
Query: 243 DEPALRPMKCAVMML 257
+P RP V +L
Sbjct: 317 GDPHQRPSMRRVSLL 331
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 9.1e-28, Sum P(2) = 9.1e-28
Identities = 55/124 (44%), Positives = 76/124 (61%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ +GSL +F W +R IAL A+G+ YLH C+ I+HCD+KP+NIL+ +
Sbjct: 591 MNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDH 650
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ KI DFGL+KL N++ F + +GY+APE IS KADVY YG+VLLE +
Sbjct: 651 FQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVS 710
Query: 187 CRKN 190
RKN
Sbjct: 711 GRKN 714
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 303 (111.7 bits), Expect = 7.1e-27, P = 7.1e-27
Identities = 72/182 (39%), Positives = 108/182 (59%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147
W QR ++A+DVAK + YLH +C ILH D+KP+NIL+DE + A + DFGL+KL D
Sbjct: 207 WEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARDES 266
Query: 148 -FVIDKRD-KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNM---EIDASKPEEI- 201
+ D R +GY+APE IS K+DVY YGIVLLE I R+++ E+ +K +++
Sbjct: 267 RVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEVKETKKKKLE 326
Query: 202 ILTNWVYKCFINREL-----NKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255
V + R++ +L+ +VD++ + LV V LWC+Q++ RP M +
Sbjct: 327 YFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCVALWCIQEKSKKRPDMTMVIE 386
Query: 256 ML 257
ML
Sbjct: 387 ML 388
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 1.6e-26, P = 1.6e-26
Identities = 72/188 (38%), Positives = 105/188 (55%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NGSL I + W + +A+ +++G+ YLH+ C I+H DIKPQNILMDE
Sbjct: 409 NGSLDKYISANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLC 468
Query: 133 AKILDFGLAKL-PNEDFVID----KRDKGYMAPECYKRT--PISVKADVYGYGIVLLETI 185
KI DFGLAKL N++ +I + GY+APE + + +S K+DVY YG+V+LE I
Sbjct: 469 PKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMI 528
Query: 186 CCR--KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK--KNLENLVKVGLWCV 241
+ + +E S + WVYK F E+ ++ + D+ K + LV V LWC+
Sbjct: 529 GAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCI 588
Query: 242 QDEPALRP 249
Q P+ RP
Sbjct: 589 QMNPSDRP 596
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 298 (110.0 bits), Expect = 1.9e-26, P = 1.9e-26
Identities = 79/196 (40%), Positives = 114/196 (58%)
Query: 74 GSLTD-IIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL D ++ + P WN R++IAL AKGI YLHDE +PP+++ D+K NIL+D +
Sbjct: 127 GSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEY 186
Query: 132 TAKILDFGLAKL-PNEDFV-IDKR---DKGYMAPECYKRTP-ISVKADVYGYGIVLLETI 185
AK+ DFGLAKL P D + + R GY APE Y+RT ++ K+DVY +G+VLLE I
Sbjct: 187 VAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPE-YQRTGYLTNKSDVYSFGVVLLELI 245
Query: 186 CCRKNMEIDASKPE-EIILTNWVYKCFINR----EL-NKLVRGTKVDKKNLENLVKVGLW 239
R+ ID +P E L W F + +L + L+RG +K+L + V
Sbjct: 246 SGRR--VIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGD-YPEKSLNQAIAVAAM 302
Query: 240 CVQDEPALRPMKCAVM 255
C+ +EP +RP+ V+
Sbjct: 303 CLHEEPTVRPLMSDVI 318
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 301 (111.0 bits), Expect = 7.3e-26, P = 7.3e-26
Identities = 70/190 (36%), Positives = 105/190 (55%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GSL ++ E++ W+QR +I DVA G+ YLH + I+H DIKP N+L+D+
Sbjct: 424 GSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNG 483
Query: 134 KILDFGLAKLPNEDFVIDKRDK----GYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
K+ DFGLAKL F + GY++PE + S +DV+ +GI++LE C R+
Sbjct: 484 KLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRR 543
Query: 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV----KVGLWCVQDEP 245
+ AS P E++LT+WV C+ + L + K D K LE V K+GL+C
Sbjct: 544 PVLPRASSPSEMVLTDWVLDCWEDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVA 603
Query: 246 ALRPMKCAVM 255
A+RP +V+
Sbjct: 604 AVRPSMSSVI 613
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 257 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-15 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-15 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-09 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 0.001 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.002 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.003 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.003 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.003 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.003 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.004 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.004 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.004 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-26
Identities = 42/116 (36%), Positives = 63/116 (54%), Gaps = 9/116 (7%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FW 131
GSL D++ E ++ +RI L + +G+ YLH I+H D+KP+NIL+D
Sbjct: 75 GGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYK-RTPISVKADVYGYGIVLLE 183
K+ DFGL+KL D + K G YMAPE + S K+D++ G++L E
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-21
Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 26/169 (15%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
G L D + + P ++ +IAL + +G+ YLH I+H D+KP+NIL+DE
Sbjct: 80 CEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDE 133
Query: 130 FWTAKILDFGLAKL------PNEDFVIDKRDKGYMAPE-CYKRTPISVKADVYGYGIVLL 182
KI DFGLAK FV YMAPE K DV+ G++L
Sbjct: 134 NGVVKIADFGLAKKLLKSSSSLTTFVGTPW---YMAPEVLLGGNGYGPKVDVWSLGVILY 190
Query: 183 ETIC--------CRKNM-EIDASKPEEIILTNWVYKCFINRELNKLVRG 222
E + + ++ + + + E L++
Sbjct: 191 ELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-19
Identities = 33/121 (27%), Positives = 53/121 (43%), Gaps = 9/121 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
G L D++ +R R + + YLH + I+H D+KP+NIL+DE
Sbjct: 79 CEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHSKG---IVHRDLKPENILLDE 132
Query: 130 FWTAKILDFGLAKLPNEDFVIDKRD--KGYMAPECYKRTPISVKADVYGYGIVLLETICC 187
K+ DFGLA+ + + YMAPE D++ G++L E +
Sbjct: 133 DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
Query: 188 R 188
+
Sbjct: 193 K 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-15
Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 14/117 (11%)
Query: 74 GSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL+ ++ ++ + V + + +G+ YLH I+H DIK NIL+D
Sbjct: 86 GSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDG 138
Query: 132 TAKILDFGLAKLPNEDFVIDKRD--KG---YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG AK + + +G +MAPE + AD++ G ++E
Sbjct: 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-15
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVI 150
+ AL +A+G+ YL + +H D+ +N L+ E KI DFGL++ L ++D+
Sbjct: 103 DLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR 159
Query: 151 DKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
+ K +MAPE K + K+DV+ +G++L E
Sbjct: 160 KRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWE 195
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDF 148
+ + AL +A+G+ YL + +H D+ +N L+ E KI DFGL++ L ++D+
Sbjct: 102 LSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158
Query: 149 VIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
K K +MAPE K + K+DV+ +G++L E
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWE 196
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-15
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 8/99 (8%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ A+ +AKG+ YL +H D+ +N L+ E KI DFGL++ +D
Sbjct: 104 LKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160
Query: 150 IDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ G +MAPE K + K+DV+ +G++L E
Sbjct: 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-15
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
+++AL +AKG+ YL + +H D+ +N L+ E KI DFGL++ ED
Sbjct: 103 DLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR 159
Query: 152 KRDKGY-----MAPECYKRTPISVKADVYGYGIVLLE 183
KR G MAPE K + K+DV+ +G++L E
Sbjct: 160 KRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWE 196
|
Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147
+ + + + KG+ YL + +H D+ +NIL++ KI DFGLAK+ ED
Sbjct: 110 RLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY 166
Query: 148 FVIDKRDKG--YMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNME 192
+V + + + APEC + + S +DV+ +G+ L E +
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-14
Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 11/173 (6%)
Query: 86 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145
RN W +R +IA+ +AK + +LH C P ++ ++ P+ I++D L L L
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-LRLSLPGLLC 833
Query: 146 EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN 205
D Y+APE + I+ K+D+YG+G++L+E + + + + I+
Sbjct: 834 TDTK-CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--E 890
Query: 206 WVYKCFINRELNKLV-----RGTKVDKKNLENLVKVGLWCVQDEPALRPMKCA 253
W C+ + L+ + V++ + ++ + L C +P RP CA
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP--CA 941
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 15/95 (15%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD- 154
+ ++ KG+ YLH I+H DIK NIL+ K++DFGL+ + D +
Sbjct: 103 VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKAR 154
Query: 155 ------KGYMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE P KAD++ GI +E
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 2e-13
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMA 159
+ YLH ILH DIKPQNI + K+ DFG++K+ + + K G Y++
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 160 PECYKRTPISVKADVYGYGIVLLE 183
PE + P + K+D++ G VL E
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 33/114 (28%), Positives = 49/114 (42%), Gaps = 6/114 (5%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
+V+ ++ + YLH I+H DIKP NIL+DE I DF +A D +
Sbjct: 101 QVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157
Query: 152 KR--DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203
GYMAPE R SV D + G+ E + ++ + + I
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-12
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 27/172 (15%)
Query: 84 AERNPYWNQRV-RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+R Q + RI + + +G+ LH++ ILH D+K NIL+ KI D G++K
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK 151
Query: 143 LPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPE 199
+ ++ K G YMAPE +K P S K+D++ G +L E E A +
Sbjct: 152 VLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--ARSMQ 207
Query: 200 EIILTNWVYKCFINRELNKLVRG--TKVDKKNLENLVKVGLWCVQDEPALRP 249
++ K+ RG + ++L +Q +P LRP
Sbjct: 208 DL--------------RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 64.8 bits (156), Expect = 4e-12
Identities = 46/193 (23%), Positives = 71/193 (36%), Gaps = 19/193 (9%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
V GSL D++ + P I + + YLH + I+H DIKP+NIL+D
Sbjct: 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDR 136
Query: 130 F-WTAKILDFGLAKL---PNEDFVIDKRDK------GYMAPECYKRT---PISVKADVYG 176
K++DFGLAKL P I GYMAPE S +D++
Sbjct: 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196
Query: 177 YGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236
GI L E + E + + + + + L + + +
Sbjct: 197 LGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS--PSNPELISKAASDL 254
Query: 237 GLWCVQDEPALRP 249
+ +P R
Sbjct: 255 LKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-12
Identities = 36/93 (38%), Positives = 57/93 (61%), Gaps = 9/93 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKR 153
+IA+ V KG+ YLH++ + I+H D+KP NIL++ K+ DFG++ +L N + K
Sbjct: 104 KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKT 158
Query: 154 DKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
G YMAPE + SVK+D++ G+ L+E
Sbjct: 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 6/116 (5%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL + + + +A VA+G+ YL ++ +H D+ +NIL+ E
Sbjct: 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGED 140
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK---GYMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFGLA+L ED + K + APE S K+DV+ +GI+L E
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYE 196
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKR 153
+IA V KG+ YLH I+H DIKP NIL+ K+ DFG++ +L N +
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGT 162
Query: 154 DKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
G YMAPE + P S+ +DV+ G+ LLE
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q ++ +LDVA+G+ YL + ++H D+ +NIL+ E AK+ DFGLA++ +
Sbjct: 101 QLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
Query: 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K + APE K S K+DV+ YG++L E
Sbjct: 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 46/163 (28%), Positives = 72/163 (44%), Gaps = 27/163 (16%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD 154
++A ++A G+ YL +H D+ +N ++ E T KI DFG+ + E K
Sbjct: 123 QMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 155 KG-----YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK 209
KG +MAPE K + K+DV+ +G+VL E M A +P Y+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE-------MATLAEQP---------YQ 223
Query: 210 CFINRELNKLVRGTKVDKK--NLEN-LVKVGLWCVQDEPALRP 249
N E+ K V N + L+++ C Q P +RP
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 56/185 (30%), Positives = 83/185 (44%), Gaps = 22/185 (11%)
Query: 29 ADIEVLSVAMRGSKCTRIRGGLLLNVP----VRAKLTSVSGKIERPVRNGSLTDI-IFCS 83
D VL + +G+ T I LL NV +R K T VSG I V +D+ + +
Sbjct: 91 PDPVVLKIGQKGT--TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLT 148
Query: 84 AERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
P +Q + I + +G+ YLH + I+H D+K +NI +++ I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 143 LPNEDFVIDKRDKGYM------APECYKRTPISVKADVYGYGIVLLETICCRKNMEIDA- 195
P V+ G APE R + KAD++ GIVL E + + D
Sbjct: 206 FP----VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 196 SKPEE 200
S PEE
Sbjct: 262 STPEE 266
|
Length = 357 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NG L ++ R +Q R + + G+ +LH + ILH DIK N+ +D +
Sbjct: 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDN 139
Query: 133 AKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
KI D G+AKL +++ G Y++PE + P + K+DV+ G+VL E CC
Sbjct: 140 VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTG 197
Query: 190 NMEIDASKPEEIIL 203
DA+ +IL
Sbjct: 198 KHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q++ ALDV +G+ YL E +H D+ +N+L+ E AK+ DFGLAK ++
Sbjct: 103 QQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159
Query: 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K + APE + S K+DV+ +GI+L E
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKRD 154
I KG+ YLH +H DIK NIL++E AK+ DFG++ +L + + KR+
Sbjct: 104 ILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRN 157
Query: 155 K--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + + KAD++ GI +E
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 4/75 (5%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVK 171
+LH D+KP NI +D K+ DFGLAK+ D K G YM+PE K
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 172 ADVYGYGIVLLETIC 186
+D++ G ++ E +C
Sbjct: 191 SDIWSLGCLIYE-LC 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 23/121 (19%)
Query: 74 GSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL D++ ++ + V IA + KG+ YLH + I+H DIKP N+L++
Sbjct: 84 GSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKG 137
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG---------YMAPECYKRTPISVKADVYGYGIVLL 182
KI DFG++K V++ YM+PE + S AD++ G+ LL
Sbjct: 138 EVKIADFGISK------VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLL 191
Query: 183 E 183
E
Sbjct: 192 E 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-10
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG--- 156
+ + Y+H ILH DIK NI + + K+ DFG++K+ ++ + + G
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINREL 216
YM+PE + + K+D++ G VL E + ++ DA+ P ++
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLV-------------- 210
Query: 217 NKLVRG--TKVDKKNLENLVKVGLWCVQDEPALRP 249
K+V+G T V L+ + +Q +P RP
Sbjct: 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 32/109 (29%), Positives = 47/109 (43%), Gaps = 24/109 (22%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN--EDFV-- 149
+ I + I Y+H + +LH D+KP NIL+ F ILD+G A E+ +
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 150 IDKRDKG-----------------YMAPECYKRTPISVKADVYGYGIVL 181
ID ++ YMAPE P S D+Y G++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 12/91 (13%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG----- 156
KG+ YLH+ I+H DIK NIL+D KI DFG++K + + K +
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 157 ----YMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE K+T + KAD++ G +++E
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 9/119 (7%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
+ GSL + + A R Q + +A VA G+ YL + +H D+ +N+L+ E
Sbjct: 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENN 140
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFGLA++ ED + + R+ + APE S+K+DV+ +GI+L E +
Sbjct: 141 ICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 74 GSLTDII-FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
GSLTDII N Q + +V +G+ YLH + ++H DIK NIL+ + +
Sbjct: 100 GSLTDIITQNFVRMNE--PQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGS 154
Query: 133 AKILDFGL-AKLPNEDFVIDKRDK--G---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG A+L E KR+ G +MAPE KR K D++ GI+ +E
Sbjct: 155 VKLADFGFAAQLTKE---KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 9/93 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPN---EDFVI 150
+IA+ V +G+ YL++ I+H DIKP NIL++ K+ DFG++ +L N + FV
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV- 163
Query: 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
YM+PE + +VK+DV+ GI ++E
Sbjct: 164 --GTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 8/131 (6%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
G L I+ ER + + + + GIL+LH I++ D+KP+N+L+D+
Sbjct: 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNC 134
Query: 134 KILDFGLAKLPNEDFVIDKR--DKGYMAPECYKRTPISVKADVYGYGIVLLETICCR--- 188
++ D GLA + I +R GYMAPE K P S D + G + E + R
Sbjct: 135 RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
Query: 189 KNMEIDASKPE 199
K+ + +K E
Sbjct: 195 KDHKEKVAKEE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 38/115 (33%), Positives = 65/115 (56%), Gaps = 13/115 (11%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GSL D + A R P N +I++ V +G+ YL ++ + I+H D+KP NIL++
Sbjct: 84 GSL-DQVLKKAGRIPE-NILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEI 139
Query: 134 KILDFGLA-----KLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG++ + N FV + YM+PE + T +V++D++ G+ L+E
Sbjct: 140 KLCDFGVSGQLIDSMANS-FV---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-09
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG--- 156
V +G+ YLH++ ++H DIK NIL + K+ DFG+A N+ D G
Sbjct: 108 VLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPY 164
Query: 157 YMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE + + S +D++ G ++E
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 6e-09
Identities = 32/122 (26%), Positives = 52/122 (42%), Gaps = 20/122 (16%)
Query: 89 YWNQRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140
+ ++ R + + A+ + YLH I++ D+KP+NIL+D K+ DFGL
Sbjct: 83 HLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGL 139
Query: 141 AK-LPNEDFVIDK--RDKGYMAPECYKRTPISVKADVYGYGIVLLETIC------CRKNM 191
AK L +E + Y+APE D + G++L E +
Sbjct: 140 AKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 192 EI 193
EI
Sbjct: 200 EI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 7e-09
Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 26/116 (22%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL------------ 143
A ++ + YLH + I+H D+KP+NIL+D+ KI DFG AK+
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 144 -PNEDFVIDKRDKG----------YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
++++ Y++PE P +D++ G ++ + + +
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKRD 154
IA+ K + YL +E + I+H D+KP NIL+D K+ DFG++ +L D + RD
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRD 167
Query: 155 KG---YMAPE---CYKRTPISVKADVYGYGIVLLE 183
G YMAPE R V++DV+ GI L E
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 20/101 (19%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG--------LAKLPNE 146
+IA+ + K + YLH + ++H D+KP N+L++ K+ DFG +AK
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160
Query: 147 DFVIDKRDKGYMAPE----CYKRTPISVKADVYGYGIVLLE 183
ID K YMAPE + VK+DV+ GI ++E
Sbjct: 161 --TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 34/98 (34%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
WN V++ L + YLH E I+H D+ P NI++ E I DFGLAK +
Sbjct: 116 WNIFVQMVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 150 IDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLET 184
+ G Y PE K P KADV+ +G +L +
Sbjct: 170 L-TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 33/86 (38%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YM 158
G+ YLHD +H DIK NIL+D K+ DFG+AK E F K KG +M
Sbjct: 113 LGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSFKGSPYWM 168
Query: 159 APECYKRT-PISVKADVYGYGIVLLE 183
APE + + AD++ G +LE
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLE 194
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 13/101 (12%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDKR 153
L + +G+ YLH I+H DIKP NI +D K+ DFG A L N + +
Sbjct: 103 VYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 154 DKG------YMAPECYKRTPISVK---ADVYGYGIVLLETI 185
+ YMAPE AD++ G V+LE
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 13/77 (16%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG--------YMAPECYKRT 166
I++ D+KP+NIL+DE K+ DFGL+K ID K YMAPE R
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKES-----IDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 167 PISVKADVYGYGIVLLE 183
+ AD + +G+++ E
Sbjct: 174 GHTQSADWWSFGVLMFE 190
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 34/117 (29%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
NGSL D + N+ + +A +A+G+ ++ +H D++ NIL+ E
Sbjct: 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLC 140
Query: 133 AKILDFGLAKL-PNEDFVIDKRDK---GYMAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFGLA+L + ++ + K + APE ++K+DV+ +GI+L E +
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKRDK 155
A ++ G+ LH E I++ D+KP+NIL+D++ +I D GLA ++P + + +
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164
Query: 156 -GYMAPECYKRTPISVKADVYGYGIVLLETI 185
GYMAPE K + D +G G ++ E I
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 26/116 (22%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
S NP + L VAKG+ YL +H D+ +N ++DE +T K+ DFGLA+
Sbjct: 90 SETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
Query: 143 LPNEDFVIDKRDKGY---------------MAPECYKRTPISVKADVYGYGIVLLE 183
D DK Y MA E + + K+DV+ +G++L E
Sbjct: 147 --------DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 38/123 (30%), Positives = 58/123 (47%), Gaps = 17/123 (13%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL D + + Q V +A +A+G+ YL +H D+ +NIL+ E
Sbjct: 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENL 140
Query: 132 TAKILDFGLAKLPNED---------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLL 182
KI DFGLA+L +D F I + APE ++K+DV+ +GI+L
Sbjct: 141 VCKIADFGLARLIEDDEYTAREGAKFPIK-----WTAPEAANYGRFTIKSDVWSFGILLT 195
Query: 183 ETI 185
E +
Sbjct: 196 EIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
G+LTDI+ + Q + L V K + +LH + ++H DIK +IL+
Sbjct: 101 GALTDIVTHTRMNEE---QIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRV 154
Query: 134 KILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG +++ K G +MAPE R P + D++ GI+++E +
Sbjct: 155 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKRDK 155
A ++ G+ LH E ++ D+KP+NIL+D++ +I D GLA K+P + + +
Sbjct: 108 AAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164
Query: 156 -GYMAPECYKRTPISVKADVYGYGIVLLETI 185
GYMAPE ++ D +G G ++ E I
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
++ +LDV + + YL +H D+ +N+L+ E AK+ DFGL K + K
Sbjct: 105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+ APE + S K+DV+ +GI+L E
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 1e-07
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ Y H ILH D+KPQNIL++ K+ DFGLA+
Sbjct: 109 RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 17/95 (17%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL-AKLPNEDFVIDKRDK--- 155
+ + + +LH ++H D+K NIL+ K+ DFG+ AK + KRD
Sbjct: 112 MLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---QKRDTFIG 165
Query: 156 --GYMAPE---C--YKRTPISVKADVYGYGIVLLE 183
+MAPE C +K P KAD++ GI L+E
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 34/152 (22%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DFVIDKRDKG- 156
V +G+ YLH + ILH D+K N+L+D KI DFG++K ++ D + +G
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 157 --YMAPECY--KRTPISVKADVYGYGIVLLETICCRK---NME-------IDASK----- 197
+MAPE S K D++ G V+LE R+ + E + +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233
Query: 198 PEEIILT------NWVYKCFINRELNKLVRGT 223
P ++ + +++ CF +N R T
Sbjct: 234 PPDVSMNLSPVALDFLNACF---TINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKR 153
RIA+ V KG+ YL ILH D+KP N+L++ K+ DFG++ +L N
Sbjct: 99 RIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLE 183
YMAPE + +DV+ GI +E
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 30/94 (31%), Positives = 56/94 (59%), Gaps = 11/94 (11%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-----KLPNEDFV 149
++++ V +G+ YL ++ + I+H D+KP NIL++ K+ DFG++ + N FV
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FV 163
Query: 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+ YM+PE + T SV++D++ G+ L+E
Sbjct: 164 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 31/99 (31%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q ++ A DVA G+ YL ++ +H D+ +N+L+ E +KI DFGL++ E+ +
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV- 173
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ G +MA E + + K+DV+ +G++L E +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 34/114 (29%), Positives = 63/114 (55%), Gaps = 11/114 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-----KLPNEDFV 149
++++ V KG+ YL ++ + I+H D+KP NIL++ K+ DFG++ + N FV
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FV 163
Query: 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203
+ YM+PE + T SV++D++ G+ L+E R + +K E++
Sbjct: 164 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 85 ERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143
E P +V+ + KG+ Y+H I+H D+KP N+L+ KI DFGLA+L
Sbjct: 92 EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARL 148
Query: 144 PNEDFVIDKRD-------KGYMAPE 161
+E+ + R + Y APE
Sbjct: 149 FSEE---EPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
S +R ++ + ALD YLH E +++ D+K +N+++D+ KI DFGL K
Sbjct: 93 SEDRARFYGAEIVSALD------YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 143 LPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
+D K G Y+APE + D +G G+V+ E +C R
Sbjct: 145 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAP 160
GI +LH I+H D+KP NI++ T KILDFGLA+ F++ + Y AP
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 161 ECYKRTPISVKADVYGYGIVLLETIC 186
E D++ G ++ E I
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q I ++ KG+ YLH E + +H DIK N+L+ E K+ DFG+A + +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 152 KRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE K++ KAD++ GI +E
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 12/91 (13%)
Query: 99 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA------KLPNEDFVIDK 152
++ KG+ YLH E + +H DIK N+L+ E K+ DFG+A ++ FV
Sbjct: 109 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--- 162
Query: 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE +++ KAD++ GI +E
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 4e-07
Identities = 42/151 (27%), Positives = 62/151 (41%), Gaps = 28/151 (18%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK--------GY 157
YLH+ I++ D+KP+N+L+D K++DFG AK + K Y
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK------KLKSGQKTWTFCGTPEY 158
Query: 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217
+APE D + GI+L E + R D P EI Y I +
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI------YN-DILKGNG 211
Query: 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248
KL +DK ++L+K L + P R
Sbjct: 212 KLEFPNYIDKAA-KDLIKQLL---RRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI DFGL++ E +V
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV-- 178
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ G +MA E + + +DV+ YG++L E +
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-07
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFVIDKRD 154
I +V G+ YLH+E + +H DIK NIL+ E K+ DFG++ +L + KR+
Sbjct: 103 ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRN 156
Query: 155 K--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE K++ KAD++ GI +E
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
+ RI V KG+ +L +E I+H D+KP N+L++ K+ DFG++ N +
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASL 157
Query: 151 DKRDKG---YMAPECYK------RTPISVKADVYGYGIVLLE 183
K + G YMAPE K +V++DV+ G+ +LE
Sbjct: 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 24/103 (23%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD 154
++ + + K + YL ++ ++H D+KP NIL+D K+ DFG++ ++D +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSKA 170
Query: 155 K-------GYMAPECYKRTPIS-------VKADVYGYGIVLLE 183
K YMAPE R ++ADV+ GI L+E
Sbjct: 171 KTRSAGCAAYMAPE---RIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 9/118 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G+LTDI+ + Q + L V + + YLH++ ++H DIK +IL+
Sbjct: 101 LEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSD 154
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG +++ K G +MAPE R P + D++ GI+++E I
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--D 154
A ++ G+ LH E I++ D+KP+NIL+D+ +I D GLA E I R
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 155 KGYMAPECYKRTPISVKADVYGYGIVLLETI 185
GYMAPE K + D + G +L E I
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-07
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155
I ++ KG+ YLH E + +H DIK N+L+ E K+ DFG+A + +
Sbjct: 106 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 156 G---YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE K++ KAD++ GI +E
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-07
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLPNEDFVIDK 152
V+I+L G+ ++HD ILH DIK QNI + + AK+ DFG+A+ N+ +
Sbjct: 108 VQISL----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 153 RDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCRKN 190
G Y++PE + P + K D++ G VL E +C K+
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYE-LCTLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 99 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDKG 156
+V G+ LH I+H DIKP+N+L+D+ K+ DFGL++ L N+ FV
Sbjct: 105 EVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV---GTPD 158
Query: 157 YMAPECYKRTPISVKADVYGYGIVLLE 183
Y+APE +D + G V+ E
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-07
Identities = 41/183 (22%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + + + +A+G+ ++ +H D++ NIL+
Sbjct: 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS 138
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLETIC 186
KI DFGLA++ ++ + + APE ++K+DV+ +GI+L+E +
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
+ S PE I R L + R + + E L + + C ++ P
Sbjct: 199 YGRIPYPGMSNPEVI------------RALERGYRMPRPENCP-EELYNIMMRCWKNRPE 245
Query: 247 LRP 249
RP
Sbjct: 246 ERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-06
Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ YLH ILH D+KP N+L+ K+ DFGLA+
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 25/163 (15%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ A +++G+ YL E ++H D+ +N+L+ E KI DFGL++ E+ KR
Sbjct: 130 ISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY 208
KG +MA E + ++DV+ +G++L E + N PE
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-PYPGIAPE--------- 236
Query: 209 KCFINRELNKLVRGTKVDKKN--LENLVKVGLWCVQDEPALRP 249
R N L G ++++ E + + L C + EP RP
Sbjct: 237 -----RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI DFGL++ ++ +
Sbjct: 113 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV- 166
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ G +MA E + + +DV+ YG++L E +
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 32/121 (26%), Positives = 61/121 (50%), Gaps = 20/121 (16%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV-RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
+G L+D + A+R + + + + LDV +G+ YL ++H D+ +N L+ E
Sbjct: 83 HGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQ 137
Query: 132 TAKILDFGLAKLPNEDFVID---------KRDKGYMAPECYKRTPISVKADVYGYGIVLL 182
K+ DFG+ + FV+D K + +PE + + S K+DV+ +G+++
Sbjct: 138 VVKVSDFGMTR-----FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 183 E 183
E
Sbjct: 193 E 193
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPEC 162
++HD ILH DIK QNI + + T K+ DFG+A++ N + + G Y++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 163 YKRTPISVKADVYGYGIVLLETICCRKNME 192
+ P + K+D++ G VL E + E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 88 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
P + +++A ++A G+ YL+ + +H D+ +N ++ +T KI DFG+ + E
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 148 FVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202
K KG +MAPE K + +D++ +G+VL E A +P
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL-------AEQP---- 221
Query: 203 LTNWVYKCFINRELNKLVR-GTKVDK-----KNLENLVKVGLWCVQDEPALRPM 250
Y+ N ++ K V G +D+ + + +L+++ C Q P +RP
Sbjct: 222 -----YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GSL D + R V +A VA G+ Y+ +H D++ NIL+ +
Sbjct: 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVC 141
Query: 134 KILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E +
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 13/98 (13%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK- 155
A + G+ +LH I++ D+KP+N+L+D+ +I D GLA + K+ K
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV----ELKGGKKIKG 153
Query: 156 -----GYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
GYMAPE + D + G L E I R
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 9/98 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVI 150
Q + A + +G+ YLH + +H D+ +N+L+D KI DFGLAK +P
Sbjct: 108 QLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164
Query: 151 DKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
R+ G + A EC K S +DV+ +G+ L E
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 14/98 (14%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDK-- 155
+ + YLH I+H D+KP NIL+D K+ DFGL+K L ++ +K
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 156 -------GYMAPECYKRTPISVKADVYGYGIVLLETIC 186
Y+APE S D + G +L E +
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG--- 156
V KG+ YLH + +H DIK NIL+ E + KI DFG++ + ++ +
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167
Query: 157 ----YMAPECYK-RTPISVKADVYGYGIVLLE 183
+MAPE + KAD++ +GI +E
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 16/112 (14%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVI 150
R+ L V + H++ I+H D+KPQNI++ AK+LDFG+ L
Sbjct: 82 GRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 151 DKR----------DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNME 192
D Y APE + P++ +D+Y +G++ LE + ++ ++
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL--PNEDFVIDKRD 154
+ +AKG+ YL E ++H D+ +N+L+ KI DFGLAKL +E +
Sbjct: 115 CVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171
Query: 155 K---GYMAPECYKRTPISVKADVYGYGIVLLE 183
K +MA E + K+DV+ YG+ + E
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 17/103 (16%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID---- 151
+ DV + + YL +H D+ +N L+ E K+ DFGLA+ +V+D
Sbjct: 105 MCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR-----YVLDDQYT 156
Query: 152 -----KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
K + PE + + S K+DV+ +G+++ E K
Sbjct: 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 13/89 (14%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL------PNEDFVIDKRDK 155
+G+ + H ILH D+KP+N+L++ K+ DFGLA+ P +V+ +
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-- 163
Query: 156 GYMAPEC-YKRTPISVKADVYGYGIVLLE 183
Y APE S D++ G + E
Sbjct: 164 -YRAPELLLGDKGYSTPVDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 18/112 (16%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
S +R ++ + AL YLH C+ +++ D+K +N+++D+ KI DFGL K
Sbjct: 93 SEDRARFYGAEIVSALG------YLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 143 LPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
E K Y+APE + D +G G+V+ E +C R
Sbjct: 144 ---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAP 160
GI +LH I+H D+KP NI++ T KILDFGLA+ F++ + Y AP
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 161 ECYKRTPISVKADVYGYGIVLLETIC 186
E D++ G ++ E I
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 29/117 (24%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
GSL D + + + + +A+G+ Y+ + +H D++ N+L+ E
Sbjct: 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLM 141
Query: 133 AKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFGLA++ ++ + + APE ++K+DV+ +GI+L E +
Sbjct: 142 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 30/185 (16%)
Query: 74 GSLTDIIFCSAERNPYWN--QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL D F E Y Q V +A +A G+ Y+ +H D++ NIL+ E
Sbjct: 85 GSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENL 139
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLETICC 187
K+ DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E
Sbjct: 140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE---- 195
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRE-LNKLVRGTKV--DKKNLENLVKVGLWCVQDE 244
+ P Y +NRE L+++ RG ++ + E+L + C + E
Sbjct: 196 ---LTTKGRVP---------YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243
Query: 245 PALRP 249
P RP
Sbjct: 244 PEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 10/107 (9%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG-LAKLPNEDFVIDKRDKG-- 156
+A+ +L +H + +H DIKP+N+L+D K+ DFG A+L V K G
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 157 -YMAPEC------YKRTPISVKADVYGYGIVLLETICCRKNMEIDAS 196
Y+APE + V+ D + G++ E I R S
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 27/170 (15%)
Query: 88 PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
P + +++A ++A G+ YL+ +H D+ +N ++ E +T KI DFG+ + E
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 148 FVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202
K KG +M+PE K + +DV+ +G+VL E + A +P
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE-------IATLAEQP---- 221
Query: 203 LTNWVYKCFINRELNKLV-RGTKVDKKN--LENLVKVGLWCVQDEPALRP 249
Y+ N ++ + V G +DK + + L ++ C Q P +RP
Sbjct: 222 -----YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 9/118 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
++ G+LTDI+ ++ Q + V + + YLH + ++H DIK +IL+
Sbjct: 100 LQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLD 153
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG ++D K G +MAPE RTP + D++ GI+++E +
Sbjct: 154 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
NQ V + +A + YLH E ILH D+K QN+ + K+ D G+A++ +
Sbjct: 102 NQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158
Query: 151 DKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
G YM+PE + P + K+DV+ G + E
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143
+G+ +LH I+H D+KPQNIL+ KI DFGLA++
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 18/100 (18%)
Query: 94 VRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVI 150
+R + VA+G+ +L + C +H D+ +N+L+ + AKI DFGLA+ + + ++V+
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 151 DKRDKG-------YMAPECYKRTPISVKADVYGYGIVLLE 183
KG +MAPE +V++DV+ YGI+L E
Sbjct: 271 ----KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 31/138 (22%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDKRDKG-- 156
V+ G+ YL +H D+ +N+L+ AKI DFGL+K L +D R G
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLET-------------------ICCRKNMEID 194
+ APEC S ++DV+ YGI + E I K ++
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP 220
Query: 195 ASKPEEI---ILTNWVYK 209
A P E+ + W+YK
Sbjct: 221 AECPPEMYALMKDCWIYK 238
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q V A +++ G+ +LH I++ D+K N+++D KI DFG+ K D V
Sbjct: 102 QAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158
Query: 152 KRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ G Y+APE P D + YG++L E +
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 104 ILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------Y 157
+L +H ++H DIK NIL+ K+ DFG +K+ V D + Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDDVGRTFCGTPYY 211
Query: 158 MAPECYKRTPISVKADVYGYGIVLLETICCRK 189
+APE ++R P S KAD++ G++L E + ++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 16/93 (17%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159
+ +G+ Y+H ++H D+KP NIL++E KI DFGLA+ + D + GY++
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR------IQDPQMTGYVS 167
Query: 160 PECYKRTPI-------SVKADVYGYGIVLLETI 185
Y+ I V+ D++ G + E +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 15/89 (16%)
Query: 104 ILYLHDECEPPILHCDIKPQNILMDEFWT-AKILDFGLAKLPNEDFVIDKRDKG------ 156
+L LH ILH D+K QNIL+D+ KI DFG++K ++ + K
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK------ILSSKSKAYTVVGT 164
Query: 157 --YMAPECYKRTPISVKADVYGYGIVLLE 183
Y++PE + P + K+D++ G VL E
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 29/121 (23%), Positives = 51/121 (42%), Gaps = 24/121 (19%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
R G L + +FC + + G+ YLH+ C ++H DIK N+++
Sbjct: 95 RFGPLPEPVFCKYTKQ------------ILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139
Query: 132 TAKILDFGLAK--------LPNEDFVIDKRDKGY-MAPECYKRTPISVKADVYGYGIVLL 182
K++DFG A+ + + + Y MAPE + K+D++ G +
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 183 E 183
E
Sbjct: 200 E 200
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
S +R ++ + ALD YLH I++ D+K +N+++D+ KI DFGL K
Sbjct: 93 SEDRTRFYGAEIVSALD------YLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 143 LPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
D K G Y+APE + D +G G+V+ E +C R
Sbjct: 144 EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 98 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG- 156
+ +AKG++YL E ++H D+ +N+L+ KI DFGLA+L D D G
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 157 ----YMAPECYKRTPISVKADVYGYGIVLLE 183
+MA EC + ++DV+ YG+ + E
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWE 203
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 18/94 (19%)
Query: 100 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDKG 156
VAKG+ +L + C +H D+ +N+L+ KI DFGLA+ + + ++V+ KG
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV----KG 201
Query: 157 -------YMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE + ++DV+ YGI+L E
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-06
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKR 153
A +VA I YLH I++ D+KP+NIL+D + DFGL K P E
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE ++ P D + G VL E +
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-06
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 16/106 (15%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA---KILDFGLAKLPNEDFVI 150
+ + +G+ YLH+ I+H D+K N+L+D T +I DFG A
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTG 160
Query: 151 DKRDKG-------YMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
+G +MAPE + DV+ G V++E + K
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE-MATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-06
Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 16/100 (16%)
Query: 93 RVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA---------KL 143
++ IA VA G+ YL + +H D+ +N L+ E KI DFGL+ K
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 144 PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
D + + +M PE + ++DV+ YG+VL E
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNED--FVIDKR 153
A+ +A G+ YL + +H D+ +NIL+ KI DFGL + LP + +V+++
Sbjct: 103 AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 154 DK---GYMAPECYKRTPISVKADVYGYGIVLLE 183
K + APE + S +DV+ +G+ L E
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 18/97 (18%)
Query: 97 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKR 153
+ VA+G+ +L +C +H D+ +NIL+ E KI DFGLA+ + D+V
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---- 230
Query: 154 DKG-------YMAPECYKRTPISVKADVYGYGIVLLE 183
KG +MAPE + ++DV+ +G++L E
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 9/118 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G+LTDI+ + Q + L V K + LH + ++H DIK +IL+
Sbjct: 99 LEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHD 152
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG +++ K G +MAPE R P + D++ GI+++E +
Sbjct: 153 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 7/116 (6%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GSL D + + Q V +A +A G+ Y+ +H D++ NIL+ +
Sbjct: 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVC 141
Query: 134 KILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E +
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 42/121 (34%), Positives = 53/121 (43%), Gaps = 24/121 (19%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIA---LDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS +DI+ + P Q V IA +G+ YLH +H DIK NIL+ E
Sbjct: 99 GSASDIL--EVHKKPL--QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEP 151
Query: 131 WTAKILDFGLAKL--PNEDFVIDKRDKG---YMAPE---CYKRTPISVKADVYGYGIVLL 182
T K+ DFG A L P FV G +MAPE K DV+ GI +
Sbjct: 152 GTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 183 E 183
E
Sbjct: 206 E 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 92 QRVRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
Q V+ ALD A G+ YL + C +H D+ +N L+ E KI DFG+++ ++
Sbjct: 94 QLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149
Query: 151 DKRDK----GYMAPECYKRTPISVKADVYGYGIVLLET 184
K + APE S ++DV+ YGI+L ET
Sbjct: 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET 187
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 27/87 (31%), Positives = 39/87 (44%), Gaps = 15/87 (17%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G---YMA 159
YLH I++ D+KP+N+L+D KI DFG AK + R G Y+A
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK------RVKGRTYTLCGTPEYLA 166
Query: 160 PECYKRTPISVKADVYGYGIVLLETIC 186
PE D + GI++ E +
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 12/104 (11%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK- 155
A ++ G+ +LH E I++ D+K N+L+D KI DFG+ K E +
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 156 -----GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194
Y+APE P D + G++L E + + E D
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG 156
A ++A G+ +LH + I++ D+K N+++D KI DFG+ K D V K G
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG 163
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE P D + +G++L E +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG 156
A ++A + YLH I++ D+KP+NIL+D + DFGL K E K
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTST 155
Query: 157 ------YMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE ++ P D + G VL E +
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 16/96 (16%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159
+ +G+ Y+H I+H D+KP N+ ++E KILDFGLA+ +++ GY+A
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------GYVA 179
Query: 160 PECYKRTPI-------SVKADVYGYGIVLLETICCR 188
Y+ I + D++ G ++ E + R
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
+G+ Y+H + ILH D+KPQN+L+ K+ DFGLA+ +P++ + + Y
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170
Query: 159 APEC-YKRTPISVKADVYGYGIVLLETI 185
P+ T S D++G G + +E +
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 25/60 (41%), Positives = 31/60 (51%), Gaps = 11/60 (18%)
Query: 91 NQRVR--------IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
N V+ L + +GI YLH+ ILH DIK NIL+D KI DFGLA+
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL--PNEDFVIDKRD 154
A VA G+ YL +H D+ +N+L+ AKI DFG+++ D+
Sbjct: 101 AHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157
Query: 155 -----KGYMAPECYKRTPISVKADVYGYGIVLLE 183
K Y APEC S K+DV+ YG+ L E
Sbjct: 158 GRWPLKWY-APECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V A VA+G+ +L + +H D+ +N+L+ E KI DFGLA+ + K
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + ++DV+ +G++L E
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147
Q+++ A+ + KG+ YL +H D+ +N+L++ KI DFGL K D
Sbjct: 110 QQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 148 FVIDKRDKG--YMAPECYKRTPISVKADVYGYGIVLLE--TIC 186
V D D + APEC ++ + +DV+ +G+ L E T C
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
+G+ Y H + ILH D+KPQN+L++E K+ DFGLA+ +P + + + Y
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYR 170
Query: 159 APEC-YKRTPISVKADVYGYGIVLLETICCR 188
P+ T S D++G G +L E R
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK--RDKGYMA 159
+G+ +LH C I+H D+KP+NIL+ K+ DFGLA++ + + Y A
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 160 PECYKRTPISVKADVYGYGIVLLE 183
PE ++ + D++ G + E
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 100 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRDK- 155
VAKG+ +L + C +H D+ +NIL+ KI DFGLA+ D +V+ +
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 156 --GYMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE + ++DV+ YGI+L E
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWE 308
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-05
Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148
+G+ YLH ++H D+KP NIL++ KI DFGLA+ + D
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAP 160
GI +LH I+H D+KP NI++ T KILDFGLA+ +F++ + Y AP
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 161 ECYKRTPISVKADVYGYGIVLLETI 185
E D++ G ++ E +
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
+ ++++LD A G+ YL + +H D+ +N L+ E KI DFG+++ E+ I
Sbjct: 93 KKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGI 147
Query: 151 DKRDKG-------YMAPECYKRTPISVKADVYGYGIVLLET 184
G + APE + ++DV+ YGI+L ET
Sbjct: 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 107 LHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAPECYK 164
L D I++ D+KP+NIL+D+ +I D GLA E + R GYMAPE
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174
Query: 165 RTPISVKADVYGYGIVLLETI 185
+ D +G G ++ E I
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 12/93 (12%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK- 155
A ++A G+ +LH + I++ D+K N+++D KI DFG+ K E+ K +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 156 -----GYMAPECYKRTPISVKADVYGYGIVLLE 183
Y+APE P D + +G++L E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+ ER ++ + AL+ YLH +++ DIK +N+++D+ KI DFGL K
Sbjct: 93 TEERARFYGAEIVSALE------YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 143 LPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
D K G Y+APE + D +G G+V+ E +C R
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
+G+ Y H +LH D+KPQN+L++E K+ DFGLA+ +P + + + Y
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 159 APEC-YKRTPISVKADVYGYGIVLLETICCR 188
P+ T S + D++G G + E R
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 29/90 (32%), Positives = 38/90 (42%), Gaps = 15/90 (16%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------ 156
G+ YLH I+H DIK NIL D K+ DFG +K I G
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ---TICSSGTGMKSVTG 169
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLE 183
+M+PE KADV+ G ++E
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVE 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
+G+ Y+H ILH D+KPQN+L+ + K+ DFGLA+ +P+ + + Y
Sbjct: 114 RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYR 170
Query: 159 APEC-YKRTPISVKADVYGYGIVLLETI 185
P+ T S D++G G + +E I
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 15/103 (14%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-----TAKILDFGLAK-LPNED 147
+ I LDVAKG +YL +H D+ +N L+ E KI DFGLA+ + D
Sbjct: 109 LDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
Query: 148 FVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K +G +MAPE + ++DV+ +G+++ E +
Sbjct: 166 YY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 11/117 (9%)
Query: 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140
+ +A+RN + I V + I YLH E I+H DIK +NI ++ + DFG
Sbjct: 172 YLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGA 228
Query: 141 AKLPNEDFVIDKRDKGYM------APECYKRTPISVKADVYGYGIVLLETICCRKNM 191
A P + + + G+ APE R P D++ GIVL E C ++
Sbjct: 229 ACFPVD--INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 7/45 (15%)
Query: 103 GILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKL 143
G+ YLH +LH D+KP NIL+ E KI D GLA+L
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+GI Y H +LH D+KPQN+L+D K+ DFGLA+
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 4e-05
Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ YLH ILH DIK NIL++ K+ DFGLA+
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--- 153
A ++ G+ ++H+ +++ D+KP NIL+DE +I D GLA DF K
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS 155
Query: 154 --DKGYMAPECYKR-TPISVKADVYGYGIVLLETI 185
GYMAPE ++ T AD + G +L + +
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 16/109 (14%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDKRDKG-- 156
+ KG+ YL +H D+ +NIL++ KI DFGL K LP + R+ G
Sbjct: 117 ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLE--TICCRKNMEIDASKPEE 200
+ APE + SV +DV+ +G+VL E T + S P E
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS-----DKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 6/69 (8%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155
+A + GI YLH I+H DIKP N+L++ KI DFG++++ +
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
Query: 156 G---YMAPE 161
G YM+PE
Sbjct: 230 GTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAP 160
GI +LH I+H D+KP NI++ T KILDFGLA+ F++ + Y AP
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 161 ECYKRTPISVKADVYGYGIVLLETI 185
E D++ G ++ E +
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 12/69 (17%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161
+G+ YLH ILH DIKP N+L++ KI DFGLA++ E+ + +M E
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV--EEP----DESKHMTQE 164
Query: 162 C---YKRTP 167
Y R P
Sbjct: 165 VVTQYYRAP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFV--- 149
++ +D+A G+ YL + +H D+ +N ++ E T + DFGL+ K+ + D+
Sbjct: 116 LKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 150 -IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
I K ++A E + K+DV+ +G+ + E
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 207
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 16/93 (17%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTA-KILDFGLAK---LPNEDFVIDKRDKGY 157
+GI Y H +LH D+KPQN+L+D A K+ DFGLA+ +P F + Y
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169
Query: 158 MAPE-----CYKRTPISVKADVYGYGIVLLETI 185
APE + TP+ D++ G + E +
Sbjct: 170 RAPEILLGSRHYSTPV----DIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-05
Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED------ 147
+ +A ++ + YL + +H D+ +N L+ E K+ DFGL++L D
Sbjct: 107 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163
Query: 148 ---FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
F I + APE S+K+DV+ +G++L E
Sbjct: 164 GAKFPIK-----WTAPESLAYNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 94 VRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFV 149
V+I L + +G+ Y H +LH D+KPQN+L++E K+ DFGLA+ +P + +
Sbjct: 106 VKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162
Query: 150 IDKRDKGYMAPEC-YKRTPISVKADVYGYGIVLLETICCR 188
+ Y P+ + S + D++G G + E R
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 35/129 (27%), Positives = 64/129 (49%), Gaps = 27/129 (20%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVR------IALDVAKGILYLHDECEPPILHCDIKPQNI 125
GS+TD++ + +R++ I + +G+ YLH+ ++H DIK QNI
Sbjct: 92 GGGSVTDLV----KGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNI 144
Query: 126 LMDEFWTAKILDFGL-AKLPNEDFVIDKRDKG-----YMAPE---C-YKRTP-ISVKADV 174
L+ + K++DFG+ A+L + + +R+ +MAPE C + ++DV
Sbjct: 145 LLTKNAEVKLVDFGVSAQLDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201
Query: 175 YGYGIVLLE 183
+ GI +E
Sbjct: 202 WSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 27/74 (36%), Positives = 38/74 (51%), Gaps = 7/74 (9%)
Query: 92 QRVRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL---PNED 147
RVR L + +GI + H I+H DIKP+NIL+ + K+ DFG A+ P E
Sbjct: 100 SRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156
Query: 148 FVIDKRDKGYMAPE 161
+ + Y APE
Sbjct: 157 YTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+ L + +G+ YLH+ I+H D+K N+L+ + KI DFGLA+
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--- 153
A ++ G+ ++H+ +++ D+KP NIL+DE +I D GLA DF K
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHAS 155
Query: 154 --DKGYMAPECY-KRTPISVKADVYGYGIVLLE 183
GYMAPE K AD + G +L +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 14/90 (15%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161
KG+ Y+H I+H D+KP N+ ++E KILDFGLA+ + + + Y APE
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPE 185
Query: 162 C------YKRTPISVKADVYGYGIVLLETI 185
Y +T D++ G ++ E +
Sbjct: 186 VILNWMHYTQT-----VDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 97 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKR 153
+ VAKG+ +L +C +H D+ +NIL+ E KI DFGLA+ + D+V K
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKG 239
Query: 154 DK----GYMAPECYKRTPISVKADVYGYGIVLLE 183
D +MAPE ++++DV+ +G++L E
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 273
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 5/81 (6%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDKRDKGYMAPECYK 164
YLH + I++ D+KP+N+L+D K+ DFG AK +P+ F + + Y+APE +
Sbjct: 133 YLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE-YLAPEVIQ 188
Query: 165 RTPISVKADVYGYGIVLLETI 185
D + G++L E I
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 54/197 (27%), Positives = 77/197 (39%), Gaps = 52/197 (26%)
Query: 69 RPVRNGSLT--DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 126
RP R SLT D++FC A DVAKG YL E +H DI +N L
Sbjct: 106 RPERPSSLTMKDLLFC--------------ARDVAKGCKYLE---ENHFIHRDIAARNCL 148
Query: 127 MDEFW---TAKILDFGLAKLPNEDFVIDKRDKG--------YMAPECYKRTPISVKADVY 175
+ AKI DFG+A+ + + KG +M PE + + K DV+
Sbjct: 149 LTCKGPGRVAKIADFGMAR---DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVW 205
Query: 176 GYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE-LNKLVRGTKVDK-KNLENL 233
+G++L E L Y N+E + + G ++D K
Sbjct: 206 SFGVLLWEIFS----------------LGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGP 249
Query: 234 V-KVGLWCVQDEPALRP 249
V ++ C Q P RP
Sbjct: 250 VYRIMTDCWQHTPEDRP 266
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDK 152
V A VA+G+ YL + +H D+ +N+L+ E KI DFGLA+ + N D+ K
Sbjct: 137 VSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY-KK 192
Query: 153 RDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + ++DV+ +G++L E
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 9/89 (10%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
KGI + H E +LH D+KPQN+L+++ K+ DFGLA+ +P F + Y
Sbjct: 111 KGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR 167
Query: 159 APECY--KRTPISVKADVYGYGIVLLETI 185
AP+ RT S D++ G ++ E I
Sbjct: 168 APDVLLGSRT-YSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 98 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG- 156
+ +AKG+ YL + ++H D+ +N+L+ KI DFGLAKL D + G
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 157 ----YMAPECYKRTPISVKADVYGYGIVLLE 183
+MA E + ++DV+ YG+ + E
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWE 203
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK-RDKG-- 156
V+ G+ YL E +H D+ +N+L+ AKI DFGL+K D K + G
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLE 183
+ APEC S K+DV+ +G+++ E
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 13/117 (11%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFV 149
Q V +A+ +A G+ YLH ++H DI +N ++DE KI D L++ P +
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 150 I---DKRDKGYMAPECYKRTPISVKADVYGYGIVLLE--TICCRKNMEIDASKPEEI 201
+ + R +MA E S +DV+ +G++L E T+ +EID P E+
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 19/105 (18%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKRDKGYM 158
+G+ + H +LH D+KPQN+L++ K+ DFGLA+ +P + + Y
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167
Query: 159 APEC-----YKRTPISVKADVYGYGIVLLETICCRK----NMEID 194
APE Y T + D++ G + E + R + EID
Sbjct: 168 APEILLGCKYYSTAV----DIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 18/41 (43%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ Y H +LH D+KPQN+L+ E K+ DFGLA+
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q V + +A G+ YL D +H D+ +NIL++ K+ DFGL+++ +D
Sbjct: 107 QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163
Query: 152 KRDKG------YMAPECYKRTPISVKADVYGYGIVLLETI 185
+G + APE + +DV+ YGIV+ E +
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161
+G+ Y+H I+H D+KP NI ++E KILDFGLA+ +++ + Y APE
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 185
Query: 162 C------YKRTPISVKADVYGYGIVLLETICCR 188
Y +T D++ G ++ E + +
Sbjct: 186 IMLNWMHYNQT-----VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 19/120 (15%)
Query: 74 GSLTDIIF--CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSLTD++ C E Q + + + + +LH ++H DIK NIL+
Sbjct: 102 GSLTDVVTETCMDE-----GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 153
Query: 132 TAKILDFGL-AKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFG A++ E KR +MAPE R K D++ GI+ +E I
Sbjct: 154 SVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 19/40 (47%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
GIL+ H +LH D+KPQN+L+D K+ DFGLA+
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 98 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG- 156
+ +AKG+ YL E ++H D+ +N+L+ KI DFGLA+L + D D G
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 157 ----YMAPECYKRTPISVKADVYGYGIVLLE 183
+MA E + ++DV+ YG+ + E
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWE 203
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 18/41 (43%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+ I Y H I+H DIKP+NIL+ E K+ DFG A+
Sbjct: 111 QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 16/94 (17%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK------- 155
G+ +LH + I++ D+KP+N+L+D +I D GLA + D + K
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE-----LKDGQSKTKGYAGT 160
Query: 156 -GYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
G+MAPE + D + G+ L E I R
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 14/88 (15%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161
+G+ Y+H I+H D+KP N+ ++E +ILDFGLA+ +++ + Y APE
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185
Query: 162 C------YKRTPISVKADVYGYGIVLLE 183
Y +T D++ G ++ E
Sbjct: 186 IMLNWMHYNQT-----VDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP-NEDF--VI 150
+ IA+ +A G+ YL +H D+ +N L+ E T KI DFGL++ + D+ V
Sbjct: 127 LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 151 DKR--DKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K +M PE + ++D++ +G+VL E
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+ +Q + + DV +G+ YL + +H D+ +N L+D+ K+ DFGL++
Sbjct: 92 EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 143 LPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+D V K + PE + S K+DV+ +G+++ E
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 6/92 (6%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKR 153
A ++A + YLH I++ D+KP+NIL+D + DFGL K N
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE + P D + G VL E +
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 13/58 (22%)
Query: 115 ILHCDIKPQNILMDEF-WTAKILDFGLAK--------LPNEDFVIDKRDKGYMAPECY 163
I+H D+KPQNI+ E + KI+D G A +P E F++D R Y APE Y
Sbjct: 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE-FLLDPR---YAAPEQY 329
|
Length = 566 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 22/119 (18%)
Query: 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
P S D++ C A VA+G+ YL + +H D+ +N+L+ E
Sbjct: 133 PEEQLSFKDLVSC--------------AYQVARGMEYLASK---KCIHRDLAARNVLVTE 175
Query: 130 FWTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
KI DFGLA+ + K G +MAPE + ++DV+ +G++L E
Sbjct: 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 15/91 (16%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL-AKLPNEDFVIDKRDK--G-- 156
KG+ YLH E +H DIK NIL+ E K+ DFG+ A+L I KR G
Sbjct: 112 KGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA---TIAKRKSFIGTP 165
Query: 157 -YMAPECY---KRTPISVKADVYGYGIVLLE 183
+MAPE ++ K D++ GI +E
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 15/41 (36%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ Y+H ++H D+KP N+L++E +I DFG+A+
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 37/121 (30%), Positives = 53/121 (43%), Gaps = 17/121 (14%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
G D + ER P ++R+ + + YLH+ I+H D+K NIL
Sbjct: 86 GGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGD 141
Query: 133 AKILDFGLAKLPNEDFVIDKRDK-----GYMAPECY-----KRTPISVKADVYGYGIVLL 182
K+ DFG++ I +RD +MAPE K P KADV+ GI L+
Sbjct: 142 IKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 183 E 183
E
Sbjct: 200 E 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 19/120 (15%)
Query: 74 GSLTDIIF--CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSLTD++ C E Q + + + + +LH ++H DIK NIL+
Sbjct: 101 GSLTDVVTETCMDE-----GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 152
Query: 132 TAKILDFGL-AKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFG A++ E KR +MAPE R K D++ GI+ +E +
Sbjct: 153 SVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV---- 149
+++ + A G+ YL + +H D+ +N L+ E KI DFG+++ ED V
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST 152
Query: 150 --IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184
+ + + APE S ++DV+ +GI+L E
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 15/120 (12%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
G D I +R Q I + + + YLH I+H D+K N+L+
Sbjct: 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDI 149
Query: 134 KILDFGLAKLPNEDFVIDKRDK-----GYMAPEC-----YKRTPISVKADVYGYGIVLLE 183
K+ DFG++ + + +RD +MAPE K TP KAD++ GI L+E
Sbjct: 150 KLADFGVSAKNVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 22/103 (21%), Positives = 48/103 (46%), Gaps = 4/103 (3%)
Query: 85 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144
E++ + ++ +A+D KG+ L+ P + ++ + L+ E + KI+ GL K+
Sbjct: 116 EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 145 NEDFVIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETI 185
+ + Y + + + ++K D+Y G+VL E
Sbjct: 174 SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 97 ALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKR 153
+ VA+G+ +L +C +H D+ +NIL+ E KI DFGLA+ + D+V
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 154 DK---GYMAPECYKRTPISVKADVYGYGIVLLE 183
+ +MAPE + ++DV+ +G++L E
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 14/90 (15%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161
G+ Y+H I+H D+KP N+ ++E KILDFGLA+ + + + Y APE
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPE 184
Query: 162 C------YKRTPISVKADVYGYGIVLLETI 185
Y +T D++ G ++ E +
Sbjct: 185 VILNWMHYNQT-----VDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 17/41 (41%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
KG+ + H +LH D+KPQN+L+++ K+ DFGLA+
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 38/118 (32%), Positives = 51/118 (43%), Gaps = 18/118 (15%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL---DVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS +D++ + P Q V IA +G+ YLH ++H DIK NIL+ E
Sbjct: 105 GSASDLL--EVHKKPL--QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEP 157
Query: 131 WTAKILDFGLAKL--PNEDFVIDKRDKGYMAPE---CYKRTPISVKADVYGYGIVLLE 183
K+ DFG A P FV +MAPE K DV+ GI +E
Sbjct: 158 GQVKLADFGSASKSSPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 8/82 (9%)
Query: 107 LHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK-----GYMAPE 161
+H ++H D+K NI + K+ DFG +K ++ +D Y+APE
Sbjct: 185 VHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 162 CYKRTPISVKADVYGYGIVLLE 183
++R S KAD++ G++L E
Sbjct: 242 LWERKRYSKKADMWSLGVILYE 263
|
Length = 478 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 20/107 (18%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
Q V + +A G+ YL + +H D+ +NIL++ K+ DFGL++
Sbjct: 105 VGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR------R 155
Query: 150 IDKRDKGY-----------MAPECYKRTPISVKADVYGYGIVLLETI 185
++ + Y APE + +DV+ +GIV+ E +
Sbjct: 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 26/102 (25%), Positives = 38/102 (37%), Gaps = 32/102 (31%)
Query: 116 LHCDIKPQNILMDEFWTAKILDFGLAK--------------------LPNEDFVIDKRDK 155
+H DIKP NIL+D K+ DFGL K N +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 156 ------------GYMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE + TP ++ D + G++L E +
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMA 159
G+ ++H++ +LH DIK +NI + + K+ DFG A+L G Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 160 PECYKRTPISVKADVYGYGIVLLETICCRKN 190
PE ++ P + K+D++ G +L E +C K+
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYE-LCTLKH 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/74 (33%), Positives = 38/74 (51%), Gaps = 4/74 (5%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDKGYMAPECYKRTPISVKA 172
+H D+KP+N L+D K+ DFGL+K + + V+ D YMAPE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD--YMAPEVLRGKGYDFTV 179
Query: 173 DVYGYGIVLLETIC 186
D + G +L E +C
Sbjct: 180 DYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG 156
A ++A + YLH I++ D+KP+NIL+D + DFGL K E
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTT 155
Query: 157 ------YMAPECYKRTPISVKADVYGYGIVLLETI 185
Y+APE ++ P D + G VL E +
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 6e-04
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 31/177 (17%)
Query: 84 AERNP----YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139
AE N +Q + IA +A G++YL + +H D+ +N L+ E KI DFG
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 140 LAKLPNEDFVIDKRDKG--------YMAPECYKRTPISVKADVYGYGIVLLETICCRKNM 191
+++ + + D G +M PE + ++DV+ G+VL E K
Sbjct: 166 MSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK-- 220
Query: 192 EIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248
+P + N V +C + + R + + + L C Q EP +R
Sbjct: 221 -----QPWYQLSNNEVIECITQGRVLQRPRTCP------KEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 94 VRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK 152
V A VA+G+ YL C +H D+ +N+L+ E KI DFGLA+ ++ K
Sbjct: 137 VSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 153 RDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + ++DV+ +GI++ E
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 26/81 (32%), Positives = 36/81 (44%), Gaps = 19/81 (23%)
Query: 91 NQRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
N+ V+ L K G+ Y+H ILH D+K NIL+ + K+ DFGLA+
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
Query: 143 LPNEDFVIDKRDKGYMAPECY 163
F + K K P Y
Sbjct: 168 ----AFSLSKNSK----PNRY 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 11/89 (12%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV-IDKRDKGYMAPE 161
G+ Y+H +LH D+KP N+L++ KI DFGLA+ +E+ Y+A
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 162 CYKRTPI-------SVKADVYGYGIVLLE 183
Y+ I + DV+ G +L E
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAE 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 23/66 (34%), Positives = 36/66 (54%), Gaps = 12/66 (18%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED------FVIDKRDK 155
+G+ Y+H +LH D+KP N+L++ KI DFGLA+ +E +V+ +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-- 173
Query: 156 GYMAPE 161
Y APE
Sbjct: 174 -YRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V VA+G+ YL + +H D+ +N+L+ E KI DFGLA+ N K
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + ++DV+ +G+++ E
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 13/121 (10%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG 156
A ++ +++LHD+ I++ D+K N+L+D K+ DFG+ K + G
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLETICCRKNME-------IDASKPEEIILTNW 206
Y+APE + D + G++L E +C E +A +E++ W
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 218
Query: 207 V 207
+
Sbjct: 219 L 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 7e-04
Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 19/120 (15%)
Query: 74 GSLTDIIF--CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSLTD++ C E Q + + + + +LH ++H DIK NIL+
Sbjct: 101 GSLTDVVTETCMDE-----GQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDG 152
Query: 132 TAKILDFGL-AKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFG A++ E KR +MAPE R K D++ GI+ +E +
Sbjct: 153 SVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 7e-04
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 8/100 (8%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
NQ + + G+ Y+H + ILH D+K +NI + KI DFG+++L +
Sbjct: 106 NQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDL 161
Query: 151 DKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
G YM+PE K K+D++ G +L E +CC
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE-MCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 94 VRIALDVAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK 152
V + VA G+ +L + C +H D+ +N+L+ E KI DFGLA+ D + D
Sbjct: 242 VGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLAR----DIMRDS 293
Query: 153 R--DKG-------YMAPECYKRTPISVKADVYGYGIVLLE 183
KG +MAPE + +DV+ +GI+L E
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 8e-04
Identities = 15/43 (34%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+ +G+ ++H H D+KP+N+L+ KI DFGLA+
Sbjct: 108 ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 9e-04
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 24/97 (24%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159
+AKG+ YL + ++H ++ +NIL+ +I DFG+A L D DK Y
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD------DKKYFY 168
Query: 160 PECYKRTPI-------------SVKADVYGYGIVLLE 183
E +TPI + ++DV+ YG+ + E
Sbjct: 169 SEH--KTPIKWMALESILFGRYTHQSDVWSYGVTVWE 203
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GS+TD+I + I ++ +G+ +LH + ++H DIK QN+L+ E
Sbjct: 94 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 150
Query: 134 KILDFGLAKLPNEDFVIDKRDK-----GYMAPE---CYKRTPIS--VKADVYGYGIVLLE 183
K++DFG++ D + +R+ +MAPE C + + K+D++ GI +E
Sbjct: 151 KLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 17/97 (17%)
Query: 96 IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID---- 151
+ DV +G+ YL +H D+ +N L+ K+ DFG+ + +V+D
Sbjct: 105 MCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR-----YVLDDEYT 156
Query: 152 -----KRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K + PE + + S K+DV+ +G+++ E
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWE 193
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 12/61 (19%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG--------YMAPECYKRT 166
I++ DIK +NIL+D + DFGL+K F+ ++ ++ YMAPE +
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 167 P 167
Sbjct: 182 S 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 19/120 (15%)
Query: 74 GSLTDIIF--CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSLTD++ C E Q + + + + +LH ++H DIK N+L+
Sbjct: 101 GSLTDVVTETCMDEA-----QIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDG 152
Query: 132 TAKILDFGL-AKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFG A++ E KR +MAPE R K D++ GI+ +E +
Sbjct: 153 SVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 31/101 (30%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKL-----P-NEDF---- 148
+ +G+ YLHD I+H DIK N+L++ + KI DFG +K P E F
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 149 ------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
VIDK +GY AP AD++ G ++E
Sbjct: 174 QYMAPEVIDKGPRGYGAP-----------ADIWSLGCTIVE 203
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 18/94 (19%)
Query: 100 VAKGILYLHDE-CEPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDKG 156
VA+G+ +L + C +H D+ +N+L+ + KI DFGLA+ + + ++V KG
Sbjct: 246 VARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYV----SKG 297
Query: 157 -------YMAPECYKRTPISVKADVYGYGIVLLE 183
+MAPE + +DV+ YGI+L E
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 19/106 (17%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q V + +A G+ YL E +H D+ +NIL++ K+ DFGL++ + D
Sbjct: 107 QLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED----D 159
Query: 152 KRDKGY------------MAPECYKRTPISVKADVYGYGIVLLETI 185
D Y APE + +DV+ YGIV+ E +
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 98 LDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK--RDK 155
+ +G+ +LH ++H D+KPQNIL+ K+ DFGLA++ + +
Sbjct: 117 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 156 GYMAPECYKRTPISVKADVYGYGIVLLE 183
Y APE ++ + D++ G + E
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 26/95 (27%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDFV--- 149
V+ D+A G+ YL + +H D+ +N +++E + DFGL+ K+ N D+
Sbjct: 115 VKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 150 -IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
I K ++A E + K+DV+ +G+ + E
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 33/121 (27%), Positives = 61/121 (50%), Gaps = 17/121 (14%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GS+TD++ + + I ++ +G+ +LH ++H DIK QN+L+ E
Sbjct: 104 GSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160
Query: 134 KILDFGL-AKLPNEDFVIDKRDK-----GYMAPECY--KRTPISV---KADVYGYGIVLL 182
K++DFG+ A+L D + +R+ +MAPE P + ++D++ GI +
Sbjct: 161 KLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217
Query: 183 E 183
E
Sbjct: 218 E 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 28/84 (33%), Positives = 42/84 (50%), Gaps = 13/84 (15%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAKL--PNED-------FVIDKRDKGYMAPECYKR 165
+LH D+KP N+L++ KI DFGLA++ P D +V + Y APE
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA---TRWYRAPEIMLN 183
Query: 166 TPISVKA-DVYGYGIVLLETICCR 188
+ KA D++ G +L E + R
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q V + +A G+ YL D +H D+ +NIL++ K+ DFGL+++ +D
Sbjct: 108 QLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164
Query: 152 KRDKG------YMAPECYKRTPISVKADVYGYGIVLLETI 185
G + APE + +DV+ +GIV+ E +
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 38/118 (32%), Positives = 52/118 (44%), Gaps = 18/118 (15%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL---DVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS +D++ + P Q V IA +G+ YLH ++H DIK NIL+ E
Sbjct: 109 GSASDLL--EVHKKPL--QEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEP 161
Query: 131 WTAKILDFGLAKL--PNEDFVIDKRDKGYMAPE---CYKRTPISVKADVYGYGIVLLE 183
K+ DFG A + P FV +MAPE K DV+ GI +E
Sbjct: 162 GQVKLADFGSASIASPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDK 152
+ IA+ +A G+ YL +H D+ +NIL+ E KI D GL++ + + D+ +
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 153 RDK----GYMAPECYKRTPISVKADVYGYGIVLLE 183
+M PE S +D++ +G+VL E
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 23/97 (23%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL----------------PNEDFV 149
YLH+ I+H D+KP N+L+ K+ DFGL+K+ +F+
Sbjct: 116 YLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 150 IDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
DK+ G Y+APE R D + GI+L E
Sbjct: 173 -DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.003
Identities = 18/40 (45%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
G+ +LHD ILH D+K N+L++ KI DFGLA+
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRT 166
I++ D+KP+NIL+D K+ DFGL K + + G YMAPE R+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 25/95 (26%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPNEDF---- 148
VR +D+A G+ YL + +H D+ +N +++E T + DFGL+ K+ + D+
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
K ++A E + +DV+ +G+ + E
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 11/86 (12%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK-----GYMAP 160
Y+H + ++H DIK NIL+ K+ DFG+A L N+ KR +MAP
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAP 170
Query: 161 ECYKR-TPISVKADVYGYGIVLLETI 185
E KAD++ GI + E
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 13/85 (15%)
Query: 104 ILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR-----DKGYM 158
+ YLH + I++ D+KP+NIL+D+ K+ DFG AK + D+ Y+
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK-----LRDRTWTLCGTPEYL 165
Query: 159 APECYKRTPISVKADVYGYGIVLLE 183
APE + + D + GI++ E
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.003
Identities = 16/41 (39%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
K + Y+H ++H D+KP NIL++ K+ DFGLA+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 17/102 (16%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA--KLPNEDFVIDK 152
R+A +VA G+L+LH + +H D+ +N + + KI D+GLA + P ED+ I K
Sbjct: 104 RMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP-EDYYITK 159
Query: 153 RDKG----YMAPECY-------KRTPISVKADVYGYGIVLLE 183
++APE + K++++ G+ + E
Sbjct: 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 27/101 (26%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFV 149
+Q + IA +A G++YL + +H D+ +N L+ KI DFG+++ + + D+
Sbjct: 123 SQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
Query: 150 IDKRDKG-------YMAPECYKRTPISVKADVYGYGIVLLE 183
R G +M PE + ++DV+ +G++L E
Sbjct: 180 ---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.004
Identities = 28/80 (35%), Positives = 35/80 (43%), Gaps = 20/80 (25%)
Query: 115 ILHCDIKPQNILMDEFWTAKILDFGLA-----KLPNEDFVIDKRDKGYMAPEC------Y 163
I H DIKP+NIL+ K+ DFG K P ++ I R Y APEC Y
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEY-ISTR--WYRAPECLLTDGYY 176
Query: 164 KRTPISVKADVYGYGIVLLE 183
K D++ G V E
Sbjct: 177 -----GPKMDIWAVGCVFFE 191
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 6/51 (11%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
G+ Y H + LH DIK NIL++ K+ DFGLA+L N + + R
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE---ESR 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 33/141 (23%), Positives = 62/141 (43%), Gaps = 10/141 (7%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK---LPNEDFVIDKR 153
A +V +++LH +++ D+K NIL+D K+ DFG+ K L
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP--EEIILTNWVYKCF 211
Y+APE + D + G+++ E + + E D E I+ + +Y +
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW 218
Query: 212 INRELNKLVRG--TKVDKKNL 230
+++E +++ TK K L
Sbjct: 219 LSKEAVSILKAFMTKNPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 257 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.56 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.56 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.54 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.53 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.31 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.29 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.26 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.91 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.84 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.57 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.57 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.74 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.01 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.93 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.82 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.55 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 90.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 90.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 90.49 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 88.83 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 87.29 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 86.95 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 86.92 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 85.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.78 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 84.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 84.38 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 84.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 83.81 | |
| PLN02236 | 344 | choline kinase | 83.39 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=328.02 Aligned_cols=244 Identities=32% Similarity=0.533 Sum_probs=209.6
Q ss_pred ccccceeeecccCCCCCeeecc---------chhhhHHHHhHhhhccccccccCCceeeeceeeeecC-ceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRV---------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-VSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~---------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~lV~E~~~~ 73 (257)
+.|+.||+|.+.++..++||+. +|.+|++.++ +++|+|++++.|+|...+ +.+||+|||++
T Consensus 86 Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls---------~l~H~Nlv~LlGyC~e~~~~~~LVYEym~n 156 (361)
T KOG1187|consen 86 GGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILS---------RLRHPNLVKLLGYCLEGGEHRLLVYEYMPN 156 (361)
T ss_pred CCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHh---------cCCCcCcccEEEEEecCCceEEEEEEccCC
Confidence 4588999999999988898843 4566666666 999999999999999999 59999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccc--c
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFV--I 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~--~ 150 (257)
|||.++|+......|+|.++.+|+.++|.||.|||+.+.+.|+|||||++|||+|+++.+||+|||+++.... ... .
T Consensus 157 GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~ 236 (361)
T KOG1187|consen 157 GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVST 236 (361)
T ss_pred CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceee
Confidence 9999999973322899999999999999999999999877899999999999999999999999999975543 222 2
Q ss_pred c-cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC----CC
Q 044568 151 D-KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT----KV 225 (257)
Q Consensus 151 ~-~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 225 (257)
. .||.+|++||+...+..+.++||||||++++|++||+.|.+... ......+..|+.+......+..++|+. ..
T Consensus 237 ~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~ 315 (361)
T KOG1187|consen 237 TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEY 315 (361)
T ss_pred ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHCcchhheeCCCccCCCC
Confidence 2 79999999999999999999999999999999999999887553 222334778888888888888888877 23
Q ss_pred CH-HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DK-KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~-~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+. +....+..++.+|++.+|++|| |.||+++|
T Consensus 316 ~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 316 PDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 33 5788899999999999999999 99998875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=315.47 Aligned_cols=229 Identities=26% Similarity=0.365 Sum_probs=192.8
Q ss_pred ccccceeeecccCCCCCeeecc-----------chhhhHHHHhHhhhccccccccCCceeeeceeeeecC-ceeEEEeec
Q 044568 4 TKLSNFYRSSFNARNSPWISRV-----------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-VSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~lV~E~~ 71 (257)
+.++.||+|++.....+++|.+ +|.+|+..+. +++|+|||++.|.+.... ..+||||||
T Consensus 52 G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~---------~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 52 GSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLS---------RLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred CCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHH---------hCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 5689999999998887888754 4677777777 899999999999999988 899999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eeeccCCCCceeeCCCC-ceEEeeecccccCC---C
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP-ILHCDIKPQNILMDEFW-TAKILDFGLAKLPN---E 146 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~---~ 146 (257)
++|+|.+++++.....+++..++.++.||+.|+.|||++ + |+|||||+.|+|++.+. ++||+|||+++... .
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 999999999864478899999999999999999999999 8 99999999999999997 99999999998654 3
Q ss_pred CcccccCCCCccCccccc--CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 147 DFVIDKRDKGYMAPECYK--RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
......||..|+|||.+. +..|+.|+||||||+++|||+||+.||..... ..... . ...--....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~---~------v~~~~~Rp~ 266 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVAS---A------VVVGGLRPP 266 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHH---H------HHhcCCCCC
Confidence 445578999999999999 66899999999999999999999999986622 11100 0 000111113
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+..+++.+..++.+||+.||++|| +.||+..|
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 4555889999999999999999999 99998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=310.48 Aligned_cols=225 Identities=21% Similarity=0.320 Sum_probs=192.1
Q ss_pred cccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.|+.|+.|+++....+++|.+. |.+|++++. +++|++||++.+++..++..+||||||+.|
T Consensus 216 ~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk---------~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 216 SGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMK---------KLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred CCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHH---------hCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 368999999999999888876533 678888888 999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-ccccC
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-VIDKR 153 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 153 (257)
||.++|+......+...+.+.++.|||+|++||.++ ++|||||.++|||++++..+||+|||+++...++. ....+
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999976778899999999999999999999999 99999999999999999999999999999544433 12222
Q ss_pred ---CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CC--CCC
Q 044568 154 ---DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GT--KVD 226 (257)
Q Consensus 154 ---~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~ 226 (257)
..-|.|||++..+.++.+|||||||++|||++| |+.||.... ..+....++ +. +.|
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLPRP 426 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCCCC
Confidence 234999999999999999999999999999999 899986441 122222233 22 557
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
..|+..+.+++..||+.+|++|| ++.+...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~ 457 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREV 457 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHH
Confidence 78999999999999999999999 9877654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.98 Aligned_cols=222 Identities=18% Similarity=0.227 Sum_probs=189.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.||.+|+++. ..++.+|+|.+. ..+|++... .+.|+|||++.+.+.+.+..|||.|+
T Consensus 29 GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr---------~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 29 GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHR---------SLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHH---------hcCCCcEEeeeeEeecCCceEEEEEe
Confidence 47999999997 778888887654 245555555 99999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CC
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---ED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~ 147 (257)
|.+++|..++. ..+.+++.+++.++.||+.|+.|||++ +|+|||||..|++++++.++||+|||++.... ..
T Consensus 100 C~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 100 CHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred cCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999999998 678899999999999999999999999 99999999999999999999999999998655 55
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (257)
....+|||.|.|||++.+...+..+||||+||++|.++.|++||+...-. ..+..+-... .+|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------------ety~~Ik~~~Y~~P 238 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------------ETYNKIKLNEYSMP 238 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------------HHHHHHHhcCcccc
Confidence 67889999999999999999999999999999999999999999855111 1111111111 344
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........+||..+|+.||.+|| +++|+.
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 45667788999999999999999 999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=287.75 Aligned_cols=228 Identities=21% Similarity=0.247 Sum_probs=185.9
Q ss_pred cccccceeeecccCCCC-Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-ceeEEEee
Q 044568 3 CTKLSNFYRSSFNARNS-PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-VSGKIERP 70 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~lV~E~ 70 (257)
++..++||+..+..+.. .|+|.+. ..+|++++. +..|++||.+.+.+.... ...|+|||
T Consensus 89 ~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~---------~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 89 SGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILR---------SCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred cCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHh---------hCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 35678999999775554 4566652 345555555 678999999999999988 59999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~ 148 (257)
|++|||++++. ..+++++...-+++.++++||.|||+ + +|+||||||+|+|+...|.+||+|||.+...... .
T Consensus 160 MDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 160 MDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred cCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 99999999998 44779999999999999999999996 7 9999999999999999999999999999865444 3
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc--CCCCC
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR--GTKVD 226 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 226 (257)
.+..||..|||||.+.+..|+.++||||||+.++|+++|+.||....+.... |. .-+..+.. +...+
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-----~~------~Ll~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-----IF------ELLCAIVDEPPPRLP 303 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-----HH------HHHHHHhcCCCCCCC
Confidence 6779999999999999999999999999999999999999999754111110 00 11122333 12334
Q ss_pred HH-HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KK-NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~-~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. +.+++..++..||++||.+|| +.|+++
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 43 788999999999999999999 999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=288.22 Aligned_cols=177 Identities=20% Similarity=0.287 Sum_probs=156.9
Q ss_pred ccccceeeecccCCC-CCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.|++||+|++.... .++||.+.- ..|++.+. .+.|+|||.+.......+..+||||||
T Consensus 21 GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLk---------el~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 21 GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILK---------ELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHH---------hcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 578999999966554 556776542 45566666 899999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC------CceEEeeecccccCC
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF------WTAKILDFGLAKLPN 145 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~------~~~kl~dfg~~~~~~ 145 (257)
.||+|.++|+ ..+++++.+++.++.||+.|+++||++ +|+||||||.|||++.. ..+||+|||+++...
T Consensus 92 ~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 92 NGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999998 566899999999999999999999999 99999999999999865 568999999999766
Q ss_pred CCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 146 EDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
... ...+|++.|||||++...+|+.|+|+||.|+++|++++|+.||+..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 443 5668999999999999999999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=271.91 Aligned_cols=236 Identities=16% Similarity=0.187 Sum_probs=185.7
Q ss_pred ccccceeeec-ccCCCCCeeeccchhhh--HHHHh-HhhhccccccccCCceeeecee-eeecCc-eeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSWTAD--IEVLS-VAMRGSKCTRIRGGLLLNVPVR-AKLTSV-SGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~~~~--~~~~~-~~~~~~~~~~~~h~~i~~~~~~-~~~~~~-~~lV~E~~~~gsL~ 77 (257)
++|+.|||+. +.++..++.|+++|... .+--. +...+ .+..+.|+|||+..+. +....+ .+||||||.+|+|.
T Consensus 30 GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~-lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLs 108 (375)
T KOG0591|consen 30 GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEIS-LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLS 108 (375)
T ss_pred CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHH-HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHH
Confidence 5799999999 78888889998886221 11111 12222 4458999999999994 444444 78999999999999
Q ss_pred HHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCCCCceEEeeecccccCCCCc---cc
Q 044568 78 DIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VI 150 (257)
Q Consensus 78 ~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~ 150 (257)
++|... +.+.+++.++++++.|++.||.++|++ .++ ++||||||.||+++.+|.+||+|||+++...... .+
T Consensus 109 qmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S 187 (375)
T KOG0591|consen 109 QMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHS 187 (375)
T ss_pred HHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHh
Confidence 999633 677899999999999999999999994 235 9999999999999999999999999999765543 56
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC-HHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD-KKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 229 (257)
..|||.||+||.+...+|+.+|||||+||++|||+.-++||.++ ....++. .+... +-.+.| .-.
T Consensus 188 ~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~---------KI~qg-d~~~~p~~~Y 253 (375)
T KOG0591|consen 188 LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCK---------KIEQG-DYPPLPDEHY 253 (375)
T ss_pred hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHH---------HHHcC-CCCCCcHHHh
Confidence 79999999999999999999999999999999999999999866 1111211 11111 111233 556
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..++..|+..||+.|| ...++.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHH
Confidence 78899999999999999999 665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=281.96 Aligned_cols=204 Identities=23% Similarity=0.291 Sum_probs=169.1
Q ss_pred hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 044568 27 WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILY 106 (257)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~ 106 (257)
..+|++++. ++.|||||++.+++...+..||||||++||.|.+.+- ..+.+.+...+.++.|++.|+.|
T Consensus 223 v~~EieILk---------kL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkY 291 (475)
T KOG0615|consen 223 VQNEIEILK---------KLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKY 291 (475)
T ss_pred hHHHHHHHH---------hcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHH
Confidence 368888888 9999999999999999999999999999999999997 66778888999999999999999
Q ss_pred HhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccccCC--CCcccccCCCCccCcccccCCCC---CccccchhHH
Q 044568 107 LHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECYKRTPI---SVKADVYGYG 178 (257)
Q Consensus 107 lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~s~G 178 (257)
||++ ||+||||||+|||+..+ ..+|++|||+++..+ ..+...+||+.|.|||++.+..+ ..+.|+||+|
T Consensus 292 LH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlG 368 (475)
T KOG0615|consen 292 LHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLG 368 (475)
T ss_pred HHHc---CcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeecc
Confidence 9999 99999999999999876 789999999999864 44578899999999999986643 3478999999
Q ss_pred HHHHHHHhcCCCCCcCCCChh-hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 179 IVLLETICCRKNMEIDASKPE-EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 179 ~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
|+||-+++|.+||.....+.. ...+..-. ..-......+..++..+|+.++|..||++|| +.|+++
T Consensus 369 cvLfvcLsG~pPFS~~~~~~sl~eQI~~G~-----------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 369 CVLFVCLSGYPPFSEEYTDPSLKEQILKGR-----------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ceEEEEeccCCCcccccCCccHHHHHhcCc-----------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 999999999999986633321 00000000 0001133455667889999999999999999 999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.16 Aligned_cols=227 Identities=19% Similarity=0.233 Sum_probs=180.1
Q ss_pred ccccceeeecccCCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEE
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV 67 (257)
+.+..||+|++ +++.+++|.... .+|++.+. +++|+|++++.+.+.. ....++|
T Consensus 31 g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 31 NDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLR---------RIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred CCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHH---------hcCCCCEEEEeeeEEecccCCCceEEE
Confidence 46788999998 577888886542 24444444 8899999999998876 3467899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++. ....+++.....++.|++.|+.|||+.. +++||||+|+||++++++.+|++|||+++.....
T Consensus 101 ~Ey~~~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 101 LEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred EEeCCCCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 99999999999997 4567899999999999999999999831 8889999999999999999999999998865554
Q ss_pred cccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 FVIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...... ... .....
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~-----~~~-----~~~~~ 243 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLII-----NKN-----NSLKL 243 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH-----hcC-----CCCCC
Confidence 455667888999999976 678999999999999999999999997542111 000000 000 01123
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 334667899999999999999999 99998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=298.21 Aligned_cols=224 Identities=18% Similarity=0.232 Sum_probs=183.6
Q ss_pred cccceeeecccCCC------CCeeec----------cchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 5 KLSNFYRSSFNARN------SPWISR----------VSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 5 ~~~~~y~~~~~~~~------~~~i~~----------~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
-|+.||+|+...-. .++||. .+|++|++.+. .+.|+|||++.|.+..++..+||+
T Consensus 498 aFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla---------~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 498 AFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLA---------ELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred hhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHH---------hccCCCeEEEEEEEccCCeeEEEE
Confidence 46778888754433 334543 34777777777 999999999999999999999999
Q ss_pred eecCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEe
Q 044568 69 RPVRNGSLTDIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIL 136 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 136 (257)
|||.+|+|.++|+... +..|+..+.++++.|||.|+.||-++ ..+||||..+|+|++++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEec
Confidence 9999999999998431 22388899999999999999999999 99999999999999999999999
Q ss_pred eecccccCCCCcccc-----cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHh
Q 044568 137 DFGLAKLPNEDFVID-----KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKC 210 (257)
Q Consensus 137 dfg~~~~~~~~~~~~-----~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 210 (257)
|||+++-.-...... .-..+|||||.+..++|+.+||||||||+|||+++ |..||.+-..+
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------------- 712 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------------- 712 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------------
Confidence 999998543333222 22356999999999999999999999999999999 99999755222
Q ss_pred hhhhhhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 211 FINRELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 211 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.-+.+..+ +.|+.++.++..|+..||+.+|.+|| ++||...|
T Consensus 713 ----EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 713 ----EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred ----HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 222222222 56888999999999999999999999 99998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=273.27 Aligned_cols=227 Identities=20% Similarity=0.243 Sum_probs=181.6
Q ss_pred ccccceeeecccC-CCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecC--ceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--VSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lV~E~~ 71 (257)
+.++.||.++..+ ++..++|.++. .+|++.+. ++.|+|||+..|.....+ ..++.|||+
T Consensus 28 Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~---------~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 28 GSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILS---------RLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred ccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHH---------hCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4678999999776 77788888776 45555555 888999999999755444 689999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCC----
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNE---- 146 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~---- 146 (257)
++|||.+++.+..+ .|++..++.++.|+++||.|||++ +++|+||||+|||++. ++.+||+|||.+.....
T Consensus 99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999987444 899999999999999999999999 9999999999999999 79999999998876542
Q ss_pred --CcccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 147 --DFVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 147 --~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
......||+.|+|||++..+. ...++||||+||++.||+||+.||.... ....+....... . ...
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~----~--~~P 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGRE----D--SLP 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhcc----C--CCC
Confidence 234578899999999998643 3459999999999999999999997420 001111111111 1 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.++...+....+++..|++.||++|| |+|+++
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 45666778899999999999999999 999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.30 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=190.7
Q ss_pred ccccceeeecccCCCC------Ceeeccch-hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNS------PWISRVSW-TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~------~~i~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.|++||+|.+.+... +++|.+.. ..+-++..+...+..+.++.|+||+++.|++......+|++|||++|+|
T Consensus 703 G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL 782 (1025)
T KOG1095|consen 703 GAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDL 782 (1025)
T ss_pred ccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcH
Confidence 5799999999887777 56666554 3344455555555567799999999999999999999999999999999
Q ss_pred HHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc-CCCCccc
Q 044568 77 TDIIFCS-----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL-PNEDFVI 150 (257)
Q Consensus 77 ~~~l~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~-~~~~~~~ 150 (257)
..+|++. ....++..+.+.++.|||.|+.||+++ +.+||||.++|+|++....+|++|||+++- .......
T Consensus 783 ~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr 859 (1025)
T KOG1095|consen 783 LSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYR 859 (1025)
T ss_pred HHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchhee
Confidence 9999973 267789999999999999999999999 999999999999999999999999999983 3322222
Q ss_pred cc----CCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-C-
Q 044568 151 DK----RDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-T- 223 (257)
Q Consensus 151 ~~----~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 223 (257)
.. ....|||||.+..+.++.|+|||||||++||++| |..||......+. + ...+.+ +
T Consensus 860 ~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~-------------~~~~~ggRL 923 (1025)
T KOG1095|consen 860 KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---L-------------LDVLEGGRL 923 (1025)
T ss_pred ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---H-------------HHHHhCCcc
Confidence 22 2245999999999999999999999999999999 8899975522111 0 011111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
..|..|+..+++++..||+.+|++|| ++.|++.
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 45778899999999999999999999 9999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=284.90 Aligned_cols=225 Identities=20% Similarity=0.247 Sum_probs=186.3
Q ss_pred ccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCC
Q 044568 6 LSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAE 85 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~ 85 (257)
-+-|++|++. ++.++||+++-.+|-+.-. +++++|+||+.+.|.|.-...+|||||||..|-|..+|+ ..
T Consensus 137 QGAVF~Grl~-netVAVKKV~elkETdIKH-------LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk--a~ 206 (904)
T KOG4721|consen 137 QGAVFLGRLH-NETVAVKKVRELKETDIKH-------LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK--AG 206 (904)
T ss_pred ccceeeeecc-CceehhHHHhhhhhhhHHH-------HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh--cc
Confidence 4568899875 5678888887654443322 338999999999999999999999999999999999998 77
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC--CCcccccCCCCccCcccc
Q 044568 86 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECY 163 (257)
Q Consensus 86 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~ 163 (257)
..++....+.|..+||.|+.|||.+ .|+|||||..|||+..+-.+||+|||.++... .+.....||..|||||++
T Consensus 207 ~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 207 RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI 283 (904)
T ss_pred CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh
Confidence 8888899999999999999999999 99999999999999999999999999987543 344667899999999999
Q ss_pred cCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccC
Q 044568 164 KRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQD 243 (257)
Q Consensus 164 ~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 243 (257)
++.+.+.|+|||||||+||||+||..||.+-++... .+ ....+...+ ..|..+++-+.-|+++||+.
T Consensus 284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------Iw--GVGsNsL~L----pvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IW--GVGSNSLHL----PVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EE--eccCCcccc----cCcccCchHHHHHHHHHHhc
Confidence 999999999999999999999999999975422110 00 001111111 45677888899999999999
Q ss_pred CCCCCC-hHHHHHh
Q 044568 244 EPALRP-MKCAVMM 256 (257)
Q Consensus 244 ~p~~RP-~~ei~~~ 256 (257)
.|..|| +++|+.-
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 999999 9999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.66 Aligned_cols=224 Identities=21% Similarity=0.238 Sum_probs=184.9
Q ss_pred cccceeeec-ccCCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 5 KLSNFYRSS-FNARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 5 ~~~~~y~~~-~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.++.||-++ ...+..++||+.++ .+|+.++. ...|+|+|++...+...+..++|||||+||
T Consensus 285 aSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~---------~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 285 ATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMR---------DLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred cccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHH---------hccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 355677776 55666778888663 46666666 889999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VID 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~ 151 (257)
+|.|++ ....|++.+...++.+++.||.|||.+ +|+|||||.+|||++.++.+||+|||++..+.... ...
T Consensus 356 sLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 356 SLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred chhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 999999 456699999999999999999999999 99999999999999999999999999987654433 566
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.||+.|+|||......|+++.||||||++++||+-|.+||-.+.+... -+.-.. +.......+.....
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-----lyLIa~-------ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIAT-------NGTPKLKNPEKLSP 497 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-----HHHHhh-------cCCCCcCCccccCH
Confidence 899999999999999999999999999999999999999975422211 111110 11111134555678
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.||++|| +.|+++
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhc
Confidence 899999999999999999 999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=270.15 Aligned_cols=239 Identities=21% Similarity=0.197 Sum_probs=182.0
Q ss_pred cceeeec-ccCCCCCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 7 SNFYRSS-FNARNSPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 7 ~~~y~~~-~~~~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.||++. ...++-++||..++. +.++.+....+ .++-+.||||++....|..++..++||.||.+||+.++++.
T Consensus 40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~--~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~ 117 (516)
T KOG0582|consen 40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQ--TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKT 117 (516)
T ss_pred eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHH--HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHH
Confidence 7899998 455566789988862 33333332222 34488899999999999999999999999999999999998
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-------ccccCCC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-------VIDKRDK 155 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~ 155 (257)
.-+.+|++..+..++.+++.||.|||.+ |.+|||+|+.|||++.+|.+||+|||.+-...... ....+|+
T Consensus 118 ~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 118 YYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTP 194 (516)
T ss_pred HccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcc
Confidence 7788899999999999999999999999 99999999999999999999999999765332221 3447899
Q ss_pred CccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 044568 156 GYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENL 233 (257)
Q Consensus 156 ~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
.|+|||.+.. ..|+.|+||||||++..|+++|..||....+- ...+.... ...+.......+..........+
T Consensus 195 ~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLq---n~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 195 CWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQ---NDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred cccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhc---CCCCCcccccCChHHhhhhcHHH
Confidence 9999999653 35999999999999999999999999744111 11111110 00011110000112233345689
Q ss_pred HHHHHHcccCCCCCCC-hHHHHH
Q 044568 234 VKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+++..||++||.+|| ++++++
T Consensus 270 ~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHHHHhhcCcccCCCHHHHhc
Confidence 9999999999999999 999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=265.99 Aligned_cols=225 Identities=17% Similarity=0.169 Sum_probs=173.9
Q ss_pred ccccceeeecccCC-CCCeeeccchhhhHHH---HhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWTADIEV---LSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~~~~~~---~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||..+..++ .-.++|..+-..+++. -...-...-+.++.||+||++...+++.+..|||+||+.||.|..+
T Consensus 36 G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~h 115 (357)
T KOG0598|consen 36 GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYH 115 (357)
T ss_pred cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHH
Confidence 34667777764433 3345544332222221 0011111133489999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~~~ 156 (257)
|. ..+.+++..++.|+..|+.||.|||++ +|+|||+||+|||++.+|+++|+|||+++.. +......+||+.
T Consensus 116 L~--~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~e 190 (357)
T KOG0598|consen 116 LQ--REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPE 190 (357)
T ss_pred HH--hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCcc
Confidence 98 678899999999999999999999999 9999999999999999999999999999842 233455699999
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC--CCCHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVDKKNLENLV 234 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 234 (257)
|+|||++.+..|+..+|+||+|+++|||++|.+||...+... -.+.+.... ..+.-...+..
T Consensus 191 YmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~----------------~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 191 YMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK----------------MYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred ccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH----------------HHHHHhcCcCCCCCccCCHHHH
Confidence 999999999999999999999999999999999998662111 111222222 22233556788
Q ss_pred HHHHHcccCCCCCCC
Q 044568 235 KVGLWCVQDEPALRP 249 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP 249 (257)
+++...++.||++|.
T Consensus 255 dll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHhccCHHHhc
Confidence 899999999999993
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=259.80 Aligned_cols=183 Identities=20% Similarity=0.178 Sum_probs=162.9
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
.+.||+++++.+.+.+.+..+|||||.+||-|..+++ ..+++++..++.++.||+.|++|||+. +|++||+||+|
T Consensus 100 ~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPEN 174 (355)
T KOG0616|consen 100 AVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPEN 174 (355)
T ss_pred hccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHH
Confidence 8889999999999999999999999999999999998 678899999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHH
Q 044568 125 ILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~ 204 (257)
||+|.+|.+|+.|||+++.........+||+.|+|||.+...+++.++|+||||+++|||+.|.+||....+..
T Consensus 175 iLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------ 248 (355)
T KOG0616|consen 175 LLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------ 248 (355)
T ss_pred eeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------
Confidence 99999999999999999988888888999999999999999999999999999999999999999998663311
Q ss_pred HHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHHHcccCCCCCC
Q 044568 205 NWVYKCFINRELNKLVRGT-KVDKKNLENLVKVGLWCVQDEPALR 248 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~R 248 (257)
-++.++.+. .+|......+.+|+...++.|-.+|
T Consensus 249 ----------iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 ----------IYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------HHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 122333333 4555566677778888888888877
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.06 Aligned_cols=231 Identities=19% Similarity=0.166 Sum_probs=183.9
Q ss_pred ccccceeeec-ccCCCCCeeeccch---hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSW---TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.+|.|++++ ...+...+||..+- .+|-++-.+.....-+.++ .|+.|+++...+++....|+|+||+++|+|.+
T Consensus 84 GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~ 163 (604)
T KOG0592|consen 84 GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLD 163 (604)
T ss_pred ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHH
Confidence 4577888888 45566677776552 2333222222222233344 79999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----------
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---------- 148 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---------- 148 (257)
+|. .-+.|++..++.++.+|+.||+|||++ |||||||||+|||++++++++|.|||.++.+....
T Consensus 164 ~i~--K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~ 238 (604)
T KOG0592|consen 164 LIK--KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPN 238 (604)
T ss_pred HHH--HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcc
Confidence 998 557899999999999999999999999 99999999999999999999999999987643221
Q ss_pred ------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 ------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 ------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
.+..||..|.+||++.....+..+|||+|||+||.|+.|.+||.... +.... +.+++-
T Consensus 239 ~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliF-------------qkI~~l 302 (604)
T KOG0592|consen 239 QASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIF-------------QKIQAL 302 (604)
T ss_pred cccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHH-------------HHHHHh
Confidence 33578889999999999999999999999999999999999997552 11111 122221
Q ss_pred C-CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 T-KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 ~-~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .++...++...+|+.+.|..||.+|+ ++||-+
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1 45666668889999999999999999 988854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=271.37 Aligned_cols=222 Identities=19% Similarity=0.225 Sum_probs=181.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchh--------------hhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT--------------ADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~--------------~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||.+... +++.+++|-.+-. +|+. .+.+++ |+||+++..+....+..++|
T Consensus 28 GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~---------~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 28 GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREIS---------ILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHH---------HHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 568899999755 4577777643221 2332 333888 99999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccC--
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLP-- 144 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~-- 144 (257)
|||+.||+|.+++. ..+++.+.++..++.|+++|++|+|++ +|+||||||+|+|++.+ +.+||+|||++...
T Consensus 99 mEy~~gGdL~~~i~--~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIV--NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred EEecCCccHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999998 468899999999999999999999999 99999999999999999 99999999999866
Q ss_pred -CCCcccccCCCCccCcccccCCC-CC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 145 -NEDFVIDKRDKGYMAPECYKRTP-IS-VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 145 -~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.......+||+.|+|||.+.+.. |+ .++||||+|++||.|++|..||+..... .. ...+..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~l---------~~ki~~ 237 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------NL---------YRKIRK 237 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------HH---------HHHHhc
Confidence 34457789999999999999877 86 7899999999999999999999864111 11 111222
Q ss_pred CC-CCCHHH-HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GT-KVDKKN-LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~-~~~~~~-~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+. .++... ...+..|+.+|+..||.+|+ +.||++
T Consensus 238 ~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 21 333334 67889999999999999999 999973
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.44 Aligned_cols=229 Identities=19% Similarity=0.267 Sum_probs=172.5
Q ss_pred ccccceeeecc------cCCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeec-Ccee
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT-SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~-~~~~ 65 (257)
+.|+.||++.. ..+..+++|... +.+|++.+. ++ .|+||+++.+.+... +..+
T Consensus 18 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 18 GAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILI---------HIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred CCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHH---------HhccCcceeeEEeEecCCCCceE
Confidence 67899999964 223457777653 223333333 55 799999999987754 4678
Q ss_pred EEEeecCCCCHHHHHhccC------------------------------------------------------------C
Q 044568 66 KIERPVRNGSLTDIIFCSA------------------------------------------------------------E 85 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------~ 85 (257)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999997421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCc
Q 044568 86 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAP 160 (257)
Q Consensus 86 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aP 160 (257)
..+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...... ....++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 3477888999999999999999999 99999999999999999999999999987532211 122345679999
Q ss_pred ccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 161 ECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 161 E~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
|.+.+..++.++||||||+++|||++ |..||........ ... ...... ....+...++.+.+++.+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~~------~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---FCQ----RLKDGT------RMRAPENATPEIYRIMLA 312 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---HHH----HHhcCC------CCCCCCCCCHHHHHHHHH
Confidence 99998889999999999999999997 9999976432211 000 000000 011233455679999999
Q ss_pred cccCCCCCCC-hHHHHHhC
Q 044568 240 CVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~~L 257 (257)
||+.||.+|| +.|+++.|
T Consensus 313 cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 313 CWQGDPKERPTFSALVEIL 331 (338)
T ss_pred HccCChhhCcCHHHHHHHH
Confidence 9999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=264.46 Aligned_cols=225 Identities=16% Similarity=0.114 Sum_probs=175.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhH--H-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADI--E-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~--~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||++... +++.+++|........ + .-.+...-..+.++.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (291)
T cd05612 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY 91 (291)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHH
Confidence 568899999976 4556777765432110 0 00000011133388999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
+. ....+++..+..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||++...........+++.|+|
T Consensus 92 ~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~a 166 (291)
T cd05612 92 LR--NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLA 166 (291)
T ss_pred HH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcC
Confidence 97 456789999999999999999999999 9999999999999999999999999998865554455678899999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKNLENLVKVGL 238 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~ 238 (257)
||.+.+..++.++||||||+++|||++|+.||....... ... ..... ..++......+.+++.
T Consensus 167 PE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~-------------~i~~~~~~~~~~~~~~~~~li~ 230 (291)
T cd05612 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYE-------------KILAGKLEFPRHLDLYAKDLIK 230 (291)
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHHhCCcCCCccCCHHHHHHHH
Confidence 999998889999999999999999999999997542111 000 11111 1233344567889999
Q ss_pred HcccCCCCCCC
Q 044568 239 WCVQDEPALRP 249 (257)
Q Consensus 239 ~cl~~~p~~RP 249 (257)
+||+.||.+||
T Consensus 231 ~~l~~dp~~R~ 241 (291)
T cd05612 231 KLLVVDRTRRL 241 (291)
T ss_pred HHcCCCHHHcc
Confidence 99999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.06 Aligned_cols=238 Identities=19% Similarity=0.249 Sum_probs=186.1
Q ss_pred cccccceeeecccCCCC-----Ceeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFNARNS-----PWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-----~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.|+.||+|++..+.. +++|...- ....+...+......+..+.|+||++++|++......+||||+|.||
T Consensus 167 eGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gG 246 (474)
T KOG0194|consen 167 EGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGG 246 (474)
T ss_pred cccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCC
Confidence 36799999999988754 57766552 22333333333333444899999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc---cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV---ID 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~ 151 (257)
+|.++|.+ ....++..++..++.+.+.||+|||++ +++||||.++|+|++.++.+|++|||+++....... ..
T Consensus 247 sL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~ 322 (474)
T KOG0194|consen 247 SLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLK 322 (474)
T ss_pred cHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccc
Confidence 99999986 445799999999999999999999999 999999999999999998999999999875431111 11
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.-...|+|||.+....|+.++||||||+++||+.+ |..||.+.... ....+.. .... ....+...+
T Consensus 323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~----~~~~-----r~~~~~~~p 389 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIV----KNGY-----RMPIPSKTP 389 (474)
T ss_pred cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHH----hcCc-----cCCCCCCCH
Confidence 23456999999999999999999999999999999 88999755211 1111110 0000 114455778
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+..++.+||..+|++|| |.++.+.|
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 8899999999999999999 99998753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.38 Aligned_cols=216 Identities=17% Similarity=0.136 Sum_probs=175.0
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... ++.+++|.... .+|++. +.++.|+|++++.+.+...+..++||||
T Consensus 29 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~---------l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI---------LMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH---------HHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 5688999999765 45567775542 223333 3388999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
+++|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 100 VVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred CCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 99999999997 456789999999999999999999999 9999999999999999999999999998866555555
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (257)
..+++.|+|||.+.+..++.++|||||||++|||++|..||....... .. ....... ..+...
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~-------------~~i~~~~~~~p~~~ 238 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY-------------EKILAGRLKFPNWF 238 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH-------------HHHhcCCcCCCCCC
Confidence 678899999999998889999999999999999999999997542110 00 0111111 223334
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 044568 230 LENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP 249 (257)
...+.+++.+||+.||.+||
T Consensus 239 ~~~~~~li~~~L~~dP~~R~ 258 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRL 258 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcC
Confidence 46788999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=271.72 Aligned_cols=220 Identities=21% Similarity=0.255 Sum_probs=184.1
Q ss_pred ccccceeeecccCCCC-Ceeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNARNS-PWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
++|+.||||+-+.+.. +++|-+. ..+|++.+. +++|+||+.....+....+.++|+|||
T Consensus 13 Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r---------~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 13 GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILR---------SLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHH---------hcCCcchhhHHHhhcccceEEEEehhh
Confidence 5799999999655554 4555322 345555555 999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
.| +|..+|. .++.|+++.+..++.++++||.|||+. +|+|||+||.|||+++++.+|++|||+++......
T Consensus 84 ~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 84 VG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 76 9999998 788999999999999999999999999 99999999999999999999999999998655433
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh-cCCCCCH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTKVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 227 (257)
....||+.|+|||.+.+.+|+..+|+||+||++||+++|++||... .+. .-...+. ++...+.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~---------~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SIT---------QLVKSILKDPVKPPS 221 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHH---------HHHHHHhcCCCCCcc
Confidence 6779999999999999999999999999999999999999999633 010 1111222 2235566
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
+....+.+++...+.+||.+|. =.+++
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 7788999999999999999998 65554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=262.52 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=172.5
Q ss_pred cccccceeeeccc-----CCCCCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFN-----ARNSPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~-----~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.|+.||+|++. .+..+++|...- .+..+.+.- .. ..+.+++|+|++++.+.+...+..++||||+++|
T Consensus 9 ~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~-e~-~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g 86 (259)
T PF07714_consen 9 EGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLN-EI-QILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGG 86 (259)
T ss_dssp EESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHH-HH-HHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTE
T ss_pred cCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeee-cc-cccccccccccccccccccccccccccccccccc
Confidence 3678999999988 234446666532 111111110 11 1333789999999999999888899999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----c
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----V 149 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~ 149 (257)
+|.++|.......+++.++..++.|++.||.|||++ +++|++|+++||+++.++.+||+|||+........ .
T Consensus 87 ~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 87 SLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp BHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence 999999875467899999999999999999999999 99999999999999999999999999987652211 2
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC--CCC
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVD 226 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 226 (257)
.......|+|||.+....++.++||||||+++||+++ |+.||.... .. .+. ..+.+.. ..+
T Consensus 164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~--~~~------------~~~~~~~~~~~~ 227 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NE--EII------------EKLKQGQRLPIP 227 (259)
T ss_dssp TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HH--HHH------------HHHHTTEETTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cc--ccc------------ccccccccceec
Confidence 2334556999999988889999999999999999999 778886441 11 000 0111111 233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..++..+.+++.+||+.||++|| ++++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 44567799999999999999999 99999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.50 Aligned_cols=228 Identities=23% Similarity=0.334 Sum_probs=182.2
Q ss_pred cccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
.+.|+.||||.+- +.++||.++ |.+|+.++. +-||.||+-++|++.+... .||+.+|
T Consensus 402 sGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lk---------kTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 402 SGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLK---------KTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred cccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHh---------hcchhhheeeehhhcCCce-eeeehhc
Confidence 3679999999974 567777655 455665555 8999999999999999998 9999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC-----CC
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP-----NE 146 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~-----~~ 146 (257)
+|.||+.+|+. ....|...+...|+.|+++|+.|||.+ +|+|+|||..||++.+++++||+|||++... ..
T Consensus 470 eGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 470 EGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred cCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 99999999997 667899999999999999999999999 9999999999999999999999999997642 12
Q ss_pred CcccccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 147 DFVIDKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
......+...|+|||++. ..+|++.+||||||+++|||++|..||... ..+.+.+.. ..+.+ ..+..
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmV------GrG~l--~pd~s 615 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMV------GRGYL--MPDLS 615 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEe------ccccc--Cccch
Confidence 224456667799999986 347999999999999999999999999822 222111110 00000 01111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
....++++++.+|+..||.++|++|| +.+|+..
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~ 649 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSK 649 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHH
Confidence 23446778999999999999999999 9999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=267.80 Aligned_cols=231 Identities=18% Similarity=0.121 Sum_probs=178.6
Q ss_pred ccccceeeecccCCC--CCeeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNARN--SPWISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~--~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++...+. .+++|....... ...-.+......+..+.|+|++++.+.+...+..++||||+++|+|.+
T Consensus 41 G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 120 (340)
T PTZ00426 41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120 (340)
T ss_pred cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 568899999865543 567776542110 000001111113338889999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCcc
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYM 158 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (257)
++. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++...........+|+.|+
T Consensus 121 ~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~ 195 (340)
T PTZ00426 121 FLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYI 195 (340)
T ss_pred HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhc
Confidence 997 456799999999999999999999999 999999999999999999999999999886655555667899999
Q ss_pred CcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHH
Q 044568 159 APECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENLVKVG 237 (257)
Q Consensus 159 aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~ 237 (257)
|||.+.+..++.++|+|||||++|||++|..||...... .... ...... .++......+.+++
T Consensus 196 aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~-------------~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ-------------KILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred CHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH-------------HHhcCCCCCCCCCCHHHHHHH
Confidence 999999888999999999999999999999999754211 1111 111111 22333446678999
Q ss_pred HHcccCCCCCC-----C-hHHHHH
Q 044568 238 LWCVQDEPALR-----P-MKCAVM 255 (257)
Q Consensus 238 ~~cl~~~p~~R-----P-~~ei~~ 255 (257)
.+||+.||++| | ++|+++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHc
Confidence 99999999999 6 677654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=258.16 Aligned_cols=223 Identities=16% Similarity=0.191 Sum_probs=175.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++... ++..+++|...- .+|++. +.++.|++++.+...+...+..++||||
T Consensus 11 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i---------l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI---------LEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHH---------HHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 578999999864 566777775431 223333 3378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--Cc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~ 148 (257)
+++|+|.+++.......+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 9999999998754556799999999999999999999999 999999999999999999999999999875432 22
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.............. ... ......+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---------~~~--~~~~~~~~~ 227 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---------RVK--EDQEEYSEK 227 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---------Hhh--cccccCCcc
Confidence 345678899999999998999999999999999999999999986533211111100 000 011123344
Q ss_pred HHHHHHHHHHHcccCCCCCCC
Q 044568 229 NLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP 249 (257)
....+.+++.+||+.||.+||
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERL 248 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhc
Confidence 556788999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=263.50 Aligned_cols=225 Identities=14% Similarity=0.119 Sum_probs=173.0
Q ss_pred ccccceeeecccC-CCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++... +..+++|...-.. .-+..........+.++.|+||+++.+.+...+..++||||+++|+|.++
T Consensus 4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 83 (312)
T cd05585 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHH 83 (312)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHH
Confidence 5689999999765 4456777543110 00000000011123378899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~ 156 (257)
+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++..... ......+|+.
T Consensus 84 l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 84 LQ--REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 97 456789999999999999999999999 999999999999999999999999999874322 1233468889
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh-cCCCCCHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTKVDKKNLENLVK 235 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 235 (257)
|+|||.+.+..++.++||||+||++|||++|+.||...... ... .... .+..++....+.+.+
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~-------------~~~~~~~~~~~~~~~~~~~~ 222 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMY-------------RKILQEPLRFPDGFDRDAKD 222 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHH-------------HHHHcCCCCCCCcCCHHHHH
Confidence 99999999888999999999999999999999999754110 000 0111 112334455677899
Q ss_pred HHHHcccCCCCCCC
Q 044568 236 VGLWCVQDEPALRP 249 (257)
Q Consensus 236 l~~~cl~~~p~~RP 249 (257)
++.+||+.||.+||
T Consensus 223 li~~~L~~dp~~R~ 236 (312)
T cd05585 223 LLIGLLSRDPTRRL 236 (312)
T ss_pred HHHHHcCCCHHHcC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=267.08 Aligned_cols=237 Identities=15% Similarity=0.095 Sum_probs=181.7
Q ss_pred ccccceeeecccC-CCCCeeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++... ++.+++|....... -+...+...-..+..+.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 12 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 91 (333)
T cd05600 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTL 91 (333)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence 5689999999765 56677776542110 0000111111133477899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
+. ....+++.++..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||++...........+++.|+|
T Consensus 92 l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~a 166 (333)
T cd05600 92 LN--NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMA 166 (333)
T ss_pred HH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccC
Confidence 97 456789999999999999999999999 9999999999999999999999999998765554455678899999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC---CHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV---DKKNLENLVKV 236 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 236 (257)
||.+.+..++.++|||||||++|||++|..||...........+..|. ..+..... .......+.++
T Consensus 167 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred hhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------ccccCCCCCccccccCHHHHHH
Confidence 999998899999999999999999999999997552221111111110 01110100 11335678899
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+||+.+|.+|| +.|+++
T Consensus 237 i~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred HHHHhhChhhhcCCHHHHHh
Confidence 9999999999999 999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=264.94 Aligned_cols=242 Identities=16% Similarity=0.157 Sum_probs=182.3
Q ss_pred cccceeeec-ccCCCCCeeeccchhhhHH---HHhHhhhccccccccCCceeeeceeeeec--CceeEEEeecCCCCHHH
Q 044568 5 KLSNFYRSS-FNARNSPWISRVSWTADIE---VLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIERPVRNGSLTD 78 (257)
Q Consensus 5 ~~~~~y~~~-~~~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~~~~gsL~~ 78 (257)
-++.|||++ ..+++.+++|++.|.++-+ ...+..+. .+.++.|+||+++.++.... ...|||+|||++ +|..
T Consensus 129 Tyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~-ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~G 206 (560)
T KOG0600|consen 129 TYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK-ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSG 206 (560)
T ss_pred chhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH-HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhh
Confidence 468899999 6677788999988644111 11111111 33399999999999999876 689999999998 9999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccccCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDKRD 154 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~ 154 (257)
++.. ....|++.+++.++.||+.||.|+|++ +++|||||.+|||++++|.+||+|||++++..... +...-|
T Consensus 207 Ll~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvT 282 (560)
T KOG0600|consen 207 LLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVT 282 (560)
T ss_pred hhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEE
Confidence 9975 567899999999999999999999999 99999999999999999999999999999654332 444556
Q ss_pred CCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh-------hh--hhhhcCC-
Q 044568 155 KGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR-------EL--NKLVRGT- 223 (257)
Q Consensus 155 ~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~- 223 (257)
.=|.|||.+.+. .|+.+.|+||.||++.||++|++.|++..+-+ ++..+..-+.... .+ ...+++.
T Consensus 283 LWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~ 359 (560)
T KOG0600|consen 283 LWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQ 359 (560)
T ss_pred eeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhCCCChhccccccCCcccccCCCC
Confidence 669999999976 59999999999999999999999998763222 1111111111000 00 0111111
Q ss_pred -------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 -------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 -------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.....+....+|+..+|..||.+|. +.++++
T Consensus 360 ~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 360 PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11223346788999999999999999 888764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=255.99 Aligned_cols=227 Identities=16% Similarity=0.200 Sum_probs=174.6
Q ss_pred ccccceeeecccC----CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNA----RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~----~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|+.||+|++.. +..+++|... +.+|++.+. +++|+|++++.+.+...+..++|||
T Consensus 16 G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG---------QFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred cCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHh---------cCCCCCcCeEEEEEecCCCcEEEEE
Confidence 5689999997642 3345555433 223333333 7789999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++++|||.........
T Consensus 87 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 87 YMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred eCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 9999999999975 345789999999999999999999999 99999999999999999999999999765432111
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....++..|+|||.+.+..++.++||||||+++||+++ |..||....... .... ..... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----------~~~~~-~~~ 228 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----------VEDGF-RLP 228 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----------HHCCC-CCC
Confidence 11223457999999998889999999999999999775 999996542111 0000 00000 112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...+..+.+++.+||+.+|.+|| ++||.+.|
T Consensus 229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 229 APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 3445667899999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.50 Aligned_cols=233 Identities=16% Similarity=0.175 Sum_probs=183.1
Q ss_pred ccccceeeecc-cCCCCCeeeccc--h--------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecC-ceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS--W--------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTS-VSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~--~--------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~-~~~lV~E~ 70 (257)
+.|+.||+++- ..++.++||+.. | .+|++.+. ++. |+||+++...+.+.+ ..++||||
T Consensus 21 GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~---------kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 21 GTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLR---------KLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred CcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHH---------hcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 45889999995 455556776533 2 34444444 888 999999999988877 99999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC--CCc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN--EDF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~--~~~ 148 (257)
|+. +|++++.+ .++.|++.+++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+++... .+.
T Consensus 92 Md~-NLYqLmK~-R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 92 MDC-NLYQLMKD-RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred hhh-hHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCc
Confidence 976 99999998 588999999999999999999999999 99999999999999988899999999998643 344
Q ss_pred ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH---------H----------
Q 044568 149 VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV---------Y---------- 208 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~---------~---------- 208 (257)
+....|.=|+|||++.. +.|+.+.|+||+||+++|+.+-++.|.+..+-+.--.++... .
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 66677778999999875 468999999999999999999999998874444322222221 0
Q ss_pred --HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 209 --KCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 209 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
+......+..+ .+. +..+..+|+.+|+.+||.+|| +.|.++.
T Consensus 247 ~~P~~~~~~l~~L-----~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 247 RFPQVKPSPLKDL-----LPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCCcCCCCChHHh-----Ccc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111111 122 668899999999999999999 9998864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.30 Aligned_cols=227 Identities=16% Similarity=0.224 Sum_probs=178.2
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++..++...++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++|+
T Consensus 15 G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 15 GQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMM---------KLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred CcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHH---------HCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 46889999998887777777533 334444444 8899999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++..+..++.|++.||.|||++ +++|+|++|+||+++.++.++++|||.+....... ...
T Consensus 86 L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 86 LLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred HHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 9999975 334689999999999999999999999 99999999999999999999999999886432211 111
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++|+||||+++||+++ |+.||....... ..... ... .....+....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i-----~~~------~~~~~~~~~~ 227 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMI-----SRG------FRLYRPKLAS 227 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-----HCC------CCCCCCCCCC
Confidence 23456999999988888999999999999999999 899996542111 11100 000 0001122234
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|.+|| ++|+++.|
T Consensus 228 ~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 228 MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6789999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=256.39 Aligned_cols=228 Identities=18% Similarity=0.254 Sum_probs=178.0
Q ss_pred ccccceeeecccCCC------CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNARN------SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++...... .+++|... +.+|++.+. ++.|+|++++.+.+...+..+++
T Consensus 16 G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~---------~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS---------DLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred ccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHH---------hcCCcccceEEEEEcCCCceEEE
Confidence 467899999865544 45566543 233444433 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 044568 68 ERPVRNGSLTDIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 133 (257)
|||+++|+|.+++..... ..+++.+...++.|++.||.|||++ +++|+||+|+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 999999999999974311 5688899999999999999999999 99999999999999999999
Q ss_pred EEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHH
Q 044568 134 KILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 134 kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~ 207 (257)
+|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|||++ |..||....... ....
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----~~~~- 238 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----VIEM- 238 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH-
Confidence 999999986432221 23344677999999988889999999999999999998 999997542111 1000
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ....+...+.++.+++.+||+.||.+|| ++||++.|
T Consensus 239 ---i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 239 ---IRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred ---HHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00000 1123455678899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=252.77 Aligned_cols=228 Identities=17% Similarity=0.270 Sum_probs=180.2
Q ss_pred ccccceeeecccCCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++...++..+++|...- .+|++.+. ++.|+|++++.+.+...+..++||||+++|+
T Consensus 17 g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 17 GQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---------TLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred cCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHH---------hCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 568899999988888788876442 23333333 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 99999764566789999999999999999999999 99999999999999999999999999987544322 122
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++|+||||+++|++++ |..||...... ... ... ..... .+.....+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~-~~~---------~~~~~-~~~~~~~~ 230 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM-SAL---------QRGYR-MPRMENCP 230 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH-HHH---------HcCCC-CCCCCCCC
Confidence 33456999999988888999999999999999998 99999644211 111 110 00001 11122345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| ++++.++|
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 6789999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=262.32 Aligned_cols=226 Identities=16% Similarity=0.145 Sum_probs=173.7
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. +++.+++|...-.. ..+.......-..+.++.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 85 (323)
T cd05571 6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 85 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence 568999999865 45566777544211 11111111111133488999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~ 156 (257)
+. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++... .......+|+.
T Consensus 86 l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 86 LS--RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred HH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 97 456789999999999999999999999 99999999999999999999999999986422 22234568899
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++||||+||++|||++|+.||..... ....... ......++......+.++
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~------------~~~~~~~p~~~~~~~~~l 225 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI------------LMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH------------HcCCCCCCCCCCHHHHHH
Confidence 9999999988899999999999999999999999975411 1000000 001113344456778999
Q ss_pred HHHcccCCCCCCC
Q 044568 237 GLWCVQDEPALRP 249 (257)
Q Consensus 237 ~~~cl~~~p~~RP 249 (257)
+.+||+.||++||
T Consensus 226 i~~~L~~dP~~R~ 238 (323)
T cd05571 226 LAGLLKKDPKQRL 238 (323)
T ss_pred HHHHccCCHHHcC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=259.41 Aligned_cols=236 Identities=18% Similarity=0.186 Sum_probs=176.9
Q ss_pred ccccceeeecccCCCC-Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNS-PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++...++. +++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 16 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH---------ECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHH---------HCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 5688999999765544 4455432 334444444 8889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVID 151 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~ 151 (257)
+|+|.+++. ....+++..+..++.|++.||.|||++. +++|+||||+||+++.++.++|+|||++..... .....
T Consensus 87 ~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 87 GGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999999997 4456899999999999999999999861 599999999999999999999999999875432 22344
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh--------------------
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-------------------- 211 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 211 (257)
.++..|+|||.+.+..++.++|||||||++|||++|+.||.......- ......+..
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccCccccccccc
Confidence 678899999999988899999999999999999999999964421110 000000000
Q ss_pred ------------hhhhhhh-hhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 212 ------------INRELNK-LVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 212 ------------~~~~~~~-~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... +.. +..........+.+++.+||+.||++|| +.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000 0011123456799999999999999999 999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.57 Aligned_cols=235 Identities=17% Similarity=0.206 Sum_probs=174.3
Q ss_pred ccccceeeecccCCC-----------------CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeece
Q 044568 4 TKLSNFYRSSFNARN-----------------SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPV 56 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-----------------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 56 (257)
+.++.||++...++. .+++|... +.+|++.+. ++.|+|++++.+
T Consensus 16 G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~ 86 (304)
T cd05096 16 GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILS---------RLKDPNIIRLLG 86 (304)
T ss_pred cCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHh---------hcCCCCeeEEEE
Confidence 578999998754332 35665432 334444444 789999999999
Q ss_pred eeeecCceeEEEeecCCCCHHHHHhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 044568 57 RAKLTSVSGKIERPVRNGSLTDIIFCSA-----------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCD 119 (257)
Q Consensus 57 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 119 (257)
.+...+..++||||+++|+|.+++.... ...+++.+...++.|++.||.|||++ +++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 9999999999999999999999986421 13467888999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh--cCCCCC
Q 044568 120 IKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC--CRKNME 192 (257)
Q Consensus 120 l~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~--g~~pf~ 192 (257)
|||+||+++.++.+||+|||+++...... ....++..|+|||.+....++.++||||||+++|||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999987532221 12234667999999988889999999999999999987 566776
Q ss_pred cCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 193 IDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... ... ........... .. ....+..++..+.+++.+||+.||++|| +.||.+.|
T Consensus 244 ~~~~~~---~~~-~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 244 ELTDEQ---VIE-NAGEFFRDQGR-QV--YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred cCCHHH---HHH-HHHHHhhhccc-cc--cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 432111 111 11111100000 00 0012234567899999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=282.35 Aligned_cols=225 Identities=19% Similarity=0.262 Sum_probs=185.7
Q ss_pred ccccceeeecccCCC----CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|++||+|.+.... .++||.+. |..|.-.++ +..||||+++.|........+||+|
T Consensus 640 GEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG---------QFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 640 GEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG---------QFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred ccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc---------cCCCCcEEEEEEEEecCceeEEEhh
Confidence 468999999987665 34666543 555555555 8999999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (257)
||++|+|+.+|+. .++.+++.+...++++|+.|+.||.+. +.+||||.++|||++.+-.+|++|||+++...++..
T Consensus 711 yMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999998 667799999999999999999999999 999999999999999999999999999997654432
Q ss_pred cc----cC--CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 150 ID----KR--DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 150 ~~----~~--~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
.. -| ..+|.|||.+...+++.+||+||||+++||.++ |..||=.-..+ ..+...-++
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIkaIe~g 850 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKAIEQG 850 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHHHHHhc
Confidence 11 11 246999999999999999999999999999998 88887422111 111222222
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 T--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
- +.|.+++..|.+|++.||++|..+|| +.+|+..|
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 2 55778999999999999999999999 99998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=264.14 Aligned_cols=222 Identities=18% Similarity=0.205 Sum_probs=183.2
Q ss_pred ceeeecccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCc-eeEEEeecCCCC
Q 044568 8 NFYRSSFNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV-SGKIERPVRNGS 75 (257)
Q Consensus 8 ~~y~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~-~~lV~E~~~~gs 75 (257)
..++.+..+. ..++|+++. .+|+++++ +++|||||.+...+..++. .+|||+||+||+
T Consensus 21 ~lvrhk~~~~-~~vlK~I~l~~~t~~~r~~A~~E~~lis---------~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~ 90 (426)
T KOG0589|consen 21 LLVRHKSDDK-LYVLKKINLEKLTEPERRSAIQEMDLLS---------KLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD 90 (426)
T ss_pred hhhhhccCCc-eEEEEEEeccccCchhhHHHHHHHHHHH---------hccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence 3444444443 677777764 23444444 8999999999999999998 999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~ 152 (257)
+.+.|.+..+..++++....|+.|++.|+.|||++ +|+|||||+.||++..+..++|+|||+++..... .....
T Consensus 91 l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvv 167 (426)
T KOG0589|consen 91 LAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVV 167 (426)
T ss_pred HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheec
Confidence 99999986667899999999999999999999999 9999999999999999999999999999976554 36679
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
||+.|++||.+.+.+|+.|+||||+||++|||++-+++|...+... ...+ ....... +.+.....+
T Consensus 168 GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-------Li~k-----i~~~~~~--Plp~~ys~e 233 (426)
T KOG0589|consen 168 GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-------LILK-----INRGLYS--PLPSMYSSE 233 (426)
T ss_pred CCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-------HHHH-----HhhccCC--CCCccccHH
Confidence 9999999999999999999999999999999999999998663221 1111 1111111 445566788
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
+..++..|++.+|+.|| +.+++..
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999 9999863
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=265.13 Aligned_cols=229 Identities=19% Similarity=0.230 Sum_probs=173.1
Q ss_pred ccccceeeecc------cCCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.|+.||++.. .+...+++|... +.+|++.+. .+ .|+||+++.+.+...+..++
T Consensus 49 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~---------~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 49 GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS---------HLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred CCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHH---------hhccCCceeeEeeEecCCCCeEE
Confidence 46889998763 233457777653 223443333 55 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC--------------------------------------------------------------
Q 044568 67 IERPVRNGSLTDIIFCSA-------------------------------------------------------------- 84 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 84 (257)
||||+++|+|.++++...
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999986321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc-----cccC
Q 044568 85 ------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV-----IDKR 153 (257)
Q Consensus 85 ------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~ 153 (257)
...+++.++..++.|++.||.|||++ +++||||||+||++++++.++|+|||++........ ...+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 12478888999999999999999999 999999999999999999999999999864332211 1123
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
+..|+|||.+.+..++.++||||||+++|||++ |+.||........ ..... ..... ...+...+..
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~~---------~~~~~-~~~~~~~~~~ 343 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKMV---------KRGYQ-MSRPDFAPPE 343 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHHH---------HcccC-ccCCCCCCHH
Confidence 456999999988889999999999999999997 9999975422111 00000 00000 0112223567
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+++.+||+.||.+|| +.+++++|
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=249.00 Aligned_cols=228 Identities=22% Similarity=0.329 Sum_probs=179.9
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++....+..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++++
T Consensus 17 g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMK---------KLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred cCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHH---------HCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 46789999998887778887654 233444444 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-ccccC-
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-VIDKR- 153 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~- 153 (257)
|.+++.......+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++....... ....+
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence 99999754446789999999999999999999999 99999999999999999999999999987544221 11122
Q ss_pred --CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 154 --DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 154 --~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
+..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ...... .... ....+...+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----------~~~~-~~~~~~~~~ 230 (261)
T cd05068 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQV----------DQGY-RMPCPPGCP 230 (261)
T ss_pred cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----------HcCC-CCCCCCcCC
Confidence 246999999988889999999999999999999 99999644211 111000 0000 011233455
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|.+|| +.++++.|
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 7899999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=254.43 Aligned_cols=238 Identities=14% Similarity=0.112 Sum_probs=176.4
Q ss_pred ccccceeeecccCC-CCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++...+ ..+++|.... .+|++.+. .+.|+|++++.+.+...+..++||||+
T Consensus 12 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR---------TLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHH---------hCCCccccchhhhEecCCEEEEEEecC
Confidence 56889999998654 4566765432 23444444 888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---- 147 (257)
+++++..+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 83 EKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9877765554 456799999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH--------hhhhhhhhhh
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK--------CFINRELNKL 219 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 219 (257)
.....++..|+|||.+.+..++.++|+||+||++|||++|+.||.................+ ..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 12346788899999998888999999999999999999999999765322211111111000 0000000000
Q ss_pred hcCC---------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT---------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+. .........+.+++.+||+.||++|| ++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00112346799999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=250.10 Aligned_cols=228 Identities=18% Similarity=0.202 Sum_probs=178.1
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++...+ +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++++
T Consensus 17 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK---------EIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred cccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHH---------hCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 4578899998765 4455666433 334444444 788999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----c
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV----I 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~ 150 (257)
+|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+........ .
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 999999754456789999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+..|+|||.+.+..++.++|+||||+++|||++ |..||....... .... ..... ....+...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----------~~~~~-~~~~~~~~ 230 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----------LEKGY-RMERPEGC 230 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----------HHCCC-CCCCCCCC
Confidence 123456999999988889999999999999999998 899986442111 0000 00000 11233445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..+.+++.+||+.+|++|| +.++++.|
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 67899999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=264.15 Aligned_cols=230 Identities=19% Similarity=0.238 Sum_probs=173.4
Q ss_pred cccccceeeecc------cCCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCcee
Q 044568 3 CTKLSNFYRSSF------NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 3 ~~~~~~~y~~~~------~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 65 (257)
.+.|+.||+++. ..+..+++|... +.+|++.+. .+ .|+||+++.+.+...+..+
T Consensus 45 ~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~---------~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 45 AGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS---------YLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred CCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHH---------HhcCCcceeeeeeeeccCCcce
Confidence 357899999863 233456676543 223444443 55 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccC-------------------------------------------------------------
Q 044568 66 KIERPVRNGSLTDIIFCSA------------------------------------------------------------- 84 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 84 (257)
+|||||++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999996421
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc---
Q 044568 85 ------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV--- 149 (257)
Q Consensus 85 ------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~--- 149 (257)
...+++..+..++.|++.||.|||++ +++||||||.||+++.++.+||+|||++........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 12478888999999999999999999 999999999999999999999999999875432211
Q ss_pred --cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 150 --IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 150 --~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
...++..|+|||.+.+..++.++||||||+++|||++ |..||........ ....... ... ...+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~~~~~-----~~~-----~~~~ 339 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYKMIKE-----GYR-----MLSP 339 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHHHHHh-----Ccc-----CCCC
Confidence 1223456999999998899999999999999999998 8888865422111 1111000 000 0112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+.++.+++.+||+.||++|| +.|+++.|
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 22346789999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=248.61 Aligned_cols=227 Identities=14% Similarity=0.214 Sum_probs=176.0
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 6 g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 6 GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILK---------QYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred ccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHH---------hCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 568899999975 55566777432 233333333 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc--
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI-- 150 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (257)
+++|.+++.. ....+++.++..++.|++.||.|||++ +++|+|++|.||+++.++.++|+|||.+.........
T Consensus 77 ~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 77 GGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred CCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9999999974 345689999999999999999999999 9999999999999999999999999998753322111
Q ss_pred ---ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 151 ---DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 151 ---~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
...+..|+|||.+.+..++.++|+||||+++||+++ |..||....... ... ..... .....+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~---------~~~~~-~~~~~~ 218 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TRE---------AIEQG-VRLPCP 218 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHH---------HHHcC-CCCCCc
Confidence 122345999999988889999999999999999998 888886431110 000 00000 011233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+..+.+++.+||+.+|++|| +.|+.++|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 44567899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=248.54 Aligned_cols=227 Identities=18% Similarity=0.235 Sum_probs=177.9
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++...+...++|... +.+|++.+. .+.|+|++++.+.+...+..++||||+++++
T Consensus 15 G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 15 GQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMM---------KLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred CCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHH---------hCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 46789999998776677776533 234444444 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-ccc---
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-VID--- 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~--- 151 (257)
|.+++.. ....+++..+..++.|++.|+.|||++ +++|+|++|+||+++.++.+|++|||.++...... ...
T Consensus 86 L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 86 LLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred HHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 9999975 345789999999999999999999999 99999999999999999999999999887533221 111
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+..|+|||.+.+..++.++|+||||+++||+++ |..||....... ... ....... ...+...+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----------~~~~~~~-~~~~~~~~ 227 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE----------SVSAGYR-LYRPKLAP 227 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH----------HHHcCCc-CCCCCCCC
Confidence 22346999999998889999999999999999999 899996542111 000 0000001 12233456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| +.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=246.55 Aligned_cols=235 Identities=18% Similarity=0.232 Sum_probs=178.9
Q ss_pred ccccceeeecccCCCCCeeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
+.++.||+++..++..+++|...- ..+.+........ .+.++.|+|++++.+.+...+..++||||+++++|.+++.
T Consensus 6 g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 84 (250)
T cd05085 6 GNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR 84 (250)
T ss_pred CCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHH
Confidence 568999999988877788876432 1111110001111 3337889999999999999999999999999999999997
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----cccCCCCc
Q 044568 82 CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV----IDKRDKGY 157 (257)
Q Consensus 82 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~ 157 (257)
. ....+++..+..++.|++.||.|+|++ +++|+|++|+||+++.++.++|+|||++........ ...++..|
T Consensus 85 ~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 160 (250)
T cd05085 85 K-KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160 (250)
T ss_pred h-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccc
Confidence 5 345689999999999999999999999 999999999999999999999999998864332221 12234569
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
+|||++....++.++|+||||+++|++++ |..||....... ... ...... ....+...+..+.++
T Consensus 161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~----------~~~~~~-~~~~~~~~~~~~~~l 226 (250)
T cd05085 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE----------QVEKGY-RMSCPQKCPDDVYKV 226 (250)
T ss_pred cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----------HHHcCC-CCCCCCCCCHHHHHH
Confidence 99999988888999999999999999998 999996442111 000 000000 112233456789999
Q ss_pred HHHcccCCCCCCC-hHHHHHhC
Q 044568 237 GLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+||+.+|++|| +.|+++.|
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred HHHHcccCcccCCCHHHHHHHh
Confidence 9999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=270.43 Aligned_cols=226 Identities=16% Similarity=0.114 Sum_probs=175.4
Q ss_pred ccccceeeecccCC--CCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNAR--NSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~--~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++..... ..+++|.... .+|++. +..+.|+||+++.+.+...+..+|||||++
T Consensus 78 G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~---------l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 78 NPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHC---------LAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred CCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHH---------HHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 46788898875443 4455554322 223333 348899999999999999999999999999
Q ss_pred CCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 73 NGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 73 ~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
+|+|.+++... ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 345688999999999999999999999 9999999999999999999999999998754332
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ..... .. .. ....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~-~~~~~-----~~----~~--~~~~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--E-IMQQV-----LY----GK--YDPF 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--H-HHHHH-----Hh----CC--CCCC
Confidence 23345888999999999888999999999999999999999999754211 0 00000 00 00 0122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+......+.+++.+||+.||++|| ++++++
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 333456789999999999999999 999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=258.56 Aligned_cols=232 Identities=17% Similarity=0.155 Sum_probs=175.6
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|...-.. .-+.......-..+..+.|+|++++...+...+..++||||+++|+|.++
T Consensus 6 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 85 (328)
T cd05593 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH 85 (328)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence 568899999865 45566677554210 00000100011133478899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~ 156 (257)
+. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.... ......+|+.
T Consensus 86 l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 86 LS--RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 87 456799999999999999999999999 999999999999999999999999999864321 1233468889
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|||||||++|||++|+.||....... .... . ......++......+.++
T Consensus 161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~-----~-------~~~~~~~p~~~~~~~~~l 225 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL-----I-------LMEDIKFPRTLSADAKSL 225 (328)
T ss_pred ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHH-----h-------ccCCccCCCCCCHHHHHH
Confidence 999999998889999999999999999999999997542110 0000 0 001112334455778999
Q ss_pred HHHcccCCCCCC-----C-hHHHHH
Q 044568 237 GLWCVQDEPALR-----P-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~R-----P-~~ei~~ 255 (257)
+.+||+.||++| | +.|+++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 999999999999 4 677654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=248.75 Aligned_cols=235 Identities=22% Similarity=0.255 Sum_probs=181.6
Q ss_pred ccccceeeecccCCCCCeeeccchhhh--HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTAD--IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
+.++.||++....+..+++|...-... .+.+. ..-..+.++.|+|++++.+.+...+..++||||+++|+|.+++.
T Consensus 17 g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (261)
T cd05148 17 GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQ--KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR 94 (261)
T ss_pred CCCccEEEeEecCCCcEEEEeccccchhhHHHHH--HHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHh
Confidence 457899999988888888876542111 11111 11113348899999999999999999999999999999999998
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCcc
Q 044568 82 CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGYM 158 (257)
Q Consensus 82 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~ 158 (257)
......+++.....++.|++.|+.|||++ +++|+|++|+||++++++.++++|||.+....... ....++..|+
T Consensus 95 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~ 171 (261)
T cd05148 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171 (261)
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEec
Confidence 65566789999999999999999999999 99999999999999999999999999887543322 1223345699
Q ss_pred CcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 044568 159 APECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVG 237 (257)
Q Consensus 159 aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 237 (257)
+||.+....++.++|+||||+++|++++ |+.||...... ...... .... ....+...++.+.+++
T Consensus 172 ~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~----------~~~~-~~~~~~~~~~~~~~~i 237 (261)
T cd05148 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI----------TAGY-RMPCPAKCPQEIYKIM 237 (261)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----------HhCC-cCCCCCCCCHHHHHHH
Confidence 9999988889999999999999999998 89999654211 011100 0000 0122345567889999
Q ss_pred HHcccCCCCCCC-hHHHHHhC
Q 044568 238 LWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 238 ~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+||+.||.+|| ++++++.|
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 238 LECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHH
Confidence 999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=251.16 Aligned_cols=229 Identities=19% Similarity=0.242 Sum_probs=176.3
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|...- ..|++ .+.++.|+|++++...+......++||||
T Consensus 4 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~---------il~~l~hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---------ILEKVNSPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHH---------HHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence 5789999998654 56666665531 11222 33388999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++|+|.+++.......+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee
Confidence 9999999998764556789999999999999999999999 9999999999999999999999999988754332 2
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||++.+..++.++|+||+||++|||++|+.||............ .. ........ .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~-----~~~~~~~~--~~~~~ 221 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KR-----RTLEDEVK--FEHQN 221 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HH-----Hhhccccc--ccccc
Confidence 3446788999999999888999999999999999999999999754222111111 00 00000000 01122
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
....+.+++..||+.||++|| ++|++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccch
Confidence 456789999999999999999 96654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=250.89 Aligned_cols=228 Identities=17% Similarity=0.235 Sum_probs=174.7
Q ss_pred ccccceeeeccc-----CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN-----ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~-----~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+|+.. .+..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 16 CAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA---------ELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred cCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHh---------hCCCCCeeeEEEEEecCCceEEEE
Confidence 568899999853 33455666553 233443433 889999999999999999999999
Q ss_pred eecCCCCHHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 044568 69 RPVRNGSLTDIIFCSA---------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 133 (257)
||+++|+|.+++.... ...+++.+...++.|++.||.|||++ +++|+|++|+||+++.++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 9999999999985211 23578889999999999999999999 99999999999999999999
Q ss_pred EEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHH
Q 044568 134 KILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 134 kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~ 207 (257)
+|+|||++...... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||...... ......
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~----~~~~~~ 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVIEMV 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH
Confidence 99999998643221 122234556999999988889999999999999999998 98998654211 000000
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.... ....+...+..+.+++.+||+.||++|| +.+|.+.|
T Consensus 240 ----~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 240 ----RKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred ----HcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 0000 0122334557789999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.14 Aligned_cols=229 Identities=14% Similarity=0.120 Sum_probs=184.2
Q ss_pred ccccceeeecccCCCCC-eeeccc---hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVS---WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+-|+.||.++..+++.+ |+|.+. ..+--++-+|......+....++++|++.-.+++.+..||||||++||++..+
T Consensus 152 GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTL 231 (550)
T KOG0605|consen 152 GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTL 231 (550)
T ss_pred ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHH
Confidence 34778888886655554 555433 33333344444444456678899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-------------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE------------- 146 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~------------- 146 (257)
|. ....|++..++.++.+.+.|++-+|+. |++||||||+|+|+|..|++||+|||++.-...
T Consensus 232 L~--~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~ 306 (550)
T KOG0605|consen 232 LM--RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQM 306 (550)
T ss_pred HH--hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhh
Confidence 98 678899999999999999999999999 999999999999999999999999999742110
Q ss_pred ------------C-----c--------------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC
Q 044568 147 ------------D-----F--------------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189 (257)
Q Consensus 147 ------------~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~ 189 (257)
. . .+..|||-|+|||++.+..|+...|+||+||++|||+.|-+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyP 386 (550)
T KOG0605|consen 307 QINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYP 386 (550)
T ss_pred hhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCC
Confidence 0 0 24478889999999999999999999999999999999999
Q ss_pred CCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 190 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
||.++.+......+.+|......+.+. ....+.++||.+|+. ||++|-
T Consensus 387 PF~s~tp~~T~rkI~nwr~~l~fP~~~-----------~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 387 PFCSETPQETYRKIVNWRETLKFPEEV-----------DLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred CCCCCCHHHHHHHHHHHhhhccCCCcC-----------cccHHHHHHHHHHhc-CHHHhc
Confidence 999887776666677775433322221 122678899999999 999997
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.30 Aligned_cols=226 Identities=17% Similarity=0.233 Sum_probs=172.6
Q ss_pred ccccceeeeccc---CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN---ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~---~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+|.+. .+..+++|... +.+|++++. ++.|+|++++.+.+. .+..++||||
T Consensus 6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred CCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHH---------hcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 568899998764 22345666443 223344444 789999999998765 4578999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 999999999975 456789999999999999999999999 99999999999999999999999999987433221
Q ss_pred ----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 149 ----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
....++..|+|||.+....++.++|+||||+++||+++ |..||....... ..... ... ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~---------~~~-~~~ 217 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VMSFI---------EQG-KRL 217 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHH---------HCC-CCC
Confidence 11122457999999988888999999999999999996 999997542111 00000 000 011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+...++.+.+++.+||+.+|++|| +.+|.+.|
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 23445567899999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=247.15 Aligned_cols=227 Identities=21% Similarity=0.230 Sum_probs=176.6
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeee-ecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK-LTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++.. +..+++|... +.+|++.+. ++.|++++++.+.+. ..+..++||||+++++
T Consensus 17 g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 17 GEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT---------QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred cCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHH---------hCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 467899999765 5666776544 234444444 888999999998754 4567899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+|++|||++............+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 163 (256)
T cd05082 87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 163 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCCCCccce
Confidence 99999864455689999999999999999999999 999999999999999999999999999875444333334456
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||++.+..++.++|+||||+++|||++ |+.||...... ..... .... .....+...+..+.
T Consensus 164 ~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~---------~~~~-~~~~~~~~~~~~~~ 229 (256)
T cd05082 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR---------VEKG-YKMDAPDGCPPVVY 229 (256)
T ss_pred eecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---------HhcC-CCCCCCCCCCHHHH
Confidence 7999999988889999999999999999998 99998643110 00000 0000 01122344567899
Q ss_pred HHHHHcccCCCCCCC-hHHHHHhC
Q 044568 235 KVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+++.+||+.+|++|| +.++++.|
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=250.20 Aligned_cols=195 Identities=19% Similarity=0.235 Sum_probs=153.7
Q ss_pred ccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 044568 42 KCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 121 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 121 (257)
.+..+.|+|++++.+.+...+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||+
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlk 144 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVC 144 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCC
Confidence 34478899999999999999999999999999999999975 456789999999999999999999999 99999999
Q ss_pred CCceeeCCCC-------ceEEeeecccccCCCCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHH-hcCCCCC
Q 044568 122 PQNILMDEFW-------TAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETI-CCRKNME 192 (257)
Q Consensus 122 ~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~-~g~~pf~ 192 (257)
|+||+++..+ .++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++||++ +|..||.
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALS-REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccc-ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9999997543 479999998753322 223456778999998875 45789999999999999995 6899987
Q ss_pred cCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 193 IDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....... ..... . ....+......+.+++.+||+.+|++|| +.++++.|
T Consensus 224 ~~~~~~~----~~~~~---------~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 224 ERTPSEK----ERFYE---------K---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccChHHH----HHHHH---------h---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 5422111 01000 0 0011112235688999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=257.50 Aligned_cols=226 Identities=16% Similarity=0.144 Sum_probs=172.9
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|....... -+.......-..+.++.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~ 85 (323)
T cd05595 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 85 (323)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHH
Confidence 578999999865 456667776542110 0010100111133488999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~ 156 (257)
+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ......+++.
T Consensus 86 l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 86 LS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred HH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 87 445789999999999999999999999 999999999999999999999999998764221 1233468889
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|+|||||++|||++|+.||....... ..... .......+....+.+.++
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~~------------~~~~~~~p~~~~~~~~~l 225 (323)
T cd05595 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI------------LMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH------------hcCCCCCCCCCCHHHHHH
Confidence 999999998889999999999999999999999997542111 00000 001112334456778999
Q ss_pred HHHcccCCCCCCC
Q 044568 237 GLWCVQDEPALRP 249 (257)
Q Consensus 237 ~~~cl~~~p~~RP 249 (257)
+.+||+.||.+||
T Consensus 226 i~~~L~~dP~~R~ 238 (323)
T cd05595 226 LAGLLKKDPKQRL 238 (323)
T ss_pred HHHHccCCHHHhC
Confidence 9999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=249.37 Aligned_cols=243 Identities=14% Similarity=0.095 Sum_probs=181.9
Q ss_pred cccceeeecccCCC-CCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 5 KLSNFYRSSFNARN-SPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 5 ~~~~~y~~~~~~~~-~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
.-++|||-+..+++ .++||+.-- ...++.+...... -+..++|+|+|++...++......||+|||++ ++.+-|
T Consensus 14 SYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIr-mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eL 91 (396)
T KOG0593|consen 14 SYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIR-MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHEL 91 (396)
T ss_pred cceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHH-HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHH
Confidence 45789998865554 456776432 2344444444444 44499999999999999999999999999987 566666
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCc
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGY 157 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~ 157 (257)
.. .+.+++.....+++.|++.|+.|+|++ +++||||||+|||++.++.+||+|||+++....+. +...-|.-|
T Consensus 92 e~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWY 167 (396)
T KOG0593|consen 92 ER-YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWY 167 (396)
T ss_pred Hh-ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhc
Confidence 55 678899999999999999999999999 99999999999999999999999999999765433 444566779
Q ss_pred cCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-------------
Q 044568 158 MAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT------------- 223 (257)
Q Consensus 158 ~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 223 (257)
.|||.+.+ .+|+...||||+||++.||++|.+.|.+.+.-+....+....- ...+.-+.++...
T Consensus 168 RaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG--~L~prhq~iF~~N~~F~Gv~lP~~~~ 245 (396)
T KOG0593|consen 168 RAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG--NLIPRHQSIFSSNPFFHGVRLPEPEH 245 (396)
T ss_pred cChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc--ccCHHHHHHhccCCceeeeecCCCCC
Confidence 99999998 5799999999999999999999999987743332211111110 0111111111110
Q ss_pred --CC---CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 --KV---DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 --~~---~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+. .......+.+++..|++.||.+|+ .+|++.
T Consensus 246 ~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 246 PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 111235789999999999999999 998863
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.17 Aligned_cols=234 Identities=15% Similarity=0.177 Sum_probs=169.9
Q ss_pred cccccceeeecccCCC-------------CCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 3 CTKLSNFYRSSFNARN-------------SPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~-------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
.+.++.||+|+...+. .+++|...-...-........-..+..+.|+|++++.+.+......++|||
T Consensus 5 ~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 84 (262)
T cd05077 5 RGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEE 84 (262)
T ss_pred cCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEe
Confidence 4678999999865433 245554321111000000111113347889999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-------eEEeeecccc
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-------AKILDFGLAK 142 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-------~kl~dfg~~~ 142 (257)
|+++|+|..++.. ....+++..+..++.|++.|+.|||++ +++||||+|+||+++.++. ++++|||.+.
T Consensus 85 ~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 85 FVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred cccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 9999999999874 445689999999999999999999999 9999999999999986553 8999999876
Q ss_pred cCCCCcccccCCCCccCccccc-CCCCCccccchhHHHHHHHHH-hcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 143 LPNEDFVIDKRDKGYMAPECYK-RTPISVKADVYGYGIVLLETI-CCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 143 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~s~G~~l~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.... .....++..|+|||.+. ...++.++||||||+++|||+ +|..||........ .. ......
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~-----~~~~~~---- 226 (262)
T cd05077 161 TVLS-RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER-----FYEGQC---- 226 (262)
T ss_pred cccC-cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH-----HHhcCc----
Confidence 4322 23345677899999887 456889999999999999998 48888764311110 00 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.........+.+++.+||+.||++|| +.+|++.|
T Consensus 227 ---~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 ---MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11112345688999999999999999 99999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.85 Aligned_cols=235 Identities=15% Similarity=0.152 Sum_probs=171.7
Q ss_pred ccccceeeecccCCCC-----CeeeccchhhhHHH-HhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVSWTADIEV-LSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~~~~~~~~-~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++.....+. +++|.......-+. ......-..+.++.|+|++++.+.+. ....++++||+++|+|.
T Consensus 18 G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~ 96 (279)
T cd05111 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLL 96 (279)
T ss_pred cCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHH
Confidence 5688999999765544 44555432111000 00000000223788999999999875 45577899999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----cccc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDK 152 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~ 152 (257)
+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||.++...... ....
T Consensus 97 ~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 172 (279)
T cd05111 97 DHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172 (279)
T ss_pred HHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCC
Confidence 99975 456789999999999999999999999 99999999999999999999999999987532211 2223
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
++..|++||.+.+..++.++|+||||+++||+++ |..||....... ...+.. .. .....+..+..
T Consensus 173 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~----~~------~~~~~~~~~~~ 238 (279)
T cd05111 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLE----KG------ERLAQPQICTI 238 (279)
T ss_pred CcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH----CC------CcCCCCCCCCH
Confidence 4567999999988889999999999999999998 999997542111 111100 00 00011223446
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+..++.+||+.+|.+|| +.|+++.|
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 788899999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.26 Aligned_cols=224 Identities=18% Similarity=0.196 Sum_probs=180.6
Q ss_pred ccccceeeecccCCCCC-eeeccc---h--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVS---W--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~---~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.|+.|+.+++..+++. +||.+. . ..+++.......-..+.. +||.++++...++..++.++||||+.||++.
T Consensus 379 GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~ 457 (694)
T KOG0694|consen 379 GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLM 457 (694)
T ss_pred CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccCCeEEEEEEecCCCcEE
Confidence 46888999987766654 555433 1 233443332222212223 7999999999999999999999999999955
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc---CCCCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL---PNEDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~---~~~~~~~~~~~ 154 (257)
.++ ....+++..++.|+..++.||+|||++ +|++||||.+|||+|..|++||+|||+++. .+......+||
T Consensus 458 ~~~---~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGT 531 (694)
T KOG0694|consen 458 HHI---HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGT 531 (694)
T ss_pred EEE---ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCC
Confidence 544 567899999999999999999999999 999999999999999999999999999985 34555778999
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh-hcCCCCCHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL-VRGTKVDKKNLENL 233 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 233 (257)
+.|+|||++.+..|+..+|+|||||++|||+.|..||.++++++- ...+ .+...+|.....+.
T Consensus 532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------FdsI~~d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------FDSIVNDEVRYPRFLSKEA 595 (694)
T ss_pred hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHhcCCCCCCCcccHHH
Confidence 999999999999999999999999999999999999987733221 1111 22235677777889
Q ss_pred HHHHHHcccCCCCCCC-h
Q 044568 234 VKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~ 250 (257)
+.++.+++..+|++|. +
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 9999999999999998 7
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=246.45 Aligned_cols=227 Identities=17% Similarity=0.227 Sum_probs=177.0
Q ss_pred ccccceeeecccCCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||.++...+..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+++|+
T Consensus 15 G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 15 GQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM---------KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred cccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHh---------cCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 457899999887777788875542 33434333 8899999999999998899999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-c---cc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-V---ID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~---~~ 151 (257)
|.+++.. ....+++.++..++.|++.|+.|||++ +++|+||+|.||+++.++.+|++|||.++...... . ..
T Consensus 86 l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 86 LLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9999975 344789999999999999999999999 99999999999999999999999999877433221 1 12
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|++||.+.+..++.++|+||||+++|||++ |..||....... .... ...... ...+....
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----------~~~~~~-~~~~~~~~ 227 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEK----------VSQGLR-LYRPHLAS 227 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----------HhcCCC-CCCCCCCC
Confidence 23456999999988889999999999999999998 999986442111 0000 000000 01122235
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|.+|| +.++++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 7889999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=252.46 Aligned_cols=241 Identities=17% Similarity=0.140 Sum_probs=174.5
Q ss_pred ccccceeeecccC--CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeee-----ecCcee
Q 044568 4 TKLSNFYRSSFNA--RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK-----LTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~--~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~~~ 65 (257)
+.++.||+++... +..+++|.... .+|++.+. .+..+.|+|++++.+.+. .....+
T Consensus 12 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 12 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR------HLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHH------hhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 5689999998643 34567775432 22333332 233567999999998875 245688
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||++ ++|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 9999996 6999999764556789999999999999999999999 99999999999999999999999999987543
Q ss_pred CC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh------
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN------ 217 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 217 (257)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..||...........+....... ......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~ 240 (290)
T cd07862 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GEEDWPRDVALP 240 (290)
T ss_pred CCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhchhhhccc
Confidence 22 234467888999999988889999999999999999999999998653222111111100000 000000
Q ss_pred -hhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 -KLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 -~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... ....+..+.+.+++.+||+.||++|| +.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 01112346778999999999999999 999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=255.18 Aligned_cols=240 Identities=18% Similarity=0.190 Sum_probs=184.1
Q ss_pred cccccceeeecccCC-CCCeeeccc----h-hhhHHHHhHhhhccccccccCCceeeeceeeeecC-----ceeEEEeec
Q 044568 3 CTKLSNFYRSSFNAR-NSPWISRVS----W-TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----VSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~-~~~~i~~~~----~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~lV~E~~ 71 (257)
|+.|++||+|++.+. +.+|||++- + ..|.+.+. .+.|+|||++...+.... ...+|||||
T Consensus 34 ~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~---------~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 34 SGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMR---------KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred ecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHH---------hcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 688999999998888 566777643 2 56777666 889999999999888533 335899999
Q ss_pred CCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccC--CC
Q 044568 72 RNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLP--NE 146 (257)
Q Consensus 72 ~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~--~~ 146 (257)
+. +|.+.++.. .+..++...++-+..||..||.|||+. +|+||||||.|+|+|.+ +.+||+|||.++.. +.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 85 999999742 467788889999999999999999999 99999999999999975 89999999999864 34
Q ss_pred CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-----------Hhhhhh
Q 044568 147 DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-----------KCFINR 214 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~ 214 (257)
+..+..+|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+++..+....+....- +.+...
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 44666788889999999875 599999999999999999999999998643332222111110 000000
Q ss_pred hhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.... .+.....++..+++.++++++|.+|. +.|++.
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 001111111 14455668899999999999999999 888764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.33 Aligned_cols=219 Identities=18% Similarity=0.142 Sum_probs=173.4
Q ss_pred ccccceeeecc----cCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSF----NARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~----~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++. ..+..+++|...- .+|++ .+.++.|+||+++.+.+...+..++||
T Consensus 7 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~---------~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD---------ILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHH---------HHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 45788998774 3455667765442 12233 333889999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999999997 456789999999999999999999999 9999999999999999999999999998754322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TK 224 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 224 (257)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .... ..... ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~-------------~i~~~~~~ 216 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT-------------MILKAKLG 216 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH-------------HHHcCCCC
Confidence 23446788999999998888899999999999999999999999754211 0000 01111 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKC 252 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~e 252 (257)
.+......+.+++.+||+.||++|| +.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3334456788999999999999999 766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=255.08 Aligned_cols=235 Identities=17% Similarity=0.186 Sum_probs=171.9
Q ss_pred ccccceeeecccCCCC-----CeeeccchhhhHH-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVSWTADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~~~~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+|+...... +++|........+ ...+.........+.|+|++++.+.+... ..++|+||+++|+|.
T Consensus 18 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~ 96 (316)
T cd05108 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLL 96 (316)
T ss_pred CCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHH
Confidence 5689999998654443 5666643110000 00000011133388899999999988764 567999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----cccc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDK 152 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~ 152 (257)
+++.. ....+++.....++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...... ....
T Consensus 97 ~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 172 (316)
T cd05108 97 DYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172 (316)
T ss_pred HHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCc
Confidence 99985 455688999999999999999999999 99999999999999999999999999987543222 1122
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.+..|++||.+.+..++.++||||||+++||+++ |..||...... . ..... .... ....+..+..
T Consensus 173 ~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~--~~~~~---------~~~~-~~~~~~~~~~ 238 (316)
T cd05108 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E--ISSIL---------EKGE-RLPQPPICTI 238 (316)
T ss_pred cceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H--HHHHH---------hCCC-CCCCCCCCCH
Confidence 3456999999998889999999999999999998 99999754111 0 11110 0000 0011223456
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.+++.+||+.+|.+|| +.+++..|
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 788999999999999999 99998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=246.86 Aligned_cols=225 Identities=17% Similarity=0.246 Sum_probs=171.7
Q ss_pred ccccceeeecc---cCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSF---NARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~---~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|.+ .++..+++|.... .+|++. +.++.|+|++++.+.+. .+..++|||
T Consensus 6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANV---------MQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHH---------HHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 56889999864 3455666765432 222333 33788999999988765 556789999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++. ....+++..+..++.|++.|+.|||++ +++|+||+|.||+++.++.++|+|||.+.......
T Consensus 76 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 76 LAELGPLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 999999999997 445789999999999999999999999 99999999999999999999999999987543221
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||.+....++.++|+||||+++||+++ |..||...... ..... ..... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~----i~~~~------~ 216 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQM----IESGE------R 216 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHCCC------C
Confidence 11122457999999988888999999999999999998 99999744111 11000 00000 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||++|| +++|.+.|
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 123334567899999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=254.87 Aligned_cols=230 Identities=16% Similarity=0.131 Sum_probs=174.0
Q ss_pred ccccceeeecccCC-CCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++...+ +.+++|..... ...+..... .........|+||+++.+.+...+..++||||+++|+|.
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~ 84 (316)
T cd05592 6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE-RRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLM 84 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHH-HHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHH
Confidence 57899999997654 45777765421 111111100 000111347999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~ 154 (257)
+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......+|
T Consensus 85 ~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 85 FHIQ--SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 9997 445789999999999999999999999 99999999999999999999999999986432 222344678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ....... .. .....+......+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i----------~~--~~~~~~~~~~~~~~ 224 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSI----------LN--DRPHFPRWISKEAK 224 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHH----------Hc--CCCCCCCCCCHHHH
Confidence 999999999988899999999999999999999999975421 1111100 00 01122334456788
Q ss_pred HHHHHcccCCCCCCC-hH-HHH
Q 044568 235 KVGLWCVQDEPALRP-MK-CAV 254 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~-ei~ 254 (257)
+++.+||+.||.+|| +. +++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999 65 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.03 Aligned_cols=236 Identities=15% Similarity=0.160 Sum_probs=173.5
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. ++..+++|.... .+|++.+. .+.|+|++++.+.+...+..++||||++
T Consensus 16 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 16 GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK---------GLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred cCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHh---------hCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 568899999976 456677776542 23444444 8889999999999999999999999996
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~ 149 (257)
++|.+++.. ....++...+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ...
T Consensus 87 -~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 87 -TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred -cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 688888865 456789999999999999999999999 999999999999999999999999998864322 223
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhh---h---hh-
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--REL---N---KL- 219 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~---~---~~- 219 (257)
...+++.|+|||.+.+. .++.++||||+||++|||++|..||......... +.......... ... . ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhccccc
Confidence 44667889999998654 5788999999999999999999999754221111 11110000000 000 0 00
Q ss_pred ------hcCCCC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 ------VRGTKV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ------~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+... .......+.+++.+||+.||++|| +.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 001124677899999999999999 999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=256.62 Aligned_cols=224 Identities=16% Similarity=0.180 Sum_probs=171.6
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccc-cccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCT-RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~-~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++... +..+++|...-. ...+... .... .+. ...|+|++++.+.+...+..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~-~e~~-~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L 83 (320)
T cd05590 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTM-TEKR-ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83 (320)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHH-HHHH-HHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchH
Confidence 5689999999765 455677765421 1111110 0000 111 23699999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.... .......|
T Consensus 84 ~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 84 MFHIQ--KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 99997 446799999999999999999999999 99999999999999999999999999876421 22234568
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (257)
|+.|+|||.+.+..++.++|+||||+++|||++|+.||....... ... ..... ...+......
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~-------------~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE-------------AILNDEVVYPTWLSQD 222 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH-------------HHhcCCCCCCCCCCHH
Confidence 889999999998889999999999999999999999997542111 110 11111 1223334567
Q ss_pred HHHHHHHcccCCCCCCC-h
Q 044568 233 LVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~ 250 (257)
+.+++.+||+.||++|| +
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 89999999999999999 7
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=256.64 Aligned_cols=226 Identities=19% Similarity=0.190 Sum_probs=173.1
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhh-ccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMR-GSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~-~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++.... +..+++|...-. .+.+.+..... -..+.++.|+|++++.+.+...+..++||||+++|+|
T Consensus 10 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 89 (324)
T cd05589 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL 89 (324)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcH
Confidence 5688999998654 556677765421 11221110000 0023467899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
...+. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......+
T Consensus 90 ~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 163 (324)
T cd05589 90 MMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCG 163 (324)
T ss_pred HHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccccccc
Confidence 99885 35799999999999999999999999 99999999999999999999999999876422 22234467
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .... ....+...+..
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~-------------~i~~~~~~~p~~~~~~ 227 (324)
T cd05589 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFD-------------SIVNDEVRYPRFLSRE 227 (324)
T ss_pred CccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHhCCCCCCCCCCHH
Confidence 88999999999888999999999999999999999999754211 1110 0111 11233345577
Q ss_pred HHHHHHHcccCCCCCCC-hH
Q 044568 233 LVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ 251 (257)
+.+++.+||+.||.+|| ++
T Consensus 228 ~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCC
Confidence 88999999999999998 54
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=244.87 Aligned_cols=227 Identities=21% Similarity=0.307 Sum_probs=177.2
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++...+..+++|... +.+|++++. ++.|+|++++.+.+. .+..++||||+++|+
T Consensus 17 g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 17 GCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMK---------KLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred cCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHH---------hCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 46789999998877777777543 234445444 888999999987764 567889999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 99999764455689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||...+..++.++|+||||+++||+++ |..||....... .. ... .... ....+...+
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-~~~---------~~~~-~~~~~~~~~ 229 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL-EQV---------ERGY-RMPCPQGCP 229 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-HHH---------HcCC-CCCCCcccC
Confidence 34556999999988889999999999999999999 899997542111 00 000 0000 012234456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.||++|| +++++++|
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 7899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=244.93 Aligned_cols=235 Identities=23% Similarity=0.249 Sum_probs=180.4
Q ss_pred cccccceeeecccCCCCCeeeccchhhh-HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVSWTAD-IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
++.++.||+++.. +..+++|....... .+.+. ... ..+.++.|+|++++.+.+...+..++||||+++++|.+++.
T Consensus 16 ~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~-~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 92 (256)
T cd05039 16 KGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFL-AEA-SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR 92 (256)
T ss_pred cCCCceEEEEEec-CcEEEEEEeccchhHHHHHH-HHH-HHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHH
Confidence 4678999999875 66778877653211 11110 011 13348889999999999999999999999999999999997
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcc
Q 044568 82 CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPE 161 (257)
Q Consensus 82 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE 161 (257)
......+++.....++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.++...........+..|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape 169 (256)
T cd05039 93 SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPE 169 (256)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccccCCCcccccCch
Confidence 54445799999999999999999999999 999999999999999999999999999876543333334455699999
Q ss_pred cccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHc
Q 044568 162 CYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWC 240 (257)
Q Consensus 162 ~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 240 (257)
.+....++.++|+||||+++||+++ |..||....... ....... .. ....+...++.+.+++.+|
T Consensus 170 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~---------~~-~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEK---------GY-RMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred hhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhc---------CC-CCCCccCCCHHHHHHHHHH
Confidence 9988888999999999999999997 999986441110 1000000 00 0112333457899999999
Q ss_pred ccCCCCCCC-hHHHHHhC
Q 044568 241 VQDEPALRP-MKCAVMML 257 (257)
Q Consensus 241 l~~~p~~RP-~~ei~~~L 257 (257)
|+.+|++|| +.|+++.|
T Consensus 236 l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 236 WELDPAKRPTFKQLREQL 253 (256)
T ss_pred hccChhhCcCHHHHHHHH
Confidence 999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.62 Aligned_cols=234 Identities=15% Similarity=0.165 Sum_probs=175.5
Q ss_pred cccccceeeeccc-CCCCCeeeccchhhhH---HHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSWTADI---EVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~~~~~---~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
.+.++.||+++.. +++.+++|...-.... ..-.....-..+.++.|+|++++...+...+..++||||+++|+|.+
T Consensus 3 ~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (280)
T cd05608 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRY 82 (280)
T ss_pred CCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHH
Confidence 3678999999865 4556777765421100 00000001112337889999999999999999999999999999998
Q ss_pred HHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccC
Q 044568 79 IIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKR 153 (257)
Q Consensus 79 ~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~ 153 (257)
.+... ....+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||.+...... .....+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 83 HIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 88532 345689999999999999999999999 9999999999999999999999999998643322 123467
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh-cCCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (257)
++.|+|||.+.+..++.++|+||||+++|||++|+.||............. .... .+...+...+..
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------QRILNDSVTYPDKFSPA 227 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH------------HhhcccCCCCcccCCHH
Confidence 889999999999899999999999999999999999997543221111100 0111 111334455678
Q ss_pred HHHHHHHcccCCCCCCC-hH
Q 044568 233 LVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ 251 (257)
+.+++.+||+.||++|| ++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCC
Confidence 89999999999999999 63
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=248.09 Aligned_cols=228 Identities=15% Similarity=0.198 Sum_probs=176.8
Q ss_pred ccccceeeecccCC------CCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++..+. ..+++|... +.+|++.+. ++.|+|++++.+.+...+..++|
T Consensus 16 g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT---------NFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred cCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHH---------hcCCCCchheeeEEecCCCeEEE
Confidence 46789999986443 556676543 233444444 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 68 ERPVRNGSLTDIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|||+++|+|.+++.... ...+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEE
Confidence 99999999999997421 24578899999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHH
Q 044568 136 LDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYK 209 (257)
Q Consensus 136 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 209 (257)
+|||.+....... ....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~-~~-- 237 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE-CI-- 237 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-HH--
Confidence 9999886432211 22234567999999998899999999999999999998 999986542111 000 00
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 210 CFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. .. ....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 238 --~~----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 238 --TQ----GR--LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred --Hc----CC--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 00 00 0122334557789999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=243.49 Aligned_cols=236 Identities=17% Similarity=0.230 Sum_probs=179.1
Q ss_pred cccccceeeeccc-CCCCCeeeccchh--hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSWT--ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
.+.++.+|+++.. ++..+++|..... ...........-..+.+++|+|++++.+.+...+..++||||+++++|.++
T Consensus 10 ~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd08529 10 KGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKL 89 (256)
T ss_pred CCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHH
Confidence 3577899999865 4566677754421 000000110000133488999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~ 156 (257)
+.......+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....... ....++..
T Consensus 90 l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 166 (256)
T cd08529 90 LKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY 166 (256)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCcc
Confidence 9864456789999999999999999999999 99999999999999999999999999877543322 23356778
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||+..+..++.++|+||||+++|+|++|+.||.... ....... ....... ..+......+.++
T Consensus 167 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~---------~~~~~~~--~~~~~~~~~~~~~ 232 (256)
T cd08529 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILK---------IIRGVFP--PVSQMYSQQLAQL 232 (256)
T ss_pred ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHH---------HHcCCCC--CCccccCHHHHHH
Confidence 999999998889999999999999999999999997552 1110000 0001111 2222455779999
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+||+.+|++|| +.++++
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHccCCcccCcCHHHHhh
Confidence 9999999999999 999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=256.05 Aligned_cols=226 Identities=18% Similarity=0.153 Sum_probs=174.1
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh-----hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA-----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++.. ++..+++|...... +.+.+. ......+..++|+|++++...+...+..++||||+++|+|.
T Consensus 6 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 84 (323)
T cd05575 6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIM-AERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELF 84 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHH-HHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHH
Confidence 568899999975 45667788765321 111111 11111233688999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~ 154 (257)
+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......++
T Consensus 85 ~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 85 FHLQ--RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 9997 456789999999999999999999999 99999999999999999999999999886422 122344678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENL 233 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 233 (257)
+.|+|||.+.+..++.++||||||+++|||++|..||...... .... .... ....+......+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~-------------~i~~~~~~~~~~~~~~~ 223 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYD-------------NILNKPLRLKPNISVSA 223 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHH-------------HHHcCCCCCCCCCCHHH
Confidence 8999999999888999999999999999999999999754211 0000 0111 112223346778
Q ss_pred HHHHHHcccCCCCCCC-hH
Q 044568 234 VKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~ 251 (257)
.+++.+||+.||.+|| ++
T Consensus 224 ~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 224 RHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHhhcCHHhCCCCC
Confidence 9999999999999999 74
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=245.73 Aligned_cols=231 Identities=16% Similarity=0.212 Sum_probs=179.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++|+||
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK---------QLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred CCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHH---------hCCCcceeeeeeeEEECCeEEEEEEe
Confidence 568899999965 55666777432 223333333 88999999999999999999999999
Q ss_pred cCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 71 VRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
+++|+|.+++... ....++...+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999988532 234588899999999999999999999 99999999999999999999999999877543322
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
....++..|+|||.+.+..++.++|+||||+++||+++|..||......... +.. .......+...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~~------~~~~~~~~~~~ 229 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LCQ------KIEQCDYPPLP 229 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-----HHH------HHhcCCCCCCC
Confidence 2345677899999998888899999999999999999999999654222111 000 01111111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 334557799999999999999999 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=258.28 Aligned_cols=232 Identities=16% Similarity=0.148 Sum_probs=175.0
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|...... .-+..........+..+.|+|++++...+...+..++||||+++|+|.++
T Consensus 6 G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~ 85 (325)
T cd05594 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 85 (325)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence 568999999854 45556666554211 00111111111133478899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~ 155 (257)
+. ....+++.++..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||+++... .......+++
T Consensus 86 l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 86 LS--RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 87 45678999999999999999999997 7 99999999999999999999999999876422 1223446889
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+..++.++||||||+++|||++|..||....... .... . .......+....+.+.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~-----i-------~~~~~~~p~~~~~~~~~ 225 (325)
T cd05594 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL-----I-------LMEEIRFPRTLSPEAKS 225 (325)
T ss_pred ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHH-----H-------hcCCCCCCCCCCHHHHH
Confidence 9999999998889999999999999999999999997542110 0000 0 00111233344567889
Q ss_pred HHHHcccCCCCCC-----C-hHHHHH
Q 044568 236 VGLWCVQDEPALR-----P-MKCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~R-----P-~~ei~~ 255 (257)
++.+||+.||++| | +.++++
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 9999999999999 5 677654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=245.44 Aligned_cols=227 Identities=22% Similarity=0.304 Sum_probs=176.5
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++..++..+++|... +.+|++.+. ++.|+|++++.+... .+..++||||+++|+
T Consensus 17 g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~---------~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 17 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK---------KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred CCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHH---------hCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 45789999998877778887654 233444444 788999999987764 466799999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----cc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV----ID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~~ 151 (257)
|.+++.......+++..+..++.|++.||.|+|++ +++|+||+|.||++++++.++|+|||.+........ ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 99999754455689999999999999999999999 999999999999999999999999999875433221 22
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||...+..++.++|+||||+++||+++ |..||....... .... ..... ....+...+
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~----------~~~~~-~~~~~~~~~ 229 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ----------VERGY-RMPCPPECP 229 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHH----------HhcCC-CCCCccccC
Confidence 34456999999988889999999999999999999 888886442111 0000 00000 012234456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.+|++|| +.+++++|
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 7889999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=249.17 Aligned_cols=238 Identities=16% Similarity=0.170 Sum_probs=176.4
Q ss_pred cccccceeeecccC------CCCCeeeccchhhhHHH-HhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 3 CTKLSNFYRSSFNA------RNSPWISRVSWTADIEV-LSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 3 ~~~~~~~y~~~~~~------~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
.+.++.||+|+... +..+++|.......-.. -.+.........+.|+|++++.+.+...+..++++||+++++
T Consensus 15 ~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~ 94 (283)
T cd05091 15 EDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94 (283)
T ss_pred CCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCc
Confidence 35689999998654 34567777653211000 000000012237889999999999999999999999999999
Q ss_pred HHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 76 LTDIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 76 L~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
|.+++... ....+++..+..++.|++.||.|+|++ +++||||||.||++++++.+||+|||++
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (283)
T cd05091 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF 171 (283)
T ss_pred HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccc
Confidence 99998521 123578888999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 142 KLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 142 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
+...... ....+++.|+|||.+....++.++||||||+++|||++ |..||...... .+... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~-i~~~- 242 (283)
T cd05091 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVIEM-IRNR- 242 (283)
T ss_pred cccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH-HHcC-
Confidence 7533221 12234567999999988889999999999999999998 88888644111 01000 0000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+....+..++..+.+++..||+.+|.+|| ++||++.|
T Consensus 243 -----~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 243 -----QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 01123455677899999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=244.38 Aligned_cols=227 Identities=21% Similarity=0.314 Sum_probs=177.6
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++....+..+++|... +.+|++++. ++.|++++++.+... .+..++||||+++++
T Consensus 17 g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~---------~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 17 GQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMK---------KLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred ccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHH---------hcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 46789999998888888887654 234444444 889999999998774 566889999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.+.....+++.++..++.|++.||.|||++ +++|+|++|+||++++++.++|+|||.+....... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 99999764456689999999999999999999999 99999999999999999999999999987543221 112
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++|+||||+++||+++ |..||....... .... .... .....+...+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----------~~~~-~~~~~~~~~~ 229 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ----------VERG-YRMPCPQDCP 229 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----------HHcC-CCCCCCCcCC
Confidence 23456999999988889999999999999999999 889996442111 1110 0000 0112334456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|.+|| ++++.+.|
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 7899999999999999999 99998765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=272.30 Aligned_cols=223 Identities=18% Similarity=0.222 Sum_probs=179.3
Q ss_pred ccccceeeecccCC-CCCeeeccc---------hhhhHHHHhHhhhcccccccc-CCceeeeceeeee-------cCcee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS---------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKL-------TSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~-------~~~~~ 65 (257)
++||.||.++...+ ...++|+.- ..+|++++. .+. |+|||.+.+.... .-+++
T Consensus 48 GGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK---------~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 48 GGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMK---------LLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred CCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHH---------HhcCCCceeeEeccccccccCCCceeEEE
Confidence 68999999999888 888888743 245555555 443 9999999993221 12667
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
|.||||+||+|-|++......+|++.++++|+.|+++|+.+||.. .++|+|||||.+|+|+..++..||+|||-+....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999865666799999999999999999999998 7789999999999999999999999999876322
Q ss_pred CCc------------ccccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh
Q 044568 146 EDF------------VIDKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC 210 (257)
Q Consensus 146 ~~~------------~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 210 (257)
... -....|+.|++||++. +.++++|+||||+||+||-++++..||+.....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------- 264 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------- 264 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------------
Confidence 211 2235678899999985 667899999999999999999999999744111
Q ss_pred hhhhhhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 211 FINRELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 211 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.++.+. +........+.+||..||+.||.+|| +-+++..
T Consensus 265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 223322 22346778999999999999999999 9988764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.18 Aligned_cols=238 Identities=16% Similarity=0.201 Sum_probs=174.3
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... ++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 16 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 16 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK---------NLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHH---------hCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 567899999865 455667775432 24444444 8889999999999999999999999997
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~ 149 (257)
|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ...
T Consensus 87 -~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 87 -SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred -cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 499999874 445688999999999999999999999 999999999999999999999999999864322 123
Q ss_pred cccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhh-hhhhhhhhh
Q 044568 150 IDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCF-INRELNKLV 220 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~ 220 (257)
...++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||................ ++.. ...+.....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 3456788999999875 458899999999999999999999997653221111110000 0000 000011100
Q ss_pred cCC-------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGT-------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
-+. .........+.+++.+||+.||.+|| ++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 00111235678999999999999999 999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=254.19 Aligned_cols=178 Identities=20% Similarity=0.238 Sum_probs=148.1
Q ss_pred ccccceeeecccCCCCC-eeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++...+... ++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 16 g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH---------ECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHH---------HCCCCcccceeEEEEECCEEEEEEecCC
Confidence 46789999997755444 444322 234444444 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVID 151 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~ 151 (257)
+|+|.+++. ....+++..+..++.|++.|+.|||++. +++|+||||+||+++.++.+||+|||++..... .....
T Consensus 87 ~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 87 GGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999999997 4456889999999999999999999741 799999999999999999999999998864322 22344
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.++..|+|||.+.+..++.++|+|||||++||+++|+.||...
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 6788899999998888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=245.38 Aligned_cols=227 Identities=18% Similarity=0.200 Sum_probs=175.6
Q ss_pred ccccceeeecccCC----CCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNAR----NSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~----~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|+...+ ..+++|.... .+|++. +.++.|+|++++.+.+...+..++|||
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASI---------MGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred CccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHH---------HHhCCCCCcceEeEEEecCCceEEEEE
Confidence 56889999987543 3446665431 223333 338889999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++++|.+++.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||++++++.++++|||++.......
T Consensus 86 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 86 YMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred cCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999975 445789999999999999999999999 99999999999999999999999999987653111
Q ss_pred ----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 149 ----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
....++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ..... ..... ..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~---------~~~~~-~~ 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKA---------VEDGY-RL 227 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHH---------HHcCC-CC
Confidence 11233456999999988889999999999999999998 99998543111 01010 00000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+...++.+.+++.+||+.+|++|| +.|+++.|
T Consensus 228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 12334567899999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.13 Aligned_cols=225 Identities=15% Similarity=0.129 Sum_probs=171.2
Q ss_pred ccccceeeeccc----CCCCCeeeccchhhh----HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVSWTAD----IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++.. .+..+++|....... .........-..+..+.|+||+++.+.+...+..++||||+++|+
T Consensus 7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (323)
T cd05584 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 86 (323)
T ss_pred cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCch
Confidence 568899998753 455667776542110 000000001113338889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Cccccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~ 152 (257)
|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.... ......
T Consensus 87 L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (323)
T cd05584 87 LFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence 999997 456688899999999999999999999 999999999999999999999999998763221 123346
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLE 231 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (257)
+++.|+|||.+.+..++.++||||||+++|||++|+.||....... . ........ ..+....+
T Consensus 162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~-------------~~~~~~~~~~~~~~~~~ 225 (323)
T cd05584 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---T-------------IDKILKGKLNLPPYLTP 225 (323)
T ss_pred CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---H-------------HHHHHcCCCCCCCCCCH
Confidence 7889999999998888999999999999999999999997542110 0 11111111 23334456
Q ss_pred HHHHHHHHcccCCCCCCC
Q 044568 232 NLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP 249 (257)
.+.+++.+||+.||++||
T Consensus 226 ~~~~li~~~l~~~p~~R~ 243 (323)
T cd05584 226 EARDLLKKLLKRNPSSRL 243 (323)
T ss_pred HHHHHHHHHcccCHhHcC
Confidence 789999999999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=254.59 Aligned_cols=237 Identities=16% Similarity=0.185 Sum_probs=171.2
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~l 66 (257)
+.++.||++... ++..+++|... +.+|++.+. +++|+|++++.+++... ...++
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 11 GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR---------LLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHH---------hCCCCCEeeecceEeccCCCCCceEEE
Confidence 568899999855 56677787653 223444443 88899999999877543 24799
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|||||+ ++|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 82 VFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999995 69999987 455799999999999999999999999 999999999999999999999999999874321
Q ss_pred Cc------ccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhh
Q 044568 147 DF------VIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCF 211 (257)
Q Consensus 147 ~~------~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~ 211 (257)
.. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||................ ....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 11 23467888999999865 568899999999999999999999997542211000000000 0000
Q ss_pred hhhh----hhhhhcCCCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 212 INRE----LNKLVRGTKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 212 ~~~~----~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... ...+......+ ....+.+.+++.+||+.||++|| ++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00111111110 11245678999999999999999 999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.09 Aligned_cols=231 Identities=16% Similarity=0.136 Sum_probs=174.8
Q ss_pred cccccceeeecccCC-CCCeeeccchhh-----hHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 3 CTKLSNFYRSSFNAR-NSPWISRVSWTA-----DIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~-~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
.+.++.||++....+ ..+++|...... ..+....... .+..+ .|+|++++.+.+...+..++||||+++|+
T Consensus 5 ~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~--il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 82 (318)
T cd05570 5 KGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR--VLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGD 82 (318)
T ss_pred eCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHH--HHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence 357899999987654 456777554211 1111100000 11122 69999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCccccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~ 152 (257)
|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++... .......
T Consensus 83 L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 83 LMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999997 445799999999999999999999999 99999999999999999999999999876421 1223345
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||..... ....... .. .....+...+..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i-----~~-------~~~~~~~~~~~~ 222 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSI-----LE-------DEVRYPRWLSKE 222 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHH-----Hc-------CCCCCCCcCCHH
Confidence 78899999999998999999999999999999999999975421 1100000 00 011233345577
Q ss_pred HHHHHHHcccCCCCCCC-h-----HHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-M-----KCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~-----~ei~~ 255 (257)
+.+++.+||+.||.+|| + .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 89999999999999999 8 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.64 Aligned_cols=230 Identities=15% Similarity=0.146 Sum_probs=173.9
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... ++.+++|...-. ...+.... ..........|++++++.+.+...+..++||||+++|+|.
T Consensus 6 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~-e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~ 84 (316)
T cd05620 6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-EKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLM 84 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHH-HHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHH
Confidence 5689999999765 455677765421 11111110 0000111347999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~ 154 (257)
+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++... ........++
T Consensus 85 ~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 85 FHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 9997 456789999999999999999999999 9999999999999999999999999987632 1222445678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
..|+|||.+.+..++.++||||+|+++|||++|+.||...... ...... . ......+......+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~----------~--~~~~~~~~~~~~~~~ 224 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI----------R--VDTPHYPRWITKESK 224 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----------H--hCCCCCCCCCCHHHH
Confidence 9999999999889999999999999999999999999754211 111100 0 011122333456788
Q ss_pred HHHHHcccCCCCCCC-hH-HHH
Q 044568 235 KVGLWCVQDEPALRP-MK-CAV 254 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~-ei~ 254 (257)
+++.+||+.||++|| +. ++.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999 74 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=248.88 Aligned_cols=228 Identities=16% Similarity=0.222 Sum_probs=174.3
Q ss_pred ccccceeeecccC------CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT---------NLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred cCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHh---------cCCCCCcceEEEEEccCCceEEEE
Confidence 4578899987432 2234555533 233444434 889999999999999999999999
Q ss_pred eecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 044568 69 RPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 134 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 134 (257)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999997422 23488999999999999999999999 999999999999999999999
Q ss_pred EeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHH
Q 044568 135 ILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVY 208 (257)
Q Consensus 135 l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~ 208 (257)
|+|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~--- 237 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC--- 237 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---
Confidence 99999986433221 22234567999999988889999999999999999999 999986442110 1100
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 209 KCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... ...+...+..+.+++.+||+.+|++|| +.+++++|
T Consensus 238 --~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 238 --ITQGRV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred --HhCCCC------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 000000 012233456789999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.92 Aligned_cols=223 Identities=18% Similarity=0.209 Sum_probs=170.2
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. +++.+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 85 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 85 GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR---------DVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHH---------hCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 578999999865 45667777642 233444444 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+|+|.+.. ..++.....++.|++.||.|||++ +++|||||++||+++.++.+||+|||++...... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 99986543 345677888999999999999999 9999999999999999999999999998754332 23
Q ss_pred cccCCCCccCcccccCC-----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 150 IDKRDKGYMAPECYKRT-----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
...++..|+|||.+... ..+.++|||||||++|||++|+.||............... .......
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----------~~~~~~~ 295 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-----------CMSQPPE 295 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----------hccCCCC
Confidence 45678899999987532 2346899999999999999999999743221111000000 0001112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+......+.+++.+||+.||++|| +.|+++
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2334557799999999999999999 999986
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=248.21 Aligned_cols=225 Identities=19% Similarity=0.241 Sum_probs=175.3
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++... +++.+++|...- .+|++.+ .++.|+|++.+.+.+...+..++||||
T Consensus 11 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---------~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL---------EKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHH---------HhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 467899999865 456677775531 2233333 388899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++|+|.+++.......+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 9999999998754456799999999999999999999999 9999999999999999999999999998754322 1
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++||||+|+++||+++|..||........ ..... ..... .....+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~------~~~~~--~~~~~~~~ 227 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVE------RRVKE--DQEEYSEK 227 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHH------HHhhh--cccccCcc
Confidence 334678899999999888899999999999999999999999975422111 00000 00000 01123334
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
.+..+.+++.+||+.||++|| +.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCC
Confidence 566789999999999999999 55
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.52 Aligned_cols=230 Identities=17% Similarity=0.144 Sum_probs=173.9
Q ss_pred ccccceeeecccCC-CCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++....+ ..+++|...-. ...+.... ..........|+|++++.+.+...+..++||||+++|+|.
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~-e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~ 84 (316)
T cd05619 6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLM 84 (316)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHH-HHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 56899999997654 45777765421 11111110 0000111357999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~ 154 (257)
+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.... .......+|
T Consensus 85 ~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 85 FHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 9997 446789999999999999999999999 99999999999999999999999999876421 222345678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
..|+|||.+.+..++.++|+|||||++|||++|+.||..... ....... .. .....+......+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i--------~~----~~~~~~~~~~~~~~ 224 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSI--------RM----DNPCYPRWLTREAK 224 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------Hh----CCCCCCccCCHHHH
Confidence 899999999988899999999999999999999999975421 1111110 00 01112233446688
Q ss_pred HHHHHcccCCCCCCC-hH-HHH
Q 044568 235 KVGLWCVQDEPALRP-MK-CAV 254 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~-ei~ 254 (257)
+++.+||+.||++|| +. ++.
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHH
Confidence 999999999999999 76 654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.51 Aligned_cols=233 Identities=15% Similarity=0.187 Sum_probs=172.6
Q ss_pred ccccceeeecccCCC-CCeeeccchh-----hhHHHHhHhhhcccccc-ccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWT-----ADIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~-----~~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++...++ .+++|...-. ...+.+.. ....+.+ ..|+|++++.+.+...+..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~--E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L 83 (329)
T cd05618 6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQT--EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHH--HHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCH
Confidence 568999999976554 4566654321 11111110 0001112 3699999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......+
T Consensus 84 ~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 84 MFHMQ--RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 99987 456799999999999999999999999 99999999999999999999999999886422 22234567
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChh-hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPE-EIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
|..|+|||++.+..++.++|+||||+++|||++|+.||........ ......+....... .....+......
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------~~~~~p~~~~~~ 231 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQIRIPRSLSVK 231 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-------CCCCCCCCCCHH
Confidence 8899999999988899999999999999999999999964221111 01111111111100 111334455677
Q ss_pred HHHHHHHcccCCCCCCC-h
Q 044568 233 LVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~ 250 (257)
+.+++.+||+.||++|| +
T Consensus 232 ~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 232 AASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHhcCCHHHcCCC
Confidence 88999999999999999 6
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=257.73 Aligned_cols=238 Identities=18% Similarity=0.170 Sum_probs=178.1
Q ss_pred cccccceeeecccC-CCCCeeeccc---hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVS---WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
.+.++.||++.... ++.+++|... +.+|++++. ++.|+||+++.+.+...+..++|+|++. ++|.+
T Consensus 102 ~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~ 171 (391)
T PHA03212 102 PGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILR---------AINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC 171 (391)
T ss_pred CCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHH---------hCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence 36788999998654 4556777644 356777766 8899999999999999999999999995 68999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC----CcccccCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE----DFVIDKRD 154 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~ 154 (257)
++. ....+++.+++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++..... ......+|
T Consensus 172 ~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 246 (391)
T PHA03212 172 YLA--AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246 (391)
T ss_pred HHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCc
Confidence 886 446789999999999999999999999 999999999999999999999999999864322 12344688
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCCh----hhHHHHHHHHHhh---------hhhhhh----
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP----EEIILTNWVYKCF---------INRELN---- 217 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~---------~~~~~~---- 217 (257)
+.|+|||++.+..++.++|||||||++|||++|..||....... ....+........ ......
T Consensus 247 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~ 326 (391)
T PHA03212 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYI 326 (391)
T ss_pred cCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHH
Confidence 99999999998889999999999999999999998875432111 0011111100000 000000
Q ss_pred hhhc-----CC--CC---CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVR-----GT--KV---DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~-----~~--~~---~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... +. .. ....+..+.+++.+||+.||++|| ++|+++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 327 GLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00 00 112356789999999999999999 999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=264.29 Aligned_cols=225 Identities=17% Similarity=0.206 Sum_probs=184.2
Q ss_pred ccccceeeecccCCCCC-eeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
++.++||.|-+..-.-. ++|.+. |..|..++. .+.|+|+|++.|.|..+..+|||+|||.+|
T Consensus 278 GQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMK---------eikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 278 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK---------EIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred CcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHH---------hhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 45688999987765443 444432 455555555 899999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-ccccC
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-VIDKR 153 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 153 (257)
+|.++|++....-++....+.++.||.+|+.||..+ +++||||.++|+|++++..+|++|||+++.+..+. +...|
T Consensus 349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 999999986667778788889999999999999999 99999999999999999999999999999765544 33333
Q ss_pred C---CCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC---CCC
Q 044568 154 D---KGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---KVD 226 (257)
Q Consensus 154 ~---~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 226 (257)
. .-|.|||.+..+.++.|+|||+||++|||+.| |-.||.+.+- .+.-.++... .-+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----------------SqVY~LLEkgyRM~~P 488 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYGLLEKGYRMDGP 488 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----------------HHHHHHHhccccccCC
Confidence 2 34999999999999999999999999999999 7788865421 1111222221 446
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..|++.+.+|++.||+.+|.+|| ++||.+.+
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqaf 520 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAF 520 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHH
Confidence 67889999999999999999999 99998753
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.32 Aligned_cols=224 Identities=17% Similarity=0.178 Sum_probs=169.3
Q ss_pred ccccceeeecccCC-CCCeeeccchh-----hhHHHHhHhhhccccccccC-CceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++...+ ..+++|..... ...+... .....+..+.| .+++.+...+...+..++||||+++|+|
T Consensus 11 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~--~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L 88 (324)
T cd05587 11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTM--VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 88 (324)
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHH--HHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcH
Confidence 67899999987654 45777765421 1111110 00111224445 4577888888888999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~ 153 (257)
.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++... ........+
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 163 (324)
T cd05587 89 MYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163 (324)
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecC
Confidence 99997 456789999999999999999999999 9999999999999999999999999987632 122234568
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
|+.|+|||++.+..++.++|+||+||++|||++|+.||...... ..... ... ....+....+.
T Consensus 164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~-------------i~~~~~~~~~~~~~~ 227 (324)
T cd05587 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS-------------IMEHNVSYPKSLSKE 227 (324)
T ss_pred CccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH-------------HHcCCCCCCCCCCHH
Confidence 89999999999988999999999999999999999999754211 11110 111 11223344567
Q ss_pred HHHHHHHcccCCCCCCC-h
Q 044568 233 LVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~ 250 (257)
+.+++.+||+.||.+|| .
T Consensus 228 ~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHhhcCHHHcCCC
Confidence 88999999999999999 6
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.13 Aligned_cols=235 Identities=14% Similarity=0.177 Sum_probs=172.6
Q ss_pred ccccceeeecccC-CCCCeeeccchh--hhHHHHh-Hhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT--ADIEVLS-VAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~--~~~~~~~-~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++... +..+++|...-. ...+... +......+..+ .|+||+++.+.+...+..++||||+++|+|.+
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 85 (329)
T cd05588 6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF 85 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHH
Confidence 5689999998765 445667655421 1111000 01111111133 69999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~~ 155 (257)
++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++... ........||+
T Consensus 86 ~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 86 HMQ--RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 987 446799999999999999999999999 9999999999999999999999999988642 22223456888
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChh-hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPE-EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++|+||||+++||+++|+.||........ ......+....... .....+......+.
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~p~~~~~~~~ 233 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-------KQIRIPRSLSVKAS 233 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-------CCCCCCCCCCHHHH
Confidence 99999999988899999999999999999999999974322110 00011111111100 11123344556789
Q ss_pred HHHHHcccCCCCCCC-h
Q 044568 235 KVGLWCVQDEPALRP-M 250 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~ 250 (257)
+++.+||+.||.+|| +
T Consensus 234 ~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 234 SVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHhccCHHHcCCC
Confidence 999999999999998 5
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=253.69 Aligned_cols=217 Identities=16% Similarity=0.159 Sum_probs=170.3
Q ss_pred ccccceeeecccCC-CCCeeeccchh------------hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT------------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~------------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...+ ..+++|..... .|.+.+. ....|+|++++.+.+...+..++||||
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~--------~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA--------LAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH--------hccCCCCccceeeEEEcCCeEEEEEeC
Confidence 56899999987654 55677765421 1111111 123699999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CC
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---ED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~ 147 (257)
+++|+|.+.+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.... ..
T Consensus 78 ~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 78 VNGGDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99999999997 456789999999999999999999999 99999999999999999999999999886422 11
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (257)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... .... ..... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~-------------~i~~~~~~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE-------------SILHDDVLYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH-------------HHHcCCCCCC
Confidence 23345788999999999888999999999999999999999999755211 1111 11111 1223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
......+.+++..||+.||++||
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcC
Confidence 33456788999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=259.89 Aligned_cols=235 Identities=16% Similarity=0.157 Sum_probs=176.2
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHH---HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIE---VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. +++.+++|........+ ...+......+..+.|+|++++...+...+..++||||+++|+|.++
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (350)
T cd05573 12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL 91 (350)
T ss_pred CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHH
Confidence 568999999976 45667777654211000 00001111123377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----------- 148 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----------- 148 (257)
+.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 92 l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 166 (350)
T cd05573 92 LIR--KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166 (350)
T ss_pred HHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccc
Confidence 974 36799999999999999999999999 99999999999999999999999999987543221
Q ss_pred ---------------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH
Q 044568 149 ---------------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 149 ---------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 207 (257)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~- 245 (350)
T cd05573 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINW- 245 (350)
T ss_pred ccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhcc-
Confidence 3346788899999999989999999999999999999999999755211110000000
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC--hHHHHH
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP--MKCAVM 255 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~ 255 (257)
...... +.....++.+.+++.+|++ ||.+|| +.|+++
T Consensus 246 ---------~~~~~~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 246 ---------KESLRF-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---------CCcccC-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 000000 1111135778899999997 999999 777764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=258.58 Aligned_cols=230 Identities=16% Similarity=0.174 Sum_probs=174.7
Q ss_pred cccccceeeecccCC------CCCeeeccc----------hhhhHHHHhHhhhcccccccc-CCceeeeceeeeecCcee
Q 044568 3 CTKLSNFYRSSFNAR------NSPWISRVS----------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~ 65 (257)
.+.|+.||+|+.... ..+++|... +.+|++++. ++. |+||+++.+.+...+..+
T Consensus 47 ~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~---------~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 47 SGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMT---------HLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred CCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHH---------hcCCCCCeeeEEEEEccCCceE
Confidence 367899999985322 236676553 233444444 664 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccC-------------------------------------------------------------
Q 044568 66 KIERPVRNGSLTDIIFCSA------------------------------------------------------------- 84 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 84 (257)
||||||++|+|.++|....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999999986421
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 044568 85 ---------------------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131 (257)
Q Consensus 85 ---------------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 131 (257)
...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 13478888899999999999999999 999999999999999999
Q ss_pred ceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHH
Q 044568 132 TAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTN 205 (257)
Q Consensus 132 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~ 205 (257)
.+||+|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---~~- 350 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---FY- 350 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---HH-
Confidence 99999999987432211 12234567999999988889999999999999999997 9999874421111 00
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 206 WVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ..... ....+...+..+.+++.+||+.||++|| +.++.++|
T Consensus 351 ---~~-----~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 351 ---NK-----IKSGY-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred ---HH-----HhcCC-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 00 00000 0122334567899999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=257.80 Aligned_cols=236 Identities=15% Similarity=0.103 Sum_probs=170.7
Q ss_pred ccccceeeecccC-CCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++... +..+++|...-.. .-+...+...-..+.++.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 91 (381)
T cd05626 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91 (381)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHH
Confidence 5789999998544 4556777654211 00000111111133378999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC------------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED------------ 147 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~------------ 147 (257)
+. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++......
T Consensus 92 l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~ 166 (381)
T cd05626 92 LI--RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166 (381)
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccc
Confidence 97 445789999999999999999999999 9999999999999999999999999986422100
Q ss_pred --------------------------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC
Q 044568 148 --------------------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189 (257)
Q Consensus 148 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~ 189 (257)
.....||+.|+|||.+.+..++.++|||||||++|||++|..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 246 (381)
T cd05626 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246 (381)
T ss_pred cccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCC
Confidence 012358889999999998889999999999999999999999
Q ss_pred CCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH--cccCCCCCCC-hHHHHH
Q 044568 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW--CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 190 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RP-~~ei~~ 255 (257)
||..............|. .... ..........+.+++.+ |+..+|..|| +.|+++
T Consensus 247 Pf~~~~~~~~~~~i~~~~----------~~~~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 247 PFLAPTPTETQLKVINWE----------NTLH-IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred CCcCCCHHHHHHHHHccc----------cccC-CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 997553221111111100 0000 01111233556677766 6667777799 999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=241.81 Aligned_cols=226 Identities=22% Similarity=0.290 Sum_probs=174.9
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++. .+..+++|... +.+|++.+. ++.|+|++++.+.+.. +..++||||+++++|
T Consensus 17 g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~---------~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 85 (254)
T cd05083 17 GEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMT---------KLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85 (254)
T ss_pred CCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHH---------hCCCCCcCeEEEEEcC-CCcEEEEECCCCCCH
Confidence 46788999875 56667777654 233444443 8889999999998765 457899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG 156 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (257)
.+++.......+++..+..++.|++.|+.|||++ +++|||++|+||+++.++.++|+|||.+............+..
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (254)
T cd05083 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK 162 (254)
T ss_pred HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCce
Confidence 9999864555689999999999999999999999 9999999999999999999999999988754333333334567
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
|+|||.+.+..++.++|+||||+++||+++ |+.||....... ..... ..... ...+...+..+.+
T Consensus 163 y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~---------~~~~~-~~~~~~~~~~~~~ 228 (254)
T cd05083 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKECV---------EKGYR-MEPPEGCPADVYV 228 (254)
T ss_pred ecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHH---------hCCCC-CCCCCcCCHHHHH
Confidence 999999988889999999999999999998 999996442110 10000 00000 0122344578899
Q ss_pred HHHHcccCCCCCCC-hHHHHHhC
Q 044568 236 VGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+||+.+|++|| ++++++.|
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=243.58 Aligned_cols=234 Identities=19% Similarity=0.216 Sum_probs=174.3
Q ss_pred ccccceeeecccCCC----CCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++..... .+++|..... ...+.+. ..-..+.++.|+|++++.+.+...+..++||||+++++|
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (268)
T cd05063 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL--SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL 93 (268)
T ss_pred CCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHH--HHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCH
Confidence 457889999976443 3556554321 1111110 000123378899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc------c
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV------I 150 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~------~ 150 (257)
.+++.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||++++++.++++|||++........ .
T Consensus 94 ~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 169 (268)
T cd05063 94 DKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169 (268)
T ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccC
Confidence 999975 456789999999999999999999999 999999999999999999999999998864432211 1
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ..... +... ...+.+.+.
T Consensus 170 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~----------i~~~-~~~~~~~~~ 235 (268)
T cd05063 170 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKA----------INDG-FRLPAPMDC 235 (268)
T ss_pred CCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHH----------HhcC-CCCCCCCCC
Confidence 112345999999988888999999999999999997 99999643211 00100 0000 011223345
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..+.+++.+||+.+|++|| +.++++.|
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 67889999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=242.48 Aligned_cols=227 Identities=19% Similarity=0.307 Sum_probs=177.3
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++....+..+++|... +.+|++++. ++.|+|++++.+.+.. ...+++|||+++|+
T Consensus 17 g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 17 GQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK---------TLQHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred ccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHH---------hcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 46789999998877778887543 233444444 8889999999888877 78899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 163 (260)
T cd05073 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163 (260)
T ss_pred HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence 99999764556688899999999999999999999 99999999999999999999999999886543221 112
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++|+||||+++|++++ |..||....... ...... ... ....+...+
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~---------~~~-~~~~~~~~~ 229 (260)
T cd05073 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALE---------RGY-RMPRPENCP 229 (260)
T ss_pred cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHh---------CCC-CCCCcccCC
Confidence 33456999999988888999999999999999999 999997542111 111100 000 001223445
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| +.++.++|
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 6799999999999999999 99998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=259.35 Aligned_cols=230 Identities=21% Similarity=0.187 Sum_probs=182.8
Q ss_pred ccccceeeecccCCCCC-eeeccch-hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVSW-TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
++|++||||....+..+ ++|.... ..+.++.+++..-..+...+++||.+..+....+...+++||||.||++.+.+.
T Consensus 24 GsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~ 103 (467)
T KOG0201|consen 24 GSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK 103 (467)
T ss_pred cccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc
Confidence 68999999997766655 5777664 222223333333333447788999999999999999999999999999999996
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCcc
Q 044568 82 CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGYM 158 (257)
Q Consensus 82 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~ 158 (257)
.+..+.+....-+++++..|+.|||.+ +.+|||||+.||++...|.+||+|||++-....+. ....||+.||
T Consensus 104 --~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwM 178 (467)
T KOG0201|consen 104 --SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWM 178 (467)
T ss_pred --cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcccccccccccc
Confidence 455557777778899999999999999 99999999999999999999999999976543322 5668999999
Q ss_pred CcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc---CCCCCHHHHHHHHH
Q 044568 159 APECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR---GTKVDKKNLENLVK 235 (257)
Q Consensus 159 aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ 235 (257)
|||++....|+.++||||||++.+||++|.+|+....+-.. .-++. +......+.+.+.+
T Consensus 179 APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----------------lflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 179 APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----------------LFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------------EEeccCCCCCccccccCHHHHH
Confidence 99999988999999999999999999999999975422110 01111 11222355677899
Q ss_pred HHHHcccCCCCCCC-hHHHHH
Q 044568 236 VGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++..||++||+.|| +.++++
T Consensus 242 FV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999 999975
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=249.70 Aligned_cols=228 Identities=20% Similarity=0.276 Sum_probs=171.6
Q ss_pred ccccceeeecccCCCC---Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS---PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~---~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++...+... ++++... +.+|++.+. ++ .|+|++++.+.+...+..++|||
T Consensus 18 G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~---------~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC---------KLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred CCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHH---------HhcCCCCcceEEEEECCCCCceEEEE
Confidence 4688999998755432 2444432 223444333 66 79999999999999999999999
Q ss_pred ecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 70 PVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|+++|+|.+++.... ...+++.+++.++.|++.|++|||++ +++||||+|+||+++.++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence 999999999997421 23588999999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 136 LDFGLAKLPNEDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 136 ~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
+|||++....... .....+..|+|||.+.+..++.++||||||+++||+++ |..||........ ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~------- 235 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK------- 235 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHH-------
Confidence 9999886322111 11123456999999988888999999999999999998 9999964421110 000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ....+...+..+.+++.+||+.+|++|| ++++++.|
T Consensus 236 ---~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 236 ---LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred ---HhcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00000 0012223456789999999999999999 99998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=242.21 Aligned_cols=227 Identities=22% Similarity=0.332 Sum_probs=177.8
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++...++..+++|... +.+|++.+. ++.|+|++++.+.. ..+..++||||+++++
T Consensus 17 G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~ 86 (260)
T cd05067 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMK---------QLQHPRLVRLYAVV-TQEPIYIITEYMENGS 86 (260)
T ss_pred CccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHH---------hcCCcCeeeEEEEE-ccCCcEEEEEcCCCCC
Confidence 56789999998888888887544 233444443 88899999998875 4567899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 87 L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05067 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence 99999764556789999999999999999999999 99999999999999999999999999987544221 122
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++|+||||+++||+++ |+.||....... .... ..... ....+...+
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----------~~~~~-~~~~~~~~~ 229 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----------LERGY-RMPRPDNCP 229 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----------HHcCC-CCCCCCCCC
Confidence 34557999999988888999999999999999999 999997542111 0100 00000 012223345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| ++++++.|
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 6799999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=245.79 Aligned_cols=226 Identities=16% Similarity=0.198 Sum_probs=173.1
Q ss_pred ccccceeeeccc------CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++.. ++...+++... +.++++.+. ++.|+|++++.+.+...+..++||
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT---------VLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHh---------cCCCCCCceEEEEEecCCceEEEE
Confidence 467889988632 22334444332 344444444 889999999999999999999999
Q ss_pred eecCCCCHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 69 RPVRNGSLTDIIFCSAE-------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
||+++|+|.+++..... ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999975321 3588999999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHH
Q 044568 136 LDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYK 209 (257)
Q Consensus 136 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 209 (257)
+|||++....... ....+++.|+|||.+.+..++.++|+||||+++||+++ |..||....... ..
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~------ 234 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI------ 234 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH------
Confidence 9999886432221 12233567999999988889999999999999999998 899986432111 00
Q ss_pred hhhhhhhhhhhc--CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 210 CFINRELNKLVR--GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 235 -------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 235 -------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred -------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 00001 0122334556789999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=252.24 Aligned_cols=233 Identities=16% Similarity=0.199 Sum_probs=172.9
Q ss_pred ccccceeeecccCCC-CCeeeccchh-----hhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWT-----ADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++...+. .+++|...-. ..++.+. .......++ .|++++.+.+.+...+..++||||+++|+|
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 83 (327)
T cd05617 6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ--TEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83 (327)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHH--HHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcH
Confidence 568999999976554 4566655421 1111111 000011133 599999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~ 153 (257)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++... ........+
T Consensus 84 ~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 84 MFHMQ--RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 99987 446799999999999999999999999 9999999999999999999999999988642 122244568
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENL 233 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
|+.|+|||.+.+..++.++|+||||+++|||++|..||......... ....+..... ...+...+......+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~-------~~~~~~~p~~~~~~~ 230 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVI-------LEKPIRIPRFLSVKA 230 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHH-------HhCCCCCCCCCCHHH
Confidence 89999999999888999999999999999999999999643221110 0001111100 011112344455678
Q ss_pred HHHHHHcccCCCCCCC-hH
Q 044568 234 VKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~ 251 (257)
.+++.+||+.||.+|| +.
T Consensus 231 ~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHhccCHHHcCCCC
Confidence 8999999999999998 64
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=244.24 Aligned_cols=242 Identities=16% Similarity=0.171 Sum_probs=169.4
Q ss_pred cccccceeeecccCC---CCCeeeccchhhhHH-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFNAR---NSPWISRVSWTADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~---~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
.+.++.||+|+...+ ...++|........+ ...+......+.++.|+|++++.+.+...+..++||||+++|+|.+
T Consensus 5 ~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 84 (269)
T cd05087 5 NGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84 (269)
T ss_pred ccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHH
Confidence 357899999986543 235666543211000 0000001113348899999999999999999999999999999999
Q ss_pred HHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----cc
Q 044568 79 IIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VI 150 (257)
Q Consensus 79 ~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~ 150 (257)
++.... ...+++..+..++.|++.|+.|||++ +++|+|+||+||+++.++.++|+|||.+....... ..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 161 (269)
T cd05087 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ 161 (269)
T ss_pred HHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCC
Confidence 997422 23456778889999999999999999 99999999999999999999999999886432221 12
Q ss_pred ccCCCCccCcccccCC-------CCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 151 DKRDKGYMAPECYKRT-------PISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~-------~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
..++..|+|||.+.+. .++.++|+||||+++||+++ |..||........ ....+ ........+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~------~~~~~~~~~- 232 (269)
T cd05087 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTV------REQQLKLPK- 232 (269)
T ss_pred cCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHh------hcccCCCCC-
Confidence 3456679999988642 35789999999999999996 9999975422111 00000 000001111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
........+.+.+++.+|| .+|++|| ++||++.|
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1112223456888999999 6899999 99999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=243.32 Aligned_cols=224 Identities=15% Similarity=0.207 Sum_probs=168.8
Q ss_pred ccccceeeecccCCC--------CCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARN--------SPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~--------~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||++...... .+++|... +.++++. +..+.|+|++++.+.+...+..++
T Consensus 6 G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~---------l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASM---------MSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred ccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHH---------HHhCCCCChhheeeEEEeCCCcEE
Confidence 578999999865432 23444432 1222222 337789999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--------eEEeee
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------AKILDF 138 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--------~kl~df 138 (257)
||||+++|+|.+++.. ....+++..+..++.|++.|+.|||++ +++||||+|+||+++.++. ++++||
T Consensus 77 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999975 344689999999999999999999999 9999999999999987654 689999
Q ss_pred cccccCCCCcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcC-CCCCcCCCChhhHHHHHHHHHhhhhhhh
Q 044568 139 GLAKLPNEDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCR-KNMEIDASKPEEIILTNWVYKCFINREL 216 (257)
Q Consensus 139 g~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (257)
|.+..... .....++..|+|||.+.+. .++.++|+||||+++||+++|. .||.... ..... ..
T Consensus 153 g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~---~~---------- 217 (258)
T cd05078 153 GISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKL---QF---------- 217 (258)
T ss_pred ccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHH---HH----------
Confidence 98764332 2334567789999999864 4789999999999999999985 5554321 11100 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 217 NKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.......+......+.+++.+||+.+|++|| ++++++.|
T Consensus 218 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 --YEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --HHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0001122223346789999999999999999 99999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=251.60 Aligned_cols=226 Identities=17% Similarity=0.162 Sum_probs=170.1
Q ss_pred ccccceeeecccCC-CCCeeeccchhh---hHHHHhHhhhcccccc-ccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWTA---DIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~~---~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||++....+ ..+++|...-.. .............+.. ..|++++++.+.+...+..++||||+++|+|.+
T Consensus 11 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~ 90 (323)
T cd05616 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHH
Confidence 56889999986654 456777544211 0000000000001112 257888899999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~ 155 (257)
.+. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......||+
T Consensus 91 ~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 165 (323)
T cd05616 91 QIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP 165 (323)
T ss_pred HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCCh
Confidence 997 446789999999999999999999999 99999999999999999999999999886432 1223446788
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++|+|||||++|||++|+.||...... ..... ... ...++......+.
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~-------------i~~~~~~~p~~~s~~~~ 229 (323)
T cd05616 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS-------------IMEHNVAYPKSMSKEAV 229 (323)
T ss_pred hhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH-------------HHhCCCCCCCcCCHHHH
Confidence 999999999999999999999999999999999999754211 11111 111 1123344567789
Q ss_pred HHHHHcccCCCCCCC-h
Q 044568 235 KVGLWCVQDEPALRP-M 250 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~ 250 (257)
+++.+|++.||.+|+ .
T Consensus 230 ~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 230 AICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHcccCHHhcCCC
Confidence 999999999999999 6
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=233.18 Aligned_cols=236 Identities=17% Similarity=0.137 Sum_probs=182.4
Q ss_pred ccccceeeec-ccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.+++||+|+ ..+++.++||++.. .+|++.+. .+.|+||+.+.+++...+..-||+|||
T Consensus 13 G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lq---------el~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 13 GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQ---------ELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHH---------HccCcchhhhhhhccCCCceEEEEEec
Confidence 3578999999 45566677887653 45666665 888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc--
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV-- 149 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~-- 149 (257)
+. +|+..|++ +...++..+.+.|+.+++.|++|||++ .|+|||+||.|+|++.++.+|++|||+++.......
T Consensus 84 ~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 84 PT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 75 99999987 778899999999999999999999999 999999999999999999999999999997665442
Q ss_pred -cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-----hhhh-----
Q 044568 150 -IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN-----RELN----- 217 (257)
Q Consensus 150 -~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~----- 217 (257)
...-|.=|.|||.+.+. .|+...|+||.||++.|++-|.+-|.+.+.-+ ++.......... +++.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHHHcCCCCcccCccccccccH
Confidence 23456669999999875 59999999999999999999988887663222 111111111000 0111
Q ss_pred -hhh--cCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 218 -KLV--RGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 218 -~~~--~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.+. +.. ..-..+.....+++..+|.+||.+|+ ++|.+++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 000 11222345679999999999999999 9998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=246.04 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=172.7
Q ss_pred ccccceeeecc-----cCCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSSF-----NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~-----~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||.++. .++..+++|... +.+|++++. ++.|+|++++.+.+... ...++
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK---------TLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred CCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEecCCCceEEE
Confidence 35677866442 344456666543 223444444 88999999999987654 35789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++|+|.+++.. ..+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999963 4599999999999999999999999 999999999999999999999999999875432
Q ss_pred Cc------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DF------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.. ....++..|+|||.+.+..++.++||||||+++|||++|..||........... ................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI--GPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh--cccccccchhhhhhhh
Confidence 21 112334559999999888899999999999999999999999875432211110 0000000111111111
Q ss_pred cC---CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RG---TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~---~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ...+...+..+.+++..||+.+|++|| ++++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11 122444567899999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=232.42 Aligned_cols=232 Identities=16% Similarity=0.137 Sum_probs=187.5
Q ss_pred ccccceeeecccCCCCCe-eeccchhhhHHHHhH--hhhc--cccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNARNSPW-ISRVSWTADIEVLSV--AMRG--SKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~-i~~~~~~~~~~~~~~--~~~~--~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+||+.||-+..+.+.-.+ +|.+ |..++....+ ++.. +-.+.++||||+++.+++.+....||++||.++|++..
T Consensus 33 gkFG~vYlarekks~~IvalKVl-fKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k 111 (281)
T KOG0580|consen 33 GKFGNVYLAREKKSLFIVALKVL-FKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYK 111 (281)
T ss_pred CccccEeEeeeccCCcEEEEeee-eHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHH
Confidence 689999999977766554 4443 3333333332 1111 14558999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC-CCCcccccCCCCc
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP-NEDFVIDKRDKGY 157 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~ 157 (257)
.|.+.....+++.....++.|++.|+.|+|.+ +++|||+||+|+|++..+.+|++|||-+... .......+||.-|
T Consensus 112 ~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dy 188 (281)
T KOG0580|consen 112 DLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDY 188 (281)
T ss_pred HHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeeccccc
Confidence 99976777899999999999999999999999 9999999999999999999999999987754 3344666889999
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENLVKV 236 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 236 (257)
++||+..+..++...|+|++|++.||++.|.+||.+....+ .+..+.+.. .++........++
T Consensus 189 l~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----------------tYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 189 LPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----------------TYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred CCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----------------HHHHHHHccccCCcccChhHHHH
Confidence 99999999999999999999999999999999998653211 122222222 2344455678889
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+|+.++|.+|. ..|+++
T Consensus 253 I~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHhccCccccccHHHHhh
Confidence 9999999999999 888864
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=247.27 Aligned_cols=228 Identities=20% Similarity=0.260 Sum_probs=172.1
Q ss_pred ccccceeeecccCCCC---Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS---PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~---~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++...+... .+++... +.+|++.+. ++ .|+|++++.+.+...+..++|||
T Consensus 13 g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLC---------KLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred CCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHH---------hhcCCCchhheEEEEccCCcceEEEE
Confidence 4678999998765432 3444332 233444443 55 69999999999999999999999
Q ss_pred ecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 70 PVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 999999999996421 13588899999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCccc--ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 136 LDFGLAKLPNEDFVI--DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 136 ~dfg~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
+|||++......... ...+..|+|||.+....++.++||||||+++|||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~------- 230 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEK------- 230 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-------
Confidence 999987643221111 122346999999988889999999999999999997 999996542111 0000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ....+...+..+.+++.+||+.+|.+|| ++++++.|
T Consensus 231 ---~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 231 ---LPQGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred ---HhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00000 0122334556789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=244.57 Aligned_cols=233 Identities=17% Similarity=0.171 Sum_probs=171.4
Q ss_pred ccccceeeecccCCCC-----Ceeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+|+...... +++|.... ....+.+ ......+..+.|+|++++.+.+.. ...++++||+++|+
T Consensus 18 G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~--~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~ 94 (279)
T cd05109 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI--LDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGC 94 (279)
T ss_pred CCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHH--HHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCC
Confidence 5689999998654444 46665432 1111100 001112337789999999988875 45678999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----cc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VI 150 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~ 150 (257)
|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||+++...... ..
T Consensus 95 l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~ 170 (279)
T cd05109 95 LLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170 (279)
T ss_pred HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCC
Confidence 9999975 355789999999999999999999999 99999999999999999999999999987543221 11
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..++..|++||...+..++.++||||||+++||+++ |..||...... ....+.. .. .....+...
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~---------~~-~~~~~~~~~ 236 (279)
T cd05109 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLE---------KG-ERLPQPPIC 236 (279)
T ss_pred CccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---------CC-CcCCCCccC
Confidence 233457999999988889999999999999999998 89998643111 1111110 00 011122345
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..+.+++.+||+.||++|| +.|+++.|
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 56789999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=243.38 Aligned_cols=228 Identities=20% Similarity=0.284 Sum_probs=172.0
Q ss_pred ccccceeeecccCCCC---Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS---PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~---~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+++..++.. .+++... +.+|++.+. ++ .|+|++++.+.+...+..++|||
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC---------KLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHH---------hhccCCCeeeEEEEEecCCCceEEEE
Confidence 5688999999866543 3454433 123444333 56 69999999999999999999999
Q ss_pred ecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 70 PVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|+++|+|.+++.... ...+++.++..++.|++.|++|||++ +++|+||+|+||++++++.+++
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEE
Confidence 999999999996421 13578999999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 136 LDFGLAKLPNEDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 136 ~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
+|||++....... .....+..|+|||.+....++.++|+||||+++|||++ |..||....... ....
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~------- 223 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK------- 223 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH-------
Confidence 9999875322111 11122456999999988889999999999999999997 999996432111 0000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ....+......+.+++.+||+.+|.+|| +.|+++.|
T Consensus 224 ---~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 224 ---LPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred ---HhCCC-CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 00000 0012223456789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=253.33 Aligned_cols=227 Identities=19% Similarity=0.173 Sum_probs=173.5
Q ss_pred ccccceeeecccCCC-CCeeeccchhh-----h-HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWTA-----D-IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~~-----~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++...++ .+++|...-.. + .+.+. ........+.|+||+++...+...+..++||||+++|+|
T Consensus 6 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~--e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L 83 (325)
T cd05602 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS--ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHH--HHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcH
Confidence 578999999976554 46676654211 1 11111 111122367899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.... .......+
T Consensus 84 ~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 84 FYHLQ--RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 99997 456688889999999999999999999 99999999999999999999999999886422 12234468
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENL 233 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
|+.|+|||.+.+..++.++||||+||++|||++|..||....... ..... .. .+..........+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i-----~~-------~~~~~~~~~~~~~ 223 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI-----LN-------KPLQLKPNITNSA 223 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH-----Hh-------CCcCCCCCCCHHH
Confidence 899999999998889999999999999999999999997542111 11000 00 0112223445678
Q ss_pred HHHHHHcccCCCCCCC-hHH
Q 044568 234 VKVGLWCVQDEPALRP-MKC 252 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~e 252 (257)
.+++.+||+.||.+|| +.+
T Consensus 224 ~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 224 RHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHcccCHHHCCCCCC
Confidence 8999999999999999 763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=255.98 Aligned_cols=224 Identities=12% Similarity=0.110 Sum_probs=173.0
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... +..+++|...- .+|++.+ ..+.|+|++++.+.+...+..++||||
T Consensus 54 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il---------~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 54 GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM---------AHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHH---------HhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 5688999998765 45567776532 2233333 378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ..++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 125 ~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 125 MPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999953 4588899999999999999999999 99999999999999999999999999987543221
Q ss_pred --ccccCCCCccCcccccCC----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 --VIDKRDKGYMAPECYKRT----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....||+.|+|||.+.+. .++.++|+|||||++|||++|..||....... ..... ... ...
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i-----~~~-----~~~ 265 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKI-----MDH-----KNS 265 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HHHHH-----HcC-----CCc
Confidence 234688999999998653 37899999999999999999999997552211 01000 000 000
Q ss_pred CCCC--HHHHHHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 223 TKVD--KKNLENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 223 ~~~~--~~~~~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
..++ ......+.+++.+||+.+|.+ || +.|+++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0111 124567889999999999988 99 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=241.28 Aligned_cols=223 Identities=17% Similarity=0.290 Sum_probs=170.6
Q ss_pred ccccceeeecccCCC-----------CCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFNARN-----------SPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-----------~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+|...... .+++|... +.++++.+ .++.|+|++++.+.+.. ...
T Consensus 6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l---------~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLM---------SQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred cccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHH---------HcCCCcchhheeeEEec-CCc
Confidence 457899999987765 23444322 22333333 38899999999999888 788
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-------ceEEee
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-------TAKILD 137 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-------~~kl~d 137 (257)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++++|
T Consensus 76 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999999975 334789999999999999999999999 999999999999999887 799999
Q ss_pred ecccccCCCCcccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 138 FGLAKLPNEDFVIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 138 fg~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
||++..... .....++..|+|||.+... .++.++|+||||+++||+++ |..||........ ..+ +.
T Consensus 152 fg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~----~~~----~~-- 220 (259)
T cd05037 152 PGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----ERF----YQ-- 220 (259)
T ss_pred CCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH----HHH----Hh--
Confidence 999875433 2334456779999999876 68899999999999999999 5777754421110 000 00
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 215 ELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+......+.+++.+||+.+|.+|| +.|+++.|
T Consensus 221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ------DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00111111226789999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.77 Aligned_cols=231 Identities=16% Similarity=0.209 Sum_probs=178.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.. .+++.+++|... +.+|++.+. .+.|+|++++.+.+...+..++||||
T Consensus 13 g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~---------~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK---------QLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred cCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHH---------HccCCchhhhhheeEeCCeEEEEEEe
Confidence 46789999995 466777777543 122333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 71 VRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
+++++|.+++... ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999998632 345689999999999999999999999 99999999999999999999999999876543221
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .. ........+...
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~------~~~~~~~~~~~~ 229 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LC------KKIEQCDYPPLP 229 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-----Hh------hhhhcCCCCCCC
Confidence 2345777899999998888899999999999999999999999654221110 00 011111111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+.+.+++.+||+.+|++|| +.+|++.+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 234567899999999999999999 99887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=247.66 Aligned_cols=229 Identities=18% Similarity=0.235 Sum_probs=174.0
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++.. .+..+++|... +.+|++.+. ++ .|+|++++.+.+...+..++
T Consensus 46 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS---------HLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred cCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHH---------hccCCCCcceEEEEEecCCceEE
Confidence 567889988742 22235555332 233444444 67 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++|+|.+++.......+++.+...++.|++.||.|||++ +++|+||+|+||+++.++.++++|||.+.....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999753444589999999999999999999999 999999999999999999999999999875432
Q ss_pred Cc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.. ....++..|+|||.+.+..++.++||||+|+++||+++ |..||........ ...... ...
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~~~---------~~~ 261 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKLIK---------EGY 261 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHHHH---------cCC
Confidence 21 11234567999999988889999999999999999998 9999875422111 101000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ...+...++.+.+++.+||+.+|++|| +.|+++.|
T Consensus 262 ~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 262 R-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred c-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 0 011223356789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=246.05 Aligned_cols=228 Identities=17% Similarity=0.224 Sum_probs=173.0
Q ss_pred ccccceeeecccC------CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++... ....++|... +.+|++.+. ++.|+|++++.+.+...+..++||
T Consensus 16 G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT---------NLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred cCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHH---------hCCCCCcceEEEEEecCCccEEEE
Confidence 4578999987422 2234555543 233444444 889999999999999999999999
Q ss_pred eecCCCCHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 69 RPVRNGSLTDIIFCSA-----------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
||+++++|.+++.... ...+++.++..++.|++.||.|||++ +++||||+|+||++++++.++|+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 9999999999997421 23589999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhh
Q 044568 138 FGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 138 fg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
||.+....... ....++..|+|||.+.+..++.++|+||||+++|||++ |..||....... .....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i----- 235 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI----- 235 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-----
Confidence 99987443221 12223557999999988889999999999999999998 899986442111 11100
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... ...+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 236 ~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 236 TQGRV------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred HcCCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 00000 011223446799999999999999999 99997754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=242.81 Aligned_cols=235 Identities=18% Similarity=0.216 Sum_probs=171.4
Q ss_pred ccccceeeecccCCCC---Ceeeccch----hhhHHHHhHhhhccccccccCCceeeeceeeeec------CceeEEEee
Q 044568 4 TKLSNFYRSSFNARNS---PWISRVSW----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~---~~i~~~~~----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~lV~E~ 70 (257)
+.++.||+|+..+... +++|.... ..+.+.+. .....+..++|+|++++.+.+... ...++||||
T Consensus 10 G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~--~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~ 87 (272)
T cd05075 10 GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL--SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87 (272)
T ss_pred ccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHH--HHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEe
Confidence 4688999999877664 56664321 11111111 111123378899999999876432 356899999
Q ss_pred cCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 71 VRNGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 71 ~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
+++|+|.+++... ....+++.....++.|++.||.|||++ +++|+||||+||+++.++.++++|||++.....
T Consensus 88 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 164 (272)
T cd05075 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164 (272)
T ss_pred CCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence 9999999988421 234589999999999999999999999 999999999999999999999999999875432
Q ss_pred Cc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.. .....++.|++||.+.+..++.++|+||||+++||+++ |..||...... . ... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~-~~~-----~~~~~~----- 231 (272)
T cd05075 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--E-IYD-----YLRQGN----- 231 (272)
T ss_pred ccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H-HHH-----HHHcCC-----
Confidence 21 22234557999999998889999999999999999999 78898643111 0 000 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 232 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 232 -RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0012234456789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=252.49 Aligned_cols=222 Identities=15% Similarity=0.139 Sum_probs=170.0
Q ss_pred ccccceeeecc----cCCCCCeeeccch-------------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSF----NARNSPWISRVSW-------------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~----~~~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||+++. .++..+++|.... .+|++.+. ++ .|++++.+...+...+..+
T Consensus 11 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE---------HVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHH---------hccCCCCcccEEEEEecCCEEE
Confidence 56889998775 3456667775432 12222222 45 4899999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999997 456789999999999999999999999 99999999999999999999999999986432
Q ss_pred C----CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 146 E----DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 146 ~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.............. ...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~------------~~~ 224 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR------------RIL 224 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH------------HHh
Confidence 1 12334688999999998765 478899999999999999999999975432221111110 011
Q ss_pred c-CCCCCHHHHHHHHHHHHHcccCCCCCCC-hH
Q 044568 221 R-GTKVDKKNLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 221 ~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
. ....+......+.+++.+||+.||++|| +.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 1 1123334556788999999999999999 54
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=283.15 Aligned_cols=236 Identities=18% Similarity=0.373 Sum_probs=182.2
Q ss_pred ccccceeeecc-cCCCCCeeeccch-----hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+|+. .++..+++|+... ..+++.+. +++|+||+++.+++...+..++||||+++|+|.
T Consensus 701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~---------~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 701 GKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG---------KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred CCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHh---------hCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 56889999996 5677788887653 23333333 889999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGY 157 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (257)
++++. ++|.++..++.|++.|++|||..+.++++|||+||+||+++.+...++. ++....... .....++..|
T Consensus 772 ~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-~~~~~~t~~y 844 (968)
T PLN00113 772 EVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTKCFISSAY 844 (968)
T ss_pred HHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-CCCccccccc
Confidence 99963 8999999999999999999995444499999999999999998888774 555432211 1233667889
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-----CCCHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-----KVDKKNLEN 232 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 232 (257)
+|||++.+..++.++|||||||++|||++|+.||+..... ......|.............+++. ..+.+...+
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHH
Confidence 9999999889999999999999999999999999643222 122334443333222233333322 344566778
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+++.+||+.||++|| |+|+++.|
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 89999999999999999 99999865
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=240.76 Aligned_cols=228 Identities=22% Similarity=0.335 Sum_probs=179.4
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++...++..+++|... +.+|++.+. ++.|+|++++.+.+......++||||+++++
T Consensus 17 g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 17 GQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMK---------KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred CcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHh---------hCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 56889999998877777777554 234444444 7889999999999998899999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 99999864456799999999999999999999999 99999999999999999999999999887543221 112
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+..|+|||.+.+..++.++|+||+|+++||+++ |+.||.... ........ ..... ...+...+
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~----------~~~~~-~~~~~~~~ 230 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQV----------ERGYR-MPRPPNCP 230 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----------HcCCC-CCCCCCCC
Confidence 23456999999988889999999999999999999 999996431 11111111 00000 11223345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| ++|+.+.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 6789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=242.87 Aligned_cols=229 Identities=17% Similarity=0.224 Sum_probs=174.5
Q ss_pred cccccceeeecccCCC-------CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCcee
Q 044568 3 CTKLSNFYRSSFNARN-------SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~-------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 65 (257)
.+.++.||+++..+.. .+++|... +.++++.+ .++.|+|++++.+.+...+..+
T Consensus 5 ~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l---------~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 5 SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLM---------SNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred cccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHH---------HhcCCCCeeeEeeeecCCCCeE
Confidence 3578899999976533 34554432 22333333 3889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-----ceEE
Q 044568 66 KIERPVRNGSLTDIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-----TAKI 135 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-----~~kl 135 (257)
+||||+++|+|.+++.... ...+++.++..++.|++.|+.|||++ +++|+|++|+||+++.+. .+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997432 23478899999999999999999999 999999999999999877 8999
Q ss_pred eeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHH
Q 044568 136 LDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYK 209 (257)
Q Consensus 136 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 209 (257)
+|||++....... ....++..|+|||.+.+..++.++|+||||+++|||++ |..||...... ......
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~-- 226 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHV-- 226 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHH--
Confidence 9999886432211 12234567999999998889999999999999999998 99999643211 110000
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 210 CFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. -.....+...+..+.+++.+||+.+|.+|| +.++++.|
T Consensus 227 --~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 227 --TA------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred --hc------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 00 001122344567889999999999999999 99998865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=251.90 Aligned_cols=228 Identities=19% Similarity=0.149 Sum_probs=173.1
Q ss_pred ccccceeeecccC-CCCCeeeccchhhh---HHHHhH-hhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTAD---IEVLSV-AMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~~---~~~~~~-~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++... +..+++|...-... .+.... .........+.|+|++++...+...+..++||||+++|+|.+
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (321)
T cd05603 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF 85 (321)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHH
Confidence 5688999999764 45567776542111 000000 111112347889999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~ 155 (257)
.+. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......+++
T Consensus 86 ~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 86 HLQ--RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 987 456788899999999999999999999 99999999999999999999999999876421 1123346788
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+..++.++|+|||||++|||++|..||..... ....... ...+...+......+.+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i------------~~~~~~~~~~~~~~~~~ 225 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNI------------LHKPLQLPGGKTVAACD 225 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHH------------hcCCCCCCCCCCHHHHH
Confidence 99999999988899999999999999999999999975421 1000000 00111233445567899
Q ss_pred HHHHcccCCCCCCC-hH
Q 044568 236 VGLWCVQDEPALRP-MK 251 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ 251 (257)
++.+||+.||.+|| +.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999999 53
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.60 Aligned_cols=234 Identities=17% Similarity=0.168 Sum_probs=173.3
Q ss_pred ccccceeeecccC------CCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++.... ...+++|..... .+..++. .-..+.++.|+|++++.+.+...+..++||||+++
T Consensus 17 g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 93 (277)
T cd05036 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM---EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG 93 (277)
T ss_pred CCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHH---HHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCC
Confidence 4578899998765 344566654421 1111111 11133488999999999999999999999999999
Q ss_pred CCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEeeecccccCC
Q 044568 74 GSLTDIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDFGLAKLPN 145 (257)
Q Consensus 74 gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~dfg~~~~~~ 145 (257)
++|.+++.... ...+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++ .++|+|||+++...
T Consensus 94 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred CCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccC
Confidence 99999997532 13589999999999999999999999 999999999999998654 58999999987543
Q ss_pred CCcc-----cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 146 EDFV-----IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 146 ~~~~-----~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
.... ....+..|+|||.+.+..++.++|||||||++|||++ |..||....... ... .....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~---~~~~~------ 237 (277)
T cd05036 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VME---FVTGG------ 237 (277)
T ss_pred CccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH---HHHcC------
Confidence 2211 1122356999999988889999999999999999997 999997542111 000 00000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+...+..+.+++.+||+.+|++|| +.++++.|
T Consensus 238 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 238 -GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 01122334557889999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=243.72 Aligned_cols=228 Identities=18% Similarity=0.229 Sum_probs=171.7
Q ss_pred ccccceeeecccC------CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++.... +..+++|.... .+|++. +..++|+|++++.+.+...+..++|
T Consensus 17 G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~---------l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV---------MKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHH---------HHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 4578899876432 23466665431 223333 3378899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999996421 12467788899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
++....... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~-----~~ 236 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV-----ME 236 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-----Hc
Confidence 886433222 11233567999999988889999999999999999999 78888644211 111000 00
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ....+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 237 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 237 GG------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 00 0122334556799999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.31 Aligned_cols=228 Identities=19% Similarity=0.239 Sum_probs=173.4
Q ss_pred ccccceeeecccCC------CCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+|..... ..+++|... +.+|++.+. .+.|+|++++.+.+...+..++|
T Consensus 11 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLK---------QVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred cCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHh---------hCCCCCEeeEEEEEecCCCcEEE
Confidence 46789999985431 234555432 233444444 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhcc----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 68 ERPVRNGSLTDIIFCS----------------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|||+.+|+|.+++... ....+++.++..++.|++.||.|||++ +++|+||+|+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 9999999999998642 123578899999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~ 199 (257)
++++++.++|+|||.++...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-- 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-- 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999999986432211 12234567999999988889999999999999999998 99999644111
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+..... .... ...+......+.+++.+||+.+|++|| ++|+++.|
T Consensus 237 --~~~~~~~---------~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 237 --RLFNLLK---------TGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred --HHHHHHh---------CCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 1111100 0000 112334557899999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.28 Aligned_cols=227 Identities=20% Similarity=0.207 Sum_probs=178.8
Q ss_pred ccccceeeecccC-CCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.+|++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++++||+++++
T Consensus 14 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~---------~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 14 GSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK---------QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHH---------hCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4678999999876 4556666654 334444444 7799999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---cccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~ 152 (257)
|.+++.. ....+++..+..++.|++.|+.|||+. +++|+|++|.||+++.++.++|+|||++....... ....
T Consensus 85 L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (256)
T cd06612 85 VSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI 160 (256)
T ss_pred HHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcccccccc
Confidence 9999975 456789999999999999999999999 99999999999999999999999999887543322 2334
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. .........+......
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 228 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP------------NKPPPTLSDPEKWSPE 228 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc------------cCCCCCCCchhhcCHH
Confidence 6778999999988889999999999999999999999997542211100000 0000111223334567
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++.+||+.+|++|| +.|+++
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhc
Confidence 89999999999999999 999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=253.73 Aligned_cols=227 Identities=18% Similarity=0.141 Sum_probs=172.7
Q ss_pred ccccceeeeccc-CCCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++.. ++..+++|...-. .+.+.+. ......+..+.|+|++++...+...+..++||||+++|+|.
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~-~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (325)
T cd05604 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIM-AERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELF 84 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHH-HHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHH
Confidence 568899999865 4556677765421 1111111 11111233688999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~ 154 (257)
+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... .......++
T Consensus 85 ~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 85 FHLQ--RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 9987 456789999999999999999999999 99999999999999999999999999986421 222344678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
..|+|||.+.+..++.++|||||||++|||++|..||...... ...... .. ............+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~-----~~-------~~~~~~~~~~~~~~ 224 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNI-----LH-------KPLVLRPGASLTAW 224 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHH-----Hc-------CCccCCCCCCHHHH
Confidence 8999999999988999999999999999999999999754211 111100 00 00111223456788
Q ss_pred HHHHHcccCCCCCCC-hH
Q 044568 235 KVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ 251 (257)
+++.+|++.+|.+|| ++
T Consensus 225 ~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 225 SILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHhccCHHhcCCCC
Confidence 999999999999999 75
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=245.51 Aligned_cols=228 Identities=19% Similarity=0.223 Sum_probs=173.5
Q ss_pred ccccceeeecccCC------CCCeeeccch----------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVSW----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||++..... ..+++|.... .+|++++. ++ .|+|++++.+.+...+..++
T Consensus 23 g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK---------MIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred cccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHH---------hhcCCCCeeeEEEEEcCCCCeEE
Confidence 46789999886543 3455664432 22333322 55 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 044568 67 IERPVRNGSLTDIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~ 132 (257)
+|||+++|+|.+++... ....+++..+..++.|++.||.|||++ +++|+||+|.||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 99999999999999631 345689999999999999999999999 9999999999999999999
Q ss_pred eEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHH
Q 044568 133 AKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNW 206 (257)
Q Consensus 133 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~ 206 (257)
++|+|||.++...... ....++..|+|||.+.+..++.++||||||+++||+++ |..||....... ....
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~ 246 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LFKL 246 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----HHHH
Confidence 9999999987543321 11223456999999988889999999999999999997 999986441111 0000
Q ss_pred HHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 207 VYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ... ....+......+.+++.+||+.+|++|| +.|+++.|
T Consensus 247 ----~~-----~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 247 ----LK-----EGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred ----HH-----cCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 00 000 0022334567789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.43 Aligned_cols=230 Identities=17% Similarity=0.209 Sum_probs=179.1
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|++++++.+.+...+..++||||
T Consensus 13 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~---------~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK---------QLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred CCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHH---------hCCCCCeeeeeeeeecCCeEEEEEec
Confidence 567899999987 56666776442 223333333 88899999999999999999999999
Q ss_pred cCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 71 VRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
+++|+|.+++... ....+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999998642 345689999999999999999999999 9999999999999999999999999987643322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....++..|.|||.+.+..++.++|+||||+++|++++|+.||........ .... ....... ...
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~------~~~~~~~-~~~ 228 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCK------KIEKCDY-PPL 228 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HHHh------hhhcCCC-CCC
Confidence 1234567789999999888899999999999999999999999965421110 0000 0000000 112
Q ss_pred CH-HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DK-KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~-~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+. .....+.+++.+||+.+|.+|| +.+|+++|
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 22 4456789999999999999999 99998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=241.94 Aligned_cols=235 Identities=15% Similarity=0.136 Sum_probs=178.0
Q ss_pred ccccceeeecccCCCCCeeeccchh------hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWT------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++..+++..++|..... ...+.-.+...-..+.++.|+|++++.+.+...+..++||||+++++|.
T Consensus 11 g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (265)
T cd06631 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSIS 90 (265)
T ss_pred cCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHH
Confidence 5678999999878888888865421 0000001111111334888999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---------Cc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---------DF 148 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---------~~ 148 (257)
+++. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 91 ~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (265)
T cd06631 91 SILN--RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165 (265)
T ss_pred HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccc
Confidence 9997 345688999999999999999999999 999999999999999999999999998764311 11
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|+||||+++|++++|..||........ .... ....... ...+..
T Consensus 166 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~-------~~~~~~~--~~~~~~ 233 (265)
T cd06631 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYI-------GAHRGLM--PRLPDS 233 (265)
T ss_pred cccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHh-------hhccCCC--CCCCCC
Confidence 233567789999999888889999999999999999999999974421110 0000 0000011 122334
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.+|.+|| +.|+++
T Consensus 234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 567789999999999999999 999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=262.96 Aligned_cols=235 Identities=16% Similarity=0.138 Sum_probs=174.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchh--hhHHHHhHhhhccccccccCCceeeeceeeeecC--------ceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT--ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--------VSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--------~~~lV~E~~~ 72 (257)
+.++.||+++.. ++..+++|..... .+.+.......-..+..+.|+|++++...+...+ ..++||||++
T Consensus 43 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~ 122 (496)
T PTZ00283 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYAN 122 (496)
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCC
Confidence 578899999854 5677788875421 1111111111111333778999998776654332 3679999999
Q ss_pred CCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 73 NGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 73 ~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
+|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~ 199 (496)
T PTZ00283 123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199 (496)
T ss_pred CCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccc
Confidence 99999999642 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...... ...
T Consensus 200 ~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~~~-----~~~~~~--~~~ 265 (496)
T PTZ00283 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVMHK-----TLAGRY--DPL 265 (496)
T ss_pred cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHH-----HhcCCC--CCC
Confidence 23456888999999999988999999999999999999999999754211 00000 000001 123
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+...++.+.+++.+||+.||.+|| +.++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 344567899999999999999999 999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=252.63 Aligned_cols=187 Identities=14% Similarity=0.117 Sum_probs=151.2
Q ss_pred cccccceeeecccC-CCCCeeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
.+.++.||+++... +..+++|...-... -..-.+......+.++.|++++++.+.+......++||||+++|+|.+
T Consensus 11 ~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (363)
T cd05628 11 RGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT 90 (363)
T ss_pred eCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHH
Confidence 35789999998654 55677776542111 000011111113347789999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----------
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----------- 147 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----------- 147 (257)
++. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++......
T Consensus 91 ~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 165 (363)
T cd05628 91 LLM--KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165 (363)
T ss_pred HHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccc
Confidence 997 456799999999999999999999999 9999999999999999999999999997643211
Q ss_pred ---------------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 148 ---------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 148 ---------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01236889999999999888999999999999999999999999755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=239.51 Aligned_cols=228 Identities=19% Similarity=0.191 Sum_probs=175.8
Q ss_pred ccccceeeecccC-CC---CCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNA-RN---SPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~---~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++...+ +. .+++|.... .+|++. +.+++|+|++++.+.+.. ...++|||
T Consensus 6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAI---------MHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred cCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHH---------HhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 5678999998765 22 246665442 233333 338899999999998888 88999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.+.....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999999999753325789999999999999999999999 99999999999999999999999999887543311
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||.+....++.++|+||||+++|||++ |..||....... ...... .....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----------~~~~~ 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKID----------KEGER 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----------hcCCc
Confidence 12345567999999988889999999999999999998 999996431111 111110 00011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 122334457899999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=239.84 Aligned_cols=226 Identities=17% Similarity=0.223 Sum_probs=171.9
Q ss_pred cccccceeeecccCCC----CCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 3 CTKLSNFYRSSFNARN----SPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~----~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
.+.++.||+|....+. ..++|...- .+|++.+ ..+.|+|++++.+.+. .+..++||
T Consensus 5 ~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l---------~~l~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVM---------AQLDHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred ccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHH---------HhcCCCCeeeEEEEEc-CCceEEEE
Confidence 3578899999865554 455655432 2223333 3788999999998765 55689999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+++|+|.+++.. ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 75 ELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EeCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999974 34789999999999999999999999 99999999999999999999999999887442222
Q ss_pred c------cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 V------IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 ~------~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
. ...++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ........ . .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~~----~------~ 215 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLES----G------E 215 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHc----C------C
Confidence 1 1112346999999988889999999999999999998 99999644211 11111100 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...+..+.+++.+||+.+|++|| +.++++.|
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 1123334557889999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=246.78 Aligned_cols=234 Identities=16% Similarity=0.106 Sum_probs=174.7
Q ss_pred ccccceeeecc-cCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++.. .++..+++|.......-+.......-..+..+.|+|++++.+.+...+..++||||+++++|.+++..
T Consensus 31 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 110 (296)
T cd06654 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110 (296)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh
Confidence 45788999985 44556667655431111100000000123377899999999999999999999999999999999953
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~a 159 (257)
..+++.+...++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...... .....+++.|+|
T Consensus 111 ---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 184 (296)
T cd06654 111 ---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184 (296)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccC
Confidence 4588999999999999999999999 9999999999999999999999999987643221 123467778999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+.+..++.++|+||||+++|++++|+.||........ +. ... .........+......+.+++.+
T Consensus 185 PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~-~~~-----~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LY-LIA-----TNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HH-HHh-----cCCCCCCCCccccCHHHHHHHHH
Confidence 9999888889999999999999999999999975422110 00 000 00001112233455678999999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||+.+|++|| +.|+++
T Consensus 253 ~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 253 CLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HCcCCcccCcCHHHHhh
Confidence 9999999999 999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=242.71 Aligned_cols=228 Identities=20% Similarity=0.258 Sum_probs=174.8
Q ss_pred ccccceeeecccCC------CCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++..... ..+++|.... .++++. +..+.|+|++++.+.+...+..++|
T Consensus 17 g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~---------l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV---------MKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred CCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHH---------HHhCCCCceeEEEEEEcCCCCcEEE
Confidence 56788999886543 3556665431 222222 3378899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcc
Confidence 99999999999996421 23478889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
+++...... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||....... ..... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~ 236 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLKFV----ID 236 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHHHH----hc
Confidence 886433221 22334567999999988889999999999999999998 899986432111 11100 00
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ....+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 237 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 237 GG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 00 0122334467899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=251.80 Aligned_cols=224 Identities=17% Similarity=0.189 Sum_probs=177.9
Q ss_pred cccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
|+++|.||+....+...++++++. |.+|++.+. .+. .|.+|++++++-..++..||||||-
T Consensus 371 ~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~-KLk-------g~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 371 SGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLN-KLK-------GHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred CCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHH-Hhc-------CCceEEEEeeeeccCceEEEEeecc
Confidence 789999999999999999888765 456666665 223 3789999999999999999999977
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+ -+|.++|.. ....++.-..+.+..|++.|+.++|.+ ||||.||||.|+|+-. |.+||+|||.+..+..+.
T Consensus 443 d-~DL~kiL~k-~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 443 D-IDLNKILKK-KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred c-ccHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence 5 599999986 334444337889999999999999999 9999999999999875 499999999998655443
Q ss_pred --ccccCCCCccCcccccCC-----------CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 149 --VIDKRDKGYMAPECYKRT-----------PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
..+.||+.|++||++... ..+.++||||+||+||+|+.|++||... .+ ....
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n------~~aK 581 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------IN------QIAK 581 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HH------HHHH
Confidence 677999999999998532 2568899999999999999999999622 11 1233
Q ss_pred hhhhhcCC---CCCHHHH-HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGT---KVDKKNL-ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~---~~~~~~~-~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.++. +++.--. .++++++..||+.||.+|| +.|+++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 44555542 2222222 2399999999999999999 999986
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=239.19 Aligned_cols=227 Identities=17% Similarity=0.272 Sum_probs=176.9
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++....+...++|... +.+|++.+. ++.|++++++.+.+......++||||+++++
T Consensus 15 g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 15 GQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMM---------KLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred cccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHH---------hCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 45788999988777777776543 334444444 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++..+..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus 86 L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 86 LSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred HHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 9999975 445689999999999999999999999 99999999999999999999999999876432221 112
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+..|+|||.+.+..++.++|+||||+++||+++ |..||...... .... ... ..... ..+...+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~---~~~~~----~~~~~~~ 227 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE----TIN---AGFRL----YKPRLAS 227 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH----HHh---CCCCC----CCCCCCC
Confidence 23457999999988889999999999999999998 99999643111 0010 000 00001 1122235
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.+|++|| +.|+++.|
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6799999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=244.81 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=172.7
Q ss_pred ccccceeeeccc-----CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEE
Q 044568 4 TKLSNFYRSSFN-----ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-----~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV 67 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+.. ....++|
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK---------SLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred CCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHH---------hCCCCCeeEEEEEEccCCCCceEEE
Confidence 568899998753 45566777653 234444444 8899999999887654 3467899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 86 MEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999999974 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred cc------cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 FV------IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ~~------~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.. ...++..|+|||.+.+..++.++|+||||+++||+++|..|+.......... .............+.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHHHHHh
Confidence 11 1112234899999988889999999999999999999887765331110000 0000000000000111111
Q ss_pred CC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ..+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 11 22334557899999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=239.57 Aligned_cols=233 Identities=15% Similarity=0.122 Sum_probs=175.7
Q ss_pred ccccceeeeccc-CCCCCeeeccchh-------hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT-------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++... ++..+++|..... .+++.+. ..-..+.++.|+|++++.+.+...+..++|+||+++++
T Consensus 13 g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 90 (263)
T cd06625 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE--CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGS 90 (263)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHH--HHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCc
Confidence 457889999854 4556666653311 1111111 00013348899999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------c
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------V 149 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------~ 149 (257)
|.+.+. ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 91 l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 165 (263)
T cd06625 91 VKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165 (263)
T ss_pred HHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccccccccc
Confidence 999997 445688999999999999999999999 99999999999999999999999999986433211 2
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...++..|+|||.+.+..++.++|+||+|+++||+++|+.||........ .... .........+...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~----------~~~~~~~~~~~~~ 232 (263)
T cd06625 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFKI----------ATQPTNPQLPSHV 232 (263)
T ss_pred CCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHHH----------hccCCCCCCCccC
Confidence 23456789999999988899999999999999999999999964411110 0000 0000111233445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
...+.+++.+||+.+|.+|| +.|+++.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 233 SPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 66789999999999999999 9999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=238.35 Aligned_cols=237 Identities=21% Similarity=0.230 Sum_probs=180.0
Q ss_pred ccccceeeecccC----CCCCeeeccchhhhHH-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA----RNSPWISRVSWTADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~----~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||++.... ...+++|.......-. .-.+...-..+.++.|+|++++.+.+......++||||+++++|.+
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (262)
T cd00192 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLD 85 (262)
T ss_pred CCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHH
Confidence 5678999999876 5556666554321100 0010011113337789999999999999999999999999999999
Q ss_pred HHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----
Q 044568 79 IIFCSA-------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 79 ~l~~~~-------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---- 147 (257)
++.... ...+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 162 (262)
T cd00192 86 YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR 162 (262)
T ss_pred HHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccc
Confidence 998521 47799999999999999999999999 9999999999999999999999999998765432
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....++..|+|||.+....++.++|+||+|+++||+++ |..||...... ..... ... ......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----------~~~-~~~~~~ 228 (262)
T cd00192 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEY----------LRK-GYRLPK 228 (262)
T ss_pred cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----------HHc-CCCCCC
Confidence 233445677999999988888999999999999999999 69999755111 00000 000 001123
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+...+..+.+++.+||+.+|.+|| +.|+++.|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 344467899999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=241.98 Aligned_cols=234 Identities=16% Similarity=0.109 Sum_probs=173.3
Q ss_pred ccccceeeecccCCCCC-eeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
+.++.||++........ +++.... ....+.... .. ..+..+.|+|++++.+.+...+..++||||+++++|..++
T Consensus 16 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-e~-~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 93 (282)
T cd06643 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EI-DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93 (282)
T ss_pred CCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHH-HH-HHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHH
Confidence 45789999997765443 4544332 111111110 00 0233788999999999999999999999999999999988
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCc
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGY 157 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~ 157 (257)
.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++...... .....++..|
T Consensus 94 ~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y 169 (282)
T cd06643 94 LE-LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169 (282)
T ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccc
Confidence 64 456799999999999999999999999 9999999999999999999999999988643221 2334577889
Q ss_pred cCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 158 MAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 158 ~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
+|||.+. ...++.++|+||||+++|||++|+.||....... ...... . ........+...+..
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~----~-----~~~~~~~~~~~~~~~ 237 (282)
T cd06643 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLKIA----K-----SEPPTLAQPSRWSSE 237 (282)
T ss_pred cCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHHHh----h-----cCCCCCCCccccCHH
Confidence 9999984 3456789999999999999999999997542111 111100 0 000011123334567
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++.+||+.||.+|| +.++++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 89999999999999999 999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=236.84 Aligned_cols=227 Identities=18% Similarity=0.225 Sum_probs=178.5
Q ss_pred ccccceeeecccCCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
++++.||++....+..+++|.... .+|++ ...++.|+|++++.+.+...+..++||||+++
T Consensus 6 g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~---------~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 6 GNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAE---------ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHH---------HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 468899999988788888886442 22333 33378899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV---- 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~---- 149 (257)
++|.+++.. ....+++..+..++.+++.|+.|||++ +++|+|++|+||+++.++.++|+|||.+........
T Consensus 77 ~~l~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 77 GSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 999999975 345688999999999999999999999 999999999999999999999999999875432111
Q ss_pred -cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 150 -IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 150 -~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....+..|+|||.+.+..++.++|+||||+++||+++ |..||....... .... .... .....+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~---------~~~~-~~~~~~~ 218 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRER---------IESG-YRMPAPQ 218 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHH---------HhcC-CCCCCCc
Confidence 1122446999999988889999999999999999999 888886542111 0000 0000 0112234
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+..+.+++.+||+.+|.+|| +.|+++.|
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHh
Confidence 4567899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=241.01 Aligned_cols=234 Identities=18% Similarity=0.199 Sum_probs=174.8
Q ss_pred ccccceeeecccCCCC----Ceeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+|....... +++|.... ....+.+. ..-..+..+.|+|++++.+.+...+..++||||+++|+|
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T cd05065 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL--SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL 92 (269)
T ss_pred CCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHH--HHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcH
Confidence 5688999999765543 66766432 11111111 111123378899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VID 151 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~ 151 (257)
.+++.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++++|||++....... ...
T Consensus 93 ~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (269)
T cd05065 93 DSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168 (269)
T ss_pred HHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence 999975 456789999999999999999999999 99999999999999999999999999876433211 111
Q ss_pred c---CCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 152 K---RDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 152 ~---~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
. .+..|++||.+.+..++.++|+||||+++||+++ |..||...... ....+.. ... ....+.
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~---------~~~-~~~~~~ 234 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE---------QDY-RLPPPM 234 (269)
T ss_pred cCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH---------cCC-cCCCcc
Confidence 1 1236999999998889999999999999999886 99999644211 1111110 000 112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+..+.+++.+||+.+|.+|| +.++++.|
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4567789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=239.75 Aligned_cols=234 Identities=21% Similarity=0.274 Sum_probs=169.0
Q ss_pred ccccceeeecccCCC----CCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeee-ecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK-LTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-~~~~~~lV~E~~~~gs 75 (257)
+.++.||+|+..+.. .+++|.... ..+.+.+. ........+.|+|++++.+.+. .++..++||||+.+|+
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 83 (262)
T cd05058 6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFL--KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGD 83 (262)
T ss_pred cCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHH--HHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCC
Confidence 467899999875433 356666532 11111111 1111234788999999999765 4556889999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-------
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------- 148 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------- 148 (257)
|.+++.. ....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 84 LRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999975 345567888889999999999999999 99999999999999999999999999886432211
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhc-CCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC-RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....++..|+|||.+.+..++.++||||||+++|||++| ..||.... ........ ... .....+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~---------~~~-~~~~~~~ 225 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYL---------LQG-RRLLQPE 225 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH---------hcC-CCCCCCC
Confidence 122345579999999888899999999999999999995 45554321 11111100 000 0111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+..+.+++..||+.+|++|| +.|+++.|
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 3456799999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=249.45 Aligned_cols=236 Identities=18% Similarity=0.206 Sum_probs=172.0
Q ss_pred ccccceeeecccC------CCCCeeeccch---hhhHHHHhHhhhccccccc-cCCceeeeceeeee-cCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVSW---TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKL-TSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~-~~~~~lV~E~~~ 72 (257)
+.|+.||++.... ++.+++|...- ..+.+.+. .... .+.++ .|+|++++.+.+.. +...+++|||++
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~-~E~~-~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~ 95 (337)
T cd05054 18 GAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-TELK-ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95 (337)
T ss_pred CcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHH-HHHH-HHHhhccCcchhheeeeEecCCCCEEEEEecCC
Confidence 5789999996433 34677776431 11111111 0000 22255 69999999998765 456789999999
Q ss_pred CCCHHHHHhccC-----------------------------------------------------------CCCCCHHHH
Q 044568 73 NGSLTDIIFCSA-----------------------------------------------------------ERNPYWNQR 93 (257)
Q Consensus 73 ~gsL~~~l~~~~-----------------------------------------------------------~~~l~~~~~ 93 (257)
+|+|.+++.... ...+++..+
T Consensus 96 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 175 (337)
T cd05054 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175 (337)
T ss_pred CCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHH
Confidence 999999986321 136889999
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCC
Q 044568 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPI 168 (257)
Q Consensus 94 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~ 168 (257)
..++.|++.||.|||++ +|+||||||.||+++.++.++|+|||++....... ....++..|+|||.+.+..+
T Consensus 176 ~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 252 (337)
T cd05054 176 ISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252 (337)
T ss_pred HHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCC
Confidence 99999999999999999 99999999999999999999999999987542211 12234567999999999999
Q ss_pred CccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCC
Q 044568 169 SVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPAL 247 (257)
Q Consensus 169 ~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~ 247 (257)
+.++|||||||++||+++ |..||......+. ... ...... ....+......+.+++.+||+.+|++
T Consensus 253 ~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~---------~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCR---------RLKEGT-RMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred CccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHH---------HHhccC-CCCCCccCCHHHHHHHHHHccCChhh
Confidence 999999999999999998 9999975422111 000 000000 01122334567899999999999999
Q ss_pred CC-hHHHHHhC
Q 044568 248 RP-MKCAVMML 257 (257)
Q Consensus 248 RP-~~ei~~~L 257 (257)
|| +.|+++.|
T Consensus 320 RPs~~ell~~l 330 (337)
T cd05054 320 RPTFSELVEIL 330 (337)
T ss_pred CcCHHHHHHHH
Confidence 99 99999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=243.66 Aligned_cols=241 Identities=15% Similarity=0.105 Sum_probs=174.1
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeee-----cCceeE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-----TSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~l 66 (257)
+.++.||++...+ +..+++|.... .+|++.+. .+..+.|+|++++.+.+.. ....++
T Consensus 11 g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLK------RLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHH------HhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 5688999998765 45566765431 23344333 2335579999999987764 345789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||++ ++|.+++.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++.....
T Consensus 85 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred EEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 999997 5899998764556699999999999999999999999 999999999999999999999999999875432
Q ss_pred Cc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh------
Q 044568 147 DF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK------ 218 (257)
Q Consensus 147 ~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 218 (257)
.. ....++..|+|||.+.+..++.++||||+||++|||++|..||................... ....+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP-PEDDWPRDVTLPR 239 (288)
T ss_pred cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC-ChhhCcccccccc
Confidence 21 33456788999999988889999999999999999999999997552221111111100000 0000000
Q ss_pred -hhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 -LVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 -~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+. .......+.+.+++.+||+.||++|| +.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 11122346788999999999999999 999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=240.52 Aligned_cols=230 Identities=19% Similarity=0.177 Sum_probs=176.3
Q ss_pred ccccceeeecccC-CCCCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++... +..+++|.... ....+.+. ..-..+.++.|+|++++.+.+......++||||+++|+|.++
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (277)
T cd06640 15 GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDL 92 (277)
T ss_pred CCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHH--HHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHH
Confidence 4678999998654 56667775442 11111111 011123378899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~ 156 (257)
+. ...+++.+...++.|++.|+.|+|++ +++|+||+|+||+++.++.++++|||++...... .....++..
T Consensus 93 i~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 166 (277)
T cd06640 93 LR---AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166 (277)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCccc
Confidence 95 34688999999999999999999999 9999999999999999999999999988653321 123356677
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|+||||+++|||++|..||........ . . .. ............+..+.++
T Consensus 167 y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~----~------~~-~~~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L----F------LI-PKNNPPTLTGEFSKPFKEF 232 (277)
T ss_pred ccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h----h------hh-hcCCCCCCchhhhHHHHHH
Confidence 9999999888889999999999999999999999964421110 0 0 00 0001123344567789999
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+||+.+|++|| +.++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred HHHHcccCcccCcCHHHHHh
Confidence 9999999999999 999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=240.03 Aligned_cols=227 Identities=19% Similarity=0.260 Sum_probs=174.3
Q ss_pred ccccceeeecccCCC----CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|+..... ..++|... +.+|++.+. ++.|+|++++.+.+...+..++|||
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG---------QFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred cCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHH---------hCCCCCcceEEEEEecCCccEEEEE
Confidence 568899999865433 35666543 223333333 7789999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++++|.+++.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++++|||.+.......
T Consensus 86 ~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 86 YMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999975 445789999999999999999999999 99999999999999999999999999887543221
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|++||.+.+..++.++|+||||+++||+++ |..||....... .. ... .....
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~-~~~---------~~~~~- 227 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI-KAI---------EEGYR- 227 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH-HHH---------hCCCc-
Confidence 11122346999999988889999999999999999886 999996442111 00 000 00000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.+|.+|| +.++++.|
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 112223456789999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=238.89 Aligned_cols=234 Identities=14% Similarity=0.155 Sum_probs=176.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|..... ...+... .....+.++.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 11 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 88 (255)
T cd08219 11 GSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQK 88 (255)
T ss_pred cCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHH--HHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHH
Confidence 356778888855 4555666754321 1111111 111133478899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~ 156 (257)
+.......++......++.|++.|+.|||++ +++|+||+|+||++++++.++++|||.+....... ....++..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 165 (255)
T cd08219 89 IKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY 165 (255)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCcc
Confidence 8754456689999999999999999999999 99999999999999999999999999886543221 23457778
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... .... ....+......+.++
T Consensus 166 ~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~-----~~~~------~~~~~~~~~~~~~~l 231 (255)
T cd08219 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKV-----CQGS------YKPLPSHYSYELRSL 231 (255)
T ss_pred ccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHH-----hcCC------CCCCCcccCHHHHHH
Confidence 999999988889999999999999999999999997542110 00000 0000 002233345678899
Q ss_pred HHHcccCCCCCCC-hHHHHHh
Q 044568 237 GLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~~ 256 (257)
+.+||+.||++|| +.|++..
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999 9999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=242.73 Aligned_cols=229 Identities=17% Similarity=0.113 Sum_probs=174.5
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+|+.. ++..+++|.... .+|+..+ .++.|+|++++.+.+...+..++||||+++
T Consensus 20 g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l---------~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV---------KECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHH---------HhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 568899999964 455566765542 2233333 378999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
++|.+++. ....+++.++..++.|++.|+.|||++ +++|+|++|.||+++.++.++++|||++...... ...
T Consensus 91 ~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 91 GSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 99999997 445789999999999999999999999 9999999999999999999999999998754322 123
Q ss_pred ccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC
Q 044568 151 DKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD 226 (257)
Q Consensus 151 ~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (257)
..++..|+|||.+. ...++.++|+||||+++|||++|..||.......... .+ ... ....+. ...
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~-----~~~---~~~~~~~~~~ 234 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LM-----SKS---NFQPPKLKDK 234 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---ee-----ecC---CCCCCCCccc
Confidence 45677899999885 3447789999999999999999999996432111100 00 000 000000 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......+.+++.+||+.+|++|| ++++++.|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 22346788999999999999999 99998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.36 Aligned_cols=235 Identities=14% Similarity=0.122 Sum_probs=174.5
Q ss_pred cccccceeeeccc-CCCCCeeeccchhh-----hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSWTA-----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
.+.++.||+++.. ++..+++|...... ..+.+. .....+....|+|++++...+...+..++||||+++|+|
T Consensus 11 ~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (330)
T cd05601 11 RGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFE--EERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL 88 (330)
T ss_pred eccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHH--HHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCH
Confidence 3568899999865 45556777655311 111111 111123367899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----cccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDK 152 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~ 152 (257)
.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 164 (330)
T cd05601 89 LSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164 (330)
T ss_pred HHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeeccc
Confidence 999975 346799999999999999999999999 99999999999999999999999999987543322 2346
Q ss_pred CCCCccCccccc------CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 153 RDKGYMAPECYK------RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 153 ~~~~~~aPE~~~------~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
+|+.|+|||.+. ...++.++||||||+++|||++|+.||....... ...... . ....... ...
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~-----~--~~~~~~~-~~~ 233 (330)
T cd05601 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIM-----N--FQRFLKF-PED 233 (330)
T ss_pred CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHH-----c--CCCccCC-CCC
Confidence 788999999986 4457899999999999999999999997542111 010000 0 0001110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.+++..|++ +|.+|| +.++++
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1245678889999998 999999 999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=257.15 Aligned_cols=220 Identities=15% Similarity=0.148 Sum_probs=168.4
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... +..+++|...- .+|++++ ..+.|+|++++.+.+...+..++||||
T Consensus 12 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il---------~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 12 GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL---------AEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH---------HhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 5688999999754 56677776542 1233333 377899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 83 LPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999997 445799999999999999999999999 99999999999999999999999999876422110
Q ss_pred ---------------------------------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC
Q 044568 149 ---------------------------------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189 (257)
Q Consensus 149 ---------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~ 189 (257)
....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 12358889999999998889999999999999999999999
Q ss_pred CCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 190 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
||...........+..|. ..+.- .......+.+.+++.+|+. +|.+|+
T Consensus 238 Pf~~~~~~~~~~~i~~~~---------~~~~~--~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 238 PFCSDNPQETYRKIINWK---------ETLQF--PDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred CCCCCCHHHHHHHHHcCC---------CccCC--CCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 997552211111110000 00000 0111234567788888986 899988
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=239.28 Aligned_cols=237 Identities=16% Similarity=0.197 Sum_probs=173.6
Q ss_pred ccccceeeecccCC----CCCeeeccchhh--hHHHHhHhhhccccccccCCceeeeceeeeecCc------eeEEEeec
Q 044568 4 TKLSNFYRSSFNAR----NSPWISRVSWTA--DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV------SGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~----~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~------~~lV~E~~ 71 (257)
+.++.||+|+.... ..+++|...... .-+..........+..+.|+|++++.+.+...+. .++||||+
T Consensus 10 G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~ 89 (273)
T cd05035 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89 (273)
T ss_pred CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEecc
Confidence 46889999987543 346777654210 0000011111113347889999999988766554 78999999
Q ss_pred CCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 72 RNGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 72 ~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
++|+|.+++... ....+++..+..++.|++.||.|||++ +++|+|++|+||++++++.+||+|||+++.....
T Consensus 90 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 166 (273)
T cd05035 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG 166 (273)
T ss_pred CCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeecccc
Confidence 999999998542 234689999999999999999999999 9999999999999999999999999998754322
Q ss_pred c-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 F-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
. .....+..|++||.+....++.++||||||+++||+++ |..||....... .... .. .. .
T Consensus 167 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~---~~-~~------~ 232 (273)
T cd05035 167 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDY---LR-HG------N 232 (273)
T ss_pred ccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH---HH-cC------C
Confidence 1 11233457999999988889999999999999999999 888886542111 0000 00 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+......+.+++.+||+.||.+|| +.|+++.|
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1123344567899999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.74 Aligned_cols=191 Identities=19% Similarity=0.190 Sum_probs=163.2
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
-+.|+|++.++..+.+..+.|+|.||+++|-|.+++- ..+.+++.++.+++.||+.|+.|+|.. +|+|||+||+|
T Consensus 68 Li~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpEN 142 (786)
T KOG0588|consen 68 LIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPEN 142 (786)
T ss_pred HhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchh
Confidence 6779999999999999999999999999999999998 678899999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeecccccCCC--CcccccCCCCccCcccccCCCCC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhH
Q 044568 125 ILMDEFWTAKILDFGLAKLPNE--DFVIDKRDKGYMAPECYKRTPIS-VKADVYGYGIVLLETICCRKNMEIDASKPEEI 201 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~ 201 (257)
+|++..+.+||+|||++..... -....+|++.|.+||++.+.+|. .++||||+|+++|.+++|+.||++++
T Consensus 143 lLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ 216 (786)
T KOG0588|consen 143 LLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------ 216 (786)
T ss_pred hhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------
Confidence 9999999999999999875433 34677999999999999999985 88999999999999999999998541
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 202 ILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.. ......+.. .+|...+.+.-+|+.+|+..||+.|- ++||++
T Consensus 217 -ir~L-LlKV~~G~f-------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 217 -IRVL-LLKVQRGVF-------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -HHHH-HHHHHcCcc-------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1111 011111111 34555667778888999999999999 999975
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.82 Aligned_cols=246 Identities=14% Similarity=0.093 Sum_probs=172.4
Q ss_pred cccceeeeccc-CCCCCeeeccchh---h-hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 5 KLSNFYRSSFN-ARNSPWISRVSWT---A-DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 5 ~~~~~y~~~~~-~~~~~~i~~~~~~---~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
++..||++... +++.+++|..... + ..+.+.. .-..+..+.|+||+++.+.+...+..++||||+++|+|.++
T Consensus 12 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (327)
T cd08227 12 DLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQG--ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 89 (327)
T ss_pred ceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHH--HHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHH
Confidence 56789998864 5566778876532 1 1111110 01123367899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----------cc
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----------FV 149 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----------~~ 149 (257)
+.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++||+........ ..
T Consensus 90 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 166 (327)
T cd08227 90 ICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPK 166 (327)
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccc
Confidence 9754456699999999999999999999999 9999999999999999999999999754322111 11
Q ss_pred cccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh------hhhhhh----
Q 044568 150 IDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF------INRELN---- 217 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~---- 217 (257)
...++..|+|||.+.+ ..++.++|||||||++||+++|+.||.................+.. ...+..
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T cd08227 167 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPS 246 (327)
T ss_pred cccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCc
Confidence 2244567999999876 3588999999999999999999999974321110000000000000 000000
Q ss_pred ---------hh-----hcC-------CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 ---------KL-----VRG-------TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ---------~~-----~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..+ ........+.+.+++.+||+.||++|| ++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 247 RSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 011223346789999999999999999 999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=242.91 Aligned_cols=225 Identities=18% Similarity=0.201 Sum_probs=174.0
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... ++.+++|...- .+|++. +.+++|++++.+...+...+..++||||
T Consensus 11 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~i---------l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI---------LEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHH---------HHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5688999998764 45566765431 223333 3388899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--Cc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~ 148 (257)
+++++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 9999999998754456799999999999999999999999 999999999999999999999999998864332 12
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|+||||+++||+++|..||........ ...+.. ..... ....+..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~------~~~~~--~~~~~~~ 227 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDR------RVLET--EEVYSAK 227 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH------hhhcc--ccccCcc
Confidence 334678899999999888899999999999999999999999975421111 111100 00000 0122333
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
....+.+++..||+.||++|| +.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCc
Confidence 456788999999999999999 65
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=252.07 Aligned_cols=226 Identities=13% Similarity=0.106 Sum_probs=170.1
Q ss_pred ccccceeeecccCC-CCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...+ +.+++|.... .+|++ ....+.|+|++++.+.+...+..++||||
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---------i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 54 GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD---------IMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHH---------HHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 56889999997654 4556665431 12222 23378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 125 ~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 125 MPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999953 4588999999999999999999999 99999999999999999999999999987543222
Q ss_pred --ccccCCCCccCcccccCCC----CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 --VIDKRDKGYMAPECYKRTP----ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~----~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|+.|+|||.+.+.. ++.++|+||+||++|||++|..||....... ...... ... ....
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~~~~i~-----~~~--~~~~- 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---TYSKIM-----DHK--NSLN- 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---HHHHHH-----hCC--cccC-
Confidence 3456889999999987542 7789999999999999999999997542111 111100 000 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
.+........+.+++..|+..+|.+ || +.|+++
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 0111223566788888999865544 89 999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=255.93 Aligned_cols=233 Identities=13% Similarity=0.088 Sum_probs=169.6
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh-----hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA-----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++... +++.+++|...-.. ..+.+. ..-..+.++.|+||+++.+.+...+..++||||+++|+|.
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 89 (377)
T cd05629 12 GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK--AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLM 89 (377)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHH--HHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHH
Confidence 568899998754 55566777653211 111111 0011233788999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----------
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---------- 147 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---------- 147 (257)
+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 164 (377)
T cd05629 90 TMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164 (377)
T ss_pred HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence 9997 456789999999999999999999999 9999999999999999999999999988521100
Q ss_pred ----------------------------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhc
Q 044568 148 ----------------------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC 187 (257)
Q Consensus 148 ----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g 187 (257)
.....||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG 244 (377)
T cd05629 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244 (377)
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC
Confidence 0013578899999999988899999999999999999999
Q ss_pred CCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCC---CC-hHHHHH
Q 044568 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPAL---RP-MKCAVM 255 (257)
Q Consensus 188 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~---RP-~~ei~~ 255 (257)
..||...........+..|. ..+. .+........+.+++.+|+. +|.+ || +.|+++
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~----------~~~~-~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 245 WPPFCSENSHETYRKIINWR----------ETLY-FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred CCCCCCCCHHHHHHHHHccC----------CccC-CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99997552211111111110 0000 00011234567888889997 6665 57 777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=239.86 Aligned_cols=227 Identities=17% Similarity=0.146 Sum_probs=170.7
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeec------CceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT------SVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~------~~~~lV 67 (257)
+.++.||+|.... +..+++|... +.++++.+. ++ .|+|++++.+.+... +..++|
T Consensus 17 g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~---------~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK---------KYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHH---------HhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 4678999998654 4445666543 223333332 44 599999999988753 457899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE- 146 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~- 146 (257)
|||+++|+|.+++.......+++..+..++.|++.|+.|||++ +++|+|++|+||++++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999999864456789999999999999999999999 999999999999999999999999999875332
Q ss_pred --CcccccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 147 --DFVIDKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 147 --~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
......++..|+|||.+. ...++.++|+||||+++|||++|..||.......... .. . ..
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~--~----~~ 231 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LI--P----RN 231 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HH--h----cC
Confidence 223446778899999986 2357889999999999999999999996431111000 00 0 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..........+..+.+++.+||+.+|.+|| +.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 001111223446789999999999999999 999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=238.61 Aligned_cols=224 Identities=18% Similarity=0.186 Sum_probs=175.4
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+|... .+..+++|... +.+|++.+. ++.|+|++++.+.+...+..
T Consensus 11 g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK---------ELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred CCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH---------hcCCCCeeeEEEEEEeCCcc
Confidence 457889999864 45556666432 223333333 88899999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
++||||+++++|.+++. ....+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||.++..
T Consensus 82 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999997 346688999999999999999999999 9999999999999999999999999988754
Q ss_pred CCCc---------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 145 NEDF---------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 145 ~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
.... ....++..|+|||.+.+..++.++|+||+|+++|++++|+.||....... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----------~ 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF----------K 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH----------H
Confidence 3211 12346678999999988888999999999999999999999997541110 000 0
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... .....+...+..+.+++.+||+.||.+|| +.|+++
T Consensus 224 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Hhcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0010 11123344567889999999999999999 999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.52 Aligned_cols=230 Identities=20% Similarity=0.194 Sum_probs=174.7
Q ss_pred ccccceeeecccC-CCCCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+|.... +..+++|..... ...+.+. ..-..+.++.|+|++++.+.+...+..++||||+++++|.++
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (277)
T cd06642 15 GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDL 92 (277)
T ss_pred CCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHH--HHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHH
Confidence 4678999998654 455677754421 1111111 000133388999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~ 156 (257)
+. ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++....... ....++..
T Consensus 93 ~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 166 (277)
T cd06642 93 LK---PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166 (277)
T ss_pred hh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCccc
Confidence 85 35689999999999999999999999 99999999999999999999999999886543321 22346777
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|+||||+++||+++|+.||........ .. . ..... ........+..+.++
T Consensus 167 y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~-~---------~~~~~-~~~~~~~~~~~~~~l 232 (277)
T cd06642 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF-L---------IPKNS-PPTLEGQYSKPFKEF 232 (277)
T ss_pred ccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh-h---------hhcCC-CCCCCcccCHHHHHH
Confidence 9999999888889999999999999999999999964321110 00 0 00000 011223345678899
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+||+.+|.+|| +.|+++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 9999999999999 999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=238.37 Aligned_cols=227 Identities=18% Similarity=0.184 Sum_probs=172.9
Q ss_pred ccccceeeecccCC-CCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+|+...+ ..+++|... +.+|++.+. +++|+|++++.+.+...+..++|+||+++
T Consensus 19 g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS---------YLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHH---------hcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 56889999996544 445666533 234444444 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCC---
Q 044568 74 GSLTDIIFCSAERNP--YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~--- 147 (257)
++|.+++.. ....+ ++..+..++.|++.|+.|||++ +++|+|++|+||+++. .+.++|+|||.+......
T Consensus 90 ~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 90 GSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCHHHHHHH-hcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999975 22344 7788889999999999999999 9999999999999976 678999999987643221
Q ss_pred cccccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....++..|+|||.+.... ++.++|+||||+++|++++|..||......... .+... ..-.....
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~--------~~~~~~~~ 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVG--------MFKIHPEI 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hhhhh--------hhccCCCC
Confidence 22345678899999987643 788999999999999999999999643211110 00000 00011123
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+....+.+.+++.+||+.+|.+|| +.|+++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 444567789999999999999999 999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=241.88 Aligned_cols=203 Identities=18% Similarity=0.230 Sum_probs=157.2
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSA---------ERNPYWNQRVRIALDVAKGILYLHDECEPPI 115 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 115 (257)
++.|+|++++.+.+...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ ++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NF 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cc
Confidence 8889999999999999999999999999999999997532 12689999999999999999999999 99
Q ss_pred eeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh--cC
Q 044568 116 LHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC--CR 188 (257)
Q Consensus 116 ~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~--g~ 188 (257)
+|+||+|+||+++.++.++++|||++....... ....++..|+|||.+....++.++||||||+++||+++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 999999999999999999999999987532221 22344567999999988889999999999999999998 67
Q ss_pred CCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 189 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.||..... ...+... ...+....... ....+...+.++.+++.+||+.||++|| +.||++.|
T Consensus 232 ~p~~~~~~---~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 232 QPYEHLTD---QQVIENA-GHFFRDDGRQI---YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred CCCCCcCh---HHHHHHH-Hhccccccccc---cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 77754311 1111111 01100000000 0112233457899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=242.25 Aligned_cols=235 Identities=16% Similarity=0.206 Sum_probs=172.4
Q ss_pred ccccceeeecccCCC---------------CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceee
Q 044568 4 TKLSNFYRSSFNARN---------------SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRA 58 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~---------------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 58 (257)
+.++.||++...... .+++|... +.+|++.+. +++|+|++++.+.+
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~---------~l~h~~i~~~~~~~ 86 (295)
T cd05097 16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS---------RLKNPNIIRLLGVC 86 (295)
T ss_pred CCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHH---------hCCCCCcCeEEEEE
Confidence 467888887654321 24565433 334555555 88999999999999
Q ss_pred eecCceeEEEeecCCCCHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 044568 59 KLTSVSGKIERPVRNGSLTDIIFCSA----------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128 (257)
Q Consensus 59 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~ 128 (257)
...+..++||||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+|++|+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEc
Confidence 99999999999999999999996421 12468889999999999999999999 999999999999999
Q ss_pred CCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh--cCCCCCcCCCChhhH
Q 044568 129 EFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC--CRKNMEIDASKPEEI 201 (257)
Q Consensus 129 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~--g~~pf~~~~~~~~~~ 201 (257)
.++.+||+|||++....... ....++..|+|||.+.+..++.++|+||||+++|||++ |..||.......
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--- 240 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--- 240 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---
Confidence 99999999999886432211 11233557999999988889999999999999999998 566775432111
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 202 ILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... ........ ... ...+...+..+.+++.+||+.||++|| +.+|++.|
T Consensus 241 ~~~~~~-~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 241 VIENTG-EFFRNQGR-QIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHH-Hhhhhccc-ccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 111110 00000000 000 011223456899999999999999999 99999876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=240.82 Aligned_cols=232 Identities=16% Similarity=0.185 Sum_probs=167.2
Q ss_pred ccccceeeecccCCC---CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARN---SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~---~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+|+...+. ..++|... +.++++.+ ..+.|+|++++.+.+...+..++||||
T Consensus 6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~---------~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 6 GWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY---------RELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHH---------HhCCCCCcceEEEEECCCCceEEEEEe
Confidence 468899999765443 23455432 12233332 377899999999999999999999999
Q ss_pred cCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 71 VRNGSLTDIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
+++|+|.+++.... ....++.....++.|++.|+.|||++ +++||||||+||+++.++.+|++|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccc
Confidence 99999999997532 23356778889999999999999999 9999999999999999999999999987643221
Q ss_pred -----cccccCCCCccCcccccC-------CCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 148 -----FVIDKRDKGYMAPECYKR-------TPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 148 -----~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....... ..... .. .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~----~~-~ 225 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQV----VR-E 225 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH----hh-c
Confidence 122234556999998743 346789999999999999999 778886442111 11100 00 0
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 215 ELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.... +.....+......+.+++..|| .||++|| ++||+++|
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 QDIK-LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCcc-CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0001 1111223345567788888999 5999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=244.09 Aligned_cols=238 Identities=15% Similarity=0.185 Sum_probs=174.2
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... ++.+++|.... .+|++.+. +++|+|++++.+.+...+..++||||++
T Consensus 17 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 17 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK---------DLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred cCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHH---------hCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 5688999998654 44567776542 23444433 7889999999999999999999999997
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+ +|.+++.. ....+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++...... ..
T Consensus 88 ~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 88 K-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred C-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 5 89998875 445688999999999999999999999 9999999999999999999999999998643222 22
Q ss_pred cccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhh-hhhhhhh
Q 044568 150 IDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFIN-RELNKLV 220 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~ 220 (257)
...++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||......+......... ++.... ......-
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3456788999999865 457899999999999999999999997653222111111000 000000 0000000
Q ss_pred cCC-------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGT-------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+. .........+.+++.+||+.||.+|| ++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 00112345678999999999999999 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=244.54 Aligned_cols=239 Identities=18% Similarity=0.193 Sum_probs=174.7
Q ss_pred cccccceeeecccCCCC-Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 3 CTKLSNFYRSSFNARNS-PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
.+.++.||+++...+.. +++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 11 ~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 11 AGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH---------ECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 35688999998765443 3444332 223333333 889999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-cc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-FV 149 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~~ 149 (257)
++++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+|++|+||+++.++.++++|||++...... ..
T Consensus 82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 99999999973 4678999999999999999999997 5 8999999999999999999999999987643222 23
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh-------------------
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC------------------- 210 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 210 (257)
...++..|+|||.+.+..++.++|+||||+++|++++|+.||...................
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 3456788999999988888999999999999999999999996442111100000000000
Q ss_pred -hhhhhhhhhhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 -FINRELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 -~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........... +..........+.+++.+||+.+|++|| +.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000 0011112345689999999999999999 999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=243.92 Aligned_cols=228 Identities=18% Similarity=0.197 Sum_probs=172.2
Q ss_pred ccccceeeeccc--------CCCCCeeeccch----------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFN--------ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~--------~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+++.. +...+++|.... .+|++.+. .+ .|+|++++.+.+...+..
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~i~~~~~~~~~~~~~ 96 (304)
T cd05101 26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK---------MIGKHKNIINLLGACTQDGPL 96 (304)
T ss_pred cCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHH---------hhccCCCchheeEEEecCCce
Confidence 568899988642 223456665432 22333322 55 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 65 GKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~ 173 (304)
T cd05101 97 YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173 (304)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCC
Confidence 99999999999999997521 23578889999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.++|+|||.++...... ....++..|+|||.+.+..++.++||||||+++||+++ |..||.... ..
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~----- 246 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VE----- 246 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HH-----
Confidence 999999999987543221 22234457999999988889999999999999999998 788886431 11
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.... ... .....+...+..+.+++.+||+.+|.+|| +.|+++.|
T Consensus 247 ~~~~~~-~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 247 ELFKLL-KEG------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHH-HcC------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 010000 000 00122334567899999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=241.79 Aligned_cols=240 Identities=17% Similarity=0.223 Sum_probs=173.3
Q ss_pred ccccceeeeccc-----CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSSFN-----ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-----~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||.+++. .+..+++|... +.+|++.+. ++.|+|++++.+.+... ...++
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 15 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR---------NLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred CCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHH---------hCCCCCeeeeeeEEecCCCCceEE
Confidence 467889888743 45556777654 233444444 78999999999988765 56789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999965 345689999999999999999999999 999999999999999999999999999875432
Q ss_pred Cc------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DF------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.. ....++..|+|||.+.+..++.++||||||+++||++++..|+.......... ................+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM-IGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh-cccccccccHHHHHHHHH
Confidence 21 12334556999999988889999999999999999999887654321100000 000000000000000011
Q ss_pred cC--CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RG--TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~--~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ...+...+..+.+++.+||+.+|.+|| +.++++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 11 122334567899999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=248.26 Aligned_cols=174 Identities=19% Similarity=0.242 Sum_probs=146.2
Q ss_pred ccccceeeecccCCC-CCeeeccc---hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS---WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++..... .+++|... ...|+..+. ++.|+|++++.+.+...+..++|||++. ++|.++
T Consensus 77 G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 146 (357)
T PHA03209 77 GSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ---------NVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTY 146 (357)
T ss_pred CCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHH---------hCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHH
Confidence 578999999976554 45555432 244555555 8889999999999999999999999995 689998
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--CcccccCCCCc
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DFVIDKRDKGY 157 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~ 157 (257)
+.. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||.++.... ......+|..|
T Consensus 147 l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y 222 (357)
T PHA03209 147 LTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222 (357)
T ss_pred HHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccc
Confidence 875 556799999999999999999999999 999999999999999999999999999874322 22345678899
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCC
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNM 191 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf 191 (257)
+|||.+.+..++.++|||||||++|||+++..|+
T Consensus 223 ~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999888999999999999999999865554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.41 Aligned_cols=237 Identities=17% Similarity=0.153 Sum_probs=178.5
Q ss_pred ccccceeeecccCCC-CCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeee--ecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK--LTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~lV~E 69 (257)
+.+++||||+...++ .+++|++.. .+|+..+. +++|+|||.+--+.. +-+..|||||
T Consensus 87 GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl---------~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 87 GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILL---------KARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHH---------hcCCCCeeeeEEEEeccccceeeeeHH
Confidence 467899999966554 557887663 34555555 889999998877665 4568999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
||++ +|...+.. -...+...+++.++.|++.|++|||.+ .|+|||||++|+|+...|.+|++|||+++..+.+
T Consensus 158 ~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9987 99999985 446899999999999999999999999 9999999999999999999999999999987665
Q ss_pred -cccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-------HHHhhhhhhhh-
Q 044568 148 -FVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-------VYKCFINRELN- 217 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~- 217 (257)
.+...-|.=|.|||.+.+.. |+...|+||+||++.|++++++.|.+..+.+.-..+-.. .++.+..-...
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 35555566799999999764 899999999999999999999999877443321111110 01111110000
Q ss_pred ---------hhhcCCCCCHH-HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 ---------KLVRGTKVDKK-NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ---------~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.. .+... ..+.-.+|+...+.+||++|- +.|.++
T Consensus 313 ~~~f~~~pyn~lr~-kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRK-KFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccCCCCchhhhh-hccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 01111 336778899999999999999 988764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=241.46 Aligned_cols=240 Identities=17% Similarity=0.136 Sum_probs=174.0
Q ss_pred cccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
.+.++.||+++.. ++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 10 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 10 EGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK---------ELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHH---------hcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3578899999975 455667775432 23333333 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 71 VRNGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
++ ++|.+++.... ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68999886422 36689999999999999999999999 99999999999999999999999999886443221
Q ss_pred --ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhh-hhhhhh
Q 044568 149 --VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCF-INRELN 217 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~-~~~~~~ 217 (257)
....++..|+|||.+.+. .++.++|+||||+++|++++|+.||................ ++.. ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 233557789999988654 47889999999999999999999997553221111000000 0000 000000
Q ss_pred hhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+.. .......+++.+++.+||+.||.+|| +.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00112346778999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=241.71 Aligned_cols=235 Identities=18% Similarity=0.254 Sum_probs=171.3
Q ss_pred ccccceeeecccC------CCCCeeeccchhhhHH-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVSWTADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+|...+ ...+++|........+ ..........+.++.|+|++++.+.+...+..++||||+++|+|
T Consensus 17 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 96 (288)
T cd05061 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96 (288)
T ss_pred CCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCH
Confidence 5688999986542 2245666543111000 00000111133488899999999999999999999999999999
Q ss_pred HHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 77 TDIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 77 ~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++......
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~ 173 (288)
T cd05061 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173 (288)
T ss_pred HHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccc
Confidence 99997421 13346678889999999999999999 99999999999999999999999999887432221
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||.+.+..++.++|+||||+++||+++ |..||....... .. . .....
T Consensus 174 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~-~------------~~~~~ 237 (288)
T cd05061 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL-K------------FVMDG 237 (288)
T ss_pred cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-H------------HHHcC
Confidence 11233456999999988889999999999999999999 788886431110 00 0 01111
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 T--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ..+...++.+.+++.+||+.+|++|| +.++++.|
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0 12334457899999999999999999 99998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=240.95 Aligned_cols=234 Identities=17% Similarity=0.125 Sum_probs=172.7
Q ss_pred ccccceeeecccC-CCCCeeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
+.++.||+++... +..+++|...- ....+.+.. .-..+..+.|+|++++.+.+...+..++||||+++++|..++
T Consensus 23 g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 100 (292)
T cd06644 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV--EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100 (292)
T ss_pred CCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHH--HHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHH
Confidence 4678999999766 45555555431 111111110 001233788999999999999999999999999999999988
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCc
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGY 157 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~ 157 (257)
.. ....+++..+..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||.+...... .....++..|
T Consensus 101 ~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y 176 (292)
T cd06644 101 LE-LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW 176 (292)
T ss_pred Hh-hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccc
Confidence 65 456789999999999999999999999 9999999999999999999999999987643221 2334567789
Q ss_pred cCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 158 MAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 158 ~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
+|||.+. ...++.++|+||||+++|||++|..||....... ..... ... .......+......
T Consensus 177 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~-----~~~----~~~~~~~~~~~~~~ 244 (292)
T cd06644 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI-----AKS----EPPTLSQPSKWSME 244 (292)
T ss_pred cCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HHHHH-----hcC----CCccCCCCcccCHH
Confidence 9999985 3446789999999999999999999996542111 00000 000 00011122334467
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++.+||+.+|++|| +.|+++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhc
Confidence 88999999999999999 999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=240.32 Aligned_cols=228 Identities=17% Similarity=0.144 Sum_probs=179.8
Q ss_pred cccccceeeecccCCCC-Ceeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFNARNS-PWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
|+..+.||...+...+. .++|.++- ...-+...++-....+..+.||.+..++..+..+...|||||||+||+|..
T Consensus 87 ~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~ 166 (459)
T KOG0610|consen 87 CGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHS 166 (459)
T ss_pred CCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHH
Confidence 67889999999888754 35554442 222223333444445558999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC------------
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE------------ 146 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~------------ 146 (257)
..++..++.+++..++.++..++-||+|||-. ||++|||||+|||+.++|++-|+||.++.....
T Consensus 167 LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~ 243 (459)
T KOG0610|consen 167 LRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRS 243 (459)
T ss_pred HHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCC
Confidence 99987888999999999999999999999999 999999999999999999999999987532100
Q ss_pred -----------------C------------------------------cccccCCCCccCcccccCCCCCccccchhHHH
Q 044568 147 -----------------D------------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGI 179 (257)
Q Consensus 147 -----------------~------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~ 179 (257)
. ..+..||-.|+|||++.+...+.++|+|+||+
T Consensus 244 ~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGI 323 (459)
T KOG0610|consen 244 SGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGI 323 (459)
T ss_pred CCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHH
Confidence 0 01224555699999999999999999999999
Q ss_pred HHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CC--CHHHHHHHHHHHHHcccCCCCCCC
Q 044568 180 VLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KV--DKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 180 ~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
++|||+.|.+||.+...... +.+.+... .+ .......+.+||.+.|.+||.+|.
T Consensus 324 flYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 324 FLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred HHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999997743321 11222211 11 124457789999999999999997
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=243.74 Aligned_cols=196 Identities=23% Similarity=0.246 Sum_probs=155.4
Q ss_pred cc-cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 044568 45 RI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHD 109 (257)
Q Consensus 45 ~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~ 109 (257)
++ +|+|++++.+.+...+..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 55 69999999999999999999999999999999997532 1358899999999999999999999
Q ss_pred CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHH
Q 044568 110 ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184 (257)
Q Consensus 110 ~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el 184 (257)
+ +++|+||+|+||+++.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|||
T Consensus 159 ~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 159 K---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred C---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999886443211 111233579999999888899999999999999999
Q ss_pred Hh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 185 IC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 185 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++ |..||..... .. .... .... .....+......+.+++.+||+.+|.+|| +.|+++.|
T Consensus 236 ~~~g~~p~~~~~~--~~-----~~~~------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 236 FTLGGSPYPGVPV--EE-----LFKL------LKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HcCCCCCCCcCCH--HH-----HHHH------HHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 98 8888864311 10 0000 0000 01122334567888999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=243.55 Aligned_cols=196 Identities=21% Similarity=0.248 Sum_probs=155.1
Q ss_pred cc-cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 044568 45 RI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHD 109 (257)
Q Consensus 45 ~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~ 109 (257)
++ .|+|++++.+.+...+..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+
T Consensus 73 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 152 (314)
T cd05099 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES 152 (314)
T ss_pred hccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 55 59999999999998899999999999999999996422 2458899999999999999999999
Q ss_pred CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHH
Q 044568 110 ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184 (257)
Q Consensus 110 ~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el 184 (257)
+ +++|+||+|+||+++.++.+||+|||.++...... ....++..|+|||.+.+..++.++|+||||+++||+
T Consensus 153 ~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 153 R---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred C---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHH
Confidence 9 99999999999999999999999999987543211 111233469999999888899999999999999999
Q ss_pred Hh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 185 IC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 185 ~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++ |..||....... .... .... .....+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 230 ~~~g~~p~~~~~~~~---~~~~-----~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 230 FTLGGSPYPGIPVEE---LFKL-----LREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HhCCCCCCCCCCHHH---HHHH-----HHcC------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99 888986441110 0000 0000 00122334556788999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.48 Aligned_cols=226 Identities=18% Similarity=0.188 Sum_probs=175.7
Q ss_pred cccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 5 KLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 5 ~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
.++.+|.++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 12 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~---------~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 12 AFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILS---------LLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred CCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHH---------hCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 466677777444 4555566533 223444444 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---c
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---V 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~ 149 (257)
+|+|.+++.......+++.++..++.|++.|+.|||+. +++|+|++|+||+++.++.+|++|||.+....... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999754456789999999999999999999999 99999999999999999999999999887543322 3
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+++.|.|||.+.+..++.++|+||||+++|||++|..||....... ...... ... ....+...
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~~~-----~~~------~~~~~~~~ 225 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVKIV-----QGN------YTPVVSVY 225 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH-----cCC------CCCCcccc
Confidence 4467888999999988888899999999999999999999997542111 000000 000 01122334
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
...+.+++.+||+.+|.+|| +.|+++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 56788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=232.69 Aligned_cols=241 Identities=18% Similarity=0.191 Sum_probs=179.7
Q ss_pred ccccceeeec-ccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeee-----cCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-----TSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~lV~E~~~~gsL~ 77 (257)
++||.||.++ +-+++..++|++-+.+.-+.-.....-..+.++.|+|++++....-. ....||+++|...|||.
T Consensus 32 GGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~ 111 (302)
T KOG2345|consen 32 GGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLL 111 (302)
T ss_pred CCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHH
Confidence 5788999999 77788889998876442221112222225669999999988776543 34589999999999999
Q ss_pred HHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--------
Q 044568 78 DIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-------- 147 (257)
Q Consensus 78 ~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-------- 147 (257)
+.+..- ++..+++.+.+.|+.+++.||++||+. .++..||||||.|||+.+++.+++.|||.+......
T Consensus 112 d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~ 190 (302)
T KOG2345|consen 112 DEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQAL 190 (302)
T ss_pred HHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHH
Confidence 999743 445689999999999999999999998 445999999999999999999999999987642211
Q ss_pred ----cccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 148 ----FVIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 148 ----~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.....+|..|.|||.+.- ...++++|||||||++|+|+.|..||+...+......+.. .++++ .
T Consensus 191 ~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv------~n~q~---s 261 (302)
T KOG2345|consen 191 RLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV------QNAQI---S 261 (302)
T ss_pred HHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee------ecccc---c
Confidence 134467888999999863 3568999999999999999999999975432221111100 00000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
- +.....++.+.+++.+|++.||.+|| +.|++..
T Consensus 262 ~--P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 262 I--PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred c--CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 11222568899999999999999999 9999764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=239.01 Aligned_cols=228 Identities=20% Similarity=0.226 Sum_probs=172.2
Q ss_pred ccccceeeecc-cCCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++.. .++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 12 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY---------KCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHH---------hCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 56889999985 4555566765432 23333333 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVID 151 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~ 151 (257)
+++|..+. .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (279)
T cd06619 83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY 153 (279)
T ss_pred CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence 99997653 368888899999999999999999 999999999999999999999999998875432 22345
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||..............+.. ... ....+........+
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~ 227 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIV-----DEDPPVLPVGQFSE 227 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHh-----ccCCCCCCCCcCCH
Confidence 678889999999988899999999999999999999999975322111110000000 000 00011111222346
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.+|++|| ++|+++
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhc
Confidence 788999999999999999 999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=240.24 Aligned_cols=223 Identities=19% Similarity=0.223 Sum_probs=172.0
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|...- .+|++ .+.++.|++++.+.+.+...+..++||||
T Consensus 11 G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~---------il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ---------ILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHH---------HHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 4678899988664 45566665431 12222 33378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++++|.+++.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9999999999754555799999999999999999999999 9999999999999999999999999988653322 1
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..||................ ..... ..+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~------~~~~~-----~~~~~ 227 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV------KEVQE-----EYSEK 227 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh------hhhhh-----hcCcc
Confidence 33467889999999998889999999999999999999999997542221111111100 00000 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCC
Q 044568 229 NLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP 249 (257)
....+.+++..||+.||++||
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~ 248 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERL 248 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHcc
Confidence 446688999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=246.44 Aligned_cols=224 Identities=17% Similarity=0.176 Sum_probs=168.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchh-----hhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT-----ADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++.. ++..+++|...-. ...+... .....+... .|++++++...+...+..++||||+++|+|
T Consensus 11 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (323)
T cd05615 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM--VEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 88 (323)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHH--HHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcH
Confidence 578999999865 4556777765421 1111110 000011133 356677888888888999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~ 153 (257)
.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++..... ......+
T Consensus 89 ~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~g 163 (323)
T cd05615 89 MYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163 (323)
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccC
Confidence 99997 446799999999999999999999999 999999999999999999999999998864321 1233457
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
|+.|+|||.+.+..++.++|+||+|+++|||++|..||...... .... .... ....+......
T Consensus 164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~-------------~i~~~~~~~p~~~~~~ 227 (323)
T cd05615 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ-------------SIMEHNVSYPKSLSKE 227 (323)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHhCCCCCCccCCHH
Confidence 88999999999888999999999999999999999999754211 1111 1111 11233445567
Q ss_pred HHHHHHHcccCCCCCCC-h
Q 044568 233 LVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~ 250 (257)
+.+++.+||+.+|.+|+ .
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHhhCCCC
Confidence 88999999999999999 5
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=244.84 Aligned_cols=178 Identities=19% Similarity=0.200 Sum_probs=142.9
Q ss_pred ccccceeeeccc---CCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEeec
Q 044568 4 TKLSNFYRSSFN---ARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~---~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|... ..+|++.+. ++.|+|++++...+.. ....++||||+
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 12 GTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLR---------ELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred CCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHH---------hcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 578999999865 34556777543 345555555 8899999999888754 45688999999
Q ss_pred CCCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEeeecc
Q 044568 72 RNGSLTDIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGL 140 (257)
Q Consensus 72 ~~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~dfg~ 140 (257)
. ++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++ +..+.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 5888887532 123588999999999999999999999 99999999999999 4567899999999
Q ss_pred cccCCCCc------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 141 AKLPNEDF------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 141 ~~~~~~~~------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
++...... ....+|+.|+|||.+.+. .++.++|+||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87543221 234668889999998764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=240.61 Aligned_cols=228 Identities=17% Similarity=0.218 Sum_probs=173.2
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. +...+++|... +.+|++.+. ++.|+|++++.+.+..++..++|
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~---------~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA---------EFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred cccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHH---------hcCCCchheEEEEEcCCCccEEE
Confidence 457889998753 34555666533 233444444 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 044568 68 ERPVRNGSLTDIIFCSA--------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 127 (257)
|||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||+|+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 99999999999997421 13478888999999999999999999 99999999999999
Q ss_pred CCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhH
Q 044568 128 DEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEI 201 (257)
Q Consensus 128 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~ 201 (257)
+.++.++++|||.+....... .....+..|+|||.+.+..++.++|+||||+++|||++ |..||.......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--- 240 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--- 240 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999876432211 12233456999999988889999999999999999997 888886431110
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 202 ILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... ...... .. ..+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 241 ~~~-----~~~~~~---~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 241 VIY-----YVRDGN---VL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred HHH-----HHhcCC---CC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 000 000000 00 12334557899999999999999999 99999865
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=241.03 Aligned_cols=238 Identities=15% Similarity=0.123 Sum_probs=175.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 12 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~---------~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 12 GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLK---------QLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHH---------hCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 4578999998764 5566666432 234444444 888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
++++|..++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 83 DHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred CccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9988888876 445699999999999999999999999 99999999999999999999999999987543322
Q ss_pred ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh-------hhhh-hhh
Q 044568 149 VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI-------NREL-NKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~ 219 (257)
....++..|+|||.+.+ ..++.++|+||||+++|||++|..||......+.............. .... ..+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23346678999999876 45789999999999999999999999755322211111110000000 0000 000
Q ss_pred hcCCC---C-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGTK---V-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~~---~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.. . .......+.+++.+||+.+|++|| +.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 0 012246788999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=239.84 Aligned_cols=237 Identities=18% Similarity=0.170 Sum_probs=174.3
Q ss_pred ccccceeeecccC-----CCCCeeeccchh-hhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-----RNSPWISRVSWT-ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-----~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL 76 (257)
+.++.||+|...+ +..+++|...-. ...+.-........+.++.|+|++++.+.+.. ....++++||+++|+|
T Consensus 17 g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L 96 (280)
T cd05043 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNL 96 (280)
T ss_pred cCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcH
Confidence 5688999999877 555666644311 11000000011112337899999999998765 5678899999999999
Q ss_pred HHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 77 TDIIFCSAE------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 77 ~~~l~~~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
.+++..... ..+++.++..++.|++.||.|||++ +++|+||+|+||++++++.+|++|||+++......
T Consensus 97 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~ 173 (280)
T cd05043 97 KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173 (280)
T ss_pred HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE
Confidence 999964321 4689999999999999999999999 99999999999999999999999999987542221
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ....+... ... ..
T Consensus 174 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~---------~~~-~~ 239 (280)
T cd05043 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYLKD---------GYR-LA 239 (280)
T ss_pred EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHHHc---------CCC-CC
Confidence 12234556999999988889999999999999999999 99999654211 11111100 000 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 1223456789999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=253.04 Aligned_cols=177 Identities=16% Similarity=0.131 Sum_probs=147.7
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|.+.- .+|++++ .++.|+|++++...+...+..++||||
T Consensus 12 G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il---------~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL---------AEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHH---------HhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 5688999998654 45567776542 2233333 377899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC----
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---- 146 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---- 146 (257)
|++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 83 IPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999997 345789999999999999999999999 999999999999999999999999998642110
Q ss_pred ----------------------------------------------CcccccCCCCccCcccccCCCCCccccchhHHHH
Q 044568 147 ----------------------------------------------DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIV 180 (257)
Q Consensus 147 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~ 180 (257)
......||+.|+|||.+.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012357888999999998889999999999999
Q ss_pred HHHHHhcCCCCCcC
Q 044568 181 LLETICCRKNMEID 194 (257)
Q Consensus 181 l~el~~g~~pf~~~ 194 (257)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=254.39 Aligned_cols=220 Identities=16% Similarity=0.122 Sum_probs=166.2
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... +..+++|.... .+|++.+ .++.|+|++++...+...+..++||||
T Consensus 12 G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il---------~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL---------AEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHH---------HhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 5688999998554 55667776532 2233333 378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC----
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---- 146 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---- 146 (257)
+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 83 IPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999997 445688999999999999999999999 999999999999999999999999998642110
Q ss_pred ------------------------------------------CcccccCCCCccCcccccCCCCCccccchhHHHHHHHH
Q 044568 147 ------------------------------------------DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLET 184 (257)
Q Consensus 147 ------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el 184 (257)
......||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00123688899999999988899999999999999999
Q ss_pred HhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 185 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
++|+.||...........+..|. .... ..........+.+++.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~----------~~~~-~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWE----------TTLH-IPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccC----------cccc-CCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 99999997653221111111110 0000 0111123455677777766 4999999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=234.56 Aligned_cols=233 Identities=17% Similarity=0.206 Sum_probs=174.8
Q ss_pred ccccceeeecccC-CCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... ++.+++|..... ...+... .... .+.+++|+|++++.+.+.. ....++||||+++++|.
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~ 88 (257)
T cd08223 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE-QEAQ-LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY 88 (257)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHH-HHHH-HHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHH
Confidence 4678899998654 455677765421 1111111 1111 3348889999999887764 44678999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~ 154 (257)
+++.......+++.++..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++...... .....++
T Consensus 89 ~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (257)
T cd08223 89 HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165 (257)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCC
Confidence 999764456689999999999999999999999 9999999999999999999999999988654221 1234567
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+.|+|||.+.+..++.++|+||+|+++|++++|+.||..... . ...... ...... ..+....+.+.
T Consensus 166 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~-----~~~~~~-----~~~~~~--~~~~~~~~~~~ 231 (257)
T cd08223 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--N-----SLVYRI-----IEGKLP--PMPKDYSPELG 231 (257)
T ss_pred cCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--H-----HHHHHH-----HhcCCC--CCccccCHHHH
Confidence 789999999988889999999999999999999999974311 1 111000 001111 22344567899
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++.+||+.+|++|| +.++++
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=253.24 Aligned_cols=238 Identities=16% Similarity=0.120 Sum_probs=176.0
Q ss_pred ccccceeeecccCCC-CCeeeccc---hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS---WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||++...... .+++|... +.+|++++. ++.|+||+++.+.+...+..++|||++. ++|.++
T Consensus 180 G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~---------~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~ 249 (461)
T PHA03211 180 GSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLR---------RLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTY 249 (461)
T ss_pred CCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHH---------HCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHH
Confidence 568899999976654 46677533 456777776 8899999999999999999999999995 799998
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRD 154 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~ 154 (257)
+.. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+++...... ....||
T Consensus 250 l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT 325 (461)
T PHA03211 250 LGA-RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325 (461)
T ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCC
Confidence 864 445799999999999999999999999 99999999999999999999999999987533221 234588
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCCh----hhHHHHHHHHHhhh-h------------hhhh
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP----EEIILTNWVYKCFI-N------------RELN 217 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~-~------------~~~~ 217 (257)
..|+|||++.+..++.++|||||||++|||++|..|+....... ....+.+....... . ....
T Consensus 326 ~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~ 405 (461)
T PHA03211 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYR 405 (461)
T ss_pred cCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHH
Confidence 99999999998889999999999999999999887654321111 01111111111000 0 0000
Q ss_pred hh----hcCC-CCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KL----VRGT-KVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~----~~~~-~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..+. ..+ ......+.+|+.+||+.||.+|| +.|+++
T Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 406 HRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0000 000 01224678899999999999999 999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.68 Aligned_cols=239 Identities=19% Similarity=0.271 Sum_probs=176.3
Q ss_pred ccccceeeecccC-----CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeE
Q 044568 4 TKLSNFYRSSFNA-----RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~-----~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 66 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+.. ....++
T Consensus 15 g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~---------~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR---------TLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred CCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHH---------hCCCCChheEEeeeecCCCCceEE
Confidence 5688999998653 4556676544 233333333 8889999999998877 568899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+|++|+||+++.++.++++|||.+.....
T Consensus 86 v~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 86 IMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999975 344699999999999999999999999 999999999999999999999999999876542
Q ss_pred Ccc------cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DFV------IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~~------~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
... ...++..|++||.+....++.++|+||||+++|||++|..|+............. .............+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 239 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLELL 239 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHHH
Confidence 211 1223445999999988889999999999999999999999986542211000000 00000001111111
Q ss_pred cC---CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RG---TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~---~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ...+..++..+.+++.+||+.+|++|| +.|++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 11 122334557899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=242.76 Aligned_cols=234 Identities=15% Similarity=0.111 Sum_probs=175.0
Q ss_pred ccccceeeecc-cCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++.. .+++.+++|........+.-.+...-..+..+.|+|++.+.+.+...+..++|+||+++++|.+++.
T Consensus 30 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~- 108 (296)
T cd06655 30 GASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT- 108 (296)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-
Confidence 45678999874 4566667776543211110000001112337889999999999999999999999999999999985
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~a 159 (257)
...+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 109 --~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 183 (296)
T cd06655 109 --ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183 (296)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccC
Confidence 34689999999999999999999999 9999999999999999999999999987643322 123356778999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+.+..++.++|+||||+++|++++|+.||......... ... . . ........+......+.+++.+
T Consensus 184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~----~-~----~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLI----A-T----NGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----H-h----cCCcccCCcccCCHHHHHHHHH
Confidence 99998888899999999999999999999999755211110 000 0 0 0000111233345678899999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||+.||++|| +.++++
T Consensus 252 ~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 252 CLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HhhcChhhCCCHHHHhh
Confidence 9999999999 999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=256.15 Aligned_cols=239 Identities=16% Similarity=0.135 Sum_probs=171.1
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeeec--------CceeEEEe
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--------SVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--------~~~~lV~E 69 (257)
+.++.||++... .+..+++|.+. ..+|++++. .++|+|++++.+.+... ...++|||
T Consensus 77 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~---------~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE 147 (440)
T PTZ00036 77 GSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMK---------NLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147 (440)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHH---------hcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence 568899999865 55677887653 234555555 88899999988765432 24668999
Q ss_pred ecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCC
Q 044568 70 PVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNE 146 (257)
Q Consensus 70 ~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~ 146 (257)
|+++ +|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||+++....
T Consensus 148 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 148 FIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred cCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 9974 787776532 456789999999999999999999999 999999999999998654 699999999875432
Q ss_pred --CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----h--hhhhhh
Q 044568 147 --DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC----F--INRELN 217 (257)
Q Consensus 147 --~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~--~~~~~~ 217 (257)
......+++.|+|||.+.+. .++.++|||||||++|||++|.+||.+................. . ..+...
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 22345678889999998764 68999999999999999999999997653222111111000000 0 000000
Q ss_pred hh----hcCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KL----VRGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~----~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..+. .++...+.++.+|+.+||+.||.+|| +.|+++
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 0000 12223456789999999999999999 999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=254.71 Aligned_cols=229 Identities=15% Similarity=0.208 Sum_probs=179.6
Q ss_pred ccccceeeecccCC-----CCCeeeccc----hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNAR-----NSPWISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-----~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
++|++||+|.+-+- -.++||... -.+--+++. ....+..++|++|++++|++.. ...+||||+++-|
T Consensus 400 GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflq---Ea~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~G 475 (974)
T KOG4257|consen 400 GQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQ---EASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLG 475 (974)
T ss_pred CcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHH---HHHHHHhCCCcchhheeeeeec-cceeEEEecccch
Confidence 57999999985443 233454422 111111111 1113338899999999999865 5679999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc--cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI--DK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~ 152 (257)
-|..+|.. +...|+..+...++.||+.||.|||+. +.+||||.++|||+.....+||+|||+++-....... ..
T Consensus 476 ELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 476 ELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred hHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 99999986 667799999999999999999999999 9999999999999999999999999999876554421 12
Q ss_pred CC--CCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC--CCCH
Q 044568 153 RD--KGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVDK 227 (257)
Q Consensus 153 ~~--~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 227 (257)
+. .-|+|||.+....++.+||||.||+++||+++ |..||.+-...+ .+..+-.+. +.|+
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIENGERLPCPP 615 (974)
T ss_pred cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecCCCCCCCCC
Confidence 22 23999999999999999999999999999998 999998652222 112222222 6788
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.|++.|..++.+||+++|.+|| +.||...
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHH
Confidence 9999999999999999999999 9998654
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.79 Aligned_cols=226 Identities=21% Similarity=0.215 Sum_probs=172.2
Q ss_pred ccccceeeecccCCCC-----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||++....... +++|... +.+|++.+. ++.|+|++++.+.+.. +..++||
T Consensus 18 g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA---------SVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred CCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHH---------hCCCCCcceEEEEEec-CceEEEE
Confidence 5688999998654333 4554432 223333433 7889999999998887 7889999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+++|+|.+++.. ....+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.++......
T Consensus 88 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 88 QLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred ecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999975 445689999999999999999999999 99999999999999999999999999987543221
Q ss_pred c-----cccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 V-----IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 ~-----~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
. ....+..|++||.+....++.++|+||||+++||+++ |..||....... +... .... ..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~---------~~~~-~~ 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDL---------LEKG-ER 229 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHH---------HhCC-CC
Confidence 1 1122456999999988888999999999999999998 999997542111 1000 0000 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+..+...+..++.+||..+|.+|| +.++++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 122233446788999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=241.63 Aligned_cols=211 Identities=17% Similarity=0.216 Sum_probs=173.2
Q ss_pred cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 15 NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 15 ~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
..+..++||.+. +.+|++.++ .+.|++|+++...+.+.+...|||||..+|.|+|++.
T Consensus 76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMS---------sLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS- 145 (668)
T KOG0611|consen 76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMS---------SLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS- 145 (668)
T ss_pred cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHh---------hcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH-
Confidence 455666766433 355666666 9999999999999999999999999999999999998
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--CcccccCCCCccCc
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DFVIDKRDKGYMAP 160 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~aP 160 (257)
..+.|++.++++++.||++|+.|+|++ +++|||||.+|||+|+++++|++|||++..... .....+|++.|.+|
T Consensus 146 -er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASP 221 (668)
T KOG0611|consen 146 -ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASP 221 (668)
T ss_pred -HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCc
Confidence 678899999999999999999999999 999999999999999999999999999876543 34677899999999
Q ss_pred ccccCCCCC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 161 ECYKRTPIS-VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 161 E~~~~~~~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
|++.+.+|. +..|.||+|++||.+..|..||++.+ -...+... ..+.+ ...+.+.....||.+
T Consensus 222 EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQI-----s~GaY--------rEP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 222 EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQI-----SRGAY--------REPETPSDASGLIRW 285 (668)
T ss_pred cccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHh-----hcccc--------cCCCCCchHHHHHHH
Confidence 999999985 89999999999999999999998661 11111111 11111 112233456788889
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||-.+|++|. +.+|+.
T Consensus 286 mLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIAS 302 (668)
T ss_pred HHhcCcccchhHHHHhh
Confidence 9999999999 998864
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=242.37 Aligned_cols=236 Identities=18% Similarity=0.221 Sum_probs=170.7
Q ss_pred cccccceeeecccCCCC-----CeeeccchhhhHH-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 3 CTKLSNFYRSSFNARNS-----PWISRVSWTADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-----~~i~~~~~~~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
.+.++.||++.....+. +++|......... ...+........++.|+|++++.+.+... ..++++||+++|+|
T Consensus 17 ~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l 95 (303)
T cd05110 17 SGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCL 95 (303)
T ss_pred cCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCH
Confidence 35789999998765443 3555433210000 00000011123378899999999988654 56789999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VID 151 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~ 151 (257)
.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||+++...... ...
T Consensus 96 ~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 171 (303)
T cd05110 96 LDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171 (303)
T ss_pred HHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccccCCC
Confidence 999975 445689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|++||.+.+..++.++||||||+++||+++ |..||....... ...+... . . ....+....
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~----~---~---~~~~~~~~~ 237 (303)
T cd05110 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEK----G---E---RLPQPPICT 237 (303)
T ss_pred ccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHC----C---C---CCCCCCCCC
Confidence 33557999999988889999999999999999997 899996542111 1111100 0 0 001122344
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++..||..+|++|| ++++++.|
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6788999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.45 Aligned_cols=230 Identities=20% Similarity=0.195 Sum_probs=176.8
Q ss_pred ccccceeeecccCCC-CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++....+. .+++|... +.+|++.+. .+.|+|++++.+.+...+..++||||++
T Consensus 16 g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH---------ECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHH---------HcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 567899999876544 44554322 233444433 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Cccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVI 150 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~ 150 (257)
+++|.+++. ....+++..+..++.+++.|+.|||+ + +++|+|++|+||++++++.++|+|||++..... ....
T Consensus 87 ~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 87 CGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred CCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 999999987 34568999999999999999999997 5 899999999999999999999999998764322 2234
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhh----HHHHHHHHHhhhhhhhhhhhc---CC
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEE----IILTNWVYKCFINRELNKLVR---GT 223 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~---~~ 223 (257)
..++..|+|||.+.+..++.++|+|||||++|++++|..||......... .....+ ...... +.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 232 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---------LQQIVQEPPPR 232 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH---------HHHHhhccCCC
Confidence 46788899999998888899999999999999999999999865332110 001111 111111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
......+..+.+++.+||+.||.+|| +.|+++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11223556789999999999999999 9999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=238.73 Aligned_cols=203 Identities=18% Similarity=0.221 Sum_probs=155.6
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSA---------ERNPYWNQRVRIALDVAKGILYLHDECEPPI 115 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 115 (257)
.+.|+|++++.+.+...+..++||||+++|+|.+++.... ...+++.+...++.|++.|+.|||++ ++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i 151 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NF 151 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 8889999999999999999999999999999999997532 13477888999999999999999999 99
Q ss_pred eeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh--cC
Q 044568 116 LHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC--CR 188 (257)
Q Consensus 116 ~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~--g~ 188 (257)
+|+||||+||+++.++.++|+|||.+....... .....+..|++||....+.++.++|+||||+++|||++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999987532221 11222456999999888889999999999999999998 77
Q ss_pred CCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 189 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.||....... ..... ...+. ....... ...+..++..+.+++.+||+.||.+|| +.||++.|
T Consensus 232 ~p~~~~~~~~---~~~~~-~~~~~-~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 232 QPYSQLSDEQ---VIENT-GEFFR-DQGRQVY--LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred CCccccChHH---HHHHH-HHHHh-hcccccc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 8886432111 11110 00000 0000000 112233457899999999999999999 99998765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=250.81 Aligned_cols=237 Identities=17% Similarity=0.169 Sum_probs=177.3
Q ss_pred ccccceeeeccc---CCCCCeeeccc----hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN---ARNSPWISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~---~~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++... .+..+++|... ..+|++.+. ++.|+|++++.+.+......++|||++. ++|
T Consensus 103 G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 172 (392)
T PHA03207 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILK---------TISHRAIINLIHAYRWKSTVCMVMPKYK-CDL 172 (392)
T ss_pred CCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHH---------hcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence 457789988643 23445666543 356777766 8889999999999999999999999996 689
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VID 151 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~ 151 (257)
.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 173 ~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 173 FTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence 99885 557799999999999999999999999 99999999999999999999999999986543221 234
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh---------h----hhhhh
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI---------N----RELNK 218 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~----~~~~~ 218 (257)
.+|..|+|||++....++.++|||||||++|||++|+.||...........+......... . .....
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQ 327 (392)
T ss_pred ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHh
Confidence 6888999999999888999999999999999999999999765332211112111110000 0 00000
Q ss_pred hh---cCC-CCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LV---RGT-KVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~---~~~-~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .+. ..+ ......+.+++.+||+.||++|| +.|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 328 YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 000 000 11235678899999999999999 999975
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=237.64 Aligned_cols=234 Identities=17% Similarity=0.122 Sum_probs=172.9
Q ss_pred ccccceeeeccc-CCCCCeeeccchh--hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT--ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
+.++.||+++.. ++..+++|..... ...+... ..-..+..++|+|++++.+.+...+..++||||+++++|.+++
T Consensus 20 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~--~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (267)
T cd06645 20 GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY 97 (267)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHH--HHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHH
Confidence 567899999865 4555666654321 1111100 0001333788999999999999999999999999999999999
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCc
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGY 157 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~ 157 (257)
. ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...... .....++..|
T Consensus 98 ~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 172 (267)
T cd06645 98 H--VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172 (267)
T ss_pred H--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccc
Confidence 7 455789999999999999999999999 9999999999999999999999999987643322 2344678889
Q ss_pred cCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHH
Q 044568 158 MAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENL 233 (257)
Q Consensus 158 ~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 233 (257)
+|||.+. ...++.++|+||+|+++|+|++|..||....+... .... ... ....+. ......+..+
T Consensus 173 ~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~-----~~~---~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM-----TKS---NFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhh-----hcc---CCCCCcccccCCCCHHH
Confidence 9999874 44578999999999999999999999864421111 0000 000 000000 0111234568
Q ss_pred HHHHHHcccCCCCCCC-hHHHHH
Q 044568 234 VKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+++.+||+.+|++|| ++++++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 8999999999999999 999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=250.00 Aligned_cols=237 Identities=17% Similarity=0.212 Sum_probs=173.4
Q ss_pred ccccceeeecc-cCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC-----ceeE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----VSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~l 66 (257)
+.++.||++.. .+++.+++|.... .+|++.+. .++|+|++++.+.+...+ ..++
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC---------FFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHH---------hCCCCCcCCHhheecCCCccccceEEE
Confidence 56889999985 4667778886532 23333333 788999999999988766 7899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+. ++|.+.+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999996 58888886 456799999999999999999999999 999999999999999999999999999875332
Q ss_pred C----cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-----H-hhhhhh
Q 044568 147 D----FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-----K-CFINRE 215 (257)
Q Consensus 147 ~----~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-----~-~~~~~~ 215 (257)
. .....++..|+|||.+.+. .++.++||||+||++|||++|+.||...........+..... . ......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2 1233567789999998764 478999999999999999999999975532211100000000 0 000000
Q ss_pred hhh-hhc----CC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNK-LVR----GT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~-~~~----~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... +.. +. .......+.+.+++.+||+.||++|| +.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 000 00 11223356789999999999999999 999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.00 Aligned_cols=226 Identities=18% Similarity=0.193 Sum_probs=176.7
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.+|.++... +..+++|.... .++++. +.++.|+|++++.+.+...+..++||||+
T Consensus 11 g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~---------l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAV---------LSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHH---------HHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 4577888888554 45567776542 223333 34888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
++++|.+++.......+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++++|||.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 999999999753445689999999999999999999999 99999999999999999999999999887543322
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|+||||+++|++++|+.||..... .. ....+ ..... ...+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~-~~~~~---------~~~~~--~~~~~~ 224 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KN-LVLKI---------IRGSY--PPVSSH 224 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HH-HHHHH---------hcCCC--CCCccc
Confidence 233567789999999888889999999999999999999999964311 10 00000 00000 123344
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.+|.+|| +.|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 567799999999999999999 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=238.80 Aligned_cols=226 Identities=19% Similarity=0.192 Sum_probs=174.7
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS---------ECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred CCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHH---------hCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 5678999999754 5556666543 223444444 88899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
++|.+++.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++++|||.+...... ...
T Consensus 87 ~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 87 GALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 999999975 446799999999999999999999999 9999999999999999999999999987643221 233
Q ss_pred ccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-C
Q 044568 151 DKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-K 224 (257)
Q Consensus 151 ~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 224 (257)
..++..|++||.+. ...++.++|+||||+++|||++|..||....... ....+ .....+. .
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~----------~~~~~~~~~ 229 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKI----------LKSEPPTLD 229 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHH----------hcCCCCCcC
Confidence 45778899999875 3346789999999999999999999996542111 11111 0000000 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+......+.+++.+||+.+|.+|| +.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 2233456788999999999999999 999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=236.33 Aligned_cols=239 Identities=15% Similarity=0.160 Sum_probs=165.7
Q ss_pred ccccceeeecccCCCCC---eeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNSP---WISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~---~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+|+....... +++.... ..+.+.+. .. ......+.|+|++++.+.+......++||||+++|+|.
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-~e-~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 83 (268)
T cd05086 6 GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFL-QQ-GDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLK 83 (268)
T ss_pred CcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHH-HH-HHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHH
Confidence 46889999975544432 3443321 11111110 00 01233788999999999999999999999999999999
Q ss_pred HHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-----Cccc
Q 044568 78 DIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-----DFVI 150 (257)
Q Consensus 78 ~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-----~~~~ 150 (257)
+++.... ...++......++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9997531 23466777889999999999999999 999999999999999999999999998753211 1123
Q ss_pred ccCCCCccCcccccC-------CCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 151 DKRDKGYMAPECYKR-------TPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
..++..|+|||++.. ..++.++||||||+++|||++ |..||....... ..... .......+.++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~-----~~~~~~~~~~~ 232 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHV-----IKDQQVKLFKP 232 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-----HhhcccccCCC
Confidence 356678999998753 235788999999999999997 566775431111 11110 01111111221
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ......+.+.+++..|| .+|.+|| ++|+++.|
T Consensus 233 ~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 233 Q-LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred c-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 11224466788999999 6799999 99999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=250.30 Aligned_cols=226 Identities=16% Similarity=0.143 Sum_probs=168.1
Q ss_pred ccccceeeecccC-CCCCeeeccchh---hhHHHHhHhhhccccccc---cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT---ADIEVLSVAMRGSKCTRI---RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~---~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++... +..+++|..... .+.+..........+.+. .|++++.+...+...+..++||||+++|+|
T Consensus 4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L 83 (330)
T cd05586 4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL 83 (330)
T ss_pred CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChH
Confidence 5789999998654 566777765421 111111110000011122 699999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~ 153 (257)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++..... ......|
T Consensus 84 ~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 84 FWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 99997 456789999999999999999999999 999999999999999999999999999864321 1234468
Q ss_pred CCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC-HHHHH
Q 044568 154 DKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD-KKNLE 231 (257)
Q Consensus 154 ~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 231 (257)
|..|+|||.+.+. .++.++||||+||++|||++|+.||...... ...... .... ...+ .....
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i-----~~~~-------~~~~~~~~~~ 223 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNI-----AFGK-------VRFPKNVLSD 223 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHH-----HcCC-------CCCCCccCCH
Confidence 8899999998754 4789999999999999999999999754211 111110 0000 0111 12346
Q ss_pred HHHHHHHHcccCCCCCCC
Q 044568 232 NLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP 249 (257)
.+.+++.+||+.||.+||
T Consensus 224 ~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred HHHHHHHHHcCCCHHHCC
Confidence 778999999999999997
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=237.29 Aligned_cols=223 Identities=21% Similarity=0.195 Sum_probs=176.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... ++..+++|.... .+|++.+ .++.|+|++++.+.+......++|+||++
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l---------~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 12 GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL---------SQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred CCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHH---------HHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 567899999966 455667776543 2233333 37789999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+|++|+||++++++.++++|||++...... ..
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 83 GGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred CCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 9999999963 3789999999999999999999999 9999999999999999999999999998765433 23
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH-
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK- 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 228 (257)
...++..|+|||.+.+..++.++|+||||+++|++++|+.||....... ... .......+ ..+..
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~----------~~~~~~~~-~~~~~~ 222 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF----------LIPKNNPP-SLEGNK 222 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH----------HhhhcCCC-CCcccc
Confidence 3456777999999998889999999999999999999999997542110 000 00000111 11111
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..+.+++.+||+.+|++|| ++++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456788999999999999999 999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=235.22 Aligned_cols=237 Identities=17% Similarity=0.195 Sum_probs=175.6
Q ss_pred ccccceeeecccC--CCCCeeeccchh------------hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNA--RNSPWISRVSWT------------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~--~~~~~i~~~~~~------------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++.... +..+++|..... ..++.+. .........+.|+|++++.+.+...+..++|||
T Consensus 11 G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~-~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 89 (269)
T cd08528 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIV-SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMD 89 (269)
T ss_pred CCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHH-HHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEe
Confidence 4588999999876 445566654311 0111000 011101124789999999999999999999999
Q ss_pred ecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 70 PVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 70 ~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|+++++|.+++... ....+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 166 (269)
T cd08528 90 LIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166 (269)
T ss_pred cCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence 99999999988531 44568999999999999999999996 6 899999999999999999999999999875433
Q ss_pred C--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 147 D--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 147 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
. .....++..|++||.+.+..++.++|+||||+++||+++|+.||....... ..... .. ....+ .
T Consensus 167 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~~~-----~~----~~~~~-~ 233 (269)
T cd08528 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LATKI-----VE----AVYEP-L 233 (269)
T ss_pred ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHHHH-----hh----ccCCc-C
Confidence 2 234456778999999998889999999999999999999999996441111 01000 00 00010 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
........+.+++.+||+.||++|| +.|+.++|
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 1113346789999999999999999 99998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=236.84 Aligned_cols=238 Identities=22% Similarity=0.282 Sum_probs=179.5
Q ss_pred ccccceeeecccCCC-CCeeeccchhhhHHHHh---HhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWTADIEVLS---VAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~~~~~~~~---~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++....+ .+++|.....+.-+... ..... .+.+++|+|++++.......+..++||||+++++|.++
T Consensus 10 G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~ 88 (260)
T PF00069_consen 10 GGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIK-ILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDY 88 (260)
T ss_dssp ESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHH-HHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHH
T ss_pred CCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhh-cccccccccccccccccccccccccccccccccccccc
Confidence 568899999988777 56777655322111111 00111 33377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~~~ 156 (257)
+. ....+++.++..++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+... ........++..
T Consensus 89 l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 163 (260)
T PF00069_consen 89 LQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPE 163 (260)
T ss_dssp HH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGG
T ss_pred cc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 97 456789999999999999999999999 9999999999999999999999999998642 233345567788
Q ss_pred ccCccccc-CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 157 YMAPECYK-RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 157 ~~aPE~~~-~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
|.|||.+. +..++.++|+||+|+++|+|++|..||................ .. .............+.+.+
T Consensus 164 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 164 YMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL-----KR---PLPSSSQQSREKSEELRD 235 (260)
T ss_dssp GSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-----HT---HHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-----cc---cccccccccchhHHHHHH
Confidence 99999998 7778999999999999999999999997541111111111100 00 000000111112378999
Q ss_pred HHHHcccCCCCCCC-hHHHHH
Q 044568 236 VGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+||+.||++|| +.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 99999999999999 999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=243.18 Aligned_cols=234 Identities=15% Similarity=0.104 Sum_probs=176.8
Q ss_pred ccccceeeecc-cCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++.. .++..+++|........+.-.....-..+..+.|+|++++.+.+...+..++||||+++++|.+++.+
T Consensus 30 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 109 (297)
T cd06656 30 GASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 109 (297)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh
Confidence 45789999985 56777788776532111111100011133378899999999999999999999999999999999953
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~a 159 (257)
..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||.+....... ....+++.|++
T Consensus 110 ---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~a 183 (297)
T cd06656 110 ---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183 (297)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccC
Confidence 4588999999999999999999999 99999999999999999999999999876533221 23456778999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+.+..++.++|+||||+++|++++|..||.......... .. ..........+......+.+++.+
T Consensus 184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LI-----ATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------ee-----ccCCCCCCCCccccCHHHHHHHHH
Confidence 999988888999999999999999999999997542211000 00 000000011233345668899999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||+.+|.+|| +.++++
T Consensus 252 ~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 252 CLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HccCChhhCcCHHHHhc
Confidence 9999999999 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=242.46 Aligned_cols=178 Identities=19% Similarity=0.201 Sum_probs=142.0
Q ss_pred ccccceeeecccC---CCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA---RNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~---~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~ 71 (257)
+.++.||+++..+ +..+++|... +.+|++.+. ++.|+|++++.+.+.. ....++||||+
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 12 GTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLR---------ELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred CCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHH---------hCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 5789999998654 3456666543 345555555 8889999999998753 55778999999
Q ss_pred CCCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEeeecc
Q 044568 72 RNGSLTDIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGL 140 (257)
Q Consensus 72 ~~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~dfg~ 140 (257)
+ ++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 7 4888877421 223588899999999999999999999 99999999999999 4567899999999
Q ss_pred cccCCCCc------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 141 AKLPNEDF------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 141 ~~~~~~~~------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
++...... ....+|..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87543321 234567889999998764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=249.69 Aligned_cols=229 Identities=18% Similarity=0.207 Sum_probs=173.1
Q ss_pred ccccceeeeccc------CCCCCeeeccch----------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++.. .+..+++|...- .+|++.+. ++. |+|++++.+.+...+..++
T Consensus 48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~---------~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 48 GAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMS---------HLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred CCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHH---------hcCCCCCeEEEEEEEccCCCcEE
Confidence 568999999853 234567776542 22333333 665 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC--------------------------------------------------------------
Q 044568 67 IERPVRNGSLTDIIFCSA-------------------------------------------------------------- 84 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 84 (257)
||||+++|+|.++++...
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 999999999999996421
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 85 ----------------------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 85 ----------------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
...+++.+...++.|++.||.|||++ +++|+||+|+||+++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCC
Confidence 12367778889999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.++|+|||+++...... ....++..|+|||.+.+..++.++|+||||+++|||++ |..||........ ..
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---~~ 352 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---FY 352 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---HH
Confidence 999999999987532211 12244667999999988889999999999999999998 8899865421110 00
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ... . .. ...+......+.+++.+||+.+|.+|| ++||++.|
T Consensus 353 ~~----~~~-~----~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 353 NA----IKR-G----YR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HH----HHc-C----CC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00 000 0 00 012333457899999999999999999 99998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=235.59 Aligned_cols=226 Identities=14% Similarity=0.171 Sum_probs=171.8
Q ss_pred ccccceeeecccCC----CCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNAR----NSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~----~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|...+. ..+++|.... .+|++. +.++.|+|++++.+.+.. +..++|||
T Consensus 17 g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~---------l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI---------MRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHH---------HHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 46789999986544 3456665442 223333 337889999999987764 56789999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||++.......
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 87 LAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred cCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999975 345689999999999999999999999 99999999999999999999999999887543221
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....++..|+|||.+....++.++|+||||+++||+++ |..||........ .... .. .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----------~~-~~~~~ 228 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----------EN-GERLP 228 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----------Hc-CCcCC
Confidence 11122346999999988888999999999999999986 9999975422110 1000 00 00112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...+..+.+++.+||..+|.+|| +.++++.|
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2344567899999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=255.27 Aligned_cols=242 Identities=14% Similarity=0.127 Sum_probs=170.1
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-CceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-SVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lV~E~~~~ 73 (257)
+.++.||++.... +..+++|.+. ...|++++...... ....|.+++++..++... .+.++|||++ +
T Consensus 140 G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~---~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g 215 (467)
T PTZ00284 140 GTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA---DPADRFPLMKIQRYFQNETGHMCIVMPKY-G 215 (467)
T ss_pred ccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhc---CcccCcceeeeEEEEEcCCceEEEEEecc-C
Confidence 5688999998654 4557788653 23344444311111 123355677777777654 5789999988 6
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCC----------------ceEEe
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFW----------------TAKIL 136 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~----------------~~kl~ 136 (257)
++|.+++. ....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++ .+||+
T Consensus 216 ~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~ 290 (467)
T PTZ00284 216 PCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290 (467)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence 79999987 44679999999999999999999997 6 999999999999998655 49999
Q ss_pred eecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH--------HHH
Q 044568 137 DFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN--------WVY 208 (257)
Q Consensus 137 dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~--------~~~ 208 (257)
|||.+...........+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. |..
T Consensus 291 DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~ 370 (467)
T PTZ00284 291 DLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG 370 (467)
T ss_pred CCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Confidence 999876544444566789999999999999999999999999999999999999976532111111100 100
Q ss_pred Hhhhhhhhhhhhc-------------------CCCC-CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 209 KCFINRELNKLVR-------------------GTKV-DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 209 ~~~~~~~~~~~~~-------------------~~~~-~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ......+.. .... .......+.+|+.+||++||++|| ++|+++
T Consensus 371 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 371 RCG-TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred hcc-chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 000000000 0000 001135678999999999999999 999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.14 Aligned_cols=228 Identities=19% Similarity=0.261 Sum_probs=180.6
Q ss_pred cccceeeecccCCCCCeeec----------cchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 5 KLSNFYRSSFNARNSPWISR----------VSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~~i~~----------~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+|++|-.-.......+++|. .+|.+|++.+. +++||||+.+.+.|..++..++|+|||++|
T Consensus 550 qFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLs---------qLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 550 QFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILS---------RLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHh---------ccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 44444444444445555553 45788888888 889999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC-CCCcccc--
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP-NEDFVID-- 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~-~~~~~~~-- 151 (257)
+|.+++..++..+........++.||++|++||.+- +++|||+.+.|+|+++++++|++|||+++.. ..+....
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999876555666677788999999999999999 9999999999999999999999999999843 2222222
Q ss_pred --cCCCCccCcccccCCCCCccccchhHHHHHHHHHh--cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC----
Q 044568 152 --KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC--CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---- 223 (257)
Q Consensus 152 --~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 223 (257)
....+|+|+|.+..++++.+||+|+||+++||+++ ...||.... ++... .+...+++..
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vv----------en~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVV----------ENAGEFFRDQGRQV 764 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHH----------HhhhhhcCCCCcce
Confidence 23457999999999999999999999999999986 788886431 11111 2223333322
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 --KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 --~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..|.-++..+.+++.+||..|-++|| ++++...|
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 45677888999999999999999999 99997653
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.27 Aligned_cols=235 Identities=12% Similarity=0.075 Sum_probs=169.1
Q ss_pred ccccceeeecccCCC-CCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++...+. .+++|...... ......+.........+.|+|++++.+.+...+..++||||+++|+|.++
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~ 133 (371)
T cd05622 54 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 133 (371)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence 567899999977554 44566543211 00000000111123377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----cccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----FVIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~ 155 (257)
+.. ..++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...... .....||+
T Consensus 134 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~ 207 (371)
T cd05622 134 MSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207 (371)
T ss_pred HHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCc
Confidence 953 4588899999999999999999999 9999999999999999999999999998754322 13456889
Q ss_pred CccCcccccCC----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 156 GYMAPECYKRT----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 156 ~~~aPE~~~~~----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.|+|||++... .++.++|||||||++|||++|..||....... ....+. .... ... .........
T Consensus 208 ~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~----~~~~---~~~-~~~~~~~s~ 276 (371)
T cd05622 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIM----NHKN---SLT-FPDDNDISK 276 (371)
T ss_pred cccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCC---ccc-CCCcCCCCH
Confidence 99999998753 27889999999999999999999997542111 111100 0000 000 011223456
Q ss_pred HHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
.+.+++..|+..++.+ || ++|+++
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 7888999999844433 78 888865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=265.58 Aligned_cols=227 Identities=16% Similarity=0.179 Sum_probs=173.9
Q ss_pred ccccceeeecccC-CCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... ++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 13 GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs---------~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 13 GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAA---------DLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHH---------hCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 5689999998654 5667887653 233444444 88899999999999999999999999
Q ss_pred cCCCCHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 71 VRNGSLTDIIFCS---------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 71 ~~~gsL~~~l~~~---------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
++||+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998631 123456677889999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC---------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhh
Q 044568 142 KLPNED---------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEE 200 (257)
Q Consensus 142 ~~~~~~---------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~ 200 (257)
...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-- 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-- 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 754110 012357889999999998889999999999999999999999997532111
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCC--CCCHHHHHHHHHHHHHcccCCCCCCC--hHHHHHh
Q 044568 201 IILTNWVYKCFINRELNKLVRGT--KVDKKNLENLVKVGLWCVQDEPALRP--MKCAVMM 256 (257)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~~ 256 (257)
.... . ....+. ....+.+..+.+++.+||+.||++|| ++++.+.
T Consensus 239 i~~~---------~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 239 ISYR---------D---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred hhhh---------h---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0000 0 001110 11123456788999999999999998 6666543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=243.49 Aligned_cols=236 Identities=14% Similarity=0.172 Sum_probs=171.6
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++... ++..+++|...- .+|++.+. ++.|+|++++.+.+... ...+
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---------HMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred CCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHH---------hcCCCchhhhhhhhcccccccccCcEE
Confidence 568899999854 555677776541 22333333 88999999998876532 4578
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+++|++ +++|.+++. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 97 ~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 97 LVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 999998 679998884 45699999999999999999999999 99999999999999999999999999988766
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELN 217 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 217 (257)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................ ..........
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 55556678889999999876 468899999999999999999999997542111100000000 0000000000
Q ss_pred hhhcCC-CCC--------HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT-KVD--------KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~-~~~--------~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... ..+ ....+.+.+++.+||+.||.+|| +.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111100 000 11234578999999999999999 999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=231.84 Aligned_cols=236 Identities=20% Similarity=0.254 Sum_probs=176.9
Q ss_pred cccccceeeecccCC-----CCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFNAR-----NSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~-----~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.++.||+++.... ..+++|...... ..+.+... . ..+..+.|+|++++.+.+...+..+++|||++++
T Consensus 9 ~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e-~-~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~ 86 (258)
T smart00219 9 EGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLRE-A-RIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGG 86 (258)
T ss_pred cCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHH-H-HHHHhcCCCchheEEEEEcCCCeeEEEEeccCCC
Confidence 367899999998763 445666554321 11111100 0 1233778999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----c
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV----I 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~----~ 150 (257)
+|.+++.......+++.++..++.|++.|+.+||++ +++|+|++|+||+++.++.++++|||.+........ .
T Consensus 87 ~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (258)
T smart00219 87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKG 163 (258)
T ss_pred CHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccccccc
Confidence 999999753333399999999999999999999999 999999999999999999999999999875433211 1
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..++..|++||.+.+..++.++|+||+|+++|++++ |..||..... ....... ... .....+...
T Consensus 164 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----------~~~-~~~~~~~~~ 229 (258)
T smart00219 164 GKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL----------KKG-YRLPKPENC 229 (258)
T ss_pred CCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----------hcC-CCCCCCCcC
Confidence 235678999999988888999999999999999998 7888864311 1001000 000 001222335
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 67799999999999999999 99999876
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=233.45 Aligned_cols=233 Identities=19% Similarity=0.174 Sum_probs=177.4
Q ss_pred cccccceeeeccc-CCCCCeeeccchhh-------hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSWTA-------DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~~~-------~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.++.||+|... +++.+++|...... ..+.+.... ..+.++.|+|++++.+.+...+..++|+||++++
T Consensus 10 ~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~--~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (258)
T cd06632 10 SGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEI--ALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGG 87 (258)
T ss_pred ecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHH--HHHHhcCCCCchheeeeEecCCeEEEEEEecCCC
Confidence 3567899999977 66777777543211 111111000 1233888999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--ccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~ 152 (257)
+|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+||+|||.+...... .....
T Consensus 88 ~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~ 162 (258)
T cd06632 88 SLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK 162 (258)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccC
Confidence 99999974 35688999999999999999999999 9999999999999999999999999987754322 23445
Q ss_pred CCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 153 RDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
++..|++||.+.... ++.++|+||||+++|++++|..||...... .....+ .........+....+
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~----------~~~~~~~~~~~~~~~ 229 (258)
T cd06632 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKI----------GRSKELPPIPDHLSD 229 (258)
T ss_pred CCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHH----------HhcccCCCcCCCcCH
Confidence 677899999987766 889999999999999999999999754211 000000 000111122334457
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.+|.+|| +.++++
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhc
Confidence 788999999999999999 999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=237.25 Aligned_cols=239 Identities=16% Similarity=0.151 Sum_probs=175.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|... +.+|++.+. +++|+|++++.+.+...+..++||||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK---------ELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred CCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHH---------hcCCCCCcchhhhcccCCcEEEEeecc
Confidence 567899999865 45666776543 334555555 889999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---c
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~ 148 (257)
. ++|.+++.......+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||++...... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 6 6899998764567799999999999999999999999 9999999999999999999999999988654322 1
Q ss_pred ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhh-hhhhhhhh
Q 044568 149 VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCF-INRELNKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~ 219 (257)
....++..|+|||.+.+.. ++.++|+||||+++||+++|+.||................ ++.. ..+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234567799999887654 5889999999999999999999997553221111111000 0000 00000000
Q ss_pred hcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... .........+.+++.+||+.||.+|| ++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 00112345678999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=237.10 Aligned_cols=234 Identities=16% Similarity=0.130 Sum_probs=170.1
Q ss_pred ccccceeeecccC-CCCCeeeccchhh-hHHHHhHhhhccccccc-cCCceeeeceeeee------cCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA-DIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKL------TSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~------~~~~~lV~E~~~~g 74 (257)
+.++.||+++... +..+++|...... +...+... .. .+.++ .|+|++++.+.+.. .+..++||||+++|
T Consensus 27 g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e-~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 104 (282)
T cd06636 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-IN-MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG 104 (282)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHH-HH-HHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCC
Confidence 5688999999754 4445566543211 11111100 00 12244 59999999988753 46789999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVID 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~ 151 (257)
+|.+++.......+++..+..++.|++.|+.|||++ +++|+|++|+||++++++.++|+|||++..... .....
T Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 181 (282)
T cd06636 105 SVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181 (282)
T ss_pred cHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcc
Confidence 999999764556688888999999999999999999 999999999999999999999999998764322 12334
Q ss_pred cCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 152 KRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 152 ~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.++..|+|||.+. ...++.++|+||||+++|||++|..||.......... ............
T Consensus 182 ~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~~ 248 (282)
T cd06636 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-------------LIPRNPPPKLKS 248 (282)
T ss_pred cccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------------hHhhCCCCCCcc
Confidence 5778899999886 3457889999999999999999999996442111000 000111111112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.||.+|| +.|+++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 23456799999999999999999 999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=234.41 Aligned_cols=230 Identities=21% Similarity=0.216 Sum_probs=175.2
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||++... ++..+++|...... ..+.+. ... ....++.|+|++++.+.+...+..++||||+++++|.++
T Consensus 15 G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 92 (277)
T cd06641 15 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 92 (277)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHH-HHH-HHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHH
Confidence 568999999864 55667777644211 111111 011 133388999999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~ 156 (257)
+. ...+++..+..++.|++.|+.+||++ +++|+|++|+||+++.++.++++|||++...... .....++..
T Consensus 93 i~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 166 (277)
T cd06641 93 LE---PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166 (277)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCcc
Confidence 85 34689999999999999999999999 9999999999999999999999999987643322 123356777
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
|+|||.+.+..++.++|+||||+++|++++|..||....... ... . ... ......+...+..+.++
T Consensus 167 y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~----~------~~~-~~~~~~~~~~~~~~~~~ 232 (277)
T cd06641 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF----L------IPK-NNPPTLEGNYSKPLKEF 232 (277)
T ss_pred ccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH----H------Hhc-CCCCCCCcccCHHHHHH
Confidence 999999988888999999999999999999999996431110 000 0 000 00112233445778899
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+||+.+|.+|| +.++++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHccCChhhCcCHHHHHh
Confidence 9999999999999 999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=235.39 Aligned_cols=236 Identities=19% Similarity=0.163 Sum_probs=174.7
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh------------hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA------------DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~------------~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+|... ++..+++|...... ..+.+. ..-..+.++.|+|++++.+.+...+..++||||
T Consensus 12 g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (272)
T cd06629 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR--SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEY 89 (272)
T ss_pred cCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHH--HHHHHHHhcCCCCcceEEEEeccCCceEEEEec
Confidence 568899999854 45667777653210 011111 000133488899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
+++|+|.+++.+ ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+......
T Consensus 90 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 164 (272)
T cd06629 90 VPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164 (272)
T ss_pred CCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccc
Confidence 999999999974 36789999999999999999999999 9999999999999999999999999988653321
Q ss_pred --cccccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
.....++..|+|||.+.... ++.++|+||||+++||+++|..||........ ... .. ........ +.
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~----~~-~~~~~~~~-~~ 235 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFK----LG-NKRSAPPI-PP 235 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHH----hh-ccccCCcC-Cc
Confidence 12335677899999987654 78999999999999999999999964311110 000 00 00000000 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+..+.+++.+||+.+|.+|| +.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 12223457899999999999999999 999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=239.77 Aligned_cols=237 Identities=14% Similarity=0.155 Sum_probs=173.6
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... ++.+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 17 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 17 GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK---------DLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHH---------hcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 5688999998654 55567776542 23444443 8899999999999999999999999997
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 88 -~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 88 -KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred -cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 599999875 455689999999999999999999999 9999999999999999999999999988643321 12
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-----
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT----- 223 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 223 (257)
...++..|+|||.+.+. .++.++|+||||+++|||++|+.||.................. .....+.......
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT-PTEETWPGILSNEEFKSY 241 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CChhhchhhhcccccccc
Confidence 33557789999998754 4788999999999999999999999755221110000000000 0000000000000
Q ss_pred -----------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 -----------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 -----------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.........+.+++.+||+.||.+|| ++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112345678999999999999999 999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.84 Aligned_cols=186 Identities=15% Similarity=0.149 Sum_probs=149.9
Q ss_pred ccccceeeecccC-CCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++... +..+++|...-.. .-..-.+......+..+.|++++++...+...+..++||||+++|+|.++
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~ 91 (360)
T cd05627 12 GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTL 91 (360)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHH
Confidence 5688999998664 5566777654211 00000111111133478899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC------------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED------------ 147 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~------------ 147 (257)
+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 92 l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~ 166 (360)
T cd05627 92 LM--KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166 (360)
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccC
Confidence 97 456789999999999999999999999 9999999999999999999999999987633211
Q ss_pred --------------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 148 --------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 148 --------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.....||+.|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred CcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 01236888999999999989999999999999999999999999755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=240.47 Aligned_cols=233 Identities=16% Similarity=0.159 Sum_probs=174.1
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++... ++..+++|..........-.....-..+..+.|+|++++.+.+...+..++||||+++++|.+++.
T Consensus 33 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~- 111 (292)
T cd06658 33 GSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT- 111 (292)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-
Confidence 567889999865 456667776543111100000000012337889999999999999999999999999999999985
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~a 159 (257)
...+++.++..++.|++.|+.|||++ +++|+||+|.||+++.++.++|+|||++....... ....++..|+|
T Consensus 112 --~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~a 186 (292)
T cd06658 112 --HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186 (292)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccC
Confidence 34689999999999999999999999 99999999999999999999999999876432221 23456788999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENLVKVGL 238 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~ 238 (257)
||.+.+..++.++|+||||+++||+++|..||....... .... ........ .........+.+++.
T Consensus 187 PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRR----------IRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----------HHhcCCCccccccccCHHHHHHHH
Confidence 999988888999999999999999999999997542111 0100 00111111 111223456888999
Q ss_pred HcccCCCCCCC-hHHHHH
Q 044568 239 WCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 239 ~cl~~~p~~RP-~~ei~~ 255 (257)
.||+.||.+|| ++|+++
T Consensus 254 ~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 254 LMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHccCChhHCcCHHHHhh
Confidence 99999999999 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=233.72 Aligned_cols=224 Identities=18% Similarity=0.172 Sum_probs=169.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch--------------hhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 66 (257)
+.++.||++... ++..+++|.... .+|++.+. +++|+|++++.+.+.. ....++
T Consensus 13 g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK---------NLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHH---------HcCCCCeeeEEEEEEcCCCCEEEE
Confidence 467889999865 456667775432 22333333 8899999999998775 356789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
++||+++++|.+++. ....+++.....++.|++.||.|||++ +++|+|++|+||+++.++.++|+|||++.....
T Consensus 84 ~~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 84 FMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999999997 345689999999999999999999999 999999999999999999999999998864322
Q ss_pred C------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 D------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. .....++..|+|||.+.+..++.++|+||||+++||+++|+.||....... . .. ......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~--~~----------~~~~~~ 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-A--IF----------KIATQP 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-H--HH----------HHhcCC
Confidence 1 122346778999999988888999999999999999999999997441111 0 00 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+....+.+..++ +||..+|++|| ++|+++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11122333445566666 78889999999 999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=232.60 Aligned_cols=228 Identities=20% Similarity=0.149 Sum_probs=175.5
Q ss_pred ccccceeeecccCC-CCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++....+ ...++|... +.++++.+ .++.|+|++++.+.+...+..+++|||+++
T Consensus 14 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l---------~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 14 GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML---------KECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred CCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHH---------HhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 56788999987654 445555433 23333333 388999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~ 150 (257)
++|.+++.. ....++..++..++.|++.|+.|||++ +++|+|++|+||++++++.++++|||.+....... ..
T Consensus 85 ~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 85 GSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 999999974 346799999999999999999999999 99999999999999999999999999886543221 23
Q ss_pred ccCCCCccCcccccCC---CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC
Q 044568 151 DKRDKGYMAPECYKRT---PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD 226 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~---~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (257)
..++..|++||.+... .++.++|+||||+++|||++|..||........ ...... ....... ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~~~~--------~~~~~~~~~~~ 229 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISK--------SNFPPPKLKDK 229 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh--------ccCCCccccch
Confidence 3567789999998766 788999999999999999999999975421111 000000 0000000 123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.+|.+|| +.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 34457799999999999999999 999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=236.78 Aligned_cols=224 Identities=21% Similarity=0.187 Sum_probs=172.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. .+..+++|.... .+|++++. ++.|+|++++.+.+...+..++||||
T Consensus 26 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ---------QLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 457899999875 455566765432 23333333 78999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
++ |++.+.+.. ....+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 97 ~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~ 170 (307)
T cd06607 97 CL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NS 170 (307)
T ss_pred hC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-CC
Confidence 97 688887754 345689999999999999999999999 9999999999999999999999999988654322 33
Q ss_pred ccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 151 DKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
..++..|+|||.+. ...++.++|+||||+++||+++|..||....... . .... .....+.....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~----~~~~------~~~~~~~~~~~ 237 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A----LYHI------AQNDSPTLSSN 237 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---H----HHHH------hcCCCCCCCch
Confidence 45677899999874 3557899999999999999999999996441111 0 0000 00001112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.+|++|| +.++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 4567799999999999999999 999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=238.07 Aligned_cols=216 Identities=19% Similarity=0.121 Sum_probs=173.4
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|...- .+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 12 g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ---------SIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH---------hCCCCCccceeeEEEcCCeEEEEEec
Confidence 5678999998765 45566665431 22333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
+++++|.+++. ....++...+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 83 VPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence 99999999997 446789999999999999999999999 9999999999999999999999999998765555455
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (257)
..+++.|++||.+.+...+.++|+||||+++|+|++|..||...... .... .... ....+...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~-------------~~~~~~~~~~~~~ 221 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE-------------KILEGKVRFPSFF 221 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-------------HHhcCCccCCccC
Confidence 56788899999998888889999999999999999999999754210 0000 0111 11233344
Q ss_pred HHHHHHHHHHcccCCCCCCC
Q 044568 230 LENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP 249 (257)
...+.+++.+||+.||.+||
T Consensus 222 ~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 222 SPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CHHHHHHHHHHccCCHHHcc
Confidence 67889999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=235.13 Aligned_cols=229 Identities=15% Similarity=0.183 Sum_probs=174.1
Q ss_pred ccccceeeecccCC------CCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.... ..+++|... +.+|++.+. ++.|+|++++.+.+...+..++|
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR---------KLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred cceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHH---------hcCCcceeeeEEEECCCCcceEE
Confidence 56789999986532 345565543 233444444 88899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecc
Q 044568 68 ERPVRNGSLTDIIFCSAE-------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~ 140 (257)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 999999999999974321 2689999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 141 AKLPNEDF----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 141 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
+....... ....++..|++||.+.+..++.++||||||+++|++++ |..||...... ...... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~-----~~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL-----QAGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH-----HcCC
Confidence 76432211 22234556999999988888899999999999999999 78888643111 001000 0000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ....+...+..+.+++.+||+.+|.+|| +.|+++.|
T Consensus 236 ~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 236 L-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred c-----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 0 0112234557899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=240.09 Aligned_cols=225 Identities=17% Similarity=0.160 Sum_probs=174.4
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++... .+..+++|.... .+|++ .+..+.|+|++++.+.+...+..++||||+++
T Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~---------~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 32 GSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV---------IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred CCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHH---------HHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 467889999865 456677776542 22222 23378899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
++|.+++. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 103 ~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 103 GALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99999884 35689999999999999999999999 9999999999999999999999999987643322 233
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..++..|+|||.+.+..++.++|+||||+++|||++|..||....... ....+. ... ...........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~-----~~~----~~~~~~~~~~~ 244 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLR-----DSP----PPKLKNAHKIS 244 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh-----ccC----CCCccccCCCC
Confidence 457788999999988889999999999999999999999997442111 111100 000 00001122334
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.+|++|| +.|+++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 6688999999999999999 999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=255.63 Aligned_cols=224 Identities=20% Similarity=0.234 Sum_probs=181.5
Q ss_pred ccceeeecccCCCCC-eeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 6 LSNFYRSSFNARNSP-WISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~-~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
-+.||.|...++.-. +||++.- .+|+.... +++|.|||+..|.+...++.-|.||-.+|||
T Consensus 588 YG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~---------~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 588 YGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHS---------TLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred eeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHH---------HHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 467999997766555 4676552 34444444 9999999999999999999999999999999
Q ss_pred HHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCC---CCcc
Q 044568 76 LTDIIFCSAERNP--YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPN---EDFV 149 (257)
Q Consensus 76 L~~~l~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~---~~~~ 149 (257)
|.+.++. .=++| ++.+.-.+..||++||.|||++ .|+|||||.+|+|+.- .|.+||+|||.+++.. .-..
T Consensus 659 LSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 9999985 44555 7778889999999999999999 9999999999999964 7899999999988643 3335
Q ss_pred cccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC
Q 044568 150 IDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD 226 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (257)
...||..|||||++..++ |+.++|||||||++.||.||++||..-.++.... +. . .+.+.. ++|
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------Fk---V-GmyKvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FK---V-GMYKVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hh---h-cceecCCCCc
Confidence 668899999999998764 8899999999999999999999997443332110 00 0 122222 678
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+...+...++++|+..||.+|| +.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 88899999999999999999999 999875
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=234.87 Aligned_cols=227 Identities=18% Similarity=0.240 Sum_probs=175.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... .+..+++|.... .+|++.+ .++.|+|++++.+.+...+..++||||++
T Consensus 12 g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l---------~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL---------HKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHH---------HhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 568899999876 566667775432 2233333 37889999999999999999999999999
Q ss_pred CCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccc
Q 044568 73 NGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~ 149 (257)
+++|.+++.... ...+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++++|||.+..... ...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 999999987421 3478999999999999999999996 5 899999999999999999999999998865322 223
Q ss_pred cccCCCCccCcccccCCC------CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc--
Q 044568 150 IDKRDKGYMAPECYKRTP------ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-- 221 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~------~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (257)
...++..|+|||.+.+.. ++.++|+||||+++|++++|..||........ . ........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~----------~~~~~~~~~~ 226 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---F----------AQLSAIVDGD 226 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---H----------HHHHHHhhcC
Confidence 345677899999985443 47899999999999999999999964421110 0 00111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+......+..++.+||+.+|.+|| +.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1123444667889999999999999999 999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=236.52 Aligned_cols=236 Identities=15% Similarity=0.110 Sum_probs=172.7
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... ++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++|+||+
T Consensus 11 g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK---------ELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHH---------hcCCCCeeeHHHHhccCCceEEEEecC
Confidence 4577899998764 4556666543 234555555 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+ ++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 82 D-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred C-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 7 588888864 456699999999999999999999999 99999999999999999999999999887543221
Q ss_pred ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh-----hhhhhhhhcC
Q 044568 149 VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI-----NRELNKLVRG 222 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 222 (257)
....++..|+|||.+.+.. ++.++||||||+++|||++|..||.......+ ........... .+......+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2345577899999987644 68999999999999999999998754322211 11111000000 0000000000
Q ss_pred C------------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 T------------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 ~------------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .......+.+.+++.+||+.||.+|| ++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00112346788999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=231.52 Aligned_cols=226 Identities=17% Similarity=0.214 Sum_probs=174.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.+|++... ++...++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK---------LLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHh---------hCCCCchhheeeeEecCCEEEEEEecC
Confidence 457889988754 44555666543 223333333 778999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccCCCCc--
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~~~~~-- 148 (257)
++++|.+++.......+++..+..++.|++.|+.|||++ +++|+|++|+||+++.+ ..++++|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 999999999764456689999999999999999999999 99999999999999854 467999999987543322
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+.+..++.++|+||||+++|++++|..||....... ..... .... ....+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---------~~~~--~~~~~~~ 224 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---------MSGT--FAPISDR 224 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---------HhcC--CCCCCCC
Confidence 23456778999999988888999999999999999999999997542111 00000 0000 0122333
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.+|.+|| +.|+++
T Consensus 225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 225 YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 566789999999999999999 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=252.93 Aligned_cols=222 Identities=18% Similarity=0.216 Sum_probs=181.1
Q ss_pred ccccceeeecccCCCCC----eeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNSP----WISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~----~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|++|.+|.+.+.... ++|-+. |.+|+..+. +++|+++++++|...+ ....||||
T Consensus 121 GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~---------~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 121 GSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHML---------KLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred cceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHH---------hccCcceeEEeeeecc-chhhHHhh
Confidence 57899999998876554 344332 455555555 9999999999999988 78889999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (257)
+++.|||.+.|++.....|.......|+.||+.|+.||.++ ++||||+.++|+++.....+||+|||+.+.......
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999975566677788889999999999999999 999999999999999999999999999986554432
Q ss_pred cc------cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 150 ID------KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 150 ~~------~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
.. .-...|+|||.+....++.+||+|+||+++|||++ |..||.+... ..+...++.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhccc
Confidence 22 22345999999999999999999999999999999 8899976521 112222222
Q ss_pred C---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 T---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 ~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .-++.|++++++++.+||..+|++|| +..|.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2 34678899999999999999999999 998864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=241.63 Aligned_cols=238 Identities=12% Similarity=0.055 Sum_probs=169.4
Q ss_pred ccccceeeecccCCCC-Ceeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNS-PWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++...+.. +++|...-. ...+...+......+....|++++++...+...+..++||||+++|+|.++
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~ 91 (332)
T cd05623 12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTL 91 (332)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHH
Confidence 5688999999776554 556654311 111110011111133377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----cccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----FVIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~ 155 (257)
+.. ....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++...... .....||+
T Consensus 92 l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~ 167 (332)
T cd05623 92 LSK-FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167 (332)
T ss_pred HHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCc
Confidence 975 356789999999999999999999999 9999999999999999999999999988643221 12346889
Q ss_pred CccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 156 GYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 156 ~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.|+|||++. ...++.++|+|||||++|||++|+.||....... ..... .... .............
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---~~~~i-----~~~~--~~~~~p~~~~~~s 237 (332)
T cd05623 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKI-----MNHK--ERFQFPAQVTDVS 237 (332)
T ss_pred cccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---HHHHH-----hCCC--ccccCCCccccCC
Confidence 999999986 3457899999999999999999999997542111 01000 0000 0000001112335
Q ss_pred HHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
+.+.+++.+|+..+|.+ || ++|+++
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 67788888887654444 67 888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=241.71 Aligned_cols=236 Identities=12% Similarity=0.038 Sum_probs=168.5
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... +..+++|...-. .+.+.+. ........+.|+|++.+...+...+..++||||+++|+|.
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (331)
T cd05597 12 GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR--EERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLL 89 (331)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHH--HHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHH
Confidence 5688999999665 556677765421 1111111 0111223678999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccccC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDKR 153 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~ 153 (257)
+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++....... ....+
T Consensus 90 ~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g 165 (331)
T cd05597 90 TLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVG 165 (331)
T ss_pred HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceec
Confidence 99974 356789999999999999999999999 99999999999999999999999999986533221 22458
Q ss_pred CCCccCcccccC-----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 154 DKGYMAPECYKR-----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 154 ~~~~~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
|+.|+|||++.. ..++.++|||||||++|||++|+.||........ .. ...... ....-......
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---~~----~i~~~~---~~~~~~~~~~~ 235 (331)
T cd05597 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YG----KIMNHK---EHFQFPPDVTD 235 (331)
T ss_pred cccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH---HH----HHHcCC---CcccCCCccCC
Confidence 899999999863 3467899999999999999999999975421110 00 000000 00110011112
Q ss_pred HHHHHHHHHHHcccC--CCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQD--EPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~--~p~~RP-~~ei~~ 255 (257)
.+..+.+++.+|+.. ++..|| +.++++
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 345677777776654 334488 888864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=232.62 Aligned_cols=234 Identities=17% Similarity=0.140 Sum_probs=174.2
Q ss_pred ccccceeeeccc-CCCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++.. .+..+++|..... +...... ...........|+|++++.+.+...+..++||||+++++|.
T Consensus 7 g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~-~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 85 (260)
T cd05611 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85 (260)
T ss_pred CCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHH-HHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHH
Confidence 468899999865 4566777765421 1111111 11111223557999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGY 157 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (257)
+++. ....+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++..... .....++..|
T Consensus 86 ~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y 159 (260)
T cd05611 86 SLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFVGTPDY 159 (260)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-cccCCCCcCc
Confidence 9997 445789999999999999999999999 999999999999999999999999998875332 2334577889
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVG 237 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 237 (257)
++||.+.+..++.++|+||||+++|++++|..||..... ........ ......+.......+..+.+++
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNIL--------SRRINWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH--------hcccCCCCcccccCCHHHHHHH
Confidence 999999888889999999999999999999999964421 11111100 0000001112223457899999
Q ss_pred HHcccCCCCCCC-hHHHHH
Q 044568 238 LWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 238 ~~cl~~~p~~RP-~~ei~~ 255 (257)
.+||+.+|.+|| +.++.+
T Consensus 229 ~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 229 NRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHccCCHHHccCCCcHHH
Confidence 999999999999 864443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=239.37 Aligned_cols=238 Identities=18% Similarity=0.165 Sum_probs=174.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|... +.+|++.+. .+.|+|++++.+.+...+..++||||+
T Consensus 12 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 12 GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLK---------QLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred CCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHH---------hcCCcchhhHHHhcccCCeEEEEEecC
Confidence 4578899999764 5666676532 223444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
++++|..+.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||++++++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 83 DHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred CccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999988776 445689999999999999999999999 99999999999999999999999999876532221
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH-------hhhhhhhh-hh
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK-------CFINRELN-KL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~ 219 (257)
....++..|+|||++.+. .++.++|+||||+++||+++|..||..............+... ........ ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 223466779999998754 4678999999999999999999999755321111111111000 00000000 00
Q ss_pred hcCC--------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT--------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+. ......+..+.+++.+||+.+|++|| +.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 00112356799999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=240.60 Aligned_cols=228 Identities=19% Similarity=0.210 Sum_probs=171.0
Q ss_pred ccccceeeecccCC--------CCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFNAR--------NSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~--------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||++..... ..+++|... +.+|++++. ++ .|+|++++.+.+...+..
T Consensus 23 G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 23 GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK---------MIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred ccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHH---------hhcCCCCeeeeeEEEccCCce
Confidence 46889998864321 134555433 223333333 66 699999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 65 GKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~ 170 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC
Confidence 99999999999999997421 23578889999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.++|+|||+++...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~---- 244 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EE---- 244 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--HH----
Confidence 999999999987543221 11222356999999988889999999999999999998 8888864311 10
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.... ... .....+...+..+.+++.+||+.+|++|| +.|+++.|
T Consensus 245 -~~~~~-~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 245 -LFKLL-KEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred -HHHHH-HcC------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 10000 000 00122334456789999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=235.38 Aligned_cols=237 Identities=15% Similarity=0.174 Sum_probs=172.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. +++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 16 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 16 GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLK---------DLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHh---------hCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 567899999976 45667777643 233555555 8889999999999999999999999998
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
++|.+++.. ....+++..+..++.|+++||.|||++ +++|+||+|+||+++.++.++|+|||.++..... ..
T Consensus 87 -~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 87 -TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred -CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 499999875 445789999999999999999999999 9999999999999999999999999987643221 12
Q ss_pred cccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh-hhhhhhhh--------
Q 044568 150 IDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-INRELNKL-------- 219 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-------- 219 (257)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||............. +..... ........
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI-FRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHhcCCCChhhhhhhhhcccccc
Confidence 2235677999999875 457899999999999999999999997553211111000 000000 00000000
Q ss_pred -----hcCCC-----CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 -----VRGTK-----VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 -----~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.. ........+.+++.+||+.+|++|| +.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0011126778999999999999999 999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=231.46 Aligned_cols=239 Identities=20% Similarity=0.208 Sum_probs=176.0
Q ss_pred cccccceeeecccC-CCCCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
.+.++.||++...+ +...++|.... ....+.+.... ..+..+.|+|++++.+.+...+..++|||++++++|.+
T Consensus 11 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~--~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~ 88 (267)
T cd06610 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEV--QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88 (267)
T ss_pred CCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHH--HHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHH
Confidence 35678999999654 44556665432 11111111000 02337889999999999999999999999999999999
Q ss_pred HHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-------cc
Q 044568 79 IIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-------VI 150 (257)
Q Consensus 79 ~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~ 150 (257)
++..... ..+++..+..++.|++.|+.|||++ +++|+|++|+||++++++.++|+|||++....... ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (267)
T cd06610 89 IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165 (267)
T ss_pred HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccccc
Confidence 9975333 5789999999999999999999999 99999999999999999999999999876543322 22
Q ss_pred ccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..++..|++||.+... .++.++|+||||+++|||++|+.||....... ....... .. .............
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~-----~~-~~~~~~~~~~~~~ 236 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQ-----ND-PPSLETGADYKKY 236 (267)
T ss_pred ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhc-----CC-CCCcCCccccccc
Confidence 2467789999998876 68899999999999999999999997542211 1111000 00 0001110111244
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+.+++.+||+.||++|| +.++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 57789999999999999999 999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=234.41 Aligned_cols=235 Identities=16% Similarity=0.125 Sum_probs=172.8
Q ss_pred ccccceeeecccC-CCCCeeeccch-----hh-hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----TA-DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++.... +..+++|...- .. +.........-.......|++++.+...+...+..++||||+++|+|
T Consensus 5 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 84 (279)
T cd05633 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL 84 (279)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCH
Confidence 5689999998754 55566764321 11 11011100000022245689999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-CcccccCCC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVIDKRDK 155 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~ 155 (257)
.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||++..... ......++.
T Consensus 85 ~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 159 (279)
T cd05633 85 HYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (279)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCc
Confidence 99997 445699999999999999999999999 999999999999999999999999998864332 223346788
Q ss_pred CccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+ ..++.++|+||+|+++||+++|..||......... ..... ....+...+...+..+.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRM-----------TLTVNVELPDSFSPELK 227 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHH-----------hhcCCcCCccccCHHHH
Confidence 9999999864 45789999999999999999999999754322211 11100 00111123444567889
Q ss_pred HHHHHcccCCCCCCC------hHHHHH
Q 044568 235 KVGLWCVQDEPALRP------MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP------~~ei~~ 255 (257)
+++.+||+.||.+|| ++|+++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 999999999999998 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=231.27 Aligned_cols=231 Identities=16% Similarity=0.149 Sum_probs=171.0
Q ss_pred ccccceeeecccC-CCCCeeeccchh-------hhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~~~~ 73 (257)
+.++.||++...+ +..+++|..... .+++.+... -..+.++.|+|++++.+.+... ...++||||+++
T Consensus 13 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E--~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~ 90 (265)
T cd06652 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECE--IQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPG 90 (265)
T ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHH--HHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCC
Confidence 5678999998654 566777765321 111111100 0123388899999999987763 467899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC------C
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE------D 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~------~ 147 (257)
++|.+++.. ...+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 91 ~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 165 (265)
T cd06652 91 GSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165 (265)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccc
Confidence 999999973 35688899999999999999999999 999999999999999999999999998864321 1
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
.....++..|+|||.+.+..++.++|+||||+++||+++|+.||....... .... ..........+.
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~----------~~~~~~~~~~~~ 232 (265)
T cd06652 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFK----------IATQPTNPVLPP 232 (265)
T ss_pred cccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHH----------HhcCCCCCCCch
Confidence 223456778999999988888999999999999999999999996431110 0000 000000112344
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+..++.+||. +|++|| ++|+++
T Consensus 233 ~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 233 HVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 455678888899984 999999 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=231.71 Aligned_cols=235 Identities=17% Similarity=0.220 Sum_probs=176.5
Q ss_pred ccccceeeecc-cCCCCCeeeccchhh--------hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWTA--------DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++. .+++.+++|...... ..+.+. ..-..+.+++|+|++++.+.+...+..++|+||++++
T Consensus 11 g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 88 (268)
T cd06630 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR--KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGG 88 (268)
T ss_pred cCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHH--HHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCC
Confidence 46788999985 445666776654211 111111 0011333789999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCCCc-----
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNEDF----- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~----- 148 (257)
+|.+++. ....+++.....++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 89 ~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 163 (268)
T cd06630 89 SVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163 (268)
T ss_pred cHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCc
Confidence 9999997 345788999999999999999999999 999999999999998765 59999999876543221
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....++..|+|||.+.+..++.++|+||+|+++|++++|..||............. ...........+
T Consensus 164 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~ 233 (268)
T cd06630 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF----------KIASATTAPSIP 233 (268)
T ss_pred cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH----------HHhccCCCCCCc
Confidence 12346778999999988888999999999999999999999997542211111000 001111122345
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+.+++.+||+.+|.+|| +.|+++
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 55667899999999999999999 999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=241.34 Aligned_cols=232 Identities=16% Similarity=0.119 Sum_probs=168.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.++.||++... .+..+++|.... .+|++.+ ..+.|+|++++.+.+...+ ..+
T Consensus 32 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l---------~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 32 GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL---------KCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred CCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHH---------HhCCCCCEeeeeeeeccCCCccccceeE
Confidence 568899999864 456677776531 2233333 3788999999999876543 468
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++ +|.+.+. ..++...+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 103 lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 103 LVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 99999975 6777764 2478889999999999999999999 99999999999999999999999999987532
Q ss_pred CC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh---------hhh
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF---------INR 214 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~ 214 (257)
.. .....+|..|+|||.+.+..++.++||||+|+++|+|++|+.||........ +........ ...
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcHHHHHHHHH
Confidence 22 2344678889999999988899999999999999999999999985532111 000000000 000
Q ss_pred hhhhh---------------hcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKL---------------VRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~---------------~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... .... .........+.+++.+||+.||++|| +.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000 01111235688999999999999999 999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=227.29 Aligned_cols=192 Identities=21% Similarity=0.235 Sum_probs=158.3
Q ss_pred ccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 46 IRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 46 ~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
..||+|+.+.+........++|+|.|+.|.|.|+|. +..++++...+.++.|+.+|+.|||.+ +|+|||+||+||
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENI 154 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENI 154 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhe
Confidence 359999999999999999999999999999999998 778899999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCC--CCcccccCCCCccCcccccC------CCCCccccchhHHHHHHHHHhcCCCCCcCCCC
Q 044568 126 LMDEFWTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECYKR------TPISVKADVYGYGIVLLETICCRKNMEIDASK 197 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~ 197 (257)
|++++.+++|+|||++.... ......+||++|+|||.+.. ..|+...|+||+|+++|.++.|.+||--.
T Consensus 155 Llddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--- 231 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--- 231 (411)
T ss_pred eeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---
Confidence 99999999999999987644 33467799999999999863 35889999999999999999999999522
Q ss_pred hhhHHHHHHHHHh--hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 198 PEEIILTNWVYKC--FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 198 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..-..++....-. +.+ +...+......+|+.+||+.||.+|- ++|.++
T Consensus 232 kQmlMLR~ImeGkyqF~s----------peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRS----------PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHHHhcccccCC----------cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111111000 111 22333456788999999999999999 998864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=237.24 Aligned_cols=234 Identities=16% Similarity=0.155 Sum_probs=171.8
Q ss_pred ccccceeeecccCC-CCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++..... ..+++|...-. +..+.+. .... .+..++|+|++++.+.+...+..++||||+++++|.
T Consensus 12 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~-~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (305)
T cd05609 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERD-ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89 (305)
T ss_pred CCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHH-HHHH-HHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHH
Confidence 45778999886554 45667654421 1111111 1111 344788999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---------
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--------- 148 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--------- 148 (257)
+++. ....+++..+..++.|++.|+.|||++ +++|+|++|.||+++.++.++++|||.++......
T Consensus 90 ~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (305)
T cd05609 90 TLLK--NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164 (305)
T ss_pred HHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccccc
Confidence 9997 345789999999999999999999999 99999999999999999999999999876311000
Q ss_pred ---------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 149 ---------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 149 ---------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
....++..|+|||.+.+..++.++|+||||+++||+++|..||.+.... ...... ... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~-----~~~---~~ 233 (305)
T cd05609 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQV-----ISD---DI 233 (305)
T ss_pred ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-----Hhc---cc
Confidence 1124566799999998888999999999999999999999999744211 111100 000 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
..+ ......+..+.+++.+||+.+|++|| +.++.++
T Consensus 234 ~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 234 EWP-EGDEALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred CCC-CccccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 000 11113456789999999999999999 7665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=231.78 Aligned_cols=240 Identities=16% Similarity=0.111 Sum_probs=177.5
Q ss_pred cccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCc-----ee
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV-----SG 65 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~-----~~ 65 (257)
.+.++.||+++... +..+++|.... .+|++.+. .+..+.|+|++++.+.+...+. .+
T Consensus 9 ~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 9 EGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLK------QLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred ccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHH------HhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 35688999999875 66777776642 23333333 2335679999999999988776 99
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
++|||++ ++|.+++.......+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+....
T Consensus 83 l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999997 5899988753445799999999999999999999999 99999999999999999999999999887543
Q ss_pred CCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhh-------
Q 044568 146 EDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINREL------- 216 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 216 (257)
... ....++..|+|||.+.+..++.++|+||||+++|||++|..||....... ....+..........
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcCCCcc
Confidence 221 23345777999999998889999999999999999999999997553221 111111111000000
Q ss_pred --hhhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 217 --NKLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 217 --~~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... ....+....+.+++.+||+.||.+|| +.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 11123457788999999999999999 999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.87 Aligned_cols=238 Identities=12% Similarity=0.049 Sum_probs=170.1
Q ss_pred ccccceeeecccCC-CCCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++...+ ..+++|...-. ...+...+...........|++++++.+.+...+..++||||+++|+|.++
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~ 91 (331)
T cd05624 12 GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTL 91 (331)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence 56889999996644 44567755321 111111111111133367899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~ 155 (257)
+.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... ....|++
T Consensus 92 l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 167 (331)
T cd05624 92 LSK-FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167 (331)
T ss_pred HHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCc
Confidence 975 356789999999999999999999999 99999999999999999999999999987543322 2246889
Q ss_pred CccCcccccC-----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 156 GYMAPECYKR-----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 156 ~~~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.|+|||.+.. ..++.++|+||||+++|||++|+.||........ .... .... ...+.........
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~i-----~~~~--~~~~~p~~~~~~~ 237 (331)
T cd05624 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKI-----MNHE--ERFQFPSHITDVS 237 (331)
T ss_pred ccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHHH-----HcCC--CcccCCCccccCC
Confidence 9999999875 4578899999999999999999999975421110 0000 0000 0000001112235
Q ss_pred HHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
+.+.+++.+|+..++.+ |+ ++++++
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 67888888988866554 45 666653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=237.91 Aligned_cols=233 Identities=13% Similarity=0.115 Sum_probs=169.9
Q ss_pred ceeeecccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 8 NFYRSSFNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 8 ~~y~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
.+|+++. ++..+++|.... .+|++.+ ..++|+|++++.+.+...+..+++|||+++|+|
T Consensus 17 ~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l---------~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 17 HLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITS---------RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred EEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHH---------HhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4444444 577778887542 2333333 378899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---------
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--------- 147 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--------- 147 (257)
.+++.......+++.....++.|++.||.|||++ +|+|+||+|+||+++.++.++++||+.+......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999865556789999999999999999999999 9999999999999999999999999977532211
Q ss_pred -cccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH---hhhhh-------
Q 044568 148 -FVIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK---CFINR------- 214 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~------- 214 (257)
.....++..|+|||.+... .++.++|+||||+++|||++|..||........ ........ .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcC
Confidence 1223455679999998763 478999999999999999999999975422111 11100000 00000
Q ss_pred hhh-----------hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELN-----------KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ...............+.+++.+||+.||++|| +.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000012233346788999999999999999 999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=231.96 Aligned_cols=229 Identities=16% Similarity=0.133 Sum_probs=174.0
Q ss_pred ccccceeeecccCCCCC-eeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
+.++.||++....+... +++...- .++.+...... ...|+|++++.+.+...+..++||||+++|+|.+++
T Consensus 27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~------~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l 100 (267)
T PHA03390 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL------MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL 100 (267)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHH------hhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHH
Confidence 45788999886655444 4444331 12222211111 125999999999999999999999999999999999
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCCCcccccCCCCccC
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
.. ...+++.++..++.|++.|+.|||+. +++|+||+|.||+++.++ .++++|||.+...... ....++..|+|
T Consensus 101 ~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~y~a 174 (267)
T PHA03390 101 KK--EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-SCYDGTLDYFS 174 (267)
T ss_pred Hh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-ccCCCCCcccC
Confidence 74 34899999999999999999999999 999999999999999988 9999999988754432 23467888999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+.+..++.++|+||+|+++||+++|..||....... .....+.... .............+.+++.+
T Consensus 175 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~ 243 (267)
T PHA03390 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ---------QKKLPFIKNVSKNANDFVQS 243 (267)
T ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh---------cccCCcccccCHHHHHHHHH
Confidence 999998889999999999999999999999997442221 1111111110 11112233456789999999
Q ss_pred cccCCCCCCC-h-HHHHH
Q 044568 240 CVQDEPALRP-M-KCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~-~ei~~ 255 (257)
||+.+|.+|| . +|+++
T Consensus 244 ~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 244 MLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HhccChhhCCchHHHHhc
Confidence 9999999999 5 88875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=238.31 Aligned_cols=231 Identities=14% Similarity=0.110 Sum_probs=174.5
Q ss_pred ccccceeeecccC-CCCCeeeccchhh-----hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA-----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++.... +..+++|...... ..+.+. ..-..+..+.|++++++.+.+...+..++||||+.+++|.
T Consensus 12 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (316)
T cd05574 12 GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89 (316)
T ss_pred CccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHH--HHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHH
Confidence 5678999998765 6666777654211 111111 1111333778999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---------
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--------- 148 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--------- 148 (257)
+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 166 (316)
T cd05574 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166 (316)
T ss_pred HHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccc
Confidence 999754456799999999999999999999999 99999999999999999999999999876432111
Q ss_pred -----------------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH
Q 044568 149 -----------------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN 205 (257)
Q Consensus 149 -----------------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~ 205 (257)
....++..|+|||.+.+..++.++||||||+++|++++|..||....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~- 242 (316)
T cd05574 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE---TFS- 242 (316)
T ss_pred ccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH---HHH-
Confidence 12246777999999998888999999999999999999999997542211 110
Q ss_pred HHHHhhhhhhhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 206 WVYKCFINRELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... ......+..+.+++.+||+.||++|| ++..++
T Consensus 243 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 243 ------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred ------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 011101 11112467899999999999999999 554443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=232.52 Aligned_cols=235 Identities=17% Similarity=0.146 Sum_probs=175.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~---------~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ---------ACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred CCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHH---------hCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567889999965 456667766542 23333333 778999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---- 147 (257)
+++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||.+......
T Consensus 82 -~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 82 -PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred -CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999999975 446799999999999999999999999 9999999999999999999999999988754432
Q ss_pred cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh-----hhhh------
Q 044568 148 FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-----INRE------ 215 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~------ 215 (257)
.....++..|+|||.+.+. .++.++||||+|+++||+++|.+||...... ..+........ ..+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcch
Confidence 2334567789999998654 4689999999999999999998888654211 11111100000 0000
Q ss_pred hhhhhcCC-------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGT-------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....-+. ....+....+.+++.+||+.+|++|| ++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 01112347899999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=231.14 Aligned_cols=226 Identities=19% Similarity=0.217 Sum_probs=175.6
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|.... .+|++. +.+++|+|++++.+.+...+..++|+||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~---------l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL---------LAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred CCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHH---------HHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 5678999999765 45556776543 233333 33888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCCCc--
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~-- 148 (257)
++++|.+++.......+++..+..++.|++.|+.|||++ +++|+|++|+||++++++ .++++|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 999999999764445689999999999999999999999 999999999999998875 46999999886543322
Q ss_pred -ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....++..|+|||.+....++.++|+||||+++||+++|..||...... .+... ....... ....
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~-----~~~~~~~--~~~~ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLK-----ICQGYFA--PISP 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHH-----HhcccCC--CCCC
Confidence 2335677899999998888899999999999999999999999644111 01000 0001111 1222
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.+|++|| +.|+++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3446789999999999999999 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=234.49 Aligned_cols=226 Identities=19% Similarity=0.220 Sum_probs=174.4
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... ++.+++|...- .+|++.+ .+++|+|++++.+.+...+..++||||
T Consensus 4 g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l---------~~l~~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL---------EKVSSRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHH---------HhCCCCCEeeeeeEEecCCeEEEEEec
Confidence 4678999987554 45556664431 2233333 377899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--Cc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~ 148 (257)
+++++|.+++.......+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc
Confidence 9999999999864445799999999999999999999999 999999999999999999999999998765332 12
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|++||.+.+..++.++|+||+|+++|++++|+.||...........+.. . ........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~ 220 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------R---TLEMAVEYPDK 220 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--------c---cccccccCCcc
Confidence 234556789999999888889999999999999999999999975532111111100 0 00111123344
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKC 252 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~e 252 (257)
..+.+.+++.+||+.||.+|| ++|
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 567889999999999999999 777
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=241.28 Aligned_cols=226 Identities=16% Similarity=0.162 Sum_probs=185.2
Q ss_pred ccccceeeecccC-CCCCeeeccc------------hhhhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS------------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E 69 (257)
++|+.||+..... ++..++|.+. ..+|++.+. ++. |+|++.+...+...+..++|||
T Consensus 46 G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~---------~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 46 GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQ---------QLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHH---------hccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 5799999999877 6666765432 356666666 666 9999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC----CceEEeeecccccCC
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF----WTAKILDFGLAKLPN 145 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~----~~~kl~dfg~~~~~~ 145 (257)
+|.||.|.+.+... .+++.++..++.|++.|+.|||+. |++|||+||+|+|+... +.+|++|||++....
T Consensus 117 L~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred ecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999863 499999999999999999999999 99999999999999743 479999999998765
Q ss_pred C--CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 146 E--DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 146 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
. ......||+.|+|||.+....|+..+|+||+|+++|.|++|.+||....+......+. ..++ --..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~--------~~~~---~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL--------RGDF---DFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--------cCCC---CCCC
Confidence 5 4577899999999999999999999999999999999999999998774332221110 0111 0011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...........+++..++..||.+|+ +.++++
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 33444567889999999999999999 999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=233.24 Aligned_cols=227 Identities=21% Similarity=0.214 Sum_probs=176.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++... ++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++|+||++++
T Consensus 30 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 30 GASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK---------DCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred CCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHH---------HCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 467889999987 455566765543 23333333 888999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVID 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~ 151 (257)
+|.+++.. ....+++..+..++.|++.||.|||+. +++|+|++|+||+++.++.++|+|||.+...... ....
T Consensus 101 ~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 101 SLTDIITQ-NFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred cHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 99999985 224799999999999999999999999 9999999999999999999999999987643322 1233
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.++..|++||.+.+..++.++|+||||+++|++++|..||....... ....+. .........+...+.
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~ 244 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLIT---------TKGIPPLKNPEKWSP 244 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---------hcCCCCCcchhhCCH
Confidence 46778999999988889999999999999999999999996441111 000000 000111111222456
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.+|.+|| +.++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhh
Confidence 789999999999999999 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=231.48 Aligned_cols=228 Identities=21% Similarity=0.263 Sum_probs=175.8
Q ss_pred ccccceeeecccC-CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++|+||++
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~---------~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH---------KCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHH---------HCCCCchhhhheeeecCCEEEEEEEecC
Confidence 5678999999875 4445666433 222333333 7779999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-VI 150 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 150 (257)
+++|.+++.. ....++......++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 83 GGSLDKILKE-VQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 9999999975 33778999999999999999999999 8 99999999999999999999999999876432211 22
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC--CCCCHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG--TKVDKK 228 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 228 (257)
..++..|+|||.+.+..++.++|+||||+++|++++|..||.......... ... ....... ...+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~ 227 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FEL---------LQYIVNEPPPRLPSG 227 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--HHH---------HHHHhcCCCCCCChh
Confidence 566778999999988889999999999999999999999997542211110 000 0111111 111222
Q ss_pred -HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 -NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 -~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||..+|++|| +.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 556789999999999999999 999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=233.44 Aligned_cols=238 Identities=17% Similarity=0.149 Sum_probs=175.4
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... ++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 12 g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLR---------QLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred cCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHH---------hcCCCCeeehhheEEECCEEEEEEecC
Confidence 5678899998765 4556676543 234444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+++.+..+.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||++++++.++|+|||.+.......
T Consensus 83 ~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 83 ERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9877766665 456689999999999999999999999 99999999999999999999999999987543322
Q ss_pred -ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH-------hh-hhhhhh-
Q 044568 149 -VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK-------CF-INRELN- 217 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-------~~-~~~~~~- 217 (257)
....++..|+|||++... .++.++|+||||+++|++++|..||.................. .+ ......
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 234556779999999887 7889999999999999999999999754221111111000000 00 000000
Q ss_pred ----hhhcCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 ----KLVRGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ----~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..... ..+...+..+.+++.+||+.+|++|| ++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 11222367899999999999999999 999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=232.70 Aligned_cols=227 Identities=19% Similarity=0.155 Sum_probs=172.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.+|++... ++..+++|... +.+|++.+. .+....|+|++++.+.+...+..++||||++
T Consensus 12 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~------~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLS------QLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred cCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHH------HhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 568899999964 55666777543 223333333 1223349999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 86 ~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 86 GGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred CCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 9999999863 3789999999999999999999999 9999999999999999999999999988754332 23
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
...++..|+|||.+.++ .++.++|+||||+++|+|++|..||........ .. .......+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~------~~~~~~~~~~~~~~ 226 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MM------LIPKSKPPRLEDNG 226 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hh------ccccCCCCCCCccc
Confidence 33567789999998754 468999999999999999999999975421110 00 00000011111112
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.||++|| +.|+++
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 456789999999999999999 999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=229.63 Aligned_cols=218 Identities=15% Similarity=0.046 Sum_probs=169.0
Q ss_pred ccccceeeecccC-CCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++.... +..+++|......+...... ......|+|++++.+.+...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~-----~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERL-----TIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHH-----HHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 4567889988654 45567777654322221111 11244589999999999999999999999999999999974
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccCccc
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPEC 162 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~ 162 (257)
...+++.....++.|++.||.|||++ +++|+|++|+||+++.++.++++|||.+...........++..|+|||.
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~ 153 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcc
Confidence 44689999999999999999999999 9999999999999999999999999987655544444555677999999
Q ss_pred ccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHccc
Q 044568 163 YKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242 (257)
Q Consensus 163 ~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 242 (257)
.....++.++|+||+|+++||+++|..|+....... .. ......+....+.+.+++.+||+
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~-~~~~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NT-HTTLNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------cc-ccccCCcccCCHHHHHHHHHHcc
Confidence 988888999999999999999999998875331100 00 00001223345678899999999
Q ss_pred CCCCCCC-h
Q 044568 243 DEPALRP-M 250 (257)
Q Consensus 243 ~~p~~RP-~ 250 (257)
.||.+|| +
T Consensus 215 ~dp~~R~~~ 223 (237)
T cd05576 215 FNPTERLGA 223 (237)
T ss_pred CCHHHhcCC
Confidence 9999999 7
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=226.49 Aligned_cols=227 Identities=20% Similarity=0.237 Sum_probs=177.9
Q ss_pred ccccceeeecccC-CCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.+|++.... +..+++|.... .++++.+. .+.|++++++.+.+...+..++++||+++
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 11 GGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK---------KCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred CCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHH---------hCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 5678999999864 55566665443 23333333 77899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VID 151 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 151 (257)
++|.+++.. ....+++..+..++.|++.|+.+||++ +++|+|++|+||++++++.++|+|||.+....... ...
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 82 GSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 999999975 336799999999999999999999999 99999999999999999999999999887654432 455
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.++..|++||.+....++.++|+||||+++|++++|..||......... ... ..........+.....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~---------~~~~~~~~~~~~~~~~ 225 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FKI---------ATNGPPGLRNPEKWSD 225 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHH---------HhcCCCCcCcccccCH
Confidence 6778899999998888899999999999999999999999754211100 000 0000000011111256
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.||++|| +.|+++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 799999999999999999 999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=233.19 Aligned_cols=228 Identities=14% Similarity=0.094 Sum_probs=169.1
Q ss_pred ccccceeeecccCC-CCCeeeccc--------hhhhHHHHhHhhhccccccc-cCCceeeeceeee-----ecCceeEEE
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS--------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAK-----LTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~-----~~~~~~lV~ 68 (257)
+.++.||+++...+ ..+++|... +.+|++.+. ++ .|+|++++.+.+. .++..++||
T Consensus 29 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~---------~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 29 GTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK---------ALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred CCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHH---------HHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 45789999986544 455666543 223333333 55 5999999999874 446789999
Q ss_pred eecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 69 RPVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 69 E~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||+++++|.+++... ....+++..+..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 999999999988632 345688899999999999999999999 999999999999999999999999998864332
Q ss_pred ---CcccccCCCCccCcccccC-----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh
Q 044568 147 ---DFVIDKRDKGYMAPECYKR-----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK 218 (257)
Q Consensus 147 ---~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (257)
......++..|+|||.+.. ..++.++|+||+|+++||+++|+.||........ .... ..
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~~~~----------~~ 243 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---LFKI----------PR 243 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---Hhhc----------cc
Confidence 1233467888999999853 3478899999999999999999999975421110 0000 00
Q ss_pred hhcC-CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 219 LVRG-TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 219 ~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.... ...+......+.+++.+||+.||++|| +.|+++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 011222345788999999999999999 9999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=247.91 Aligned_cols=233 Identities=18% Similarity=0.131 Sum_probs=182.7
Q ss_pred ccccceeeec-ccCCCCCeeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
++|+-||-+. ..+++.++||+.++ +..-++-++...-.++..++|||++.+-+++-.+...+||||||- ||-.|+
T Consensus 37 GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDl 115 (948)
T KOG0577|consen 37 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDL 115 (948)
T ss_pred CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHH
Confidence 4677777777 45556667988775 122222222222224559999999999999999999999999996 588888
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
+.- ..++|.+.+...|+.+.+.||.|||+. +.+|||||+.|||+++.|.+||+|||.+.. ..+..+..|||.|+|
T Consensus 116 leV-hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi-~~PAnsFvGTPywMA 190 (948)
T KOG0577|consen 116 LEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASI-MAPANSFVGTPYWMA 190 (948)
T ss_pred HHH-HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhh-cCchhcccCCccccc
Confidence 865 567899999999999999999999999 999999999999999999999999998864 345577899999999
Q ss_pred ccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 044568 160 PECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKV 236 (257)
Q Consensus 160 PE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (257)
||++. .+.|+.++||||+|++..|+.-+++|+.+-+ .....+.-. .--.|.....+....+.++
T Consensus 191 PEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----------AMSALYHIA---QNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 191 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYHIA---QNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhHheeccccccCCccceeeccchhhhhhhcCCCccCch----------HHHHHHHHH---hcCCCCCCCchhHHHHHHH
Confidence 99875 5789999999999999999999999975331 111111110 0111223356778899999
Q ss_pred HHHcccCCCCCCC-hHHHHH
Q 044568 237 GLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 237 ~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..||++-|.+|| .+++++
T Consensus 258 vd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHhhCcccCCcHHHHhh
Confidence 9999999999999 888764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=233.65 Aligned_cols=240 Identities=13% Similarity=0.088 Sum_probs=169.5
Q ss_pred ccccceeeecccCC---C-CCeeeccchhh-----hHHHHh-------HhhhccccccccCCceeeeceeeeecC----c
Q 044568 4 TKLSNFYRSSFNAR---N-SPWISRVSWTA-----DIEVLS-------VAMRGSKCTRIRGGLLLNVPVRAKLTS----V 63 (257)
Q Consensus 4 ~~~~~~y~~~~~~~---~-~~~i~~~~~~~-----~~~~~~-------~~~~~~~~~~~~h~~i~~~~~~~~~~~----~ 63 (257)
+.|+.||+++...+ . ..++|...+.+ +...+. +.... .+..+.|++++++.+.+.... .
T Consensus 23 G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~-~~~~~~h~~i~~~~~~~~~~~~~~~~ 101 (294)
T PHA02882 23 GGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK-NIHNIDHLGIPKYYGCGSFKRCRMYY 101 (294)
T ss_pred CCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHH-HhccCCCCCCCcEEEeeeEecCCceE
Confidence 67899999997665 2 33444333222 111110 11111 344678999999988766544 4
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++++|++. .++.+.+.. ....++.....++.|++.|+.|||++ +++||||||+||+++.++.++|+|||+++.
T Consensus 102 ~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~ 175 (294)
T PHA02882 102 RFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASH 175 (294)
T ss_pred EEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCcee
Confidence 467888774 477777753 23467888899999999999999999 999999999999999999999999999875
Q ss_pred CCC----------CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 144 PNE----------DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 144 ~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
... ......+|+.|+|||...+..++.++||||||+++|||++|+.||................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~------ 249 (294)
T PHA02882 176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD------ 249 (294)
T ss_pred eccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH------
Confidence 321 1123368889999999998899999999999999999999999998663332211111110
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
-...+..+......+++.+.+++..||+.+|++|| ++++.+.|
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 250 -FIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred -HHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00111111111223457799999999999999999 99998864
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=235.61 Aligned_cols=234 Identities=15% Similarity=0.095 Sum_probs=174.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.||++... ++..+++|..........-.....-....++.|+|++++.+.+...+..++|+||+++++|.+++.+
T Consensus 30 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 109 (293)
T cd06647 30 GASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 109 (293)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh
Confidence 568899999854 4556677765431111100000000123378899999999999999999999999999999999953
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~a 159 (257)
..+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||++....... ....++..|++
T Consensus 110 ---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~ 183 (293)
T cd06647 110 ---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183 (293)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcC
Confidence 4588999999999999999999999 99999999999999999999999999876432221 23356777999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+....++.++|+||||+++|++++|+.||.......... .. .. ........+......+.+++.+
T Consensus 184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~---~~----~~-----~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LI----AT-----NGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee---eh----hc-----CCCCCCCCccccCHHHHHHHHH
Confidence 999988888999999999999999999999997542211100 00 00 0000011223345678899999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||+.+|++|| +.+++.
T Consensus 252 ~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 252 CLEMDVEKRGSAKELLQ 268 (293)
T ss_pred HccCChhhCcCHHHHhc
Confidence 9999999999 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=232.05 Aligned_cols=236 Identities=22% Similarity=0.222 Sum_probs=174.3
Q ss_pred ccccceeeecccC-CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+... +..++||||
T Consensus 12 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 12 GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINK---------SCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred CCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHH---------hCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 4568899999754 4555666443 234444444 88999999999987654 467999999
Q ss_pred cCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 71 VRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
+++++|.+++... ....++......++.|++.||.|||+. +++|+|++|.||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999987532 345688899999999999999999999 99999999999999999999999999876433222
Q ss_pred -ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCCh-hhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP-EEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....++..|++||.+.+..++.++|+||+|+++|+|++|..||.....+. .......+... .....+.......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 235 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDEPGNG 235 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccCCCCC
Confidence 23345677999999988889999999999999999999999998653211 11111111111 0000111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+.+++.+||+.+|.+|| +.|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 23457789999999999999999 999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=232.62 Aligned_cols=228 Identities=15% Similarity=0.108 Sum_probs=168.6
Q ss_pred ccccceeeecccC-CCCCeeeccch--------hhhHHHHhHhhhccccccc-cCCceeeeceeeeec-----CceeEEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW--------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT-----SVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~-----~~~~lV~ 68 (257)
+.++.||++...+ +..+++|.... .+++..+. ++ .|+|++++.+.+... +..++||
T Consensus 33 g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~---------~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 33 GTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ---------SLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHH---------HhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 4578899998754 44556665532 12222222 44 699999999988754 3579999
Q ss_pred eecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 69 RPVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 69 E~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||+++|+|.+++... ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999999988632 345689999999999999999999999 999999999999999999999999998775332
Q ss_pred C---cccccCCCCccCcccccCCC-----CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh
Q 044568 147 D---FVIDKRDKGYMAPECYKRTP-----ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK 218 (257)
Q Consensus 147 ~---~~~~~~~~~~~aPE~~~~~~-----~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (257)
. .....++..|+|||.+.... ++.++|+||||+++||+++|+.||....... ....+. ..
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---~~~~~~---------~~ 248 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---TLFKIP---------RN 248 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH---HHHHHh---------cC
Confidence 1 12345677899999986432 5789999999999999999999996442111 011100 00
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.......+......+.+++.+||+.+|++|| +.|+++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000011233446789999999999999999 999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=234.00 Aligned_cols=233 Identities=16% Similarity=0.139 Sum_probs=173.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.++.+|++... ++..+++|..........-........+..+.|+|++++.+.+...+..++|+||+++++|.+++..
T Consensus 30 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 109 (285)
T cd06648 30 GSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH 109 (285)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh
Confidence 456899999854 4556677765421110000000000123377899999999999999999999999999999999963
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~a 159 (257)
..+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+...... .....++..|+|
T Consensus 110 ---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~a 183 (285)
T cd06648 110 ---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183 (285)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccC
Confidence 5689999999999999999999999 9999999999999999999999999987643221 123357788999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENLVKVGL 238 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~ 238 (257)
||.+.+..++.++|+||||+++||+++|..||....... .... ......+. ..+...+..+.+++.
T Consensus 184 PE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMKR----------IRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHHH----------HHhcCCCCCcccccCCHHHHHHHH
Confidence 999988889999999999999999999999996542110 0000 00000000 112224567999999
Q ss_pred HcccCCCCCCC-hHHHHH
Q 044568 239 WCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 239 ~cl~~~p~~RP-~~ei~~ 255 (257)
+||+.+|++|| +.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 99999999999 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=230.22 Aligned_cols=221 Identities=18% Similarity=0.127 Sum_probs=173.2
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... +..+++|...- .+|++. +.++.|+|++++.+.+..++..++||||
T Consensus 4 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI---------LEECNHPFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHH---------HHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence 5678899999765 55666665431 223333 3388899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++++|.+++.+ ...++...+..++.|+++||.|||++ +++|+|++|.||+++.++.++|+|||.+...... .
T Consensus 75 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 75 CLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc
Confidence 999999999973 45689999999999999999999999 9999999999999999999999999998754432 2
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|++||.+....++.++|+||+|+++|++++|..||......... ... ...........+..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~----------~~~~~~~~~~~~~~ 218 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IYN----------DILKGNGKLEFPNY 218 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HHH----------HHhccCCCCCCCcc
Confidence 3345677899999998888899999999999999999999999765321110 000 00000111123333
Q ss_pred HHHHHHHHHHHcccCCCCCCC
Q 044568 229 NLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP 249 (257)
....+.+++.+||+.+|.+||
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred cCHHHHHHHHHHccCChhhCc
Confidence 467899999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=239.40 Aligned_cols=229 Identities=20% Similarity=0.239 Sum_probs=168.7
Q ss_pred ccccceeeecc------cCCCCCeeeccch----------hhhHHHHhHhhhccccccc-cCCceeeeceeeeec-Ccee
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVSW----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT-SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~-~~~~ 65 (257)
+.++.||++.. ..+..+++|...- .+|++.+. ++ .|+|++++.+.+... ...+
T Consensus 18 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 18 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI---------HIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred CccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHH---------hccCCccHhhhcceeecCCCceE
Confidence 56899999863 3455677776531 23443333 55 579999999877654 4678
Q ss_pred EEEeecCCCCHHHHHhccC-------------------------------------------------------------
Q 044568 66 KIERPVRNGSLTDIIFCSA------------------------------------------------------------- 84 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 84 (257)
+||||+++|+|.+++....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999986421
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCC
Q 044568 85 ----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDK 155 (257)
Q Consensus 85 ----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~ 155 (257)
...+++.+...++.|++.||.|||++ +++||||||.||+++.++.++++|||++....... ....++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 12367888899999999999999999 99999999999999999999999999887532211 1123345
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++|+||||+++||+++ |..||........ .... ...... ...+....+.+.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~---------~~~~~~-~~~~~~~~~~~~ 312 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR---------LKEGTR-MRAPDYTTPEMY 312 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---HHHH---------HhccCC-CCCCCCCCHHHH
Confidence 6999999988889999999999999999997 8999865421111 0000 000000 011222345789
Q ss_pred HHHHHcccCCCCCCC-hHHHHHhC
Q 044568 235 KVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+++..||+.+|++|| +.||++.|
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999 99998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=230.88 Aligned_cols=233 Identities=18% Similarity=0.138 Sum_probs=178.7
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... +..+++|..... ...+.+. ... ..+.++.|+|++++...+...+..++|+||+++++|.
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~-~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (258)
T cd05578 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL-NER-RILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88 (258)
T ss_pred CCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHH-HHH-HHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHH
Confidence 5688999999764 566666654321 1111111 000 1333889999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRDK 155 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 155 (257)
+++.. ...+++.++..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||.+...... .....++.
T Consensus 89 ~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 163 (258)
T cd05578 89 YHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP 163 (258)
T ss_pred HHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCCh
Confidence 99974 36789999999999999999999999 9999999999999999999999999988754332 23345677
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+..++.++|+||+|+++|++++|..||............ . .... .....+...+..+.+
T Consensus 164 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~-----~~~~--~~~~~~~~~~~~~~~ 231 (258)
T cd05578 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-----A-----KQET--ADVLYPATWSTEAID 231 (258)
T ss_pred hhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----H-----Hhcc--ccccCcccCcHHHHH
Confidence 899999998888899999999999999999999999865332111100 0 0000 122344455688999
Q ss_pred HHHHcccCCCCCCC-h--HHHHH
Q 044568 236 VGLWCVQDEPALRP-M--KCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~--~ei~~ 255 (257)
++.+||+.||.+|| + +|+++
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhc
Confidence 99999999999999 9 77754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=230.78 Aligned_cols=228 Identities=17% Similarity=0.158 Sum_probs=170.6
Q ss_pred ccccceeeecccC-CCCCeeeccch--------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecC------ceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW--------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTS------VSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~------~~~lV 67 (257)
+.++.+|+++... +...++|.... .+|++.+. ++ .|+|++++.+.+.... ..++|
T Consensus 17 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~---------~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 17 GTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR---------KYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHH---------HhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 4678899999754 44556665442 23333333 55 5999999999887644 48999
Q ss_pred EeecCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 68 ERPVRNGSLTDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
|||+++++|.+++.... +..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999987432 56789999999999999999999999 99999999999999999999999999876433
Q ss_pred CC---cccccCCCCccCcccccC-----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 146 ED---FVIDKRDKGYMAPECYKR-----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 146 ~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
.. .....++..|+|||.+.. ..++.++|+||||+++|++++|..||....... ..... ..
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---------~~ 232 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---ALFKI---------PR 232 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---HHHHh---------hc
Confidence 22 133456778999998753 246788999999999999999999996431111 00000 00
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........+......+.+++.+||+.||++|| +.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00111122233556889999999999999999 999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=227.80 Aligned_cols=227 Identities=19% Similarity=0.204 Sum_probs=178.2
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.+|+++... +..+++|.... .++++. ..++.|+|++++.+.+...+..++||||++
T Consensus 12 g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~---------l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT---------LRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHH---------HHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4578899999775 66667766443 222333 337789999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+++|.+++.. ...++...+..++.|++.|+.|||+ . +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999973 4778999999999999999999999 9 99999999999999999999999999887543322
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|+|||.+....++.++|+||||+++|++++|+.||.............. .... .....+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------~~~~-~~~~~~~~ 226 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----------ICDG-PPPSLPAE 226 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----------HhcC-CCCCCCcc
Confidence 134567789999999888889999999999999999999999976532111000000 0000 00122233
Q ss_pred -HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 -NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 -~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..+.+++.+||+.+|++|| +.|+++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 567899999999999999999 999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=228.68 Aligned_cols=233 Identities=16% Similarity=0.168 Sum_probs=174.8
Q ss_pred ccccceeeecccCC-CCCeeeccch----hhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~~~gsL 76 (257)
+.++.||++....+ ..+++|.... ....+.+.. .. ..+.++.|+|++++.+.+.. ....+++|||+++++|
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~-e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L 88 (265)
T cd08217 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EV-NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL 88 (265)
T ss_pred CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHH-HH-HHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCH
Confidence 56789999986544 4455665432 111111110 00 12338899999999887653 4567899999999999
Q ss_pred HHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 77 TDIIFCS--AERNPYWNQRVRIALDVAKGILYLH-----DECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 77 ~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
.+++... ....+++..+..++.|++.||.||| +. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 89 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 165 (265)
T cd08217 89 AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165 (265)
T ss_pred HHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCcc
Confidence 9999642 2567899999999999999999999 77 99999999999999999999999999987543322
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....++..|+|||.+.+..++.++|+||||+++|++++|+.||.... ....... .... .....+
T Consensus 166 ~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~----------~~~~-~~~~~~ 231 (265)
T cd08217 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASK----------IKEG-KFRRIP 231 (265)
T ss_pred cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHH----------HhcC-CCCCCc
Confidence 23467888999999988888999999999999999999999997552 1111100 0000 011234
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.+|.+|| +.+|++
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 45567899999999999999999 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=235.19 Aligned_cols=237 Identities=16% Similarity=0.120 Sum_probs=173.9
Q ss_pred ccccceeeeccc-CCCCCeeeccch--------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+|... ++..+++|.... .+|++.+ .++.|+|++++.+.+...+..++||
T Consensus 11 g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l---------~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL---------QELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHH---------hhcCCCCChhhhheeecCCEEEEEE
Confidence 567899999965 466777776542 1233333 3788999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+ +|+|.+++.. ....+++..+..++.|+++||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 8999999975 224799999999999999999999999 99999999999999999999999999987543321
Q ss_pred ---ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh---------h
Q 044568 149 ---VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR---------E 215 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~ 215 (257)
....++..|+|||.+.+ ..++.++|+||||+++||+++|..||................. ..... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG-TPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC-CCchhhhhhcccccc
Confidence 22344667999998865 4578999999999999999999888865432111111100000 00000 0
Q ss_pred hhhhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........ .........+.+++.+||+.+|++|| +.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000 11123357889999999999999999 999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=233.51 Aligned_cols=239 Identities=18% Similarity=0.141 Sum_probs=174.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 10 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLK---------ELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHH---------hcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999865 56666677543 234555544 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+ ++|.+++.......+++..+..++.|++.||.|||++ +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 6999999753335789999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhh-hhhhhhhh
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCF-INRELNKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~ 219 (257)
....++..|+|||.+.+. .++.++|+||||+++|++++|+.||................ +... ..++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223456779999988654 46889999999999999999999997542211111110000 0000 00000000
Q ss_pred hc-CC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VR-GT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~-~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .. .........+.+++.+||+.+|++|| ++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 11122336788999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=230.75 Aligned_cols=237 Identities=14% Similarity=0.166 Sum_probs=171.4
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... +++.+++|.... .+|++.+. .++|+|++++.+.+...+..++||||+.
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~---------~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 16 GSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLK---------GLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred cCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHH---------hcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 467899999754 566777776432 23444444 7889999999999999999999999996
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
++|.+.+.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++..... ..
T Consensus 87 -~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 87 -TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred -CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 688887764 445688888999999999999999999 9999999999999999999999999988643221 23
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh-hhh---hhh-------
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-INR---ELN------- 217 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~---~~~------- 217 (257)
...++..|+|||.+.+. .++.++|+||||+++||+++|..||.......+ .....|..... ... ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 33467789999998754 478899999999999999999999975432111 11111110000 000 000
Q ss_pred hhhc---CCC-----CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVR---GTK-----VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~---~~~-----~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... +.. ........+.+++.+|++.||.+|| +.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000 0001245788999999999999999 999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=232.59 Aligned_cols=224 Identities=19% Similarity=0.173 Sum_probs=172.3
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|.... .+|++. +.++.|+|++++.+.+...+..++||||
T Consensus 36 G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF---------LQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHH---------HHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 567899999965 455666776542 223333 3388899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
++ |+|.+.+.. ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 107 ~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-~~~ 180 (317)
T cd06635 107 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-ANS 180 (317)
T ss_pred CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-ccc
Confidence 97 588888764 456689999999999999999999999 999999999999999999999999998764332 234
Q ss_pred ccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 151 DKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
..++..|+|||.+. ...++.++|+||||+++|||++|..||....... ....+. ....+.....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~----------~~~~~~~~~~ 247 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIA----------QNESPTLQSN 247 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH----------hccCCCCCCc
Confidence 46778899999974 3567899999999999999999999986431111 111110 0001111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.+|.+|| +.++++
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 3456789999999999999999 999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=239.74 Aligned_cols=232 Identities=16% Similarity=0.131 Sum_probs=168.2
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++... .+..+++|...- .+|+.. +..+.|+|++++.+.+... ...+
T Consensus 35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~---------l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 35 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL---------MKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHH---------HHhcCCCCccccceeecccccccccCeEE
Confidence 568899999854 455567776531 122222 3378899999998876543 3579
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 106 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 106 IVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 9999997 478887752 478889999999999999999999 99999999999999999999999999987544
Q ss_pred CCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh---------hhhh
Q 044568 146 EDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC---------FINR 214 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~ 214 (257)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ........ ....
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHhhhH
Confidence 322 344678889999999998899999999999999999999999975422111 11100000 0000
Q ss_pred hh---------------hhhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 EL---------------NKLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~---------------~~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..+.... .........+.+++.+||+.||.+|| +.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 0000000 01111235688999999999999999 999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=232.43 Aligned_cols=237 Identities=18% Similarity=0.158 Sum_probs=172.8
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEe
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E 69 (257)
+.++.||+++... +...++|.... .+|++.+. +++|+|++++.+.+... +..++|||
T Consensus 16 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL---------KLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHH---------hcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 5688999999765 44556665542 23333333 88899999999988877 89999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
|++ ++|.+.+.. ....+++.+...++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 ~~~-~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 87 YVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hcC-cCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 997 599999875 344689999999999999999999999 9999999999999999999999999988754332
Q ss_pred -cccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH-HH------HHhhhh-hhhh
Q 044568 148 -FVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN-WV------YKCFIN-RELN 217 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~-~~------~~~~~~-~~~~ 217 (257)
.....++..|+|||.+.+.. ++.++|+||+|+++|||++|..||...........+.. +. ++.+.. ....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 12345567799999987644 68899999999999999999999975532211110000 00 000000 0000
Q ss_pred --h-------hhcCCCCCHH-HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 --K-------LVRGTKVDKK-NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 --~-------~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .+.. .++.. ..+.+.+++.+||+.+|++|| +.|+++
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000 11111 356788999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.56 Aligned_cols=232 Identities=18% Similarity=0.184 Sum_probs=173.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhh----HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTAD----IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~----~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.+|++... ++..+++|....... .+.+. ..-..+.+++|+|++++.+.....+..++|+||+++++|.+
T Consensus 11 G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~--~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 88 (264)
T cd06626 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA--DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88 (264)
T ss_pred CCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHH--HHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHH
Confidence 467899999865 455566665442111 11111 01113338899999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc-------cc
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV-------ID 151 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~-------~~ 151 (257)
++. ....+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 89 ~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 163 (264)
T cd06626 89 LLE--HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163 (264)
T ss_pred HHh--hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCC
Confidence 997 345688899999999999999999999 999999999999999999999999998875432221 23
Q ss_pred cCCCCccCcccccCCC---CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH-
Q 044568 152 KRDKGYMAPECYKRTP---ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK- 227 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (257)
.++..|+|||.+.... ++.++|+||||+++|++++|..||........ . .... . . ......+.
T Consensus 164 ~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~-----~~~~--~----~-~~~~~~~~~ 230 (264)
T cd06626 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-I-----MFHV--G----A-GHKPPIPDS 230 (264)
T ss_pred cCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-H-----HHHH--h----c-CCCCCCCcc
Confidence 4567899999998765 78999999999999999999999964421110 0 0000 0 0 00111122
Q ss_pred -HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 -KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 -~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.+|++|| +.|+++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2256788999999999999999 999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=238.32 Aligned_cols=231 Identities=14% Similarity=0.159 Sum_probs=187.6
Q ss_pred ccccceeeec-ccCCCCCeeeccchh--hhHHHHh-HhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSWT--ADIEVLS-VAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~~--~~~~~~~-~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+-|++|-.++ ..+++.+++|.++-. .++..-. ++... |+.-..|+|||+++.........|||+|+-++|+|.|+
T Consensus 29 GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVR-CMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~Dy 107 (864)
T KOG4717|consen 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVR-CMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDY 107 (864)
T ss_pred CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHH-HHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHH
Confidence 3466666665 567788888765521 1111111 11222 55578899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee-CCCCceEEeeecccccC--CCCcccccCCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-DEFWTAKILDFGLAKLP--NEDFVIDKRDKG 156 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-~~~~~~kl~dfg~~~~~--~~~~~~~~~~~~ 156 (257)
|-+ ...++.++.+.+|+.||+.|+.|+|+- .++||||||+|+.+ .+-|-+||.|||++..+ +......+|+..
T Consensus 108 ImK-He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLA 183 (864)
T KOG4717|consen 108 IMK-HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLA 183 (864)
T ss_pred HHh-hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhh
Confidence 987 678899999999999999999999999 99999999999966 46789999999998754 334467788999
Q ss_pred ccCcccccCCCCC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHH
Q 044568 157 YMAPECYKRTPIS-VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKNLENLV 234 (257)
Q Consensus 157 ~~aPE~~~~~~~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 234 (257)
|-|||++.+..|+ ++.||||+|++||-+.+|+.||+... ..+.+..+++.. ..|.....++.
T Consensus 184 YSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDCKYtvPshvS~eCr 247 (864)
T KOG4717|consen 184 YSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDCKYTVPSHVSKECR 247 (864)
T ss_pred ccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhcccccCchhhhHHHH
Confidence 9999999999997 78899999999999999999998552 223444566655 66777888999
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+||..||..||++|. .+||+.
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhc
Confidence 999999999999999 999863
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=229.03 Aligned_cols=229 Identities=15% Similarity=0.139 Sum_probs=173.4
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... +..+++|..... +..+.+. ..-..+.++.|+|++++.+.+...+..++||||+++++|.
T Consensus 4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~--~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (265)
T cd05579 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL--TERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA 81 (265)
T ss_pred CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHH--HHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHH
Confidence 4678999999875 666677754321 1111111 0011333788999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----------
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---------- 147 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---------- 147 (257)
+++.+ ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 82 SLLEN--VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99974 34789999999999999999999999 9999999999999999999999999987643222
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKV 225 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 225 (257)
.....++..|++||.......+.++|+||||+++|++++|..||...... ..... ... ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~-------------~~~~~~~~ 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQN-------------ILNGKIEW 220 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-------------HhcCCcCC
Confidence 12234567799999998888899999999999999999999999754211 00100 000 0011
Q ss_pred CHH--HHHHHHHHHHHcccCCCCCCC-h---HHHHH
Q 044568 226 DKK--NLENLVKVGLWCVQDEPALRP-M---KCAVM 255 (257)
Q Consensus 226 ~~~--~~~~l~~l~~~cl~~~p~~RP-~---~ei~~ 255 (257)
+.. .+..+.+++.+||+.+|.+|| + .|+++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 122 267889999999999999999 9 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=230.15 Aligned_cols=245 Identities=17% Similarity=0.143 Sum_probs=179.4
Q ss_pred cccccceeeecccCCC-CCeeeccchhhhHH---HHhHhhhccccccccCCc-eeeeceeeeecC------ceeEEEeec
Q 044568 3 CTKLSNFYRSSFNARN-SPWISRVSWTADIE---VLSVAMRGSKCTRIRGGL-LLNVPVRAKLTS------VSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~-~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~~-i~~~~~~~~~~~------~~~lV~E~~ 71 (257)
++-.++||+|.....+ .+++|++....+-+ .-.+...- .+.+++|+| ++.+.+.+...+ ..+||+||+
T Consensus 21 eGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREis-llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~ 99 (323)
T KOG0594|consen 21 EGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREIS-LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL 99 (323)
T ss_pred CCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHH-HHHHhCCCcceEEEEeeeeecccccccceEEEEEEee
Confidence 4567899999955554 78899887644311 11111111 233888999 999999999887 788999999
Q ss_pred CCCCHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 72 RNGSLTDIIFCSAE--RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
. -+|.+++..... ..++...++.++.|++.|++|||++ +|+||||||.|+|+++.+.+||+|||+++....+
T Consensus 100 d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~ 175 (323)
T KOG0594|consen 100 D-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR 175 (323)
T ss_pred c-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcc
Confidence 6 499999986433 4788889999999999999999999 9999999999999999999999999999865433
Q ss_pred -cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh-----hhhhhh
Q 044568 148 -FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR-----ELNKLV 220 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 220 (257)
......|.-|.|||.+.+. .|+...||||+||++.||++++.-|.+..+.+ .+.........+. ....+-
T Consensus 176 ~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 176 TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCccCCCCccccc
Confidence 3455666779999999987 68999999999999999999999998764321 2222211111110 000000
Q ss_pred c----------CCCCCH---HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 R----------GTKVDK---KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~----------~~~~~~---~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+ +..... .......+++..|++++|.+|. ++.++.
T Consensus 253 ~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 253 DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 0 000001 1114789999999999999999 888765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=236.62 Aligned_cols=190 Identities=18% Similarity=0.194 Sum_probs=152.7
Q ss_pred cccccCCceeeeceeeee--cCceeEEEeecCCCCHHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 044568 43 CTRIRGGLLLNVPVRAKL--TSVSGKIERPVRNGSLTDIIFCSAERN-PYWNQRVRIALDVAKGILYLHDECEPPILHCD 119 (257)
Q Consensus 43 ~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 119 (257)
+.++.|+|+|++.....+ .+..|||+|||..|.+...= .+.. +++.++++|+.+++.||+|||.+ ||+|||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRD 235 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRD 235 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence 339999999999998875 57899999999998876654 4444 89999999999999999999999 999999
Q ss_pred CCCCceeeCCCCceEEeeecccccCCCC--------cccccCCCCccCcccccCCC---C-CccccchhHHHHHHHHHhc
Q 044568 120 IKPQNILMDEFWTAKILDFGLAKLPNED--------FVIDKRDKGYMAPECYKRTP---I-SVKADVYGYGIVLLETICC 187 (257)
Q Consensus 120 l~~~nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~---~-~~~~Di~s~G~~l~el~~g 187 (257)
|||+|+|++.++++||+|||.+...... .....||+.|+|||.+..+. + +.+.||||+|++||-++.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999998754111 14568999999999998632 3 4778999999999999999
Q ss_pred CCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 188 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
+.||-++... .....+.... +...+..+.+.+|+.++|++||++|- ..+|.
T Consensus 316 ~~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 316 QLPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred cCCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 9999754111 0111122211 22234578899999999999999999 88874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=231.92 Aligned_cols=224 Identities=17% Similarity=0.161 Sum_probs=173.6
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++... ++..+++|.... .+|+..+. ++.|+|+++..+.+...+..++||||+++
T Consensus 31 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 31 GSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMR---------DYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred CCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHH---------hcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 356889999875 566677776542 22333333 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
++|.+++. ...+++.....++.|++.|+.|||++ +++|+|++|.||+++.++.++++|||.+...... ...
T Consensus 102 ~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 102 GALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 99999884 34689999999999999999999999 9999999999999999999999999987643321 123
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (257)
..++..|++||.+....++.++|+||+|+++|++++|..||....... ..... ....+.. ......
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI----------RDNLPPKLKNLHKV 242 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----------HhhCCcccCCcccC
Confidence 456778999999988888999999999999999999999997542111 00000 0011111 111223
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.+++.+||+.+|.+|| +.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45688899999999999999 999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=238.29 Aligned_cols=232 Identities=16% Similarity=0.140 Sum_probs=168.6
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++... .+..+++|...- .+|+.. +..+.|+|++++.+.+... ...+
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~---------l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL---------MKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred cCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHH---------HHHhCCCchhceeeeeeccccccccceeE
Confidence 568899998754 456667776542 122222 3377899999999887643 3568
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 99 lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 99 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred EEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 99999974 77777742 488889999999999999999999 99999999999999999999999999987543
Q ss_pred CCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh---------hhh
Q 044568 146 EDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF---------INR 214 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~ 214 (257)
... ....+|..|+|||.+.+..++.++|+|||||++|||++|+.||........ ......... ...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhhcH
Confidence 322 344678899999999988899999999999999999999999975421111 000000000 000
Q ss_pred hhhhhhc---------------CC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVR---------------GT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~---------------~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... .. .........+.+++.+||+.||++|| +.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 00 11112245788999999999999999 999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=228.90 Aligned_cols=236 Identities=18% Similarity=0.147 Sum_probs=173.4
Q ss_pred cccccceeeeccc-CCCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
.+.++.||++... +++.+++|..... .+.+.+. ..........|+|++++.+.+...+..++||||++ |+|.
T Consensus 11 ~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~ 87 (283)
T cd06617 11 RGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM--DLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLD 87 (283)
T ss_pred ccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHH--HHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHH
Confidence 3578899999976 4677788865421 1222221 11112335679999999999999999999999996 6888
Q ss_pred HHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccC
Q 044568 78 DIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKR 153 (257)
Q Consensus 78 ~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~ 153 (257)
+++... ....+++.++..++.|++.|+.|||++. +++|+||+|+||+++.++.+||+|||.+....... ....+
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (283)
T cd06617 88 KFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165 (283)
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccC
Confidence 887642 3356899999999999999999999853 89999999999999999999999999987543222 23456
Q ss_pred CCCccCcccccC----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 154 DKGYMAPECYKR----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 154 ~~~~~aPE~~~~----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......+. +... . .-..+.......
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~---------~-~~~~~~~~~~~~ 233 (283)
T cd06617 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LKQV---------V-EEPSPQLPAEKF 233 (283)
T ss_pred CccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH--HHHH---------H-hcCCCCCCcccc
Confidence 778999998864 34688999999999999999999999643211111 0000 0 000011111234
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.+++.+||+.+|.+|| +.++++
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56789999999999999999 999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=258.85 Aligned_cols=228 Identities=18% Similarity=0.150 Sum_probs=168.7
Q ss_pred ccccceeeecccCCCCC-eeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEe
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E 69 (257)
+.|+.||+++....... ++|.+. +..|++++. .+.|+||+++.+.+... ...+||||
T Consensus 24 GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~---------~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR---------ELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHH---------HcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 56899999997766544 444332 233444444 88999999999987643 56899999
Q ss_pred ecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeeccCCCCceeeCC--------------
Q 044568 70 PVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECE----PPILHCDIKPQNILMDE-------------- 129 (257)
Q Consensus 70 ~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~----~~i~h~dl~~~nil~~~-------------- 129 (257)
|+++|+|.++|... ....+++..++.|+.||+.||.|||+... .+|+|+||||+|||++.
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 99999999999642 23569999999999999999999998510 15999999999999964
Q ss_pred ---CCceEEeeecccccCCCC--cccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHH
Q 044568 130 ---FWTAKILDFGLAKLPNED--FVIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202 (257)
Q Consensus 130 ---~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~ 202 (257)
...+||+|||++...... .....+|+.|+|||++.. ..++.++|||||||++|||++|..||........
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q--- 251 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ--- 251 (1021)
T ss_pred cCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH---
Confidence 235899999998754322 234468899999999864 3578999999999999999999999974421110
Q ss_pred HHHHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 203 LTNWVYKCFINRELNKLVRGT-KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... .+.... ......+..+.+|+..||+.+|.+|| +.|++.
T Consensus 252 ---li~---------~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 252 ---LIS---------ELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ---HHH---------HHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 000 000001 11112346789999999999999999 999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=224.51 Aligned_cols=233 Identities=18% Similarity=0.193 Sum_probs=178.6
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh----hHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~~~~gsL 76 (257)
+.++.+|+|... ++..+++|...... +.+.+... . ..+.++.|+|++++.+.+... +..++|+||+++++|
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e-~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L 88 (260)
T cd06606 11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALERE-I-RILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSL 88 (260)
T ss_pred cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHH-H-HHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcH
Confidence 467899999987 45556666543221 11111110 0 023378899999999999988 899999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----cccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-----FVID 151 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~ 151 (257)
.+++.. ...+++.++..++.|++.|+.|||+. +++|+|++|+||+++.++.++|+|||.+...... ....
T Consensus 89 ~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 163 (260)
T cd06606 89 SSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163 (260)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCC
Confidence 999974 33899999999999999999999999 9999999999999999999999999988754433 2344
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.++..|.+||.+.....+.++|+||||+++|++++|..||........ .. .. ..........+...+.
T Consensus 164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~------~~~~~~~~~~~~~~~~ 231 (260)
T cd06606 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--AL----YK------IGSSGEPPEIPEHLSE 231 (260)
T ss_pred CCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HH----Hh------ccccCCCcCCCcccCH
Confidence 667789999999888889999999999999999999999975531100 00 00 0000111133444567
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+|++.+|.+|| +.|+++
T Consensus 232 ~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 232 EAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHHhCcCChhhCCCHHHHhh
Confidence 899999999999999999 999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=266.45 Aligned_cols=225 Identities=19% Similarity=0.204 Sum_probs=180.8
Q ss_pred ccccceeeec-ccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
|-|+.||.+- .++|+.-++|... ..+|++++. .+.|+|+++.+|+-.+.+..+|-||||
T Consensus 1246 G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE---------~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1246 GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLE---------GLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHH---------hccCccccccCceeecHHHHHHHHHHh
Confidence 5678899887 5555555666543 356777777 899999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
.+|+|.+.+. .++..++....-+..|++.|+.|||++ ||||||+||.||+++.+|.+|++|||.+.......
T Consensus 1317 ~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1317 EGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred ccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999997 566677777778999999999999999 99999999999999999999999999987654332
Q ss_pred ----ccccCCCCccCcccccCCC---CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 ----VIDKRDKGYMAPECYKRTP---ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....||+.|||||.+.+.. -..++||||+||++.||+||+.||..-+.. |+ .+..- ..-.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~a--IMy~V---~~gh 1458 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WA--IMYHV---AAGH 1458 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hH--HHhHH---hccC
Confidence 4568999999999997643 457899999999999999999999643111 11 11110 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....|.....+-.+++.+|++.||++|- +.|+++
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2245666778889999999999999999 888875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=227.46 Aligned_cols=241 Identities=14% Similarity=0.138 Sum_probs=174.2
Q ss_pred ceeeec-ccCCCCCeeeccc--hhhhHHHHhH-hhhccccccccCCceeeeceeeee-----cCceeEEEeecCCCCHHH
Q 044568 8 NFYRSS-FNARNSPWISRVS--WTADIEVLSV-AMRGSKCTRIRGGLLLNVPVRAKL-----TSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 8 ~~y~~~-~~~~~~~~i~~~~--~~~~~~~~~~-~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~lV~E~~~~gsL~~ 78 (257)
+|-.+. -.+++.++||+.. |.+.+..... .... .+.+++|+||+.+.++... -+..|+|+|+|+ .+|.+
T Consensus 37 vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElk-lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~ 114 (359)
T KOG0660|consen 37 VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELK-LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQ 114 (359)
T ss_pred eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHH-HHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHH
Confidence 344443 4556778898877 5444432221 1111 4449999999999988875 357899999995 59999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC-----CCcccccC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN-----EDFVIDKR 153 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~-----~~~~~~~~ 153 (257)
+|+ ....|+..-+..++.|++.||.|+|+. +++|||+||.|+++..+..+|++|||+++... ...+...-
T Consensus 115 iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVa 189 (359)
T KOG0660|consen 115 IIK--SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVA 189 (359)
T ss_pred HHH--cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhccee
Confidence 997 556699999999999999999999999 99999999999999999999999999999764 23345566
Q ss_pred CCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-------HHHhhhhhhhhhhhc----
Q 044568 154 DKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-------VYKCFINRELNKLVR---- 221 (257)
Q Consensus 154 ~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~---- 221 (257)
|.-|.|||.+... .|+.+.||||.||++.||++|++.|.+.+.-..-..+... ......+..+...+.
T Consensus 190 TRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~ 269 (359)
T KOG0660|consen 190 TRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ 269 (359)
T ss_pred eeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC
Confidence 7779999998754 6999999999999999999999999875322211000000 001111111111111
Q ss_pred CCCC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... -....+..++|+.+||..||.+|+ ++|.++
T Consensus 270 ~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 270 IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111 113347889999999999999999 999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=230.68 Aligned_cols=239 Identities=17% Similarity=0.174 Sum_probs=171.2
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+|+.. +++.+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 13 GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK---------EMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred CCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHH---------hccCCCEeeEEEEEecCCeEEEEEecc
Confidence 457899999976 455677775432 23444444 888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCC---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~--- 147 (257)
+ ++|.+.+.......+++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.+|++|||++......
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 6 5888888653444568888889999999999999999 9999999999999985 557899999998653322
Q ss_pred cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH----hhh----hhhhhh
Q 044568 148 FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK----CFI----NRELNK 218 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~----~~~~~~ 218 (257)
.....++..|+|||.+.+. .++.++|+||+|+++|++++|..||..............+... .+. -+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 1233456789999988664 5789999999999999999999999765322111110000000 000 000000
Q ss_pred hhcC---C---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LVRG---T---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~~~---~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... . .......+.+.+++.+|++.+|++|| +.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 01122346689999999999999999 999875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=233.84 Aligned_cols=247 Identities=15% Similarity=0.110 Sum_probs=172.8
Q ss_pred ccccceeeeccc-CCCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
..++.||+++.. .++.+++|..... ...+.+.... .....+.|+|++++.+.+...+..++||||+.+++|.+
T Consensus 11 ~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~--~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 11 CNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEV--VLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHH--HHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 356789999865 5677777765421 1122111100 02226789999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----------
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---------- 148 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---------- 148 (257)
++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++||+.+.......
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccc
Confidence 99764456789999999999999999999999 99999999999999999999999997543211110
Q ss_pred ccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-------------HHHhhhh
Q 044568 149 VIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-------------VYKCFIN 213 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------------~~~~~~~ 213 (257)
....++..|++||.+.+. .++.++|+||||+++||+++|..||............... .......
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd08226 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245 (328)
T ss_pred ccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhcc
Confidence 111234569999998764 4789999999999999999999999754221110000000 0000000
Q ss_pred h--hh---------h-----hhhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 R--EL---------N-----KLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ~--~~---------~-----~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .. . .... ....+......+.+++.+||+.||++|| +.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00 0 0000 0012234567899999999999999999 999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=229.75 Aligned_cols=238 Identities=16% Similarity=0.137 Sum_probs=173.6
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEe
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E 69 (257)
+.++.||+++..+ +...++|.... .+|++.+. .+.|+|++++.+.+... +..++|||
T Consensus 10 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQ---------KLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHH---------hccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678999999765 55566665542 23444444 77899999999999988 89999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++ +|.+++.. ....+++.++..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 99999875 335789999999999999999999999 99999999999999999999999999987544332
Q ss_pred ---ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhh-hh
Q 044568 149 ---VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINR-EL 216 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~-~~ 216 (257)
....++..|+|||.+.+ ..++.++|+||||+++||+++|..||................ ++....- ..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 23345677999998765 457899999999999999999999997653221111110000 0000000 00
Q ss_pred hhhhcCCC--------CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 217 NKLVRGTK--------VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 217 ~~~~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........ .....+..+.+++.+||+.+|++|| ++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 0111257889999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=226.55 Aligned_cols=247 Identities=15% Similarity=0.140 Sum_probs=174.7
Q ss_pred ccccceeeecccC-CCCCeeeccchh--hhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT--ADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+|+..+ +..+++|+..-. ..-+........ .+.+++ |+|++++.+.+...+..++||||+ +|+|.+.
T Consensus 10 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~ 87 (283)
T cd07830 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK-SLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQL 87 (283)
T ss_pred CCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHH-HHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHH
Confidence 5678999999865 455667764321 000000000111 333777 999999999999999999999999 7899999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccCCCCc
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKRDKGY 157 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~ 157 (257)
+.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ....++..|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 164 (283)
T cd07830 88 MKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWY 164 (283)
T ss_pred HHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccc
Confidence 9753445789999999999999999999999 99999999999999999999999999887543321 234567789
Q ss_pred cCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH---------HHHHhhhhhhhhhhhcCC----
Q 044568 158 MAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN---------WVYKCFINRELNKLVRGT---- 223 (257)
Q Consensus 158 ~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~---- 223 (257)
+|||.+.. ..++.++|+||||+++||+++|+.||.............. |.............+...
T Consensus 165 ~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd07830 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS 244 (283)
T ss_pred cCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccccc
Confidence 99998854 4578999999999999999999999975532221111110 000000000000000000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 --KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 --~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.........+.+++.+||+.+|++|| +.|+++
T Consensus 245 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00011246799999999999999999 999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=226.71 Aligned_cols=245 Identities=16% Similarity=0.086 Sum_probs=169.1
Q ss_pred ccccceeeecccC-CCCCeeeccch--hhhHHHHhHhhhccccccc-cCCceeeeceeeeec--CceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW--TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT--SVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... +..+++|.... ............. .+.++ .|+|++++.+.+... +..++||||++ |+|.
T Consensus 10 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 87 (282)
T cd07831 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQ-ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLY 87 (282)
T ss_pred cccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHH-HHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHH
Confidence 4578899998654 55556665332 1100000001111 22245 399999999999887 88999999997 5888
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccCCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKRDK 155 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 155 (257)
+.+.. ....+++.++..++.|++.||.|||++ +++|+||+|.||+++. +.++|+|||.+....... ....++.
T Consensus 88 ~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~ 162 (282)
T cd07831 88 ELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTR 162 (282)
T ss_pred HHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCc
Confidence 88864 345789999999999999999999999 9999999999999999 999999999987543221 2335677
Q ss_pred CccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhhhhhcCC----
Q 044568 156 GYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELNKLVRGT---- 223 (257)
Q Consensus 156 ~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~---- 223 (257)
.|+|||.+.. ..++.++|+||+|+++|||++|..||......+......... .............-+.
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (282)
T cd07831 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242 (282)
T ss_pred ccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccc
Confidence 8999997654 456889999999999999999999997653221101110000 0000000000000000
Q ss_pred ---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 ---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+..+.+++.+||+.+|++|| ++++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 243 GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00123457899999999999999999 999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=227.32 Aligned_cols=229 Identities=17% Similarity=0.128 Sum_probs=169.9
Q ss_pred ccccceeeeccc-CCCCCeeeccch------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++... +++.+++|.... ..+.................|++++.+...+...+..++||||+++|+|
T Consensus 5 g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L 84 (278)
T cd05606 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 84 (278)
T ss_pred CCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcH
Confidence 467899999865 456777775431 1111111100000022245689999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-CcccccCCC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVIDKRDK 155 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~ 155 (257)
.+++. ....+++..+..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||++..... ......++.
T Consensus 85 ~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (278)
T cd05606 85 HYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159 (278)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCc
Confidence 99997 456799999999999999999999999 999999999999999999999999998764322 223446788
Q ss_pred CccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.++ .++.++|+||+|+++|||++|+.||.............. ........+......+.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------TLTMAVELPDSFSPELR 227 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH------------hhccCCCCCCcCCHHHH
Confidence 89999998754 588999999999999999999999975532221110000 00011122333457789
Q ss_pred HHHHHcccCCCCCCC
Q 044568 235 KVGLWCVQDEPALRP 249 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP 249 (257)
+++.+|++.+|.+||
T Consensus 228 ~li~~~l~~~p~~R~ 242 (278)
T cd05606 228 SLLEGLLQRDVNRRL 242 (278)
T ss_pred HHHHHHhhcCHHhcc
Confidence 999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=221.40 Aligned_cols=197 Identities=18% Similarity=0.196 Sum_probs=158.3
Q ss_pred ccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 044568 42 KCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 121 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 121 (257)
.|..+.|||||++..........+||+|+|.|++|-.-|- ...-+++..+.+++.||++||.|+|.+ +|+|||+|
T Consensus 63 IC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvk 137 (355)
T KOG0033|consen 63 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLK 137 (355)
T ss_pred HHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCC
Confidence 6779999999999999999999999999999998866553 235578888999999999999999999 99999999
Q ss_pred CCceeeC---CCCceEEeeecccccCCCCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCC
Q 044568 122 PQNILMD---EFWTAKILDFGLAKLPNEDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDAS 196 (257)
Q Consensus 122 ~~nil~~---~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~ 196 (257)
|+|+++. ...-+||+|||++...+... ....|||.|++||++++.+|+..+|||+.|++||-++.|..||.+++.
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 9999996 34568999999998655322 456889999999999999999999999999999999999999986421
Q ss_pred ChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 197 KPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..... .... .+ +........++..+|+.+||..||.+|. +.|.++
T Consensus 218 ~r---lye~I-----~~g~----yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 218 HR---LYEQI-----KAGA----YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HH---HHHHH-----hccc----cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 11111 0011 11 1122333456788899999999999999 998864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=226.52 Aligned_cols=228 Identities=17% Similarity=0.247 Sum_probs=169.3
Q ss_pred ccccceeeecccC----CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------
Q 044568 4 TKLSNFYRSSFNA----RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------ 62 (257)
Q Consensus 4 ~~~~~~y~~~~~~----~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------ 62 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 10 GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMK---------EFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHh---------cCCCCCcceEEEEEccCCCCCccc
Confidence 4578999998643 3556776433 223333333 889999999999776532
Q ss_pred ceeEEEeecCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeee
Q 044568 63 VSGKIERPVRNGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
..++++||+++|+|.+++... ....+++.....++.|++.|+.|||++ +++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999999987532 223578899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 139 GLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 139 g~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
|.++...... ....++..|++||.+.+..++.++||||||+++||+++ |..||...... ....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~~---- 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYLI---- 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHHH----
Confidence 9887543211 12233456999999988888999999999999999999 88888644211 1111100
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. .....+...+..+.+++.+||+.+|.+|| +.|+++.|
T Consensus 230 ~~------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 230 KG------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred cC------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 00112234557899999999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=228.97 Aligned_cols=238 Identities=16% Similarity=0.170 Sum_probs=174.4
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++... +++..++|.... .+|++.+. ++.|++++++.+.+...+..++|+||+
T Consensus 10 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK---------ELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHH---------HhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999875 455566665432 22333333 778999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
++ +|.+++.. ....+++.++..++.|++.||.|||++ +++|+|++|+||+++.++.++++|||.+.......
T Consensus 81 ~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 75 99998875 346789999999999999999999999 99999999999999999999999999887544322
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-------HHHhhhh--hhh-h
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-------VYKCFIN--REL-N 217 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~--~~~-~ 217 (257)
....++..|.|||.+.+. .++.++|+||+|+++|++++|+.||......+........ .+..... ... .
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234566779999998876 6889999999999999999999999754321110000000 0000000 000 0
Q ss_pred hhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... .........+.+++.+||+.||.+|| +.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 11223457899999999999999999 999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=228.63 Aligned_cols=240 Identities=16% Similarity=0.141 Sum_probs=169.5
Q ss_pred cccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCc-----e
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSV-----S 64 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~-----~ 64 (257)
.+.++.||++.... +..+++|.... .+|++.+. .+. |+|++++.+.+...+. .
T Consensus 11 ~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQ---------MLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred ccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHH---------HccCCCCccceeeeEeecCCCCCceE
Confidence 35788999999764 55666775432 23444443 553 5999999998887665 7
Q ss_pred eEEEeecCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecc
Q 044568 65 GKIERPVRNGSLTDIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGL 140 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~ 140 (257)
++||||+++ +|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.++|+|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 8999886422 34689999999999999999999999 9999999999999998 88999999998
Q ss_pred cccCCCC---cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-Hhh-hhh
Q 044568 141 AKLPNED---FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-KCF-INR 214 (257)
Q Consensus 141 ~~~~~~~---~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~-~~~ 214 (257)
+...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||................. +.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8743322 122345677999998865 4578999999999999999999999975532211111100000 000 000
Q ss_pred hhhhhh-----cC-C-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLV-----RG-T-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~-----~~-~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... .. . .........+.+++.+||+.||.+|| +.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00 0 00112456789999999999999999 999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=230.71 Aligned_cols=238 Identities=16% Similarity=0.148 Sum_probs=167.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC--------c
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--------V 63 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--------~ 63 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++.|+|++++.+.+...+ .
T Consensus 23 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ---------LLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHH---------hCCCCCccceEEEEecccccccCCCce
Confidence 467899999865 455666765432 22333433 888999999998876554 4
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+. ++|.+.+.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..
T Consensus 94 ~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 499999996 588888864 445789999999999999999999999 999999999999999999999999998875
Q ss_pred CCCCc-------ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------
Q 044568 144 PNEDF-------VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY------- 208 (257)
Q Consensus 144 ~~~~~-------~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~------- 208 (257)
..... ....++..|+|||.+.+.. ++.++|+||||+++||+++|..||...........+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 43221 1234566799999887643 68899999999999999999999976532211111111000
Q ss_pred Hhhhhhhh-hhhhcCCC---------CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 209 KCFINREL-NKLVRGTK---------VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 209 ~~~~~~~~-~~~~~~~~---------~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+....... .....+.. .+......+.+++.+||+.||.+|| ++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 00000000 0011234567899999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=228.83 Aligned_cols=238 Identities=18% Similarity=0.179 Sum_probs=168.2
Q ss_pred ccccceeeecccC-CCCCeeeccchh---hhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT---ADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++... +..+++|..... .....+. ... ..+.++. |+|++++.+.+...+..+++|||+.. ++.+
T Consensus 15 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-~e~-~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~ 91 (288)
T cd06616 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLL-MDL-DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDK 91 (288)
T ss_pred CCceEEEEEEECCCCCEEEEEEehhccChHHHHHHH-HHH-HHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHH
Confidence 4578999998654 455667755421 1111110 000 0223554 99999999999999999999999864 6555
Q ss_pred H---HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccC
Q 044568 79 I---IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKR 153 (257)
Q Consensus 79 ~---l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~ 153 (257)
+ +.......+++..+..++.|++.|+.|||+.. +++||||+|+||+++.++.++|+|||++...... .....+
T Consensus 92 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 169 (288)
T cd06616 92 FYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169 (288)
T ss_pred HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccC
Confidence 4 33223467999999999999999999999731 8999999999999999999999999998643322 233456
Q ss_pred CCCccCcccccCC---CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 154 DKGYMAPECYKRT---PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 154 ~~~~~aPE~~~~~---~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
+..|+|||.+.+. .++.++|+||||+++||+++|+.||...... .... .... ...... + ........+
T Consensus 170 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~-~~~~~~-~-~~~~~~~~~ 240 (288)
T cd06616 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQL-TQVV-KGDPPI-L-SNSEEREFS 240 (288)
T ss_pred ccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHH-hhhc-CCCCCc-C-CCcCCCccC
Confidence 7889999998766 5889999999999999999999999644200 0000 0000 000000 0 011122356
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.+|++|| +.||++
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7899999999999999999 999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=228.57 Aligned_cols=231 Identities=17% Similarity=0.149 Sum_probs=170.3
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+|+... +..+++|..... ...+.+.. .. ..+.+++|+|++++.+.+...+..++||||+. |++.
T Consensus 32 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~ 108 (313)
T cd06633 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EV-KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSAS 108 (313)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHH-HH-HHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHH
Confidence 4578999998654 445566654321 11111110 01 13348889999999999999999999999996 5888
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGY 157 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (257)
+.+.. ....+++.++..++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||.+.... ......++..|
T Consensus 109 ~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-~~~~~~~~~~y 183 (313)
T cd06633 109 DLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-PANSFVGTPYW 183 (313)
T ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-CCCCccccccc
Confidence 88864 456789999999999999999999999 99999999999999999999999999876432 22344677889
Q ss_pred cCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 158 MAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 158 ~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+|||.+. ...++.++|+||||+++|+|++|..||........ ... .. ....+..........+.
T Consensus 184 ~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~----~~------~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH----IA------QNDSPTLQSNEWTDSFR 250 (313)
T ss_pred cChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHH----HH------hcCCCCCCccccCHHHH
Confidence 9999984 35678899999999999999999999965421110 000 00 00001111222345688
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++.+||+.+|++|| +.++++
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999 999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=222.06 Aligned_cols=226 Identities=18% Similarity=0.226 Sum_probs=177.6
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----------hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|..... +++++ +.+++|+|++++.+.+...+..++|+||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~---------l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI---------LKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHH---------HHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 5678999999764 555566665432 22333 33778999999999999999999999999
Q ss_pred CCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 72 RNGSLTDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
++++|.+++.... ...+++.+...++.+++.|+.|||++ +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999997532 47799999999999999999999999 99999999999999999999999999887543322
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+++.|+|||.+....++.++|+||+|+++|++++|..||....... ... . ..... ....+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~----~-----~~~~~--~~~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL----K-----ILKGQ--YPPIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH----H-----HhcCC--CCCCC
Confidence 23456778999999988888999999999999999999999996542110 000 0 00000 11223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.+++.+||+.+|.+|| +.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 34557789999999999999999 999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=233.29 Aligned_cols=191 Identities=19% Similarity=0.236 Sum_probs=165.3
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
++..+.||.+.-.+...+..|||+..|.||+|.-+|....+..+++..++.++.+|+.||++||.. +|++||+||+|
T Consensus 241 kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeN 317 (591)
T KOG0986|consen 241 KVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPEN 317 (591)
T ss_pred HhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhh
Confidence 777889999999999999999999999999999999977778999999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeecccccCC--CCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHH
Q 044568 125 ILMDEFWTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~ 202 (257)
||+|+.|+++|+|+|++..+. .+.....||.+|||||++.+..|+...|+||+||++|||+.|+.||....+
T Consensus 318 ILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke------ 391 (591)
T KOG0986|consen 318 ILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE------ 391 (591)
T ss_pred eeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh------
Confidence 999999999999999987543 334556899999999999999999999999999999999999999964421
Q ss_pred HHHHHHHhhhhhhhhh--hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hH
Q 044568 203 LTNWVYKCFINRELNK--LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 203 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
.....++.. +-++..+++...++...++...|+.||++|. .+
T Consensus 392 -------Kvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 392 -------KVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -------hhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 122223333 2233367777888999999999999999997 54
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=221.21 Aligned_cols=224 Identities=21% Similarity=0.203 Sum_probs=175.6
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.+|+++... +..+++|.... .++++.+. +++|+|++++.+.+...+..++||||+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLK---------NLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHH---------hCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 4578899998664 44566665432 23333333 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
++++|.+++.. ...+++..+..++.|++.|+.+||++ +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 82 ENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred CCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 99999999974 36789999999999999999999999 99999999999999999999999999887544322
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....++..|++||......++.++|+||+|+++|++++|..||....... . .+... .......+..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~---~--~~~~~---------~~~~~~~~~~ 222 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA---A--LFRIV---------QDDHPPLPEG 222 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH---H--HHHHh---------ccCCCCCCCC
Confidence 23456778999999987778899999999999999999999997442110 0 00000 0011123334
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.+|++|| +.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 467889999999999999999 999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=232.51 Aligned_cols=234 Identities=15% Similarity=0.131 Sum_probs=172.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------------------hhhHHHHhHhhhccccccccCCceeeeceeee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK 59 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 59 (257)
+.++.||++... .+..+++|.... .+|++++. ++.|+|++++.+.+.
T Consensus 20 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN---------EIKHENIMGLVDVYV 90 (335)
T ss_pred CCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH---------hCCCcceeeeeEEEe
Confidence 568899999854 566677775432 23444444 888999999999999
Q ss_pred ecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 60 LTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 60 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
..+..++||||+. |+|.+++. ....+++.....++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999997 69999996 455689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCC-----------------CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH
Q 044568 140 LAKLPNE-----------------DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEI 201 (257)
Q Consensus 140 ~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~ 201 (257)
.+..... ......++..|+|||.+.+. .++.++|+||+|+++||+++|..||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-- 242 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-- 242 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 8865431 11122346679999998764 468999999999999999999999976532211
Q ss_pred HHHHHHHHhhhh--hhhh---hh---------hcCC--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 202 ILTNWVYKCFIN--RELN---KL---------VRGT--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 202 ~~~~~~~~~~~~--~~~~---~~---------~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.......... ..+. .+ .+.. .........+.+++.+||+.+|++|| ++|++.
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 -LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11110000000 0000 00 0000 01112346788999999999999999 999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=229.32 Aligned_cols=239 Identities=18% Similarity=0.110 Sum_probs=172.1
Q ss_pred ccccceeeecccC---CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSSFNA---RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~---~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||+++... +..+++|.... .+|++.+. ++.|+|++++.+.+... +..++
T Consensus 11 g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR---------ELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred CCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHH---------hcCCCCccceEEEEeCCCCceEEE
Confidence 5678999999765 56667765543 23444444 88899999999999988 88999
Q ss_pred EEeecCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC----CCceEEeeec
Q 044568 67 IERPVRNGSLTDIIFCS---AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE----FWTAKILDFG 139 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~----~~~~kl~dfg 139 (257)
||||+++ +|.+.+... ....++...+..++.|++.||.|||++ +++|+||+|+||+++. ++.+|++|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 777776432 223688999999999999999999999 9999999999999999 8999999999
Q ss_pred ccccCCCCc------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChh------hHHHHHH
Q 044568 140 LAKLPNEDF------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPE------EIILTNW 206 (257)
Q Consensus 140 ~~~~~~~~~------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~------~~~~~~~ 206 (257)
++....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 887543221 223456779999988764 578999999999999999999999976533220 0011111
Q ss_pred HHHhh-----------hhhhhhh---hhcCCCCC-----------HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 207 VYKCF-----------INRELNK---LVRGTKVD-----------KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 207 ~~~~~-----------~~~~~~~---~~~~~~~~-----------~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... ..++... .......+ ......+.+++.+||+.||++|| +.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000000 00000111 02345789999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=231.96 Aligned_cols=236 Identities=17% Similarity=0.191 Sum_probs=172.0
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~ 70 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+|++++.+.+.. .+..++||||
T Consensus 21 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK---------HLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred cCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHH---------hcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 467899999855 66667777532 233444444 8889999999998865 5678999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
+ +++|.+++. ...++......++.|+++||.|||++ +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 92 ~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (328)
T cd07856 92 L-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG 164 (328)
T ss_pred h-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence 9 469999885 34578888889999999999999999 9999999999999999999999999998765544444
Q ss_pred ccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH--------HHHhhhhhh---hhh
Q 044568 151 DKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW--------VYKCFINRE---LNK 218 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~ 218 (257)
..++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+.++ ......... ...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 566778999998765 46889999999999999999999999754221111111110 000000000 000
Q ss_pred hhcCCCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LVRGTKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+......+ ......+.+++.+||+.+|++|| +.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000111 12347899999999999999999 999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=227.73 Aligned_cols=224 Identities=18% Similarity=0.155 Sum_probs=170.3
Q ss_pred ccccceeeecccCC-CCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+|+...+ ..++++.... .++++. +..+.|+|++++.+.+...+..++||||
T Consensus 26 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF---------LQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHH---------HHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 56789999996544 4456665432 123333 3378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
+. |++.+.+.. ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+..... ...
T Consensus 97 ~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~~ 170 (308)
T cd06634 97 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANX 170 (308)
T ss_pred cC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC-ccc
Confidence 96 688888764 445689999999999999999999999 999999999999999999999999998765432 233
Q ss_pred ccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 151 DKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
..++..|+|||.+. ...++.++||||||+++|++++|..||....... ....+. ....+.....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~----------~~~~~~~~~~ 237 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIA----------QNESPALQSG 237 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHh----------hcCCCCcCcc
Confidence 45678899999975 3457889999999999999999999986431110 000000 0000111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.+|++|| +.++++
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 3456788999999999999999 999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=229.30 Aligned_cols=233 Identities=18% Similarity=0.186 Sum_probs=190.8
Q ss_pred ccccceeee------cccCCCCCeeecc-chhhhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEeecCCCC
Q 044568 4 TKLSNFYRS------SFNARNSPWISRV-SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~------~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gs 75 (257)
+.|+.+|+| ++++.+++.+|.+ ++..++++......+..+..+.|+|++++.+.+.. .+..+.++.++.-|+
T Consensus 295 GtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gN 374 (563)
T KOG1024|consen 295 GTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGN 374 (563)
T ss_pred CchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcch
Confidence 468999999 7777777777764 56888888887777777788889999999998875 567788899999999
Q ss_pred HHHHHh-----cc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc
Q 044568 76 LTDIIF-----CS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149 (257)
Q Consensus 76 L~~~l~-----~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (257)
|+.++. +. ..++++..+.+.++.|++.|++|||++ +++|.||.++|+++++.-.+||+|=.+++-......
T Consensus 375 LK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DY 451 (563)
T KOG1024|consen 375 LKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDY 451 (563)
T ss_pred HHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccc
Confidence 999997 22 345678889999999999999999999 999999999999999999999999888874333322
Q ss_pred cc-----cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-C
Q 044568 150 ID-----KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-G 222 (257)
Q Consensus 150 ~~-----~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 222 (257)
.. .....|++||.+.+..|+.++|+||||+++||++| |+.|+..-++ .+....++ +
T Consensus 452 hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----------------fEm~~ylkdG 514 (563)
T KOG1024|consen 452 HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----------------FEMEHYLKDG 514 (563)
T ss_pred cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----------------HHHHHHHhcc
Confidence 22 23345999999999999999999999999999999 9999863311 12222222 2
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 223 T--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 223 ~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
. ..|.+++.+|..++.-||..+|++|| +++++.-
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 2 56888999999999999999999999 9998764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=222.27 Aligned_cols=224 Identities=18% Similarity=0.151 Sum_probs=171.4
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+|++++.+.+... ...++
T Consensus 13 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK---------NLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHH---------HcCCCCcceEEEEEEcCCCCEEEE
Confidence 567899999864 46666777542 122333333 88899999999988764 45789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|+||+++++|.+++. ....+++.....++.|++.|+.|||++ +++|+|++|+||+++.++.++|+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 84 FVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999999999997 345588999999999999999999999 999999999999999999999999999875322
Q ss_pred C------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 D------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. .....++..|+|||.+.+..++.++|+||||+++|++++|+.||....... .... ....-
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----------~~~~~ 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---AIFK----------IATQP 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---HHHH----------HHcCC
Confidence 1 123356778999999988888999999999999999999999997441110 0000 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+....+.+.+++.+||+ +|..|| +.+++.
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1123455566789999999999 579999 888864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=243.75 Aligned_cols=207 Identities=16% Similarity=0.131 Sum_probs=149.1
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSA---ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 121 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 121 (257)
++.|+||+++.+++...+..++|+|++. ++|.+++.... .......++..++.|++.||.|||++ +|+|||||
T Consensus 219 ~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK 294 (501)
T PHA03210 219 RLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK 294 (501)
T ss_pred hCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 8899999999999999999999999995 57888775321 12234566778999999999999999 99999999
Q ss_pred CCceeeCCCCceEEeeecccccCCCCc----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCC
Q 044568 122 PQNILMDEFWTAKILDFGLAKLPNEDF----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASK 197 (257)
Q Consensus 122 ~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~ 197 (257)
|+|||++.++.+||+|||++....... ....|+..|+|||.+.+..++.++|||||||++|||++|..++......
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 999999999999999999987543321 2346889999999999989999999999999999999988654332221
Q ss_pred hhhHHHHHHHHHhh-hh-------hhhhhhhcCC-------CC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 198 PEEIILTNWVYKCF-IN-------RELNKLVRGT-------KV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 198 ~~~~~~~~~~~~~~-~~-------~~~~~~~~~~-------~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+........ .. ..+.+.+... .. .......+.+++.+||+.||.+|| +.|+++
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111111110000 00 0000010000 00 001224567789999999999999 999975
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=225.72 Aligned_cols=228 Identities=17% Similarity=0.129 Sum_probs=170.8
Q ss_pred ccccceeeeccc----CCCCCeeeccch-------------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVSW-------------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||+++.. ++..+++|.... .+|++++. ++ .|+|++++.+.+......+
T Consensus 11 G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~---------~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE---------AVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHH---------hccCCcchhhhheeeecCCEEE
Confidence 567889988743 345566665432 22333333 56 4899999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++|+|.+++. ....+++.....++.|++.||.|||+. +++|+|++|.||+++.++.++++|||++....
T Consensus 82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999997 345689999999999999999999999 99999999999999999999999999876533
Q ss_pred CCc----ccccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 146 EDF----VIDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 146 ~~~----~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
... ....++..|++||.+.+.. .+.++|+||||+++|||++|..||.......... ..... ....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~------~~~~ 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS---EISRR------ILKS 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH---HHHHH------HHcc
Confidence 221 1234677899999987654 6789999999999999999999996442211111 11000 0000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
....+......+.+++.+||+.||++|| +.++.+.
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 1122333456788999999999999999 8777543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=224.46 Aligned_cols=239 Identities=16% Similarity=0.163 Sum_probs=173.4
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... +..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 11 GTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMK---------ELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred CCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHH---------hhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 4578899999764 55566775442 23333333 7789999999999999999999999998
Q ss_pred CCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---c
Q 044568 73 NGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 73 ~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~ 148 (257)
+ +|.+++.... ...+++..+..++.|++.||.|||++ +++|+|++|+||++++++.++++|||.+...... .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 4 8999886422 35689999999999999999999999 9999999999999999999999999988643321 1
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhh-hhhhhhh
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFI-NRELNKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~ 219 (257)
....++..|++||.+.+. .++.++|+||||+++|++++|+.||.............+... +... .+....-
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234557789999988654 468899999999999999999999976533221111111000 0000 0000000
Q ss_pred hcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... .........+.+++.+||+.||.+|| +.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 01112346788999999999999999 999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=240.01 Aligned_cols=236 Identities=16% Similarity=0.148 Sum_probs=179.7
Q ss_pred ccccceeeecccCCCCCee-eccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFNARNSPWI-SRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+-|+.||++...++...+. |.++...+-+.-++...-..+....||+|+.+++.++.++..+|..|||+||-.+.++-+
T Consensus 43 GAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE 122 (1187)
T KOG0579|consen 43 GAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE 122 (1187)
T ss_pred ccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH
Confidence 3578899998886665543 333322222222211111133366799999999999999999999999999999999886
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~a 159 (257)
-+..|++.+..-++.|++.||.|||++ +|+|||||+.|||+..+|.++|+|||++-..... .....||+.|+|
T Consensus 123 -L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMA 198 (1187)
T KOG0579|consen 123 -LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMA 198 (1187)
T ss_pred -hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCccccc
Confidence 788999999999999999999999999 9999999999999999999999999987543322 256689999999
Q ss_pred ccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 160 PECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 160 PE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
||+.. ..+|+.++||||||++|.||..+.+|-..-. -.+...+ ...++.-.+ ..|......+.
T Consensus 199 PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllK-iaKSePPTL----lqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 199 PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLK-IAKSEPPTL----LQPSHWSRSFS 266 (1187)
T ss_pred chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHH-HhhcCCCcc----cCcchhhhHHH
Confidence 99874 4579999999999999999999888865221 0111100 001111112 33556778899
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++.+||.+||..|| ++++++
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhh
Confidence 999999999999999 999975
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=227.76 Aligned_cols=238 Identities=17% Similarity=0.155 Sum_probs=170.9
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEe
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E 69 (257)
+.++.||++.... ++.+++|.... .+|++.+. ++.|+|++++.+.+... +..++|||
T Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 18 GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLL---------NLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHH---------hCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 5678999999754 56667776542 23444444 88999999999887654 56899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
|+. ++|.+++.. ....+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 89 ~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 89 YCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred cCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 996 589988875 346789999999999999999999999 9999999999999999999999999998754332
Q ss_pred -cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhhh
Q 044568 148 -FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELNK 218 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 218 (257)
......+..|+|||.+.+ ..++.++|+||+|+++|||++|..||................ ++.........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 122234667999999875 457899999999999999999999997543221111111100 00000000000
Q ss_pred hh--cCCCC------CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LV--RGTKV------DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~--~~~~~------~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..... .....+.+.+++.+||+.||++|| +.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000 011246678899999999999999 999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=231.10 Aligned_cols=232 Identities=16% Similarity=0.160 Sum_probs=169.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++... ++..+++|...- .+|++.+. ++.|+|++++.+.+... ...+
T Consensus 27 g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 27 GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK---------LVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred CCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHH---------hcCCCCCcceeeeeccCCCccccCcEE
Confidence 467889999855 566677776531 12333333 78899999999877543 3579
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+. ++|.+.+.. .++...+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 98 lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 98 LVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 9999996 589998853 288899999999999999999999 99999999999999999999999999987544
Q ss_pred CCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh-------------
Q 044568 146 EDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC------------- 210 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 210 (257)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ........
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhhh
Confidence 322 233567789999999988899999999999999999999999975422110 10000000
Q ss_pred ----hhh-------hhhhhhhcCC-------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 ----FIN-------RELNKLVRGT-------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 ----~~~-------~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.. .....+.+.. ..+......+.+++.+||+.||++|| +.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0000111100 00123356788999999999999999 999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=219.71 Aligned_cols=223 Identities=17% Similarity=0.137 Sum_probs=174.9
Q ss_pred ccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.+|+++... ++.+++|...- .++++. +.++.|+|++++.+.+...+..++||||
T Consensus 4 G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNI---------LSRINHPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHH---------HHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence 5678999999764 55556665332 222333 3378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
+++++|.+++. ....+++.+...++.|++.|+.|+|+. +++|+|++|.||+++.++.++++|||.+......
T Consensus 75 ~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 75 APGGELFSHLS--KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCc
Confidence 99999999997 344689999999999999999999999 9999999999999999999999999988754332
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
.....++..|++||...+...+.++|+||||+++|++++|+.||..... ....... .. .....+.
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---------~~---~~~~~~~ 214 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---------LK---DPLRFPE 214 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---------hc---CCCCCCC
Confidence 2344567789999999888888999999999999999999999964421 1111000 00 1112334
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-h---HHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-M---KCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~---~ei~~ 255 (257)
..+..+.+++.+||..||++|| + .++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 4467889999999999999999 8 66654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=221.61 Aligned_cols=234 Identities=17% Similarity=0.198 Sum_probs=171.1
Q ss_pred ccccceeeecccCCCCC----eeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNSP----WISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~----~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
++++.||+++....... +++.... .+.-+............++.|+|++++.+.+...+..++||||+++++|.
T Consensus 11 g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 90 (260)
T cd08222 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLD 90 (260)
T ss_pred CCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHH
Confidence 57889999987665332 2222110 00000111111111233888999999999999999999999999999999
Q ss_pred HHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccccc
Q 044568 78 DIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDK 152 (257)
Q Consensus 78 ~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~ 152 (257)
+.+... ....+++.++..++.|++.|+.|||++ +++|+|++|+||+++. +.++++|||.+...... .....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 166 (260)
T cd08222 91 CKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFT 166 (260)
T ss_pred HHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCC
Confidence 998642 346789999999999999999999999 9999999999999986 47999999988654322 12345
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
++..|+|||.+....++.++|+||||+++|++++|..||.... . ..... . ... ......+...+..
T Consensus 167 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~-~~~~~----~------~~~-~~~~~~~~~~~~~ 232 (260)
T cd08222 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--F-LSVVL----R------IVE-GPTPSLPETYSRQ 232 (260)
T ss_pred CCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--H-HHHHH----H------HHc-CCCCCCcchhcHH
Confidence 6778999999988888899999999999999999999996331 1 00000 0 000 0111234455678
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++.+||+.+|++|| +.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhh
Confidence 99999999999999999 999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=226.06 Aligned_cols=233 Identities=17% Similarity=0.191 Sum_probs=169.3
Q ss_pred ccccceeeecccC-CCCCeeeccchh----hhHHHHh-HhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT----ADIEVLS-VAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~----~~~~~~~-~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++... +..+++|..... ...+.+. ... ......|+|++++.+.+......++||||++ +++.
T Consensus 26 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~---~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~ 101 (296)
T cd06618 26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---VLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLD 101 (296)
T ss_pred cCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHH---HHhccCCCchHhhheeeecCCeEEEEeeccC-cCHH
Confidence 5678999999876 666677765421 1111111 111 1113359999999999999999999999985 5788
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~ 154 (257)
+.+.. ....+++.++..++.|++.|+.|||+ . +++|+||+|+||++++++.++|+|||.+...... .....++
T Consensus 102 ~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 177 (296)
T cd06618 102 KLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177 (296)
T ss_pred HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCC
Confidence 77764 34578999999999999999999997 6 9999999999999999999999999988654322 1233466
Q ss_pred CCccCcccccCCC----CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 155 KGYMAPECYKRTP----ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 155 ~~~~aPE~~~~~~----~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ...+..+ ...............
T Consensus 178 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~~ 246 (296)
T cd06618 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI---------LQEEPPSLPPNEGFS 246 (296)
T ss_pred ccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH---------hcCCCCCCCCCCCCC
Confidence 7899999987543 788999999999999999999999643111 0011110 000000011111245
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.||.+|| +.++++
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 6789999999999999999 999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=225.32 Aligned_cols=235 Identities=16% Similarity=0.133 Sum_probs=170.0
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----------hhHHHHhHhhhccccccccCCceeeeceeeeecC---------
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--------- 62 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--------- 62 (257)
+.++.||+|.... +..+++|..... +|++.+. +++|+|++++.+.+...+
T Consensus 18 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~---------~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 18 GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR---------QLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHH---------hCCCCCeeeeeheecCcchhhhccccC
Confidence 4578999999765 556667765432 2333333 889999999998887654
Q ss_pred -ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 63 -VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 63 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||.|||++ +++|+|++|+||++++++.+||+|||.+
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999975 78787764 355799999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCc----ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--h
Q 044568 142 KLPNEDF----VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--R 214 (257)
Q Consensus 142 ~~~~~~~----~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 214 (257)
....... ....++..|++||.+.+. .++.++||||||+++||+++|+.||....... .+.......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLCGSPCPA 240 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChh
Confidence 7543222 222346679999988654 46889999999999999999999997542211 111111100000 0
Q ss_pred hhhhhhc--------C------C--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVR--------G------T--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~--------~------~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... . . ......+..+.+++.+||+.+|.+|| +.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 0 0 00112356789999999999999999 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=224.45 Aligned_cols=229 Identities=16% Similarity=0.157 Sum_probs=174.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++.. ++..+++|.... .+..+.+. .......++. |+|++++.+.+...+..++||||+++++|
T Consensus 12 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~--~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd05581 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK--IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGEL 89 (280)
T ss_pred CCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHH--HHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcH
Confidence 567899999976 455556665432 01111110 0001222666 99999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--------
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-------- 148 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------- 148 (257)
.+++.. ...+++.++..++.|++.||.+||++ +++|+|++|+||+++.++.++++|||++.......
T Consensus 90 ~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 164 (280)
T cd05581 90 LQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164 (280)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCC
Confidence 999974 45799999999999999999999999 99999999999999999999999999877543222
Q ss_pred ---------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 149 ---------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 149 ---------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
....++..|++||......++.++|+||||++++++++|..||..... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~--------- 232 (280)
T cd05581 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ--------- 232 (280)
T ss_pred CccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH---------
Confidence 122456679999998888889999999999999999999999975521 11010
Q ss_pred hhhhhhhc-CCCCCHHHHHHHHHHHHHcccCCCCCCC-h----HHHHH
Q 044568 214 RELNKLVR-GTKVDKKNLENLVKVGLWCVQDEPALRP-M----KCAVM 255 (257)
Q Consensus 214 ~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~----~ei~~ 255 (257)
.... ....+...++.+.+++.+||+.+|.+|| + +++++
T Consensus 233 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 ----KILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 1123344467799999999999999999 9 88865
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=235.30 Aligned_cols=184 Identities=17% Similarity=0.245 Sum_probs=155.1
Q ss_pred ccccceeeec-ccCCCCCeeeccc----h----hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVS----W----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~----~----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.|+.|.|+. ..+++.++||-+. | ..|++.+..... ...-.-.|+|+...++...++.|||+|.+. -
T Consensus 197 GtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~---~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~ 272 (586)
T KOG0667|consen 197 GSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNK---HDPDDKYNIVRMLDYFYFRNHLCIVFELLS-T 272 (586)
T ss_pred cccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhc---cCCCCCeeEEEeeeccccccceeeeehhhh-h
Confidence 3577788887 5557788887543 3 344555552221 114456789999999999999999999995 5
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--CceEEeeecccccCCCCccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF--WTAKILDFGLAKLPNEDFVIDK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~--~~~kl~dfg~~~~~~~~~~~~~ 152 (257)
||+++|....-.+++....+.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.+...........
T Consensus 273 NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYi 349 (586)
T KOG0667|consen 273 NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYI 349 (586)
T ss_pred hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcceeee
Confidence 999999987788899999999999999999999999 99999999999999753 4799999999987777767778
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.+..|+|||++.+.+|+.+.|+|||||++.||.+|.+.|.++
T Consensus 350 QSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 350 QSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 888999999999999999999999999999999999888876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=219.12 Aligned_cols=235 Identities=19% Similarity=0.162 Sum_probs=176.1
Q ss_pred ccccceeeeccc-CCCCCeeeccchh--hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT--ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
+.++.+|+++.. ++...++|..... ...+.......-..+.++.|+|++++.+.+......++||||+++++|.+++
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (256)
T cd08530 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI 90 (256)
T ss_pred CCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHH
Confidence 356889998755 4455666654421 1111111111111334788999999999999999999999999999999998
Q ss_pred hcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-cccccCCCCc
Q 044568 81 FCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-FVIDKRDKGY 157 (257)
Q Consensus 81 ~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 157 (257)
.+. ....+++..+..++.|++.|+.|||+. +++|+|++|.||+++.++.++|+|||.+...... .....++..|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 167 (256)
T cd08530 91 SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHY 167 (256)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccc
Confidence 642 235689999999999999999999999 9999999999999999999999999988754332 2334567789
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVG 237 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 237 (257)
++||.+.+..++.++|+||+|+++||+++|+.||...... ...... .... ....+......+.+++
T Consensus 168 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---------~~~~--~~~~~~~~~~~~~~li 233 (256)
T cd08530 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV---------QRGK--YPPIPPIYSQDLQNFI 233 (256)
T ss_pred cCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---------hcCC--CCCCchhhCHHHHHHH
Confidence 9999998888899999999999999999999999754211 000000 0000 1122335567799999
Q ss_pred HHcccCCCCCCC-hHHHHH
Q 044568 238 LWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 238 ~~cl~~~p~~RP-~~ei~~ 255 (257)
.+||+.+|++|| +.|+++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHcCCCcccCCCHHHHhc
Confidence 999999999999 999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=238.83 Aligned_cols=203 Identities=21% Similarity=0.289 Sum_probs=164.4
Q ss_pred hhhhHHHHhHhhhccccccccCCceeeeceeeeecCc--eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 044568 27 WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV--SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGI 104 (257)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l 104 (257)
|.+|+.++. .+.|+||+++...+..... ..+|+|+|..|+|.++.. ..+.++....+.|++||+.||
T Consensus 88 ~~~Ev~lLK---------sL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL 156 (632)
T KOG0584|consen 88 LYSEVHLLK---------SLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGL 156 (632)
T ss_pred HHHHHHHHc---------cCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHh
Confidence 455565665 8999999999999987765 678999999999999998 456677789999999999999
Q ss_pred HHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCCc-ccccCCCCccCcccccCCCCCccccchhHHHHHH
Q 044568 105 LYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNEDF-VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLL 182 (257)
Q Consensus 105 ~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~ 182 (257)
.|||++ +|+|+|||||.+||++.+ .|.+||+|+|++....... ....|||.|||||+.. ..|+...||||||++++
T Consensus 157 ~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmL 234 (632)
T KOG0584|consen 157 VYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCML 234 (632)
T ss_pred hhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHH
Confidence 999999 999999999999999975 5899999999998655443 4569999999999987 67999999999999999
Q ss_pred HHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 183 ETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 183 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
||+|+..||.-...+. ..|+.. ...++|..+.+-..+++.++|.+|+.. ..+|| +.|+++
T Consensus 235 EMvT~eYPYsEC~n~A-------QIYKKV-----~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 235 EMVTSEYPYSECTNPA-------QIYKKV-----TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhccCChhhhCCHH-------HHHHHH-----HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999999997442111 112211 122222233333457788999999999 99999 999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=231.96 Aligned_cols=232 Identities=18% Similarity=0.225 Sum_probs=167.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lV 67 (257)
+.++.||++... ++..+++|.... .+|++.+. +++|+|++++.+.+... ...++|
T Consensus 16 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 16 GAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILR---------RFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred cCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHH---------hCCCCCcCchhheeecccccccceEEEE
Confidence 467899999854 456677776531 22333333 78899999999876644 357899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
+||++ ++|.+.+. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 87 QELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99996 58888884 45799999999999999999999999 9999999999999999999999999988653321
Q ss_pred c------ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh---hhhh
Q 044568 148 F------VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN---RELN 217 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~ 217 (257)
. ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... ....+. ..... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~-~~~~~~~~~~~~ 235 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLIL-GVLGTPSQEDLN 235 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-HHcCCCCHHHHH
Confidence 1 22356778999998754 457899999999999999999999996542111 000000 00000 0000
Q ss_pred --------hhhc----CCCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 --------KLVR----GTKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 --------~~~~----~~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... ....+ ......+.+++.+||+.+|++|| +.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 00000 12246788999999999999999 999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=231.07 Aligned_cols=234 Identities=15% Similarity=0.151 Sum_probs=169.2
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV 67 (257)
+.++.||++.... +..+++|.... .+|++. +.++.|+|++++.+.+.. ....++|
T Consensus 16 g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~---------l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 16 GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKI---------LRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHH---------HHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 4578899998654 55666665432 123333 337889999999887653 3467899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+. |+|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 87 MDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred Eehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99996 69999987 445699999999999999999999999 9999999999999999999999999988643221
Q ss_pred c-------ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh--------
Q 044568 148 F-------VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-------- 211 (257)
Q Consensus 148 ~-------~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 211 (257)
. ....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ +........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVLN 237 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhhh
Confidence 1 23356778999999865 4578999999999999999999999975422111 110000000
Q ss_pred --hhhhhhhhh---cCC-CC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 212 --INRELNKLV---RGT-KV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 212 --~~~~~~~~~---~~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......... ... .. .......+.+++.+||+.+|.+|| ++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000011111 100 11 122457899999999999999999 999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=222.41 Aligned_cols=220 Identities=16% Similarity=0.149 Sum_probs=167.7
Q ss_pred ccccceeeecc----cCCCCCeeeccch-------------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSF----NARNSPWISRVSW-------------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~----~~~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||+++. .++..+++|.... .+|++.+. ++ .|+|++.+...+......+
T Consensus 11 G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE---------HIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred CCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHH---------hcccCCChhceeeEeecCCeEE
Confidence 45788998875 3566677775432 22333333 55 4899999999999889999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++++|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLS--QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999997 445688899999999999999999999 99999999999999999999999999887543
Q ss_pred CCc----ccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 146 EDF----VIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 146 ~~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
... ....++..|++||.+... .++.++|+||||+++|++++|..||.......... .+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~~~---------~~ 224 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA---EISR---------RI 224 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH---HHHH---------Hh
Confidence 221 234567789999998753 46789999999999999999999997542211111 1100 11
Q ss_pred hc-CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 220 VR-GTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 220 ~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
.. ....+......+.+++.+||+.||.+||
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 11 1123444567889999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=245.84 Aligned_cols=235 Identities=18% Similarity=0.211 Sum_probs=175.2
Q ss_pred ccccceeeecccC--------CCCCeeeccc---hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA--------RNSPWISRVS---WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~--------~~~~~i~~~~---~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+-|+.|++|.+.. .-.+++|... ...+.+.+...+.- .+.-..|+|++++.+.+...+..++|+||+.
T Consensus 307 g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~-m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~ 385 (609)
T KOG0200|consen 307 GAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNV-LKELGKHPNIVNLLGACTQDGPLYVIVEYAE 385 (609)
T ss_pred ccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHH-HHHhcCCcchhhheeeeccCCceEEEEEecc
Confidence 4567788877442 2334555432 12223322222221 2335569999999999999999999999999
Q ss_pred CCCHHHHHhccC------C--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeee
Q 044568 73 NGSLTDIIFCSA------E--------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 73 ~gsL~~~l~~~~------~--------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
+|+|.++++... . ..++..+.+.++.||+.|++||+++ +++|||+.++|||+..+..+|++||
T Consensus 386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDF 462 (609)
T KOG0200|consen 386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADF 462 (609)
T ss_pred CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccc
Confidence 999999998532 0 2388899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCccc----ccC--CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhh
Q 044568 139 GLAKLPNEDFVI----DKR--DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 139 g~~~~~~~~~~~----~~~--~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
|+++........ ..+ ...|+|||.+....|+.+|||||||+++||+++ |..||.+-. ...+. ..+
T Consensus 463 Glar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l--~~~----- 534 (609)
T KOG0200|consen 463 GLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEEL--LEF----- 534 (609)
T ss_pred cceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHH--HHH-----
Confidence 999853332211 111 223999999999999999999999999999999 889987521 11111 111
Q ss_pred hhhhhhhhhcCC--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVRGT--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+-++. ..|..+..++..+++.||+.+|++|| +.|+.+.|
T Consensus 535 -------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 535 -------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred -------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 11111 44667788999999999999999999 99998754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=227.91 Aligned_cols=236 Identities=15% Similarity=0.119 Sum_probs=168.2
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeec--CceeEEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLT--SVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~~lV~ 68 (257)
+.++.||+|.... +..+++|+.. +.+|++.+. ++ .|+|++++.+.+... ...++||
T Consensus 18 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 18 GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQ---------ELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred CCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHH---------HhcCCCCccceeeeeccCCCceEEEEe
Confidence 4578999998764 4556666542 122333333 77 899999999987654 3679999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||++ ++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 89 e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 89 EYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred cccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9997 599999863 2788999999999999999999999 99999999999999999999999999887432211
Q ss_pred --------ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhh
Q 044568 149 --------VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFI 212 (257)
Q Consensus 149 --------~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~ 212 (257)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||................. ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 22346778999998765 4578899999999999999999999975422211100000000 0000
Q ss_pred hhhhhhhhc----CC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 213 NRELNKLVR----GT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 213 ~~~~~~~~~----~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+++ .. ......+..+.+++.+||+.||.+|| +.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000001110 00 11112457789999999999999999 999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=225.38 Aligned_cols=238 Identities=18% Similarity=0.144 Sum_probs=167.9
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC--------c
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--------V 63 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--------~ 63 (257)
+.++.||+++... +..+++|... +.+|++.+. +++|+|++++.+.+.... .
T Consensus 19 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK---------KLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHH---------hcCCCCccchhhheecccccccccCce
Confidence 4678999999664 4556666542 234555555 888999999988765433 4
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+.+ +|.+.+.. ....+++.++..++.|+++||.|||++ +++|+|++|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 6999999974 78887764 456799999999999999999999999 999999999999999999999999998875
Q ss_pred CCCCc--------------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-
Q 044568 144 PNEDF--------------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV- 207 (257)
Q Consensus 144 ~~~~~--------------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~- 207 (257)
..... ....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 33221 112346679999988654 47899999999999999999999997553222111111000
Q ss_pred ------HHhhhh-hhhhh-hhcCC-C-----CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 208 ------YKCFIN-RELNK-LVRGT-K-----VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 208 ------~~~~~~-~~~~~-~~~~~-~-----~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.. ..... ..... . ......+.+.+++.+||+.||++|| +.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 00000 00000 0 0011226788999999999999999 999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=228.61 Aligned_cols=237 Identities=16% Similarity=0.171 Sum_probs=169.9
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~l 66 (257)
+.++.||+++... +..+++|...- .+|++. +.++.|+|++++.+.+... ...++
T Consensus 16 G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~---------l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 16 GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKL---------LRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred CCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHH---------HHhcCCCCccchHHheecccccccCcEEE
Confidence 4578899998654 55666775431 223333 3378899999998877643 35799
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|+||+. ++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 87 VYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 999996 69999987 456799999999999999999999999 999999999999999999999999999875433
Q ss_pred C---cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhhhhh
Q 044568 147 D---FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFINRE 215 (257)
Q Consensus 147 ~---~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~ 215 (257)
. .....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||................. .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 2 123356778999998865 4588999999999999999999999975422111100100000 0000000
Q ss_pred hhhhh---cCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLV---RGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~---~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... ... .........+.+++.+||+.+|++|| ++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00000 000 01123457789999999999999999 999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=229.16 Aligned_cols=237 Identities=16% Similarity=0.179 Sum_probs=174.2
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-----ceeE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----VSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~l 66 (257)
+.++.||+++... ++.+++|... +.++++.+. .+.|+|++++.+.+...+ ..++
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 11 GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR---------HLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred CCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHH---------hcCCcchhhhhhhhcccCcccccceEE
Confidence 5788999999765 5666676433 223333333 778999999999888765 7899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||++ ++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|.||+++.++.++|+|||.+.....
T Consensus 82 v~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 82 VTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred Eecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 999997 58999987 444899999999999999999999999 999999999999999999999999999875443
Q ss_pred C------cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhh
Q 044568 147 D------FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFI 212 (257)
Q Consensus 147 ~------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~ 212 (257)
. .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||................. ....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 2 2234567779999999877 789999999999999999999999976532111000000000 0000
Q ss_pred hhhhhhhhc---CC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 213 NRELNKLVR---GT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 213 ~~~~~~~~~---~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.......+. .. ......+..+.+++.+||+.+|.+|| ++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000 00 01122356789999999999999999 999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=235.29 Aligned_cols=187 Identities=17% Similarity=0.174 Sum_probs=157.1
Q ss_pred cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcee
Q 044568 47 RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 126 (257)
Q Consensus 47 ~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 126 (257)
.|+|+++..+.+...-+.++|||++.++-+.+.+.. ...+. .++..|+.+++.|+.|||++ |++|||+||+|||
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~--~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS--KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNIL 447 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHh--cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhhee
Confidence 599999999999999999999999999988888763 23333 77888999999999999999 9999999999999
Q ss_pred e-CCCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH
Q 044568 127 M-DEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN 205 (257)
Q Consensus 127 ~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~ 205 (257)
+ ++.++++|+|||.++..........-|..|.|||.+....|++++||||||++||+|++|+.||......
T Consensus 448 ~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------- 519 (612)
T KOG0603|consen 448 LDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------- 519 (612)
T ss_pred ecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------
Confidence 9 5889999999999987666555566778899999999989999999999999999999999999866322
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 206 WVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.++...+....++........+|+.+||+.||.+|| +.++..
T Consensus 520 --------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 --------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 122333333344455567788899999999999999 999853
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=226.68 Aligned_cols=236 Identities=14% Similarity=0.130 Sum_probs=170.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+|++++.+.+...+ ..+
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK---------HMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHH---------hcCCCCccceeeeecCCccccccceEE
Confidence 567889999744 56667777642 123333333 889999999998876543 358
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+ +++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++....
T Consensus 97 lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 97 LVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999999 679999885 35689999999999999999999999 99999999999999999999999999988655
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELN 217 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 217 (257)
.......++..|++||.+.+ ..++.++|+||+|+++|++++|..||................ ..........
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 54445567788999999876 357899999999999999999999997542211111100000 0000000000
Q ss_pred hhhc----CC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVR----GT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~----~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... .. .........+.+++.+|++.||++|| +.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 01122345688999999999999999 999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=220.83 Aligned_cols=238 Identities=18% Similarity=0.153 Sum_probs=173.3
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++... ++.+++|.... .++++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 10 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~---------~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLK---------ELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred cCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHH---------hcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4678899999876 55666664442 22333333 777999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+ ++|.+++.. ....+++..+..++.|++.||.|||++ +++|+|++|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 7 599999975 335799999999999999999999999 99999999999999999999999999887543322
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhh-hhhhh
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINR-ELNKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~ 219 (257)
.....+..|+|||.+... .++.++|+||||+++||+++|..||................ +.....- .....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223445679999998766 68899999999999999999999997653211100000000 0000000 00000
Q ss_pred hcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.. .........+.+++.+||+.+|++|| +.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00011246799999999999999999 999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=226.43 Aligned_cols=232 Identities=16% Similarity=0.157 Sum_probs=167.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.++.||++... ++..+++|... +.++++++. ++.|+|++++.+.+.... ..+
T Consensus 26 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK---------HMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred cCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHH---------hcCCCCccchhheecccccCCCCceEE
Confidence 467889999854 56667777543 123344443 788999999998876543 468
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+|+||+. .+|.+++. ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||+++...
T Consensus 97 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 97 LVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 9999996 47777652 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH----------hhhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK----------CFINR 214 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~ 214 (257)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ ....... .....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhccc
Confidence 44444566778999999876 4578999999999999999999999975421111 1100000 00000
Q ss_pred hhhhhhcC-CCC--------CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRG-TKV--------DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~-~~~--------~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........ ... .......+.+++.+||+.||++|| ++|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 000 011345688999999999999999 999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=236.83 Aligned_cols=187 Identities=16% Similarity=0.201 Sum_probs=154.5
Q ss_pred ccccceeeec-ccCCCCCeeeccch-----hhhHHHHhHhhhccccccccCCceeeeceeeeec------CceeEEEeec
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~lV~E~~ 71 (257)
+.++.||+|. -..|+.+|||..+- +.+.....+.... ++.|+|||+..++-... +...+|||||
T Consensus 24 Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eieilk----KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 24 GAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILK----KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred CccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHH----HcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 4689999999 77888889987663 2333333333333 88899999998877653 4778999999
Q ss_pred CCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CC--ceEEeeecccccCCC
Q 044568 72 RNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FW--TAKILDFGLAKLPNE 146 (257)
Q Consensus 72 ~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~--~~kl~dfg~~~~~~~ 146 (257)
.+|||...+.+. +..+|++.+.+.++.+++.||.|||++ +|+||||||.||++.. ++ ..||+|||.++..+.
T Consensus 100 ~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d 176 (732)
T KOG4250|consen 100 SGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD 176 (732)
T ss_pred CCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence 999999999865 456899999999999999999999999 9999999999998843 23 369999999997654
Q ss_pred Cc--ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCC
Q 044568 147 DF--VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASK 197 (257)
Q Consensus 147 ~~--~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~ 197 (257)
.. .+..||..|++||.+.. ..|+...|.|||||++|+++||..||-....+
T Consensus 177 ~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 177 NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 43 67789999999999984 77899999999999999999999999765444
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=221.56 Aligned_cols=183 Identities=21% Similarity=0.223 Sum_probs=158.9
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
..+||.+..+--.++..+..|+||||..||.|.-+|. ..+.+++...+.+...|++||.|||++ +|++||+|.+|
T Consensus 224 ~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLEN 298 (516)
T KOG0690|consen 224 NCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLEN 298 (516)
T ss_pred hccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC---Ceeeeechhhh
Confidence 7789999999999999999999999999999999997 578899999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeeccccc---CCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH
Q 044568 125 ILMDEFWTAKILDFGLAKL---PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI 201 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~ 201 (257)
.+++.+|++|+.|||+++. .+......+||+.|+|||++....|+.+.|+|.+|+++|||++|+.||...+..
T Consensus 299 LlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---- 374 (516)
T KOG0690|consen 299 LLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---- 374 (516)
T ss_pred heeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----
Confidence 9999999999999999974 344557789999999999999999999999999999999999999999855211
Q ss_pred HHHHHHHHhhhhhhhhh--hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 202 ILTNWVYKCFINRELNK--LVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 202 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
.+-. +.....+|....++...|+...|.+||.+|.
T Consensus 375 -------------kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 375 -------------KLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -------------HHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1111 1122245666667778888899999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=225.96 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=177.0
Q ss_pred ccccceeeecccCCCCCeeeccc------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC----ceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS----VSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----~~~lV~E~~~~ 73 (257)
++|+.||||++.+ +.++||... |.+|-+.++ ...+.|+||+++.+.-+..+ ..+||+||.+.
T Consensus 221 Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~-------lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 221 GRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYS-------LPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred CccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHh-------ccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 6899999999988 788888765 445554444 44778999999999988777 89999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeeeccCCCCceeeCCCCceEEeeecccccCCC-
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE- 146 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~- 146 (257)
|||.++| ...+.+|....+++..++.||+|||+-- +++|+|||+|..|||+.++++..|+|||++.+...
T Consensus 293 GsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 293 GSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred CcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 9999999 5578999999999999999999999863 67899999999999999999999999999876432
Q ss_pred ----CcccccCCCCccCcccccCCC-CC-----ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHH---------HHH
Q 044568 147 ----DFVIDKRDKGYMAPECYKRTP-IS-----VKADVYGYGIVLLETICCRKNMEIDASKPEEIILT---------NWV 207 (257)
Q Consensus 147 ----~~~~~~~~~~~~aPE~~~~~~-~~-----~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~---------~~~ 207 (257)
+.....||.+|||||++.+.. +. .+.||||+|.++||++++-.-++....++...... .-.
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 224578999999999997542 22 46899999999999998654442110111000000 000
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+........+..++...........+.+.+..||+.||+.|. +.-+-+
T Consensus 450 q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 450 QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 111111111122221111224467889999999999999999 665543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=227.06 Aligned_cols=236 Identities=16% Similarity=0.182 Sum_probs=170.6
Q ss_pred ccccceeeecccCC-CCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCc------ee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV------SG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~------~~ 65 (257)
+.++.||+++...+ ..+++|.... .++++ .+.++.|+|++++.+.+...+. .+
T Consensus 26 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~---------~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR---------LLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred CCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHH---------HHHhccCCCHHHHHHHhhccccccccccEE
Confidence 45789999997654 4556665432 12222 3347889999999887765554 89
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+|+||+ +++|.+++.. ..+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 97 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 97 LVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 999999 5699999953 5699999999999999999999999 99999999999999999999999999987655
Q ss_pred CCcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELN 217 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 217 (257)
.......++..|+|||.+.+. .++.++|+||||+++||+++|+.||...........+.... ..........
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 444455677789999998653 57899999999999999999999997542211100000000 0000000011
Q ss_pred hhhcCC---------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT---------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+... .........+.+++.+||+.+|++|| +.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 111100 00011256789999999999999999 999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=222.78 Aligned_cols=245 Identities=14% Similarity=0.120 Sum_probs=169.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch--hhhHHHHhHhhhccccccccCCceeeeceeeeec------CceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~lV~E~~~~g 74 (257)
+.++.||++... ++..+++|...- ............-..+.+++|+|++++.+.+... ...+++++++ ++
T Consensus 28 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~ 106 (345)
T cd07877 28 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA 106 (345)
T ss_pred cCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-cc
Confidence 567889999854 566667776531 1110000000000133388999999998877543 3468888887 67
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCC
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD 154 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (257)
+|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++...........++
T Consensus 107 ~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~ 180 (345)
T cd07877 107 DLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180 (345)
T ss_pred CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccccccccccC
Confidence 9999885 34689999999999999999999999 99999999999999999999999999987655554555678
Q ss_pred CCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhhhhhhhhh---hcCC
Q 044568 155 KGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFINRELNKL---VRGT 223 (257)
Q Consensus 155 ~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~---~~~~ 223 (257)
..|+|||.+.+ ..++.++|+||||+++||+++|+.||................ ............ ++..
T Consensus 181 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (345)
T cd07877 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 260 (345)
T ss_pred CCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhccc
Confidence 88999998866 457889999999999999999999996542211100000000 000000000000 0000
Q ss_pred ---CC---CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 ---KV---DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ---~~---~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+ .....+.+.+++.+|++.||.+|| +.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 261 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 001345688999999999999999 999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=240.43 Aligned_cols=229 Identities=21% Similarity=0.238 Sum_probs=180.8
Q ss_pred cccccceeeecc-cCCCCC----eeeccch-h---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSF-NARNSP----WISRVSW-T---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~----~i~~~~~-~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+-|+.||||-+ .+++.+ +||.+.- . .-.+++. ....+.+++|+|++++.+.+.... ..||++||+.
T Consensus 706 sgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~Ld---eAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~ 781 (1177)
T KOG1025|consen 706 SGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLD---EALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPL 781 (1177)
T ss_pred cccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHH---HHHHHhcCCCchHHHHhhhcccch-HHHHHHhccc
Confidence 356889999984 444443 3444332 1 1122222 222344999999999999999877 8899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccc--
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID-- 151 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 151 (257)
|+|.++++. ...++.....+.|..||++|+.|||++ .++||||.++|+|+.....+|+.|||+++.........
T Consensus 782 G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 782 GCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred chHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 999999987 667788899999999999999999999 99999999999999999999999999998755443221
Q ss_pred -cC--CCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC---C
Q 044568 152 -KR--DKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---K 224 (257)
Q Consensus 152 -~~--~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 224 (257)
.+ .+-|+|-|.+....|+.++||||||+++||++| |..|+++..- .++.++++.. +
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKGERLS 920 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhccccCC
Confidence 22 234999999999999999999999999999999 9999976521 2222333322 5
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.|.-+.-.++-++.+||..|+..|| ++++...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 6777888999999999999999999 9998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=212.95 Aligned_cols=193 Identities=17% Similarity=0.165 Sum_probs=158.1
Q ss_pred cCCceeeeceeeee----cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 044568 47 RGGLLLNVPVRAKL----TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 47 ~h~~i~~~~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 122 (257)
.|+|||++...+.+ .....+|||.|+||.|...+.+.....+++.++..++.||+.|+.|||+. +|.|||+||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKp 189 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKP 189 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCCh
Confidence 59999999987775 34556899999999999999987888899999999999999999999999 999999999
Q ss_pred CceeeC---CCCceEEeeecccccCC--CCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCC
Q 044568 123 QNILMD---EFWTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASK 197 (257)
Q Consensus 123 ~nil~~---~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~ 197 (257)
+|+|.. .+..+||+|||+++... ......+.|+.|.|||.+....|+...|+||+|+++|-|++|.+||.+....
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred hheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 999986 45679999999998755 4456778899999999999888999999999999999999999999865332
Q ss_pred hhhHHHHHHHHHhhhhhhhhhhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 198 PEEIILTNWVYKCFINRELNKLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.-... ....+... +......+...++++.+|..+|.+|. +.|++.
T Consensus 270 aispg-------------Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 270 AISPG-------------MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCChh-------------HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 21111 11111111 12233457788999999999999999 998864
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=230.49 Aligned_cols=223 Identities=15% Similarity=0.153 Sum_probs=180.2
Q ss_pred ccccceeeec-ccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSS-FNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~-~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
++|+.|..++ -+++.+++||-.. +.+|++.+. .+.|||||++..........++||||+
T Consensus 67 g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk---------~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 67 GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMK---------SLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHH---------hcCCcceeeeeeeeeecceeEEEEEec
Confidence 5677787777 4566677776433 234444444 899999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--Ccc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DFV 149 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~~ 149 (257)
.+|.+.+++. ....+.+..+..++.|+++|++|||++ +|+|||||+.|++++.+.++||+|||++..... ...
T Consensus 138 ~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 138 SGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred cCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 9999999998 566777799999999999999999999 999999999999999999999999999886543 336
Q ss_pred cccCCCCccCcccccCCCCC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPIS-VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
..+|++.|.|||.+.+..|. +++|+||+|+++|-++.|..||++..-.. ..... +......+.-
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------Lr~rv---l~gk~rIp~~ 277 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------LRPRV---LRGKYRIPFY 277 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------------ccchh---eeeeecccce
Confidence 77899999999999988874 89999999999999999999998652111 00001 1111134445
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+++.+++-.+|.+|+ +++|.+
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhh
Confidence 556788888999999999999 998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=220.65 Aligned_cols=236 Identities=16% Similarity=0.119 Sum_probs=165.7
Q ss_pred ccccceeeecccCC---CCCeeeccch-----------hhhHHHHhHhhhccccccc-cCCceeeeceeeee----cCce
Q 044568 4 TKLSNFYRSSFNAR---NSPWISRVSW-----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKL----TSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~---~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~----~~~~ 64 (257)
+.++.||++..... ..+++|...- .+|++.+. ++ .|+|++++.+.+.. ....
T Consensus 11 G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 11 GAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLR---------HFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred cCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHH---------HhcCCCChheeeeeeeeccccCCcE
Confidence 46789999997653 4566775431 22333222 45 49999999886543 2457
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
++++||+. ++|.+.+. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 88999986 69999986 556799999999999999999999999 9999999999999999999999999998743
Q ss_pred CCC-------cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH------------HHH
Q 044568 145 NED-------FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI------------ILT 204 (257)
Q Consensus 145 ~~~-------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~------------~~~ 204 (257)
... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|..||.......... .+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 122356788999998765 468899999999999999999999997542111000 000
Q ss_pred HHHHHhhhhhhhhhhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 205 NWVYKCFINRELNKLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..+.. .......-... .........+.+++.+||+.||++|| +.|+++
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKA-QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhH-HHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 00111246788999999999999999 999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=209.51 Aligned_cols=225 Identities=19% Similarity=0.176 Sum_probs=175.2
Q ss_pred ccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 6 LSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 6 ~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
++.+|++.... ++.+++|.... .++++.+. ++.|++++++.+.+...+..++++||++++
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~---------~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 72 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILK---------KLKHPNIVRLYDVFEDEDKLYLVMEYCDGG 72 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH---------hCCCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence 67899999875 66677776543 23333333 678999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--ccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~ 152 (257)
+|.+++.. ...+++..+..++.+++.++.+||+. +++|+|++|.||++++++.++++|||.+...... .....
T Consensus 73 ~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 147 (244)
T smart00220 73 DLFDLLKK--RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFV 147 (244)
T ss_pred CHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccccccccc
Confidence 99999974 23388999999999999999999999 9999999999999999999999999998765442 34456
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
++..|++||.+....++.++|+||+|+++|++++|..||....... ....... . ............+..
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~~~~~~~----~----~~~~~~~~~~~~~~~ 216 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---ELFKKIG----K----PKPPFPPPEWKISPE 216 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHh----c----cCCCCccccccCCHH
Confidence 6778999999988888999999999999999999999997531111 0000000 0 000000111114567
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++.+||..+|++|| +.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999 999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=223.35 Aligned_cols=236 Identities=13% Similarity=0.147 Sum_probs=164.3
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeec------------
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------------ 61 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------------ 61 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.....
T Consensus 16 g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIR---------RLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHH---------hcCCCcchhhHhhhccccccccccccccc
Confidence 5678999998654 5566666543 234444444 88899999988655543
Q ss_pred --CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeee
Q 044568 62 --SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDF 138 (257)
Q Consensus 62 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~df 138 (257)
...++||||++ ++|.+++. ...+++..+..++.|+++||.|||++ +++|+||+|+||+++. ++.++++||
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 59998885 34689999999999999999999999 9999999999999974 557899999
Q ss_pred cccccCCCCc------ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH-H----
Q 044568 139 GLAKLPNEDF------VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN-W---- 206 (257)
Q Consensus 139 g~~~~~~~~~------~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~-~---- 206 (257)
|.+....... ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.............. .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9886532211 22345677999998754 4578899999999999999999999975422111100000 0
Q ss_pred --HHHhhhhhhhhhhh---cCCC-----CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 207 --VYKCFINRELNKLV---RGTK-----VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 207 --~~~~~~~~~~~~~~---~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.............. .... ........+.+++.+||+.||++|| +.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000 0000 0112346788999999999999999 999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=218.47 Aligned_cols=223 Identities=20% Similarity=0.176 Sum_probs=180.9
Q ss_pred ccceeeecccCCCCC-eeeccc----hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 6 LSNFYRSSFNARNSP-WISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~-~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
.+.||++-..+.+.+ +||++. ++.+++-+++ +.....+.+|+++|.....+..++|||||.-||+.+++
T Consensus 46 YGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISI------MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~ 119 (502)
T KOG0574|consen 46 YGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISI------MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIM 119 (502)
T ss_pred chHHHHHHHhccCcEEEEEecCccchHHHHHHHHHH------HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHH
Confidence 355677766665554 577755 4566665553 22456788999999998999999999999999999999
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---ccccCCCCc
Q 044568 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VIDKRDKGY 157 (257)
Q Consensus 81 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~ 157 (257)
+- .+++|++.+...++.+.+.||+|||.. .-+|||||+.|||+.-+|..||+|||++-....+. ....||+.|
T Consensus 120 R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFW 195 (502)
T KOG0574|consen 120 RA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFW 195 (502)
T ss_pred HH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCccc
Confidence 86 778999999999999999999999999 99999999999999999999999999986554443 456899999
Q ss_pred cCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc---CC--CCCHHHHHH
Q 044568 158 MAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR---GT--KVDKKNLEN 232 (257)
Q Consensus 158 ~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~ 232 (257)
+|||++..-.|+.++||||+|+...||.-|++||..-.+-. ..-+++ +. .-+.....+
T Consensus 196 MAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-----------------AIFMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 196 MAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-----------------AIFMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred ccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-----------------eeEeccCCCCCCCCChHhhhhH
Confidence 99999999999999999999999999999999997431100 001111 11 235667788
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++..||-++|++|- +.++++
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhh
Confidence 99999999999999999 888765
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=206.81 Aligned_cols=236 Identities=16% Similarity=0.185 Sum_probs=171.1
Q ss_pred ccccceeeecccCCCCC-eeeccch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.|.+..+..++.. ++|+..- ..|.+-+-.-+.- -+....-+.||+..|++......++.||.|. ..++..
T Consensus 103 GtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldv-v~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekL 180 (391)
T KOG0983|consen 103 GTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDV-VLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKL 180 (391)
T ss_pred CCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhH-HhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHH
Confidence 45677888887765444 4665431 2222221111111 1113335889999999999999999999994 356666
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCCCCc
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRDKGY 157 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~ 157 (257)
+.. -...+++...-++...+++||.||-++ ++|+|||+||+|||+|+.|++|++|||.+-+.... .....|.+.|
T Consensus 181 lkr-ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~Y 257 (391)
T KOG0983|consen 181 LKR-IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAY 257 (391)
T ss_pred HHH-hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccccccccCCccc
Confidence 654 556688888889999999999999887 59999999999999999999999999998754433 3566788899
Q ss_pred cCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 158 MAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 158 ~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+|||.+. +..|+.++||||||+.++|+.||+.||.+...+- ..+... .+.+. ..+++. ....+.+.
T Consensus 258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkv-----ln~eP-P~L~~~---~gFSp~F~ 326 (391)
T KOG0983|consen 258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKV-----LNEEP-PLLPGH---MGFSPDFQ 326 (391)
T ss_pred cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHH-----HhcCC-CCCCcc---cCcCHHHH
Confidence 9999986 3468999999999999999999999998753221 111111 11111 222222 12557789
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++..||.+|+.+|| -.++++
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhc
Confidence 999999999999999 998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=216.30 Aligned_cols=236 Identities=23% Similarity=0.265 Sum_probs=182.1
Q ss_pred ccccceeeecccCCCCCeeeccc------hhhhHHHHhHhhhccccccccCCceeeeceeeeec----CceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT----SVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----~~~~lV~E~~~~ 73 (257)
+.+++|.||++ .|+.+++|-+. +.+|.|.+. -.-+||+||+.+++....+ .+.+||++|.++
T Consensus 222 GRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYq-------TvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 222 GRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQ-------TVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred ccccceeeccc-cCCceEEEEecccchhhhhhHHHHHH-------HHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 56889999998 47888988654 566676665 2356799999998877654 378899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-----~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
|||.|+|. ..+++....++++..+++||.|||.. ++|.|.|||||+.|||+.+++.+-|+|+|++......
T Consensus 294 GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t 370 (513)
T KOG2052|consen 294 GSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT 370 (513)
T ss_pred CcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccC
Confidence 99999994 47899999999999999999999964 5889999999999999999999999999998754333
Q ss_pred ------cccccCCCCccCcccccCCC----CC--ccccchhHHHHHHHHHhc----------CCCCCcCCCChhhHHHHH
Q 044568 148 ------FVIDKRDKGYMAPECYKRTP----IS--VKADVYGYGIVLLETICC----------RKNMEIDASKPEEIILTN 205 (257)
Q Consensus 148 ------~~~~~~~~~~~aPE~~~~~~----~~--~~~Di~s~G~~l~el~~g----------~~pf~~~~~~~~~~~~~~ 205 (257)
.....||.+|||||++...- +. ..+||||||.++||++-+ +.||..-.+.+.....
T Consensus 371 ~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee-- 448 (513)
T KOG2052|consen 371 DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE-- 448 (513)
T ss_pred CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH--
Confidence 36779999999999997532 21 468999999999999852 4677654333221110
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHH
Q 044568 206 WVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCA 253 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei 253 (257)
..+..-...++..+++...+.+....+.+++..||..+|..|- +=-|
T Consensus 449 -MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 449 -MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred -HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 0111112334455555566788889999999999999999998 5433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=232.37 Aligned_cols=132 Identities=17% Similarity=0.195 Sum_probs=106.5
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh-----hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA-----DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++... ++..+++|.+.... ..+.+. ..-..+..++|+||+++...+...+..+|||||+.+++|.
T Consensus 15 G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~--~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~ 92 (669)
T cd05610 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQ--AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92 (669)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHH--HHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHH
Confidence 568899999977 45667777654210 011111 0011223778999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++
T Consensus 93 ~li~--~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 93 SLLH--IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9997 345688899999999999999999999 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=214.07 Aligned_cols=182 Identities=19% Similarity=0.234 Sum_probs=157.4
Q ss_pred cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcee
Q 044568 47 RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 126 (257)
Q Consensus 47 ~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil 126 (257)
+.+.++++...++..+..|+||||+.||+|--+|+ +-+.+.+..+..++..|+-||-+||++ +|++||||.+|++
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvm 482 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVM 482 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceE
Confidence 56788899999999999999999999999999997 667888899999999999999999999 9999999999999
Q ss_pred eCCCCceEEeeeccccc---CCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHH
Q 044568 127 MDEFWTAKILDFGLAKL---PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203 (257)
Q Consensus 127 ~~~~~~~kl~dfg~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~ 203 (257)
++.+|++||+|||+++. .+.+....+||+.|+|||++...+|+..+|+||||++||||+.|++||+++++.+ ..
T Consensus 483 Ld~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF 559 (683)
T KOG0696|consen 483 LDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF 559 (683)
T ss_pred eccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HH
Confidence 99999999999999874 2344467799999999999999999999999999999999999999999773222 11
Q ss_pred HHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 204 TNWVYKCFINRELNKLVR-GTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
+++.+ .-.+|+....+...++...+.+.|.+|.
T Consensus 560 -------------~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 560 -------------QAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------------HHHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 12222 2256677777888888999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=227.10 Aligned_cols=240 Identities=18% Similarity=0.118 Sum_probs=150.3
Q ss_pred ccccceeeecccCC-----CCCeeeccchhhhHHHHhHhhhccccccccCCceeeecee------eeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNAR-----NSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVR------AKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~------~~~~~~~~lV~E~~~ 72 (257)
+.|+.||+++...+ ..+++|+..-..+.+........ +..+.++..+... ....+..+|||||++
T Consensus 143 G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~----~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~ 218 (566)
T PLN03225 143 GAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVR----RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEG 218 (566)
T ss_pred CCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHH----hhchhhHHHHHHhhhcccccccCCceEEEEEecC
Confidence 67899999998764 66778875532222211100000 1111111111111 345678899999999
Q ss_pred CCCHHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCce
Q 044568 73 NGSLTDIIFCSAER------------------NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTA 133 (257)
Q Consensus 73 ~gsL~~~l~~~~~~------------------~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~ 133 (257)
+++|.+++...... ......+..++.|++.||.|||++ +|+||||||+|||++. ++.+
T Consensus 219 ~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~~~ 295 (566)
T PLN03225 219 ESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSF 295 (566)
T ss_pred CCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCCcE
Confidence 99999999642100 011234567999999999999999 9999999999999985 5789
Q ss_pred EEeeecccccCCCC----cccccCCCCccCcccccCC----------------------CCCccccchhHHHHHHHHHhc
Q 044568 134 KILDFGLAKLPNED----FVIDKRDKGYMAPECYKRT----------------------PISVKADVYGYGIVLLETICC 187 (257)
Q Consensus 134 kl~dfg~~~~~~~~----~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Di~s~G~~l~el~~g 187 (257)
||+|||++...... .....+++.|+|||.+... .++.++|||||||++|||+++
T Consensus 296 KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~ 375 (566)
T PLN03225 296 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFP 375 (566)
T ss_pred EEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhC
Confidence 99999998743221 1344678899999965422 133466999999999999997
Q ss_pred CCCCCcCCCChhhHHHHHHHHH-hhhhhhhhhhhcCC---------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 188 RKNMEIDASKPEEIILTNWVYK-CFINRELNKLVRGT---------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 188 ~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..|++.. .......... ......+.....+. ...+......++|+.+||+.||++|| ++|+++
T Consensus 376 ~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 376 NLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred cCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 7765422 1111100000 00001111111111 11111234567899999999999999 999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=222.02 Aligned_cols=189 Identities=17% Similarity=0.142 Sum_probs=164.1
Q ss_pred cccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 044568 43 CTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 43 ~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 122 (257)
+-..+.+.||+++-.+.+....|+.||-|-||.|..+++ ..+.+...+++.++..+++|++|||++ +|++|||||
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKP 548 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKP 548 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCCh
Confidence 336678999999999999999999999999999999998 567899999999999999999999999 999999999
Q ss_pred CceeeCCCCceEEeeecccccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhh
Q 044568 123 QNILMDEFWTAKILDFGLAKLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEE 200 (257)
Q Consensus 123 ~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~ 200 (257)
+|++++.+|.+||.|||+++..... ....+||+.|.|||++.+...+.++|.||+|+++||+++|++||.+.++-
T Consensus 549 ENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--- 625 (732)
T KOG0614|consen 549 ENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--- 625 (732)
T ss_pred hheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---
Confidence 9999999999999999999975543 35668999999999999999999999999999999999999999866321
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 201 IILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
..-..+..-++-..+|....++..+|+++....+|.+|.
T Consensus 626 ----------ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 626 ----------KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred ----------HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhh
Confidence 111223334444467777888889999999999999996
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=231.82 Aligned_cols=145 Identities=17% Similarity=0.184 Sum_probs=131.8
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
....+.|+++.-.+++.+..|+|||||+||+|...+.+. + .+|++.++.|+..++.||.-+|+. |+|||||||+|
T Consensus 131 ~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~-~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDN 205 (1317)
T KOG0612|consen 131 FGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF-D-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDN 205 (1317)
T ss_pred cCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc-C-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcce
Confidence 555788999999999999999999999999999999852 3 899999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeecccccCCCCc----ccccCCCCccCccccc----C-CCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 125 ILMDEFWTAKILDFGLAKLPNEDF----VIDKRDKGYMAPECYK----R-TPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~aPE~~~----~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
||+|..|++||+|||.+-.+..++ ....|||-|.+||++. + +.|+...|+||+|+++|||++|.+||..+
T Consensus 206 vLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 206 VLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred eEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 999999999999999887665443 5668999999999996 2 56899999999999999999999999855
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=221.07 Aligned_cols=224 Identities=15% Similarity=0.240 Sum_probs=178.4
Q ss_pred cccccceeeecccCC-CCCeeeccc---h--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 3 CTKLSNFYRSSFNAR-NSPWISRVS---W--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~-~~~~i~~~~---~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+++|+.||.|+...+ ..++||.++ | .+|+..+. .+.||-|+++...+...+..+.|||-
T Consensus 574 SGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq---------~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 574 SGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQ---------NLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred CCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHH---------hcCCCCeeEEEEeecCCceEEEEehh
Confidence 679999999997654 555665433 3 45555555 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCC
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~ 147 (257)
+. |+..++|-.++.++|++.....+..||+.||.|||.+ +|+|+||||+|+|+.. -..+||+|||++++++..
T Consensus 645 l~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 645 LH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 95 5777776666889999999999999999999999999 9999999999999964 347899999999987755
Q ss_pred c--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 F--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
. .+-.||+.|+|||++.+..|+..-|+||.|+++|--++|..||..+..-.+.+....+ +-+...
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF-------------MyPp~P 787 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF-------------MYPPNP 787 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc-------------ccCCCc
Confidence 4 5568999999999999999999999999999999999999999754222222222222 222223
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKC 252 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~e 252 (257)
..+.....+++|...|+..-++|- ...
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 344556778888888888888887 543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=205.46 Aligned_cols=201 Identities=18% Similarity=0.180 Sum_probs=158.5
Q ss_pred eeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--
Q 044568 51 LLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-- 128 (257)
Q Consensus 51 i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-- 128 (257)
.++..+++...++.|||+|.+ |-|+.++|...+-..++...++.++.|+++++.+||+. +++|.||||+|||+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 356778899999999999999 45999999876677899999999999999999999999 999999999999984
Q ss_pred ------------------CCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCC
Q 044568 129 ------------------EFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKN 190 (257)
Q Consensus 129 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~p 190 (257)
.+..++++|||.+............|..|.|||++.+-.++..+||||+||+|.|+.+|...
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 23468999999998877777888899999999999999999999999999999999999999
Q ss_pred CCcCCCChhhHHHHHHH-------------HHhhhhhh------------------hhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 191 MEIDASKPEEIILTNWV-------------YKCFINRE------------------LNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 191 f~~~~~~~~~~~~~~~~-------------~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
|+.....+......... .+.+.... ...+-.-....+.....|.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 98775333211111110 00000000 000001113345566789999999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
+|.+||.+|+ ++|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 9999999999 999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=190.34 Aligned_cols=161 Identities=20% Similarity=0.185 Sum_probs=122.6
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccC
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (257)
|||.+++.. ....+++.++..++.|++.||.|||++ + ||+||+++.++.+++ ||.+...... ...+
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~--~~~g 66 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE--QSRV 66 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--cCCC
Confidence 799999975 456799999999999999999999999 6 999999999999998 9988754432 2367
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHHHH-
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKNLE- 231 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 231 (257)
++.|+|||.+.+..++.++|||||||++|||++|+.||........ ....+... ....... ...+.....
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~------~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNG------MPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHH------hccCCccccccHHHHHhh
Confidence 8999999999999999999999999999999999999965422111 11111100 0000000 011222223
Q ss_pred -HHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 232 -NLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 232 -~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.+.+++.+||+.+|.+|| +.|+++.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHH
Confidence 699999999999999999 9999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=199.16 Aligned_cols=237 Identities=16% Similarity=0.218 Sum_probs=170.0
Q ss_pred cccceeeecccCCCCC-eeeccchh-----------hhHHHHhHhhhccccccccCCceeeeceeeeec--------Cce
Q 044568 5 KLSNFYRSSFNARNSP-WISRVSWT-----------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--------SVS 64 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~-~i~~~~~~-----------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--------~~~ 64 (257)
-|..|+++...+++.- +++.+-+. ++++++. .+.|+|++++..++... ...
T Consensus 29 tfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~---------~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 29 TFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQ---------LLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred hHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHH---------HhcchhHHHHHHHHhhccCCccccccee
Confidence 4566888876665554 66554432 3444444 77899999998877642 358
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
||||.+|++ +|..++.+ ....++..+..+++.++.+||.|+|.. .|+|||+|+.|+|++.++.+||+|||+++..
T Consensus 100 ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 999999987 99999975 557899999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCc-------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-------HHH
Q 044568 145 NEDF-------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-------VYK 209 (257)
Q Consensus 145 ~~~~-------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-------~~~ 209 (257)
.... +...-|.-|++||.+.+. .|++..|+|.-||++.||++|++.+++..+...-..+... .|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 4322 233346679999999875 5899999999999999999999999876433321111111 011
Q ss_pred h------hhhhhhhhhhcCC-CCCHH------HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 210 C------FINRELNKLVRGT-KVDKK------NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 210 ~------~~~~~~~~~~~~~-~~~~~------~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. +..-+...+-.+. .--++ ......+|+..++.+||.+|| +.+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1 1111111000000 00000 113667889999999999999 988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=224.01 Aligned_cols=222 Identities=21% Similarity=0.241 Sum_probs=167.8
Q ss_pred cceeeecccCCCCCeeeccc-----h-hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHH
Q 044568 7 SNFYRSSFNARNSPWISRVS-----W-TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDII 80 (257)
Q Consensus 7 ~~~y~~~~~~~~~~~i~~~~-----~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l 80 (257)
.+||+|.+..+ .+++|++- | ++|++.+. ..-.|+|+|++.+.-++..+.||+.|+|.. ||.+++
T Consensus 524 t~Vf~G~ye~R-~VAVKrll~e~~~~A~rEi~lL~--------eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dli 593 (903)
T KOG1027|consen 524 TVVFRGVYEGR-EVAVKRLLEEFFDFAQREIQLLQ--------ESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLI 593 (903)
T ss_pred cEEEEEeeCCc-eehHHHHhhHhHHHHHHHHHHHH--------hccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHH
Confidence 57999999877 78888754 1 45555444 144699999999999999999999999975 999999
Q ss_pred hcc-CCCCC-CHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---C--CceEEeeecccccCCCCc-----
Q 044568 81 FCS-AERNP-YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---F--WTAKILDFGLAKLPNEDF----- 148 (257)
Q Consensus 81 ~~~-~~~~l-~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~--~~~kl~dfg~~~~~~~~~----- 148 (257)
..+ ....+ .......+..|+++|+++||+- +|+||||||.|||++. + ..++|+|||+++......
T Consensus 594 e~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r 670 (903)
T KOG1027|consen 594 ESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR 670 (903)
T ss_pred hccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence 753 11111 1145678899999999999998 9999999999999976 2 468999999998754333
Q ss_pred -ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhc-CCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC-RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....||-+|.|||++....-+.++||+|+||++|+.++| .+||.....++.++...+ ..+..+ . . .
T Consensus 671 ~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~--------~~L~~L-~--~-~ 738 (903)
T KOG1027|consen 671 LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN--------YTLVHL-E--P-L 738 (903)
T ss_pred ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc--------cceeee-c--c-C
Confidence 345778889999999988878899999999999999995 999986643333222111 001111 1 1 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.++ +..+||.+|++.+|..|| +.+|+.
T Consensus 739 ~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 739 PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 678899999999999999 999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.93 Aligned_cols=224 Identities=17% Similarity=0.149 Sum_probs=175.6
Q ss_pred ccceeeecccCCCCCe-eec--cc--hhhhHHHHhHhhhccccccccCCceeeeceeeee-----cCceeEEEeecCCCC
Q 044568 6 LSNFYRSSFNARNSPW-ISR--VS--WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-----TSVSGKIERPVRNGS 75 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~~-i~~--~~--~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~lV~E~~~~gs 75 (257)
.+-||+++.....+-+ +|- .. ...|+|.-.--+.. ...|+|++.+.+++.. +++.+||||||.+||
T Consensus 32 ygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~----~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGS 107 (953)
T KOG0587|consen 32 YGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKK----YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGS 107 (953)
T ss_pred ceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHh----ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCcc
Confidence 4568888865555543 332 22 34444433322222 4469999999998874 579999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~ 152 (257)
..|++.+..+..+.|....-|++.++.|+.+||.+ .++|||+|-.|||+..++.+||.|||++.-...+ .....
T Consensus 108 VTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~i 184 (953)
T KOG0587|consen 108 VTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFI 184 (953)
T ss_pred HHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcC
Confidence 99999987788899999999999999999999999 9999999999999999999999999997644332 35668
Q ss_pred CCCCccCcccccCC-----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc---CC-
Q 044568 153 RDKGYMAPECYKRT-----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR---GT- 223 (257)
Q Consensus 153 ~~~~~~aPE~~~~~-----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 223 (257)
||+.|+|||++... .|+..+|+||+|++..||.-|.+|+...-+ ...++. ..
T Consensus 185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------------------mraLF~IpRNPP 245 (953)
T KOG0587|consen 185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------------------MRALFLIPRNPP 245 (953)
T ss_pred CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------------------hhhhccCCCCCC
Confidence 99999999998643 367899999999999999999999864411 111111 11
Q ss_pred ---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 ---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.-+....+.+.++|..||.+|-++|| +.++++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 22667788999999999999999999 998875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=212.27 Aligned_cols=170 Identities=19% Similarity=0.191 Sum_probs=146.1
Q ss_pred HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 044568 33 VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECE 112 (257)
Q Consensus 33 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 112 (257)
+..+.-..+.+.....+.+|++...+++.+..|+||+|.+||++-.+|. ..+.|++..++.|+..+..|+++.|+.
T Consensus 673 vaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm-- 748 (1034)
T KOG0608|consen 673 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM-- 748 (1034)
T ss_pred hhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc--
Confidence 3444444446668889999999999999999999999999999999987 678899999999999999999999999
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--------------------------------------------
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-------------------------------------------- 148 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------- 148 (257)
|++||||||+|||||.+|++||.|||++.-+.-+.
T Consensus 749 -GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ 827 (1034)
T KOG0608|consen 749 -GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL 827 (1034)
T ss_pred -cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence 99999999999999999999999999975211000
Q ss_pred -ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 207 (257)
....||+.|+|||++....|+...|+||.|++||||+.|+.||-.+.+......+.+|.
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh
Confidence 24478899999999999999999999999999999999999998776665555555654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=231.75 Aligned_cols=173 Identities=17% Similarity=0.232 Sum_probs=125.4
Q ss_pred CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-----------
Q 044568 62 SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF----------- 130 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~----------- 130 (257)
+..+.++|++ +++|.++|.. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++..
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~ 127 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASC 127 (793)
T ss_pred chhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeecccc
Confidence 3456778987 5699999974 456699999999999999999999999 99999999999999654
Q ss_pred --------CceEEeeecccccCCCC-------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHH
Q 044568 131 --------WTAKILDFGLAKLPNED-------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183 (257)
Q Consensus 131 --------~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~e 183 (257)
+.+|++|||+++..... .....+|+.|+|||.+.+..++.++|||||||++||
T Consensus 128 ~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~E 207 (793)
T PLN00181 128 SDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFE 207 (793)
T ss_pred CcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHH
Confidence 44556666665431100 011246777999999999899999999999999999
Q ss_pred HHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 184 TICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 184 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
|++|..|+.... .....+.. ...++. . .........++.+||+.+|.+|| +.|+++
T Consensus 208 Ll~~~~~~~~~~-----~~~~~~~~---------~~~~~~-~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 208 LFCPVSSREEKS-----RTMSSLRH---------RVLPPQ-I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhhCCCchhhHH-----HHHHHHHH---------hhcChh-h-hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999888874220 01111100 011110 0 11123456788899999999999 999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=200.53 Aligned_cols=240 Identities=18% Similarity=0.146 Sum_probs=170.5
Q ss_pred ccccceeeecccCCCCC-eeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSP-WISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.|+.|+|..+...+.. ++|+++..++ .+-+-..... -...-.-+|||++.|+.-.++.++|.||+|. .||+.+
T Consensus 75 G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~-~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDkl 152 (361)
T KOG1006|consen 75 GAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDT-VMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKL 152 (361)
T ss_pred CcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHH-HHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHH
Confidence 45778888887666555 5787765332 2211111111 2224456899999999999999999999995 476655
Q ss_pred H---hccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCC
Q 044568 80 I---FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRD 154 (257)
Q Consensus 80 l---~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~ 154 (257)
. .......+++...-++..-.+.||.||-+. ..|+|||+||+|||++..|.+||+|||.+-..... .+...|.
T Consensus 153 Yk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGC 230 (361)
T KOG1006|consen 153 YKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGC 230 (361)
T ss_pred HHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCC
Confidence 3 344677899988889999999999999886 49999999999999999999999999987532221 2445677
Q ss_pred CCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 155 KGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 155 ~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
.+|+|||.+... .|+.+||+||+|+++||+.||+.|+..-.+.-+ .++. ...+....+.. .....+....
T Consensus 231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe--ql~~-----Vv~gdpp~l~~-~~~~~~~s~~ 302 (361)
T KOG1006|consen 231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE--QLCQ-----VVIGDPPILLF-DKECVHYSFS 302 (361)
T ss_pred ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH--HHHH-----HHcCCCCeecC-cccccccCHH
Confidence 889999998743 489999999999999999999999963211000 0000 00011100111 1112224567
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.+++..|+-+|-..|| ..++.+
T Consensus 303 ~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 303 MVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHHhhcccccCcchhhhhc
Confidence 89999999999999999 998865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=198.13 Aligned_cols=193 Identities=16% Similarity=0.250 Sum_probs=157.4
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQN 124 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~n 124 (257)
.-.||.++-+...++.++..++|.||.+||+|--++. ..+.+|++-++.+...|+.||.|||++ ||++||+|.+|
T Consensus 307 asn~pflvglhscfqtesrlffvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldn 381 (593)
T KOG0695|consen 307 ASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDN 381 (593)
T ss_pred ccCCCeEEehhhhhcccceEEEEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc---Ceeeeeccccc
Confidence 4468999999999999999999999999999988887 667899999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeeeccccc---CCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH
Q 044568 125 ILMDEFWTAKILDFGLAKL---PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI 201 (257)
Q Consensus 125 il~~~~~~~kl~dfg~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~ 201 (257)
+|++..+++||.|+|+++. .+......+||+.|.|||++.+..|....|+|++|++++||+.|+.||+--..+..+.
T Consensus 382 vlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ 461 (593)
T KOG0695|consen 382 VLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM 461 (593)
T ss_pred eEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc
Confidence 9999999999999999874 3444577799999999999999999999999999999999999999998443222211
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 202 ILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
....+.++.....++ ..|.........++..-|++||.+|.
T Consensus 462 ntedylfqvilekqi-------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 462 NTEDYLFQVILEKQI-------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred chhHHHHHHHhhhcc-------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 222222222222111 23444445566777889999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=194.98 Aligned_cols=149 Identities=21% Similarity=0.187 Sum_probs=128.5
Q ss_pred ccccccCCceeeeceeeee-cCceeEEEeecCCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 044568 42 KCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGSLTDIIFCS---AERNPYWNQRVRIALDVAKGILYLHDECEPPILH 117 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 117 (257)
.|+.+.|+|++.+...+-. +...+|++||.++ +|.++|+-+ ..+.++...++.++.||+.|+.|||++ =++|
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlH 155 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLH 155 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heee
Confidence 5669999999999998887 7889999999987 999999633 345689999999999999999999999 8999
Q ss_pred ccCCCCceeeCCC----CceEEeeecccccCCCCcccc------cCCCCccCcccccCCC-CCccccchhHHHHHHHHHh
Q 044568 118 CDIKPQNILMDEF----WTAKILDFGLAKLPNEDFVID------KRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETIC 186 (257)
Q Consensus 118 ~dl~~~nil~~~~----~~~kl~dfg~~~~~~~~~~~~------~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~ 186 (257)
|||||.|||+..+ |.+||+|||+++....+.... .-|.-|.|||.+.+.. |+.+.|+||.||+..||++
T Consensus 156 RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 156 RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 9999999999877 899999999999766554222 2344499999999865 8999999999999999999
Q ss_pred cCCCCCcC
Q 044568 187 CRKNMEID 194 (257)
Q Consensus 187 g~~pf~~~ 194 (257)
-.+.|.+.
T Consensus 236 l~PlF~g~ 243 (438)
T KOG0666|consen 236 LEPLFKGR 243 (438)
T ss_pred cCccccch
Confidence 99888754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=196.99 Aligned_cols=212 Identities=17% Similarity=0.193 Sum_probs=157.1
Q ss_pred hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 044568 27 WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILY 106 (257)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~ 106 (257)
..+|++.+. .|. .|+||++++.++.+++.+|||||-|.||+|..+|. +..-+++.++..+..+|++||.|
T Consensus 122 vfREVe~f~------~Cq--gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdF 191 (463)
T KOG0607|consen 122 VFREVETFY------QCQ--GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDF 191 (463)
T ss_pred HHHHHHHHH------Hhc--CCccHHHHHHHhcccceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHH
Confidence 345555555 232 49999999999999999999999999999999998 67789999999999999999999
Q ss_pred HhhCCCCCeeeccCCCCceeeCCCCc---eEEeeecccccCC--C--------CcccccCCCCccCccccc-----CCCC
Q 044568 107 LHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLAKLPN--E--------DFVIDKRDKGYMAPECYK-----RTPI 168 (257)
Q Consensus 107 lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~~~~~--~--------~~~~~~~~~~~~aPE~~~-----~~~~ 168 (257)
||.+ ||.|||+||+|||-..... +||+||.+..-+. . ......|+..|||||+.. ..-|
T Consensus 192 lH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~Y 268 (463)
T KOG0607|consen 192 LHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFY 268 (463)
T ss_pred Hhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccc
Confidence 9999 9999999999999986654 6999998765321 1 113446666799999874 2347
Q ss_pred CccccchhHHHHHHHHHhcCCCCCcCCCCh---hhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHH----HHHHHHHHHHc
Q 044568 169 SVKADVYGYGIVLLETICCRKNMEIDASKP---EEIILTNWVYKCFINRELNKLVRGT-KVDKKN----LENLVKVGLWC 240 (257)
Q Consensus 169 ~~~~Di~s~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~l~~l~~~c 240 (257)
+.+.|.||+|+++|-|++|.+||.+.-..+ +....++.-... -...+-++. ++|+++ ..+..+++...
T Consensus 269 DKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~----LFesIQEGkYeFPdkdWahIS~eakdlisnL 344 (463)
T KOG0607|consen 269 DKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK----LFESIQEGKYEFPDKDWAHISSEAKDLISNL 344 (463)
T ss_pred cccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH----HHHHHhccCCcCChhhhHHhhHHHHHHHHHH
Confidence 899999999999999999999998652221 111111110000 011122222 444443 35677888888
Q ss_pred ccCCCCCCC-hHHHHH
Q 044568 241 VQDEPALRP-MKCAVM 255 (257)
Q Consensus 241 l~~~p~~RP-~~ei~~ 255 (257)
+-.|+.+|. +.++++
T Consensus 345 lvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 345 LVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccHHhhhhhhhccC
Confidence 999999999 887754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=201.01 Aligned_cols=235 Identities=19% Similarity=0.258 Sum_probs=169.5
Q ss_pred ccccceeeecccCCCCCe-eecc----chhhhHH--HHhH-hhhccccccccCCceeeeceeeee-cCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNARNSPW-ISRV----SWTADIE--VLSV-AMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~-i~~~----~~~~~~~--~~~~-~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~g 74 (257)
+.||.||++=..+....+ +|-- ++..|-+ +... ...-.....+.|+-||++.+++.. .+.+|-|+|||+|.
T Consensus 474 GGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGN 553 (775)
T KOG1151|consen 474 GGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGN 553 (775)
T ss_pred ccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCC
Confidence 578999998755554443 3321 1222221 1110 111112337889999999999985 56788999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccccCCCCc---
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~~~~~~~--- 148 (257)
+|+-+|. ..+-+++.+++.|+.||++||.||-+. +++|+|-||||.|||+.+. |.+||.|||+++.++...
T Consensus 554 DLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~ 630 (775)
T KOG1151|consen 554 DLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNS 630 (775)
T ss_pred chhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCc
Confidence 9999998 778899999999999999999999998 8999999999999999654 578999999999876544
Q ss_pred -------ccccCCCCccCcccccCC----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 149 -------VIDKRDKGYMAPECYKRT----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
....||.-|++||.+.-+ .++.++||||.|++.|.++.|+.||.......+ +... .
T Consensus 631 vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-ILqe---------N--- 697 (775)
T KOG1151|consen 631 VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-ILQE---------N--- 697 (775)
T ss_pred ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HHhh---------h---
Confidence 233566779999998643 368999999999999999999999975522211 1111 1
Q ss_pred hhhcCC--CC--CHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 218 KLVRGT--KV--DKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 218 ~~~~~~--~~--~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
.+++.. .+ -+-...+...+|.+||++.-++|- ..+++
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111 11 111234567788899999999998 77765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=181.15 Aligned_cols=195 Identities=27% Similarity=0.348 Sum_probs=164.1
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.+|+++..+ ++..++|.... .++++.+. ++.|++++++...+...+..++++|+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~---------~l~~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILK---------KLNHPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHH---------hcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence 5678999999876 55566665443 23344444 7788999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCC---c
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~---~ 148 (257)
+++|.+++.. ....+++..+..++.+++.++.+||++ +++|+|++|.||+++. ++.++++|||.+...... .
T Consensus 75 ~~~l~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 75 GGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence 9999999974 225689999999999999999999999 9999999999999999 889999999988755443 3
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....+...|.+||..... ..+.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 445567779999998876 778999999999999998
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++..|++.+|.+|| +.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577888899999999999 99998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=203.71 Aligned_cols=185 Identities=19% Similarity=0.154 Sum_probs=129.0
Q ss_pred cCceeEEEeecCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 044568 61 TSVSGKIERPVRNGSLTDIIFCSA----------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHC 118 (257)
Q Consensus 61 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 118 (257)
.+..+|||||+++|+|.++++... ...+++..+..++.|++.||.|+|++ +++||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHr 333 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHR 333 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence 456899999999999999997421 11245677889999999999999999 99999
Q ss_pred cCCCCceeeCCCCceEEeeecccccCCCCc----ccccCCCCccCcccccCCCC----------------------Cccc
Q 044568 119 DIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDKRDKGYMAPECYKRTPI----------------------SVKA 172 (257)
Q Consensus 119 dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~----------------------~~~~ 172 (257)
||||+||+++.++.+||+|||++....... .....++.|++||.+..... ..+.
T Consensus 334 DLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 999999999999999999999986432211 12234678999998764321 1246
Q ss_pred cchhHHHHHHHHHhcCC-CCCcCCCChhhH-----HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCC-
Q 044568 173 DVYGYGIVLLETICCRK-NMEIDASKPEEI-----ILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEP- 245 (257)
Q Consensus 173 Di~s~G~~l~el~~g~~-pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p- 245 (257)
|+||+||++|+|++|.. ||.....-..+. ....|.. +... ..+ ....+......++++.+++..+|
T Consensus 414 DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~----~~~-~~~~d~~s~~~~dLi~~LL~~~~~ 486 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQ----KYD-FSLLDRNKEAGWDLACKLITKRDQ 486 (507)
T ss_pred chhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hccc----CCC-cccccccChHHHHHHHHHhccCCC
Confidence 99999999999999875 664321110000 1111110 0000 000 01223345788999999999876
Q ss_pred --CCCC-hHHHHH
Q 044568 246 --ALRP-MKCAVM 255 (257)
Q Consensus 246 --~~RP-~~ei~~ 255 (257)
.+|+ ++|+++
T Consensus 487 ~~~~RlSa~eaL~ 499 (507)
T PLN03224 487 ANRGRLSVGQALS 499 (507)
T ss_pred CcccCCCHHHHhC
Confidence 6899 999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=213.40 Aligned_cols=171 Identities=27% Similarity=0.388 Sum_probs=131.6
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
..||=||||+.-.+.+++++ +...-......+++.+|++||.|+|++ |++||||||.||+++.+..+||+|||++.
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccch
Confidence 35789999999888888864 221114577889999999999999999 99999999999999999999999999986
Q ss_pred cCC---------------------CCcccccCCCCccCcccccCCC---CCccccchhHHHHHHHHHhcCCCCCcCCCCh
Q 044568 143 LPN---------------------EDFVIDKRDKGYMAPECYKRTP---ISVKADVYGYGIVLLETICCRKNMEIDASKP 198 (257)
Q Consensus 143 ~~~---------------------~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~ 198 (257)
... ...+...||..|+|||.+.+.. |+.|+|+||+|++++||+. ||....++
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER- 821 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER- 821 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH-
Confidence 510 1125668888999999998654 9999999999999999995 56533111
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 199 EEIILTNWVYKCFINRELNKLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+.++-++. .+..+..+.-.+++.++++.||.+|| +.|+++
T Consensus 822 --------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 822 --------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 01112222221 23444556778999999999999999 999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=189.12 Aligned_cols=119 Identities=20% Similarity=0.239 Sum_probs=90.2
Q ss_pred cccceeeecccCCCCC-e---eeccch-----hhhHHHHhHhhhccccccccCCceeeeceeee----ecCceeEEEeec
Q 044568 5 KLSNFYRSSFNARNSP-W---ISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK----LTSVSGKIERPV 71 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~-~---i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~----~~~~~~lV~E~~ 71 (257)
-||.|+.+-.-++... + +|.++| ..|++.+...-.+ .-....-.++|+++..|. ++.+.|||+|++
T Consensus 90 HFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~-Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL 168 (590)
T KOG1290|consen 90 HFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG-DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL 168 (590)
T ss_pred ccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc-CCCCCCCceeeeeeccceecCCCCcEEEEEehhh
Confidence 4666666665544433 2 345555 3455555533333 122344567888888776 466999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 127 (257)
|-+|..+|....-++++...++.|+.|++.||.|||..| +|+|.||||+|||+
T Consensus 169 -GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 169 -GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred -hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 459999998878899999999999999999999999998 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=173.38 Aligned_cols=235 Identities=15% Similarity=0.206 Sum_probs=171.0
Q ss_pred ccccceeeecccCCCCC-ee------eccchhhhHHHHhHhhhcccccccc-CCceeeeceeeeec--CceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSP-WI------SRVSWTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLT--SVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~-~i------~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~--~~~~lV~E~~~~ 73 (257)
+|-|.|+.|....+++- +| |.+...+|++.+. .++ |+||+.+..+..+. ....||+||..+
T Consensus 49 GKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~---------nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 49 GKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQ---------NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred ccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHH---------hccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 57788999985555444 33 3445678888877 333 99999999988864 467899999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCCc--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNEDF--VI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~~--~~ 150 (257)
.+..+... +|+..+.+.++.+++.||.|+|+. ||+|||+||+|++++. ...++|+|.|++.+..... ..
T Consensus 120 ~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV 191 (338)
T KOG0668|consen 120 TDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
T ss_pred ccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence 88887763 478889999999999999999999 9999999999999996 4579999999998654433 44
Q ss_pred ccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhh-HHHHHH-----------HHHhhhhhhhh
Q 044568 151 DKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEE-IILTNW-----------VYKCFINRELN 217 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~ 217 (257)
...+..|.-||.+..- .|+..-|+|||||++..|+..+.||--..+..+. ..+... .+....+++..
T Consensus 192 RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~ 271 (338)
T KOG0668|consen 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE 271 (338)
T ss_pred eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence 4555668899999865 4788899999999999999999998644332221 111111 01111223333
Q ss_pred hhhcCC----------CCCHH-HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT----------KVDKK-NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~----------~~~~~-~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++... +.... ..++.++++...|.+|..+|| +.|...
T Consensus 272 ~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 272 DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 322211 00111 126788999999999999999 998753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=167.63 Aligned_cols=233 Identities=16% Similarity=0.131 Sum_probs=173.9
Q ss_pred ccceeeec-ccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 6 LSNFYRSS-FNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 6 ~~~~y~~~-~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.|++++ .++.+.+++|+++. .+|+..+. .+.|.||+++......+...-+|+|||..
T Consensus 15 ygtvfkarn~~t~eivalkrvrlddddegvpssalreicllk---------elkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 15 YGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLK---------ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred ceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHH---------HhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 35678888 45566678888774 23444444 88999999999999999999999999965
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~ 150 (257)
+|..+... -++.++...++.++.|++.|+.|+|++ +++|||+||.|.++..+|.+|++|||+++..+.+. ..
T Consensus 86 -dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 86 -DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred -HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 88888765 677899999999999999999999999 99999999999999999999999999998765543 33
Q ss_pred ccCCCCccCcccccCCC-CCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhh--h---hhhhhcCC
Q 044568 151 DKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINR--E---LNKLVRGT 223 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~ 223 (257)
..-|.-|.+|.++.+.. |+...|+||-||++.|+.. |++.|.+.+ ....+.+..+...... + ...+-+-.
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d---vddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc---HHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 34566699999998765 7899999999999999998 666676542 2223333322222111 1 11111111
Q ss_pred C------------CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 K------------VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~------------~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. ........-.+++...+.-+|.+|. +++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 1112224556788889999999999 887765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=181.95 Aligned_cols=206 Identities=19% Similarity=0.150 Sum_probs=154.7
Q ss_pred ccccccCCceeeeceeeeec------CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 044568 42 KCTRIRGGLLLNVPVRAKLT------SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI 115 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 115 (257)
+...+.|+|+++..+.+.-. ...|+|||||. +||.+.+. -.++-.+...+..|.+.|++|||+. +|
T Consensus 68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~I 139 (369)
T KOG0665|consen 68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GI 139 (369)
T ss_pred hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ce
Confidence 44478899999999988743 37899999995 69999986 2356678889999999999999999 99
Q ss_pred eeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCc
Q 044568 116 LHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEI 193 (257)
Q Consensus 116 ~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~ 193 (257)
+||||||+||++..+..+|+.|||+++..+.+ .+....|..|.|||++.+..+.+.+||||.||++.||++|..-|.+
T Consensus 140 ihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 140 IHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred eecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 99999999999999999999999999865544 3555677789999999998899999999999999999999999985
Q ss_pred CCCChhhHH---------------HHHHHH------HhhhhhhhhhhhcCC------CCCHHHHHHHHHHHHHcccCCCC
Q 044568 194 DASKPEEII---------------LTNWVY------KCFINRELNKLVRGT------KVDKKNLENLVKVGLWCVQDEPA 246 (257)
Q Consensus 194 ~~~~~~~~~---------------~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~ 246 (257)
...-+.-.. +..... +.+..-....+++.. +.+.........++.+||-.||+
T Consensus 220 ~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 220 KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 422111000 000000 000001111122211 12223446778899999999999
Q ss_pred CCC-hHHHHH
Q 044568 247 LRP-MKCAVM 255 (257)
Q Consensus 247 ~RP-~~ei~~ 255 (257)
+|- ++++++
T Consensus 300 ~Risv~daL~ 309 (369)
T KOG0665|consen 300 KRISVDDALR 309 (369)
T ss_pred hcccHHHHhc
Confidence 999 999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=172.17 Aligned_cols=147 Identities=24% Similarity=0.251 Sum_probs=124.6
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 122 (257)
...-+.++.+.|........++.||.|. -||+.+-.+. .+..+++...-+++..++.||.|||++- .++|||+||
T Consensus 101 ~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKP 177 (282)
T KOG0984|consen 101 TVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKP 177 (282)
T ss_pred CCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCc
Confidence 4456778999998889999999999996 4887765432 5778899888999999999999999984 999999999
Q ss_pred CceeeCCCCceEEeeecccccCCCCc--ccccCCCCccCcccccC----CCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 123 QNILMDEFWTAKILDFGLAKLPNEDF--VIDKRDKGYMAPECYKR----TPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 123 ~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~----~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
+|||++.+|++|++|||.+-...+.. +...|...|+|||.+.. ..|+.+|||||+|+.+.||.+++.||+.-
T Consensus 178 sNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 178 SNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999999999999999876543322 33567788999999863 36899999999999999999999999744
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=174.65 Aligned_cols=184 Identities=17% Similarity=0.170 Sum_probs=147.2
Q ss_pred ccccceeeecccC-CCCCeeeccchhh---hHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA---DIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.+|++...+ +...++|...-.. ..+.+... -....+++|+|++++.+.+...+..++++||+++++|.++
T Consensus 10 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e--~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 87 (225)
T smart00221 10 GAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLRE--IRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDY 87 (225)
T ss_pred CCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHH--HHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHH
Confidence 5678999999876 5566666654211 11111100 0123377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~ 155 (257)
+.. ....+++.....++.+++.++.+||++ +++|+|+++.|++++.++.++++|||.+....... ....++.
T Consensus 88 ~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 163 (225)
T smart00221 88 LRK-KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTP 163 (225)
T ss_pred HHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccC
Confidence 974 222288999999999999999999999 99999999999999999999999999887544332 3445667
Q ss_pred CccCcccc-cCCCCCccccchhHHHHHHHHHhcCCCCCc
Q 044568 156 GYMAPECY-KRTPISVKADVYGYGIVLLETICCRKNMEI 193 (257)
Q Consensus 156 ~~~aPE~~-~~~~~~~~~Di~s~G~~l~el~~g~~pf~~ 193 (257)
.|++||.+ ....++.++|+|+||++++|+++|+.||..
T Consensus 164 ~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 164 FYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 79999998 566678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=180.07 Aligned_cols=236 Identities=18% Similarity=0.201 Sum_probs=166.5
Q ss_pred cccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-----ceeEE
Q 044568 5 KLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----VSGKI 67 (257)
Q Consensus 5 ~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~lV 67 (257)
-|++|+..+... ++.+++|+.- +-++.+++. ..+|.|++...++.+-.. +.|.+
T Consensus 65 AFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLc---------fFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 65 AFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLS---------SFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred ceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHH---------hhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 467777766443 4444444432 333444444 778999999888877543 66789
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
+|+|. .+|..+|- ++..++.+-++-+..||+.||.|||+. +|+||||||.|.|+..+..+|++|||+++.-..+
T Consensus 136 TELmQ-SDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHH-hhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 99995 59999887 778899888889999999999999999 9999999999999999999999999999864433
Q ss_pred c----ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHH-----------HHHhh
Q 044568 148 F----VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW-----------VYKCF 211 (257)
Q Consensus 148 ~----~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-----------~~~~~ 211 (257)
. +...-|..|.|||.+.+. .|+.+.||||.||+..|++.++..|+...+-.....+... +-+.-
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 2 344556679999999876 4899999999999999999999999755332221111111 11111
Q ss_pred hhhhhhhhhcCC--------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 212 INRELNKLVRGT--------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 212 ~~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...-++...+.. .-+.....+-..+...++..||.+|. .++.+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111111111111 11223335667788889999999999 777654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-25 Score=175.72 Aligned_cols=235 Identities=13% Similarity=0.165 Sum_probs=159.1
Q ss_pred ccceeeecccCCCCCeeeccch---hhhHHHHhHhhhccccccccCCcee-eeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 6 LSNFYRSSFNARNSPWISRVSW---TADIEVLSVAMRGSKCTRIRGGLLL-NVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~-~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
|+.+....+...+..++-+.-. ..+.++..-.-.+ ..--.|.+|+ ..-+.++..+...+++||++.|+|..-+
T Consensus 37 FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~--~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv- 113 (378)
T KOG1345|consen 37 FGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYS--FFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV- 113 (378)
T ss_pred eeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccc--eeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc-
Confidence 4455555666666555432221 1222222211112 1223466666 4445677888888999999999999998
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 82 CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 82 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
.+.++-+.-...++.|+++|+.|||++ +++|||||.+|||+- +...+||+|||..+..+........+..|.+
T Consensus 114 --~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~ 188 (378)
T KOG1345|consen 114 --EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHA 188 (378)
T ss_pred --CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCC
Confidence 567788889999999999999999999 999999999999995 3458999999998876666666666778999
Q ss_pred ccccc---CCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 160 PECYK---RTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 160 PE~~~---~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
||.+. ++. ..+.+|+|.||++++.+++|..||+.....+ ... |.+..|...... .....-....+.+.
T Consensus 189 pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y--~~~~~w~~rk~~---~~P~~F~~fs~~a~ 261 (378)
T KOG1345|consen 189 PELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPY--WEWEQWLKRKNP---ALPKKFNPFSEKAL 261 (378)
T ss_pred cHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chH--HHHHHHhcccCc---cCchhhcccCHHHH
Confidence 98764 232 4688999999999999999999998442221 112 222222221111 10011112335667
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++..+-+..+|++|- ..+..+
T Consensus 262 r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 262 RLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHHHHhcCCcccccchhHHHHH
Confidence 777888999999997 666544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=194.52 Aligned_cols=234 Identities=16% Similarity=0.088 Sum_probs=176.0
Q ss_pred ccccceeeecccCCC-CCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhc
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC 82 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 82 (257)
+.-++|||++..... -.++|-+...--..+-..+..-.-....+|+||+.+.+.....+..+++||||.+|+|.++-+
T Consensus 26 gTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~- 104 (829)
T KOG0576|consen 26 GTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH- 104 (829)
T ss_pred CcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-
Confidence 445789999865544 445666554222222222222224558899999999999999999999999999999999987
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccC
Q 044568 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMA 159 (257)
Q Consensus 83 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~a 159 (257)
....+++.+....++..+.|+.|||++ +=+|||||-.||++.+.+.+|++|||.+-.+..+ .....||+.|+|
T Consensus 105 -~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywma 180 (829)
T KOG0576|consen 105 -VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMA 180 (829)
T ss_pred -ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccc
Confidence 678899999999999999999999999 9999999999999999999999999987544333 256689999999
Q ss_pred ccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC--CCCHHHHHHHH
Q 044568 160 PECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVDKKNLENLV 234 (257)
Q Consensus 160 PE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 234 (257)
||+.. ++.|+..+|||+.|+...|+.--++|....- ..+.. ..+.. ...++. .......+.+-
T Consensus 181 pEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh------pmr~l--~LmTk----S~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 181 PEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH------PMRAL--FLMTK----SGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhHHHHHhcccccccccccccccchhhhhhcCCcccccc------hHHHH--HHhhc----cCCCCCcccCCccchHHHH
Confidence 99874 5679999999999999999987777753220 01100 11111 111111 22444567899
Q ss_pred HHHHHcccCCCCCCC-hHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~ 254 (257)
++++.|+-++|++|| ++.++
T Consensus 249 ~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred HHHHHHhcCCCccCCChhhhe
Confidence 999999999999999 77654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=187.40 Aligned_cols=184 Identities=20% Similarity=0.149 Sum_probs=141.3
Q ss_pred cccceeeecc-cCCCCCeeeccc-----h---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 5 KLSNFYRSSF-NARNSPWISRVS-----W---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 5 ~~~~~y~~~~-~~~~~~~i~~~~-----~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
=||.|.++.. ..+..++||-+. + ..|++++....... .-.-.+.+.+.-.|...++.|||+|-+ ..+
T Consensus 444 vFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD---~Edk~Hclrl~r~F~hknHLClVFE~L-slN 519 (752)
T KOG0670|consen 444 VFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDAD---PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLN 519 (752)
T ss_pred eeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccC---chhhhHHHHHHHHhhhcceeEEEehhh-hch
Confidence 3778888884 445566776544 1 45555555222111 111223356667778889999999987 579
Q ss_pred HHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccCCCCc-cccc
Q 044568 76 LTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLPNEDF-VIDK 152 (257)
Q Consensus 76 L~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~~~~~-~~~~ 152 (257)
|.++|... .+.+|....+..|+.|+..||..|-.. +++|.||||.|||+.+. ..+||+|||.+...+... +...
T Consensus 520 LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYL 596 (752)
T KOG0670|consen 520 LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYL 596 (752)
T ss_pred HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccccHHH
Confidence 99999754 466788899999999999999999998 99999999999999864 467999999987654332 3334
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCC
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDA 195 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~ 195 (257)
-+..|.|||++.+-+|+...|+||.||+|||+.||+..|.+..
T Consensus 597 VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 597 VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 4556999999999999999999999999999999999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=177.28 Aligned_cols=236 Identities=17% Similarity=0.182 Sum_probs=171.6
Q ss_pred ccccceeeecccC----CCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA----RNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~----~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||++++.+ ++.+++|.+. ..+|++.+. . -..+.|++++.+.+.+.++..+|+||++
T Consensus 47 GsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~-~-------~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 47 GSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLY-R-------LGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred cchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHH-H-------hccchhhhcchhhhccCCeeEEEecccC
Confidence 5689999999766 4556676644 356666555 2 2348899999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccC-------
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLP------- 144 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~------- 144 (257)
+....++..+ ++..++..++..+..||.++|++ ||+|||+||+|+|.+. .+.-.|.|||++...
T Consensus 119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 9999999975 67899999999999999999999 9999999999999985 456688999998610
Q ss_pred ----------CC-Cc-----------------------------ccccCCCCccCcccccCCC-CCccccchhHHHHHHH
Q 044568 145 ----------NE-DF-----------------------------VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLE 183 (257)
Q Consensus 145 ----------~~-~~-----------------------------~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~e 183 (257)
.. .. ....||++|.|||++.+.+ .++++||||.|++++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 00 00 2347888999999998765 5789999999999999
Q ss_pred HHhcCCCCCcCCCChhhHH----------HHHHHHHh-----hh------hhh---------hhhhhcCC-------CCC
Q 044568 184 TICCRKNMEIDASKPEEII----------LTNWVYKC-----FI------NRE---------LNKLVRGT-------KVD 226 (257)
Q Consensus 184 l~~g~~pf~~~~~~~~~~~----------~~~~~~~~-----~~------~~~---------~~~~~~~~-------~~~ 226 (257)
+++++.||-....+...+. +...+... +. ..+ ...+.+.. ...
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 9999999975433222110 11111000 00 000 01111100 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+..+.+++.+|++.||.+|- ++|.++
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 22235899999999999999999 999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=186.61 Aligned_cols=155 Identities=22% Similarity=0.209 Sum_probs=137.0
Q ss_pred hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec-CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 044568 27 WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV-RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGIL 105 (257)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~ 105 (257)
.+.|++.++ .+.+..|+||+++...+.+.+.++|+||-. ++.+|.++|. -...+++.++..++.|++.|++
T Consensus 613 Vp~EIqIla------~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~ 684 (772)
T KOG1152|consen 613 VPSEIQILA------TLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIK 684 (772)
T ss_pred cchhHHHHH------HhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccc
Confidence 366777666 444666999999999999999999999976 4559999997 6778999999999999999999
Q ss_pred HHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc-CCCCcccccCCCCccCcccccCCCCC-ccccchhHHHHHHH
Q 044568 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL-PNEDFVIDKRDKGYMAPECYKRTPIS-VKADVYGYGIVLLE 183 (257)
Q Consensus 106 ~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~l~e 183 (257)
+||++ +|+|||||-+|+.++.+|.+||+|||.+.. .+.+.....||..|.|||.+.+.+|- ...|||++|+++|.
T Consensus 685 hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyt 761 (772)
T KOG1152|consen 685 HLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYT 761 (772)
T ss_pred ccccc---CceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeE
Confidence 99999 999999999999999999999999998753 45566778899999999999998874 66899999999999
Q ss_pred HHhcCCCCC
Q 044568 184 TICCRKNME 192 (257)
Q Consensus 184 l~~g~~pf~ 192 (257)
++...-||.
T Consensus 762 ivykenpyy 770 (772)
T KOG1152|consen 762 IVYKENPYY 770 (772)
T ss_pred EEeccCCCc
Confidence 999988886
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=176.02 Aligned_cols=202 Identities=22% Similarity=0.277 Sum_probs=155.7
Q ss_pred cccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-eeccCCCC
Q 044568 45 RIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPI-LHCDIKPQ 123 (257)
Q Consensus 45 ~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i-~h~dl~~~ 123 (257)
.+.|.|+.++.+.+.++...+.|.+||..|+|.|.+.. ....+++.-...+..+++.|+.|+|.. .| .|+.++..
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~ 78 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSS 78 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccc
Confidence 67899999999999999999999999999999999986 678889999999999999999999998 66 99999999
Q ss_pred ceeeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCC-------CCccccchhHHHHHHHHHhcCCCC
Q 044568 124 NILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTP-------ISVKADVYGYGIVLLETICCRKNM 191 (257)
Q Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~-------~~~~~Di~s~G~~l~el~~g~~pf 191 (257)
|++++....+|++|||+........ ........|.|||.+.... .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999976543211 1112233499999997641 357799999999999999999999
Q ss_pred CcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC-CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 192 EIDASKPEEIILTNWVYKCFINRELNKLVRGTKV-DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..........+...... .....+.|... ..+..+.+..++..||..+|.+|| ++.|-.
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 875443332111111111 11112222211 114455899999999999999999 988754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=160.59 Aligned_cols=196 Identities=22% Similarity=0.260 Sum_probs=147.5
Q ss_pred ccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 044568 44 TRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 123 (257)
Q Consensus 44 ~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 123 (257)
.-..||||+.+.+.+....+..++..||+.|||+..+++......+..++++++.+++.|+.|||+- .+-|.--.+...
T Consensus 242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~ 320 (448)
T KOG0195|consen 242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSK 320 (448)
T ss_pred eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccc
Confidence 3567999999999999999999999999999999999976666678899999999999999999997 444555668899
Q ss_pred ceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCC---ccccchhHHHHHHHHHhcCCCCCcCCCChhh
Q 044568 124 NILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPIS---VKADVYGYGIVLLETICCRKNMEIDASKPEE 200 (257)
Q Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~ 200 (257)
.++++++.+.+++- +-.++ +.........+.|++||.+...+.+ .++|+|||++++||+.|+..||..-.+-+-.
T Consensus 321 hvmidedltarism-ad~kf-sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg 398 (448)
T KOG0195|consen 321 HVMIDEDLTARISM-ADTKF-SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG 398 (448)
T ss_pred eEEecchhhhheec-cccee-eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh
Confidence 99999988877632 21111 1111233456789999999876643 5789999999999999999999754211100
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 201 IILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..-.++.+-. ..|......+.+|+.-|+..||.+|| +..|+-
T Consensus 399 -----------mkialeglrv--~ippgis~hm~klm~icmnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 399 -----------MKIALEGLRV--HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVP 441 (448)
T ss_pred -----------hhhhhccccc--cCCCCccHHHHHHHHHHhcCCCCcCCCcceehh
Confidence 0011111111 23445567788999999999999999 988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=179.82 Aligned_cols=201 Identities=15% Similarity=0.122 Sum_probs=153.0
Q ss_pred ccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 044568 44 TRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 123 (257)
Q Consensus 44 ~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 123 (257)
..+.|+|++.............-+||||++ +|...+. ....+...++..++.|++.|++|+|+. |+.|||+|++
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~e 449 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLE 449 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccc
Confidence 367899987777766665555555999998 9999996 345788899999999999999999999 9999999999
Q ss_pred ceeeCCCCceEEeeecccccCCCCc-------ccccCCCCccCcccccCCCCCc-cccchhHHHHHHHHHhcCCCCCcCC
Q 044568 124 NILMDEFWTAKILDFGLAKLPNEDF-------VIDKRDKGYMAPECYKRTPISV-KADVYGYGIVLLETICCRKNMEIDA 195 (257)
Q Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~~~-~~Di~s~G~~l~el~~g~~pf~~~~ 195 (257)
|+++..++.+|++|||.+....... ....|+.+|+|||.+.+..|++ ..||||.|+++..|.+|+.||....
T Consensus 450 nll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 450 NLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred cEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 9999999999999999877533222 3457778899999999999975 4699999999999999999998663
Q ss_pred CChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 196 SKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
..+.... .............+.......+.+...++.++|+.||.+|- +.+|++.
T Consensus 530 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 530 KSDNSFK------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccchh------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 3322110 00000000001111122334457788899999999999999 9999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-18 Score=149.93 Aligned_cols=233 Identities=16% Similarity=0.085 Sum_probs=163.5
Q ss_pred ccccceeeecccCCC--CCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceee-eecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNARN--SPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRA-KLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~--~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~~~~~~~lV~E~~ 71 (257)
+.|+.||.+...... ..++|... +..|.+++..... ......+..+...+ ......++||+.+
T Consensus 29 G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-----~~~~~~~~~~~~~G~~~~~~~~iVM~l~ 103 (322)
T KOG1164|consen 29 GGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-----KNGPSHFPKLLDHGRSTEDFNFIVMSLL 103 (322)
T ss_pred cCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-----hcCCCCCCEEEEeccCCCceeEEEEecc
Confidence 568899999977764 44444322 3345555552221 11124556777777 4777899999988
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-----CceEEeeecccc--cC
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-----WTAKILDFGLAK--LP 144 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-----~~~kl~dfg~~~--~~ 144 (257)
|.||.++......+.++..++..++.|++.+|+++|+. |++||||||.|++++.. ..+.+.|||+++ ..
T Consensus 104 -G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 104 -GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred -CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence 67999988654568899999999999999999999999 99999999999999865 468999999998 31
Q ss_pred CCC-----------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 145 NED-----------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 145 ~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
... .....||..|.++.+..+...+.+.|+||++.++.|+..|..||...................
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~--- 256 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL--- 256 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh---
Confidence 111 112348889999999999999999999999999999999999997653332211111111111
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... .....+..+..+...+-..+..++| ...+.+
T Consensus 257 -----~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 257 -----LTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred -----cccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 1100 1222345566666666668888888 666644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-17 Score=141.13 Aligned_cols=244 Identities=18% Similarity=0.165 Sum_probs=165.2
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHH---HHhHhhhccccccccCC-ceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIE---VLSVAMRGSKCTRIRGG-LLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~-~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||++... ...+++......... ...+.........+.|+ +++.+...+......++++|++.++++.++
T Consensus 11 g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 88 (384)
T COG0515 11 GSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDL 88 (384)
T ss_pred CCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHH
Confidence 455788888877 444554433211110 00000000023377777 699999999777778999999999999977
Q ss_pred HhccCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCCC---------c
Q 044568 80 IFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNED---------F 148 (257)
Q Consensus 80 l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~---------~ 148 (257)
+..... ..++......+..|++.++.|+|+. +++|||+||.|++++... .+++.|||.+...... .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (384)
T COG0515 89 LKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165 (384)
T ss_pred HHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccc
Confidence 763111 2788999999999999999999999 999999999999999888 7999999988743322 3
Q ss_pred ccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 149 VIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
....++..|.+||.+.. ..++...|+||+|++++++++|..||...................... ........ ..
T Consensus 166 ~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~ 243 (384)
T COG0515 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASPLSP-SN 243 (384)
T ss_pred cccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccccCc-cc
Confidence 56678888999999987 567899999999999999999999976553210000111100000000 00000000 00
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
.......+.+++..++..+|..|. +.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 244 PELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred cchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 012235788899999999999999 66543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=167.46 Aligned_cols=225 Identities=18% Similarity=0.203 Sum_probs=159.8
Q ss_pred cccccceeeecccCCCCCeeec----c------chhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 3 CTKLSNFYRSSFNARNSPWISR----V------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~----~------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+|-|-.+.|++..+|. +++|. . .|.+.++-+.. .-.+++|.+.+.-.-....-.|||-+|..
T Consensus 33 stRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~-------~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 33 STRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKF-------ALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred chhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHH-------HhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 4567778888888888 44443 1 14444443332 24568898888888777888899999998
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC----CCCc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP----NEDF 148 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~----~~~~ 148 (257)
+ +|+|.|. ...=+...+++-|+-|++.|+.-+|+. ||.|||||.+|||+..=+++.|+||.--+.. +.+.
T Consensus 105 h-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 105 H-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred h-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 6 9999994 333356667778899999999999999 9999999999999999889999999764421 1111
Q ss_pred ------ccccCCCCccCcccccCC----------C-CCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHh
Q 044568 149 ------VIDKRDKGYMAPECYKRT----------P-ISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKC 210 (257)
Q Consensus 149 ------~~~~~~~~~~aPE~~~~~----------~-~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 210 (257)
.......+|.|||.+... + .+++.||||+||++.|+++ |++||... .+ .++..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL--~aYr~ 249 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QL--LAYRS 249 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HH--HhHhc
Confidence 222333459999988531 2 5678899999999999999 78888632 11 11221
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.++...+ ...+.+|+..|++.||.+|- +++.++
T Consensus 250 ~~~~~~e~~Le~Ie-----d~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIE-----DVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred cCccCHHHHHHhCc-----CccHHHHHHHHHccCchhccCHHHHHH
Confidence 11222222333221 13688999999999999999 998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=148.49 Aligned_cols=138 Identities=22% Similarity=0.181 Sum_probs=102.5
Q ss_pred ccccceeeecccC--CCCCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA--RNSPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~--~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++..... .+..+||
T Consensus 29 G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~---------~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 29 DVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALK---------TVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred cCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHH---------hccCCCCCcEEEE---cCCcEEE
Confidence 5789999998764 3444776532 345555555 8889998743222 2567999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCceeeCCCCceEEeeecccccCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDI-KPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl-~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|||++|++|... . ... ...++.|+++||.|||++ +|+|||| ||.||+++.++.++|+|||+++....
T Consensus 97 mE~~~G~~L~~~-~--~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 97 RGWTEGVPLHLA-R--PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEccCCCCHHHh-C--ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999732 1 111 146789999999999999 9999999 99999999889999999999885433
Q ss_pred Cc-----------ccccCCCCccCcccccC
Q 044568 147 DF-----------VIDKRDKGYMAPECYKR 165 (257)
Q Consensus 147 ~~-----------~~~~~~~~~~aPE~~~~ 165 (257)
.. ....+++.|.+||++..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32 23355667999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=132.70 Aligned_cols=183 Identities=18% Similarity=0.113 Sum_probs=141.9
Q ss_pred cccccceeeecc-cCCCCCeeec----cch---hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSF-NARNSPWISR----VSW---TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~----~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
|++|+++|.|.. ..++.++||- +.+ .-|.+++.....|..+.++ ..++.+.+.-.|||++. |.
T Consensus 25 sGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i--------~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 25 SGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHI--------RHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred CCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchh--------hhhccccccceeeeecc-Cc
Confidence 789999999995 5566677753 223 4566676654444333333 33455677788999998 57
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccccCCCCc---
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~~~~~~~--- 148 (257)
||++...= -.+.++..+++.++-|++.-++|+|.+ +.+||||||+|+|++-+ ..+.++|||+++...+..
T Consensus 96 sLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 96 SLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred cHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 99998753 567799999999999999999999999 99999999999999854 357899999998643222
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCCh
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP 198 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~ 198 (257)
....||..|.+-.+..+...+.+.|+-|+|.++...--|+.||++-....
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 44577888998888877777889999999999999999999999764443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=141.93 Aligned_cols=184 Identities=16% Similarity=0.196 Sum_probs=133.6
Q ss_pred ccCCceeeeceeeeec---------------------------CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHH
Q 044568 46 IRGGLLLNVPVRAKLT---------------------------SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIAL 98 (257)
Q Consensus 46 ~~h~~i~~~~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~ 98 (257)
.+|||||.+.+.+-+. ...|+||.-.++ +|.+++. ....+.....-++.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~---~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW---TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh---cCCCchHHHHHHHH
Confidence 5789998877665432 256789987765 9999995 34466677888999
Q ss_pred HHHHHHHHHhhCCCCCeeeccCCCCceeeC--CC--CceEEeeecccccCCC---------CcccccCCCCccCcccccC
Q 044568 99 DVAKGILYLHDECEPPILHCDIKPQNILMD--EF--WTAKILDFGLAKLPNE---------DFVIDKRDKGYMAPECYKR 165 (257)
Q Consensus 99 ~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~--~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~aPE~~~~ 165 (257)
|+++|+.|||++ |+.|||+|.+|||+. ++ ..+.++|||++---+. .....-|+-..+|||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 999999999999984 33 3568999998642211 1234455666899998864
Q ss_pred CC-----C-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 166 TP-----I-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 166 ~~-----~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
.+ . -.++|.|+.|.+.||+++..-||....+-. ....+ +...++- ..+..+++.+.+++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~-----Yqe~qLP------alp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRT-----YQESQLP------ALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhh-----hhhhhCC------CCcccCChHHHHHHHH
Confidence 32 1 268999999999999999999998631111 01111 1222221 3455677889999999
Q ss_pred cccCCCCCCC
Q 044568 240 CVQDEPALRP 249 (257)
Q Consensus 240 cl~~~p~~RP 249 (257)
.|+.||.+||
T Consensus 493 lL~r~pskRv 502 (598)
T KOG4158|consen 493 LLKRDPSKRV 502 (598)
T ss_pred HhcCCccccC
Confidence 9999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=153.82 Aligned_cols=204 Identities=16% Similarity=0.123 Sum_probs=157.7
Q ss_pred eeeecccCCCCCeeeccch-hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCC
Q 044568 9 FYRSSFNARNSPWISRVSW-TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAER 86 (257)
Q Consensus 9 ~y~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~ 86 (257)
.|+.+.........+...+ ..+..++. ..+ |+.++++.-.++.+...+++++|..+|.|...+. ...
T Consensus 24 ~yamkvl~k~t~~~~~~~~t~~er~il~---------~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~--~~~ 92 (612)
T KOG0603|consen 24 LYAMKVLKKATLKVRDRTHTKQERIILA---------FVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS--KEV 92 (612)
T ss_pred hhhhhcccccccccccccccccHHHHHh---------hccCCCceeeeeeeeccccchhHhhhhcccchhhhccc--cCC
Confidence 3444444444444444444 23333444 333 8999999999999999999999999999999987 566
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCC
Q 044568 87 NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRT 166 (257)
Q Consensus 87 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~ 166 (257)
.+.......+...++.|++++|+. +++|+|+|++||+++.+|++++.|||+++..-.... .+||..|+|||+..
T Consensus 93 ~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-~cgt~eymApEI~~-- 166 (612)
T KOG0603|consen 93 MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-ACGTYEYRAPEIIN-- 166 (612)
T ss_pred chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-cccchhhhhhHhhh--
Confidence 778888889999999999999999 999999999999999999999999999875433222 28899999999998
Q ss_pred CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHHHHHHHcccCCC
Q 044568 167 PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLVKVGLWCVQDEP 245 (257)
Q Consensus 167 ~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p 245 (257)
.....+|.||||++.+|+++|..||..+ ....++. ...+|.......-.++..+...+|
T Consensus 167 gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 167 GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 4578899999999999999999999741 1112222 224556666667777778888888
Q ss_pred CCCC
Q 044568 246 ALRP 249 (257)
Q Consensus 246 ~~RP 249 (257)
.+|.
T Consensus 227 ~nrL 230 (612)
T KOG0603|consen 227 ENRL 230 (612)
T ss_pred HHHh
Confidence 8887
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.7e-19 Score=152.24 Aligned_cols=165 Identities=21% Similarity=0.254 Sum_probs=128.9
Q ss_pred ceeEEEeecCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 63 VSGKIERPVRNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
..++.|++|..++|.++|.+. .....++...+.++.|++.|++| + +.+|+|++|.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999632 44557788899999999999999 7 9999999999999999989999999987
Q ss_pred ccCCC---------CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhh
Q 044568 142 KLPNE---------DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 142 ~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
..... ..+...+|..|++||.+.+..|+.++||||+|++++|++. -..++...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 64322 2356688999999999999999999999999999999997 45554311
Q ss_pred hhhhhhhhhcCCCCC---HHHHHHHHHHHHHcccCCCCCCC-hHHH
Q 044568 212 INRELNKLVRGTKVD---KKNLENLVKVGLWCVQDEPALRP-MKCA 253 (257)
Q Consensus 212 ~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RP-~~ei 253 (257)
....++-++. +| ....+.-..|+.+++...|.+|| +.+.
T Consensus 467 --~t~~d~r~g~-ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 --ATLTDIRDGI-IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HhhhhhhcCC-CChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1111222211 11 11224456788899999999999 7654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=132.76 Aligned_cols=124 Identities=14% Similarity=0.115 Sum_probs=92.4
Q ss_pred cccccceeeecccCCCCCeeeccchh-----h------------------------------hHHHHhHhhhcccccccc
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVSWT-----A------------------------------DIEVLSVAMRGSKCTRIR 47 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~~~-----~------------------------------~~~~~~~~~~~~~~~~~~ 47 (257)
.++++.||++...+++.+++|..... + |.+. +.++.
T Consensus 7 ~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---------l~~l~ 77 (190)
T cd05147 7 TGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRN---------LKRLV 77 (190)
T ss_pred cccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHH---------HHHHH
Confidence 46899999999888889999875421 1 2222 22444
Q ss_pred CCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeccCCCCcee
Q 044568 48 GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYL-HDECEPPILHCDIKPQNIL 126 (257)
Q Consensus 48 h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h~dl~~~nil 126 (257)
++++ ..+..... ...+|||||++++++..... ....++..+...++.|++.+|.++ |+. +++|||+||+||+
T Consensus 78 ~~~v-~~p~~~~~-~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 78 TAGI-PCPEPILL-KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred HCCC-CCCcEEEe-cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 4443 22222222 23489999999887766543 346789999999999999999999 798 9999999999999
Q ss_pred eCCCCceEEeeeccccc
Q 044568 127 MDEFWTAKILDFGLAKL 143 (257)
Q Consensus 127 ~~~~~~~kl~dfg~~~~ 143 (257)
+++ +.++|+|||++..
T Consensus 151 i~~-~~v~LiDFG~a~~ 166 (190)
T cd05147 151 YHD-GKLYIIDVSQSVE 166 (190)
T ss_pred EEC-CcEEEEEcccccc
Confidence 984 6899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=134.75 Aligned_cols=182 Identities=16% Similarity=0.115 Sum_probs=144.8
Q ss_pred cccccceeeec-ccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSS-FNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~-~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
|++|++.+.|+ +.+++.++||--. +.-|-..+. +.+ ..+.|=++.-.++.+-+-.||+|++ |-
T Consensus 38 eGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YK--lL~------g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 38 EGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYK--LLG------GTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred cCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHH--HHc------CCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 88999999999 6677777886422 222333333 222 2344555666777888888999999 56
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-----CceEEeeecccccCCCCc-
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-----WTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-----~~~kl~dfg~~~~~~~~~- 148 (257)
||+|+.. .-++.|+..++..++.|++.-++++|++ .+|+|||||+|+||+.. ..+.++|||+++...++.
T Consensus 109 SLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 109 SLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred CHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9999764 3788999999999999999999999999 99999999999999743 357899999998654333
Q ss_pred ---------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCC
Q 044568 149 ---------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASK 197 (257)
Q Consensus 149 ---------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~ 197 (257)
.+..||.+||+.....+...+.+.|+-|+|.+....+-|..||++--.+
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 4557888999999999988899999999999999999999999976333
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=127.53 Aligned_cols=134 Identities=12% Similarity=0.004 Sum_probs=93.0
Q ss_pred cccccceeeecccCCCCCeeeccchh-----hhHHH-------------------Hh--HhhhccccccccCCceeeece
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVSWT-----ADIEV-------------------LS--VAMRGSKCTRIRGGLLLNVPV 56 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~~~-----~~~~~-------------------~~--~~~~~~~~~~~~h~~i~~~~~ 56 (257)
.++++.||+++..+++.+++|...-. +..+. .. ....-..+.++.++++.. +.
T Consensus 7 ~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~-p~ 85 (190)
T cd05145 7 TGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV-PE 85 (190)
T ss_pred cCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC-ce
Confidence 36789999999888889998865521 00000 00 000111333555655421 22
Q ss_pred eeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEE
Q 044568 57 RAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 57 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
.... ...+|||||++++++..... ....++..+...++.|++.++.++|+ + |++|||+||.||+++ ++.++|
T Consensus 86 ~~~~-~~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 86 PILL-KKNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred EEEe-cCCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEE
Confidence 2211 23589999999886544422 33567888999999999999999999 8 999999999999998 789999
Q ss_pred eeecccccC
Q 044568 136 LDFGLAKLP 144 (257)
Q Consensus 136 ~dfg~~~~~ 144 (257)
+|||++...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05145 159 IDVSQAVEL 167 (190)
T ss_pred EEcccceec
Confidence 999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=138.70 Aligned_cols=163 Identities=18% Similarity=0.240 Sum_probs=109.6
Q ss_pred ceeEEEeecCCCCHHHHHh---ccCCC--CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 63 VSGKIERPVRNGSLTDIIF---CSAER--NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~---~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
..+++|+-+ .+||.+++. ..... .+....+..+..|++..+++||+. |++|+||+++|++++.+|.+.|+|
T Consensus 113 n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGD 188 (288)
T ss_dssp SEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--
T ss_pred hhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcC
Confidence 336677777 468888864 21222 233344566779999999999999 999999999999999999999999
Q ss_pred ecccccCCCCcccccCCCCccCcccccCC--------CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH
Q 044568 138 FGLAKLPNEDFVIDKRDKGYMAPECYKRT--------PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK 209 (257)
Q Consensus 138 fg~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 209 (257)
|+.....+........+..|.|||..... .++.+.|.|++|+++|.++++..||....+......
T Consensus 189 F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------- 261 (288)
T PF14531_consen 189 FSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------- 261 (288)
T ss_dssp GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------
T ss_pred hHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------
Confidence 99877666554445556779999976432 467889999999999999999999986522211100
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 044568 210 CFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248 (257)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 248 (257)
.+. .+. +.++.+..|+..+|+.+|++|
T Consensus 262 ---------~f~--~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ---------DFS--RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------GGT--TSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------cch--hcC-CcCHHHHHHHHHHccCCcccC
Confidence 111 233 667888999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.2e-16 Score=129.21 Aligned_cols=149 Identities=12% Similarity=0.041 Sum_probs=105.5
Q ss_pred ccccceeeecccCCCCCeeeccc------------------hhhhHHHHhHhhhccccccccCCceeeeceeeee-----
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----- 60 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----- 60 (257)
++++.||...- ++...++|... +.++++. +.++.|+++......+..
T Consensus 42 ~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~---------l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 42 IDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ---------TDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred CCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH---------HHHHHHCCCCcceEeeeeccccc
Confidence 57888888544 56778888764 1222222 336778887766655442
Q ss_pred ---cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 61 ---TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 61 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
.+..+|||||++|.+|.++.. ++. ....+++.++..+|+. |++|+|++|+|++++.++ ++++|
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEE
Confidence 245789999999999988742 222 3456999999999999 999999999999999888 99999
Q ss_pred ecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHH
Q 044568 138 FGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETI 185 (257)
Q Consensus 138 fg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~ 185 (257)
||.......... ...+.....++.++|+||||+.+.-..
T Consensus 178 fg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh---------HHHHHHHhHhcccccccceeEeehHHH
Confidence 998754321110 011333445678999999998876543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.9e-15 Score=118.35 Aligned_cols=143 Identities=14% Similarity=0.022 Sum_probs=100.6
Q ss_pred hhhhHHHHhHhhhccccccccC-CceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHH
Q 044568 27 WTADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGIL 105 (257)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~ 105 (257)
+.+|++.+. ++.| +++.++..+ +..+++|||+.|.+|.+.+.. ....++.|++.++.
T Consensus 48 ~~rE~~iL~---------~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~ 105 (218)
T PRK12274 48 ARREALALR---------QLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQ 105 (218)
T ss_pred HHHHHHHHH---------hcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHH
Confidence 356666666 4433 444444443 456999999999998765421 12357889999999
Q ss_pred HHhhCCCCCeeeccC-CCCceeeCCCCceEEeeecccccCCCCcc----------------cccCCCCccCcccccCC-C
Q 044568 106 YLHDECEPPILHCDI-KPQNILMDEFWTAKILDFGLAKLPNEDFV----------------IDKRDKGYMAPECYKRT-P 167 (257)
Q Consensus 106 ~lh~~~~~~i~h~dl-~~~nil~~~~~~~kl~dfg~~~~~~~~~~----------------~~~~~~~~~aPE~~~~~-~ 167 (257)
++|++ |++|||| ||.||+++.++.++|+|||++........ ....++.++.|+...-- .
T Consensus 106 ~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~ 182 (218)
T PRK12274 106 QLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKR 182 (218)
T ss_pred HHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhcc
Confidence 99999 9999999 79999999999999999999975443321 11223445555432211 2
Q ss_pred CC-ccccchhHHHHHHHHHhcCCCCCcC
Q 044568 168 IS-VKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 168 ~~-~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.+ ...++++-|..+|.++|+..|.-++
T Consensus 183 ~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 183 TSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chhHHHHHHHhcchHHHHHhccCCcccc
Confidence 33 5678888999999999999987655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=143.33 Aligned_cols=178 Identities=15% Similarity=0.164 Sum_probs=136.9
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHH-hHhhhcccccccc---CCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVL-SVAMRGSKCTRIR---GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~---h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+..+-||+|+..+++.+++|.-.=++-.+++ ..++.. |++ -+.|..+.......+...||+||.+.|+|.++
T Consensus 709 g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~----RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~ 784 (974)
T KOG1166|consen 709 GSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVME----RLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDL 784 (974)
T ss_pred ccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHH----hhchhhhcchHHHHHHHccCCcceeeeeccccccHHHh
Confidence 3567899999999999999864422222211 111111 222 12333444444456778899999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-------CCCceEEeeeccccc----CCC-C
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-------EFWTAKILDFGLAKL----PNE-D 147 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-------~~~~~kl~dfg~~~~----~~~-~ 147 (257)
+. ..+.+++..+..++.|++.-+++||.. +|||+||||+|+++. +...++|+|||.+.- .+. .
T Consensus 785 ~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~ 859 (974)
T KOG1166|consen 785 IN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTK 859 (974)
T ss_pred hc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcE
Confidence 98 778899999999999999999999999 999999999999995 345689999998752 222 2
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKN 190 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~p 190 (257)
.....+|-.+-.+|+..+.+++..+|.|.++.+++-|+.|+..
T Consensus 860 F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 860 FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3455667789999999999999999999999999999998754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-15 Score=124.49 Aligned_cols=194 Identities=19% Similarity=0.219 Sum_probs=135.7
Q ss_pred ccccccCCceeeeceeeeec-----CceeEEEeecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 044568 42 KCTRIRGGLLLNVPVRAKLT-----SVSGKIERPVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPP 114 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 114 (257)
.+..+.|.|++++.-++.+. ....++.|||..|++.++|++. ....+......+|+.||.+||.|||+. +|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 56677799999888777643 3567899999999999999854 345677788889999999999999996 999
Q ss_pred eeeccCCCCceeeCCCCceEEeeeccccc-CC------CCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhc
Q 044568 115 ILHCDIKPQNILMDEFWTAKILDFGLAKL-PN------EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC 187 (257)
Q Consensus 115 i~h~dl~~~nil~~~~~~~kl~dfg~~~~-~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g 187 (257)
|+|+++..+.+.+..++.+|+....-... .. .......+.++|.+||+=.....+.++|||+||....||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999988888744221111 00 001222345678899987666778899999999999999987
Q ss_pred CCCCCcCCCCh-hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 188 RKNMEIDASKP-EEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 188 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
..-.....+.- .+....+. +..+-+ ..-..++..|++-.|..|| |++++
T Consensus 279 Eiq~tnseS~~~~ee~ia~~---------i~~len---------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANV---------IIGLEN---------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eeccCCCcceeehhhhhhhh---------eeeccC---------ccccCcCcccccCCCCCCcchhhhh
Confidence 76433221111 11111110 000001 1123455689999999999 99875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=118.23 Aligned_cols=131 Identities=14% Similarity=0.084 Sum_probs=89.0
Q ss_pred ccccceeeec--ccCCCCCeeeccchhh-------------------------hHHHHhHhhhccccccccCCceeeece
Q 044568 4 TKLSNFYRSS--FNARNSPWISRVSWTA-------------------------DIEVLSVAMRGSKCTRIRGGLLLNVPV 56 (257)
Q Consensus 4 ~~~~~~y~~~--~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~h~~i~~~~~ 56 (257)
++++.||++. ..++..+++|...... +++... ...-..+.++.+ +.+.++.
T Consensus 39 G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~E~~~L~~L~~-~~i~~p~ 116 (237)
T smart00090 39 GKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA-EKEFRNLQRLYE-AGVPVPK 116 (237)
T ss_pred CcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH-HHHHHHHHHHHh-cCCCCCe
Confidence 5789999998 6788888888654211 000000 000001123322 1222232
Q ss_pred eeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-eeeccCCCCceeeCCCCceEE
Q 044568 57 RAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP-ILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 57 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-i~h~dl~~~nil~~~~~~~kl 135 (257)
.... ...+|||||+++++|..... ....+...+...++.|++.++.+||++ + ++|+|++|+||+++ ++.+++
T Consensus 117 ~~~~-~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~L 189 (237)
T smart00090 117 PIAW-RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVI 189 (237)
T ss_pred eeEe-cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEE
Confidence 2222 34589999999988877653 233456667789999999999999999 9 99999999999999 779999
Q ss_pred eeeccccc
Q 044568 136 LDFGLAKL 143 (257)
Q Consensus 136 ~dfg~~~~ 143 (257)
+|||.+..
T Consensus 190 iDFg~a~~ 197 (237)
T smart00090 190 IDVSQSVE 197 (237)
T ss_pred EEChhhhc
Confidence 99998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=115.52 Aligned_cols=120 Identities=18% Similarity=0.196 Sum_probs=92.3
Q ss_pred ccccceeeecccCCCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+|.. .+..+++|... +.+|++.+. .+.|+++......+...+..++
T Consensus 7 G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 7 GAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS---------RARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred CceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHH---------HHHHCCCCCCeEEEEeCCCCEE
Confidence 67899999987 56667777422 122333333 5556665544445556778899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
||||++|++|.+.+... .. ....++.+++.++.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998631 12 7789999999999999999 999999999999999 67899999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-14 Score=113.05 Aligned_cols=117 Identities=20% Similarity=0.204 Sum_probs=86.8
Q ss_pred ccccceeeecccCCCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
++++.||+|.+ ++..+++|... +.+|++.+. .+.|.++..........+..++
T Consensus 5 G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 5 GAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLS---------RARKAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHH---------HHHHCCCCCCEEEEEECCCCEE
Confidence 57899999985 45667776522 112333333 4445544333334445667799
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
||||++|++|.+.+... .. .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 v~e~~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999988531 11 7899999999999999 999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.5e-14 Score=112.26 Aligned_cols=124 Identities=17% Similarity=0.052 Sum_probs=89.5
Q ss_pred ccccceeeecccCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC---c-eeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS---V-SGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~---~-~~lV~E~ 70 (257)
+.++.||. ..+....+||... +.+|++.+....+. ...|+||+++.+.+.... . ..+|+||
T Consensus 13 G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~----~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 13 GRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRR----LIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred CCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhcc----CCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 46788886 4344444676433 46677766622111 246899999999998864 3 3378999
Q ss_pred --cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCceeeCC----CCceEEeeeccc
Q 044568 71 --VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGI-LYLHDECEPPILHCDIKPQNILMDE----FWTAKILDFGLA 141 (257)
Q Consensus 71 --~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dl~~~nil~~~----~~~~kl~dfg~~ 141 (257)
+.+|+|.+++.+ ..+++. ..++.|++.++ +|||++ +|+||||||+||+++. +..++|+|++.+
T Consensus 87 ~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 87 DGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 557999999964 246554 46678888777 999999 9999999999999973 347999995443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.52 E-value=6e-14 Score=128.41 Aligned_cols=117 Identities=18% Similarity=0.217 Sum_probs=91.3
Q ss_pred ccccceeeecccCCCCCeeeccc----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
++++.||++.+..+...+.+... +.+|++.+. .++|++++.........+..++|
T Consensus 344 G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 344 GAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLS---------EARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHH---------hhcccCCCeeEEEEEeCCCCEEE
Confidence 56899999987666544322111 223333333 67788877666666667788999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
|||+++++|.+++. ....++.+++.++.+||+. +++|||+||+||++ .++.++++|||+++.
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999884 3567899999999999999 99999999999999 567999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-14 Score=135.16 Aligned_cols=134 Identities=22% Similarity=0.268 Sum_probs=103.5
Q ss_pred HHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------------------ccccCCCCccCccc
Q 044568 101 AKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------------------VIDKRDKGYMAPEC 162 (257)
Q Consensus 101 ~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------------------~~~~~~~~~~aPE~ 162 (257)
+.+++|+|+- +|+|||+||+|.++..-|++|+.|||+.+...... ..-.+|+.|.|||+
T Consensus 153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 7899999999 99999999999999999999999999987532111 33478999999999
Q ss_pred ccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHccc
Q 044568 163 YKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242 (257)
Q Consensus 163 ~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 242 (257)
+....|...+|+|++|+++||.+.|..||.++.+++ .+..+.. +.+.-.+-+....++...++.+.|+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~vis---------d~i~wpE~dea~p~Ea~dli~~LL~ 297 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVIS---------DDIEWPEEDEALPPEAQDLIEQLLR 297 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhh---------hhccccccCcCCCHHHHHHHHHHHH
Confidence 999999999999999999999999999998773332 1221111 1111111133344667788889999
Q ss_pred CCCCCCC
Q 044568 243 DEPALRP 249 (257)
Q Consensus 243 ~~p~~RP 249 (257)
.+|..|-
T Consensus 298 qnp~~Rl 304 (1205)
T KOG0606|consen 298 QNPLCRL 304 (1205)
T ss_pred hChHhhc
Confidence 9999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=5e-13 Score=106.88 Aligned_cols=128 Identities=14% Similarity=0.044 Sum_probs=86.3
Q ss_pred cccccceeeecccCCCCCeeeccchhh-----h---HHHHh--------------HhhhccccccccCCceeeeceeeee
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVSWTA-----D---IEVLS--------------VAMRGSKCTRIRGGLLLNVPVRAKL 60 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~~~~-----~---~~~~~--------------~~~~~~~~~~~~h~~i~~~~~~~~~ 60 (257)
.+.++.||++...+++.+++|...... . .+... ....-..+..+.+.++ .++... .
T Consensus 25 ~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~v~~~~-~ 102 (198)
T cd05144 25 VGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF-PVPKPI-D 102 (198)
T ss_pred cCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC-CCCcee-e
Confidence 367899999998888889998533210 0 00000 0000001223333321 112111 1
Q ss_pred cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecc
Q 044568 61 TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140 (257)
Q Consensus 61 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~ 140 (257)
....++||||+++++|.+.... .....++.+++.++.++|+. +++|+|++|.||+++.++.++|+|||.
T Consensus 103 ~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 103 WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 2455899999999999876431 33567889999999999999 999999999999999999999999998
Q ss_pred ccc
Q 044568 141 AKL 143 (257)
Q Consensus 141 ~~~ 143 (257)
+..
T Consensus 172 ~~~ 174 (198)
T cd05144 172 MVS 174 (198)
T ss_pred ccc
Confidence 853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.2e-14 Score=128.03 Aligned_cols=192 Identities=20% Similarity=0.197 Sum_probs=148.5
Q ss_pred CCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeccCCCCce
Q 044568 48 GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAER-NPYWNQRVRIALDVAKGILYLH-DECEPPILHCDIKPQNI 125 (257)
Q Consensus 48 h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~dl~~~ni 125 (257)
|.|++..++.....+..++++||..+|++.+.+.. .+. .++...+..++.|+..++.|+| .. ++.|+|++|+|.
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~ 155 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNS 155 (601)
T ss_pred cccccccCCccCCCcccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccc
Confidence 99999999999999999999999999999999943 333 6777889999999999999999 88 999999999999
Q ss_pred eeCCCC-ceEEeeecccccCCC-C-----cccccC-CCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCC
Q 044568 126 LMDEFW-TAKILDFGLAKLPNE-D-----FVIDKR-DKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDAS 196 (257)
Q Consensus 126 l~~~~~-~~kl~dfg~~~~~~~-~-----~~~~~~-~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~ 196 (257)
+++..+ ..+++|||++..... . .....| ++.|.+||...+..+ .+..|+||.|+++.-+++|..|+.....
T Consensus 156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 999999 999999999875433 1 144566 889999999988544 5778999999999999999999986643
Q ss_pred ChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHH
Q 044568 197 KPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCA 253 (257)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei 253 (257)
.... ...|... . .. ..............+++..++..+|..|. .+++
T Consensus 236 ~~~~--~~~~~~~-----~--~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 236 KDGR--YSSWKSN-----K--GR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred cccc--ceeeccc-----c--cc-cccCccccCChhhhhcccccccCCchhccccccc
Confidence 3311 1111100 0 00 00012223345567777788889999998 7765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-11 Score=100.45 Aligned_cols=69 Identities=19% Similarity=0.224 Sum_probs=59.0
Q ss_pred eEEEeecCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 65 GKIERPVRN-GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 65 ~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
++|||++++ .+|.+++.+ ..++.. .+.+++.++.+||++ ||+|+|++|.|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 599999997 699999853 345543 357899999999999 999999999999999888999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=97.22 Aligned_cols=76 Identities=13% Similarity=0.040 Sum_probs=59.2
Q ss_pred CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecc
Q 044568 62 SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGL 140 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~ 140 (257)
...++||||++++++...... ..... .++..++.+++.++.++|. . +++|+|++|+||+++ ++.++++|||.
T Consensus 88 ~~~~lv~e~~~g~~~~~~~l~--~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~ 160 (187)
T cd05119 88 NRHVLVMEFIGGDGIPAPRLK--DVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQ 160 (187)
T ss_pred CCCEEEEEEeCCCCccChhhh--hhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECcc
Confidence 346899999998544322110 00111 6678899999999999999 8 999999999999999 88999999999
Q ss_pred cccC
Q 044568 141 AKLP 144 (257)
Q Consensus 141 ~~~~ 144 (257)
+...
T Consensus 161 a~~~ 164 (187)
T cd05119 161 AVEI 164 (187)
T ss_pred cccc
Confidence 8643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.9e-11 Score=90.63 Aligned_cols=120 Identities=17% Similarity=0.132 Sum_probs=90.2
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccC--CceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRG--GLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h--~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.+|+++..+ ...++|... +.+|.+.+. .+.+ ..+.++.......+..+++|||++++
T Consensus 9 g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~---------~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 9 GLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQ---------LLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHH---------HHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4578899999766 566666542 445555554 3333 35556666666667899999999887
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
++... +......++.+++.++.++|.....+++|+|++|.|+++++.+.++++||+.+.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 76654 456677889999999999999522369999999999999998899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=102.63 Aligned_cols=92 Identities=23% Similarity=0.162 Sum_probs=68.9
Q ss_pred CCceeeeceeeee-cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHhhCCCCCeeeccCCCCce
Q 044568 48 GGLLLNVPVRAKL-TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAK-GILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 48 h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~-~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
+.+-+.++..+.. .+..+|||||++|++|.+.... ..... ....++.+++. .+..+|.. |++|+|++|.||
T Consensus 216 ~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNi 288 (437)
T TIGR01982 216 NDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNI 288 (437)
T ss_pred CCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccE
Confidence 4445666665543 4567999999999999988753 11122 23456666665 46788999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCC
Q 044568 126 LMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~ 146 (257)
++..++.++++|||++...+.
T Consensus 289 lv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 289 FVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred EECCCCcEEEEeCCCeeECCH
Confidence 999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5e-10 Score=101.01 Aligned_cols=135 Identities=13% Similarity=0.113 Sum_probs=103.5
Q ss_pred ccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 044568 44 TRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ 123 (257)
Q Consensus 44 ~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ 123 (257)
..+|||||+++.......+..|||+|-+ -.|..++.. +......--+.||+.||.|||..| +++|+|+...
T Consensus 64 KtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~ 134 (690)
T KOG1243|consen 64 KTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKD 134 (690)
T ss_pred hhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeee
Confidence 3899999999999999999999999988 478888864 334555566889999999999766 9999999999
Q ss_pred ceeeCCCCceEEeeecccccCCCCcc---cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC
Q 044568 124 NILMDEFWTAKILDFGLAKLPNEDFV---IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189 (257)
Q Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~ 189 (257)
.+++...|.-||++|.++........ ....-..|..|+...... -..|.|.||+++||++.|..
T Consensus 135 SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 135 SVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred eEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 99999999999999988764333221 111111255555433222 23599999999999999843
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=108.78 Aligned_cols=177 Identities=16% Similarity=0.111 Sum_probs=131.3
Q ss_pred eeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 58 AKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 58 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
+...+..+||++|..+++|...++ .....+.+-++.+...+..+.++||+. .+.|+|++|.|.+...++..++.+
T Consensus 873 ~~~rsP~~L~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 873 FPCRSPLPLVGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCCCcchhhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 456778899999999999999998 444566677778888999999999998 899999999999999999999999
Q ss_pred ecccccCCCC----------------------------------cccccCCCCccCcccccCCCCCccccchhHHHHHHH
Q 044568 138 FGLAKLPNED----------------------------------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183 (257)
Q Consensus 138 fg~~~~~~~~----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~e 183 (257)
|+........ .....+|+.|.+||.+.+......+|+|++|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9743211000 023356777999999999998999999999999999
Q ss_pred HHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hH
Q 044568 184 TICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 184 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
.++|.+||.....+... . .-+..-+....-+.....+.-+++...+..+|.+|- +.
T Consensus 1028 ~l~g~pp~na~tpq~~f---~---------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIF---E---------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhhh---h---------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999866333211 0 001011111122334445666777788888998887 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.1e-10 Score=98.78 Aligned_cols=188 Identities=19% Similarity=0.144 Sum_probs=133.1
Q ss_pred cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeeccCCC
Q 044568 47 RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAK----GILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 47 ~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~----~l~~lh~~~~~~i~h~dl~~ 122 (257)
.|+|.++..-.+...+..++-+|+|. .+|.++... ...-++.........+..+ |+.++|+. +++|-|++|
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp 250 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKP 250 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccch
Confidence 47777776666777888888999985 688888863 2233666777777777777 99999999 999999999
Q ss_pred CceeeCCC-CceEEeeecccccCCCCc--------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCc
Q 044568 123 QNILMDEF-WTAKILDFGLAKLPNEDF--------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEI 193 (257)
Q Consensus 123 ~nil~~~~-~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~ 193 (257)
.|+.+..+ ...+++|||+...++... ....+...|++||...+ -++..+|++++|.+..+..++..++..
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 99999988 889999999887554332 11245566999998754 468899999999999999998887753
Q ss_pred CCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 194 DASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
.-. ..| .+.+....+.++-..-..++...+.++++.+|..|+ ++.+.
T Consensus 330 g~~-------~~W-------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 330 GKN-------SSW-------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CCC-------CCc-------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 300 011 111111111111111123455588899999999999 66554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.9e-09 Score=95.15 Aligned_cols=90 Identities=19% Similarity=0.113 Sum_probs=62.1
Q ss_pred CCceeeeceeeee-cCceeEEEeecCCCCHHHHHhccCCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 044568 48 GGLLLNVPVRAKL-TSVSGKIERPVRNGSLTDIIFCSAER----NPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 48 h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 122 (257)
+...+.++....+ .+..+|||||++|+++.++-.-...+ .+....+..++.|+ ... |++|+|++|
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~---GffHaDpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRD---GFFHADMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhC---CeeeCCCCh
Confidence 4455666666654 56788999999999998753210111 13333333344444 456 999999999
Q ss_pred CceeeCCCC----ceEEeeecccccCCCC
Q 044568 123 QNILMDEFW----TAKILDFGLAKLPNED 147 (257)
Q Consensus 123 ~nil~~~~~----~~kl~dfg~~~~~~~~ 147 (257)
.||+++.++ .++++|||+....+..
T Consensus 289 GNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 289 GNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 999999887 8999999998765443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.4e-09 Score=79.97 Aligned_cols=113 Identities=17% Similarity=0.058 Sum_probs=74.8
Q ss_pred cccceeeecccCCCCCeeecc--------chhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 5 KLSNFYRSSFNARNSPWISRV--------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
.++.+|+.+.. ++..++|.. .+.+|.+.+.... +.+++.-+ .....+..++||||++|.++
T Consensus 10 ~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~---------~~~~~P~~-~~~~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 10 MTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAA---------EAGIGPKL-YYFDPETGVLITEFIEGSEL 78 (170)
T ss_pred ccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHH---------HhCCCCce-EEEeCCCCeEEEEecCCCcc
Confidence 45688888865 555666553 2345555555221 11222111 12233456899999999887
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCceeeCCCCceEEeeecccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP-----ILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-----i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+.- .....+..+++.++..||+. + ++|+|+++.||+++ ++.++++||+.+.
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6530 11234567899999999998 6 59999999999999 5689999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.8e-08 Score=78.90 Aligned_cols=76 Identities=11% Similarity=0.086 Sum_probs=59.0
Q ss_pred CceeEEEeecCCCCHHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 62 SVSGKIERPVRNGSLTD-IIFCSAERNPYWNQRVRIALDVAKGILYL-HDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
...+|||||+.++.+.. .+. +..++..+...+..+++.++..+ |+. +++|+|+++.||++.+ +.+.++|||
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~~-~~v~iIDF~ 169 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWHD-GKVWFIDVS 169 (197)
T ss_pred cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEC-CcEEEEECC
Confidence 56788999997654422 232 23455566778889999999988 888 9999999999999974 589999999
Q ss_pred ccccC
Q 044568 140 LAKLP 144 (257)
Q Consensus 140 ~~~~~ 144 (257)
.+...
T Consensus 170 qav~~ 174 (197)
T cd05146 170 QSVEP 174 (197)
T ss_pred CceeC
Confidence 87643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.3e-08 Score=75.51 Aligned_cols=79 Identities=22% Similarity=0.291 Sum_probs=62.9
Q ss_pred eeeceeee-ecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 52 LNVPVRAK-LTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 52 ~~~~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++.|.... +.+...|+|||.+|..|.+.+... ...++..+-.-+.-||.. +|+|+|++++|+++.++
T Consensus 61 V~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~ 128 (204)
T COG3642 61 VPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG 128 (204)
T ss_pred CCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC
Confidence 34444444 456667999999999999999742 245677777778889999 99999999999999987
Q ss_pred CceEEeeeccccc
Q 044568 131 WTAKILDFGLAKL 143 (257)
Q Consensus 131 ~~~kl~dfg~~~~ 143 (257)
.+.++|||++..
T Consensus 129 -~i~~IDfGLg~~ 140 (204)
T COG3642 129 -RIYFIDFGLGEF 140 (204)
T ss_pred -cEEEEECCcccc
Confidence 489999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=78.88 Aligned_cols=78 Identities=21% Similarity=0.081 Sum_probs=65.5
Q ss_pred CceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------CCce
Q 044568 62 SVSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-------FWTA 133 (257)
Q Consensus 62 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-------~~~~ 133 (257)
...+||||++++. +|.+++........+...+..++.+++..+.-||.. |++|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999876 899998643334556677889999999999999999 9999999999999975 4678
Q ss_pred EEeeecccc
Q 044568 134 KILDFGLAK 142 (257)
Q Consensus 134 kl~dfg~~~ 142 (257)
.++||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.6e-09 Score=91.66 Aligned_cols=184 Identities=16% Similarity=0.064 Sum_probs=125.9
Q ss_pred CCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 044568 48 GGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127 (257)
Q Consensus 48 h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~ 127 (257)
|.+.+.....+...++.++=.|||+++++...+. ....+.....+.+..|++.++.++|+. .++|+|++|.||++
T Consensus 325 ~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i 399 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILI 399 (524)
T ss_pred ccccCCCCCCccccccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceee
Confidence 4555555555556667778889999998888773 556678888999999999999999999 99999999999999
Q ss_pred CCC-CceEEeeecccccCCCCcccccCCCCcc--CcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHH
Q 044568 128 DEF-WTAKILDFGLAKLPNEDFVIDKRDKGYM--APECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204 (257)
Q Consensus 128 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~ 204 (257)
..+ +..++.||+++....-..........+. ++.......+..+.|++|||.-+.|.+++..--.....
T Consensus 400 ~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------- 471 (524)
T KOG0601|consen 400 SNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------- 471 (524)
T ss_pred ccchhhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------
Confidence 986 7889999998754222222222222333 45555566788999999999999999987754432100
Q ss_pred HHHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 205 NWVYKCFINRELNKLVRGT-KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+..+. .........+-.+...+...++..|| +.++..
T Consensus 472 -----------~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 472 -----------SLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -----------ceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 00011110 00111114455566678889999999 776643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.7e-08 Score=91.70 Aligned_cols=151 Identities=15% Similarity=0.203 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------------ccccCCCCcc
Q 044568 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------------VIDKRDKGYM 158 (257)
Q Consensus 91 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~~ 158 (257)
++...=+.+++.|+.|+|.+. +++|+++.|++|.+...+..|++.|+.+....... ........|.
T Consensus 99 e~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ 176 (700)
T KOG2137|consen 99 EDGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL 176 (700)
T ss_pred cHhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence 444455667779999999984 99999999999999999999999998765433211 1112233499
Q ss_pred CcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 044568 159 APECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVG 237 (257)
Q Consensus 159 aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 237 (257)
+||++.....+.++|++|+|+++|.+.. |+.-+............. ...-......+.+.+.++.+-+
T Consensus 177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----------~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----------NLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred cchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----------cccccccccccccCcHHHHHHH
Confidence 9999998777899999999999999994 555554332221110000 0000001123455667888888
Q ss_pred HHcccCCCCCCC-hHHHH
Q 044568 238 LWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 238 ~~cl~~~p~~RP-~~ei~ 254 (257)
...+..++..|| +.++.
T Consensus 246 ~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHhcCCcccCcchhhhh
Confidence 899999999999 77764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=72.32 Aligned_cols=83 Identities=23% Similarity=0.271 Sum_probs=63.1
Q ss_pred eeeecCceeEEEeecCC-CCHHHHHhccCCCCCCHHHH-HHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---
Q 044568 57 RAKLTSVSGKIERPVRN-GSLTDIIFCSAERNPYWNQR-VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW--- 131 (257)
Q Consensus 57 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~-~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~--- 131 (257)
++.+...-.|+|||.++ .++.+++... ...-..+.. ..++.++-+.+.-||.. +++|+||+.+||++..++
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~-~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILST-MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHH-ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcC
Confidence 34455566789999976 3889998753 222233333 67889999999999999 999999999999986554
Q ss_pred ceEEeeeccccc
Q 044568 132 TAKILDFGLAKL 143 (257)
Q Consensus 132 ~~kl~dfg~~~~ 143 (257)
.+.++|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 357999999763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9e-07 Score=76.72 Aligned_cols=188 Identities=12% Similarity=0.131 Sum_probs=121.7
Q ss_pred eeEEEeecCCC-CHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeee
Q 044568 64 SGKIERPVRNG-SLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 64 ~~lV~E~~~~g-sL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
.++.|...++- -+.+++.-. +-.-..|.-.+..+..++.+..-||.+ |..-+|+++.|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 67888877654 344444311 122367889999999999999999999 9999999999999999999999885
Q ss_pred ccccc--CCCCcccccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhc-CCCCCcCCCC-----hhhHHHHH
Q 044568 139 GLAKL--PNEDFVIDKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICC-RKNMEIDASK-----PEEIILTN 205 (257)
Q Consensus 139 g~~~~--~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g-~~pf~~~~~~-----~~~~~~~~ 205 (257)
..-.. .+.......+...|.+||.-. +-.-+...|.|.+|+++++++.| ++||.+.... ..+..+..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 43222 222234556777899999765 22346789999999999999996 9999864211 11111111
Q ss_pred HHHHhhhhhhhhhhhc--CCCCCHHH-HHHHHHHHHHcccCC--CCCCC-hHHHHHh
Q 044568 206 WVYKCFINRELNKLVR--GTKVDKKN-LENLVKVGLWCVQDE--PALRP-MKCAVMM 256 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~-~~~l~~l~~~cl~~~--p~~RP-~~ei~~~ 256 (257)
..+. ..++.+.... +++.+.+. ++.+-.|..+|+... +.-|| ++-.+..
T Consensus 242 g~f~--ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 242 GRFA--YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred ceee--echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 1111 1111111111 22333333 356666677887654 56899 8776654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.7e-06 Score=76.72 Aligned_cols=158 Identities=13% Similarity=0.090 Sum_probs=116.4
Q ss_pred ccceeeec-ccCCCCCeeecc-----chh----hhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeec
Q 044568 6 LSNFYRSS-FNARNSPWISRV-----SWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPV 71 (257)
Q Consensus 6 ~~~~y~~~-~~~~~~~~i~~~-----~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~ 71 (257)
++..||.. --+|....+++. .+. ..++.+. ++.|.|+|.+...+.. +...++|+.|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wk---------kl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWK---------KLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHH---------HhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 44566766 557777788887 232 2244444 8889999999888873 45778999998
Q ss_pred CC-CCHHHHHhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 72 RN-GSLTDIIFCS-------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 72 ~~-gsL~~~l~~~-------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
++ ++|.+.-+.. ++...++...+.++.|+..||.++|+. |+.-+-+.+.+|+++++.+++++.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEec
Confidence 75 5898887643 223466788899999999999999999 999999999999999988898887
Q ss_pred ecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC
Q 044568 138 FGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189 (257)
Q Consensus 138 fg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~ 189 (257)
.|.......+. . +.+. -..+.|.-.||.++.-+.||..
T Consensus 437 C~i~Dvl~~d~---------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 437 CGIMDVLQEDP---------T--EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ccceeeecCCC---------C--cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 77654332221 0 1111 1246799999999999999854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-06 Score=70.28 Aligned_cols=128 Identities=17% Similarity=0.140 Sum_probs=83.6
Q ss_pred cccceeeecccCCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec---CceeEEEeec
Q 044568 5 KLSNFYRSSFNARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT---SVSGKIERPV 71 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~---~~~~lV~E~~ 71 (257)
....+|+.+..+++..++|... +.+|.+.+...... .+..+ ++....... +..++||||+
T Consensus 10 ~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~----~~~vp---~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 10 QSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGT----GVPVP---KVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCC----CCCCC---CEEEECCCCCccCCceEEEEEe
Confidence 4667888887766677776433 24455544411111 12222 233333332 3568999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC---------------------------------------- 111 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------- 111 (257)
+|.++.+.+.. ..++..+...++.+++.++..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888776531 34666777777888888887777531
Q ss_pred -------------CCCeeeccCCCCceeeCC--CCceEEeeecccc
Q 044568 112 -------------EPPILHCDIKPQNILMDE--FWTAKILDFGLAK 142 (257)
Q Consensus 112 -------------~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~ 142 (257)
...++|+|+++.||+++. ++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 136799999999999998 5668899998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.1e-07 Score=73.17 Aligned_cols=76 Identities=26% Similarity=0.271 Sum_probs=65.1
Q ss_pred ceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEeee
Q 044568 63 VSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDF 138 (257)
Q Consensus 63 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~df 138 (257)
..+||+|++++. +|.+++... ..++......++.+++..+.-||+. |++|+|+++.|||+..+. .+.++||
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDl 165 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDL 165 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence 458999999874 899999742 2266677889999999999999999 999999999999999886 7899999
Q ss_pred ccccc
Q 044568 139 GLAKL 143 (257)
Q Consensus 139 g~~~~ 143 (257)
+.++.
T Consensus 166 d~~~~ 170 (206)
T PF06293_consen 166 DRMRF 170 (206)
T ss_pred hhcee
Confidence 87653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.8e-06 Score=66.12 Aligned_cols=77 Identities=16% Similarity=-0.000 Sum_probs=64.9
Q ss_pred ceeEEEeecCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--eEEeeec
Q 044568 63 VSGKIERPVRN-GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--AKILDFG 139 (257)
Q Consensus 63 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~dfg 139 (257)
..+||+|-+++ -||.+++.+..-..++...+..+..+++..+.-||+. |+.|+|+.+.||+++.++. +.++||.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 46799997754 4999998754445667788889999999999999999 9999999999999986566 8999997
Q ss_pred ccc
Q 044568 140 LAK 142 (257)
Q Consensus 140 ~~~ 142 (257)
.++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 655
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.4e-07 Score=71.70 Aligned_cols=74 Identities=22% Similarity=0.237 Sum_probs=49.9
Q ss_pred CceeEEEeecC--CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeeeccCCCCceeeCCCCceEEeee
Q 044568 62 SVSGKIERPVR--NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILY-LHDECEPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 62 ~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
+...|||||++ |..+..+... .++......++.+++..+.. +|.. |++|+|+++.||+++++ .+.++||
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred eCCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 35579999998 5555444321 12234556778888885555 5788 99999999999999988 9999999
Q ss_pred ccccc
Q 044568 139 GLAKL 143 (257)
Q Consensus 139 g~~~~ 143 (257)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-05 Score=72.08 Aligned_cols=88 Identities=18% Similarity=0.109 Sum_probs=60.9
Q ss_pred eeeceeeee-cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCceeeCC
Q 044568 52 LNVPVRAKL-TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGI-LYLHDECEPPILHCDIKPQNILMDE 129 (257)
Q Consensus 52 ~~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dl~~~nil~~~ 129 (257)
+.+|.+..+ .+...|+||||+|..+.|.-.- ...+++... ++..+.++. .-+-.. |.+|+|-+|.||++..
T Consensus 264 V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~---i~~~l~~~~~~qIf~~---GffHaDPHPGNilv~~ 336 (538)
T KOG1235|consen 264 VLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHD---ILNKLVEAYLEQIFKT---GFFHADPHPGNILVRP 336 (538)
T ss_pred eeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHH---HHHHHHHHHHHHHHhc---CCccCCCCCCcEEEec
Confidence 557777775 4688999999999877666332 344555553 333333332 333444 9999999999999983
Q ss_pred ----CCceEEeeecccccCCC
Q 044568 130 ----FWTAKILDFGLAKLPNE 146 (257)
Q Consensus 130 ----~~~~kl~dfg~~~~~~~ 146 (257)
+..+.+.|||+......
T Consensus 337 ~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 337 NPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCCCCccEEEEcccccccccH
Confidence 66889999998765443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.1e-05 Score=64.80 Aligned_cols=68 Identities=24% Similarity=0.191 Sum_probs=54.3
Q ss_pred cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecc
Q 044568 61 TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140 (257)
Q Consensus 61 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~ 140 (257)
....+|||||++|..|.+... ++. .+...+.+++.-+|+. |+.|+|.+|+|++++++ .++++||+.
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcc
Confidence 456678999999988877642 222 3556677889999999 99999999999999966 589999976
Q ss_pred cc
Q 044568 141 AK 142 (257)
Q Consensus 141 ~~ 142 (257)
-+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.6e-05 Score=70.76 Aligned_cols=93 Identities=19% Similarity=0.138 Sum_probs=66.1
Q ss_pred CCceeeeceeeee-cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHH-HHHHhhCCCCCeeeccCCCCce
Q 044568 48 GGLLLNVPVRAKL-TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKG-ILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 48 h~~i~~~~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~-l~~lh~~~~~~i~h~dl~~~ni 125 (257)
...-+.+|..+.. .+...|+|||++|-.+.+...- ...+.+ ...++..++.+ +..+-.. |+.|+|.+|.||
T Consensus 224 ~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d---~k~ia~~~~~~f~~q~~~d---gffHaDpHpGNi 296 (517)
T COG0661 224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGID---RKELAELLVRAFLRQLLRD---GFFHADPHPGNI 296 (517)
T ss_pred CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCC---HHHHHHHHHHHHHHHHHhc---CccccCCCccce
Confidence 3444677776664 6778899999999999988532 224454 33344433332 3334445 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCC
Q 044568 126 LMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~ 147 (257)
++..++.+.+.|||+....+..
T Consensus 297 ~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 297 LVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred EEecCCcEEEEcCcceecCCHH
Confidence 9999999999999998765443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.4e-05 Score=60.94 Aligned_cols=77 Identities=16% Similarity=0.078 Sum_probs=56.1
Q ss_pred ceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 63 VSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 63 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
...|||||+... .-.-.| .+..+...+...+..+++..+.-|-..+ +++|+||+.-|||+. ++.+.++|++-+
T Consensus 140 ~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~Qa 213 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQA 213 (268)
T ss_pred CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccc
Confidence 345899999543 111122 2233444478888899999988887732 999999999999999 679999999987
Q ss_pred ccCC
Q 044568 142 KLPN 145 (257)
Q Consensus 142 ~~~~ 145 (257)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 6443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.1e-05 Score=62.14 Aligned_cols=70 Identities=16% Similarity=0.078 Sum_probs=50.1
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
--.+||||.+|--|...= ++......++..|+.-+...-.. |++|+|++.-||++++++.+.++||--+.
T Consensus 181 RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 181 RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCcccc
Confidence 345799999875544321 12344445555666555555566 99999999999999999999999996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00016 Score=70.02 Aligned_cols=185 Identities=16% Similarity=0.095 Sum_probs=126.6
Q ss_pred ccccccCCceeeeceeeeecCcee----EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 044568 42 KCTRIRGGLLLNVPVRAKLTSVSG----KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILH 117 (257)
Q Consensus 42 ~~~~~~h~~i~~~~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 117 (257)
+..++.|.|+....++.-..-... +..|+|..-++.+.+. .-...+..+.+.+..++..|+.|+|+. ...|
T Consensus 235 ~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~---~l~~ 309 (1351)
T KOG1035|consen 235 SLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL---SLEH 309 (1351)
T ss_pred HHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh---ccce
Confidence 455788999988888777655444 3447888888888887 556678889999999999999999999 7777
Q ss_pred ccCCCC---ceeeCCCCceEEe--eecccccCCCCc--ccccCCCCccCcccccCCCCC--ccccchhHHHHHHHHHhcC
Q 044568 118 CDIKPQ---NILMDEFWTAKIL--DFGLAKLPNEDF--VIDKRDKGYMAPECYKRTPIS--VKADVYGYGIVLLETICCR 188 (257)
Q Consensus 118 ~dl~~~---nil~~~~~~~kl~--dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~--~~~Di~s~G~~l~el~~g~ 188 (257)
.-+..+ +...+..+....+ +|+.+....... ........+.++|......+. ...|+|.+|.....+..|.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 766666 4455555566555 777665433222 222334447778877766554 4479999999999999877
Q ss_pred CCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 189 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+-.... ....+++.-. ...+......|+..++++|+ +.+++.
T Consensus 390 ~i~~~~~-------------------~~~~~l~~~~-----~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 390 DISEKSA-------------------VPVSLLDVLS-----TSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred ccccccc-------------------chhhhhcccc-----chhhhhhhhhhcchhhhhccchhhhhh
Confidence 7653221 1111111110 11455666789999999999 988875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0024 Score=52.54 Aligned_cols=30 Identities=23% Similarity=0.206 Sum_probs=26.1
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+.++|+|+.+.|++++++....|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 368999999999999998778899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=9.2e-05 Score=67.59 Aligned_cols=140 Identities=16% Similarity=0.020 Sum_probs=101.8
Q ss_pred cccCCc-eeeeceeeeecCceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 044568 45 RIRGGL-LLNVPVRAKLTSVSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122 (257)
Q Consensus 45 ~~~h~~-i~~~~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~ 122 (257)
+..|+| .+...+-.+.++..+++++++.++ |-..-... ....+...+...+...-..+++++|+. .-+|+|
T Consensus 289 K~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d--- 361 (829)
T KOG0576|consen 289 KVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD--- 361 (829)
T ss_pred HccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc---
Confidence 888999 666666666778889999999877 32222211 223333344455666777889999997 668887
Q ss_pred CceeeCCCCceEEeeecccccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCc
Q 044568 123 QNILMDEFWTAKILDFGLAKLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEI 193 (257)
Q Consensus 123 ~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~ 193 (257)
||+..+ ...+..+|+........ .....+++.+++||....+.+..+.|.|+.|.-..++.-|.+|-..
T Consensus 362 -~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 362 -NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred -cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 776655 47888999887655544 3556778899999999999999999999999877777777776543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0053 Score=49.50 Aligned_cols=29 Identities=38% Similarity=0.520 Sum_probs=20.1
Q ss_pred CeeeccCCCCceeeC-CCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMD-EFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~-~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.||+++ +++.+.++||+.+.
T Consensus 167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred EEEEeccccccceeeeccceeEEEecccce
Confidence 799999999999999 55566799998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0019 Score=51.11 Aligned_cols=89 Identities=21% Similarity=0.162 Sum_probs=67.1
Q ss_pred ceeeeceeeeecCceeEEEeecCCCCHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 044568 50 LLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFC-SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128 (257)
Q Consensus 50 ~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~ 128 (257)
++.++.|.| ..++|.||.+.+++...-.. ..-...+|..+.+++.+++..+.+++......+.-.|++++|+-+.
T Consensus 21 ~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~ 96 (188)
T PF12260_consen 21 PFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN 96 (188)
T ss_pred CCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe
Confidence 556667666 23579999987766432000 0112368999999999999999999985333678899999999999
Q ss_pred CCCceEEeeecccc
Q 044568 129 EFWTAKILDFGLAK 142 (257)
Q Consensus 129 ~~~~~kl~dfg~~~ 142 (257)
+++.+|++|...+.
T Consensus 97 ~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 97 DDGRLKLIDLDDVF 110 (188)
T ss_pred CCCcEEEEechhcc
Confidence 99999999997654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0031 Score=56.80 Aligned_cols=185 Identities=16% Similarity=0.106 Sum_probs=98.8
Q ss_pred ceeeecccCCCCCeeeccch-hhhHHHHhHhhhccccccccCCceeeeceeeeecCc-eeEEEeecCCCCHHHHHhccCC
Q 044568 8 NFYRSSFNARNSPWISRVSW-TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV-SGKIERPVRNGSLTDIIFCSAE 85 (257)
Q Consensus 8 ~~y~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~ 85 (257)
..+.++...+..- ...... ++.++.++... .+..+.|++++......+.... ..+|||++ +.||++.+....
T Consensus 4 ~~~~a~~~~~~~c-~nglplt~~s~~ilgr~~---~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~- 77 (725)
T KOG1093|consen 4 FTFFAQEKPGDVC-SNGLPLTPNSIQILGRFQ---YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN- 77 (725)
T ss_pred eEEehhcCCCccc-cCCCcCCCcHHHHhhhhH---HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-
Confidence 3444444444333 333333 56666666322 2237789999988887775433 56789998 469999986422
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccC
Q 044568 86 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKR 165 (257)
Q Consensus 86 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~ 165 (257)
+-..+ ++ .+ ++.|-++ .+.+| .+... | |
T Consensus 78 --l~~~s----------~~----~~---~~~~~~~------------~~~td-~~~t~-------------~--~----- 105 (725)
T KOG1093|consen 78 --LKDES----------LL----AH---GVLHLNI------------IYITD-HFLTK-------------Y--P----- 105 (725)
T ss_pred --cchhh----------hc----cc---ccceehh------------hhccc-ccccc-------------C--C-----
Confidence 21111 00 22 3333222 11222 11100 0 0
Q ss_pred CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh-hhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCC
Q 044568 166 TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-INRELNKLVRGTKVDKKNLENLVKVGLWCVQDE 244 (257)
Q Consensus 166 ~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~ 244 (257)
.+..+|+||||+|.++.|+.-|..-+..... ........+.+ .+.+...+.....+..++.+.+.++...|+-..
T Consensus 106 ~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~----s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~ 181 (725)
T KOG1093|consen 106 SPIGPKSDVWSLGFIILELYLGISLEAELTE----SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLE 181 (725)
T ss_pred CCCCcchhhhhHHHHHHHHHHhhHHHHHHHH----HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccc
Confidence 0112599999999999999998887753211 11111111111 111111111111334556678899999999999
Q ss_pred CCCCC-hHHHH
Q 044568 245 PALRP-MKCAV 254 (257)
Q Consensus 245 p~~RP-~~ei~ 254 (257)
|..|| ..+..
T Consensus 182 ~~ir~l~~~~~ 192 (725)
T KOG1093|consen 182 PIIRPLPMELS 192 (725)
T ss_pred cccccchhHHh
Confidence 99999 66553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.008 Score=49.01 Aligned_cols=29 Identities=21% Similarity=0.204 Sum_probs=25.3
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+.++|+|+.|.|+++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3678999999999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.00019 Score=71.54 Aligned_cols=184 Identities=14% Similarity=0.085 Sum_probs=124.1
Q ss_pred ceeeecccCCCCCee-----eccchhhhHHHHh---HhhhccccccccCCceeeeceeeee--cCceeEEEeecCCCCHH
Q 044568 8 NFYRSSFNARNSPWI-----SRVSWTADIEVLS---VAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPVRNGSLT 77 (257)
Q Consensus 8 ~~y~~~~~~~~~~~i-----~~~~~~~~~~~~~---~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~~~gsL~ 77 (257)
...|+++......+. ++..|++--+-+. +.... ..+...|+++...+..... ....+.+++|+.+|.+.
T Consensus 1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~d-e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERD-ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred eeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhh-hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 356777777777663 3344433222222 22222 3345678988877776653 45778999999999999
Q ss_pred HHHhccCCCCCC-HHHHHHHHHHH-HHHHHHHhhCCCC--CeeeccCCCCceeeCCCCceEEeeecccccCCCCc---cc
Q 044568 78 DIIFCSAERNPY-WNQRVRIALDV-AKGILYLHDECEP--PILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---VI 150 (257)
Q Consensus 78 ~~l~~~~~~~l~-~~~~~~~~~~i-~~~l~~lh~~~~~--~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---~~ 150 (257)
+.|-++.....+ ........+++ +.+..-+|+..+. --+|+++++.|.++..+..++++++|+.+...... ..
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 999764332222 12333444444 6777776766422 24789999999999999999999999987322221 33
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCC
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
..+++-|+.|+....-.++.++|+|..|+-+|+...|..+|-
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 355556778887777778888999999999999998888873
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.025 Score=49.23 Aligned_cols=79 Identities=10% Similarity=0.116 Sum_probs=59.1
Q ss_pred ceeEEEeecCCCC-HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 63 VSGKIERPVRNGS-LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 63 ~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
...|||+|+..-. -.-.| .+..++...+..+-.|++.-+.-|-+.| +++|.||+--|+|+-+ |.+.++|.+-+
T Consensus 238 ~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyiIDVSQS 311 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKLYIIDVSQS 311 (520)
T ss_pred cceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEEEEEEcccc
Confidence 3458999995322 12222 3456777888889899999888888877 9999999999999875 48999999877
Q ss_pred ccCCCC
Q 044568 142 KLPNED 147 (257)
Q Consensus 142 ~~~~~~ 147 (257)
.....+
T Consensus 312 VE~DHP 317 (520)
T KOG2270|consen 312 VEHDHP 317 (520)
T ss_pred ccCCCh
Confidence 654443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.058 Score=43.05 Aligned_cols=97 Identities=14% Similarity=0.096 Sum_probs=66.3
Q ss_pred hhhhHHHHhHhh-hccccccccCCceeeeceeeeecCceeEEEeecCC------CCHHHHHhccCCCCCCHHHHHHHHHH
Q 044568 27 WTADIEVLSVAM-RGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN------GSLTDIIFCSAERNPYWNQRVRIALD 99 (257)
Q Consensus 27 ~~~~~~~~~~~~-~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~~~~~ 99 (257)
..+|++.+.... .+ ...+..|-++.|...+.-..++|+|...+ -+|.+++.+ ..++. .+...
T Consensus 58 ~~~E~~~y~~l~~~~----~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~ 126 (199)
T PF10707_consen 58 NRRELRYYKQLSLRR----GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQA 126 (199)
T ss_pred HHHHHHHHHHHhhcc----CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHH
Confidence 345555444222 22 55677888999999999999999997632 278888843 34554 33333
Q ss_pred HHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEee
Q 044568 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILD 137 (257)
Q Consensus 100 i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~d 137 (257)
+-.-..||-+. +|+.+|++|.||++.... .+.++|
T Consensus 127 L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 127 LDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEe
Confidence 33456777888 999999999999996432 466676
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.13 Score=50.17 Aligned_cols=30 Identities=30% Similarity=0.488 Sum_probs=23.7
Q ss_pred CeeeccCCCCceeeCCC--CceEEeeeccccc
Q 044568 114 PILHCDIKPQNILMDEF--WTAKILDFGLAKL 143 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~--~~~kl~dfg~~~~ 143 (257)
.++|+|.++.|++++.+ ...-|.|+..+..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 59999999999999752 2356889987654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.019 Score=49.13 Aligned_cols=68 Identities=16% Similarity=0.161 Sum_probs=49.4
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
..++|||+..+-.|.+.-+- .....+...+..-+--|..+ |++|+|..--||++.++..++++||--.
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeechHh
Confidence 34679999988777765421 11223444444445667778 9999999999999999999999999543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.088 Score=46.64 Aligned_cols=28 Identities=29% Similarity=0.445 Sum_probs=24.6
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|||+++.||++..+ .++++|+.++.
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 78999999999999876 68999998664
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.24 Score=42.14 Aligned_cols=28 Identities=18% Similarity=0.226 Sum_probs=21.7
Q ss_pred CCCeeeccCCCCceeeCCC-Cc-eEEeeec
Q 044568 112 EPPILHCDIKPQNILMDEF-WT-AKILDFG 139 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~-~~-~kl~dfg 139 (257)
.+.++|||+++.|++++.+ +. +.+.|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 3578999999999999854 33 5677765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.06 Score=45.58 Aligned_cols=28 Identities=25% Similarity=0.340 Sum_probs=18.9
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 112 EPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
.|.++|+||.+.|++.+.++.+.|.|-.
T Consensus 187 ~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 187 KPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp --EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred CceeeEcCccccceeecCCCCceeeccc
Confidence 5678999999999999999889998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.12 Score=40.32 Aligned_cols=115 Identities=14% Similarity=0.095 Sum_probs=70.4
Q ss_pred cccceeeecccCCCCCeee------ccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 5 KLSNFYRSSFNARNSPWIS------RVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
-.|+||.|.+..+...+.. +.++..|.+++.... . ..+.......+..++.|||..|-+|.+
T Consensus 34 ~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~---------g---~~~~p~vy~yg~~~i~me~i~G~~L~~ 101 (201)
T COG2112 34 TTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILA---------G---EGVTPEVYFYGEDFIRMEYIDGRPLGK 101 (201)
T ss_pred cccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhh---------h---cCCCceEEEechhhhhhhhhcCcchhh
Confidence 3688999988776433332 244678888777221 1 122333344555667799999888887
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC-ceeeCCCCceEEeeeccccc
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQ-NILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~-nil~~~~~~~kl~dfg~~~~ 143 (257)
.-.. .+ .+-...+++...-|-.. ||-|+.++-. ..++.++..+.|+||.-+..
T Consensus 102 ~~~~-----~~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIG-----GD----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhc-----cc----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7642 11 22334455554445555 9999988643 33444445999999988763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.064 Score=46.67 Aligned_cols=71 Identities=17% Similarity=0.175 Sum_probs=53.8
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
..+++|++- |+++.-+ ..-.+.++..++.+.+.-+.-+..+ ...-|||+.-.||+++ .|.+.|+||.+++
T Consensus 300 y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence 345666655 3344322 1235688999999888877777766 4889999999999999 8899999999988
Q ss_pred c
Q 044568 143 L 143 (257)
Q Consensus 143 ~ 143 (257)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.3 Score=41.95 Aligned_cols=33 Identities=33% Similarity=0.603 Sum_probs=28.6
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 112 EPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
.+.++|+|+++.|+++++..-+-+.||+.+...
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 347999999999999999888999999987643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.87 Score=40.54 Aligned_cols=30 Identities=13% Similarity=0.281 Sum_probs=24.6
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 112 EPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+.++|||+++.||++.+++ .+++|..++.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 45899999999999999874 7888876553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.11 Score=42.40 Aligned_cols=30 Identities=30% Similarity=0.584 Sum_probs=25.5
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+.++|+|+.+.|++++++....++||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 368999999999999987666799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.26 Score=41.95 Aligned_cols=30 Identities=30% Similarity=0.500 Sum_probs=26.3
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+++|+|+++.|+++++++...++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 389999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.76 E-value=0.18 Score=41.00 Aligned_cols=66 Identities=23% Similarity=0.221 Sum_probs=45.9
Q ss_pred ecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 60 LTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 60 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
+.-..+++.|.|... ..++. .++.--+.+|.-.|+. +.+.+|+|..|+||+-|+.|.+||.|-+
T Consensus 125 n~~~yGvIlE~Cy~~-----------~i~~~----N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 125 NNYKYGVILERCYKI-----------KINFS----NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred CCceeEEEEeeccCc-----------ccchh----HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChh
Confidence 444667888988432 11111 1222224667888965 5699999999999999999999999976
Q ss_pred cc
Q 044568 140 LA 141 (257)
Q Consensus 140 ~~ 141 (257)
..
T Consensus 189 ~L 190 (308)
T PF07387_consen 189 CL 190 (308)
T ss_pred hh
Confidence 53
|
The function of this family is unknown. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.32 E-value=0.57 Score=39.66 Aligned_cols=31 Identities=26% Similarity=0.297 Sum_probs=26.6
Q ss_pred CCCeeeccCCCCceeeCCC----CceEEeeecccc
Q 044568 112 EPPILHCDIKPQNILMDEF----WTAKILDFGLAK 142 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~----~~~kl~dfg~~~ 142 (257)
...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3478999999999999874 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.11 E-value=0.53 Score=39.96 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.0
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 38899999999999987 578899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.97 E-value=0.16 Score=43.45 Aligned_cols=29 Identities=24% Similarity=0.405 Sum_probs=25.4
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+++|+|+.+.||+++++....++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 89999999999999977556899998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.4 Score=38.91 Aligned_cols=29 Identities=28% Similarity=0.402 Sum_probs=25.6
Q ss_pred CeeeccCCCCceeeCC-CCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDE-FWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~-~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.||++++ +..+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6899999999999997 5789999998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=90.49 E-value=0.43 Score=40.21 Aligned_cols=29 Identities=28% Similarity=0.421 Sum_probs=25.8
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+++|+|+.|.|++++++..+.++||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.06 E-value=0.32 Score=38.34 Aligned_cols=29 Identities=21% Similarity=0.314 Sum_probs=25.0
Q ss_pred CeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
..+|+|+.|.|+++.+++ ++++|++.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 569999999999998876 88999987653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=88.83 E-value=0.34 Score=40.06 Aligned_cols=28 Identities=25% Similarity=0.409 Sum_probs=24.6
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.||++++++ +.++||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 689999999999999876 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.29 E-value=1.5 Score=37.86 Aligned_cols=28 Identities=36% Similarity=0.622 Sum_probs=24.9
Q ss_pred eeeccCCCCceeeCCCCc-eEEeeecccc
Q 044568 115 ILHCDIKPQNILMDEFWT-AKILDFGLAK 142 (257)
Q Consensus 115 i~h~dl~~~nil~~~~~~-~kl~dfg~~~ 142 (257)
++|+|+.+.||+++.+.. ..++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=86.95 E-value=0.61 Score=39.22 Aligned_cols=29 Identities=34% Similarity=0.556 Sum_probs=24.5
Q ss_pred CeeeccCCCCceeeCCCCc-eEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWT-AKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~-~kl~dfg~~~ 142 (257)
.++|+|+++.|+++++++. ..++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 6899999999999997444 5699999775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.92 E-value=1.9 Score=38.49 Aligned_cols=61 Identities=16% Similarity=0.118 Sum_probs=44.0
Q ss_pred CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCceeeC
Q 044568 62 SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGI-LYLHDECEPPILHCDIKPQNILMD 128 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dl~~~nil~~ 128 (257)
....|+-+|++|.++..++. ....++..+..++.--+.|+ ..+--. +.+|.|++|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~---~~~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVK---WKSQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhh---cccChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence 34456778999999999995 34455556666666666665 333444 899999999999985
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=85.81 E-value=5 Score=33.07 Aligned_cols=26 Identities=27% Similarity=0.326 Sum_probs=21.8
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeee
Q 044568 112 EPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
.|..+|+||...|+....++ +.+.|-
T Consensus 186 qPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 186 QPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred CcceeecccccccccccCCC-Ceeecc
Confidence 46899999999999999887 666563
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.78 E-value=0.52 Score=37.70 Aligned_cols=29 Identities=34% Similarity=0.541 Sum_probs=20.3
Q ss_pred CeeeccCCCCceee-CCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILM-DEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~-~~~~~~kl~dfg~~~ 142 (257)
.+.|+|+.+.||++ ..++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 67899999999999 778899999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=84.94 E-value=0.93 Score=35.92 Aligned_cols=29 Identities=24% Similarity=0.335 Sum_probs=24.3
Q ss_pred CeeeccCCCCceeeCCCC-----ceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFW-----TAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~-----~~kl~dfg~~~ 142 (257)
.++|||+.+.|+++..+. .+.++||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 789999999999997543 57899998765
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=84.38 E-value=0.62 Score=39.71 Aligned_cols=30 Identities=20% Similarity=0.319 Sum_probs=26.8
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+++|+|+.++|+++++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 379999999999999988889999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=84.30 E-value=0.9 Score=38.06 Aligned_cols=29 Identities=24% Similarity=0.355 Sum_probs=26.4
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
-.+|+|+.+.|++.++.+.++|+||..+.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 48999999999999998899999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=83.81 E-value=3.4 Score=36.19 Aligned_cols=29 Identities=28% Similarity=0.474 Sum_probs=24.2
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
..++|||+.+.||++.++ .++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 378999999999999876 57789987654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=83.39 E-value=2 Score=37.36 Aligned_cols=29 Identities=31% Similarity=0.493 Sum_probs=25.3
Q ss_pred CeeeccCCCCceeeCC-CCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDE-FWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~-~~~~kl~dfg~~~ 142 (257)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4679999998765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 257 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-26 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 257 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-60 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-52 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-49 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-39 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-37 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-34 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-31 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-31 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-29 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-29 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-29 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-29 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-28 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-28 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-27 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-17 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-16 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-16 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-16 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-16 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-15 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-15 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-15 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-15 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-15 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-14 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-14 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-14 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-14 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-14 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-14 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-14 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-13 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-13 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-13 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-13 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-12 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-12 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-12 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-12 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-12 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-12 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-11 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-11 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-11 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-11 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-10 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-10 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-10 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-10 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-10 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-10 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-10 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-10 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-10 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-10 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-10 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-10 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-10 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-10 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-10 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-10 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-10 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-09 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-09 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-09 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-09 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-09 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-09 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-09 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-09 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-09 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-09 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-09 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-09 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-09 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-09 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-09 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-09 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-09 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-09 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 7e-09 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-09 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-09 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-09 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-09 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-08 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-08 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-08 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-08 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-08 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-08 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-08 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-08 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-08 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-08 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 5e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-08 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 6e-08 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-08 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-08 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-08 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-08 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-07 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-07 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-07 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-07 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-07 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-07 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-07 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-07 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-07 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-07 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-07 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-07 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-07 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-07 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-07 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-07 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-07 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 9e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-06 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-06 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-06 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-06 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-06 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-06 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-06 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-06 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-06 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-06 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-06 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-06 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-06 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-06 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-05 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-05 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-04 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-60
Identities = 72/200 (36%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 71 VRNGSLTDIIFCSAERNPY--WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
+ NGS+ + E P W +R RIAL A+G+ YLHD C+P I+H D+K NIL+D
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 129 EFWTAKILDFGLAKL-PNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLET 184
E + A + DFGLAKL +D + +G ++APE S K DV+GYG++LLE
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228
Query: 185 ICCRKNMEIDASKP---EEIILTNWVYKCFINRELNKLV---RGTKVDKKNLENLVKVGL 238
I ++ D ++ ++++L +WV ++L LV + +E L++V L
Sbjct: 229 ITGQRA--FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL 286
Query: 239 WCVQDEPALRP-MKCAVMML 257
C Q P RP M V ML
Sbjct: 287 LCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-52
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 73 NGSLTDIIFCSAERNP-YWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
NGSL D + C P W+ R +IA A GI +LH+ +H DIK NIL+DE +
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170
Query: 132 TAKILDFGLAKLPNEDFVIDKRDK-----------GYMAPECYKRTPISVKADVYGYGIV 180
TAKI DFGLA+ +K + YMAPE R I+ K+D+Y +G+V
Sbjct: 171 TAKISDFGLARA------SEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVV 223
Query: 181 LLETICCRKNMEIDASKPEEIILTNWVYKCFIN-RELNKLV--RGTKVDKKNLENLVKVG 237
LLE I +D + +++L + + + + + D ++E + V
Sbjct: 224 LLEIITGLPA--VDEHREPQLLLD-IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA 280
Query: 238 LWCVQDEPALRP-MKCAVMML 257
C+ ++ RP +K +L
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-49
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 71 VRNGSLTDIIFCSAERNPY--WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
+ NG+L ++ S W QR+ I + A+G+ YLH I+H D+K NIL+D
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173
Query: 129 EFWTAKILDFGLAKLPNEDFVIDKRDK-----------GYMAPECYKRTPISVKADVYGY 177
E + KI DFG++K E D+ GY+ PE + + ++ K+DVY +
Sbjct: 174 ENFVPKITDFGISKKGTEL------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 178 GIVLLETICCRKNMEIDASKP-EEIILTNWVYKCFINRELNKLV----RGTKVDKKNLEN 232
G+VL E +C R I S P E + L W + N +L ++V K+ ++L
Sbjct: 228 GVVLFEVLCARSA--IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPESLRK 284
Query: 233 LVKVGLWCVQDEPALRP-MKCAVMML 257
+ C+ RP M + L
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 33/213 (15%)
Query: 73 NGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDE-------CEPPILHCDIKPQN 124
GSL+D + N WN+ IA +A+G+ YLH++ +P I H DIK +N
Sbjct: 106 KGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 125 ILMDEFWTAKILDFGLAKL--PNEDFVIDKRDKG---YMAPE-----CYKRTPISVKADV 174
+L+ TA I DFGLA + G YMAPE + ++ D+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 175 YGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD-------- 226
Y G+VL E + R + + + ++ ++V K
Sbjct: 222 YAMGLVLWE-LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280
Query: 227 -KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
+ L + C + R C +
Sbjct: 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-37
Identities = 45/121 (37%), Positives = 70/121 (57%), Gaps = 5/121 (4%)
Query: 72 RNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GSL ++ S R +R+ +A DVAKG+ YLH PPI+H ++K N+L+D+
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKK 175
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
+T K+ DFGL++L F+ K G +MAPE + P + K+DVY +G++L E
Sbjct: 176 YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 188 R 188
+
Sbjct: 236 Q 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 8/124 (6%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
GSL +++ + Y + L ++G+ YLH ++H D+KP N+L+
Sbjct: 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140
Query: 130 FWT-AKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
T KI DFG A +KG +MAPE ++ + S K DV+ +GI+L E I
Sbjct: 141 GGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197
Query: 186 CCRK 189
RK
Sbjct: 198 TRRK 201
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 43/221 (19%), Positives = 74/221 (33%), Gaps = 39/221 (17%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDE------CEPPILHCDIKPQNIL 126
NGSL + W R+A V +G+ YLH E +P I H D+ +N+L
Sbjct: 96 NGSLXKYLS---LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 127 MDEFWTAKILDFGLAKLPNEDFVIDKRD-----------KGYMAPE-------CYKRTPI 168
+ T I DFGL+ + ++ + YMAPE
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 169 SVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV------- 220
+ D+Y G++ E C ++ ++ V ++ LV
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 221 ---RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
K + + +L + C + R + A +
Sbjct: 273 KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 28/123 (22%), Positives = 55/123 (44%), Gaps = 12/123 (9%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
GSL +++ +Q V+ ALD+A+G+ +LH EP I + +++++DE
Sbjct: 92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM 150
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISV---KADVYGYGIVLLETI 185
TA+I + ++APE ++ P AD++ + ++L E +
Sbjct: 151 TARISMADVKF-----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 186 CCR 188
Sbjct: 206 TRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 16/128 (12%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF- 130
R G L ++ + + + V A+ +A+G+ YLHDE PI+H D+K NIL+ +
Sbjct: 89 RGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 131 -------WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIV 180
KI DFGLA+ + G +MAPE + + S +DV+ YG++
Sbjct: 146 ENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVL 203
Query: 181 LLETICCR 188
L E +
Sbjct: 204 LWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 34/129 (26%), Positives = 56/129 (43%), Gaps = 15/129 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
V G L + W+ ++R+ LD+A GI Y+ + PPI+H D++ NI +
Sbjct: 103 VPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSL 160
Query: 131 W-----TAKILDFGLAKLPNEDFVIDKRDKG---YMAPE--CYKRTPISVKADVYGYGIV 180
AK+ DFGL++ G +MAPE + + KAD Y + ++
Sbjct: 161 DENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 181 LLETICCRK 189
L +
Sbjct: 218 LYTILTGEG 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-29
Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 24/135 (17%)
Query: 73 NGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNIL 126
GSL D + + +RI L +A G+ +LH E +P I H D+K +NIL
Sbjct: 90 MGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145
Query: 127 MDEFWTAKILDFGLAKL-PNEDFVIDKRDKG------YMAPECYKRTPISV------KAD 173
+ + I D GLA + +D + YMAPE T + D
Sbjct: 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVD 205
Query: 174 VYGYGIVLLETICCR 188
++ +G+VL E + R
Sbjct: 206 IWAFGLVLWE-VARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-29
Identities = 38/135 (28%), Positives = 57/135 (42%), Gaps = 24/135 (17%)
Query: 73 NGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNIL 126
NGSL D + + +++A G+ +LH E +P I H D+K +NIL
Sbjct: 119 NGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 127 MDEFWTAKILDFGLAKL----PNEDFVIDKRDKG---YMAPE------CYKRTPISVKAD 173
+ + T I D GLA NE + G YM PE + AD
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 174 VYGYGIVLLETICCR 188
+Y +G++L E + R
Sbjct: 235 MYSFGLILWE-VARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-29
Identities = 39/134 (29%), Positives = 56/134 (41%), Gaps = 23/134 (17%)
Query: 73 NGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDE-----CEPPILHCDIKPQNIL 126
+GSL D + R +++AL A G+ +LH E +P I H D+K +NIL
Sbjct: 124 HGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 127 MDEFWTAKILDFGLAKL----PNEDFVIDKRDKG---YMAPE------CYKRTPISVKAD 173
+ + T I D GLA + + G YMAPE K +AD
Sbjct: 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 174 VYGYGIVLLETICC 187
+Y G+V E
Sbjct: 240 IYAMGLVFWEIARR 253
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 25/144 (17%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
+ +L ++ A+ N+ +IA ++ KG+ YLH ILH D+K +N+ D
Sbjct: 112 KGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-G 166
Query: 132 TAKILDFGLAKLPNEDFVIDKRDK--------GYMAPECYKRT---------PISVKADV 174
I DFGL + + DK ++APE ++ P S +DV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226
Query: 175 YGYGIVLLETICCR---KNMEIDA 195
+ G + E K +A
Sbjct: 227 FALGTIWYELHAREWPFKTQPAEA 250
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-28
Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
SL + ++E + + IA A+G+ YLH I+H D+K NI + E
Sbjct: 102 EGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDN 157
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYK---RTPISVKADVYGYGIVLLE 183
T KI DFGLA + + ++ +MAPE + P S ++DVY +GIVL E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 184 TICCR 188
+ +
Sbjct: 218 LMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 21/136 (15%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
++ G+L II + P W+QRV A D+A G+ YLH I+H D+ N L+ E
Sbjct: 89 IKGGTLRGIIKSMDSQYP-WSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN 144
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----------------YMAPECYKRTPISVKAD 173
+ DFGLA+L ++ + + +MAPE K D
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204
Query: 174 VYGYGIVLLETICCRK 189
V+ +GIVL E I
Sbjct: 205 VFSFGIVLCEIIGRVN 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 33/136 (24%), Positives = 54/136 (39%), Gaps = 21/136 (15%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV-RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
G L + + R P V +I + + ++H +PPI+H D+K +N+L+
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG 175
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG---------------YMAPE---CYKRTPISVKAD 173
T K+ DFG A + + Y PE Y PI K D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 174 VYGYGIVLLETICCRK 189
++ G +L +C R+
Sbjct: 236 IWALGCILYL-LCFRQ 250
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-17
Identities = 37/204 (18%), Positives = 65/204 (31%), Gaps = 55/204 (26%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALD----VAKGILYLHDECEPPILHCDIKPQNILM 127
R +L D + R ++ + L +A+ + +LH + ++H D+KP NI
Sbjct: 144 RKENLKDWM---NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRDKG---------------YMAPECYKRTPISVKA 172
K+ DFGL ++D YM+PE S K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 173 DVYGYGIVLLETICCRKN--MEIDASKPEEIILTNWVYKCFINRELNKLVRGT-----KV 225
D++ G++L E + + ME R + +
Sbjct: 258 DIFSLGLILFE-LLYSFSTQME-------------------RVRIITDVRNLKFPLLFTQ 297
Query: 226 DKKNLENLVKVGLWCVQDEPALRP 249
+V+ + P RP
Sbjct: 298 KYPQEHMMVQ---DMLSPSPTERP 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-17
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
+ +G+L + +R +V + KG+ +LH PPI+H D+K NI +
Sbjct: 111 MTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFIT 165
Query: 129 -EFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
+ KI D GLA L F K G +MAPE Y+ DVY +G+ +LE
Sbjct: 166 GPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLE 221
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPP--ILHCDIKPQNILMD 128
G L +I + Y ++ R+ + + H + +LH D+KP N+ +D
Sbjct: 91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 129 EFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFGLA++ N D K G YM+PE R + K+D++ G +L E +
Sbjct: 151 GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-L 209
Query: 186 CCRK 189
C
Sbjct: 210 CALM 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 25/134 (18%), Positives = 48/134 (35%), Gaps = 21/134 (15%)
Query: 73 NGSLTDIIFCSAERNPYWNQR--VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G+L + I ++ + + + + L + +G+ +H H D+KP NIL+ +
Sbjct: 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDE 170
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG------------YMAPE---CYKRTPISVKADVY 175
++D G ++ Y APE I + DV+
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230
Query: 176 GYGIVLLETICCRK 189
G VL + +
Sbjct: 231 SLGCVLYA-MMFGE 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-16
Identities = 34/188 (18%), Positives = 66/188 (35%), Gaps = 31/188 (16%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L+ +I ++ +R + + + + ++H ++H DIKP N+ +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITAT 172
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
K+ D GL + + G YM+PE + K+D++ G +L E
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG------TKVDKKNLENLVKVGLWCV 241
+ D + K+ + + + L LV C+
Sbjct: 233 QSPFYGDKMNLYSLC--------------KKIEQCDYPPLPSDHYSEELRQLVN---MCI 275
Query: 242 QDEPALRP 249
+P RP
Sbjct: 276 NPDPEKRP 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-16
Identities = 40/123 (32%), Positives = 56/123 (45%), Gaps = 21/123 (17%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
+ +L++ I P + + + GI + HD I+H DIKPQNIL+D
Sbjct: 93 IEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDS 146
Query: 130 FWTAKILDFGLAKLPNE------DFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIV 180
T KI DFG+AK +E + V+ G Y +PE K D+Y GIV
Sbjct: 147 NKTLKIFDFGIAKALSETSLTQTNHVL-----GTVQYFSPEQAKGEATDECTDIYSIGIV 201
Query: 181 LLE 183
L E
Sbjct: 202 LYE 204
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 41/184 (22%), Positives = 69/184 (37%), Gaps = 34/184 (18%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G+L I R ++ + + + KG+ Y+H + +++ D+KP NI + +
Sbjct: 104 KGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
KI DFGL D R KG YM+PE + D+Y G++L E +
Sbjct: 159 KQVKIGDFGLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK--KNLENLVKVGLWCVQDEP 245
E ++ L G D K + L++ + +P
Sbjct: 218 CD-------TAFE-----------TSKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKP 256
Query: 246 ALRP 249
RP
Sbjct: 257 EDRP 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 27/99 (27%), Positives = 42/99 (42%), Gaps = 17/99 (17%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE------D 147
V I + + H H D+KP+NIL+ A ++DFG+A +
Sbjct: 137 VAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 148 FVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
+ G YMAPE + + + +AD+Y VL E
Sbjct: 194 NTV-----GTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 20/118 (16%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
V SL ++ P + + L++ + YLH +++ D+KP+NI++ E
Sbjct: 166 VGGQSLKRSK---GQKLP-VAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE 218
Query: 131 WTAKILDFGLAKLPNEDFVIDKRD-----KGYMAPECYKRTPISVKADVYGYGIVLLE 183
K++D G I+ G+ APE + P +V D+Y G L
Sbjct: 219 -QLKLIDLGAVSR------INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-15
Identities = 30/131 (22%), Positives = 50/131 (38%), Gaps = 25/131 (19%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALD----VAKGILYLHDECEPPILHCDIKPQNILM 127
R +L D + R + + L +A+ + +LH + ++H D+KP NI
Sbjct: 98 RKENLKDWM---NGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFF 151
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRDKG---------------YMAPECYKRTPISVKA 172
K+ DFGL ++D YM+PE S K
Sbjct: 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211
Query: 173 DVYGYGIVLLE 183
D++ G++L E
Sbjct: 212 DIFSLGLILFE 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 32/137 (23%)
Query: 73 NGSLTDII-----FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127
N L + ER YW + + + +H I+H D+KP N L+
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIHQHG---IVHSDLKPANFLI 188
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRD--KG---YMAPECYKRTP-----------ISVK 171
+ K++DFG+A D +D G YM PE K IS K
Sbjct: 189 VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 172 ADVYGYGIVLLETICCR 188
+DV+ G +L +
Sbjct: 248 SDVWSLGCILYYMTYGK 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-15
Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
V +L DI+ P + + + D + + + H + I+H D+KP NI++
Sbjct: 98 VDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISA 151
Query: 130 FWTAKILDFGLAKLPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLE 183
K++DFG+A+ + + Y++PE + + ++DVY G VL E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-15
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 6/97 (6%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR- 153
D + +LH + ++H D+KP NI + K+ DFGL + +
Sbjct: 161 GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 154 -DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK 189
D YMAPE + ADV+ G+ +LE C +
Sbjct: 218 GDPRYMAPELL-QGSYGTAADVFSLGLTILEVACNME 253
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-15
Identities = 35/122 (28%), Positives = 63/122 (51%), Gaps = 11/122 (9%)
Query: 73 NGSLTDIIFCSAERNPYW--NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L I +A++ + +Q + + + + ++HD ILH DIK QNI + +
Sbjct: 107 GGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD 161
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
T ++ DFG+A++ N + + G Y++PE + P + K+D++ G VL E +C
Sbjct: 162 GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYE-LCT 220
Query: 188 RK 189
K
Sbjct: 221 LK 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 9/96 (9%), Positives = 23/96 (23%), Gaps = 5/96 (5%)
Query: 93 RVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDK 152
+ + + L + ++H P N+ + + D
Sbjct: 196 LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS 252
Query: 153 RDKGYMAPECYKR--TPISVKADVYGYGIVLLETIC 186
Y E + + + G+ + C
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 21/115 (18%), Positives = 46/115 (40%), Gaps = 15/115 (13%)
Query: 83 SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
S ++ + R+++ L V + + LH ++H ++P +I++D+ + F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 143 LPNEDFVIDKRDKGYMAPE-----------CYKRTPISVKADVYGYGIVLLETIC 186
V +G+ PE +RT ++ D + G+V+ C
Sbjct: 255 RDGARVVSS-VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 33/137 (24%), Positives = 52/137 (37%), Gaps = 32/137 (23%)
Query: 73 NGSLTDII-----FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127
N L + ER YW + + + +H I+H D+KP N L+
Sbjct: 92 NIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIHQHG---IVHSDLKPANFLI 141
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRD--KG---YMAPE-----------CYKRTPISVK 171
+ K++DFG+A D +D G YM PE ++ IS K
Sbjct: 142 VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200
Query: 172 ADVYGYGIVLLETICCR 188
+DV+ G +L +
Sbjct: 201 SDVWSLGCILYYMTYGK 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 31/123 (25%), Positives = 46/123 (37%), Gaps = 16/123 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
+ GSL +I + R +G+ YLH ILH D+K N+L+
Sbjct: 132 LEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185
Query: 130 F-WTAKILDFGLAKLPNEDFVIDKRDKG--------YMAPECYKRTPISVKADVYGYGIV 180
A + DFG A D + G +MAPE P K D++ +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 181 LLE 183
+L
Sbjct: 246 MLH 248
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 32/137 (23%)
Query: 73 NGSLTDII-----FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127
N L + ER YW + + + +H I+H D+KP N L+
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIHQHG---IVHSDLKPANFLI 160
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRD--KG---YMAPECYKRTP-----------ISVK 171
+ K++DFG+A D +D G YM PE K IS K
Sbjct: 161 VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 172 ADVYGYGIVLLETICCR 188
+DV+ G +L +
Sbjct: 220 SDVWSLGCILYYMTYGK 236
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + Q V +A +A G+ Y+ +H D++ NIL+ E
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 399
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E
Sbjct: 400 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 456
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + Q V +A +A G+ Y+ +H D++ NIL+ E
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 316
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E
Sbjct: 317 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-14
Identities = 27/117 (23%), Positives = 52/117 (44%), Gaps = 7/117 (5%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G+L D + + + +A ++ + YL + +H ++ +N L+ E
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGEN 354
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY----MAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFGL++L D + APE S+K+DV+ +G++L E
Sbjct: 355 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 38/133 (28%), Positives = 55/133 (41%), Gaps = 26/133 (19%)
Query: 71 VRNGSLTDIIFCSAERNPYWN--QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
NG+L D+I N + R+ + + + Y+H + I+H D+KP NI +D
Sbjct: 97 CENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFID 150
Query: 129 EFWTAKILDFGLAKLPNEDFVIDKRDKG-----------------YMAPE-CYKRTPISV 170
E KI DFGLAK + I K D Y+A E +
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210
Query: 171 KADVYGYGIVLLE 183
K D+Y GI+ E
Sbjct: 211 KIDMYSLGIIFFE 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 14/107 (13%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ R+++ L V + + LH ++H ++P +I++D+ + F V
Sbjct: 210 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
Query: 150 IDKRDKGYMAPE----------CYKRTPISVKADVYGYGIVLLETIC 186
+G+ PE + T ++ D + G+ + C
Sbjct: 267 -SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-14
Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
V GSL+ ++ Q + + +G+ YLHD I+H DIK N+L++
Sbjct: 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINT 157
Query: 130 FW-TAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPI--SVKADVYGYGIVLLE 183
+ KI DFG +K + G YMAPE + P AD++ G ++E
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-14
Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 32/189 (16%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
V+ G + + +++ D A G+ YL + +H D+ +N L+ E
Sbjct: 194 VQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEK 249
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY-----MAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFG+++ + APE S ++DV+ +GI+L
Sbjct: 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL---- 305
Query: 186 CCRKNMEI--DASKPEEIILTNWVYKCFINRE-LNKLVRGTKVDKKNL--ENLVKVGLWC 240
E + P Y N++ + +G ++ L + + ++ C
Sbjct: 306 -----WETFSLGASP---------YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 241 VQDEPALRP 249
EP RP
Sbjct: 352 WAYEPGQRP 360
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 32/96 (33%), Positives = 57/96 (59%), Gaps = 15/96 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA-KLPN---EDFVI 150
++++ V KG+ YL ++ + I+H D+KP NIL++ K+ DFG++ +L + FV
Sbjct: 135 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 191
Query: 151 DKRDKG---YMAPECYKRTPISVKADVYGYGIVLLE 183
G YM+PE + T SV++D++ G+ L+E
Sbjct: 192 -----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 29/120 (24%), Positives = 57/120 (47%), Gaps = 9/120 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + + + +A+G+ ++ +H D++ NIL+
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
KI DFGLA++ ++ R+ + APE ++K+DV+ +GI+L+E +
Sbjct: 321 LVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-13
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 17/117 (14%)
Query: 74 GSLTDIIFCSAERNPYW-NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
G+LTDI+ + Q + V + + YLH + ++H DIK +IL+
Sbjct: 127 GALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR 179
Query: 133 AKILDFGL-AKLPNEDFVIDKRDK--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG A++ + + KR G +MAPE R+ + + D++ GI+++E
Sbjct: 180 VKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-13
Identities = 31/123 (25%), Positives = 59/123 (47%), Gaps = 20/123 (16%)
Query: 74 GSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
SL ++ + + +IA+ + K + +LH + ++H D+KP N+L++
Sbjct: 90 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALG 147
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKG-------YMAPE----CYKRTPISVKADVYGYGIV 180
K+ DFG++ +++D K YMAPE + SVK+D++ GI
Sbjct: 148 QVKMCDFGISG-----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202
Query: 181 LLE 183
++E
Sbjct: 203 MIE 205
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 29/128 (22%), Positives = 44/128 (34%), Gaps = 20/128 (15%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL-DVAKGILYLHDECEPPILHCDIKPQNILMDE--- 129
+L + + + + L G+ +LH I+H D+KP NIL+
Sbjct: 102 ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNA 156
Query: 130 --FWTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPI---SVKADVYGYG 178
A I DFGL K R G++APE + D++ G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 179 IVLLETIC 186
V I
Sbjct: 217 CVFYYVIS 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-12
Identities = 29/141 (20%), Positives = 49/141 (34%), Gaps = 32/141 (22%)
Query: 73 NGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMDE- 129
GSL D I + Y+ + + L V +G+ Y+H ++H DIKP NI +
Sbjct: 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT 151
Query: 130 ------------------FWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPE-CYKRTP 167
KI D G + V +G ++A E +
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE----EGDSRFLANEVLQENYT 207
Query: 168 ISVKADVYGYGIVLLETICCR 188
KAD++ + ++
Sbjct: 208 HLPKADIFALALTVVCAAGAE 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 34/117 (29%), Positives = 53/117 (45%), Gaps = 17/117 (14%)
Query: 74 GSLTDIIFCSAERNPYW-NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
GSLTD++ Q + + + + +LH ++H DIK NIL+ +
Sbjct: 102 GSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 133 AKILDFGL-AKLPNEDFVIDKRDK--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG A++ E KR G +MAPE R K D++ GI+ +E
Sbjct: 155 VKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL-AKLPNEDFVIDKR 153
+I L K + +L + + I+H DIKP NIL+D K+ DFG+ +L + I K
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKT 183
Query: 154 D----KGYMAPE----CYKRTPISVKADVYGYGIVLLE 183
+ YMAPE R V++DV+ GI L E
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 29/121 (23%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127
E+ + + + + + + VAKG+ +L +H D+ +NIL+
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL 226
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLL 182
E KI DFGLA+ +D ++ +MAPE ++++DV+ +G++L
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286
Query: 183 E 183
E
Sbjct: 287 E 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL-AKLPNEDFVIDKR 153
++ + + K + YL ++ ++H D+KP NIL+DE K+ DFG+ +L ++ K
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKD 182
Query: 154 D----KGYMAPE-----CYKRTPISVKADVYGYGIVLLE 183
YMAPE + ++ADV+ GI L+E
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 13/124 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
G L + E + + D++ + YLH+ I+H D+KP+NI++
Sbjct: 100 CEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQ 155
Query: 129 ---EFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLL 182
+ KI+D G AK ++ + + G Y+APE ++ +V D + +G +
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 183 ETIC 186
E I
Sbjct: 215 ECIT 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 31/146 (21%), Positives = 51/146 (34%), Gaps = 35/146 (23%)
Query: 73 NGSLTDII-----FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM 127
N +L D++ + + + +A G+ +LH I+H D+KPQNIL+
Sbjct: 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILV 148
Query: 128 D-------------EFWTAKILDFGLAK-LPNEDFVIDKRDK------GYMAPE------ 161
E I DFGL K L + G+ APE
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208
Query: 162 -CYKRTPISVKADVYGYGIVLLETIC 186
+ ++ D++ G V +
Sbjct: 209 NLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 15/119 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + ++ +LDV + + YL +H D+ +N+L+ E
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 325
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLE 183
AK+ DFGL K + APE + S K+DV+ +GI+L E
Sbjct: 326 NVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 13/116 (11%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GS++DII + ++ I KG+ YLH +H DIK NIL++ A
Sbjct: 109 GSVSDIIRLRNKTLTE-DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA 164
Query: 134 KILDFGL-AKLPNEDFVIDKRDK--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG+ +L + + KR+ G +MAPE + + AD++ GI +E
Sbjct: 165 KLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-11
Identities = 33/118 (27%), Positives = 62/118 (52%), Gaps = 9/118 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL D + + N+ + +A +A+G+ ++ + +H D++ NIL+ +
Sbjct: 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
+ KI DFGLA+L ++ R+ + APE ++K+DV+ +GI+L E
Sbjct: 146 LSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 16/91 (17%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFVIDKRD 154
+ +G+ YLH I+H D+KPQNIL+ KI+DFG+++ + R+
Sbjct: 140 ILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----RE 192
Query: 155 K----GYMAPECYKRTPISVKADVYGYGIVL 181
Y+APE PI+ D++ GI+
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-11
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ + VAKG+ +L +H D+ +NIL+ KI DFGLA+ D +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+MAPE + ++DV+ YGI L E
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 33/121 (27%), Positives = 55/121 (45%), Gaps = 10/121 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + E P + + V+ G+ YL ++ +H ++ +N+L+
Sbjct: 417 AGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNR 472
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLET 184
AKI DFGL+K L +D R G + APEC S ++DV+ YG+ + E
Sbjct: 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 185 I 185
+
Sbjct: 533 L 533
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-11
Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 13/138 (9%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFV 149
Q+++ A+ + KG+ YL +H D+ +N+L++ KI DFGL K + +
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 150 IDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI-CCRKNMEIDASKPEEIIL 203
+D + APEC ++ + +DV+ +G+ L E + C + A + I
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 204 TNWVYKCFINRELNKLVR 221
T + L ++
Sbjct: 243 T---HGQMTVTRLVNTLK 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 20/128 (15%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA-----------KILDFG 139
+ A+ + I +HD I+H DIKP N ++ + ++D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 140 LAK-----LPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194
+ F G+ E P + + D +G + + M++
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC-MLFGTYMKVK 287
Query: 195 ASKPEEII 202
E
Sbjct: 288 NEGGECKP 295
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFVIDK 152
+ + + KG+ YL +H D+ +NIL++ KI DFGLAK LP +
Sbjct: 130 LLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 153 RDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
R+ G + APE S ++DV+ +G+VL E
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD 128
R TD F A + + VA+G+ +L + +H D+ +N+L+
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198
Query: 129 EFWTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
AKI DFGLA+ D + +MAPE +V++DV+ YGI+L E
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFV 149
+ ++ + KG+ YL + +H D+ +NIL++ KI DFGL K LP +
Sbjct: 114 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 150 IDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
++ G + APE + SV +DV+ +G+VL E
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 28/133 (21%), Positives = 48/133 (36%), Gaps = 22/133 (16%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILM- 127
GSL ++ + + DV G+ +L + I+H +IKP NI+
Sbjct: 91 CPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRV 146
Query: 128 ---DEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPI--------SVKAD 173
D K+ DFG A+ +D G Y+ P+ Y+R + D
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVD 205
Query: 174 VYGYGIVLLETIC 186
++ G+
Sbjct: 206 LWSIGVTFYHAAT 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 21/130 (16%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRV------RIALDVAKGILYLHDECEPPILHCDIKPQN 124
+ N S+ + + + I V Y+H+E I H D+KP N
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182
Query: 125 ILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------YMAPE--CYKRTPISVKADVYG 176
ILMD+ K+ DFG ++ +++DK+ KG +M PE + + K D++
Sbjct: 183 ILMDKNGRVKLSDFGESE-----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 177 YGIVLLETIC 186
GI L
Sbjct: 238 LGICLYVMFY 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 9/120 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G+L D + + + +A ++ + YL + +H D+ +N L+ E
Sbjct: 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN 147
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFGL++L D + APE S+K+DV+ +G++L E
Sbjct: 148 HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK-LPNEDFV 149
+ ++ + KG+ YL + +H D+ +NIL++ KI DFGL K LP +
Sbjct: 145 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 150 IDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
++ G + APE + SV +DV+ +G+VL E
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 16/158 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
V GSL D + + Q + A + +G+ YLH + +H D+ +N+L+D
Sbjct: 117 VPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDND 170
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLET 184
KI DFGLAK +P R+ G + APEC K +DV+ +G+ L E
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 185 I-CCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221
+ C + E I + L +L+
Sbjct: 231 LTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTELLE 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-10
Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 11/121 (9%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + R+ + + V+ G+ YL + +H D+ +N+L+
Sbjct: 99 AELGPLNK--YLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ 153
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLET 184
AKI DFGL+K L ++ + G + APEC S K+DV+ +G+++ E
Sbjct: 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 213
Query: 185 I 185
Sbjct: 214 F 214
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 28/133 (21%), Positives = 48/133 (36%), Gaps = 22/133 (16%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRV--RIALDVAKGILYLHDECEPPILHCDIKPQNILM- 127
GSL ++ + + DV G+ +L + I+H +IKP NI+
Sbjct: 91 CPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRV 146
Query: 128 ---DEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPI--------SVKAD 173
D K+ DFG A+ +D G Y+ P+ Y+R + D
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVD 205
Query: 174 VYGYGIVLLETIC 186
++ G+
Sbjct: 206 LWSIGVTFYHAAT 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 31/132 (23%), Positives = 54/132 (40%), Gaps = 18/132 (13%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK------G 156
G+ +LH I++ D+KP+N+L+D+ +I D GLA E + K G
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPG 354
Query: 157 YMAPECYKRTPISVKADVYGYGIVLLETICCR-----KNMEIDASKPEEIILTNWV-YKC 210
+MAPE D + G+ L E I R + +++ + ++ +L V Y
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD 414
Query: 211 FINRELNKLVRG 222
+
Sbjct: 415 KFSPASKDFCEA 426
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 14/102 (13%)
Query: 92 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
R A ++ G+ LH E I++ D+KP+NIL+D+ +I D GLA
Sbjct: 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV----HVPE 338
Query: 151 DKRDK------GYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ K GYMAPE K + D + G +L E I
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 10/121 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + E P + + V+ G+ YL ++ +H D+ +N+L+
Sbjct: 91 AGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 146
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLET 184
AKI DFGL+K L +D R G + APEC S ++DV+ YG+ + E
Sbjct: 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206
Query: 185 I 185
+
Sbjct: 207 L 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKL--PNEDFVIDKR 153
+ G+ YLH + I H D+KP+NI++ K++DFGLA +F +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----K 176
Query: 154 DK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ ++APE P+ ++AD++ G++
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 16/123 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
R SL ++ R R + G YLH ++H D+K N+ ++E
Sbjct: 123 CRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNE 176
Query: 130 FWTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVLLE 183
KI DFGLA D +R K Y+APE + S + DV+ G ++
Sbjct: 177 DLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 184 TIC 186
+
Sbjct: 234 LLV 236
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 16/118 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
R SL ++ R R + G YLH ++H D+K N+ ++E
Sbjct: 97 CRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNE 150
Query: 130 FWTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVL 181
KI DFGLA D +R K Y+APE + S + DV+ G ++
Sbjct: 151 DLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q V + +A G+ YL + +H D+ +NIL++ K+ DFGL+++ +D
Sbjct: 148 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 152 KRDKG------YMAPECYKRTPISVKADVYGYGIVLLE 183
G + APE + +DV+ +GIV+ E
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-10
Identities = 33/121 (27%), Positives = 61/121 (50%), Gaps = 11/121 (9%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
+G L I S +RNP + L VA+G+ YL ++ +H D+ +N ++DE +
Sbjct: 106 CHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESF 161
Query: 132 TAKILDFGLAKLPNED--FVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLET 184
T K+ DFGLA+ + + + + + A E + + K+DV+ +G++L E
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 185 I 185
+
Sbjct: 222 L 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ A VAKG+ +L + +H D+ +N+L+ KI DFGLA+ D R
Sbjct: 175 LCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+MAPE ++K+DV+ YGI+L E
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKL--PNEDFVIDKR 153
+ G+ YLH + I H D+KP+NI++ K++DFGLA +F +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----K 176
Query: 154 DK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ ++APE P+ ++AD++ G++
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNIL---MDEFWTAKILDFGLAKLPNEDFVID 151
+ V + YLH+ I+H D+KP+N+L +E I DFGL+K+ +
Sbjct: 110 LVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-- 164
Query: 152 KRDK----GYMAPECYKRTPISVKADVYGYGIVL 181
GY+APE + P S D + G++
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-10
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 12/97 (12%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD 154
++A + Y H + ++H DIKP+N+L+ KI DFG + +R
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRT 165
Query: 155 -----KGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
Y+ PE + K D++ G++ E +
Sbjct: 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-10
Identities = 22/97 (22%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ + +AKG+ YL + ++H ++ +N+L+ ++ DFG+A L D
Sbjct: 118 LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ +MA E + ++DV+ YG+ + E +
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-10
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 17/92 (18%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKL--PNEDFVIDKR 153
+ G+ YLH + I H D+KP+NI++ K++DFG+A +F +
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----K 169
Query: 154 DK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ ++APE P+ ++AD++ G++
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-10
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ + +AKG+ YL D ++H D+ +N+L+ KI DFGLAKL +
Sbjct: 120 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
+ G +MA E + ++DV+ YG+ + E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 18/125 (14%)
Query: 74 GSLTDIIFCSAERNPYWNQRVR---IAL---DVAKGILYLHDECEPPILHCDIKPQNILM 127
GS+ DII + + + + IA +V +G+ YLH +H D+K NIL+
Sbjct: 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILL 154
Query: 128 DEFWTAKILDFGLAKLPNEDFVIDKRDK-----G---YMAPECYKRT-PISVKADVYGYG 178
E + +I DFG++ I + G +MAPE ++ KAD++ +G
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214
Query: 179 IVLLE 183
I +E
Sbjct: 215 ITAIE 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 33/121 (27%), Positives = 55/121 (45%), Gaps = 10/121 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL + + Q V + +A G+ YL D +H D+ +NIL++
Sbjct: 128 MENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLET 184
K+ DFGL ++ +D +G + +PE + +DV+ YGIVL E
Sbjct: 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243
Query: 185 I 185
+
Sbjct: 244 M 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL + + + Q V + V G+ YL D +H D+ +N+L+D
Sbjct: 132 MENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSN 187
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFGL+++ +D G + APE S +DV+ +G+V+ E
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 21/119 (17%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL---DVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS D++ IA ++ KG+ YLH E +H DIK N+L+ E
Sbjct: 105 GSALDLLEPGPLDETQ------IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH 155
Query: 131 WTAKILDFGL-AKLPNEDFVIDKRDK--G---YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ DFG+ +L + KR+ G +MAPE K++ KAD++ GI +E
Sbjct: 156 GEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ + VAKG+ +L +H D+ +NIL+ E KI DFGLA+ +D ++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+MAPE ++++DV+ +G++L E
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 24/99 (24%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
+ A ++ + YL + +H DI +N+L+ K+ DFGL++ +
Sbjct: 117 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY- 172
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K KG +MAPE + +DV+ +G+ + E +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 25/120 (20%), Positives = 48/120 (40%), Gaps = 10/120 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + + + V +L + K + YL +H DI +NIL+
Sbjct: 94 YPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASP 149
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFGL++ ++ K +M+PE + +DV+ + + + E +
Sbjct: 150 ECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 15/90 (16%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KILDFGLAKL--PNEDFVIDKRDK 155
+ +GI ++H ILH D+KP+NIL KI+DFGLA+ P E +
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----KVN 248
Query: 156 ----GYMAPECYKRTPISVKADVYGYGIVL 181
++APE +S D++ G++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
+ + LDV +G+ YL + C ++H D+ +N L+ E K+ DFG+ + +D
Sbjct: 105 TLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 160
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+ +PE + + S K+DV+ +G+++ E
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 21/106 (19%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
R A+ VA+G+ YL + +H D+ +N+L+ KI DFGL + +
Sbjct: 122 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA------LP 172
Query: 152 KRDKGY------------MAPECYKRTPISVKADVYGYGIVLLETI 185
+ D Y APE K S +D + +G+ L E
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-09
Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 12/93 (12%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G 156
+ G+LYLH ILH D+ N+L+ KI DFGLA ++ G
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---HEKHYTLCG 174
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLETIC 186
Y++PE R+ +++DV+ G + +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 17/92 (18%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKL--PNEDFVIDKR 153
+ G+ YLH I H D+KP+NI++ KI+DFGLA +F +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----K 175
Query: 154 DK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ ++APE P+ ++AD++ G++
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 13/120 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + ++ +LDV + + YL +H D+ +N+L+ E
Sbjct: 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 153
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
AK+ DFGL K +D G + APE + S K+DV+ +GI+L E
Sbjct: 154 NVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V A VA+G+ YL +H D+ +N+L+ E KI DFGLA+ + K
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
G +MAPE + ++DV+ +G++L E
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V +A+G+ YL + +H D+ +N+L+ E KI DFGLA+ N K
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
G +MAPE + ++DV+ +G+++ E
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
R R ++ + YLH E +++ D+K +N+++D+ KI DFGL K E
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG 303
Query: 152 KRDK------GYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K Y+APE + D +G G+V+ E +C R
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 24/99 (24%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
+ A ++ + YL + +H DI +N+L+ K+ DFGL++ +
Sbjct: 492 SLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY- 547
Query: 152 KRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
K KG +MAPE + +DV+ +G+ + E +
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 15/97 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRD 154
+I + + I LH I+H D+KP+NIL+D+ K+ DFG + + + R+
Sbjct: 128 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--RE 182
Query: 155 K----GYMAPE------CYKRTPISVKADVYGYGIVL 181
Y+APE + D++ G+++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVIDKR--D 154
+ + + YLH+ I+H D+KP+N+L KI DFGL+K+ ++
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213
Query: 155 KGYMAPECYKRTPISVKADVYGYGIVL 181
GY APE + + D++ GI+
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 38/144 (26%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 92 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
+R A ++ G+ ++H+ +++ D+KP NIL+DE +I D GLA
Sbjct: 292 ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD-----FS 343
Query: 151 DKRDK------GYMAPE-CYKRTPISVKADVYGYGIVLLETIC----CRKNMEIDASKPE 199
K+ GYMAPE K AD + G +L + + R++ D + +
Sbjct: 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 200 EIILTNWV-YKCFINRELNKLVRG 222
+ LT V + EL L+ G
Sbjct: 404 RMTLTMAVELPDSFSPELRSLLEG 427
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKILDFGLAKLPNEDFVIDKRDK-- 155
+G+ ++H+ I+H DIKP+NI+ + + KI+DFGLA N D ++ +
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTA 212
Query: 156 --GYMAPECYKRTPISVKADVYGYGIVL 181
+ APE R P+ D++ G++
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 3e-09
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 16/91 (17%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFVIDKRD 154
+ + I Y H I+H ++KP+N+L+ + K+ DFGLA +E +
Sbjct: 114 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HG 166
Query: 155 K----GYMAPECYKRTPISVKADVYGYGIVL 181
GY++PE K+ P S D++ G++L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 16/91 (17%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFVIDKRD 154
+ + I Y H I+H ++KP+N+L+ + K+ DFGLA +E +
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HG 189
Query: 155 K----GYMAPECYKRTPISVKADVYGYGIVL 181
GY++PE K+ P S D++ G++L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-09
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 15/90 (16%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKILDFGLAKL--PNEDFVIDKRDK 155
V + + +LH I H DI+P+NI+ T KI++FG A+ P ++F R
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RLL 163
Query: 156 ----GYMAPECYKRTPISVKADVYGYGIVL 181
Y APE ++ +S D++ G ++
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 8/95 (8%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDE------FWTAKILDFGLAKLPNEDF 148
+I+ + G+ Y+H C I+H DIKP+N+LM+ KI D G A +E +
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+ + Y +PE P AD++ ++ E
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
RI V GI Y+H I+H D+KP+N+L+ + +I+DFGL+ +
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK 186
Query: 152 KR--DKGYMAPECYKRTPISVKADVYGYGIVL 181
+ Y+APE K DV+ G++L
Sbjct: 187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 18/139 (12%)
Query: 59 KLTSVSGKIERPV-------RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC 111
L + + E ++G L + I + NP + L VAKG+ +L +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASK- 211
Query: 112 EPPILHCDIKPQNILMDEFWTAKILDFGLAK--LPNEDFVIDKRDKG-----YMAPECYK 164
+H D+ +N ++DE +T K+ DFGLA+ E + + +MA E +
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 165 RTPISVKADVYGYGIVLLE 183
+ K+DV+ +G++L E
Sbjct: 270 TQKFTTKSDVWSFGVLLWE 288
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ + +AKG+ YL D ++H D+ +N+L+ KI DFGLAKL +
Sbjct: 120 LNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
+ G +MA E + ++DV+ YG+ + E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q + + DV +G+ +L +H D+ +N L+D K+ DFG+ + +D +
Sbjct: 105 QLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161
Query: 152 KRDKGY----MAPECYKRTPISVKADVYGYGIVLLE 183
+ APE + S K+DV+ +GI++ E
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWE 197
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 11/119 (9%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
++G L + I + NP + L VAKG+ YL + +H D+ +N ++DE +
Sbjct: 110 KHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 165
Query: 132 TAKILDFGLAKLPNED--FVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
T K+ DFGLA+ + + + + +MA E + + K+DV+ +G++L E
Sbjct: 166 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133
GS+TD+I + I ++ +G+ +LH ++H DIK QN+L+ E
Sbjct: 112 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168
Query: 134 KILDFGL-AKLPNEDFVIDKRDK--G---YMAPE-----CYKRTPISVKADVYGYGIVLL 182
K++DFG+ A+L + +R+ G +MAPE K+D++ GI +
Sbjct: 169 KLVDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225
Query: 183 E 183
E
Sbjct: 226 E 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
I V G+ YLH I+H D+KP+N+L+ ++ KI+DFGL+ + +
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196
Query: 152 KR--DKGYMAPECYKRTPISVKADVYGYGIVL 181
+R Y+APE ++ K DV+ G++L
Sbjct: 197 ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V +A+G+ YL +H D+ +N+L+ E KI DFGLA+ N K
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
G +MAPE + ++DV+ +G+++ E
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAK-LPNEDFVIDKR-- 153
+ + + Y HD I+H D+KP +L+ + K+ FG+A L V R
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVL 181
+MAPE KR P DV+G G++L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 9/87 (10%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVIDKR--D 154
+ GI YLH I+H DIKP+NIL+ + KI+DFGL+ ++D+ + R
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 155 KGYMAPECYKRTPISVKADVYGYGIVL 181
Y+APE K+ + K DV+ G+++
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIM 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 24/100 (24%), Positives = 47/100 (47%), Gaps = 11/100 (11%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
Q + + DV + + YL + LH D+ +N L+++ K+ DFGL++ +D
Sbjct: 121 QLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EY 175
Query: 152 KRDKG------YMAPECYKRTPISVKADVYGYGIVLLETI 185
G + PE + S K+D++ +G+++ E
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-09
Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ A +++G+ YL + ++H D+ +NIL+ E KI DFGL++ E+ KR
Sbjct: 153 ISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
+G +MA E + ++DV+ +G++L E
Sbjct: 210 SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-09
Identities = 24/94 (25%), Positives = 42/94 (44%), Gaps = 13/94 (13%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
I D+ I +LH I H D+KP+N+L ++ K+ DFG AK ++ +
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-- 186
Query: 152 KRDK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ Y+APE D++ G+++
Sbjct: 187 -QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-09
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 13/103 (12%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
R R ++ + YLH +++ DIK +N+++D+ KI DFGL K E
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG 159
Query: 152 KRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K G Y+APE + D +G G+V+ E +C R
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 17/106 (16%)
Query: 91 NQRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ V++ ++ + YL ++ I+H D+KP NIL+DE I DF +A
Sbjct: 114 EETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA----MLP 166
Query: 150 IDKRD------KGYMAPECYKRTPI---SVKADVYGYGIVLLETIC 186
+ + K YMAPE + S D + G+ E +
Sbjct: 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-09
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 14/93 (15%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV------IDKR 153
+A + Y H+ ++H DIKP+N+LM KI DFG + +D
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD-- 177
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
Y+ PE + K D++ G++ E +
Sbjct: 178 ---YLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
VR +D+A G+ YL +H D+ +N ++ E T + DFGL++ +
Sbjct: 140 VRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
++A E +V +DV+ +G+ + E +
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-09
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+++A ++A G+ YL+ +H D+ +N ++ E +T KI DFG+ + E K
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 154 DKGY-----MAPECYKRTPISVKADVYGYGIVLLETI 185
KG M+PE K + +DV+ +G+VL E
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAK-LPNEDFVIDKR-- 153
+ + +L+ H ++H ++KP+N+L+ + K+ DFGLA + E
Sbjct: 119 ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 154 DKGYMAPECYKRTPISVKADVYGYGIVL 181
GY++PE ++ P D++ G++L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 24/121 (19%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL---DVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS +D++ E + Q V IA +G+ YLH ++H D+K NIL+ E
Sbjct: 138 GSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 190
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK--G---YMAPE---CYKRTPISVKADVYGYGIVLL 182
K+ DFG A + + + G +MAPE K DV+ GI +
Sbjct: 191 GLVKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 183 E 183
E
Sbjct: 245 E 245
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 14/113 (12%), Positives = 28/113 (24%), Gaps = 31/113 (27%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+R GSL ++ + +P +R +A H + P + +
Sbjct: 113 IRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSID 165
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
+ M + + D+ G G L
Sbjct: 166 GDVVLAYP-----------------ATMPDA-------NPQDDIRGIGASLYA 194
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 13/103 (12%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
A ++A G+ +L + I++ D+K N+++D KI DFG+ K E+
Sbjct: 443 HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 496
Query: 152 KRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K G Y+APE P D + +G++L E + +
Sbjct: 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ +LH ++H D+KPQNIL+ K+ DFGLA+
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 15/96 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
I + + ++HD ++H D+KP+N+L ++ KI+DFG A+L D +
Sbjct: 110 YIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---N 163
Query: 152 KRDK------GYMAPECYKRTPISVKADVYGYGIVL 181
+ K Y APE + D++ G++L
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 19/99 (19%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL--PNEDFVIDK 152
I + + + +LH I+H D+KP+NIL+D+ ++ DFG + P E
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---- 256
Query: 153 RDK----GYMAPE------CYKRTPISVKADVYGYGIVL 181
R+ GY+APE + D++ G++L
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 14/98 (14%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKILDFGLAKLPNEDFVIDK 152
I + + YLH++ I H DIKP+N L ++ + K++DFGL+K + +
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 153 RD-------KGYMAPE--CYKRTPISVKADVYGYGIVL 181
++APE K D + G++L
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 20/122 (16%)
Query: 74 GSLTDIIFCSAERNPYWNQRVR-IALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
G++ I+ +++ + + + + +LH + I+H D+K N+LM
Sbjct: 101 GAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD 155
Query: 133 AKILDFGL-AKLPNEDFVIDKRDK--G---YMAPE-----CYKRTPISVKADVYGYGIVL 181
++ DFG+ AK + KRD G +MAPE K TP KAD++ GI L
Sbjct: 156 IRLADFGVSAKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 182 LE 183
+E
Sbjct: 213 IE 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
RI V GI Y+H I+H D+KP+NIL+ ++ KI+DFGL+ ++ +
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 152 KR--DKGYMAPECYKRTPISVKADVYGYGIVL 181
R Y+APE + K DV+ G++L
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ +LH C I+H D+KP+NIL+ T K+ DFGLA+
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 22/97 (22%), Positives = 44/97 (45%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
++ +D+A G+ YL + LH D+ +N ++ + T + DFGL+K +
Sbjct: 150 LKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
++A E + K+DV+ +G+ + E
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-08
Identities = 16/41 (39%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
KG+ + H +LH D+KPQN+L++ K+ +FGLA+
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KILDFGLAKL--PNEDFV 149
V V KG+ ++H+ +H D+KP+NI+ + K++DFGL P +
Sbjct: 258 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVL 181
+ + APE + P+ D++ G++
Sbjct: 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 13/103 (12%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
A ++A G+ +L + I++ D+K N+++D KI DFG+ K E+
Sbjct: 122 HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDG 175
Query: 152 KRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K G Y+APE P D + +G++L E + +
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 3e-08
Identities = 16/41 (39%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ + H +LH D+KPQN+L++ K+ DFGLA+
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 13/104 (12%)
Query: 92 QRVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
R R A ++ +++LHD+ I++ D+K N+L+D K+ DFG+ K E
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICN 177
Query: 151 DKRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
G Y+APE + D + G++L E +C
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-08
Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ + H ILH D+KPQN+L++ K+ DFGLA+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 3e-08
Identities = 20/41 (48%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
GI Y HD +LH D+KPQN+L++ KI DFGLA+
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-08
Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
+G+ + H+ ILH D+KPQN+L+++ K+ DFGLA
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G 156
+A + YLH I++ D+KP+NIL+D + DFGL K E+ + G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
Y+APE + P D + G VL E +
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 5e-08
Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ YLH ILH D+KP N+L+DE K+ DFGLAK
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 5e-08
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAK 142
+G+ Y H + +LH D+KPQN+L++E K+ DFGLA+
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
R + +++ + YLH+ I++ D+K N+L+D K+ D+G+ K E
Sbjct: 154 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG 207
Query: 152 KRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
G Y+APE + D + G+++ E + R
Sbjct: 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-08
Identities = 21/51 (41%), Positives = 28/51 (54%), Gaps = 4/51 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKL--PNEDFV 149
+ I LH + H DIKP N+L++E T K+ DFG AK P+E V
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-08
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 93 RVRI-ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID 151
R + +++ + YLH+ I++ D+K N+L+D K+ D+G+ K E
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPG 164
Query: 152 KRDK---G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
G Y+APE + D + G+++ E + R
Sbjct: 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-08
Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 97 ALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK- 155
A ++ G+ +LH + I++ D+K NIL+D+ KI DFG+ K E+ + D +
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNT 177
Query: 156 --G---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
G Y+APE + D + +G++L E + +
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 16/96 (16%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFV 149
I + + I YLH I H D+KP+N+L K+ DFG AK +
Sbjct: 165 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 220
Query: 150 IDKRDK----GYMAPECYKRTPISVKADVYGYGIVL 181
Y+APE D++ G+++
Sbjct: 221 ---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 15/97 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
+ + YLH+ I+H D+KP+N+L+ +E KI DFG +K+ E ++
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM- 298
Query: 152 KRDK----GYMAPE---CYKRTPISVKADVYGYGIVL 181
R Y+APE + D + G++L
Sbjct: 299 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 14/96 (14%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAK-LPNEDFV 149
+ + K + YLH + ++H D+KP NIL + +I DFG AK L E+ +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 150 IDKRDK----GYMAPECYKRTPISVKADVYGYGIVL 181
+ ++APE +R D++ G++L
Sbjct: 177 L--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ +A VA G++YL +H D+ +N L+ + KI DFG+++
Sbjct: 161 LAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
+ +M PE + ++DV+ +G+VL E
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-08
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
G+ Y+H ILH D+K N+L+ K+ DFGLA
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-08
Identities = 22/127 (17%), Positives = 40/127 (31%), Gaps = 25/127 (19%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIAL---DVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GS D+I + IA V K + Y+H +H +K +IL+
Sbjct: 111 GSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD 164
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGY------------MAPECYKRTPI--SVKADVYG 176
+ ++ + ++PE ++ K+D+Y
Sbjct: 165 GKVYLSGLRSNLSMISH--GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 177 YGIVLLE 183
GI E
Sbjct: 223 VGITACE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
GI + H I+H DIKP+NIL+ + K+ DFG A
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 15/97 (15%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
+ + YLH+ I+H D+KP+N+L+ +E KI DFG +K+ E ++
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM- 173
Query: 152 KRDK----GYMAPE---CYKRTPISVKADVYGYGIVL 181
R Y+APE + D + G++L
Sbjct: 174 -RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 24/86 (27%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK--G---YMAP 160
YLH + I+H D+KP+NIL++E +I DFG AK+ + + + + G Y++P
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 161 ECYKRTPISVKADVYGYGIVLLETIC 186
E +D++ G ++ + +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 6/51 (11%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAK--LPNEDFV 149
+ + Y+H I H DIKPQN+L+D K++DFG AK + E V
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ IA +A G++YL + +H D+ +N L+ KI DFG+++
Sbjct: 136 LHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+M PE + ++DV+ +G++L E
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 30/89 (33%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 99 DVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG-- 156
D+ KGI YLH + I+H DIKP N+L+ E KI DFG++ + G
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 157 -YMAPEC---YKRTPISVKADVYGYGIVL 181
+MAPE ++ DV+ G+ L
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 12/92 (13%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G--- 156
+ +LH + I++ D+KP+NI+++ K+ DFGL K E G
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIE 186
Query: 157 YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
YMAPE R+ + D + G ++ + +
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 9/87 (10%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVIDKR--D 154
V GI Y+H I+H D+KP+NIL+ ++ KI+DFGL+ ++ + R
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186
Query: 155 KGYMAPECYKRTPISVKADVYGYGIVL 181
Y+APE + K DV+ G++L
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
+ + + H +H D+KP+NIL+ + K+ DFG A
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 17/46 (36%), Positives = 24/46 (52%), Gaps = 8/46 (17%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTA-----KILDFGLAK 142
G+ + H LH D+KPQN+L+ + KI DFGLA+
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 25/80 (31%), Positives = 35/80 (43%), Gaps = 16/80 (20%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFV 149
+ DVA + +LH++ I H D+KP+NIL ++ KI DF L N D
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 150 IDKRDK--------GYMAPE 161
+ YMAPE
Sbjct: 172 PISTPELLTPCGSAEYMAPE 191
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G 156
+A + +LH I++ D+KP+NIL+DE K+ DFGL+K E +K+ G
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCG 188
Query: 157 ---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
YMAPE R + AD + +G+++ E +
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 91 NQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI DFGL++ ++ V
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQE-VY 195
Query: 151 DKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLE 183
K+ G +MA E + + +DV+ YG++L E
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 11/100 (11%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDFGLAKLPNEDFVI 150
+ +A D+A G YL + +H DI +N L+ AKI DFG+A+
Sbjct: 143 LHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 151 DKRDKGY-----MAPECYKRTPISVKADVYGYGIVLLETI 185
K M PE + + K D + +G++L E
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KILDFGLAKLPNEDF--VI 150
+ A + + + LH I+HCD+KP+NIL+ + + K++DFG + ++ I
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260
Query: 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
R Y APE + D++ G +L E
Sbjct: 261 QSRF--YRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 6/85 (7%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGY 157
+ + YL + I+H DIK +NI++ E +T K++DFG A + Y
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 158 MAPECYKRTP-ISVKADVYGYGIVL 181
APE P + +++ G+ L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 20/51 (39%), Positives = 28/51 (54%), Gaps = 6/51 (11%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAK--LPNEDFV 149
+ + Y+H I H DIKPQN+L+D + K+ DFG AK + E V
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 19/46 (41%), Positives = 23/46 (50%), Gaps = 7/46 (15%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTA----KILDFGLAKL 143
GI YLH +LH D+KP NIL+ KI D G A+L
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 17/91 (18%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKL--PNEDFVIDKRD 154
+ + Y H + ++H D+KP+NIL KI+DFGLA+L +E +
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS----TN 185
Query: 155 K----GYMAPECYKRTPISVKADVYGYGIVL 181
YMAPE +KR ++ K D++ G+V+
Sbjct: 186 AAGTALYMAPEVFKR-DVTFKCDIWSAGVVM 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-07
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDFVID 151
RI DV + Y H + H D+KP+N L K++DFGLA ++
Sbjct: 110 RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 152 KR--DKGYMAPECYKRTPISVKADVYGYGIVL 181
+ Y++P+ + + D + G+++
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 18/103 (17%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 92 QRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------AKILDFGLAKL 143
++ +A +A + +L + ++H ++ +NIL+ K+ D G++
Sbjct: 114 WKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 144 PNEDFVIDKRDKGYMAPECYK-RTPISVKADVYGYGIVLLETI 185
++ +R ++ PEC + +++ D + +G L E
Sbjct: 171 VLPKDILQERIP-WVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 23/83 (27%), Positives = 38/83 (45%), Gaps = 8/83 (9%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG---YMA 159
+ Y H + I+H D+K +N+L+D KI DFG + + G Y A
Sbjct: 126 AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFCGAPPYAA 181
Query: 160 PECYKRTP-ISVKADVYGYGIVL 181
PE ++ + DV+ G++L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-07
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 11/98 (11%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDFGLAKLPNEDFVI 150
+ +A D+A G YL + +H DI +N L+ AKI DFG+A+
Sbjct: 184 LHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 151 DKRDKGY-----MAPECYKRTPISVKADVYGYGIVLLE 183
K M PE + + K D + +G++L E
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-07
Identities = 25/97 (25%), Positives = 42/97 (43%), Gaps = 8/97 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
V + +A G+ YL ++H D+ +N+L+ + KI D GL +
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 154 DKG-----YMAPECYKRTPISVKADVYGYGIVLLETI 185
+MAPE S+ +D++ YG+VL E
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-07
Identities = 20/51 (39%), Positives = 31/51 (60%), Gaps = 6/51 (11%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAK--LPNEDFV 149
+ + ++H I H DIKPQN+L++ + T K+ DFG AK +P+E V
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-07
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
G+ Y+H ILH D+KP N L+++ + K+ DFGLA
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-07
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 15/87 (17%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G---YMA 159
YLH +++ D+KP+N+L+D+ ++ DFG AK + R G +A
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALA 206
Query: 160 PECYKRTPISVKADVYGYGIVLLETIC 186
PE + D + G+++ E
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153
+ IA VA G+ YL + +H D+ +N L+ E KI DFGL++
Sbjct: 177 LCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 154 DKGY-----MAPECYKRTPISVKADVYGYGIVLLE 183
M PE + ++DV+ YG+VL E
Sbjct: 234 GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 19/90 (21%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------ 156
G++YLH I H DIKP+N+L+DE KI DFGLA + +
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-----YNNRERLLNKMC 168
Query: 157 ----YMAPECYKRTP-ISVKADVYGYGIVL 181
Y+APE KR + DV+ GIVL
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 15/46 (32%), Positives = 23/46 (50%), Gaps = 3/46 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
G+ LH+ ++H D+ P NIL+ + I DF LA+ D
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 9/66 (13%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYM--- 158
+G+ Y+H +LH D+KP N+L++ KI DFGLA++ + D Y+
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 159 ---APE 161
APE
Sbjct: 196 WYRAPE 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 26/87 (29%), Positives = 38/87 (43%), Gaps = 12/87 (13%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK------G 156
G+ YLH + I+H DIKP N+L+ T KI G+A+ F D +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFAADDTCRTSQGSPA 176
Query: 157 YMAPECY--KRTPISVKADVYGYGIVL 181
+ PE T K D++ G+ L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 24/101 (23%), Positives = 33/101 (32%), Gaps = 26/101 (25%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-------FVIDKRDK 155
I +H +H DIKP NIL+D ++ DFG D V
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV------ 224
Query: 156 G---YMAPECYKRTPISVKADVYG-------YGIVLLETIC 186
G Y++PE + YG G+ E
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
KG+ Y+H ++H D+KP N+ ++E KILDFGLA+ + +
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 16/73 (21%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG----- 156
+ + LH ++H D+KP N+L++ K+ DFGLA++ +E + G
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 157 --------YMAPE 161
Y APE
Sbjct: 180 VEFVATRWYRAPE 192
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148
GI +LH I+H D+KP NI++ T KILDFGLA+ F
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 17/96 (17%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------ 156
+ +LH I++ DIK +NIL+D + DFGL+K +FV D+ ++
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK----EFVADETERAYDFCGT 223
Query: 157 --YMAPE--CYKRTPISVKADVYGYGIVLLETICCR 188
YMAP+ + D + G+++ E +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 19/90 (21%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG------ 156
G++YLH I H DIKP+N+L+DE KI DFGLA + +
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR-----YNNRERLLNKMC 168
Query: 157 ----YMAPECYKRTP-ISVKADVYGYGIVL 181
Y+APE KR + DV+ GIVL
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 25/98 (25%), Positives = 36/98 (36%), Gaps = 22/98 (22%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-------FV--IDKR 153
I +H +H DIKP NILMD ++ DFG ED V D
Sbjct: 187 AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-- 241
Query: 154 DKGYMAPECYKRTPISVK-----ADVYGYGIVLLETIC 186
Y++PE + D + G+ + E +
Sbjct: 242 ---YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148
GI +LH I+H D+KP NI++ T KILDFGLA+ F
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
KG+ Y+H I+H D+KP N+ ++E KILDFGLA+ + +
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 16/40 (40%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
G ++H E I+H D+KP N L+++ + K+ DFGLA
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
K I YLH +LH D+KP NIL++ K+ DFGL+
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 15/87 (17%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK---G---YMA 159
YLH + I++ D+KP+NIL+D+ KI DFG AK + G Y+A
Sbjct: 121 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK------YVPDVTYTLCGTPDYIA 171
Query: 160 PECYKRTPISVKADVYGYGIVLLETIC 186
PE P + D + +GI++ E +
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 17/45 (37%), Positives = 26/45 (57%), Gaps = 3/45 (6%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
I Y H I+H D+KP+N+L+D+ KI DFGL+ + +
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141
+G+ Y+H I+H D+KP N+ ++E KILDFGLA
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 23/82 (28%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR--DKGYMAP 160
+ Y H ++H D+KP+N+L+D AKI DFGL+ + ++ + Y AP
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 161 ECYKRTP-ISVKADVYGYGIVL 181
E + D++ G++L
Sbjct: 180 EVISGRLYAGPEVDIWSCGVIL 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 27/91 (29%), Positives = 39/91 (42%), Gaps = 18/91 (19%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAKLPN----EDFVIDKRD 154
V + + + H+ +LH DIK +NIL+D K++DFG L DF
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----- 209
Query: 155 KG---YMAPECYKRTP-ISVKADVYGYGIVL 181
G Y PE + A V+ GI+L
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-06
Identities = 17/45 (37%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147
G+ Y H ++H D+KP+N+L+D AKI DFGL+ + ++
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 23/113 (20%)
Query: 92 QRVRIALDVAK--------GILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143
+ A+ + +H +H D+KP N+L+D+ K+ DFG
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 144 PNEDFVIDKR------DKGYMAPECYKRTPISVK----ADVYGYGIVLLETIC 186
N++ ++ D Y++PE K D + G+ L E +
Sbjct: 218 MNKEGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 29/91 (31%), Positives = 41/91 (45%), Gaps = 18/91 (19%)
Query: 100 VAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAKLPN----EDFVIDKRD 154
V I + H ++H DIK +NIL+D AK++DFG L + DF
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199
Query: 155 KG---YMAPECYKRTP-ISVKADVYGYGIVL 181
G Y PE R ++ A V+ GI+L
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 18/67 (26%), Positives = 32/67 (47%), Gaps = 10/67 (14%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAKLPNEDFVIDKRDKGYM-- 158
+G+ Y+H +LH D+KP N+ ++ E KI DFGLA++ + + +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 159 ----APE 161
+P
Sbjct: 188 KWYRSPR 194
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 15/54 (27%), Positives = 28/54 (51%), Gaps = 8/54 (14%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK-----ILDFGLAK 142
+ IA+ + + Y+H + +++ D+KP+N L+ I+DF LAK
Sbjct: 108 LMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA--KILDFGLAKLPNED--FVI 150
+ A + +L+L E I+HCD+KP+NIL+ + KI+DFG + + I
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
R Y +PE P + D++ G +L+E
Sbjct: 220 QSRF--YRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 32/166 (19%), Positives = 50/166 (30%), Gaps = 67/166 (40%)
Query: 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGIL--------YLHDECEPPILHCDIKPQNIL 126
L I ++ Y + L K I+ YLH +C I+H DIKP+NIL
Sbjct: 130 HLLKWI----IKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENIL 179
Query: 127 M-------------------------------------------------DEFWTAKILD 137
+ E KI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 138 FGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLE 183
G A ++ F D + + Y + E + + AD++ + E
Sbjct: 240 LGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFE 285
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 27/85 (31%), Positives = 35/85 (41%), Gaps = 10/85 (11%)
Query: 103 GILYLHDECEPPILHCDIKPQNILMDEFWTA--KILDFGLAKLPNEDFVIDKRDKG---Y 157
G+ Y H I H D+K +N L+D KI DFG +K G Y
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAY 183
Query: 158 MAPECYKRTP-ISVKADVYGYGIVL 181
+APE R ADV+ G+ L
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTL 208
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 15/41 (36%), Positives = 25/41 (60%), Gaps = 4/41 (9%)
Query: 102 KGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLA 141
K + Y H I+H D+KP N+++D E +++D+GLA
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 8/54 (14%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK-----ILDFGLAK 142
A + + +H++ +++ DIKP N L+ + ++DFG+ K
Sbjct: 109 AMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 18/51 (35%), Positives = 24/51 (47%), Gaps = 6/51 (11%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAK 142
I + + I YLH I H D+KP+N+L K+ DFG AK
Sbjct: 121 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 9/50 (18%), Positives = 24/50 (48%), Gaps = 5/50 (10%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI--LDFGLAK 142
++A + + +LH+ +H ++ +NI +D +++ +G A
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 11/50 (22%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI--LDFGLAK 142
++ + + + Y+H+ +H DIK N+L+ ++ D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK---ILDFGLAK 142
+ +A + I Y+H + +H D+KP N LM I+DFGLAK
Sbjct: 108 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 19/52 (36%), Positives = 27/52 (51%), Gaps = 6/52 (11%)
Query: 94 VRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK---ILDFGLAK 142
+ +A + + ++H + LH DIKP N LM A I+DFGLAK
Sbjct: 106 LMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 12/39 (30%), Positives = 22/39 (56%), Gaps = 5/39 (12%)
Query: 106 YLHDECEPPILHCDIKPQNILMDEFWTAKI--LDFGLAK 142
Y+H+ +H DIK N+L++ ++ +D+GLA
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 257 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.39 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.75 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.5 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.31 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.9 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.82 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.88 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 94.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 92.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.07 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 87.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 86.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 82.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 81.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 80.45 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=348.15 Aligned_cols=228 Identities=17% Similarity=0.220 Sum_probs=186.3
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.|+.||+|++. ++..++||.+. |.+|++++. +++|+|||++.+++...+..+||
T Consensus 37 G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~---------~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 37 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA---------RLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp CSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHH---------hCCCCCCCCcceEEEECCEEEEE
Confidence 579999999873 44567887653 556666666 88999999999999999999999
Q ss_pred EeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 044568 68 ERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA 133 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~ 133 (257)
||||++|||.++|.... ...+++.++..++.|++.||.|||++ +|+||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999996421 24689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHH
Q 044568 134 KILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 134 kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~ 207 (257)
||+|||+++..... .....||+.|+|||++.+..|+.++|||||||++|||+| |..||..... . .+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~--~~~~~- 259 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--Q--DVVEM- 259 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--H--HHHHH-
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--H--HHHHH-
Confidence 99999998753221 234567889999999999999999999999999999998 8999975421 1 11110
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.... ...+.+.+++..+.+++.+||+.||++|| |+||++.|
T Consensus 260 ---i~~~------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 260 ---IRNR------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp ---HHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHcC------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0000 01134566788899999999999999999 99998865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=343.24 Aligned_cols=227 Identities=23% Similarity=0.297 Sum_probs=179.3
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||+|++.. .++||.+. |.+|++.+. +++|+|||++.+++. .+..+||||||+
T Consensus 47 G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~---------~l~HpNIV~l~g~~~-~~~~~iVmEy~~ 114 (307)
T 3omv_A 47 GSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLR---------KTRHVNILLFMGYMT-KDNLAIVTQWCE 114 (307)
T ss_dssp CSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEC-SSSCEEEEECCS
T ss_pred CCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEE-CCeEEEEEEcCC
Confidence 6799999999764 47777643 345555555 899999999999875 467899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+|||.++|.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 115 gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 115 GSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 9999999975 556799999999999999999999999 9999999999999999999999999999754321
Q ss_pred cccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC--
Q 044568 148 FVIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-- 222 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (257)
.....||+.|+|||++.. .+|+.++|||||||++|||+||+.||....... .+...... ....+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~~~~--------~~~~p~~ 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGR--------GYASPDL 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHT--------TCCCCCS
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHHHhc--------CCCCCCc
Confidence 244579999999999863 468999999999999999999999997542211 11111100 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+.++++.+.+++.+||+.||++|| |+||++.|
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 134556678899999999999999999 99998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=344.62 Aligned_cols=228 Identities=17% Similarity=0.226 Sum_probs=184.1
Q ss_pred ccccceeeeccc------CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+|++. ++..++||.+. |.+|++.+. +++|+|||++.+++...+..+|||
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~---------~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 24 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT---------NLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp --CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHH---------hCCCCCCccEEEEEeeCCEEEEEE
Confidence 579999999864 34557887654 455666655 899999999999999999999999
Q ss_pred eecCCCCHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 69 RPVRNGSLTDIIFCS-----------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 69 E~~~~gsL~~~l~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
|||++|||.++|+.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 999999999999752 245799999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhh
Q 044568 138 FGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 138 fg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
||+++...... ....+|+.|+|||.+.+..|+.++|||||||++|||+| |+.||..... .......
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i----- 243 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI----- 243 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHH-----
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH-----
Confidence 99997533222 23357889999999999999999999999999999998 8999975421 1111100
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... .....+..+++.+.+++.+||+.||++|| ++||++.|
T Consensus 244 ~~~------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 244 TQG------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp HHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcC------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 000 01134556778899999999999999999 99998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=345.01 Aligned_cols=228 Identities=17% Similarity=0.184 Sum_probs=180.6
Q ss_pred ccccceeeeccc------CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+|++. ++..++||.+. |.+|++++. +++|+|||++.+++...+..+|||
T Consensus 52 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~---------~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT---------MLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp CSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEE
Confidence 578999999864 35567888654 455666665 899999999999999999999999
Q ss_pred eecCCCCHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 69 RPVRNGSLTDIIFCSA-------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|||++|||.++++... ...+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEE
Confidence 9999999999997532 24699999999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHH
Q 044568 136 LDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYK 209 (257)
Q Consensus 136 ~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 209 (257)
+|||+++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i--- 273 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI--- 273 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHH---
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHH---
Confidence 9999998543221 34568889999999999999999999999999999999 8999975421 1111100
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 210 CFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... .....+..+++.+.+++.+||+.||++|| |+||++.|
T Consensus 274 --~~g------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 274 --TQG------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp --HHT------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred --HcC------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 000 01134556778899999999999999999 99998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=339.48 Aligned_cols=226 Identities=19% Similarity=0.192 Sum_probs=183.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.|+.||+++.. +++.+++|.+. +.+|++.+. ++.|+|||++.+.+...+..|||||||
T Consensus 35 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~---------~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 35 GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA---------NMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHH---------HCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 578999999864 56778888754 344555555 889999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+||+|.++|.......+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999999999764566789999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ...... ... .....+..
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i-----~~~------~~~~~~~~ 248 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKI-----ISG------SFPPVSLH 248 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH-----HHT------CCCCCCTT
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH-----HcC------CCCCCCcc
Confidence 3457999999999999999999999999999999999999999755211 111111 000 01123444
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.++.+.+|+.+||+.||++|| ++|+++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 567899999999999999999 999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=338.61 Aligned_cols=227 Identities=15% Similarity=0.093 Sum_probs=184.9
Q ss_pred ccccceeeeccc-CCCCCeeeccch----hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.|+.||+++.. ++..+++|.+.. .+|++.+. ++.|+|||++.+.+...+..+||||||+||+|.+
T Consensus 69 G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~---------~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACA---------GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTT---------TCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 578999999965 466788887653 45666555 8899999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCCCc--------c
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNEDF--------V 149 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~~~--------~ 149 (257)
+|. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 140 ~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~ 214 (336)
T 4g3f_A 140 LIK--QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214 (336)
T ss_dssp HHH--HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred HHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence 997 446799999999999999999999999 999999999999999887 69999999998653321 2
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||.......-.. .... ...+....+...
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~---------~~~~~~~~~~~~ 282 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIAS---------EPPPIREIPPSC 282 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHH---------SCCGGGGSCTTS
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHc---------CCCCchhcCccC
Confidence 3468999999999999999999999999999999999999997653322111 1100 000001234456
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
++.+.+++.+||+.||.+|| +.|+++.
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 67899999999999999999 9999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=336.26 Aligned_cols=224 Identities=16% Similarity=0.150 Sum_probs=185.7
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.|+.||+++.. +++.+|||.+. +.+|++++. ++.|+|||++.+.+...+..|||||||+|
T Consensus 85 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~---------~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 85 GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR---------DYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 579999999965 56678888764 345666666 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
|+|.+++.. ..+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 156 g~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 156 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 999999964 4699999999999999999999999 9999999999999999999999999999865432 345
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (257)
..||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ...+... ..-..+ .......
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i----------~~~~~~~~~~~~~~ 296 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI----------RDNLPPRLKNLHKV 296 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----------HHSSCCCCSCGGGS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHH----------HcCCCCCCCccccC
Confidence 6899999999999999999999999999999999999999975421 1111111 111111 1233445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+|+.+||+.||++|| ++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 67899999999999999999 999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=328.30 Aligned_cols=225 Identities=17% Similarity=0.209 Sum_probs=177.6
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV 67 (257)
+.|+.||+|.... +..+++|.+. |.+|++.+. ++.|||||++.+.+.. .+..+||
T Consensus 37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~---------~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK---------GLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 5789999998654 5567777643 345555555 8899999999998865 3567999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCC-CCceEEeeecccccC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDE-FWTAKILDFGLAKLP 144 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~ 144 (257)
||||++|+|.+++. ....+++.++..++.|++.||.|||++ + |+||||||+|||++. ++.+||+|||+++..
T Consensus 108 mEy~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999997 456799999999999999999999999 7 999999999999974 789999999999864
Q ss_pred CC-CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 145 NE-DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 145 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
.. ......||+.|+|||++.+ .|+.++|||||||++|||+||+.||....... .+... +.....+.
T Consensus 183 ~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~---~~~~~---------i~~~~~~~ 249 (290)
T 3fpq_A 183 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRR---------VTSGVKPA 249 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHH---------HTTTCCCG
T ss_pred CCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH---HHHHH---------HHcCCCCC
Confidence 43 3355689999999998865 69999999999999999999999996442111 11100 00111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+...++++.+++.+||+.||++|| ++|+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22233446789999999999999999 999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=329.44 Aligned_cols=221 Identities=17% Similarity=0.158 Sum_probs=182.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+++.. +++.+++|.++ +.+|++++. ++.|+||+++...+.+.+..+|||||
T Consensus 43 G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS---------RLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 578999999964 56667888754 234444444 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
|+||+|.++|. ..+.+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999997 456799999999999999999999999 9999999999999999999999999999865322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ......... . ....+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~-----~-------~~~~~ 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKII-----K-------LEYDF 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-----H-------TCCCC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH-----c-------CCCCC
Confidence 245589999999999999999999999999999999999999997542 111111110 0 01133
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCA 253 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei 253 (257)
+....+.+.+|+.+||+.||++|| ++|+
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 445567789999999999999999 9886
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=336.81 Aligned_cols=224 Identities=16% Similarity=0.151 Sum_probs=184.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.|+.||+++.. +++.+|||.+. +.+|++++. ++.|+|||++.+.+...+..|||||||+|
T Consensus 162 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~---------~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 162 GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR---------DYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred CcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHH---------hCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 578999999965 46678888754 345666666 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
|+|.+++.. ..+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 233 G~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 233 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 999999963 4699999999999999999999999 9999999999999999999999999999865432 345
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (257)
..||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... ..+... ..-..+ .......
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i----------~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI----------RDNLPPRLKNLHKV 373 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----------HHSCCCCCSCTTSS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH----------HcCCCCCCcccccC
Confidence 68999999999999999999999999999999999999999754211 111111 111111 1223345
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+|+.+||+.||++|| ++|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 57889999999999999999 999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=318.48 Aligned_cols=222 Identities=18% Similarity=0.227 Sum_probs=172.2
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||++... +++.+++|.++ +.+|++.+. ++.|+||+++.+.+...+..+|||||
T Consensus 24 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---------~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 24 GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR---------LLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp ---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHH---------HCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 578999999864 56777887643 345555555 88899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
| +|+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 95 ~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 95 A-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp C-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred C-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 9 689999997 456799999999999999999999999 9999999999999999999999999999764432 3
Q ss_pred ccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 149 VIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ......... . ....++.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~-----~-------~~~~~p~ 233 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNIS-----N-------GVYTLPK 233 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-----H-------TCCCCCT
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH-----c-------CCCCCCC
Confidence 45689999999999998876 589999999999999999999997542 111111110 0 0112344
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..++.+.+++.+||+.||++|| ++|+++
T Consensus 234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 4567789999999999999999 999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=328.60 Aligned_cols=248 Identities=21% Similarity=0.181 Sum_probs=179.3
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecC----ceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS----VSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----~~~lV~E~~~~gsL~~~ 79 (257)
+.|+.||+|++ ++..+|||.++-....+...-.... ...+++|+||+++.+.+...+ ..+||||||++|||.++
T Consensus 14 G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~-~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~ 91 (303)
T 3hmm_A 14 GRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIY-QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 91 (303)
T ss_dssp CSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHH
T ss_pred CCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHH-HHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHH
Confidence 67999999997 5788999987643322222111111 234789999999999998764 57999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------ 148 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------ 148 (257)
|+. ..+++.++..++.|++.||.|||+++ +++|+||||||+|||++.++.+||+|||+++......
T Consensus 92 l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 168 (303)
T 3hmm_A 92 LNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168 (303)
T ss_dssp HHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC
T ss_pred HHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeee
Confidence 964 46999999999999999999999752 3489999999999999999999999999987533221
Q ss_pred -ccccCCCCccCcccccCC------CCCccccchhHHHHHHHHHhcCCCCCcCCCChh--------hHHHHHHHHHhhhh
Q 044568 149 -VIDKRDKGYMAPECYKRT------PISVKADVYGYGIVLLETICCRKNMEIDASKPE--------EIILTNWVYKCFIN 213 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~------~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~ 213 (257)
....||+.|+|||++.+. .++.++|||||||++|||+||..||........ ........ .....
T Consensus 169 ~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~ 247 (303)
T 3hmm_A 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCE 247 (303)
T ss_dssp -----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTT
T ss_pred cccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH-HHHhc
Confidence 234789999999999754 367899999999999999999888754321110 00000000 00000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......++....+.+.++.+.+|+.+||+.||++|| |+||++.|
T Consensus 248 ~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 001111111122345678899999999999999999 99998865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=325.59 Aligned_cols=218 Identities=19% Similarity=0.156 Sum_probs=175.4
Q ss_pred ccccceeeeccc----CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+++.. .++.+++|.+. +.+|++.+ .++.|+||+++.+.+...+..+|||
T Consensus 35 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il---------~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL---------VEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCC---------CCCCCTTEECEEEEEEETTEEEEEE
T ss_pred CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHH---------HHCCCCCCCeEEEEEEECCEEEEEE
Confidence 578999999753 34457887643 23344333 4889999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-- 146 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-- 146 (257)
|||+||+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 Ey~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 106 DFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999997 456799999999999999999999999 999999999999999999999999999975322
Q ss_pred -CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 147 -DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 147 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
......||+.|+|||.+.+..|+.++||||+||++|||++|+.||...... ....... . ....+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~-----~-------~~~~~ 245 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMIL-----K-------AKLGM 245 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-----H-------CCCCC
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHH-----c-------CCCCC
Confidence 234568999999999999999999999999999999999999999755211 1111110 0 11133
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-h
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~ 250 (257)
+...++.+.+++.+||+.||++|| +
T Consensus 246 p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 445567899999999999999999 6
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=330.42 Aligned_cols=229 Identities=19% Similarity=0.220 Sum_probs=180.3
Q ss_pred ccccceeeecccCCC------CCeeeccc----------hhhhHHHHhHhhhccccccccC-Cceeeeceeeeec-Ccee
Q 044568 4 TKLSNFYRSSFNARN------SPWISRVS----------WTADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLT-SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~-~~~~ 65 (257)
+.|+.||+|+....+ .+++|.+. |.+|++.+. ++.| +|||++.+.+... +..+
T Consensus 75 G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~---------~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 75 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI---------HIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp CSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECCTTSCCE
T ss_pred CCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHH---------HcCCCCcEEEEEEEEEecCCEEE
Confidence 579999999865432 45666543 344555555 7766 8999999998764 5689
Q ss_pred EEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 044568 66 KIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 131 (257)
||||||++|||.++|+... ...+++.++..++.|++.||.|||++ +|+||||||+|||+++++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCC
Confidence 9999999999999997421 34589999999999999999999999 999999999999999999
Q ss_pred ceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHH
Q 044568 132 TAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTN 205 (257)
Q Consensus 132 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~ 205 (257)
.+||+|||+++...... ....+|+.|+|||++.+..|+.++|||||||++|||+| |+.||........ +..
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---~~~ 299 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCR 299 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---HHH
Confidence 99999999998643322 23467888999999999999999999999999999998 9999976532211 111
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 206 WVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ..-. ....+..+++++.+++.+||+.||++|| ++||++.|
T Consensus 300 ~i---------~~g~-~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 300 RL---------KEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HH---------HHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH---------HcCC-CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 10 0000 1134455677899999999999999999 99998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=305.99 Aligned_cols=222 Identities=17% Similarity=0.195 Sum_probs=164.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC----------
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS---------- 62 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~---------- 62 (257)
+.|+.||+++.. ++..+++|.+.. .+|++.+. ++.|+|||++.+.+...+
T Consensus 16 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~---------~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA---------KLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp CC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEEEC----------
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEecCccccccccCC
Confidence 578999999854 566788887642 33444444 889999999999887654
Q ss_pred --ceeEEEeecCCCCHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 63 --VSGKIERPVRNGSLTDIIFCSAE-RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 63 --~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
..+||||||++|+|.+++..... ...++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999974221 2345677889999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc---------------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHH
Q 044568 140 LAKLPNEDF---------------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204 (257)
Q Consensus 140 ~~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~ 204 (257)
+++...... ....||+.|+|||.+.+..|+.++|||||||++|||++ ||... .+. ..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~--~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MER--VR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHH--HH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHH--HH
Confidence 997643321 23469999999999999999999999999999999996 77532 110 00
Q ss_pred HHHHHhhhhhhhhhhhcCC--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 205 NWVYKCFINRELNKLVRGT--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ....... .......+.+.+++.+||+.||++|| +.|+++
T Consensus 236 ~~----------~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TL----------TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH----------HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----------HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000100 11122335677899999999999999 999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.37 Aligned_cols=174 Identities=18% Similarity=0.258 Sum_probs=145.8
Q ss_pred ccccceeeeccc----CCCCCeeeccc-------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVS-------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.|+.||+++.. .++.+++|.+. +.+|++.+. .+ .|+||+++...+...+..+||||||
T Consensus 32 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~---------~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 32 GTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLT---------VAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp CSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHH---------HTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred ccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHH---------HhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 579999999753 34567887643 234444444 44 5999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccCCCC---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~~~~--- 147 (257)
++|+|.+++. .+++.+++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 103 ~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 103 EHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 9999999994 399999999999999999999999 99999999999999876 79999999999743321
Q ss_pred ----------------------------cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 148 ----------------------------FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 148 ----------------------------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
.....||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1234689999999999876 4899999999999999999999999654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=300.51 Aligned_cols=234 Identities=15% Similarity=0.154 Sum_probs=177.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.|+.||++... +++.+|||.+. +.+|++++. ++.|+|||++.+++... +..|
T Consensus 65 G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~---------~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 65 GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK---------HFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHH---------hcCCCCcceEeeeeecccccccCCEEE
Confidence 578999999864 56778888753 234555555 88999999999987643 5789
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
||||||+ |+|.+++. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++...
T Consensus 136 ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 136 VVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9999996 68999997 567899999999999999999999999 99999999999999999999999999997543
Q ss_pred C-------CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh---
Q 044568 146 E-------DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR--- 214 (257)
Q Consensus 146 ~-------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 214 (257)
. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..... .+...........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCChHH
Confidence 2 22456899999999998875 46899999999999999999999998652211 1111111100000
Q ss_pred -------hhhhh---hcCC-CCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 -------ELNKL---VRGT-KVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 -------~~~~~---~~~~-~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... +... ..+ ....+.+.+|+.+||+.||.+|| ++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000 111 12246788999999999999999 999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=315.87 Aligned_cols=229 Identities=17% Similarity=0.119 Sum_probs=178.7
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhH-----H-HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADI-----E-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~-----~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.|+.||+++.. ++..+|+|.+.-.... . .......-..+..+.|+|||++...+.+.+..|||||||+||+|
T Consensus 200 G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL 279 (689)
T 3v5w_A 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279 (689)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcH
Confidence 678999999965 4566788876421110 0 00000000123367899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-CcccccCCC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVIDKRDK 155 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~ 155 (257)
.++|. ....+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..... .....+||+
T Consensus 280 ~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp 354 (689)
T 3v5w_A 280 HYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354 (689)
T ss_dssp HHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCG
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCc
Confidence 99998 456799999999999999999999999 999999999999999999999999999986543 335668999
Q ss_pred CccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||++.+ ..|+.++||||+||++|||++|..||.............. .+.....++....+.+.
T Consensus 355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~------------i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------TLTMAVELPDSFSPELR 422 (689)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH------------HHHCCCCCCTTSCHHHH
T ss_pred CccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------hcCCCCCCCccCCHHHH
Confidence 9999999975 5799999999999999999999999976533221111000 01112234455667889
Q ss_pred HHHHHcccCCCCCCC
Q 044568 235 KVGLWCVQDEPALRP 249 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP 249 (257)
+|+.+||+.||.+|+
T Consensus 423 dLI~~lL~~dP~~Rl 437 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRL 437 (689)
T ss_dssp HHHHHHTCSCGGGCT
T ss_pred HHHHHHccCCHhHCC
Confidence 999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=312.04 Aligned_cols=228 Identities=17% Similarity=0.160 Sum_probs=181.6
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.|+.||++... +++.+++|.+.. .+|++.+. .+.|+||+++.+.+...+..+||||||+|
T Consensus 168 G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~---------~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS---------VLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHH---------HTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHH---------hCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 468999999865 456667776432 33444444 88899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--CceEEeeecccccCCCC--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF--WTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~--~~~kl~dfg~~~~~~~~--~~ 149 (257)
|+|.++|.. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 239 g~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 239 GELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999975 456799999999999999999999999 99999999999999854 78999999999865433 35
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...||+.|+|||++.+..|+.++||||+||++|||++|..||.+.... ..+..... .. ..-+.......
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~-----~~---~~~~~~~~~~~ 383 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKS-----CD---WNMDDSAFSGI 383 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHT-----TC---CCCCSGGGTTS
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHh-----CC---CCCCcccccCC
Confidence 568999999999999999999999999999999999999999755211 11111100 00 00000111233
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+|+.+||+.||.+|| +.|+++
T Consensus 384 s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 384 SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 46788999999999999999 999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.96 Aligned_cols=245 Identities=30% Similarity=0.497 Sum_probs=196.2
Q ss_pred ccccceeeecccCCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++..++..+++|... +.+|++.+. .+.|+||+++.+.+...+..++||||+++
T Consensus 41 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 3uim_A 41 GGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS---------MAVHRNLLRLRGFCMTPTERLLVYPYMAN 111 (326)
T ss_dssp CSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG---------TCCCTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred CCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH---------hccCCCccceEEEEecCCceEEEEEeccC
Confidence 57899999998888899998754 234444444 78899999999999999999999999999
Q ss_pred CCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 74 GSLTDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 74 gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
|+|.+++.... ...+++..+..++.|++.||.|||+++.++++||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (326)
T 3uim_A 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191 (326)
T ss_dssp CBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc
Confidence 99999998532 3349999999999999999999999866689999999999999999999999999987543221
Q ss_pred -ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCC-ChhhHHHHHHHHHhhhhhhhhhhhcCC---
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDAS-KPEEIILTNWVYKCFINRELNKLVRGT--- 223 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (257)
....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........|..............+..
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 3uim_A 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG 271 (326)
T ss_dssp ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT
T ss_pred cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc
Confidence 334588899999999888899999999999999999999999963211 111222333333333333333333322
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+....+.+.+++.+||+.||.+|| ++|+++.|
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 55777889999999999999999999 99999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=287.56 Aligned_cols=241 Identities=27% Similarity=0.450 Sum_probs=192.7
Q ss_pred ccccceeeecccCCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++..++..+++|.... .+|++.+. +++|+||+++.+.+...+..++||||+++|
T Consensus 50 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 50 GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS---------FCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGG---------SCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred CCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 578999999988888889986542 33443333 788999999999999999999999999999
Q ss_pred CHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 75 SLTDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 75 sL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+|.+++.... ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997532 23589999999999999999999999 9999999999999999999999999998753321
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC---C
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---K 224 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 224 (257)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....|.............+++. .
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhhhccccccHHHhcChhhccc
Confidence 1233578889999999888899999999999999999999999976543321 12223332222223333333322 4
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.+.+..+.+++.+||+.||++|| ++|+++.|
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 5677889999999999999999999 99998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=282.12 Aligned_cols=228 Identities=21% Similarity=0.342 Sum_probs=175.8
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++. .+..+++|... +.+|++.+. +++|+||+++.+.+...+..++||||++
T Consensus 48 G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 48 GSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK---------RLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp CSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred CCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 57899999986 56678887643 234555555 7889999999999999999999999999
Q ss_pred CCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 73 NGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
+|+|.+++.... ...+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 999999997421 12389999999999999999999999 8 999999999999999999999999998754332
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ...........+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~----------~~~~~~~~~~~~ 261 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVA----------AVGFKCKRLEIP 261 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHH----------HHHHSCCCCCCC
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----------HHHhcCCCCCCC
Confidence 24457889999999999999999999999999999999999999754211 0000 000111122344
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 55667899999999999999999 99998864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=279.99 Aligned_cols=225 Identities=18% Similarity=0.153 Sum_probs=181.1
Q ss_pred ccccceeeecc-cCCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++.. .++..+++|.... .+|++.+. ++.|+||+++.+.+...+..++||||+++
T Consensus 31 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR---------ENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp ETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred CCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHh---------cCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 57899999985 5566778876542 33444444 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
|+|.+++.. ..+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ...
T Consensus 102 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 999999964 3699999999999999999999999 9999999999999999999999999998754332 234
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+|+.|+|||.+.+..++.++||||||+++|||++|..||....... ..... ..........+...+
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~---------~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI---------ATNGTPELQNPEKLS 243 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---------HHHCSCCCSCGGGSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---------HhCCCCCCCCccccC
Confidence 578889999999999999999999999999999999999997542111 11000 001111112344556
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.||++|| ++|+++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 7899999999999999999 999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=281.15 Aligned_cols=229 Identities=22% Similarity=0.295 Sum_probs=182.0
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+++
T Consensus 21 G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 21 GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR---------CLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHH---------hCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 5789999999765 5556677542 334555554 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc----
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV---- 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~---- 149 (257)
|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 92 GTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 999999986 467799999999999999999999999 999999999999999999999999999875433221
Q ss_pred -------------cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhh
Q 044568 150 -------------IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINREL 216 (257)
Q Consensus 150 -------------~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (257)
...||+.|+|||.+.+..++.++||||||+++|||++|..||............. .....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------~~~~~ 240 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------VRGFL 240 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------HHHHH
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------hhccc
Confidence 3468889999999999999999999999999999999999997543322111000 00000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 217 NKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ..+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 241 ~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 241 DR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 11233445688999999999999999 99998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=281.84 Aligned_cols=222 Identities=14% Similarity=0.167 Sum_probs=180.8
Q ss_pred ccccceeeecc-cCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.. .++..+++|...- .+|++.+. .+.|+||+++.+.+...+..++||||+
T Consensus 26 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK---------ILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 57899999996 5667788886532 23444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC--CCcc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN--EDFV 149 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~--~~~~ 149 (257)
++|+|.+++.. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.... ....
T Consensus 97 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 97 SGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp TTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 99999999973 46699999999999999999999999 99999999999999999999999999987533 2335
Q ss_pred cccCCCCccCcccccCCCCC-ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCH
Q 044568 150 IDKRDKGYMAPECYKRTPIS-VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDK 227 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~-~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (257)
...+|+.|+|||.+.+..+. .++||||+||++|||++|+.||....... ... ..... ...+.
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~-------------~i~~~~~~~p~ 235 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE-------------RVLRGKYRIPF 235 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-------------HHHHCCCCCCT
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHHhCCCCCCC
Confidence 56789999999999888765 89999999999999999999997552110 000 11111 12344
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.||.+|| ++|+++
T Consensus 236 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 236 YMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4567789999999999999999 999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=284.43 Aligned_cols=245 Identities=12% Similarity=0.094 Sum_probs=183.9
Q ss_pred ccccceeeecccCC------CCCeeeccc-----hhhhHHHHhHhhhc------cccccccCCceeeeceeeeec----C
Q 044568 4 TKLSNFYRSSFNAR------NSPWISRVS-----WTADIEVLSVAMRG------SKCTRIRGGLLLNVPVRAKLT----S 62 (257)
Q Consensus 4 ~~~~~~y~~~~~~~------~~~~i~~~~-----~~~~~~~~~~~~~~------~~~~~~~h~~i~~~~~~~~~~----~ 62 (257)
+.++.||++....+ ..+++|... +.++++.+...... .....+.|+||+++.+.+... .
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 125 (364)
T 3op5_A 46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125 (364)
T ss_dssp C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEE
T ss_pred CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcc
Confidence 57899999987765 456777644 23444444311110 023477899999999998875 4
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEeeecc
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKILDFGL 140 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~dfg~ 140 (257)
..+|||||+ +++|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 126 ~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~ 200 (364)
T 3op5_A 126 YRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGL 200 (364)
T ss_dssp EEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTT
T ss_pred eEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCc
Confidence 589999999 8999999986 557799999999999999999999999 999999999999998 889999999999
Q ss_pred cccCCCCc----------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh
Q 044568 141 AKLPNEDF----------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC 210 (257)
Q Consensus 141 ~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 210 (257)
++...... ....+|+.|+|||.+.+..++.++||||||+++|||++|+.||.................
T Consensus 201 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-- 278 (364)
T 3op5_A 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRY-- 278 (364)
T ss_dssp CEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH--
T ss_pred ceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHh--
Confidence 87543221 233488999999999998999999999999999999999999986533332221111111
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 211 FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......+++........+..+.+++..||+.||.+|| +++|++.|
T Consensus 279 --~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 279 --RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp --HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred --hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 1122222221111233456799999999999999999 99998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.15 Aligned_cols=227 Identities=16% Similarity=0.215 Sum_probs=182.1
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+|+.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 125 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK---------QYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp ETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHT---------TCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 578999999986 56667887643 344555555 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccc-
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVID- 151 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~- 151 (257)
+|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||+|+||+++.++.+||+|||+++.........
T Consensus 196 ~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 196 GGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 9999999975 445689999999999999999999999 99999999999999999999999999987544332211
Q ss_pred ----cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 152 ----KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 152 ----~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.++..|+|||.+....++.++||||||+++|||++ |..||...... ...... .. ......+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~~~---------~~-~~~~~~~ 337 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFV---------EK-GGRLPCP 337 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHHHH---------HT-TCCCCCC
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---------Hc-CCCCCCC
Confidence 23456999999998889999999999999999998 99999754211 111100 00 0011334
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..++..+.+++.+||+.||++|| ++++++.|
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 45667899999999999999999 99998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.69 Aligned_cols=227 Identities=18% Similarity=0.247 Sum_probs=179.9
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+++....+. +++|... +.+|++.+. ++.|+||+++.+.+...+..++|||
T Consensus 60 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG---------QFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp TTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred CCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEeCCccEEEee
Confidence 5789999999864443 6777654 233444444 7889999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 131 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 131 YMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 9999999999975 456799999999999999999999999 99999999999999999999999999987644322
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|..|+|||.+.+..++.++||||||+++|||++ |..||...... ..... .... ..
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----------~~~~-~~ 272 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS----------VEEG-YR 272 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH----------HHTT-CC
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----------HHcC-CC
Confidence 22234567999999998889999999999999999999 99999654111 11100 0000 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||++|| +.|+++.|
T Consensus 273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 123445667899999999999999999 99998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.65 Aligned_cols=227 Identities=19% Similarity=0.248 Sum_probs=171.9
Q ss_pred ccccceeeeccc----CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|+.. .+..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|||
T Consensus 56 G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG---------QFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEeeCCceEEEEe
Confidence 578999999876 45667888754 233444444 7889999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 127 ~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 127 YMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp CCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999985 456799999999999999999999999 99999999999999999999999999987543321
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .. .... ......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~-~~~~---------i~~~~~- 268 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QD-VIKA---------VDEGYR- 268 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HH-HHHH---------HHTTEE-
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HH-HHHH---------HHcCCC-
Confidence 11233567999999998899999999999999999998 9999964411 10 1000 000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 122345567899999999999999999 99998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=292.86 Aligned_cols=227 Identities=21% Similarity=0.239 Sum_probs=182.7
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-ceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-VSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-~~~lV~E~~~~gs 75 (257)
+.++.||+|+.. +..+++|... +.+|++.+. ++.|+||+++.+.+...+ ..++||||+++|+
T Consensus 204 G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 204 GEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT---------QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp CSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHH---------TCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred cCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHH---------hccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 578999999876 5678888654 455666665 889999999999987665 7899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
|.+++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..........++.
T Consensus 274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 350 (450)
T 1k9a_A 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350 (450)
T ss_dssp HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCT
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCc
Confidence 99999864455589999999999999999999999 999999999999999999999999999886554444456678
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++||||||+++|||++ |+.||........ ... +.... ....+..+++.+.
T Consensus 351 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~----------i~~~~-~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----------VEKGY-KMDAPDGCPPAVY 416 (450)
T ss_dssp TTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHH----------HHTTC-CCCCCTTCCHHHH
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----------HHcCC-CCCCCCcCCHHHH
Confidence 8999999999999999999999999999998 9999975532211 000 00000 1133455678899
Q ss_pred HHHHHcccCCCCCCC-hHHHHHhC
Q 044568 235 KVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+++.+||+.||.+|| +.|+++.|
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999999999 99998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=273.04 Aligned_cols=227 Identities=17% Similarity=0.253 Sum_probs=184.4
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++...++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++|+
T Consensus 21 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 21 GQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM---------KLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp CSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred CCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHH---------hCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 57899999999888888888754 345555555 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 92 L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 92 LSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 9999975 556799999999999999999999999 99999999999999999999999999987543322 233
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..... ..... ....+...+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~----------~~~~~-~~~~~~~~~ 233 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----------ISTGF-RLYKPRLAS 233 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----------HHTTC-CCCCCTTSC
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----------HhcCc-cCCCCCcCC
Confidence 44567999999998889999999999999999999 99999754211 11110 00000 112233445
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.||++|| ++|+++.|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 7799999999999999999 99998864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=275.89 Aligned_cols=224 Identities=17% Similarity=0.151 Sum_probs=181.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++.. ++..+++|... +.+|++.+. +++|+|++++.+.+...+..++||||+++
T Consensus 56 G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 56 GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR---------DYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHT---------TCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHH---------hCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 568999999976 67778888654 234444444 88899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~ 150 (257)
|+|.+++. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ...
T Consensus 127 ~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 127 GALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp CBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 99999985 45799999999999999999999999 9999999999999999999999999998754432 244
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (257)
..+|+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... +.....+. ......
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~----------~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR----------LRDSPPPKLKNSHKV 267 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----------HHHSSCCCCTTGGGS
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----------HhcCCCCCcCccccC
Confidence 57888999999999888999999999999999999999999754211 11110 11111111 122334
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+.+++.+||+.||++|| ++|+++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56789999999999999999 999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=278.83 Aligned_cols=242 Identities=20% Similarity=0.194 Sum_probs=177.2
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++. ++..+++|............-...- ....+.|+|++++.+.+.. .+..++||||+++|+|.++
T Consensus 19 G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~-~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 96 (301)
T 3q4u_A 19 GRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELY-NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY 96 (301)
T ss_dssp CSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHH-HHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHH
T ss_pred CCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHH-HHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHH
Confidence 57899999987 6778889876543222211100000 1123789999999988654 3468899999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLH--------DECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+. ...+++..+..++.|++.||.||| ++ +++||||||+||+++.++.+||+|||++.......
T Consensus 97 l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 170 (301)
T 3q4u_A 97 LQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170 (301)
T ss_dssp HT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred Hh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc
Confidence 94 457999999999999999999999 88 99999999999999999999999999986432221
Q ss_pred ----ccccCCCCccCcccccCC------CCCccccchhHHHHHHHHHhc----------CCCCCcCCCChhhH-HHHHHH
Q 044568 149 ----VIDKRDKGYMAPECYKRT------PISVKADVYGYGIVLLETICC----------RKNMEIDASKPEEI-ILTNWV 207 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~------~~~~~~Di~s~G~~l~el~~g----------~~pf~~~~~~~~~~-~~~~~~ 207 (257)
....+|+.|+|||.+.+. .++.++||||||+++|||++| ..||.......... ......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 250 (301)
T 3q4u_A 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250 (301)
T ss_dssp ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHH
Confidence 233788999999999876 445799999999999999999 88886543222111 111000
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..............+...+..+.+++.+||+.||++|| +.|+++.|
T Consensus 251 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 251 ----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp ----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 00000001111122345678999999999999999999 99999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.60 Aligned_cols=228 Identities=18% Similarity=0.221 Sum_probs=179.2
Q ss_pred ccccceeeecccC--------CCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFNA--------RNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~--------~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+++... +..+++|... +.+|++.+. ++ .|+||+++.+.+...+..
T Consensus 92 G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK---------MIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHH---------HSCCCTTBCCEEEEECSSSSC
T ss_pred CCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHH---------HhcCCCCEeeEEEEEccCCCE
Confidence 5689999998532 2336777654 233444444 66 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 65 GKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 99999999999999997532 24589999999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.+||+|||+++..... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~ 316 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK 316 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence 99999999998754322 123345677999999999999999999999999999999 999997542111 000
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. +... .....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 317 ~----------~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 317 L----------LKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp H----------HHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H----------HhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0 0000 01123445667899999999999999999 99998864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=275.79 Aligned_cols=233 Identities=13% Similarity=0.088 Sum_probs=183.2
Q ss_pred cccccceeeecc-cCCCCCeeeccc-------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVS-------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.++.||+++. .+++.+++|... +.+|++.+. ++ .|+|++++.+.+...+..++||||+ +
T Consensus 19 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~---------~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 19 CGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK---------QLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp C-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHH---------HHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred ccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHH---------HhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 367899999995 556667787543 456666666 66 7999999999999999999999999 8
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-----eEEeeecccccCCCC-
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-----AKILDFGLAKLPNED- 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-----~kl~dfg~~~~~~~~- 147 (257)
++|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++......
T Consensus 89 ~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 89 PSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 999999975 467899999999999999999999999 9999999999999998877 999999998753322
Q ss_pred ---------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh
Q 044568 148 ---------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK 218 (257)
Q Consensus 148 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (257)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||..............+....... ....
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-PIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-CHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-CHHH
Confidence 135578899999999999999999999999999999999999998754333222222211110000 0000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 219 LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 219 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+ ....+ .+.+++..||+.||.+|| +++|.+.|
T Consensus 244 ~------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 244 L------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp H------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred H------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 0 11123 799999999999999999 99998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=293.67 Aligned_cols=227 Identities=19% Similarity=0.327 Sum_probs=182.5
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+|+...+..+++|... +.+|++++. ++.|+||+++.+.+. .+..++||||+++|+
T Consensus 199 G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 199 GQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK---------TLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHT---------TCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred CCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHh---------hCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 57899999999888888988755 345555555 888999999998876 677899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence 99999753345689999999999999999999999 99999999999999999999999999998654322 222
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... +.... ....+..++
T Consensus 346 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----------i~~~~-~~~~~~~~~ 411 (454)
T 1qcf_A 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----------LERGY-RMPRPENCP 411 (454)
T ss_dssp SSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----------HHHTC-CCCCCTTSC
T ss_pred cccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----------HHcCC-CCCCCCCCC
Confidence 34567999999998889999999999999999999 99999754211 11110 00000 112344566
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||++|| +++|++.|
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 7899999999999999999 99998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=269.72 Aligned_cols=228 Identities=18% Similarity=0.273 Sum_probs=181.0
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+.... ++
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS---------NLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT---------TCCCTTBCCEEEEETTTT--EE
T ss_pred CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH---------hCCCCCchhhheeecCCC--eE
Confidence 578999999975 55667788652 334444444 778999999998875544 79
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCCCCc-----eEEeeec
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWT-----AKILDFG 139 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~-----~kl~dfg 139 (257)
||||+++|+|.+.+.. ....+++..+..++.|++.||.|||++ + ++|+||||+||+++.++. +||+|||
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 9999999999999976 566799999999999999999999999 8 999999999999987766 9999999
Q ss_pred ccccCCCCcccccCCCCccCccccc--CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 140 LAKLPNEDFVIDKRDKGYMAPECYK--RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
++...........+|+.|+|||.+. ...++.++||||+|+++|||++|+.||.......... .... .
T Consensus 175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~---------~ 243 (287)
T 4f0f_A 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMI---------R 243 (287)
T ss_dssp TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHH---------H
T ss_pred ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHH---------h
Confidence 9987666666778899999999984 4457899999999999999999999997553322110 1000 0
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
........+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 244 EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 00111133445667899999999999999999 99999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=271.60 Aligned_cols=227 Identities=15% Similarity=0.249 Sum_probs=182.4
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++...+..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+++++
T Consensus 19 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 19 GQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMM---------KLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp ETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred CCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHH---------hCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 57899999998888788887654 344555555 7789999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 90 L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 90 LLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 9999975 445699999999999999999999999 99999999999999999999999999987544332 222
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.+++.|+|||.+.+..++.++||||+|+++|||++ |..||....... ..... .. ......+...+
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----------~~-~~~~~~~~~~~ 231 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLKV----------SQ-GHRLYRPHLAS 231 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH----------HT-TCCCCCCTTSC
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHHH----------Hc-CCCCCCCCcCh
Confidence 34456999999988889999999999999999999 999997542111 00000 00 00112233345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||.+|| ++|+++.|
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6789999999999999999 99998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=269.33 Aligned_cols=233 Identities=13% Similarity=0.042 Sum_probs=181.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc-------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++.. .++..+++|... +.+|++.+. .+ .|++++++.+.+......++||||+ ++
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~---------~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 21 GSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK---------LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHH---------HTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred cCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHH---------HHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 56899999995 566677777543 345555554 44 5889999999999999999999999 89
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-----eEEeeecccccCCCC--
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT-----AKILDFGLAKLPNED-- 147 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~-----~kl~dfg~~~~~~~~-- 147 (257)
+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++......
T Consensus 91 ~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 91 SLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred CHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 99999985 456799999999999999999999999 9999999999999987665 999999998754322
Q ss_pred --------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 148 --------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 148 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..................... ......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPLREL 245 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCHHHH
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-ccHHHH
Confidence 23446888999999999988999999999999999999999999875433322222221111100 001111
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....++.+.+++.+||+.||++|| +++|++.|
T Consensus 246 ------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 246 ------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp ------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred ------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 113456799999999999999999 99998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=295.01 Aligned_cols=228 Identities=18% Similarity=0.206 Sum_probs=185.0
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+|.... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..+|||||+++|
T Consensus 231 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK---------EIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp GTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHH---------hcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 5789999999876 5667887654 345555555 788999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 150 (257)
+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 378 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence 999999865567799999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..++..|+|||.+....++.++||||||+++|||++ |..||....... .... +.... ....+..+
T Consensus 379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~~~~---------~~~~~-~~~~~~~~ 444 (495)
T 1opk_A 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYEL---------LEKDY-RMERPEGC 444 (495)
T ss_dssp CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHH---------HHTTC-CCCCCTTC
T ss_pred CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHH---------HHcCC-CCCCCCCC
Confidence 234567999999998889999999999999999999 999997542111 1000 00000 11234456
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+.+++.+||+.||++|| +.|+++.|
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 67899999999999999999 99998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.49 Aligned_cols=239 Identities=16% Similarity=0.158 Sum_probs=182.6
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC--ceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--VSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lV~E~ 70 (257)
+.++.||+++... ++.+++|...- .+|++.+. ++.|+|++++.+.+...+ ..++||||
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK---------KLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHH---------hcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 5789999999765 56677876542 24444444 788999999999888765 77999999
Q ss_pred cCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEeeecccccCC
Q 044568 71 VRNGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 71 ~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~dfg~~~~~~ 145 (257)
+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++||||||+||++ +..+.+||+|||++....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999997532 23499999999999999999999999 99999999999999 777889999999997644
Q ss_pred CC--cccccCCCCccCccccc--------CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH-HHHHHHHHhhhhh
Q 044568 146 ED--FVIDKRDKGYMAPECYK--------RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI-ILTNWVYKCFINR 214 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 214 (257)
.. .....+|+.|+|||.+. +..++.++||||||+++|||++|+.||.......... ......... ...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-p~~ 246 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK-PSG 246 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC-CTT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC-Ccc
Confidence 32 23456888999999986 4678899999999999999999999997543322211 111111100 000
Q ss_pred hhh--------------hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELN--------------KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... .+......+......+.+++.+||+.||++|| ++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 000 01111245677888999999999999999999 999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=273.59 Aligned_cols=238 Identities=14% Similarity=0.110 Sum_probs=180.9
Q ss_pred ccccceeeecccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++..+++.+++|.... .+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 32 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 32 GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLK---------ELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp CSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHH---------HCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred CCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHH---------HcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 578999999998888899987642 34444444 7889999999999999999999999998
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~ 149 (257)
|+|.+.+.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ...
T Consensus 103 -~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 103 -KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp -EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred -CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 588888875 556799999999999999999999999 999999999999999999999999999876442 224
Q ss_pred cccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh--hhhhh---hhh---
Q 044568 150 IDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI--NRELN---KLV--- 220 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~--- 220 (257)
...+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...........+......... ..... ...
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 4567889999999876 45899999999999999999999999866443322111111000000 00000 000
Q ss_pred ----cCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 ----RGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ----~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... .......+++.+++.+||+.||++|| ++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 01112346788999999999999999 999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=278.08 Aligned_cols=244 Identities=11% Similarity=0.048 Sum_probs=179.0
Q ss_pred ccccceeeeccc----CCCCCeeeccch-----hhhHHHHhHhhh------ccccccccCCceeeeceeeee----cCce
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVSW-----TADIEVLSVAMR------GSKCTRIRGGLLLNVPVRAKL----TSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~~-----~~~~~~~~~~~~------~~~~~~~~h~~i~~~~~~~~~----~~~~ 64 (257)
+.++.||++... .+..+++|.... .++.+++..... -.....+.|+||+++.+.+.. ....
T Consensus 48 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 127 (345)
T 2v62_A 48 GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYR 127 (345)
T ss_dssp ----CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEE
T ss_pred cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEE
Confidence 578999999976 456667776442 233333331100 012346789999999999988 7789
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC--ceEEeeecccc
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW--TAKILDFGLAK 142 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~--~~kl~dfg~~~ 142 (257)
++||||+ +++|.+++.. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||+++
T Consensus 128 ~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~ 201 (345)
T 2v62_A 128 FMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201 (345)
T ss_dssp EEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCE
T ss_pred EEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCce
Confidence 9999999 8999999974 33899999999999999999999999 999999999999998777 99999999987
Q ss_pred cCCCC----------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 143 LPNED----------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 143 ~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
..... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 281 (345)
T 2v62_A 202 RYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL 281 (345)
T ss_dssp ESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT
T ss_pred ecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc
Confidence 54321 13447888999999999988999999999999999999999999754333222111111111111
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......... ....++.+.+++.+||+.||++|| ++++++.|
T Consensus 282 ~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 282 PQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp THHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 111111111 113456799999999999999999 99998864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=271.10 Aligned_cols=227 Identities=17% Similarity=0.218 Sum_probs=182.1
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++...+..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+++|+
T Consensus 35 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 35 GQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM---------NLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp --CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred CCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHh---------cCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 56889999999888888888754 345555555 7789999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 106 L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 106 LLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp HHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 9999975 356799999999999999999999999 99999999999999999999999999987543322 223
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ... .+.... ....+...+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~----------~~~~~~-~~~~~~~~~ 247 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE----------HIAQGL-RLYRPHLAS 247 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----------HHHTTC-CCCCCTTCC
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHH----------HHhccc-CCCCCCcCC
Confidence 44567999999998889999999999999999998 999997542111 000 000100 112233345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||.+|| ++|+++.|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 6789999999999999999 99998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.20 Aligned_cols=222 Identities=18% Similarity=0.204 Sum_probs=179.6
Q ss_pred ccccceeeecccC-CCCCeeeccc---------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 23 G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR---------QVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEE
T ss_pred CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHH---------hCCCcCCCcEEEEEEeCCEEEEE
Confidence 5789999999764 5556776543 234555555 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~dfg~~~~ 143 (257)
|||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..
T Consensus 94 ~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 94 LELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999997 456799999999999999999999999 999999999999998776 799999999876
Q ss_pred CCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.... .....||+.|+|||.+.+..++.++||||+|+++|+|++|..||..... ....... ..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i-------------~~ 232 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANI-------------TA 232 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH-------------HT
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-------------Hh
Confidence 4432 3455789999999999988999999999999999999999999975521 1111111 11
Q ss_pred CC-CCC----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GT-KVD----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~-~~~----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .++ ....+.+.+++.+||+.||.+|| +.|+++
T Consensus 233 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 111 12346788999999999999999 999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=291.43 Aligned_cols=227 Identities=22% Similarity=0.297 Sum_probs=179.5
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+|+...+..+++|... +.+|++.+. +++|+||+++.+.+.. +..++||||+++|+
T Consensus 195 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 195 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK---------KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp CSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred CCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHH---------hCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 57899999999888788888754 345555555 8889999999998866 77899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...... ...
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 341 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence 99999753445699999999999999999999999 99999999999999999999999999987543221 223
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... +... .....+..++
T Consensus 342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----------i~~~-~~~~~~~~~~ 407 (452)
T 1fmk_A 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----------VERG-YRMPCPPECP 407 (452)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----------HHTT-CCCCCCTTSC
T ss_pred cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----------HHcC-CCCCCCCCCC
Confidence 45567999999998899999999999999999999 99999754211 00100 0000 0113345567
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||++|| ++++++.|
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 7899999999999999999 99998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=271.55 Aligned_cols=229 Identities=22% Similarity=0.232 Sum_probs=174.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++... .+..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 22 GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS---------QLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHT---------TCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHh---------cCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 568899999854 45567777642 233443333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 93 IEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 999999999973 45799999999999999999999999 99999999999999999999999999987544322
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+|+.|+|||.+.+..++.++||||+|+++|||++|+.||....... .... .... ...... ....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~~~~-----~~~~-~~~~~~--~~~~ 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--IAIK-----HIQD-SVPNVT--TDVR 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--HHHH-----HHSS-CCCCHH--HHSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-----Hhhc-cCCCcc--hhcc
Confidence 33468899999999999889999999999999999999999997552111 0000 0000 000000 0122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC--hHHHHHh
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP--MKCAVMM 256 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~~ 256 (257)
...++.+.+++.+||+.||.+|| ++++.+.
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~ 269 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHH
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHH
Confidence 33457899999999999999999 6666554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=277.39 Aligned_cols=236 Identities=18% Similarity=0.243 Sum_probs=177.5
Q ss_pred ccccceeeecc-----cCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEE
Q 044568 4 TKLSNFYRSSF-----NARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~-----~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV 67 (257)
+.++.||++++ .++..+++|... +.+|++.+. ++.|+|++++.+.+... ...++|
T Consensus 21 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK---------SLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp CSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred cCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEecCCCCceEEE
Confidence 57899999974 355667787654 234555554 78899999999988653 568999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 92 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999999975 455699999999999999999999999 9999999999999999999999999998754332
Q ss_pred c------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH----hhhhhhh-
Q 044568 148 F------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK----CFINREL- 216 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~- 216 (257)
. ....++..|+|||.+.+..++.++||||||+++|||++|..||...... ....... .......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHHHH
Confidence 1 2234555699999999889999999999999999999999998643110 0000000 0000011
Q ss_pred hhhhcC--CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 217 NKLVRG--TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 217 ~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+... ...+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 111111 134556678899999999999999999 99998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.03 Aligned_cols=223 Identities=17% Similarity=0.167 Sum_probs=178.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. +++.+++|...- .+|.+.+ ..+.|+|++++.+.+...+..++||||
T Consensus 16 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l---------~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL---------QNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHH---------HSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHH---------HhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 578999999865 466678876542 2223333 378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CC
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---ED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~ 147 (257)
+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++... ..
T Consensus 87 ~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 87 ANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999999997 346799999999999999999999999 99999999999999999999999999987532 22
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
.....||+.|+|||.+.+..++.++|+||||+++|||++|..||..... ....... ......++.
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i------------~~~~~~~p~ 226 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI------------LMEEIRFPR 226 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HHCCCCCCT
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHH------------HcCCCCCCC
Confidence 3455789999999999998999999999999999999999999975421 1111100 001123344
Q ss_pred HHHHHHHHHHHHcccCCCCCCC------hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP------MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP------~~ei~~ 255 (257)
...+.+.+++.+||+.||++|| ++|+++
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 5567899999999999999996 556543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=275.19 Aligned_cols=226 Identities=20% Similarity=0.179 Sum_probs=180.4
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... +++.+++|... +.+|++.+. .+.|+||+++.+.+...+..++||||++
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK---------MLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHH---------hCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 578999999866 56667777643 344555555 7789999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 89 GGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999997 556799999999999999999999999 9999999999999999999999999998753211
Q ss_pred cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.... ......
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~----------~~~~~~ 231 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK----------TYLNPW 231 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTC----------TTSTTG
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhccc----------ccCCcc
Confidence 234578889999999987765 7889999999999999999999976533221 111111100 000112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.+++.+||+.||++|| ++|+++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 33456788999999999999999 999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=276.52 Aligned_cols=225 Identities=15% Similarity=0.083 Sum_probs=178.9
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHH---HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIE---VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. +++.+++|...-....+ .-........+..+.|+||+++.+.+...+..++||||+++|+|.++
T Consensus 52 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 131 (350)
T 1rdq_E 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131 (350)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence 568999999976 56667888654221110 00000011123377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...........||+.|+|
T Consensus 132 l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~a 206 (350)
T 1rdq_E 132 LRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALA 206 (350)
T ss_dssp HHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCC
T ss_pred HHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCcccccCCccccC
Confidence 974 45699999999999999999999999 9999999999999999999999999999876666666788999999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLVKVGL 238 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~ 238 (257)
||.+.+..++.++|+||||+++|||++|..||..... ..... .+.. ...++......+.+++.
T Consensus 207 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~-------------~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE-------------KIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH-------------HHHHCCCCCCTTCCHHHHHHHH
T ss_pred HHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHH-------------HHHcCCCCCCCCCCHHHHHHHH
Confidence 9999998999999999999999999999999975421 11111 1111 11334455678999999
Q ss_pred HcccCCCCCCC
Q 044568 239 WCVQDEPALRP 249 (257)
Q Consensus 239 ~cl~~~p~~RP 249 (257)
+||+.||.+||
T Consensus 271 ~lL~~dp~~R~ 281 (350)
T 1rdq_E 271 NLLQVDLTKRF 281 (350)
T ss_dssp HHSCSCTTTCT
T ss_pred HHhhcCHHhcc
Confidence 99999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.64 Aligned_cols=225 Identities=16% Similarity=0.129 Sum_probs=178.2
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHH---HHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIE---VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|...-....+ .-........+..+.|+||+++.+.+...+..++||||+++|+|.++
T Consensus 17 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 96 (318)
T 1fot_A 17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL 96 (318)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHH
Confidence 578999999876 45667777654211100 00000011123377899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCCCccC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMA 159 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~a 159 (257)
+. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...........||+.|+|
T Consensus 97 l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~a 171 (318)
T 1fot_A 97 LR--KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIA 171 (318)
T ss_dssp HH--HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCC
T ss_pred HH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCccccccCCccccC
Confidence 98 446799999999999999999999999 9999999999999999999999999999876666666789999999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKKNLENLVKVGL 238 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~ 238 (257)
||.+.+..++.++|+||+|+++|||++|..||..... .... ...... ..++......+.+++.
T Consensus 172 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~-------------~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTY-------------EKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH-------------HHHHHCCCCCCTTSCHHHHHHHH
T ss_pred HhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH-------------HHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999998999999999999999999999999975421 1111 111111 1234445577899999
Q ss_pred HcccCCCCCCC
Q 044568 239 WCVQDEPALRP 249 (257)
Q Consensus 239 ~cl~~~p~~RP 249 (257)
+||+.||++||
T Consensus 236 ~lL~~dp~~R~ 246 (318)
T 1fot_A 236 RLITRDLSQRL 246 (318)
T ss_dssp HHTCSCTTTCT
T ss_pred HHhccCHHHcC
Confidence 99999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=273.21 Aligned_cols=224 Identities=18% Similarity=0.165 Sum_probs=179.5
Q ss_pred ccccceeeecccCC-CCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++...+ ..+++|... +.+|++.+. .+.|+||+++.+.+...+..++||||+++|
T Consensus 16 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN---------IARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHH---------HSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHH---------hCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 57899999997654 455666543 234555444 778999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEeeecccccCCCC--ccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKILDFGLAKLPNED--FVI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~--~~~ 150 (257)
+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++...... ...
T Consensus 87 ~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 87 DIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp BHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 99999975 445799999999999999999999999 9999999999999987 789999999998765332 245
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC----
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD---- 226 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 226 (257)
..+|+.|+|||.+.+..++.++||||+|+++|+|++|..||..... ........... ..++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~------------~~~~~~~~ 227 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAE------------YTFDEEAF 227 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTC------------CCCCHHHH
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCC------------CCCChhhh
Confidence 5788999999999988889999999999999999999999975421 11111111000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.||.+|| +.|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12346789999999999999999 999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.51 Aligned_cols=227 Identities=16% Similarity=0.174 Sum_probs=176.5
Q ss_pred cccccceeeecccCCCC-----Ceeecc----------chhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 3 CTKLSNFYRSSFNARNS-----PWISRV----------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~-----~~i~~~----------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
.+.++.||++....++. +++|.. .+.++++.+. ++.|+||+++.+++. .+..++|
T Consensus 23 ~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 23 SGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---------SLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp CCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHH---------TCCCTTBCCEEEEEC-BSSEEEE
T ss_pred ecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHh---------cCCCCCcCeEEEEEc-CCccEEE
Confidence 36789999999765544 344432 2345555555 778999999999876 5678899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999975 456789999999999999999999999 9999999999999999999999999999864332
Q ss_pred c-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 F-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
. ....++..|+|||.+.+..++.++||||||+++||+++ |..||......... .. ... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~---------~~~-~~ 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP----DL---------LEK-GE 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH----HH---------HHT-TC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH----HH---------HHc-CC
Confidence 2 34456678999999998889999999999999999999 99999765322210 00 000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...+..+.+++.+||+.||.+|| ++|+++.|
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1122333455688999999999999999 99998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=277.08 Aligned_cols=226 Identities=19% Similarity=0.220 Sum_probs=175.9
Q ss_pred ccccceeeecccCCC-CC----eeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARN-SP----WISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~----~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++...++ .+ ++|... +.+|++.+. ++.|+||+++.+.+...+ .++|+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA---------SVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp ETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHH---------HCCBTTBCCEEEEEESSS-EEEEE
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHH---------hCCCCCEeEEEEEEecCC-eEEEE
Confidence 578999999965443 33 555432 344555555 788999999999988754 77899
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 96 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 96 QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 99999999999986 567799999999999999999999999 99999999999999999999999999987533221
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ... ...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~---------~~~-~~~ 237 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI---------LEK-GER 237 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH---------HHT-TCC
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHH---------HHc-CCC
Confidence 23345668999999999999999999999999999999 999997542211 0000 000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+......+.+++.+||+.||++|| ++|+++.|
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 123445567899999999999999999 99998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=270.83 Aligned_cols=227 Identities=17% Similarity=0.208 Sum_probs=180.2
Q ss_pred ccccceeeecccC-CCCCeeeccc---------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 22 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK---------EIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHH---------hCCCCCCCcEEEEEEeCCEEEEE
Confidence 5789999999764 5566776432 345555555 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~dfg~~~~ 143 (257)
|||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..
T Consensus 93 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 93 LELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999997 456799999999999999999999999 999999999999998877 799999999876
Q ss_pred CC--CCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PN--EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...... ........... ..
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~---~~----- 236 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNY---EF----- 236 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHTCC---CC-----
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHhcCC---Cc-----
Confidence 43 2234557899999999999888999999999999999999999999754211 11111100000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+.......+..+.+++.+||+.||++|| +.|+++
T Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000112346788999999999999999 999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=277.56 Aligned_cols=221 Identities=18% Similarity=0.211 Sum_probs=179.7
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.. .++..+++|... +.+|++.+. .+.|+||+++.+.+...+..++||||
T Consensus 20 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK---------LLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 57899999996 556677887543 234444444 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+ +|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 91 ~-~g~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 91 A-GGELFDYIV--EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp C-CEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred C-CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 9 689999987 346799999999999999999999999 9999999999999999999999999998754432 2
Q ss_pred ccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCC
Q 044568 149 VIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVD 226 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (257)
....+|+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||........ ....... ...+
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~~~~p 228 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCVYVMP 228 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSCCCCC
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCCCCCc
Confidence 45578999999999988776 6899999999999999999999975522210 0011111 1234
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| ++|+++
T Consensus 229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 44567789999999999999999 999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.40 Aligned_cols=248 Identities=20% Similarity=0.213 Sum_probs=179.3
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecCc----eeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV----SGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~----~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. +..+++|.......-........ ..+.++.|+||+++.+.+..... .++||||+++|+|.++
T Consensus 35 G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 112 (322)
T 3soc_A 35 GRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEV-YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112 (322)
T ss_dssp STTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHH-HTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHH
T ss_pred cCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHH-HHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHH
Confidence 578999999876 67788888654221111111111 13447889999999999987554 6999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC-------EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+.. ..+++.++..++.|++.||.|||++. +.+++||||||+||+++.++.+||+|||++......
T Consensus 113 l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~ 189 (322)
T 3soc_A 113 LKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189 (322)
T ss_dssp HHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCC
T ss_pred HHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccc
Confidence 964 45999999999999999999999751 228999999999999999999999999998653322
Q ss_pred cccccCCCCccCcccccCC-----CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh--
Q 044568 148 FVIDKRDKGYMAPECYKRT-----PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-- 220 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 220 (257)
.....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||............... .............
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 268 (322)
T 3soc_A 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-GQHPSLEDMQEVVVH 268 (322)
T ss_dssp CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-CSSCCHHHHHHHHTT
T ss_pred cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-ccCCchhhhhhhhhc
Confidence 2335678999999999863 4567889999999999999999999865332211100000 0000000111100
Q ss_pred ---cCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 ---RGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ---~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+. ......++.+.+++.+||+.||++|| +.|+++.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 269 KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 110 12334567899999999999999999 99999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=279.87 Aligned_cols=231 Identities=15% Similarity=0.142 Sum_probs=175.0
Q ss_pred ccccceeeecccC-CCCCeeeccchhhhHH---HHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTADIE---VLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++... ++.+++|...-....+ ..........+..+ .|+||+++.+.+...+..++||||+++|+|.+
T Consensus 34 G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 113 (353)
T 3txo_A 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113 (353)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 5689999998654 5667888655211100 00000000011133 59999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~ 155 (257)
++.. ...+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++... .......||+
T Consensus 114 ~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~ 188 (353)
T 3txo_A 114 HIQK--SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188 (353)
T ss_dssp HHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCG
T ss_pred HHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCc
Confidence 9973 46799999999999999999999999 99999999999999999999999999987532 2234557899
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++||||+||++|||++|+.||...... .... .+.. ...++......+.
T Consensus 189 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~-------------~i~~~~~~~p~~~~~~~~ 252 (353)
T 3txo_A 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE-------------AILNDEVVYPTWLHEDAT 252 (353)
T ss_dssp GGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH-------------HHHHCCCCCCTTSCHHHH
T ss_pred CeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH-------------HHHcCCCCCCCCCCHHHH
Confidence 999999998888999999999999999999999999755211 1111 1111 1133444567789
Q ss_pred HHHHHcccCCCCCCC-h------HHHHH
Q 044568 235 KVGLWCVQDEPALRP-M------KCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~------~ei~~ 255 (257)
+++.+||+.||.+|| + .|+++
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999999999999999 8 66654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=274.46 Aligned_cols=183 Identities=19% Similarity=0.225 Sum_probs=155.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++.. ++..+++|... +..|++.+..... ..+.|+||+++.+.+...+..++||||+ ++
T Consensus 46 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~----~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~ 120 (360)
T 3llt_A 46 GTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN----DDINNNNIVKYHGKFMYYDHMCLIFEPL-GP 120 (360)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC----CSTTGGGBCCEEEEEEETTEEEEEECCC-CC
T ss_pred cCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc----cCCCCCCeecccceeeECCeeEEEEcCC-CC
Confidence 578999999974 55567888654 2334444441111 2445999999999999999999999999 89
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------------------------
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE------------------------- 129 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~------------------------- 129 (257)
+|.+++.......+++.++..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 121 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T 3llt_A 121 SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197 (360)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence 999999865556799999999999999999999999 9999999999999975
Q ss_pred CCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 130 FWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 130 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
++.+||+|||++...........+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 198 ~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78899999999987666666778899999999999999999999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=280.29 Aligned_cols=225 Identities=15% Similarity=0.184 Sum_probs=175.9
Q ss_pred ccccceeeecccCCC-CCeeeccch------------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSW------------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+++...++ .+++|.+.- .+|.+++. ++ .|+||+++.+.+...+..++|||
T Consensus 63 G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~---------~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE---------QASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHH---------HHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHH---------hcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 578999999976554 566665431 22333322 33 69999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CC
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NE 146 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~ 146 (257)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.. ..
T Consensus 134 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 134 YVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp CCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999999997 346799999999999999999999999 9999999999999999999999999998752 23
Q ss_pred CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHH-HHHHHHHhhhhhhhhhhhc-CCC
Q 044568 147 DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII-LTNWVYKCFINRELNKLVR-GTK 224 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~ 224 (257)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||........... ..... ...... ...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~--------~~~i~~~~~~ 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------FQVILEKQIR 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH--------HHHHHHCCCC
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH--------HHHHhccccC
Confidence 33556789999999999999999999999999999999999999975422211000 00000 011111 123
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-h
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~ 250 (257)
++......+.+++.+||+.||.+|| +
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 4555667899999999999999999 7
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=267.88 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=185.9
Q ss_pred ccccceeeecccCCCCCeeeccc-------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++. ++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 42 G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 42 GGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA---------KCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp CSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHH---------hcCCCCeEEEEEEEecCCceEEEEEe
Confidence 56889999987 56677777542 234444444 77899999999999999999999999
Q ss_pred cCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 71 VRNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
+++|+|.+++... ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 9999999999743 245699999999999999999999999 99999999999999999999999999987543321
Q ss_pred ----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-
Q 044568 149 ----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT- 223 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (257)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.... ......+...++..
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI--EDEEKTIEDYIDKKM 265 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH--HTTSCCHHHHSCSSC
T ss_pred cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh--hhhhhhhhhhccccc
Confidence 23467889999998765 47899999999999999999999998653332111111100 00111222333322
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 -KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 -~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+...++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 34667788999999999999999999 99998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=271.28 Aligned_cols=227 Identities=22% Similarity=0.335 Sum_probs=171.6
Q ss_pred ccccceeeecccCCCCCeeeccch-------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW-------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++.. +..+++|...- .+|++.+. ++.|+||+++.+.+. +..++||||+++|+|
T Consensus 19 G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 19 GAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLS---------RVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86 (307)
T ss_dssp CSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHH---------HCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred CCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHh---------cCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence 578999999875 56788887642 34444444 788999999988776 568999999999999
Q ss_pred HHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeeeccCCCCceeeCCCCc-eEEeeecccccCCCCcccc
Q 044568 77 TDIIFCSAE-RNPYWNQRVRIALDVAKGILYLHD---ECEPPILHCDIKPQNILMDEFWT-AKILDFGLAKLPNEDFVID 151 (257)
Q Consensus 77 ~~~l~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~~~~i~h~dl~~~nil~~~~~~-~kl~dfg~~~~~~~~~~~~ 151 (257)
.+++..... ..+++..+..++.|++.||.|||+ + +++||||||+||+++.++. +||+|||++..........
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~---~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK---ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 163 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS---CCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC---CeecCCCChhHEEEeCCCCEEEEcccccccccccccccC
Confidence 999985322 247889999999999999999999 7 9999999999999988776 7999999987655555566
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.+|+.|+|||.+.+..++.++||||||+++|||++|+.||........... +... . ..........+.
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~--------~-~~~~~~~~~~~~ 231 (307)
T 2eva_A 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVH--------N-GTRPPLIKNLPK 231 (307)
T ss_dssp -CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHH--------T-TCCCCCBTTCCH
T ss_pred CCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHh--------c-CCCCCcccccCH
Confidence 789999999999988999999999999999999999999975432221110 0000 0 001122334557
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.+++.+||+.||++|| ++|+++.|
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 789999999999999999 99998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=266.35 Aligned_cols=233 Identities=17% Similarity=0.186 Sum_probs=178.4
Q ss_pred ccccceeeecccCCCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeec--CceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++.. +..+++|..... ...+. +...-..+.++.|+||+++.+.+... +..++||||+++|+|.
T Consensus 21 G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~--~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~ 97 (271)
T 3kmu_A 21 NHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD--FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLY 97 (271)
T ss_dssp ETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHH--HHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHH
T ss_pred CCcceEEEEEEC-CeeEEEEEecccccCHHHHHH--HHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHH
Confidence 568999999985 677888876531 11111 11111134478899999999998876 7889999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
+++.......+++.++..++.|++.||.|||++ + ++|+||+|+||+++.++.+++.|||+..... .....+|+
T Consensus 98 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--~~~~~~t~ 172 (271)
T 3kmu_A 98 NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--SPGRMYAP 172 (271)
T ss_dssp HHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--CTTCBSCG
T ss_pred HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec--ccCccCCc
Confidence 999864445699999999999999999999999 8 9999999999999999999999988765422 23456788
Q ss_pred CccCcccccCCCCC---ccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 044568 156 GYMAPECYKRTPIS---VKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLEN 232 (257)
Q Consensus 156 ~~~aPE~~~~~~~~---~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
.|+|||.+.+..++ .++||||||+++|||++|+.||....... ..... ... ......+...+..
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~---------~~~-~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGMKV---------ALE-GLRPTIPPGISPH 239 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHHHH---------HHS-CCCCCCCTTCCHH
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHHHH---------Hhc-CCCCCCCCCCCHH
Confidence 99999999876544 47999999999999999999997542111 00000 000 0111334455678
Q ss_pred HHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 233 LVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+++.+||+.||++|| ++|+++.|
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999 99999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.95 Aligned_cols=239 Identities=14% Similarity=0.103 Sum_probs=178.4
Q ss_pred cccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 5 KLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 5 ~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
.++.||+++.. ++..+++|.... .+|++.+. .+.|+||+++.+.+...+..++|||||+
T Consensus 39 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 39 DLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK---------LFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHH---------hCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 67899999976 566778887653 22444444 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC------
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE------ 146 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~------ 146 (257)
+|+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~ 186 (389)
T 3gni_B 110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186 (389)
T ss_dssp TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECS
T ss_pred CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccccccc
Confidence 99999999865557799999999999999999999999 999999999999999999999999998653211
Q ss_pred ----CcccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh--------
Q 044568 147 ----DFVIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI-------- 212 (257)
Q Consensus 147 ----~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 212 (257)
......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.................+...
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (389)
T 3gni_B 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266 (389)
T ss_dssp CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------
T ss_pred ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccc
Confidence 1123467788999999987 57899999999999999999999999765333211110000000000
Q ss_pred -----------hhhhhh------------hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 213 -----------NRELNK------------LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 213 -----------~~~~~~------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... .......+....+.+.+++.+||+.||++|| ++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000 0000012334457799999999999999999 999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=280.25 Aligned_cols=228 Identities=16% Similarity=0.197 Sum_probs=178.4
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 82 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS---------KFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp CSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHH---------hCCCCCCCeEEEEEecCCCCEEE
Confidence 578999999854 33457788753 233444444 77899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~dfg 139 (257)
|||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999997532 24689999999999999999999999 999999999999998544 59999999
Q ss_pred ccccC-----CCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLP-----NEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
+++.. ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~-------- 298 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF-------- 298 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH--------
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------
Confidence 98632 122234456788999999998899999999999999999998 99999754211 10000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... ......+...+..+.+++.+||+.||++|| +.|+++.|
T Consensus 299 --i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 299 --VTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp --HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHc-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 000 001123445567799999999999999999 99998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=267.58 Aligned_cols=225 Identities=20% Similarity=0.259 Sum_probs=171.9
Q ss_pred ccccceeeecccCCCCCeeeccch-------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW-------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. +..+++|.... .+|++.+. .+.|+|++++.+.+...+..++||||
T Consensus 18 G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 18 GGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA---------MLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp ETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHH---------HCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred CCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHH---------hcCCCCEeeEEEEEecCCceEEEEEc
Confidence 578999999965 67788876542 23444444 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC---eeeccCCCCceeeCC--------CCceEEeeec
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP---ILHCDIKPQNILMDE--------FWTAKILDFG 139 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~---i~h~dl~~~nil~~~--------~~~~kl~dfg 139 (257)
+++++|.+++. ...+++..+..++.|++.||.|||++ + ++|+||||+||+++. ++.++|+|||
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 88 ARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred CCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999994 45799999999999999999999999 7 999999999999986 6789999999
Q ss_pred ccccCCCC-cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh
Q 044568 140 LAKLPNED-FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK 218 (257)
Q Consensus 140 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (257)
.+...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~----------~~~ 228 (271)
T 3dtc_A 162 LAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYG----------VAM 228 (271)
T ss_dssp C-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH----------HHT
T ss_pred cccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHh----------hhc
Confidence 98754332 23457888999999999888999999999999999999999999754211 00000 000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 219 LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 219 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.......+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 0001133445567899999999999999999 99999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=265.96 Aligned_cols=233 Identities=16% Similarity=0.120 Sum_probs=178.1
Q ss_pred ccccceeeecc-cCCCCCeeecc-------chhhhHHHHhHhhhccccccccCCceeeeceee-eecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRV-------SWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRA-KLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~-------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++. .+++.+++|.. .+.+|++.+. .+.|++++.....+ ...+..++||||+ ++
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~---------~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK---------MMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHH---------HHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred CCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHH---------HhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 57899999995 55566777742 2455665555 66677766665555 5677889999999 89
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCCCc---
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||++ +.++.+||+|||++.......
T Consensus 90 ~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 90 SLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp BHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 99999975 456799999999999999999999999 99999999999999 788899999999987543321
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......................+ ...
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 241 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEV--- 241 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHH---
T ss_pred cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-hhh---
Confidence 245778899999999998999999999999999999999999986543332222222111111100 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....++.+.+++.+||+.||++|| ++|+++.|
T Consensus 242 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 242 ---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp ---HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ---hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 1112346799999999999999999 99998864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=267.90 Aligned_cols=223 Identities=18% Similarity=0.204 Sum_probs=180.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeee----------------c
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----------------T 61 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----------------~ 61 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+.. .
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 22 GGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALA---------KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp SSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHH---------HCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHH---------hCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 578999999976 66777887654 456666666 7889999999998754 4
Q ss_pred CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 62 SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
...++||||+++|+|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 169 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV 169 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhh
Confidence 5679999999999999999764556799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 142 KLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 142 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
...... .....+++.|+|||.+.+..++.++||||||+++|||++|..||... .. . ...+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~----~---------~~~~ 231 (284)
T 2a19_B 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SK----F---------FTDL 231 (284)
T ss_dssp EESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HH----H---------HHHH
T ss_pred eeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HH----H---------HHHh
Confidence 754332 24456888999999999888999999999999999999999987421 00 0 0001
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+...+..+.+++.+||+.||++|| +.|+++.|
T Consensus 232 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 232 -RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp -HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11112233446688999999999999999 99998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=276.08 Aligned_cols=228 Identities=18% Similarity=0.203 Sum_probs=179.8
Q ss_pred ccccceeeecccC------CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA------RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~------~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 58 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA---------EFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEEccCCceEEE
Confidence 5689999999754 2556777653 234444444 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 68 ERPVRNGSLTDIIFCSA----------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 99999999999997532 25789999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~ 199 (257)
+++.++.+||+|||++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh---
Confidence 9999999999999998643221 233456778999999998889999999999999999999 9999975421
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... .... .....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 283 ~~~~~~-----~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 283 EEVIYY-----VRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHHHH-----HHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHH-----HhCC------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 100000 0000 01123445567899999999999999999 99998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=265.71 Aligned_cols=227 Identities=17% Similarity=0.247 Sum_probs=182.7
Q ss_pred ccccceeeecccCCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++..++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+++++
T Consensus 19 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 19 GQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM---------KLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp ETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred CCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHH---------hCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 568899999988888888886542 34444444 7789999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 90 L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 90 LSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp HHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 9999975 456789999999999999999999999 99999999999999999999999999987543322 233
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ..... ..... ....+...+
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----------i~~~~-~~~~~~~~~ 231 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----------ISTGF-RLYKPRLAS 231 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----------HHTTC-CCCCCTTSC
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----------HhcCC-cCCCCccCc
Confidence 45567999999998889999999999999999999 89999754211 10100 00000 012233445
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.||++|| ++|+++.|
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 7789999999999999999 99998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=274.73 Aligned_cols=227 Identities=16% Similarity=0.134 Sum_probs=178.5
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|.... .+|++.+. ++.|+||+++.+.+...+..++||||+
T Consensus 40 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR---------KLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 5689999998654 55677776532 23444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccccCCCCc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~~~~~~~ 148 (257)
++|+|.+.+. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++.......
T Consensus 111 ~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 111 TGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999999997 456799999999999999999999999 99999999999999864 459999999987654322
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... ......... .. ...+....
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~-----~~---~~~~~~~~ 254 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKA-----GA---YDYPSPEW 254 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----TC---CCCCTTGG
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh-----CC---CCCCcccc
Confidence 345789999999999988999999999999999999999999975421 111111100 00 00001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||++|| +.|+++
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23457789999999999999999 999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.22 Aligned_cols=227 Identities=15% Similarity=0.108 Sum_probs=177.7
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++... ++..+++|.+. +.+|++.+. ++.|+||+++.+.+...+..++||||+
T Consensus 22 G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR---------LLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHH---------HCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH---------hCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 578999999854 45556666533 234444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEeeecccccCCCCc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~dfg~~~~~~~~~ 148 (257)
++|+|.+.+. ....+++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++.......
T Consensus 93 ~gg~L~~~i~--~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 93 TGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp BCCBHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred CCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999998 446799999999999999999999999 999999999999998 46789999999997654332
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
....||+.|+|||.+.+..++.++||||+|+++|+|++|..||.... ......... ... ...+...
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~-----~~~---~~~~~~~ 236 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIK-----AGA---YDFPSPE 236 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH-----HTC---CCCCTTT
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHH-----hCC---CCCCccc
Confidence 34578999999999999899999999999999999999999997542 111111110 000 0001111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....++.+.+++.+||+.||.+|| +.|+++
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 223457789999999999999999 999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.98 Aligned_cols=232 Identities=15% Similarity=0.172 Sum_probs=175.3
Q ss_pred ccccceeeecccC-CCCCeeeccchh-----hhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWT-----ADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++... +..+++|..... +..+.+. .....+.++ .|+||+++.+.+...+..++||||+++|+|
T Consensus 20 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~--~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L 97 (345)
T 3a8x_A 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97 (345)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHH--HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHH--HHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcH
Confidence 5789999999765 455677765421 1111111 001011143 799999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++... .......|
T Consensus 98 ~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~g 172 (345)
T 3a8x_A 98 MFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172 (345)
T ss_dssp HHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCS
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCC
Confidence 999973 45799999999999999999999999 99999999999999999999999999987522 23345578
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH-HHHHHHHHhhhhhhhhhhhc-CCCCCHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI-ILTNWVYKCFINRELNKLVR-GTKVDKKNLE 231 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (257)
|+.|+|||.+.+..++.++|+||+||++|||++|+.||.......... ........ .... ...++.....
T Consensus 173 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~~~~~~~p~~~s~ 244 (345)
T 3a8x_A 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VILEKQIRIPRSLSV 244 (345)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHHHCCCCCCTTSCH
T ss_pred CccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHHcCCCCCCCCCCH
Confidence 999999999999899999999999999999999999997532221100 00000000 1111 1134445567
Q ss_pred HHHHHHHHcccCCCCCCC-h
Q 044568 232 NLVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~ 250 (257)
.+.+++.+||+.||.+|| +
T Consensus 245 ~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHhcCCHhHCCCC
Confidence 899999999999999999 7
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=274.28 Aligned_cols=225 Identities=17% Similarity=0.192 Sum_probs=180.1
Q ss_pred ccccceeeecccCC-CCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++....+ ..+++|...- .+|++.+. .+.|+||+++.+.+...+..++||||
T Consensus 26 G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~---------~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ---------GLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 57899999986654 4567776432 23444444 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--Cc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE--DF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~--~~ 148 (257)
+.+|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..... ..
T Consensus 97 ~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 97 LLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp CTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 99999999998 556799999999999999999999999 999999999999999999999999999976432 33
Q ss_pred ccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 149 VIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
....||+.|+|||.+.. ..++.++|||||||++|||++|..||............... .......
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------~~~~~~~ 239 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ETTVVTY 239 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------HHCCCCC
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------hhcccCC
Confidence 55678999999999874 35889999999999999999999999765333221111110 0011133
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC--hHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP--MKCAV 254 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP--~~ei~ 254 (257)
+......+.+++.+||+.||.+|| ++++.
T Consensus 240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 445567899999999999999999 55554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=267.61 Aligned_cols=224 Identities=18% Similarity=0.159 Sum_probs=173.9
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------------------------------hhhhHHHHhHhhhcccccccc
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------------------------------WTADIEVLSVAMRGSKCTRIR 47 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~ 47 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.
T Consensus 24 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~ 94 (298)
T 2zv2_A 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK---------KLD 94 (298)
T ss_dssp --CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH---------TCC
T ss_pred cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH---------hCC
Confidence 5789999998654 5556777543 344555555 788
Q ss_pred CCceeeeceeeee--cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 48 GGLLLNVPVRAKL--TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 48 h~~i~~~~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|+||+++.+.+.. .+..++||||+++|+|.+++ ....+++.++..++.|++.||.|||++ +++||||||+||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 9999999999886 56889999999999999876 446799999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCC---cccccCCCCccCcccccCCC---CCccccchhHHHHHHHHHhcCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMAPECYKRTP---ISVKADVYGYGIVLLETICCRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~ 199 (257)
+++.++.+||+|||++...... .....+|+.|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence 9999999999999998764432 23457889999999998665 36889999999999999999999975411
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... ..............++.+.+++.+||+.||++|| +.|+++
T Consensus 246 ~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCLHSK----------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHH----------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHH----------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 100000 0000000111223456789999999999999999 999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=283.34 Aligned_cols=222 Identities=19% Similarity=0.268 Sum_probs=181.2
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|...- .+|++.+. .+.|+||+++.+.+...+..++||||
T Consensus 27 G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~---------~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK---------LFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 678999999976 667788887642 23333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 98 ~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 98 VSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp CSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 99999999997 456799999999999999999999999 9999999999999999999999999998764432 3
Q ss_pred ccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC
Q 044568 149 VIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD 226 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (257)
....+|+.|+|||.+.+..+ +.++||||+|+++|||++|..||....... ... ...+.. ..+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~-------------~i~~~~~~~p 236 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFK-------------KICDGIFYTP 236 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHH-------------HHHTTCCCCC
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHH-------------HHhcCCcCCC
Confidence 45578999999999988765 689999999999999999999997552211 111 111111 223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+.+++.+||+.||.+|| ++|+++
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 33456789999999999999999 999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.31 Aligned_cols=228 Identities=20% Similarity=0.210 Sum_probs=179.3
Q ss_pred ccccceeeecccCC--------CCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFNAR--------NSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~--------~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+++.... ..+++|... +.+|++.+. ++ .|+||+++.+.+...+..
T Consensus 80 G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK---------MIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSC
T ss_pred CCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHH---------HhcCCchhhhheeeeccCCce
Confidence 57899999985432 246776643 234444444 55 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 65 GKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++||||||+||+++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence 99999999999999997532 24599999999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.+||+|||++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ..
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~-~~ 303 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E-LF 303 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-HH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H-HH
Confidence 99999999998754322 233345677999999999999999999999999999999 99999754211 0 00
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. +... .....+...+..+.+++.+||+.||++|| ++|+++.|
T Consensus 304 ~~---------~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 304 KL---------LKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HH---------HHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH---------HHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 0000 01123344567899999999999999999 99998864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=267.47 Aligned_cols=226 Identities=15% Similarity=0.187 Sum_probs=168.7
Q ss_pred ccccceeeecccCCC----CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++....++ .+++|... +.+|++.+. ++.|+|++++.+.+ ..+..++|||
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~-~~~~~~lv~e 95 (281)
T 1mp8_A 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR---------QFDHPHIVKLIGVI-TENPVWIIME 95 (281)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHH---------hCCCCccceEEEEE-ccCccEEEEe
Confidence 578999999876543 35666543 233444444 77899999999987 4567899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 96 LCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp CCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999999975 455799999999999999999999999 99999999999999999999999999987543322
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....+++.|+|||.+....++.++||||||+++|||++ |..||....... ..... .. .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----------~~-~~~~~ 237 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----------EN-GERLP 237 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----------HT-TCCCC
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----------Hc-CCCCC
Confidence 23345667999999998889999999999999999997 999997552211 11000 00 00112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...++.+.+++.+||+.||++|| +.|+++.|
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3445667899999999999999999 99998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=277.41 Aligned_cols=237 Identities=13% Similarity=0.053 Sum_probs=181.0
Q ss_pred ccccceeeecccC---------CCCCeeeccc----hhhhHHHHhHhhhccccccccCCceee---------------ec
Q 044568 4 TKLSNFYRSSFNA---------RNSPWISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLN---------------VP 55 (257)
Q Consensus 4 ~~~~~~y~~~~~~---------~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~---------------~~ 55 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|+++ +.
T Consensus 53 G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~i~~~~ 123 (352)
T 2jii_A 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ---------RAAKPLQVNKWKKLYSTPLLAIPTCM 123 (352)
T ss_dssp ETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHH---------HHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred CCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHH---------HhcccchhhhhhhhccCCccCccchh
Confidence 5688999999875 6778888754 567777776 667777776 56
Q ss_pred eeeee-cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC--c
Q 044568 56 VRAKL-TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW--T 132 (257)
Q Consensus 56 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~--~ 132 (257)
+.+.. .+..++||||+ +++|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++.++ .
T Consensus 124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp EEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEE
T ss_pred hccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCce
Confidence 66665 67889999999 89999999864357899999999999999999999999 999999999999999988 8
Q ss_pred eEEeeecccccCCCCc----------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHH
Q 044568 133 AKILDFGLAKLPNEDF----------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202 (257)
Q Consensus 133 ~kl~dfg~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~ 202 (257)
+||+|||++....... ....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~- 278 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI- 278 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH-
Confidence 9999999987543221 33478889999999999899999999999999999999999998653222211
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 203 LTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....... ......+..........++.+.+++.+||+.||++|| ++|+++.|
T Consensus 279 -~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 279 -MKQKQKF--VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp -HHHHHHH--HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred -HHHHHhc--cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 1111000 0111111111111123357899999999999999999 99998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=275.63 Aligned_cols=229 Identities=16% Similarity=0.140 Sum_probs=177.9
Q ss_pred ccccceeeecccC-CCCCeeeccchhh-----hHHHHhHhhhcccccc-ccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTA-----DIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++... ++.+++|...-.. ..+... .....+.. ..|+||+++.+.+...+..++||||+++|+|
T Consensus 28 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L 105 (345)
T 1xjd_A 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM--VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105 (345)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHH--HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHH--HHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcH
Confidence 5789999999764 5567788664321 111111 00001113 3799999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++.. ...+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++... .......|
T Consensus 106 ~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~g 180 (345)
T 1xjd_A 106 MYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG 180 (345)
T ss_dssp HHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCS
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCC
Confidence 999973 45799999999999999999999999 99999999999999999999999999987532 23345678
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENL 233 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
|+.|+|||.+.+..++.++|+||+|+++|||++|..||..... ........ .....++....+.+
T Consensus 181 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~------------~~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIR------------MDNPFYPRWLEKEA 245 (345)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------HCCCCCCTTSCHHH
T ss_pred CcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH------------hCCCCCCcccCHHH
Confidence 9999999999998999999999999999999999999975421 11111110 01112344456788
Q ss_pred HHHHHHcccCCCCCCC-hH-HHH
Q 044568 234 VKVGLWCVQDEPALRP-MK-CAV 254 (257)
Q Consensus 234 ~~l~~~cl~~~p~~RP-~~-ei~ 254 (257)
.+++.+||+.||++|| +. |+.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHH
Confidence 9999999999999999 86 664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.29 Aligned_cols=228 Identities=17% Similarity=0.118 Sum_probs=172.5
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||++... ++..+++|.... ....+.+. ..........|+|++++.+.+...+..++||||+ +++|.
T Consensus 68 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~ 144 (311)
T 3p1a_A 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA--EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQ 144 (311)
T ss_dssp ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHH--HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHH--HHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHH
Confidence 578999999976 567788886431 11111111 1110111337999999999999999999999999 67999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccCCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKRDK 155 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 155 (257)
+++.. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ....+|+
T Consensus 145 ~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 220 (311)
T 3p1a_A 145 QHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP 220 (311)
T ss_dssp HHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCG
T ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCc
Confidence 99876 456799999999999999999999999 99999999999999999999999999987544322 3446889
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+ .++.++||||||+++|||++|..||... . ....+ . ....+...+....+.+.+
T Consensus 221 ~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~---~~~~~-----~-----~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---E---GWQQL-----R-----QGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp GGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---H---HHHHH-----T-----TTCCCHHHHTTSCHHHHH
T ss_pred cccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---c---HHHHH-----h-----ccCCCcccccCCCHHHHH
Confidence 9999998876 6899999999999999999997776532 0 00000 0 000000111223477999
Q ss_pred HHHHcccCCCCCCC-hHHHHH
Q 044568 236 VGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+||+.||++|| ++|+++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999 999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.23 Aligned_cols=227 Identities=17% Similarity=0.118 Sum_probs=170.8
Q ss_pred cccccceeeeccc-CCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.++.||+++.. +++.+++|... +.+|++.+. +++|+||+++.+.+...+..++||||+++
T Consensus 30 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHR---------SLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp SSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHH---------hCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 3678999999976 55667787654 234554444 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--eEEeeecccccCC--CCcc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--AKILDFGLAKLPN--EDFV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~dfg~~~~~~--~~~~ 149 (257)
|+|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++. +||+|||+++... ....
T Consensus 101 ~~L~~~l~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 101 GELYERIC--NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp CBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999997 345699999999999999999999999 9999999999999987665 9999999987422 2234
Q ss_pred cccCCCCccCcccccCCCCCcc-ccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC---CC
Q 044568 150 IDKRDKGYMAPECYKRTPISVK-ADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT---KV 225 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~-~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 225 (257)
...+|+.|+|||.+.+..++.+ +||||+|+++|+|++|+.||............ ........ ..
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT------------IQRILSVKYSIPD 243 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH------------HHHHHTTCCCCCT
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH------------HHHHhcCCCCCCC
Confidence 5578999999999988877655 89999999999999999999865332211111 01111111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+.+++.+||+.||++|| +.|+++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 122456789999999999999999 999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=277.90 Aligned_cols=233 Identities=15% Similarity=0.111 Sum_probs=173.7
Q ss_pred ccccceeeecccC-CCCCeeeccc----hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~~~g 74 (257)
+.++.||++.... ++.+++|... +.+|++.+. ....|+||+++.+.+.. .+..+||||||++|
T Consensus 73 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~--------~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg 144 (400)
T 1nxk_A 73 GINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW--------RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144 (400)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHH--------HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSE
T ss_pred ccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHH--------HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCC
Confidence 5688999998664 5567888764 244444432 13469999999998876 56789999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCC--cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~--~~ 149 (257)
+|.+++.......+++.++..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+++..... ..
T Consensus 145 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~ 221 (400)
T 1nxk_A 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221 (400)
T ss_dssp EHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------
T ss_pred cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccc
Confidence 999999864456799999999999999999999999 9999999999999997 788999999998754432 24
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH-HHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI-ILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
...+|+.|+|||++.+..++.++|||||||++|||++|..||.......... ....... .. ...+......
T Consensus 222 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-----~~---~~~~~~~~~~ 293 (400)
T 1nxk_A 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----GQ---YEFPNPEWSE 293 (400)
T ss_dssp -----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----TC---CCCCTTTTTT
T ss_pred cCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----Cc---ccCCCccccc
Confidence 5577899999999998899999999999999999999999997653322110 1111100 00 0001111123
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+++.+||+.||++|| +.|+++
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 456789999999999999999 999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.48 Aligned_cols=235 Identities=18% Similarity=0.179 Sum_probs=177.7
Q ss_pred ccccceeeecccCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++..+++.+++|.... .+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 13 G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 13 GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK---------ELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp ETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG---------GCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHH---------hcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 578999999997788889886542 23444443 7889999999999999999999999997
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~ 149 (257)
+ +|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ...
T Consensus 84 ~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp E-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred C-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 5 99999975 456799999999999999999999999 999999999999999999999999999875332 223
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-----hhhhhh--hc
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN-----RELNKL--VR 221 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~~ 221 (257)
...+|+.|+|||.+.+. .++.++||||+|+++|||++|..||....... ............ +..... .+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccccc
Confidence 45678899999998764 58999999999999999999999997552111 111111100000 000000 00
Q ss_pred CC----------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GT----------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~----------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+. .......+.+.+++.+||+.||++|| ++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 11123457789999999999999999 999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=274.46 Aligned_cols=229 Identities=16% Similarity=0.185 Sum_probs=160.9
Q ss_pred ccccceeeecccC-CCCCeeeccch------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++.... +..+++|...- .+|++.+. .+. |+||+++.+.+...+..++||||+++|+
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~---------~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 22 GSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALK---------LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHH---------HTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHH---------HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 5789999999764 56677876542 34444444 444 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEeeecccccCCCC---cc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~dfg~~~~~~~~---~~ 149 (257)
|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++...... ..
T Consensus 93 L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 93 LFERIK--KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp HHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 999998 456799999999999999999999999 999999999999997655 8999999998754322 24
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCC--
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVD-- 226 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 226 (257)
...+|+.|+|||.+.+..++.++||||||+++|||++|..||............... ......+. ..+
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI---------MKKIKKGDFSFEGE 238 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH---------HHHHTTTCCCCCSH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH---------HHHHHcCCCCCCcc
Confidence 456788999999999989999999999999999999999999765322110000000 11111111 111
Q ss_pred --HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 --KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 --~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| ++|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 22457899999999999999999 999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=272.06 Aligned_cols=227 Identities=19% Similarity=0.262 Sum_probs=174.3
Q ss_pred ccccceeeecccCCCC-----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||++....... +++|... +.+|++.+. ++.|+||+++.+.+...+..++||
T Consensus 55 G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG---------QFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEecCCCcEEEE
Confidence 5789999998765432 6777644 223343443 788999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 126 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 126 EYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp ECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 99999999999975 556799999999999999999999999 99999999999999999999999999987543321
Q ss_pred ------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 ------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 ------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ...... +....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~----------~~~~~- 267 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA----------INDGF- 267 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH----------HHTTC-
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----------HHCCC-
Confidence 12234567999999998899999999999999999999 9999964411 100100 00000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1122344567899999999999999999 99998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=271.03 Aligned_cols=223 Identities=18% Similarity=0.158 Sum_probs=177.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||++... ++..+++|... +.+|++.+. .+.|+||+++.+.+...+..++||
T Consensus 35 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH---------MLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHH---------hCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568999999865 46667888653 234444444 778999999999999999999999
Q ss_pred eecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEeeeccccc
Q 044568 69 RPVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLAKL 143 (257)
Q Consensus 69 E~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~~~ 143 (257)
|||++|+|.+.+... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999888642 344689999999999999999999999 9999999999999976544 99999999876
Q ss_pred CCCC---cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 144 PNED---FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 144 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.... .....+|+.|+|||.+.+..++.++||||+|+++|+|++|..||... .. ...... .
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~-~~~~~i-------------~ 245 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---KE-RLFEGI-------------I 245 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HH-HHHHHH-------------H
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HH-HHHHHH-------------H
Confidence 5433 23457899999999999888999999999999999999999999754 11 111111 1
Q ss_pred cCC-CCC----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGT-KVD----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~-~~~----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ..+ ...++.+.+++.+||+.||++|| +.|+++
T Consensus 246 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 111 12346789999999999999999 999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.26 Aligned_cols=226 Identities=15% Similarity=0.229 Sum_probs=177.8
Q ss_pred ccccceeeecccC---CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA---RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~---~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+|.... +..+++|... +.+|++++. ++.|+||+++.+.+.. +..++||||
T Consensus 347 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~---------~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH---------QLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp CSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHT---------TCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHH---------hCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 5789999998753 3346777643 334555554 7899999999999875 668999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 417 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 417 AGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred CCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 999999999975 456799999999999999999999999 99999999999999999999999999997643221
Q ss_pred ----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 149 ----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 149 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
....++..|+|||++....++.++||||||+++|||++ |+.||....... .... +... ...
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~---------i~~~-~~~ 558 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF---------IEQG-KRM 558 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHH---------HHTT-CCC
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH---------HHcC-CCC
Confidence 12234567999999998899999999999999999998 999997652211 1000 0000 011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+..++..+.+++.+||+.||++|| +.++++.|
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 34455678899999999999999999 99998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.99 Aligned_cols=226 Identities=17% Similarity=0.154 Sum_probs=175.7
Q ss_pred ccccceeeecccC-CCCCeeeccchhhhHH---HHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSWTADIE---VLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~~~~~~---~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++... +..+++|...-....+ ..........+..+ .|++++++.+.+...+..++||||+++|+|.+
T Consensus 31 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 110 (353)
T 2i0e_A 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 110 (353)
T ss_dssp ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 5688999999765 4567788655321110 00000000011133 69999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~ 155 (257)
++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.... .......||+
T Consensus 111 ~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~ 185 (353)
T 2i0e_A 111 HIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185 (353)
T ss_dssp HHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCG
T ss_pred HHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCc
Confidence 9973 45699999999999999999999999 99999999999999999999999999987532 2334567899
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++|+||||+++|||++|+.||..... ..... .+.. ...++......+.
T Consensus 186 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~-------------~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ-------------SIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp GGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH-------------HHHHCCCCCCTTSCHHHH
T ss_pred cccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHH-------------HHHhCCCCCCCCCCHHHH
Confidence 99999999998999999999999999999999999975421 11111 1111 1134445667899
Q ss_pred HHHHHcccCCCCCCC-h
Q 044568 235 KVGLWCVQDEPALRP-M 250 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~ 250 (257)
+++.+||+.||.+|| +
T Consensus 250 ~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHHTCSCTTSCTTC
T ss_pred HHHHHHhhcCHHHcCCC
Confidence 999999999999999 6
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=276.90 Aligned_cols=229 Identities=19% Similarity=0.220 Sum_probs=177.3
Q ss_pred ccccceeeecc------cCCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecC-cee
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTS-VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~-~~~ 65 (257)
+.++.||+++. .++..+++|... +.+|++.+. ++ .|+||+++.+.+...+ ..+
T Consensus 33 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI---------HIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSTTSCCE
T ss_pred CCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHH---------hhcCCcceeeeeeeeecCCCceE
Confidence 57899999963 344567777653 334444444 55 6899999999988755 489
Q ss_pred EEEeecCCCCHHHHHhccCC------------------------------------------------------------
Q 044568 66 KIERPVRNGSLTDIIFCSAE------------------------------------------------------------ 85 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~------------------------------------------------------------ 85 (257)
+||||+++|+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999975321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-----ccccCCCC
Q 044568 86 ----RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKG 156 (257)
Q Consensus 86 ----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~ 156 (257)
..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... ....+|+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 1289999999999999999999999 99999999999999999999999999987543221 23456778
Q ss_pred ccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 157 YMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 157 ~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
|+|||.+.+..++.++||||||+++|||++ |..||......... ... ... ......+....+.+.+
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~---------~~~-~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---CRR---------LKE-GTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH---HHH---------HHH-TCCCCCCTTCCHHHHH
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH---HHH---------HHc-CCCCCCCCCCCHHHHH
Confidence 999999998899999999999999999998 99999765332211 000 000 0111233445577999
Q ss_pred HHHHcccCCCCCCC-hHHHHHhC
Q 044568 236 VGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+||+.||.+|| ++|+++.|
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHH
Confidence 99999999999999 99998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=273.55 Aligned_cols=228 Identities=19% Similarity=0.209 Sum_probs=171.7
Q ss_pred ccccceeeecccC-CCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+++|+
T Consensus 64 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 64 GATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL---------RLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEC----------CHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHH---------hCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 5689999999775 4557777654 334555555 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCC--ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNED--FVI 150 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~--~~~ 150 (257)
|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++...... ...
T Consensus 135 L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 135 LFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp HHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999997 456799999999999999999999999 9999999999999975 789999999998754332 234
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+|+.|+|||.+.+..++.++||||||+++|||++|..||....... ....... ... ...........+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~-----~~~---~~~~~~~~~~~~ 279 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRIL-----NCE---YYFISPWWDEVS 279 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHH-----TTC---CCCCTTTTTTSC
T ss_pred ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHH-----hCC---CccCCchhhhCC
Confidence 568899999999999889999999999999999999999997542211 1111110 000 000111223455
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.||++|| +.|+++
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7789999999999999999 999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=265.05 Aligned_cols=239 Identities=15% Similarity=0.115 Sum_probs=180.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-----c
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----V 63 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~ 63 (257)
+.++.||+++. .+++.+++|... +.+|++.+. .+..+.|+|++++.+.+.... .
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 20 GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR------RLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp SSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHH------HHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHH------HHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 67899999996 455667888654 335555544 233556999999999988765 5
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+. |+|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred EEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence 799999997 6999999865555699999999999999999999999 999999999999999999999999999875
Q ss_pred CCC--CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh--hhh--
Q 044568 144 PNE--DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR--ELN-- 217 (257)
Q Consensus 144 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 217 (257)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... ............. .+.
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp STTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSCSS
T ss_pred cCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccch
Confidence 432 2345578999999999999999999999999999999999999997552211 1111111100000 000
Q ss_pred -----hhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 -----KLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 -----~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... ....+..+.+.+++.+||+.||++|| +.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 01123447789999999999999999 999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.65 Aligned_cols=228 Identities=18% Similarity=0.158 Sum_probs=176.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+..+|||||+++
T Consensus 100 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN---------QLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHH---------hCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 568999999865 46667777644 234444444 78999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee--CCCCceEEeeecccccCCCC--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM--DEFWTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~--~~~~~~kl~dfg~~~~~~~~--~~ 149 (257)
|+|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++...... ..
T Consensus 171 ~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 171 GELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 999999975 456799999999999999999999999 99999999999999 56778999999998865432 23
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+|+.|+|||.+....++.++||||||+++|||++|..||..... ...+..+....+. .+.......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~--------~~~~~~~~~ 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWD--------LEDEEFQDI 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC--------SCSGGGTTS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCC--------CChhhhccC
Confidence 44689999999999888899999999999999999999999975521 1111111110000 000111234
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+++.+||+.||.+|| +.|+++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 56789999999999999999 999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=268.00 Aligned_cols=228 Identities=18% Similarity=0.203 Sum_probs=183.8
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++++
T Consensus 24 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 24 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK---------EIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp GTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred CCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 6789999999776 4556777543 345555555 788999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 150 (257)
+|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 95 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp EHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred cHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 999999875667799999999999999999999999 99999999999999999999999999987654332 22
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ... .... .....+...
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----~~~---------~~~~-~~~~~~~~~ 237 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YEL---------LEKD-YRMERPEGC 237 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----HHH---------HHTT-CCCCCCTTC
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHH---------Hhcc-CCCCCCCCC
Confidence 344667999999998889999999999999999999 9999975422110 000 0000 011234445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 67899999999999999999 99998864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=271.08 Aligned_cols=228 Identities=19% Similarity=0.242 Sum_probs=179.1
Q ss_pred ccccceeeeccc------CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK---------QVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp CSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHh---------hCCCCceeeEEEEEecCCceEEE
Confidence 578899999752 335567776542 23333333 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 68 ERPVRNGSLTDIIFCSAE----------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|||+++|+|.+++..... ..+++.++..++.|++.||.|||++ +++|+||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999975322 3488999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~ 199 (257)
+++.++.+||+|||++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 260 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER- 260 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999987543322 23345667999999988889999999999999999999 999997552211
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. .. ... ......+...++.+.+++.+||+.||++|| +.|+++.|
T Consensus 261 --~~-~~---------~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 261 --LF-NL---------LKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp --HH-HH---------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HH-HH---------hhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 00 000 001123445567899999999999999999 99998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=263.91 Aligned_cols=233 Identities=16% Similarity=0.120 Sum_probs=177.6
Q ss_pred ccccceeeecc-cCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceee-eecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRA-KLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++. .++..+++|... +.+|++.+. .+.|++++.....+ ...+..++||||+ ++
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~---------~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK---------MMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHH---------HHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHH---------HhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 56889999995 566677787533 455666555 66677766555544 5667789999999 89
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCCC----
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~~---- 147 (257)
+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||++ +.++.+||+|||.+......
T Consensus 90 ~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 90 SLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 99999975 456799999999999999999999999 99999999999999 47889999999998754332
Q ss_pred ------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 ------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.....+|+.|+|||.+.+..++.++||||||+++|||++|+.||......................+ ...
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 241 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEV--- 241 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHH---
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hHH---
Confidence 1345688899999999998999999999999999999999999986533322222222211111100 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 242 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 242 ---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp ---HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ---HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 1122346799999999999999999 99998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.60 Aligned_cols=229 Identities=23% Similarity=0.318 Sum_probs=169.0
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... .+++|... +.+|++.+. ++.|+|++++.++. ..+..++||||++
T Consensus 35 G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 35 GSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR---------KTRHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp CSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred CCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHH---------hCCCCcEEEEEeec-cCCccEEEEEecC
Confidence 5789999998765 37776543 234444444 88899999998854 5667899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-----C
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-----D 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-----~ 147 (257)
+++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..... .
T Consensus 103 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 103 GSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp EEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 9999999975 566799999999999999999999999 999999999999999999999999999875332 1
Q ss_pred cccccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 148 FVIDKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
.....+|+.|+|||.+. ...++.++||||||+++|||++|+.||....... ........ .... .+...
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~----~~~~--~~~~~ 249 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGR----GSLS--PDLSK 249 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH---HHHHHHHH----TSCC--CCTTS
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH---HHHHHhcc----cccC--cchhh
Confidence 23446789999999986 5668899999999999999999999997552221 11111111 0000 00112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 3345567899999999999999999 99999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=263.12 Aligned_cols=223 Identities=19% Similarity=0.236 Sum_probs=161.2
Q ss_pred ccccceeeecc-cCCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++. .++..+++|...- .+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 22 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC---------QLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT---------TBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH---------hCCCCCeEeEEEEEccCCeEEEEEec
Confidence 56889999986 4566778887542 23333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
+++++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 93 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 93 CHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 999999999985 456799999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh-cCCCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 226 (257)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||........ ..... .....+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~ 232 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVLADYEMP 232 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCCCCC
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhhcccCCc
Confidence 2345678899999999988889999999999999999999999975532210 00000 111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.+++.+||+.||++|| ++|+++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 34456789999999999999999 999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=275.40 Aligned_cols=228 Identities=19% Similarity=0.183 Sum_probs=179.8
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++.... +..+++|... +.+|++.+. .+.|+||+++.+.+...+..++||||+++
T Consensus 62 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN---------QLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT---------TCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHH---------hCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 5689999998765 4455666543 234444444 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEeeecccccCCCC--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~--~~ 149 (257)
|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++. .+.+||+|||++...... ..
T Consensus 133 g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 133 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred CcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 999999975 455799999999999999999999999 9999999999999974 467999999998865432 24
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+|+.|+|||.+.+..++.++||||||+++|||++|..||..... ......... . ............
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~-----~---~~~~~~~~~~~~ 277 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR-----C---DWEFDEDAFSSV 277 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH-----C---CCCCCSSTTTTS
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh-----C---CCCCCccccccC
Confidence 45789999999999988899999999999999999999999975421 111111100 0 000011122334
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.+++.+||+.||++|| +.|+++
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 57789999999999999999 999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.11 Aligned_cols=227 Identities=22% Similarity=0.298 Sum_probs=182.7
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.|+.||+++...+..+++|.+. |.+|++++. ++.|+||+++.+.+.. +..+|||||+++|+
T Consensus 278 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 278 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK---------KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred CCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHH---------hCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 57899999999888788888654 345555555 7889999999998865 77899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 424 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence 99999753445699999999999999999999999 99999999999999999999999999997654322 223
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... +.... ....+..++
T Consensus 425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----------i~~~~-~~~~~~~~~ 490 (535)
T 2h8h_A 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----------VERGY-RMPCPPECP 490 (535)
T ss_dssp TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----------HHTTC-CCCCCTTCC
T ss_pred cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----------HHcCC-CCCCCCCCC
Confidence 44567999999998899999999999999999999 99999754111 11100 00000 112344566
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+++.+||+.||++|| +++|++.|
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 7899999999999999999 99998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.00 Aligned_cols=218 Identities=18% Similarity=0.180 Sum_probs=179.2
Q ss_pred cccccceeeecc-cCCCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 64 (257)
.+.++.||++.. .++..+++|... +.+|++.+. ++.|+||+++.+.+...+..
T Consensus 34 ~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS---------RVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp SSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHT---------TCCCTTBCCEEEEEECSSEE
T ss_pred ecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEeeCCEE
Confidence 367899999984 455567777543 344666666 78899999999999999999
Q ss_pred eEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 65 GKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 65 ~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
++||||+.+| +|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 105 ~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999999777 9999997 556799999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC--cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 144 PNED--FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 144 ~~~~--~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.... .....+|+.|+|||.+.+..+ +.++||||||+++|||++|..||..... ......
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------~~~~~~ 241 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------TVEAAI 241 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------GTTTCC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------HHhhcc
Confidence 4432 245578999999999988776 7899999999999999999999964210 000111
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+....+.+.+++.+||+.||++|| ++|+++
T Consensus 242 ---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 242 ---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12223456789999999999999999 999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=270.00 Aligned_cols=218 Identities=15% Similarity=0.128 Sum_probs=172.4
Q ss_pred ccccceeeecc----cCCCCCeeeccc-------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSF----NARNSPWISRVS-------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~----~~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++. .++..+++|... +.+|++.+. ++.|+||+++.+.+...+..++
T Consensus 28 G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE---------EVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHH---------HCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHH---------hCCCCCccceeEEEEcCCEEEE
Confidence 56899999986 466677777543 223444444 7889999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 99 ILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999973 45689999999999999999999999 999999999999999999999999999864322
Q ss_pred ---CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-C
Q 044568 147 ---DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-G 222 (257)
Q Consensus 147 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 222 (257)
......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .... .
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~-------------~i~~~~ 237 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTID-------------KILKCK 237 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH-------------HHHHTC
T ss_pred CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHH-------------HHHhCC
Confidence 22345689999999999988899999999999999999999999975421 11111 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hH
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ 251 (257)
...+......+.+++.+||+.||.+|| +.
T Consensus 238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred CCCCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 123344567889999999999999998 53
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=281.09 Aligned_cols=229 Identities=14% Similarity=0.084 Sum_probs=179.3
Q ss_pred ccccceeeecccCC-CCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...+ +.+++|.+. +.+|.+.+. .+.|+||+++.+.+...+..+|||||
T Consensus 85 G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~---------~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV---------NGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHH---------HSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57899999998764 456777654 233444443 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
|++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 156 ~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 156 YVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 999999999985 457799999999999999999999999 99999999999999999999999999987543322
Q ss_pred --ccccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 --VIDKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...... ... ....
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~-----~~~--~~~~ 301 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIM-----NHK--ERFQ 301 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH-----THH--HHCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhh-----hcc--cccc
Confidence 2357899999999987 4568999999999999999999999997552111 111110 000 0011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
-........+.+.+++.+||..+|++ || ++|+++
T Consensus 302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11111234567889999999998888 99 999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=266.27 Aligned_cols=227 Identities=16% Similarity=0.246 Sum_probs=179.0
Q ss_pred cccccceeeeccc---CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 3 CTKLSNFYRSSFN---ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 3 ~~~~~~~y~~~~~---~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
.+.++.||++... ++..+++|.... .+|++.+. ++.|+||+++.+.+ ..+..++|||
T Consensus 20 ~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 20 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH---------QLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp CCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred ccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHH---------hCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 3678999999854 344567776542 23444444 77899999999998 5667899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 90 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp CCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred eCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 9999999999975 556799999999999999999999999 99999999999999999999999999987653222
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... +.. ...
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~---------i~~-~~~ 231 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF---------IEQ-GKR 231 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHH---------HHT-TCC
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHH---------Hhc-CCc
Confidence 22344677999999988888999999999999999998 999997542211 1000 000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...++.+.+++.+||+.||++|| +.|+++.|
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 133455667899999999999999999 99998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.31 Aligned_cols=236 Identities=20% Similarity=0.241 Sum_probs=169.3
Q ss_pred ccccceeeecccCCC----CCeeeccchh-hhHHHHhHhhhccccccccCCceeeeceeee-ecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSWT-ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK-LTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-~~~~~~lV~E~~~~gsL~ 77 (257)
+.++.||+++..+.. .+++|..... ...+.-.+......+.++.|+||+++.+.+. ..+..++||||+++|+|.
T Consensus 100 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~ 179 (373)
T 3c1x_A 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179 (373)
T ss_dssp CSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHH
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHH
Confidence 578999999975443 3466654321 1001111111111344889999999999865 456889999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-------cc
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-------VI 150 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-------~~ 150 (257)
+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 180 ~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 255 (373)
T 3c1x_A 180 NFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255 (373)
T ss_dssp HHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------------------
T ss_pred HHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCC
Confidence 99975 556789999999999999999999999 99999999999999999999999999987542221 23
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..+++.|+|||.+.+..++.++||||||+++|||++ |..||............ . .. .....+...
T Consensus 256 ~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~----~~------~~~~~p~~~ 321 (373)
T 3c1x_A 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----L----QG------RRLLQPEYC 321 (373)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----H----TT------CCCCCCTTC
T ss_pred CCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----H----cC------CCCCCCCCC
Confidence 345667999999998899999999999999999999 67777654322211000 0 00 011223445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..+.+++.+||+.||++|| ++|+++.|
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 67899999999999999999 99998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=265.61 Aligned_cols=227 Identities=20% Similarity=0.323 Sum_probs=179.7
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||+++...+..+++|... +.+|++.+. ++.|+|++++.+.+. .+..++||||+++++
T Consensus 24 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMK---------QLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp ETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred CCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHH---------hCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 56889999998877778887654 345555555 778999999998876 556899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 94 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 99999743334799999999999999999999999 99999999999999999999999999987654322 223
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... .... ....+...+
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----------~~~~-~~~~~~~~~ 236 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL----------ERGY-RMVRPDNCP 236 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----------HTTC-CCCCCTTCC
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH----------hccc-CCCCccccc
Confidence 45667999999988888999999999999999999 99999754211 111100 0000 112234456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||++|| +.++++.|
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 7899999999999999999 99998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.80 Aligned_cols=229 Identities=18% Similarity=0.196 Sum_probs=178.6
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++.. .+..+++|... +.+|++.+. ++ .|+||+++.+.+...+..++
T Consensus 56 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT---------QLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSCEE
T ss_pred CCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHH---------hhcCCCCeeeEEEEEeeCCccEE
Confidence 568899999862 23346776643 334555544 66 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 67 IERPVRNGSLTDIIFCSAE---------------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
||||+++|+|.+++..... ..+++.++..++.|++.||.|||++ +++||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence 9999999999999975321 2489999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~ 199 (257)
+++.++.+||+|||++....... ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 99999999999999987432221 23345677999999998889999999999999999998 9999976532221
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... .... ....+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 284 ---~~~~~---------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 284 ---FYKLI---------QNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ---HHHHH---------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHHHH---------hcCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 11100 0000 1122344567899999999999999999 99998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.52 Aligned_cols=237 Identities=20% Similarity=0.280 Sum_probs=179.5
Q ss_pred ccccceeeeccc-----CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSSFN-----ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-----~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||++.+. ++..+++|... +.+|++.+. ++.|+|++++.+.+... ...++
T Consensus 42 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR---------TLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp CSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTTTEEEE
T ss_pred CCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHH---------hCCCcchhhEEEEEecCCCceEEE
Confidence 568889776543 45557777654 234555554 78899999999999874 57799
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++|+|.+++.. ..+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999964 3599999999999999999999999 999999999999999999999999999876543
Q ss_pred Cc------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 DF------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.. ....++..|+|||.+.+..++.++||||||+++|||++|..||...... ......+.............+
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK--FLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh--hhhhhcccccchhHHHHHHHH
Confidence 22 2335566799999999888999999999999999999999999743110 000000000001111111222
Q ss_pred c---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 R---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ....+...+..+.+++.+||+.||++|| ++|+++.|
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 1134555678899999999999999999 99998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=262.71 Aligned_cols=223 Identities=16% Similarity=0.173 Sum_probs=176.6
Q ss_pred ccccceeeecccCCC-CCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++....++ .+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS---------HLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHH---------cCCCCCCcchhheEecCCEEEEEEec
Confidence 568899999866655 56677543 223333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFV 149 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~ 149 (257)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 91 ~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 91 APLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 999999999973 45699999999999999999999999 999999999999999999999999998865432 224
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .... ... .....+...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----------~~~--~~~~~~~~~ 230 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKR----------ISR--VEFTFPDFV 230 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH----------HHH--TCCCCCTTS
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHHH----------HHh--CCCCCCCcC
Confidence 5578889999999998889999999999999999999999997542111 1100 000 011233445
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+.+++.+||+.||.+|| +.|+++
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 57789999999999999999 999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=268.14 Aligned_cols=224 Identities=17% Similarity=0.193 Sum_probs=171.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC----------
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS---------- 62 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~---------- 62 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+
T Consensus 17 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 17 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA---------KLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp C-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHT---------SCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 578999999976 67778888754 234444444 788999999999876543
Q ss_pred -----------------------------------------------ceeEEEeecCCCCHHHHHhccC-CCCCCHHHHH
Q 044568 63 -----------------------------------------------VSGKIERPVRNGSLTDIIFCSA-ERNPYWNQRV 94 (257)
Q Consensus 63 -----------------------------------------------~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~ 94 (257)
..++||||+++|+|.+++.... ....++..+.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 2789999999999999997532 2335667789
Q ss_pred HHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---------------ccccCCCCccC
Q 044568 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF---------------VIDKRDKGYMA 159 (257)
Q Consensus 95 ~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~a 159 (257)
.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... ....+|+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999999 99999999999999999999999999987654321 23468889999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH
Q 044568 160 PECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLW 239 (257)
Q Consensus 160 PE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 239 (257)
||.+.+..++.++||||||+++|||++|..|+... ..... ..... ..........+.+.+++.+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~~~---------~~~~~-~~~~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRIIT---------DVRNL-KFPLLFTQKYPQEHMMVQD 308 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHHHH---------HHHTT-CCCHHHHHHCHHHHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHHHH---------Hhhcc-CCCcccccCChhHHHHHHH
Confidence 99999989999999999999999999987765311 00000 00000 0001112334677899999
Q ss_pred cccCCCCCCC-hHHHHH
Q 044568 240 CVQDEPALRP-MKCAVM 255 (257)
Q Consensus 240 cl~~~p~~RP-~~ei~~ 255 (257)
||+.||++|| ++|+++
T Consensus 309 ~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCSSGGGSCCHHHHHH
T ss_pred HccCCCCcCCCHHHHhh
Confidence 9999999999 999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=267.05 Aligned_cols=227 Identities=21% Similarity=0.254 Sum_probs=173.1
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gs 75 (257)
+.++.||+++.. +..+++|... +.+|++.+. ++.|+|++++.+.+.. .+..++||||+++|+
T Consensus 32 G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 32 GEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT---------QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp CSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHT---------TCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred CCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 568899999874 6677887654 334554444 7889999999998654 457899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...........++.
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 178 (278)
T 1byg_A 102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 178 (278)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccc
Confidence 99999753333488999999999999999999999 999999999999999999999999999876555555556788
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ...... ....+...++.+.
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----------~~~~~~-~~~~~~~~~~~l~ 244 (278)
T 1byg_A 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----------RVEKGY-KMDAPDGCPPAVY 244 (278)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----------HHTTTC-CCCCCTTCCHHHH
T ss_pred cccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------HHhcCC-CCCCcccCCHHHH
Confidence 8999999998889999999999999999998 999997542111 000 000000 1123445567899
Q ss_pred HHHHHcccCCCCCCC-hHHHHHhC
Q 044568 235 KVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+++.+||+.||.+|| +.|+++.|
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHHHH
Confidence 999999999999999 99998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=269.45 Aligned_cols=236 Identities=17% Similarity=0.223 Sum_probs=180.8
Q ss_pred ccccceeeec-----ccCCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec--CceeE
Q 044568 4 TKLSNFYRSS-----FNARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT--SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~-----~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 66 (257)
+.++.||+++ ..++..+++|... +.+|++.+. ++.|+|++++.+.+... +..++
T Consensus 32 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR---------NLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp CSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHH---------TCCCTTBCCEEEEEEC---CCEEE
T ss_pred CCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHH---------hCCCCCeeeeeeEEecCCCceEEE
Confidence 5788999998 3456667777644 234555555 78899999999998876 67899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999999965 456799999999999999999999999 999999999999999999999999999876443
Q ss_pred Cc------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh---hhhhhhh
Q 044568 147 DF------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC---FINRELN 217 (257)
Q Consensus 147 ~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~ 217 (257)
.. ....+|..|+|||.+.+..++.++||||+|+++|||++|..|+..... .......+. .......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHHHHH
Confidence 22 234566679999999988899999999999999999999999753310 000000000 0001111
Q ss_pred h-hhc--CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 218 K-LVR--GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 218 ~-~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ... ....+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 1 111 1134455668899999999999999999 99999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=265.04 Aligned_cols=227 Identities=19% Similarity=0.261 Sum_probs=172.8
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceee-eecCceeEEE
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRA-KLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-~~~~~~~lV~ 68 (257)
+.++.||+++..++.. +++|... +.+|++.+. ++.|+|++++.+.+ ...+..++||
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK---------DFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp ETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHH---------TCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred cCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHH---------hCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5689999999765442 4555533 233444444 78899999999985 4566889999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 107 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 107 PYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp ECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred eCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999975 567789999999999999999999999 99999999999999999999999999987543322
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
....+++.|+|||.+.+..++.++||||+|+++||+++ |.+||.......... .. .. .
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~----------~~-~ 248 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YL----------LQ-G 248 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HH----------HT-T
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HH----------hc-C
Confidence 23345667999999998889999999999999999999 555665432221100 00 00 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+...+..+.+++.+||+.||++|| ++|+++.|
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 01122334456799999999999999999 99998864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=272.54 Aligned_cols=230 Identities=18% Similarity=0.194 Sum_probs=178.9
Q ss_pred ccccceeeecccC-CCCCeeeccc-----hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++.... +..+++|... ..+|++.+. ++ .|+||+++.+.+...+..++||||+++|+|
T Consensus 33 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~---------~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 33 GSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILL---------RYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHH---------HHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHH---------HhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 5688999998764 5567777653 345665554 43 699999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC----CceEEeeecccccCCC---Ccc
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF----WTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~----~~~kl~dfg~~~~~~~---~~~ 149 (257)
.+++. ....+++.++..++.|++.||.|||++ +++||||||+||++.+. +.+||+|||++..... ...
T Consensus 104 ~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 178 (342)
T 2qr7_A 104 LDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178 (342)
T ss_dssp HHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred HHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence 99997 456799999999999999999999999 99999999999998533 3599999999875432 224
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+|+.|+|||.+.+..++.++||||||+++|||++|..||................. .. ...........
T Consensus 179 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-----~~---~~~~~~~~~~~ 250 (342)
T 2qr7_A 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-----GK---FSLSGGYWNSV 250 (342)
T ss_dssp CSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-----CC---CCCCSTTTTTS
T ss_pred ccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-----CC---cccCccccccC
Confidence 55778999999999887789999999999999999999999976432222111111110 00 00011122345
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+++.+||+.||++|| +.|+++
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 57789999999999999999 999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=269.57 Aligned_cols=225 Identities=14% Similarity=0.192 Sum_probs=175.6
Q ss_pred ccccceeeecccCCCC--------Ceeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARNS--------PWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~--------~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||++....... +++|... +.+|++.+. ++.|+||+++.+.+...+..++
T Consensus 19 G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS---------KLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHH---------TSCCTTBCCEEEEECCTTCCEE
T ss_pred CCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHH---------hCCCCCEeEEEEEEEeCCCCEE
Confidence 5689999998776653 6676543 233444444 7889999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--------eEEeee
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--------AKILDF 138 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--------~kl~df 138 (257)
||||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++. +||+||
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 9999999999999985 445599999999999999999999999 9999999999999988876 999999
Q ss_pred cccccCCCCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 139 GLAKLPNEDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 139 g~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
|.+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|+......... ..
T Consensus 166 g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~------------- 229 (289)
T 4fvq_A 166 GISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQ------------- 229 (289)
T ss_dssp CSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH-------------
T ss_pred cccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HH-------------
Confidence 998654332 34457888999999987 66899999999999999999965555433111110 00
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
........+...+..+.+++.+||+.||.+|| ++|+++.|
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 230 FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00111122223345688999999999999999 99998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.03 Aligned_cols=236 Identities=17% Similarity=0.212 Sum_probs=170.2
Q ss_pred ccccceeeecc-cCCCCCeeeccchh--hhHH-HHhHhhhccccccccCCceeeeceeeeecCce----eEEEeecCCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWT--ADIE-VLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS----GKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~--~~~~-~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~----~lV~E~~~~gs 75 (257)
+.++.||+++. .++..+++|..... ...+ ...+...-..+.++.|+||+++.+.+...+.. ++||||+++|+
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~ 102 (311)
T 3ork_A 23 GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT 102 (311)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEE
T ss_pred CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCC
Confidence 56899999995 55666778865421 1101 11111111134488999999999998876654 99999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------c
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------V 149 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------~ 149 (257)
|.+++.. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... .
T Consensus 103 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 177 (311)
T 3ork_A 103 LRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177 (311)
T ss_dssp HHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--------------
T ss_pred HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccc
Confidence 9999973 45799999999999999999999999 99999999999999999999999999987543221 2
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... . ..... ... ...+.......
T Consensus 178 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~-~~~~~----~~~----~~~~~~~~~~~ 246 (311)
T 3ork_A 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--V-AYQHV----RED----PIPPSARHEGL 246 (311)
T ss_dssp ----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H-HHHHH----HCC----CCCHHHHSTTC
T ss_pred ccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--H-HHHHh----cCC----CCCcccccCCC
Confidence 3457899999999999899999999999999999999999997542111 1 00000 000 00000011224
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.+++.+||+.||++|| +.++++
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 56789999999999999999 766653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=269.45 Aligned_cols=226 Identities=18% Similarity=0.266 Sum_probs=168.8
Q ss_pred ccccceeeecccCCC----CCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce----
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS---- 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~---- 64 (257)
+.++.||+++...++ .+++|... +.+|++.+. ++.|+|++++.+.+...+..
T Consensus 34 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK---------EFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHT---------TCCCTTBCCCCEEEECC-------
T ss_pred cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHH---------HCCCCceehhhceeeccccccCCC
Confidence 578999999987765 46777653 233444444 78899999999999877655
Q ss_pred --eEEEeecCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeee
Q 044568 65 --GKIERPVRNGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDF 138 (257)
Q Consensus 65 --~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~df 138 (257)
++||||+++|+|.+++... ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 9999999999999999642 223689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 139 GLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 139 g~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
|++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~-------- 250 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN-------- 250 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH--------
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH--------
Confidence 9987543222 23345667999999998889999999999999999999 999997552211 000
Q ss_pred hhhhhhhhc--CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVR--GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.... ....+...++.+.+++.+||+.||++|| +.|+++.|
T Consensus 251 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 251 -----YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -----HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1111 1123445567899999999999999999 99998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=267.66 Aligned_cols=229 Identities=19% Similarity=0.250 Sum_probs=179.5
Q ss_pred ccccceeeecc------cCCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++. .++..+++|... +.+|++.+. ++ .|+||+++.+.+...+..++
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS---------YLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSCEE
T ss_pred cCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHh---------hcccCCCeeeEEEEEecCCCcEE
Confidence 56889999974 344566777654 234444444 66 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 67 IERPVRNGSLTDIIFCSAE----------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
||||+++|+|.+++..... ..+++.++..++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 9999999999999975322 2489999999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.+||+|||++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~ 258 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY 258 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---HH
Confidence 999999999987654332 12334567999999998889999999999999999999 9999976532221 11
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... ..... ...+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 259 ~~~---------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 259 KMI---------KEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHH---------HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHh---------ccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 100 00011 122334557899999999999999999 99998864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=271.63 Aligned_cols=224 Identities=18% Similarity=0.153 Sum_probs=178.3
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++. .++..+++|... +.+|++.+. +++|+|++++.+.+...+..++||||
T Consensus 65 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ---------KLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEECCeEEEEEec
Confidence 56899999985 566677888754 234444444 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
+. |+|.+.+.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... ...
T Consensus 136 ~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-~~~ 209 (348)
T 1u5q_A 136 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANS 209 (348)
T ss_dssp CS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCC
T ss_pred CC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-CCc
Confidence 97 689888864 456799999999999999999999999 999999999999999999999999999876543 345
Q ss_pred ccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 151 DKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
..+|+.|+|||.+. ...++.++||||||+++|||++|+.||...... ...... .....+...+.
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~---~~~~~~----------~~~~~~~~~~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI----------AQNESPALQSG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----------HHSCCCCCCCT
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH----------HhcCCCCCCCC
Confidence 57899999999985 567899999999999999999999999754211 111000 00011112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..++.+.+++.+||+.||++|| ++|+++
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 4456789999999999999999 999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=262.77 Aligned_cols=228 Identities=21% Similarity=0.289 Sum_probs=176.8
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce-eEEE
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS-GKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~-~lV~ 68 (257)
+.++.||++...++.. +++|... +.+|++.+. ++.|+|++++.+.+...+.. ++||
T Consensus 32 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR---------GLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp ETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHH---------TCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred CCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHH---------hCCCCCeeeEEEEEecCCCCcEEEE
Confidence 5789999998655543 5666543 223444444 77899999999999876655 9999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
||+.+|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 103 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 103 PYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999985 567789999999999999999999999 9999999999999999999999999998754322
Q ss_pred ------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 ------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..... .. ..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~---------~~-~~ 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFL---------AQ-GR 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHH---------HT-TC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHh---------hc-CC
Confidence 1334556779999999998999999999999999999996666543322111 10000 00 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...+..+.+++.+||+.||.+|| ++|+++.|
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1123344557899999999999999999 99998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=269.25 Aligned_cols=226 Identities=18% Similarity=0.199 Sum_probs=173.0
Q ss_pred ccccceeeecccCCC-CC----eeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARN-SP----WISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~----~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||++....++ .+ ++|... +.+|++.+. ++.|+||+++.+.+...+ .++|+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA---------SVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp CSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHT---------TCCBTTBCCCCEEEESSS-EEEEE
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHH---------hCCCCCeeEEEEEEecCC-ceEEE
Confidence 578999999965444 33 444331 344555555 788999999999988654 78899
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+.+|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 96 QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999999986 566799999999999999999999999 99999999999999999999999999987543222
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ... . .....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----~~~---------~-~~~~~ 237 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----SSI---------L-EKGER 237 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----HHH---------H-HTTCC
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----HHH---------H-HcCCC
Confidence 23344667999999999999999999999999999999 9999975522110 000 0 00011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 123444567799999999999999999 99998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.03 Aligned_cols=222 Identities=14% Similarity=0.094 Sum_probs=169.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeec-------eeeeecC-
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVP-------VRAKLTS- 62 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~-------~~~~~~~- 62 (257)
+.++.||+++. .+++.+++|... +.+|++.+. .+.++.|+||+++. +.+...+
T Consensus 84 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~------~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR------LLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGG------GSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHH------hccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 57899999996 457788888754 234443333 45577899999887 4444332
Q ss_pred ----------------ceeEEEeecCCCCHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 044568 63 ----------------VSGKIERPVRNGSLTDIIFCSA-----ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 121 (257)
Q Consensus 63 ----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 121 (257)
..+|||||+ +|+|.+++.... ...+++..+..++.|++.||.|||++ +|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 378999999 589999997421 12234578888999999999999999 99999999
Q ss_pred CCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCC-----------CCCccccchhHHHHHHHHHhcCCC
Q 044568 122 PQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRT-----------PISVKADVYGYGIVLLETICCRKN 190 (257)
Q Consensus 122 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~s~G~~l~el~~g~~p 190 (257)
|+||+++.++.+||+|||+++..........+ +.|+|||.+.+. .++.++||||||+++|||++|+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999876665566677 899999999877 799999999999999999999999
Q ss_pred CCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 191 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 191 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
|........ ....... ....++.+.+++.+||+.||++|| +.|+++
T Consensus 313 f~~~~~~~~----------------~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 313 ITKDAALGG----------------SEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp C------CC----------------SGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred Ccccccccc----------------hhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 975421110 0111111 122346788999999999999999 999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=266.14 Aligned_cols=222 Identities=18% Similarity=0.202 Sum_probs=179.7
Q ss_pred ccccceeeecccC-CCCCeeeccc---------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++|
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR---------QVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHH---------hCCCCCcceEEEEEecCCEEEEE
Confidence 5789999999764 5566776542 345555555 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~dfg~~~~ 143 (257)
|||+++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++..
T Consensus 94 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 94 LELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp ECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999997 456789999999999999999999999 999999999999999887 799999999875
Q ss_pred CCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.... .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... ....... ..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i-------------~~ 232 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANI-------------TS 232 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHH-------------HT
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH-------------Hh
Confidence 4432 2445688899999999988899999999999999999999999975421 1111111 00
Q ss_pred CC-CCC----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GT-KVD----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~-~~~----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ..+ ...+..+.+++.+||+.||++|| +.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 111 12346789999999999999999 999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=273.53 Aligned_cols=227 Identities=19% Similarity=0.173 Sum_probs=176.1
Q ss_pred ccccceeeecccCCC-CCeeeccchhhhH---HHHhH-hhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVSWTADI---EVLSV-AMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~~~~~~---~~~~~-~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++...++ .+++|...-.... +...+ ......+..+.|+||+++.+.+...+..++||||+++|+|.+
T Consensus 49 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 128 (373)
T 2r5t_A 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128 (373)
T ss_dssp CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 578999999976644 4677765432111 11111 111112346889999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC---CCCcccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP---NEDFVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~---~~~~~~~~~~~ 155 (257)
++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.. ........||+
T Consensus 129 ~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~ 203 (373)
T 2r5t_A 129 HLQ--RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203 (373)
T ss_dssp HHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCC
T ss_pred HHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCc
Confidence 997 346789999999999999999999999 9999999999999999999999999998742 22335567899
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++|+||||+++|||++|..||..... ...... +.. ...++......+.
T Consensus 204 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~-------------i~~~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDN-------------ILNKPLQLKPNITNSAR 267 (373)
T ss_dssp CCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHH-------------HHHSCCCCCSSSCHHHH
T ss_pred cccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHH-------------HHhcccCCCCCCCHHHH
Confidence 99999999999999999999999999999999999975421 111111 111 1123344557789
Q ss_pred HHHHHcccCCCCCCC-hH
Q 044568 235 KVGLWCVQDEPALRP-MK 251 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ 251 (257)
+++.+||+.||.+|| +.
T Consensus 268 ~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHcccCHHhCCCCC
Confidence 999999999999999 74
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=267.44 Aligned_cols=245 Identities=20% Similarity=0.171 Sum_probs=176.7
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeec----CceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT----SVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. +..+++|................- ....+.|+||+++.+.+... ...++||||+++|+|.++
T Consensus 48 G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~-~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 125 (337)
T 3mdy_A 48 GRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIY-QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125 (337)
T ss_dssp ETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHH
T ss_pred CCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHH-HHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHH
Confidence 578999999875 778888876543222221111111 12245899999999998877 688999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF------ 148 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~------ 148 (257)
+.. ..+++.++..++.|++.||.|||+++ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 126 l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 202 (337)
T 3mdy_A 126 LKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202 (337)
T ss_dssp HHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred hhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCC
Confidence 964 46999999999999999999999751 2389999999999999999999999999986543222
Q ss_pred -ccccCCCCccCcccccCCCCCcc------ccchhHHHHHHHHHhc----------CCCCCcCCCChhhH-HHHHHHHHh
Q 044568 149 -VIDKRDKGYMAPECYKRTPISVK------ADVYGYGIVLLETICC----------RKNMEIDASKPEEI-ILTNWVYKC 210 (257)
Q Consensus 149 -~~~~~~~~~~aPE~~~~~~~~~~------~Di~s~G~~l~el~~g----------~~pf~~~~~~~~~~-~~~~~~~~~ 210 (257)
....+|+.|+|||.+.+...+.. +||||||+++|||++| ..||.......... .....
T Consensus 203 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~---- 278 (337)
T 3mdy_A 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI---- 278 (337)
T ss_dssp CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH----
T ss_pred CCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHH----
Confidence 23468899999999987765554 9999999999999999 56665432221110 00000
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 211 FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..........+....+..+++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 000000000000011336788899999999999999999 99998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.24 Aligned_cols=239 Identities=18% Similarity=0.206 Sum_probs=180.2
Q ss_pred ccccceeeecc-----cCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeee--ecCceeEE
Q 044568 4 TKLSNFYRSSF-----NARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK--LTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~-----~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~lV 67 (257)
+.++.||++++ .++..+++|... +.+|++.+. ++.|+|++++.+.+. ..+..++|
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK---------ALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp ETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred CCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHH---------hcCCCceeEEEEEEecCCCceEEEE
Confidence 56889999984 455567777654 344555555 779999999999876 45668899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999999975 345699999999999999999999999 9999999999999999999999999998754332
Q ss_pred c------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 F------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .....+.............+.
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC----CCHHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccccccccHHHHHHHhh
Confidence 2 23345667999999988888999999999999999999999997431100 000000000000011111111
Q ss_pred ---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 ---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1134555678899999999999999999 99998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=261.88 Aligned_cols=226 Identities=15% Similarity=0.173 Sum_probs=174.9
Q ss_pred ccccceeeecccCCC----CCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++...... .+++|.... .+|++.+. ++.|+|++++.+.+.. +..++|||
T Consensus 23 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK---------NLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp CSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHH---------HHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHH---------hCCCCCcceEEEEEcC-CCCEEEEe
Confidence 578999999865443 267776442 23444444 7789999999998764 55689999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++++|.+++.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 93 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 93 LYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred cCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999999975 456699999999999999999999999 99999999999999999999999999987544322
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .... .. .....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~----------~~-~~~~~ 234 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVL----------EK-GDRLP 234 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHH----------HH-TCCCC
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHH----------hc-CCCCC
Confidence 23345667999999988889999999999999999998 9999975422111 1000 00 01112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 2334567799999999999999999 99998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=265.10 Aligned_cols=238 Identities=15% Similarity=0.143 Sum_probs=175.7
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 14 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK---------QLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHH---------hCCCCCccchhheeecCCeEEEEEEeC
Confidence 5789999999765 5667777542 234444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---c
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~ 148 (257)
++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 85 ~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 85 DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp SEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9999999987 556799999999999999999999999 9999999999999999999999999998764422 2
Q ss_pred ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhhhhhhhhhh
Q 044568 149 VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFINRELNKLV 220 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 220 (257)
....+|..|+|||.+.+ ..++.++||||+|+++|+|++|..||................. ..+.........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 34567888999999976 5689999999999999999999999976532221111111100 000000000000
Q ss_pred ---cCCCC------CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 ---RGTKV------DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ---~~~~~------~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++... ....+..+.+++.+||+.||.+|| ++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 012346789999999999999999 999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=276.88 Aligned_cols=226 Identities=14% Similarity=0.127 Sum_probs=178.2
Q ss_pred ccccceeeecccC-CCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++... +..+++|... +.+|.+.+. .+.|+||+++.+.+...+..+|||||
T Consensus 80 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~---------~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA---------FANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 5789999999765 4556777543 234444444 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 151 ~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 151 MPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999999964 4689999999999999999999999 99999999999999999999999999997654332
Q ss_pred --ccccCCCCccCcccccCCC----CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 --VIDKRDKGYMAPECYKRTP----ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~----~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... ...... .... . +.
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~-----~~~~-~-~~- 293 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSKIM-----NHKN-S-LT- 293 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH-----THHH-H-CC-
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHHHH-----hccc-c-cc-
Confidence 3557899999999998655 7899999999999999999999997552111 111110 0000 0 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCC--CC-hHHHHH
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPAL--RP-MKCAVM 255 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~--RP-~~ei~~ 255 (257)
.+......+.+.+++.+||+.+|.+ || ++||++
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0111234567889999999999988 99 999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.86 Aligned_cols=236 Identities=15% Similarity=0.120 Sum_probs=177.1
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++... +..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK---------ELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHh---------cCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 5789999999765 55577876542 23444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---c
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~ 148 (257)
++ ++.+.+.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 84 DQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp SE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred CC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 75 66666654 567799999999999999999999999 9999999999999999999999999998754422 2
Q ss_pred ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hh---hhhhhcC
Q 044568 149 VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RE---LNKLVRG 222 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~ 222 (257)
....+|+.|+|||.+.+.. ++.++||||+|+++|||++|..||....... ............. .. .....+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccc
Confidence 4456788899999998765 7999999999999999999888864332111 1111111110000 00 0000000
Q ss_pred ------------CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 ------------TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 ------------~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..........+.+++.+||+.||++|| ++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 011223457788999999999999999 999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.00 Aligned_cols=245 Identities=18% Similarity=0.142 Sum_probs=183.5
Q ss_pred ccccceeeecc--cCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSF--NARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~--~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++.. .++..+++|... +.+|++.+...... ....|++++++.+.+...+..++||||+ +
T Consensus 25 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 100 (339)
T 1z57_A 25 GAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT---DPNSTFRCVQMLEWFEHHGHICIVFELL-G 100 (339)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHH---CTTCTTCBCCEEEEEEETTEEEEEEECC-C
T ss_pred CCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhc---CCCCceeeEeeecccccCCcEEEEEcCC-C
Confidence 56889999975 345667887654 34455555421111 1334556899999999999999999999 7
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------------------CCceE
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-------------------FWTAK 134 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-------------------~~~~k 134 (257)
++|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++. ++.+|
T Consensus 101 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~k 177 (339)
T 1z57_A 101 LSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177 (339)
T ss_dssp CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEE
T ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCce
Confidence 8999999865556799999999999999999999999 9999999999999987 66799
Q ss_pred EeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----
Q 044568 135 ILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC---- 210 (257)
Q Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 210 (257)
|+|||.+...........+|+.|+|||.+.+..++.++||||||+++|||++|..||.................+.
T Consensus 178 l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 257 (339)
T 1z57_A 178 VVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257 (339)
T ss_dssp ECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHH
T ss_pred EeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9999999876666666788999999999998889999999999999999999999997652221111111100000
Q ss_pred -------------------------hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 -------------------------FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 -------------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........+...........+.+.+++.+||+.||.+|| ++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 000000011111123445678899999999999999999 999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.37 Aligned_cols=227 Identities=20% Similarity=0.175 Sum_probs=179.2
Q ss_pred cccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
.+.++.||++... +++.+++|.... .+|++.+. .+.|+|++++.+.+...+..++||||+
T Consensus 17 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK---------MLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp ECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHH---------TCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHH---------hcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 3578999999876 566677876542 23333333 778999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC----
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---- 147 (257)
++++|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 88 ~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 88 SGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999997 456799999999999999999999999 9999999999999999999999999998753221
Q ss_pred -cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....+++.|+|||.+.+..+ +.++||||||+++|||++|..||........ ....+.... .....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~----------~~~~~ 230 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK----------TYLNP 230 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTC----------TTSTT
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhcc----------cccCc
Confidence 234467888999999987765 7889999999999999999999976533221 111111100 00011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+..+.+++.+||+.||.+|| ++|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 223456788999999999999999 999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=275.99 Aligned_cols=228 Identities=14% Similarity=0.097 Sum_probs=176.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. +++.+++|...- .+|.+++ ..+.|+||+++.+.+...+..+|||||
T Consensus 72 G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il---------~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL---------VNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHH---------HHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHH---------HhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 578999999975 566778886542 2233333 377899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 143 ~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 143 YVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 999999999975 345799999999999999999999999 99999999999999999999999999987654332
Q ss_pred --ccccCCCCccCccccc-------CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 149 --VIDKRDKGYMAPECYK-------RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~-------~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
....||+.|+|||++. ...++.++|+|||||++|||++|+.||....... ...... .. ...
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~-----~~--~~~ 288 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYGKIV-----HY--KEH 288 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH-----TH--HHH
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHHHHH-----hc--ccC
Confidence 2357899999999987 3568999999999999999999999997552111 111110 00 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCC---C-hHHHHH
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALR---P-MKCAVM 255 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---P-~~ei~~ 255 (257)
......+...++.+.+++.+||. +|.+| | ++|+++
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11111123345778999999999 99998 7 888764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.31 Aligned_cols=222 Identities=17% Similarity=0.143 Sum_probs=179.5
Q ss_pred ccccceeeecccCC-CCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...+ ..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 25 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS---------HLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHh---------cCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 57889999997654 456777653 233444444 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFV 149 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~ 149 (257)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 96 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (284)
T 2vgo_A 96 APRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170 (284)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence 999999999974 35689999999999999999999999 999999999999999999999999998865432 234
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 228 (257)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ... .... ....+..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~-------------~~~~~~~~~~~~ 234 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THR-------------RIVNVDLKFPPF 234 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH-------------HHHTTCCCCCTT
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHH-------------HHhccccCCCCc
Confidence 4567889999999998889999999999999999999999997542111 000 1111 1123344
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..+.+++.+||+.||.+|| +.|+++
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 557789999999999999999 999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=269.93 Aligned_cols=221 Identities=18% Similarity=0.225 Sum_probs=173.0
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccC--CceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRG--GLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h--~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++...++..+++|... +.+|++.+. ++.| +||+++.+.+...+..++|||
T Consensus 20 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 20 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN---------KLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp CSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred CCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHH---------hhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 67899999999888888988654 234555444 5555 899999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+.+|+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||+++ ++.+||+|||++.......
T Consensus 90 ~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 CGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CCSEEHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 55789999998 456799999999999999999999999 999999999999997 5689999999987643322
Q ss_pred ---ccccCCCCccCcccccC-----------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 149 ---VIDKRDKGYMAPECYKR-----------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------- 228 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------- 228 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------------
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---------------
Confidence 34578999999999864 5688999999999999999999999974321110
Q ss_pred hhhhhhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....++ ....+......+.+++.+||+.||.+|| +.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 0111111 1123344456789999999999999999 999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.60 Aligned_cols=249 Identities=20% Similarity=0.237 Sum_probs=174.4
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeee-----cCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-----TSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++. ++..+++|.......-+........ ....+.|+|++++.+.+.. ....++||||+++|+|.+
T Consensus 24 G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~-~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 101 (336)
T 3g2f_A 24 GRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIY-RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK 101 (336)
T ss_dssp CSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHH
T ss_pred CCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHH-HHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHH
Confidence 57899999976 5778888887643322222211111 2335789999999875442 336689999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
++.. ...++..+..++.|++.||.|||++. .++++||||||+||+++.++.+||+|||++......
T Consensus 102 ~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~ 178 (336)
T 3g2f_A 102 YLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178 (336)
T ss_dssp HHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--
T ss_pred HHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCc
Confidence 9964 34588999999999999999999762 238999999999999999999999999998754321
Q ss_pred ------cccccCCCCccCcccccC-------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhh-HHHHHHHHHhhhh
Q 044568 148 ------FVIDKRDKGYMAPECYKR-------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEE-IILTNWVYKCFIN 213 (257)
Q Consensus 148 ------~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 213 (257)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|..||......... .............
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3g2f_A 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF 258 (336)
T ss_dssp -------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCH
T ss_pred cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchH
Confidence 123468889999999976 34567899999999999999998777543221110 0000000000000
Q ss_pred hhhhhhh---------c-CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLV---------R-GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~---------~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....... + ........++.+.+++.+||+.||++|| ++|+++.|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 259 EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 0000000 0 1122334667899999999999999999 99998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=279.59 Aligned_cols=223 Identities=16% Similarity=0.223 Sum_probs=180.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. +++.+++|...- .+|.+.+. ++.|+||+++.+.+...+..++||||
T Consensus 196 G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~---------~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA---------KVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHH---------hcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 578999999975 466678887642 22333333 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 71 VRNGSLTDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999997532 45799999999999999999999999 99999999999999999999999999997644322
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh-cCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV-RGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 224 (257)
....||+.|+|||.+.+..++.++|+|||||++|||++|+.||...........+.. ... ....
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~------------~i~~~~~~ 411 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RVLEQAVT 411 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH------------HHHHCCCC
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH------------HHhhcccC
Confidence 334789999999999998999999999999999999999999986533221111111 111 1123
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-h
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-M 250 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~ 250 (257)
++...+..+.+++.+||+.||++|| +
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 4455667899999999999999999 7
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=257.27 Aligned_cols=221 Identities=15% Similarity=0.190 Sum_probs=176.8
Q ss_pred ccccceeeecccCCC-CCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++....+. .+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+++
T Consensus 20 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK---------SLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHH---------hCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 578999999976654 45666543 345555555 77899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCC--Cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNE--DF 148 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~--~~ 148 (257)
++|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||++ +.++.++|+|||.+..... ..
T Consensus 91 ~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 91 GELFERVV--HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999997 345699999999999999999999999 99999999999999 7888999999999875432 23
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (257)
....+|+.|+|||.+.+. ++.++||||||+++|||++|..||..... ...... ..... ..+.
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~-------------~~~~~~~~~~ 228 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLK-------------IREGTFTFPE 228 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-------------HHHCCCCCCH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHH-------------HHhCCCCCCc
Confidence 455788999999988654 89999999999999999999999975421 111111 11111 1122
Q ss_pred ----HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 ----KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ----~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..++.+.+++.+||+.||++|| +.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2356789999999999999999 999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=260.24 Aligned_cols=225 Identities=17% Similarity=0.226 Sum_probs=173.5
Q ss_pred ccccceeeecccCCC-CCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEE
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV 67 (257)
+.++.||++....+. .+++|... +.+|++.+. ++.|+||+++.+.+.. ....++|
T Consensus 37 G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK---------GLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHH---------hCCCCCeeeeeeeeccccCCCceEEEE
Confidence 578999999865544 45555543 223444443 7889999999998765 3568999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeC-CCCceEEeeecccccC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMD-EFWTAKILDFGLAKLP 144 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~-~~~~~kl~dfg~~~~~ 144 (257)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++ + ++|+||+|+||+++ .++.++|+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999973 46789999999999999999999999 8 99999999999997 7889999999998754
Q ss_pred CCC-cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 145 NED-FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 145 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
... .....+++.|+|||.+. ..++.++||||+|+++|+|++|+.||........ ... .......+.
T Consensus 183 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~---------~~~~~~~~~ 249 (290)
T 1t4h_A 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYR---------RVTSGVKPA 249 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHH---------HHTTTCCCG
T ss_pred cccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHH---------HHhccCCcc
Confidence 433 34557899999999886 4589999999999999999999999975422111 100 000111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+....+.+.+++.+||+.||.+|| ++|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22233346799999999999999999 999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=259.33 Aligned_cols=227 Identities=16% Similarity=0.130 Sum_probs=177.8
Q ss_pred ccccceeeecccC-CCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++.... +..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 17 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 17 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR---------KLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHH---------HcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 5788999998654 55667776432 23444444 778999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEeeecccccCCCCc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLAKLPNEDF 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~~~~~~~~ 148 (257)
++|+|.+.+.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++. +||+|||.+.......
T Consensus 88 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 88 TGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99999999873 46699999999999999999999999 9999999999999976554 9999999987544332
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+++.|+|||.+.+..++.++||||+|+++|+|++|..||...... ........ . ....+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~-----~---~~~~~~~~~ 231 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKA-----G---AYDYPSPEW 231 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH-----T---CCCCCTTTT
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHh-----c---cccCCchhh
Confidence 3457888999999999988999999999999999999999999754211 11111100 0 000011112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||++|| ++|+++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 23456789999999999999999 999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.23 Aligned_cols=228 Identities=18% Similarity=0.208 Sum_probs=177.2
Q ss_pred ccccceeeeccc--------CCCCCeeeccch----------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFN--------ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~--------~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++ .|+||+++.+.+...+..
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK---------MIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp CSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSCC
T ss_pred cCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHH---------HhhcCCCEeeEEEEEccCCce
Confidence 578999999864 344577776542 23333333 55 799999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 65 GKIERPVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCC
Confidence 99999999999999997532 13489999999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~ 204 (257)
+.+||+|||++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ..
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~-~~ 269 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E-LF 269 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-HH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H-HH
Confidence 999999999987544322 23345667999999988889999999999999999999 99999754111 0 10
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... ... .....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 270 ~~~---------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 270 KLL---------KEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHH---------HHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHH---------hcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 000 000 01123344567899999999999999999 99998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=263.06 Aligned_cols=225 Identities=18% Similarity=0.244 Sum_probs=175.8
Q ss_pred ccccceeeeccc---CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFN---ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~---~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||++... .+..+++|... +.+|++.+. .+.|+|++++.+.+ ..+..++|||
T Consensus 28 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ---------QLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH---------TCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 578999999543 23456676543 233444444 77899999999998 6678899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 98 MAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp CCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred eCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999984 45699999999999999999999999 99999999999999999999999999987543322
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..... ... ...
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~---------~~~-~~~ 238 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM---------LEK-GER 238 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH---------HHT-TCC
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH---------HHc-CCC
Confidence 22234577999999988888999999999999999999 99999754211 01000 000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 133445667899999999999999999 99998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.84 Aligned_cols=223 Identities=18% Similarity=0.207 Sum_probs=180.4
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|.+.. .+|++.+. ++.|+||+++.+.+...+..++||||
T Consensus 195 G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~---------~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE---------KVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHH---------HcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 568999999975 566677876542 23333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++|+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...... .
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 9999999999864556699999999999999999999999 9999999999999999999999999999765332 3
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKK 228 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+..++..
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---------~--~~~~~~p~~ 411 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---------K--EVPEEYSER 411 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---------H--HCCCCCCTT
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---------h--cccccCCcc
Confidence 45688999999999998889999999999999999999999998653322111111110 0 011233445
Q ss_pred HHHHHHHHHHHcccCCCCCCC
Q 044568 229 NLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP 249 (257)
....+.+++.+||+.||.+||
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~ 432 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERL 432 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGST
T ss_pred CCHHHHHHHHHhccCCHHHcC
Confidence 567899999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=262.93 Aligned_cols=228 Identities=16% Similarity=0.218 Sum_probs=170.8
Q ss_pred ccccceeeecccCCC----CCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC-----c
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----V 63 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~ 63 (257)
+.++.||+++..... .+++|.... .+|++.+. ++.|+|++++.+.+...+ .
T Consensus 45 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK---------DFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp -CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHH---------TCCCTTBCCCCEEEEC-------C
T ss_pred cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHh---------cCCCCCeeeeeEEEeeccccCCcc
Confidence 578999999876543 467776542 23333333 788999999999988655 3
Q ss_pred eeEEEeecCCCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 64 SGKIERPVRNGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
.++||||+++|+|.+++... ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 49999999999999999531 446799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~------- 262 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL------- 262 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH-------
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH-------
Confidence 98754322 123345667999999999899999999999999999999 889997542211 00000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... .....+...+..+.+++.+||+.||.+|| +.++++.|
T Consensus 263 ---~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 263 ---LHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp ---HTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ---HcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 000 01123344567899999999999999999 99998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=270.31 Aligned_cols=229 Identities=18% Similarity=0.209 Sum_probs=177.9
Q ss_pred ccccceeeecccCCC------CCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARN------SPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~------~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++....+ .+++|... +.+|++.+. ++ .|+||+++.+.+...+..++
T Consensus 57 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS---------HLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp CSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSCEE
T ss_pred CCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHH---------hhcCCCCeeeEEEEEecCCceEE
Confidence 578899999865543 35666543 234444444 66 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 044568 67 IERPVRNGSLTDIIFCSA------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 134 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 134 (257)
||||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 999999999999997431 35689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHH
Q 044568 135 ILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVY 208 (257)
Q Consensus 135 l~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~ 208 (257)
|+|||++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ......
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~ 281 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---FYKLVK 281 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---HHHHHH
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---HHHHHh
Confidence 99999987432221 22344567999999998889999999999999999998 9999976532221 111100
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 209 KCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
... ....+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 282 ---------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 282 ---------DGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp ---------HTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------cCC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 000 1122333457789999999999999999 99998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=258.18 Aligned_cols=223 Identities=17% Similarity=0.221 Sum_probs=171.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|.... .+|++.+. .+.|+|++++.+.+...+..++||||
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK---------LFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHh---------cCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578899999976 567788886542 23333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--c
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--F 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~ 148 (257)
+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 93 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 93 VSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 999999999974 35689999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred ccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 149 VIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.... ........ .. .....+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~----------~~--~~~~~~~ 232 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKI----------RG--GVFYIPE 232 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----------HH--CCCCCCT
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHh----------hc--CcccCch
Confidence 34567888999999987765 689999999999999999999997541 11111100 00 0012233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.||.+|| ++|+++
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 4456789999999999999999 999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=267.21 Aligned_cols=228 Identities=20% Similarity=0.279 Sum_probs=177.5
Q ss_pred ccccceeeecccCCCC---Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS---PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~---~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+++...++. +++|... +.+|++.+. ++ .|+||+++.+.+...+..++|||
T Consensus 36 G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 36 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC---------KLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHT---------TCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHH---------hccCCCchhhhceeeeeCCceEEEEe
Confidence 5789999999766553 2555443 334444444 66 79999999999999999999999
Q ss_pred ecCCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 044568 70 PVRNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKI 135 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl 135 (257)
|+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999997522 24799999999999999999999999 9999999999999999999999
Q ss_pred eeecccccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 136 LDFGLAKLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 136 ~dfg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
+|||++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~-------- 252 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE-------- 252 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--------
T ss_pred cccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHH--------
Confidence 999998743321 233355678999999988888999999999999999998 999997542110 000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... ....+...+..+.+++.+||+.||.+|| ++|+++.|
T Consensus 253 --~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 253 --KLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp --HGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HhhcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 000000 1123344567899999999999999999 99998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=290.46 Aligned_cols=225 Identities=18% Similarity=0.255 Sum_probs=175.9
Q ss_pred ccccceeeecccC---CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNA---RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~---~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|+.||+|.+.. +..+++|... +.+|++++. +++|+||+++.+++. .+..++|||
T Consensus 380 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~l~~~~~-~~~~~lv~E 449 (635)
T 4fl3_A 380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ---------QLDNPYIVRMIGICE-AESWMLVME 449 (635)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHH---------HCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEe-cCCEEEEEE
Confidence 5789999996543 3456777543 334444454 788999999999886 456889999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
||++|+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 450 ~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 450 MAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred ccCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999999997 456799999999999999999999999 99999999999999999999999999987543321
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... +.. ...
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~---------i~~-~~~ 590 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAM---------LEK-GER 590 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHH---------HHT-TCC
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH---------HHc-CCC
Confidence 22344567999999998899999999999999999998 999997542111 0000 000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+..++..+.+++..||+.||++|| ++++++.|
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 134455678899999999999999999 99998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=269.51 Aligned_cols=248 Identities=18% Similarity=0.137 Sum_probs=183.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeee----ecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK----LTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~----~~~~~~lV~E~ 70 (257)
+.++.||++... ++..+++|... +.+|++.+...... ......|+|++++.+.+. .....++||||
T Consensus 48 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~ 126 (397)
T 1wak_A 48 GHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS-DPNDPNREMVVQLLDDFKISGVNGTHICMVFEV 126 (397)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHS-CTTCGGGGGBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhc-CCCCCCcceeeeeecceeecCCCCceEEEEEec
Confidence 568999999854 45567788654 23555555522111 111234888999999887 55688999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-------------------
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW------------------- 131 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~------------------- 131 (257)
+ +++|.+.+.......+++.++..++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 127 ~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 203 (397)
T 1wak_A 127 L-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203 (397)
T ss_dssp C-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC--------
T ss_pred c-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC
Confidence 9 567777776545577999999999999999999999963 899999999999998765
Q ss_pred ------------------------------ceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHH
Q 044568 132 ------------------------------TAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVL 181 (257)
Q Consensus 132 ------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l 181 (257)
.+||+|||.+...........+|+.|+|||.+.+..++.++|||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 283 (397)
T 1wak_A 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMA 283 (397)
T ss_dssp -------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred CCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHH
Confidence 79999999998766666667889999999999998999999999999999
Q ss_pred HHHHhcCCCCCcCCCChh---hHHHHHHHHHhhh-------hhh-----------------------hhhhhcCCCCCHH
Q 044568 182 LETICCRKNMEIDASKPE---EIILTNWVYKCFI-------NRE-----------------------LNKLVRGTKVDKK 228 (257)
Q Consensus 182 ~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~-------~~~-----------------------~~~~~~~~~~~~~ 228 (257)
|||++|+.||........ ...+......... ... ...+......+..
T Consensus 284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
T 1wak_A 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363 (397)
T ss_dssp HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHH
T ss_pred HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchh
Confidence 999999999976533321 1111111000000 000 0011111234667
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+.+|+.+||+.||++|| ++|+++
T Consensus 364 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 364 EAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 788999999999999999999 999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=261.26 Aligned_cols=231 Identities=16% Similarity=0.209 Sum_probs=171.3
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.. .++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||
T Consensus 43 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK---------QLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 56889999986 456677888654 223444444 78899999999999999999999999
Q ss_pred cCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 71 VRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
+++|+|.+++... ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999999642 356789999999999999999999999 9999999999999999999999999998754332
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ... .......+...
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~---------~~~~~~~~~~~ 259 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LCK---------KIEQCDYPPLP 259 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--HHH---------HHHTTCSCCCC
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--HHH---------HhhcccCCCCc
Confidence 23446788899999999888999999999999999999999999754222111 000 00000001111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....++.+.+++.+||+.||.+|| ++|+++.|
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 234456799999999999999999 99998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.37 Aligned_cols=221 Identities=18% Similarity=0.217 Sum_probs=173.1
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhcccccccc--CCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIR--GGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++...++..+++|.+. +.+|++.+. ++. |+||+++.+++...+..+||||
T Consensus 67 G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~---------~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 67 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN---------KLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp CSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred CCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHH---------HcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 57899999998888888988653 234444444 444 5999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+.+++|.+++.. ...+++.++..++.|++.||.|||++ +|+||||||+||+++ ++.+||+|||++.......
T Consensus 137 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 567899999984 45789999999999999999999999 999999999999996 4789999999987643322
Q ss_pred ---ccccCCCCccCcccccC-----------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 149 ---VIDKRDKGYMAPECYKR-----------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~------------ 276 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K------------ 276 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H------------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--H------------
Confidence 34568999999999865 3688999999999999999999999975421110 0
Q ss_pred hhhhhhcC---CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRG---TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+...+++ ...+......+.+++.+||+.||.+|| +.|+++
T Consensus 277 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111111 122333356789999999999999999 999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=259.96 Aligned_cols=228 Identities=15% Similarity=0.141 Sum_probs=174.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||++... ++..+++|.... ..+.+.+. ... .+.++ .|+||+++.+.+...+..++||||+++|+|
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--e~~-~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 98 (289)
T 1x8b_A 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR--EVY-AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98 (289)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHH--HHH-HHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHH--HHH-HHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcH
Confidence 568899999976 667778876542 11111111 000 12244 799999999999999999999999999999
Q ss_pred HHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------------------CCceEE
Q 044568 77 TDIIFCSA--ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-------------------FWTAKI 135 (257)
Q Consensus 77 ~~~l~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-------------------~~~~kl 135 (257)
.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||+++. ...++|
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl 175 (289)
T 1x8b_A 99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175 (289)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEE
T ss_pred HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEE
Confidence 99997431 26789999999999999999999999 9999999999999984 447999
Q ss_pred eeecccccCCCCcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 136 LDFGLAKLPNEDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 136 ~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
+|||.+...... ....+|+.|+|||.+.+. .++.++||||||+++|++++|..|+... . ..... ..
T Consensus 176 ~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~---~~~~~-----~~- 242 (289)
T 1x8b_A 176 GDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---D---QWHEI-----RQ- 242 (289)
T ss_dssp CCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---H---HHHHH-----HT-
T ss_pred cccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---h---HHHHH-----Hc-
Confidence 999998765443 334688899999999876 5678999999999999999998877533 1 00000 00
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ...+...+..+.+++.+||+.||++|| +.|+++
T Consensus 243 ---~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 243 ---GRL--PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---TCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCC--CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 000 123344567899999999999999999 999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.29 Aligned_cols=225 Identities=12% Similarity=0.094 Sum_probs=175.4
Q ss_pred ccccceeee------cccCCCCCeeeccch------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRS------SFNARNSPWISRVSW------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~------~~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++ ....+..+++|...- ..+.+.+. .+....|+|++.+.+.+...+..+|||||+
T Consensus 76 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~------~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 149 (365)
T 3e7e_A 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME------RLKPSMQHMFMKFYSAHLFQNGSVLVGELY 149 (365)
T ss_dssp CSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHH------HSCGGGGGGBCCEEEEEECSSCEEEEECCC
T ss_pred cCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHH------HhhhhhhhhhhhhheeeecCCCcEEEEecc
Confidence 578999999 466777888887653 33344433 233556999999999999999999999999
Q ss_pred CCCCHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----------CCceEEee
Q 044568 72 RNGSLTDIIFCS---AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----------FWTAKILD 137 (257)
Q Consensus 72 ~~gsL~~~l~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-----------~~~~kl~d 137 (257)
++|+|.+++... ....+++.++..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|
T Consensus 150 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D 226 (365)
T 3e7e_A 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226 (365)
T ss_dssp CSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred CCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEee
Confidence 999999999642 356799999999999999999999999 9999999999999988 89999999
Q ss_pred ecccccCC-----CCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 138 FGLAKLPN-----EDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 138 fg~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
||+++... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------- 293 (365)
T 3e7e_A 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------- 293 (365)
T ss_dssp CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------------
T ss_pred CchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------------
Confidence 99986321 222455789999999999998999999999999999999999999964421110
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC--hHHHHHh
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP--MKCAVMM 256 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~~ 256 (257)
.....+... ...+.+.+++..|++.+|.+|| ++++.+.
T Consensus 294 --~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 294 --KPEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp --EECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred --eechhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 001111111 1245677888899999999997 7766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=273.78 Aligned_cols=240 Identities=16% Similarity=0.144 Sum_probs=182.3
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecC--ceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--VSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lV~E~ 70 (257)
+.++.||++.... +..+++|...- .+|++.+. ++.|+||+++.+.+...+ ..++||||
T Consensus 20 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK---------KLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHH---------hcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 5789999999765 66678886542 24444444 788999999999988765 67999999
Q ss_pred cCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEeeecccccCC
Q 044568 71 VRNGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 71 ~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~dfg~~~~~~ 145 (257)
+++|+|.+++.... ...+++.++..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999997532 23499999999999999999999999 99999999999999 777789999999997654
Q ss_pred CCc--ccccCCCCccCcccccC--------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH-HHHHHHHHhhhhh
Q 044568 146 EDF--VIDKRDKGYMAPECYKR--------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEI-ILTNWVYKCFINR 214 (257)
Q Consensus 146 ~~~--~~~~~~~~~~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 214 (257)
... ....+|+.|+|||.+.. ..++.++||||||+++|||++|+.||.......... ......... ...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-p~~ 246 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK-PSG 246 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC-CTT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC-Ccc
Confidence 332 34568899999999864 456789999999999999999999997543322211 111111100 000
Q ss_pred hh-------------h-hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 215 EL-------------N-KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 215 ~~-------------~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.+ . ..-.....+......+.+++.+||+.||++|| +.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 00 0 01111145577889999999999999999999 9999765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=261.55 Aligned_cols=226 Identities=19% Similarity=0.236 Sum_probs=180.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++.. +++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (304)
T 2jam_A 20 GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK---------KIKHENIVTLEDIYESTTHYYLVMQLVSG 90 (304)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHH---------hCCCCCeeehhhhcccCCEEEEEEEcCCC
Confidence 568899999865 56667777654 345555555 78899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCCC-cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNED-FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~~-~~ 149 (257)
++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||++ +.++.++|+|||.+...... ..
T Consensus 91 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 91 GELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp CBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred ccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 999999973 45689999999999999999999999 99999999999999 77889999999998754332 24
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 228 (257)
...+++.|+|||.+.+..++.++||||+|+++|||++|..||..... ......... .... +......
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~---------~~~~~~~~~~~~ 233 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKE---------GYYEFESPFWDD 233 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH---------CCCCCCTTTTTT
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc---------CCCCCCcccccc
Confidence 45688999999999998999999999999999999999999975421 111111100 0000 1122234
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..+.+++.+||+.||++|| +.|+++
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 557899999999999999999 999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.96 Aligned_cols=237 Identities=18% Similarity=0.161 Sum_probs=181.6
Q ss_pred ccccceeeecccCCCCCeeeccc--------------------------hhhhHHHHhHhhhccccccccCCceeeecee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVR 57 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 57 (257)
+.++.||+++. ++..+++|... +.+|++.+. ++.|+|++++.+.
T Consensus 42 G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~ 111 (348)
T 2pml_X 42 GKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT---------DIKNEYCLTCEGI 111 (348)
T ss_dssp CSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT---------TCCCTTBCCCSEE
T ss_pred CCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH---------hCCCCCcceEEEE
Confidence 57899999999 88888888644 234444444 7889999999999
Q ss_pred eeecCceeEEEeecCCCCHHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCC
Q 044568 58 AKLTSVSGKIERPVRNGSLTDI------IFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 58 ~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~ 130 (257)
+...+..++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ + +++|+||+|+||+++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence 9999999999999999999999 654336789999999999999999999999 8 99999999999999999
Q ss_pred CceEEeeecccccCCC-CcccccCCCCccCcccccCC-CCCc-cccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH
Q 044568 131 WTAKILDFGLAKLPNE-DFVIDKRDKGYMAPECYKRT-PISV-KADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 207 (257)
+.++|+|||.+..... ......++..|+|||.+.+. .++. ++||||||+++|||++|..||......... .....
T Consensus 189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~i~ 266 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL--FNNIR 266 (348)
T ss_dssp SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH--HHHHT
T ss_pred CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHh
Confidence 9999999999875432 33455778889999999877 5665 999999999999999999999865332111 11000
Q ss_pred HHhhhhhh-----hhhhhcC--CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 208 YKCFINRE-----LNKLVRG--TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 208 ~~~~~~~~-----~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+. ....... .......+..+.+++.+||+.||.+|| ++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0000000 001134557899999999999999999 999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.00 Aligned_cols=235 Identities=16% Similarity=0.151 Sum_probs=175.5
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 13 GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK---------DLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHS---------CCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHH---------hcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 678999999976 566677886542 34555555 7889999999999999999999999997
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ..
T Consensus 84 -~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp -EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred -cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 599999976 556799999999999999999999999 9999999999999999999999999998754322 23
Q ss_pred cccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh-----------hhhhhh
Q 044568 150 IDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF-----------INRELN 217 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~ 217 (257)
...+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||....... .......... ......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4467888999999876 568999999999999999999999997652211 1111111000 000000
Q ss_pred hhhcCC-------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT-------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....+. .........+.+++.+||+.||.+|| ++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 01112346788999999999999999 999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=271.99 Aligned_cols=184 Identities=16% Similarity=0.182 Sum_probs=156.0
Q ss_pred ccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++.... +..+++|... +.+|++.+.... ......|+|++.+.+.+...+..++||||+. +
T Consensus 108 G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 183 (429)
T 3kvw_A 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR---KQDKDNTMNVIHMLENFTFRNHICMTFELLS-M 183 (429)
T ss_dssp SSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHH---TTCTTSCSCBCCEEEEEEETTEEEEEECCCC-C
T ss_pred CccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHh---hccccCCcCEEEEEeecccCCeEEEEEeccC-C
Confidence 5789999997654 5667888654 234444444211 1224478899999999999999999999996 6
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--eEEeeecccccCCCCccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT--AKILDFGLAKLPNEDFVIDK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 152 (257)
+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++...........
T Consensus 184 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~ 260 (429)
T 3kvw_A 184 NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260 (429)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSC
T ss_pred CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccC
Confidence 999999875556799999999999999999999999 9999999999999998877 99999999987666666778
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
+|+.|+|||.+.+..++.++|||||||++|||++|..||...
T Consensus 261 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999999999999999999999765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=267.27 Aligned_cols=228 Identities=18% Similarity=0.231 Sum_probs=178.2
Q ss_pred ccccceeeeccc------CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. .+..+++|.... .+|++.+. ++.|+|++++.+.+...+..++|
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK---------EFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGG---------GCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHH---------hcCCCCEeeeEEEEccCCccEEE
Confidence 568899998765 355677776542 23333333 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCSA--------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence 99999999999997421 24678999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
++....... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ....... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~-----~~ 255 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV-----ME 255 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH-----HT
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHHH-----Hc
Confidence 987433221 22344677999999998889999999999999999999 8999975411 1100000 00
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. .....+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 256 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 256 G------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 00123345567799999999999999999 99998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=262.91 Aligned_cols=235 Identities=18% Similarity=0.180 Sum_probs=175.8
Q ss_pred ccccceeeecccC-CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 16 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 16 GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMK---------ELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ---CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHT---------TCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHH---------hcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 5789999998654 5567777653 234444444 7889999999999999999999999998
Q ss_pred CCCHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--
Q 044568 73 NGSLTDIIFCS----AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-- 146 (257)
Q Consensus 73 ~gsL~~~l~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-- 146 (257)
|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 6999998642 235689999999999999999999999 999999999999999999999999999875432
Q ss_pred -CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-----hhhhh-
Q 044568 147 -DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN-----RELNK- 218 (257)
Q Consensus 147 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 218 (257)
......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ............. +....
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhhhhhh
Confidence 22445778999999999764 5899999999999999999999999755221 1111111100000 00000
Q ss_pred -----------------hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 -----------------LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 -----------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+ .........+.+++.+||+.||++|| ++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQP-HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGG-GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcc-cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00112346789999999999999999 999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=274.19 Aligned_cols=233 Identities=16% Similarity=0.136 Sum_probs=179.3
Q ss_pred ccccceeeecc-cCCCCCeeeccc-------hhhhHHHHhHhhhccccccccC-CceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+++. .++..+++|... +.+|++.+. .+.| .++..+..++...+..+|||||+ ++
T Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~---------~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYR---------ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHH---------HTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHH---------HhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 57899999995 556677887533 455666655 4445 44445566667788889999999 89
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCCCc---
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
+|.+++.. ....+++.+++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 88 sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 88 SLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp BHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 99999975 466799999999999999999999999 99999999999999 578899999999987543322
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....+|..|+|||.+.+..++.++||||||+++|||++|+.||...........+..+..... ......+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l~~ 242 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEALCR 242 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHHHHT
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHHHhc
Confidence 255788999999999999999999999999999999999999987644333222222221111 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+..+.+++..||+.+|++|| +.+|+++|
T Consensus 243 ------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 243 ------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp ------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred ------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2346789999999999999999 99998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.91 Aligned_cols=227 Identities=15% Similarity=0.170 Sum_probs=175.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEe
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E 69 (257)
+.++.||+++.. +++.+++|... +.+|++.+. ++.|+|++++.+.+.. .+..++|||
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 17 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR---------ELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH---------hcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 568899999876 45556777654 223444444 7789999999997754 568899999
Q ss_pred ecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCceeeCCCCceEEeeecccc
Q 044568 70 PVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPP-----ILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 70 ~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~-----i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
|+++|+|.+++... ....+++..+..++.|++.||.|||++ + ++|+||+|+||+++.++.+||+|||.+.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999743 345599999999999999999999999 8 9999999999999999999999999987
Q ss_pred cCCCCc---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 143 LPNEDF---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 143 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
...... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i-----~~~----- 231 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI-----REG----- 231 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH-----HHT-----
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH-----hhc-----
Confidence 654332 334678899999999988899999999999999999999999975421 1000000 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
.....+...+..+.+++.+||+.||++|| +.|+++.
T Consensus 232 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 232 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01123344567899999999999999999 9999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=259.27 Aligned_cols=222 Identities=17% Similarity=0.169 Sum_probs=178.3
Q ss_pred ccccceeeecccCCCC-Ceeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNS-PWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...++. +++|... +.+|++.+. .+.|+||+++.+.+...+..++||||
T Consensus 26 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR---------SLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHH---------hCCCCCEeeeeeeeccCCEEEEEEec
Confidence 5788999999776554 4555432 123333333 77899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---C
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---D 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~ 147 (257)
+++++|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 97 ~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 97 CRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp CTTCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999987 345799999999999999999999999 999999999999999999999999999875432 2
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 226 (257)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... ... .... ....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~-------------~~~~~~~~~~ 235 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL-------------RIKKNEYSIP 235 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH-------------HHHTTCCCCC
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHhhccCCCc
Confidence 344567889999999998889999999999999999999999997542111 000 0111 11233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......+.+++.+||+.||++|| ++|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 44557789999999999999999 999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.59 Aligned_cols=229 Identities=17% Similarity=0.155 Sum_probs=179.5
Q ss_pred ccccceeeecccCC-CCCeeeccchhh-----hHHHHhHhhhcccccc-ccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVSWTA-----DIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++...+ +.+++|.+.-.. ..+.... ... .+.. ..|++|+.+...+...+..+|||||+++|+|
T Consensus 352 G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~-E~~-~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L 429 (674)
T 3pfq_A 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-EKR-VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429 (674)
T ss_dssp TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHH-HHH-HHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHH-HHH-HHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcH
Confidence 57899999997654 457888755211 1111100 000 1112 2699999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCcccccC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVIDKR 153 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~~~~ 153 (257)
.+++.. ...+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++... .......|
T Consensus 430 ~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~G 504 (674)
T 3pfq_A 430 MYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 504 (674)
T ss_dssp HHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCS
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccC
Confidence 999984 45799999999999999999999999 99999999999999999999999999987532 23345678
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHHH
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLEN 232 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
|+.|+|||++.+..++.++||||||+++|||++|..||..... .... ..+.. ...++....+.
T Consensus 505 T~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~-------------~~i~~~~~~~p~~~s~~ 568 (674)
T 3pfq_A 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF-------------QSIMEHNVAYPKSMSKE 568 (674)
T ss_dssp CSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH-------------HHHHSSCCCCCTTSCHH
T ss_pred CCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHH-------------HHHHhCCCCCCccCCHH
Confidence 9999999999999999999999999999999999999975521 1111 11112 12445566788
Q ss_pred HHHHHHHcccCCCCCCC-h-----HHHHH
Q 044568 233 LVKVGLWCVQDEPALRP-M-----KCAVM 255 (257)
Q Consensus 233 l~~l~~~cl~~~p~~RP-~-----~ei~~ 255 (257)
+.+|+.+||+.||++|| + +||.+
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 99999999999999999 8 66653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=261.74 Aligned_cols=226 Identities=18% Similarity=0.176 Sum_probs=179.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++|+
T Consensus 40 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 40 GSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQ---------QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp ---CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHH---------TCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred CCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHH---------hCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 5688999998765 5667787654 344555555 7889999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---ccccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDK 152 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~ 152 (257)
|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 111 L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 186 (314)
T 3com_A 111 VSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186 (314)
T ss_dssp HHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccC
Confidence 9999964 456799999999999999999999999 9999999999999999999999999998754332 23446
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHHHH
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKNLE 231 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (257)
+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .. .. ...... ....+...+.
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~--~~--------~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI--FM--------IPTNPPPTFRKPELWSD 253 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH--HH--------HHHSCCCCCSSGGGSCH
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH--HH--------HhcCCCcccCCcccCCH
Confidence 7888999999998889999999999999999999999997542110 00 00 000001 1122333457
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.||.+|| +.|+++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHHh
Confidence 899999999999999999 999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=267.58 Aligned_cols=226 Identities=16% Similarity=0.180 Sum_probs=176.2
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 64 (257)
+.++.||++... +++.+++|.... .+|++.+. ++ .|+||+++.+.+...+..
T Consensus 105 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR---------QVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHH---------HHTTCTTBCCEEEEEEBSSEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHH---------HhcCCCCEeEEEEEEeeCCEE
Confidence 568999999976 677888885432 22333332 55 699999999999999999
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 176 ~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999973 45799999999999999999999999 9999999999999999999999999988754
Q ss_pred CC--CcccccCCCCccCcccccC------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhh
Q 044568 145 NE--DFVIDKRDKGYMAPECYKR------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINREL 216 (257)
Q Consensus 145 ~~--~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (257)
.. ......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||.... .......... ..
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~-----~~- 321 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMIME-----GQ- 321 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH-----TC-
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh-----CC-
Confidence 43 2345578899999999863 357889999999999999999999997541 1111111100 00
Q ss_pred hhhhcCC-CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 217 NKLVRGT-KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 217 ~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... ......+..+.+++.+||+.||++|| +.|+++
T Consensus 322 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 ---YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 00012345689999999999999999 999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=264.44 Aligned_cols=229 Identities=18% Similarity=0.199 Sum_probs=177.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++.... +..+++|... +.+|++.+. .+ .|+|++++.+.+...+..++||||
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~---------~l~~~~~iv~~~~~~~~~~~~~lv~e~ 110 (327)
T 3lm5_A 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE---------LAKSCPRVINLHEVYENTSEIILILEY 110 (327)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHH---------HTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHH---------hccCCCCEEEEEEEEEeCCeEEEEEEe
Confidence 5789999998664 6666777543 233444443 34 469999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCC
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNED 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~ 147 (257)
+++|+|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++......
T Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp CTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999754567899999999999999999999999 9999999999999987 789999999998765433
Q ss_pred c--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 F--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
. ....+|+.|+|||.+.+..++.++||||||+++|||++|..||....... ........ ....+...
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~--------~~~~~~~~ 256 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNISQV--------NVDYSEET 256 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHT--------CCCCCTTT
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHhc--------ccccCchh
Confidence 2 34578899999999998999999999999999999999999997542111 11110000 00001122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+.+++.+||+.||.+|| ++|+++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 334557789999999999999999 999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=259.52 Aligned_cols=223 Identities=22% Similarity=0.238 Sum_probs=178.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||++... ++..+++|.... .+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 33 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 33 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS---------QCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHH---------hCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 578999999854 456677876532 33444443 7789999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+++|.+++. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 104 ~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 104 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp TEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 999999995 45799999999999999999999999 9999999999999999999999999998754332 23
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ... .. ... ......+...
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~-~~---------~~~-~~~~~~~~~~ 243 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVL-FL---------IPK-NNPPTLEGNY 243 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH-HH---------HHH-SCCCCCCSSC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHH-HH---------hhc-CCCCCCcccc
Confidence 446788899999999888999999999999999999999999744111 000 00 000 0111223344
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+..+.+++.+||+.||++|| +.|+++
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 56799999999999999999 999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=274.90 Aligned_cols=232 Identities=16% Similarity=0.135 Sum_probs=177.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhh---HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTAD---IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||+++.. ++..+++|...-... -...........+..++|+||+++.+.+...+..++||||+++|+|.++
T Consensus 159 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~ 238 (446)
T 4ejn_A 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 238 (446)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHH
T ss_pred CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHH
Confidence 578999999854 456678886542110 0011111111144488899999999999999999999999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccCCC
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKRDK 155 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~ 155 (257)
+. ....+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++.... ......||+
T Consensus 239 l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~ 313 (446)
T 4ejn_A 239 LS--RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313 (446)
T ss_dssp HH--HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCG
T ss_pred HH--hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCc
Confidence 97 34679999999999999999999998 8 999999999999999999999999999875322 234557899
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ......++....+.+.+
T Consensus 314 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i------------~~~~~~~p~~~~~~~~~ 378 (446)
T 4ejn_A 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI------------LMEEIRFPRTLGPEAKS 378 (446)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HHCCCCCCTTSCHHHHH
T ss_pred cccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHH------------HhCCCCCCccCCHHHHH
Confidence 99999999999999999999999999999999999975421 1111100 01112334455678999
Q ss_pred HHHHcccCCCCCCC------hHHHHH
Q 044568 236 VGLWCVQDEPALRP------MKCAVM 255 (257)
Q Consensus 236 l~~~cl~~~p~~RP------~~ei~~ 255 (257)
++.+||+.||.+|| ++|+++
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999996 556553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=271.51 Aligned_cols=227 Identities=17% Similarity=0.179 Sum_probs=169.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+||+++.+.+. .+..+
T Consensus 146 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~l~~~~~-~~~~~ 215 (419)
T 3i6u_A 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK---------KLNHPCIIKIKNFFD-AEDYY 215 (419)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHH---------HCCCTTBCCCCEEEE-SSEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHH---------hCCCCCEeeEEEEEe-cCceE
Confidence 5789999998655 4566776532 345666666 789999999999875 45578
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccc
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAK 142 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~ 142 (257)
+||||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++||||||+||+++.+ ..+||+|||+++
T Consensus 216 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 216 IVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999999997 556799999999999999999999999 99999999999999654 459999999998
Q ss_pred cCCCCc--ccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 143 LPNEDF--VIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 143 ~~~~~~--~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
...... ....+|+.|+|||.+.. ..++.++||||||+++|+|++|..||.......... ..... ....
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~---~~i~~----~~~~ 363 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITS----GKYN 363 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH---HHHHT----TCCC
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH---HHHhc----CCCC
Confidence 654332 44578999999999863 567899999999999999999999997543222110 00000 0000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... .......+.+.+++.+||+.||++|| ++|+++
T Consensus 364 -~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 364 -FIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -CCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCc--hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00112346789999999999999999 999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=259.13 Aligned_cols=227 Identities=17% Similarity=0.215 Sum_probs=176.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. +++.+++|... +.+|++.+. ++.|+|++++.+.+...+..++|
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR---------EIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHH---------hCCCCCeeehhheecCCCeEEEE
Confidence 568899999976 46666776432 345555555 78899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~dfg~~~~ 143 (257)
|||+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 87 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 87 LELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999973 45799999999999999999999999 999999999999998876 799999999875
Q ss_pred CCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~---~~----- 230 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNY---DF----- 230 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCC---CC-----
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhccc---CC-----
Confidence 4332 2344678889999999988899999999999999999999999975421 111111100000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........++.+.+++.+||+.||.+|| +.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000112346789999999999999999 999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=263.27 Aligned_cols=237 Identities=16% Similarity=0.110 Sum_probs=172.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhcccccc-ccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++.. ++..+++|... +.+|++.+. + ..|+||+++.+.+...+..++||||++
T Consensus 24 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (316)
T 2ac3_A 24 GAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY---------QCQGHRNVLELIEFFEEEDRFYLVFEKMR 94 (316)
T ss_dssp CSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHH---------HTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHH---------HhcCCCCeeeEEEEEeeCCEEEEEEEcCC
Confidence 467899999854 56677887653 234444443 4 469999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEeeecccccCCCC--
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLAKLPNED-- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~~~~~~~-- 147 (257)
+|+|.+++.. ...+++.++..++.|++.||.|||++ +++||||||+||+++.++. +||+|||++......
T Consensus 95 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 95 GGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp TCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999999974 45789999999999999999999999 9999999999999987765 999999988643211
Q ss_pred --------cccccCCCCccCcccccC-----CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 148 --------FVIDKRDKGYMAPECYKR-----TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 148 --------~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
.....+|+.|+|||.+.. ..++.++||||||+++|||++|..||.............. ........
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE-ACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc-cchhHHHH
Confidence 123458889999999875 4578899999999999999999999976533220000000 00000000
Q ss_pred hhhhhhcCC-CCCH----HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRGT-KVDK----KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~~-~~~~----~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......... ..+. ..+..+.+++.+||+.||.+|| ++|+++
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 001111111 1221 2346789999999999999999 999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.33 Aligned_cols=223 Identities=17% Similarity=0.153 Sum_probs=178.3
Q ss_pred ccccceeeecccCCCC-Ceeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNS-PWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++...++. +++|... +.+|++.+. .+.|+||+++.+.+...+..++||||
T Consensus 52 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR---------SLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEecCCeEEEEEec
Confidence 5788999999776554 4565432 123333333 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---C
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---D 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~ 147 (257)
+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++..... .
T Consensus 123 ~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 123 CRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 999999999873 46799999999999999999999999 999999999999999999999999999875432 2
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...... . .....+.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~-----~-------~~~~~~~ 262 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIK-----K-------NEYSIPK 262 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH-----H-------TCCCCCT
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHh-----c-------CCCCCCc
Confidence 244567889999999998889999999999999999999999997542111 110000 0 0112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+++.+||+.||++|| ++|+++
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4456788999999999999999 999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.45 Aligned_cols=228 Identities=16% Similarity=0.138 Sum_probs=170.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++... ++..+++|.... .+|++.+ .++.|+||+++.+.+...+..++||||
T Consensus 45 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l---------~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTA---------GRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHH---------TTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHH---------hhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 578999999965 455677776542 2233333 378899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++.......
T Consensus 116 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 116 INGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999999974 45699999999999999999999999 99999999999999999999999999987543322
Q ss_pred --ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 --VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 --~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ....... .........+
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~-~~~~~~~--------~~~~~~~~~~ 258 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LS-VMGAHIN--------QAIPRPSTVR 258 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HH-HHHHHHH--------SCCCCGGGTS
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HH-HHHHHhc--------cCCCCccccC
Confidence 34467888999999998889999999999999999999999997541 11 1100000 0000011223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC--hHHHHHhC
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP--MKCAVMML 257 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~~L 257 (257)
...+..+.+++.+||+.||++|| ++++++.|
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHH
Confidence 34456789999999999999999 88887653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=268.20 Aligned_cols=237 Identities=20% Similarity=0.184 Sum_probs=177.0
Q ss_pred ccccceeeecccCCCCCeeeccchh------hhHHHHhHhhhccccccccCCceeeeceeeeecC----ceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWT------ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS----VSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----~~~lV~E~~~~ 73 (257)
+.++.||+++. ++..+++|...-. +|.+.+. ...++|+|++++.+.+...+ ..++||||+++
T Consensus 53 G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~-------~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~ 124 (342)
T 1b6c_B 53 GRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQ-------TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124 (342)
T ss_dssp ETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHH-------HSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTT
T ss_pred CCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHH-------HhhcCCCcEEEEEeeecccCCccceeEEEEeecCC
Confidence 56889999997 4777888876532 2222222 11378999999999998776 78999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLH--------DECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
|+|.+++.. ..+++.++..++.|++.||.||| ++ +++|+||||+||+++.++.+||+|||++....
T Consensus 125 g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 198 (342)
T 1b6c_B 125 GSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198 (342)
T ss_dssp CBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence 999999964 46899999999999999999999 88 99999999999999999999999999986533
Q ss_pred CC-------cccccCCCCccCcccccCCC------CCccccchhHHHHHHHHHhc----------CCCCCcCCCChhhHH
Q 044568 146 ED-------FVIDKRDKGYMAPECYKRTP------ISVKADVYGYGIVLLETICC----------RKNMEIDASKPEEII 202 (257)
Q Consensus 146 ~~-------~~~~~~~~~~~aPE~~~~~~------~~~~~Di~s~G~~l~el~~g----------~~pf~~~~~~~~~~~ 202 (257)
.. .....+|+.|+|||.+.+.. ++.++||||||+++|||++| ..||..........
T Consensus 199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~- 277 (342)
T 1b6c_B 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 277 (342)
T ss_dssp TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-
T ss_pred ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH-
Confidence 22 13446788999999997652 33789999999999999999 77886543222111
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 203 LTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+... .........+.....+.+....+.+++.+||+.||++|| +.|+++.|
T Consensus 278 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 278 -EEMRKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp -HHHHHH-HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHH-HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 111100 000000000000012346678899999999999999999 99998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=257.68 Aligned_cols=227 Identities=19% Similarity=0.221 Sum_probs=172.1
Q ss_pred ccccceeeecccC-CCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||++
T Consensus 33 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~---------~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 33 GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK---------SLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred CCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHH---------hCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 5789999998654 5556666543 234555555 7889999999999999999999999999
Q ss_pred CCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCCC
Q 044568 73 NGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 73 ~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~~ 147 (257)
+|+|.+.+... ....+++..+..++.|++.||.|||++ +++|+||+|+||++ +.++.+||+|||++......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999642 346799999999999999999999999 99999999999999 45678999999998754322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
.....+++.|+|||.+. ..++.++||||||+++|||++|..||...... . ..... .. ........
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~-~~~~~--------~~-~~~~~~~~ 247 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--E-VQQKA--------TY-KEPNYAVE 247 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHHH--------HH-CCCCCCC-
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--H-HHhhh--------cc-CCcccccc
Confidence 34556788999999875 46889999999999999999999999754211 0 00000 00 00000011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.+.+++.+||+.||++|| ++|+++
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111346788999999999999999 999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=264.11 Aligned_cols=238 Identities=18% Similarity=0.199 Sum_probs=176.1
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK---------QLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHh---------hCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 5789999999765 5667777542 223444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---c
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~ 148 (257)
++++|.+++. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...... .
T Consensus 107 ~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 107 DHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp SEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 9999998876 556799999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH-------HHhhh-hhhhhhh
Q 044568 149 VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV-------YKCFI-NRELNKL 219 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~ 219 (257)
....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||................ ...+. .+.....
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 445678899999999875 68999999999999999999999997653221111110000 00000 0000000
Q ss_pred hcCC--------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGT--------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+. ......++.+.+++.+||+.||++|| ++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00113457899999999999999999 999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.77 Aligned_cols=229 Identities=15% Similarity=0.099 Sum_probs=171.6
Q ss_pred ccccceeeecccCCC-CCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARN-SPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||++.....+ .+++|... +.+|++.+. ++.|+||+++.+.+...+..++||
T Consensus 37 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK---------KLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHH---------hCCCCCcceeehhhccCCeEEEEE
Confidence 578999999875544 45777543 334555555 778999999999999999999999
Q ss_pred eecCCCCHHHHHhcc--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 044568 69 RPVRNGSLTDIIFCS--------------------------------------AERNPYWNQRVRIALDVAKGILYLHDE 110 (257)
Q Consensus 69 E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~ 110 (257)
||+++|+|.+++... ....+++..+..++.|++.||.|||++
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999999521 012235677888999999999999999
Q ss_pred CCCCeeeccCCCCceeeCCCC--ceEEeeecccccCCC-------CcccccCCCCccCcccccC--CCCCccccchhHHH
Q 044568 111 CEPPILHCDIKPQNILMDEFW--TAKILDFGLAKLPNE-------DFVIDKRDKGYMAPECYKR--TPISVKADVYGYGI 179 (257)
Q Consensus 111 ~~~~i~h~dl~~~nil~~~~~--~~kl~dfg~~~~~~~-------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~ 179 (257)
+++||||+|+||+++.++ .+||+|||++..... ......+|+.|+|||.+.+ ..++.++||||||+
T Consensus 188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999998766 899999999874321 1245578889999999875 56889999999999
Q ss_pred HHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 180 VLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 180 ~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++|||++|+.||....... ........ .............+.+.+++.+||+.||.+|| +.|+++
T Consensus 265 il~el~~g~~pf~~~~~~~---~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDAD---TISQVLNK--------KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHH---HHHHHHHC--------CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHH---HHHHHHhc--------ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999997552111 11111000 00000011122457789999999999999999 999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.19 Aligned_cols=231 Identities=6% Similarity=-0.074 Sum_probs=162.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeecee-------eeec--
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVR-------AKLT-- 61 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~-------~~~~-- 61 (257)
+.++.||+++.. ++..+++|.... .+|++.+. .+.+ .|+|++++... +...
T Consensus 73 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~------~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA------RLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHH------HHHC-----------CBCCCCEEEEETTS
T ss_pred CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHH------Hhcc-cChhhhhhceeEEeeehheecCCC
Confidence 578999999965 566778887553 12222222 2335 79998775432 2222
Q ss_pred ---------------CceeEEEeecCCCCHHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCeeeccC
Q 044568 62 ---------------SVSGKIERPVRNGSLTDIIFCSAERNPYWNQR------VRIALDVAKGILYLHDECEPPILHCDI 120 (257)
Q Consensus 62 ---------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~~~~~i~~~l~~lh~~~~~~i~h~dl 120 (257)
...+|||||++ |+|.+++... ...+++..+ ..++.|++.||.|||++ +|+||||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDi 220 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHF 220 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcC
Confidence 34799999998 8999999752 333454555 67779999999999999 9999999
Q ss_pred CCCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCCCcCCCCh
Q 044568 121 KPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNMEIDASKP 198 (257)
Q Consensus 121 ~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~ 198 (257)
||+|||++.++.+||+|||+++..........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 999999999999999999999877665546677799999999987 678999999999999999999999998663221
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 199 EEIILTNWVYKCFINRELNKLVRGT---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... +............ ......++.+.+++.+||+.||++|| +.|+++
T Consensus 301 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 301 KGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100 0000000000000 11224567899999999999999999 999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=268.57 Aligned_cols=236 Identities=19% Similarity=0.255 Sum_probs=178.7
Q ss_pred ccccceeeecc-----cCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC--ceeEE
Q 044568 4 TKLSNFYRSSF-----NARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS--VSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~-----~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lV 67 (257)
+.++.||++++ .++..+++|... +.+|++.+. ++.|+|++++.+.+...+ ..++|
T Consensus 52 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK---------SLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp CSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECC----CCEEE
T ss_pred CCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHH---------hCCCCCeeeEEEEEEecCCCceEEE
Confidence 57889999984 356667777654 334555554 788999999999877544 78999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++......
T Consensus 123 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp ECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999999986 456799999999999999999999999 9999999999999999999999999998765433
Q ss_pred c------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH----hhhhhhhh
Q 044568 148 F------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK----CFINRELN 217 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~ 217 (257)
. ....++..|+|||.+.+..++.++||||||+++|||++|..||..... . ....... ......+.
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---E--FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---H--HHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---H--HHHhhccccchhhhHHHHH
Confidence 2 223445669999999888889999999999999999999999863310 0 0000000 00000111
Q ss_pred hhhcC---CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 218 KLVRG---TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 218 ~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.. ...+...+..+.+++.+||+.||++|| +.|+++.|
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111 123455667899999999999999999 99998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.30 Aligned_cols=245 Identities=15% Similarity=0.155 Sum_probs=178.7
Q ss_pred ccccceeeecccCCC--CCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNARN--SPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~--~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||++.....+ .+++|... +.+|++.+...... ....+.+++.+...+...+..++||||+ +
T Consensus 30 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~---~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~ 105 (355)
T 2eu9_A 30 GTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK---DKENKFLCVLMSDWFNFHGHMCIAFELL-G 105 (355)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHH---CTTSCSCBCCEEEEEEETTEEEEEEECC-C
T ss_pred cCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhc---CCCCceeEEEeeeeeeeCCeEEEEEecc-C
Confidence 568899999865543 57777654 23444444411111 1223344788888888999999999999 6
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee-------------------CCCCceE
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-------------------DEFWTAK 134 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-------------------~~~~~~k 134 (257)
++|.+.+.......+++.++..++.|++.||.|||++ +++||||||+||++ +.++.+|
T Consensus 106 ~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~k 182 (355)
T 2eu9_A 106 KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182 (355)
T ss_dssp CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEE
T ss_pred CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEE
Confidence 6888888754556799999999999999999999999 99999999999999 5678999
Q ss_pred EeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----
Q 044568 135 ILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC---- 210 (257)
Q Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 210 (257)
|+|||++...........+|+.|+|||.+.+..++.++||||||+++|||++|..||.................+.
T Consensus 183 l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 262 (355)
T 2eu9_A 183 VADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262 (355)
T ss_dssp ECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred EeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHH
Confidence 9999999876666666788999999999999899999999999999999999999997552211111111100000
Q ss_pred -------------------------hhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 -------------------------FINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 -------------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........+.............+.+++.+||+.||.+|| ++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000001122334456899999999999999999 999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=266.04 Aligned_cols=233 Identities=15% Similarity=0.141 Sum_probs=176.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+||+++.+.+...+ ..+
T Consensus 36 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 36 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK---------HMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH---------HCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH---------hCCCcCCCCceeeEecCCccccCceEE
Confidence 568899999864 56678888763 123444444 788999999999988653 459
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999999 7899999964 5699999999999999999999999 99999999999999999999999999998776
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----------hhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC----------FINR 214 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~ 214 (257)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .+....... ....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhhhH
Confidence 66666788999999999887 678999999999999999999999997652211 111111100 0000
Q ss_pred hhhhhh---cC---C---CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLV---RG---T---KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~---~~---~---~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+ .. . .......+.+.+++.+||+.||.+|| ++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 001100 00 0 11223457789999999999999999 999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=275.21 Aligned_cols=226 Identities=19% Similarity=0.204 Sum_probs=177.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|.+. +.+|++.+. ++.|+||+++.+.+...+..++||||+
T Consensus 33 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK---------KLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHH---------hCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 678999999975 56667887653 234555555 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEeeecccccCCCC-
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~dfg~~~~~~~~- 147 (257)
++|+|.+.+.. ...+++.++..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++......
T Consensus 104 ~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 104 TGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999999973 46799999999999999999999999 999999999999995 4567999999998754332
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....+|+.|+|||.+.+ .++.++||||+|+++|+|++|..||..... ......... .. .....+..
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~-----~~---~~~~~~~~ 246 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVET-----GK---YAFDLPQW 246 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----TC---CCSCSGGG
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh-----CC---CCCCCccc
Confidence 245578999999999875 589999999999999999999999975521 111111110 00 00000112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| +.|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23456789999999999999999 999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=257.40 Aligned_cols=228 Identities=17% Similarity=0.196 Sum_probs=177.7
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++... +..+++|... +.+|++.+. .+.|+|++++.+.+...+..++||||+++
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 33 GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK---------HLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHH---------TCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHH---------hCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 5689999999644 4556777543 234555554 77899999999999999999999999999
Q ss_pred CCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCCCC---c
Q 044568 74 GSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPNED---F 148 (257)
Q Consensus 74 gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~~~---~ 148 (257)
++|.+++... ....+++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.++|+|||.+...... .
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9999999753 234567888999999999999999999 9999999999999987 889999999998754322 2
Q ss_pred ccccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 149 VIDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.......... +. ..........+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~--------~~~~~~~~~~~ 248 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----FK--------VGMFKVHPEIP 248 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH----HH--------HHHHCCCCCCC
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH----Hh--------hcccccccccc
Confidence 3446788899999987643 7899999999999999999999997442211100 00 00001111334
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.||++|| +.|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 45567899999999999999999 999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=263.92 Aligned_cols=228 Identities=16% Similarity=0.208 Sum_probs=175.4
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 41 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS---------KFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp -CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHh---------hCCCCCCCeEEEEEcCCCCcEEE
Confidence 578999999853 34467888753 223333333 77899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCSAE-----RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~dfg 139 (257)
|||+++|+|.+++..... ..+++.++..++.|++.||.|||++ +++|+||+|+||+++ .+..++|+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999985322 4589999999999999999999999 999999999999998 44569999999
Q ss_pred ccccCCC-----CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNE-----DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
++..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~------ 258 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFV------ 258 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHH------
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHHH------
Confidence 8863211 1233456778999999988889999999999999999998 99999754111 010000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ......+...+..+.+++.+||+.||.+|| +.|+++.|
T Consensus 259 ---~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 259 ---TS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp ---HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---hc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 00 001123344567899999999999999999 99998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=265.31 Aligned_cols=221 Identities=16% Similarity=0.127 Sum_probs=174.6
Q ss_pred ccccceeeecc----cCCCCCeeeccc-------------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSF----NARNSPWISRVS-------------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~----~~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||+++. .++..+++|.+. +.+|++++. ++ .|+||+++.+.+...+..+
T Consensus 65 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE---------HIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHH---------HHHTCTTBCCEEEEEEETTEEE
T ss_pred CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHH---------HccCCCceeEEEEEEeeCceEE
Confidence 57899999987 366777777542 345566555 55 4999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+++|+|.+++.. ...+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999974 45799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCc----ccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 146 EDF----VIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 146 ~~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
... ....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||...........+... . .
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------~--~ 279 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---------I--L 279 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------H--H
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH---------H--h
Confidence 222 334689999999999853 4789999999999999999999999755332221111110 0 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
......+......+.+++.+||+.||.+||
T Consensus 280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 309 (355)
T 1vzo_A 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRL 309 (355)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred ccCCCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence 111234455567889999999999999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.66 Aligned_cols=238 Identities=19% Similarity=0.204 Sum_probs=176.5
Q ss_pred ccccceeeecccC-CCCCeeeccch----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... +..+++|.... .+|++.+ .++.|+||+++.+.+...+..++||||++
T Consensus 44 G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l---------~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 44 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL---------HECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGG---------GGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHH---------HHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 6789999999774 45566665432 2333333 37889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCC-CCccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN-EDFVI 150 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~-~~~~~ 150 (257)
+|+|.+++.. ...+++..+..++.|++.||.|||+ + +++|+||||+||+++.++.++|+|||++.... .....
T Consensus 115 ~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 115 GGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp TCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 9999999974 4568999999999999999999998 5 89999999999999999999999999876322 22234
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHH----------------------HHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTN----------------------WVY 208 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~----------------------~~~ 208 (257)
..+|+.|+|||.+.+..++.++||||||+++|||++|+.||.............. +..
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 5788999999999999999999999999999999999999975421111000000 000
Q ss_pred Hh----hhhhhhhhhhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 209 KC----FINRELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 209 ~~----~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ........... +..........+.+++.+||+.||++|| ++|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 00000011111 1111223456799999999999999999 999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.38 Aligned_cols=238 Identities=14% Similarity=0.112 Sum_probs=158.0
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||++... ++..+++|...-.......... ......|+|++++.+.+.. ....++||||+++|+|.+
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~----~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~ 115 (336)
T 3fhr_A 40 GVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDH----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS 115 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHH----HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHH----HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHH
Confidence 568999999976 5667788876432111110001 1225679999999999886 455899999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCC-cccccCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNED-FVIDKRD 154 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~-~~~~~~~ 154 (257)
++.......+++.++..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++...... .....+|
T Consensus 116 ~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t 192 (336)
T 3fhr_A 116 RIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192 (336)
T ss_dssp HHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCC
Confidence 99865556799999999999999999999999 9999999999999976 455999999998754332 2455678
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+.|+|||.+....++.++||||||+++|+|++|..||.............. ... ......+.......+..+.
T Consensus 193 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~~ 265 (336)
T 3fhr_A 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----RIR---LGQYGFPNPEWSEVSEDAK 265 (336)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTTSTTCCHHHH
T ss_pred cCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----hhh---ccccccCchhhccCCHHHH
Confidence 899999999888889999999999999999999999975532211000000 000 0000001111234567789
Q ss_pred HHHHHcccCCCCCCC-hHHHHH
Q 044568 235 KVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+++.+||+.||++|| ++|+++
T Consensus 266 ~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 266 QLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999 999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=262.24 Aligned_cols=225 Identities=20% Similarity=0.270 Sum_probs=173.1
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.++.||+++... .+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||++
T Consensus 44 G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 44 GRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYR---------QTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp SSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGT---------TCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred CCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHh---------cCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 5788999998754 46666543 334555554 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC-------
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN------- 145 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~------- 145 (257)
+++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++ ++.++|+|||++....
T Consensus 113 ~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 113 GRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp SEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999975 455799999999999999999999999 999999999999998 5699999999876432
Q ss_pred -CCcccccCCCCccCcccccC---------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 146 -EDFVIDKRDKGYMAPECYKR---------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 146 -~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
.......+++.|+|||.+.. ..++.++||||||+++|||++|..||..... ......
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~---------- 254 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQ---------- 254 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHH----------
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----------
Confidence 11233457788999999864 3578899999999999999999999975421 111100
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......+.......+..+.+++.+||+.||++|| +.|+++.|
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 0111111111223446789999999999999999 99998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=262.81 Aligned_cols=229 Identities=19% Similarity=0.207 Sum_probs=175.6
Q ss_pred ccccceeeecc------cCCCCCeeeccch----------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecC-cee
Q 044568 4 TKLSNFYRSSF------NARNSPWISRVSW----------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTS-VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~------~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~-~~~ 65 (257)
+.++.||+++. .++..+++|.... .+|++.+. ++ .|+|++++.+.+...+ ..+
T Consensus 38 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI---------HIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECCTTSCCE
T ss_pred CCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHH---------hcccCCCeeeEEEEEecCCCceE
Confidence 56889999974 3445567776432 23343333 55 5899999999987754 589
Q ss_pred EEEeecCCCCHHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 044568 66 KIERPVRNGSLTDIIFCSAE--------------RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~ 131 (257)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 99999999999999985321 1288999999999999999999999 999999999999999999
Q ss_pred ceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHH
Q 044568 132 TAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTN 205 (257)
Q Consensus 132 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~ 205 (257)
.+||+|||++....... ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||......... ...
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--~~~ 263 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR 263 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--HHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--HHH
Confidence 99999999987543221 23355678999999998889999999999999999998 99999765322211 000
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 206 WVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
. ... .....+....+.+.+++.+||+.||.+|| +.|+++.|
T Consensus 264 ~----------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 264 L----------KEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp H----------HHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred h----------ccC-ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0 000 01122334557799999999999999999 99998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=276.29 Aligned_cols=226 Identities=19% Similarity=0.180 Sum_probs=179.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||
T Consensus 37 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK---------QLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 568899999976 56667787642 234555555 78899999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEeeecccccCCC-
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEFWTAKILDFGLAKLPNE- 146 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~---~~~~~~kl~dfg~~~~~~~- 146 (257)
+.+|+|.+.+. ....+++.++..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++.....
T Consensus 108 ~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 108 YTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred CCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999997 556799999999999999999999999 99999999999999 5678999999999875433
Q ss_pred -CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 147 -DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 147 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
......+|+.|+|||.+.+ .++.++||||+|+++|+|++|..||..... ......... .. ...+.+.
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~-----~~---~~~~~~~ 250 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEK-----GK---YTFELPQ 250 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----CC---CCCCSGG
T ss_pred cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc-----CC---CCCCCcc
Confidence 2345678999999999876 689999999999999999999999975521 111111100 00 0000011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....++.+.+++.+||+.||.+|| +.|+++
T Consensus 251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 233457789999999999999999 999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=271.13 Aligned_cols=233 Identities=18% Similarity=0.166 Sum_probs=167.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc--h---------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecC--ceeEEE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS--W---------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTS--VSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~--~---------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~--~~~lV~ 68 (257)
+.++.||++.. .+++.+++|.+. + .+|++.+. ++. |+||+++.+.+...+ ..++||
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~---------~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 20 GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT---------ELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp ----CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHH---------HTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHH---------hccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 57899999985 456667888652 1 22333333 565 999999999987544 689999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC--
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-- 146 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-- 146 (257)
|||+ |+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 91 DYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp ECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred cccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9997 699999964 4789999999999999999999999 999999999999999999999999999875322
Q ss_pred ----------------------CcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHH
Q 044568 147 ----------------------DFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203 (257)
Q Consensus 147 ----------------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~ 203 (257)
......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~ 240 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN---QL 240 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 1133468888999999986 568999999999999999999999997652211 11
Q ss_pred HHHHHHhhhhh--hh---------------------------------hhhhcCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 044568 204 TNWVYKCFINR--EL---------------------------------NKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248 (257)
Q Consensus 204 ~~~~~~~~~~~--~~---------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 248 (257)
........... .+ ..............+.+.+|+.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 11110000000 00 00000000011234678999999999999999
Q ss_pred C-hHHHHH
Q 044568 249 P-MKCAVM 255 (257)
Q Consensus 249 P-~~ei~~ 255 (257)
| ++|+++
T Consensus 321 ~t~~e~l~ 328 (388)
T 3oz6_A 321 ISANDALK 328 (388)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhC
Confidence 9 999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.31 Aligned_cols=235 Identities=20% Similarity=0.156 Sum_probs=178.3
Q ss_pred ccccceeeecccC-CCCCeeeccch--------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW--------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~--------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.++.||+++... +..+++|.... .+|++.+. ++.|+||+++.+.+...+..++||
T Consensus 21 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ---------ELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH---------HCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHh---------hCCCCCCCeEEEEEeeCCceEEEE
Confidence 5689999999765 56677876542 24444444 778999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
||+++ +|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 92 DFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp ECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99985 89999975 456789999999999999999999999 9999999999999999999999999998764322
Q ss_pred --cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhhhhhhc-
Q 044568 148 --FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RELNKLVR- 221 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 221 (257)
.....+|+.|+|||.+.+. .++.++||||||+++|||++|..||..... ...+.......... ..+.....
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhhhhhccC
Confidence 2445778899999998764 478999999999999999999999976521 11111111110000 00000000
Q ss_pred -----CC---CC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 -----GT---KV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 -----~~---~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .. .......+.+++.+||+.||.+|| ++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 123347899999999999999999 999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.42 Aligned_cols=227 Identities=16% Similarity=0.177 Sum_probs=175.0
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||++.... +..+++|... +.+|++.+. ++.|+||+++.+.+...+ .+
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~-~~ 90 (322)
T 2ycf_A 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK---------KLNHPCIIKIKNFFDAED-YY 90 (322)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHH---------HCCCTTBCCEEEEEESSS-EE
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHH---------hCCCCCCceEeeEEcCCc-eE
Confidence 5789999998654 4567777542 345666665 778999999999886654 89
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEeeecccc
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLAK 142 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~~ 142 (257)
+||||+++|+|.+++. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++. +||+|||++.
T Consensus 91 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 91 IVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 9999999999999997 556799999999999999999999999 9999999999999987654 9999999988
Q ss_pred cCCCCc--ccccCCCCccCccccc---CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhh
Q 044568 143 LPNEDF--VIDKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELN 217 (257)
Q Consensus 143 ~~~~~~--~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (257)
...... ....+|+.|+|||.+. ...++.++||||||+++|+|++|..||......... ...... ...
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~----~~~- 237 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITS----GKY- 237 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH---HHHHHH----TCC-
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH---HHHHHh----Ccc-
Confidence 654432 3446889999999974 456889999999999999999999999755332211 000000 000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... ......++.+.+++.+||+.||++|| ++|+++
T Consensus 238 ~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCc--hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000 00112346789999999999999999 999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.68 Aligned_cols=232 Identities=15% Similarity=0.191 Sum_probs=176.6
Q ss_pred ccccceeeecc-cCCCCCeeeccc------hhhhHHHHhHhhhcccccccc-CCceeeeceeeee--cCceeEEEeecCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKL--TSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~--~~~~~lV~E~~~~ 73 (257)
+.++.||++.. .+++.+++|... +.+|++.+. ++. |+|++++.+.+.. ....++||||+++
T Consensus 47 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~---------~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 47 GKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE---------NLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHH---------HHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHH---------HcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 57899999985 556677777654 456666665 665 9999999999987 6678999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCC--Cccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNE--DFVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~--~~~~ 150 (257)
++|.+++.. +++.++..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..... ....
T Consensus 118 ~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 189 (330)
T 3nsz_A 118 TDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189 (330)
T ss_dssp CCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred hhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccc
Confidence 999999853 89999999999999999999999 999999999999999766 899999999875432 2345
Q ss_pred ccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhh-------------
Q 044568 151 DKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINREL------------- 216 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------- 216 (257)
..++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+....... .....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~-~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVL-GTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHH-CHHHHHHHHHHTTCCCCT
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhc-CCchhhhHHHHhcccccc
Confidence 567888999999887 5689999999999999999999999964422211 111111110 00111
Q ss_pred --hhhhcCC-----------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 217 --NKLVRGT-----------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 217 --~~~~~~~-----------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... .......+.+.+++.+||+.||++|| ++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111000 11122457899999999999999999 999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=263.81 Aligned_cols=234 Identities=16% Similarity=0.139 Sum_probs=170.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||++... +++.+++|... +.+|++.+. ++.|+||+++.+.+...+..++||||+
T Consensus 45 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK---------ELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGG---------GCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHH---------HcCCCCcceEEEEEecCCEEEEEEecC
Confidence 578999999844 56667788654 234444444 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee-----CCCCceEEeeecccccCCC
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-----DEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~-----~~~~~~kl~dfg~~~~~~~ 146 (257)
+ |+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||++ +..+.+||+|||++.....
T Consensus 116 ~-~~L~~~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 116 E-NDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp S-EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred C-CCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 7 59999997 445699999999999999999999999 99999999999999 4555699999999875332
Q ss_pred ---CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhhhhh-
Q 044568 147 ---DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RELNKL- 219 (257)
Q Consensus 147 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 219 (257)
......+|+.|+|||.+.+. .++.++||||||+++|||++|..||....... ............ ......
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhhhh
Confidence 22445678899999999875 48999999999999999999999997552211 111111110000 000000
Q ss_pred --------hcC-C------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 --------VRG-T------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 --------~~~-~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... . ..+....+.+.+++.+||+.||++|| ++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0 00111346789999999999999999 999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=257.63 Aligned_cols=239 Identities=17% Similarity=0.149 Sum_probs=180.2
Q ss_pred ccccceeeeccc--CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeee-----ecCcee
Q 044568 4 TKLSNFYRSSFN--ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK-----LTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~--~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~~~ 65 (257)
+.++.||++... ++..+++|... +.+|++.+. .+..+.|+||+++.+.+. .....+
T Consensus 22 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~------~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR------HLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHH------HHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHH------hhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 568899999873 45567777542 334555554 233558999999999887 567889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||++ |+|.+++.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||.+....
T Consensus 96 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence 9999998 6999999865556799999999999999999999999 99999999999999999999999999987654
Q ss_pred CC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhhh----
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RELN---- 217 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~---- 217 (257)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ............. ..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGSCTTCS
T ss_pred CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCcccCccccc
Confidence 32 23456788999999999888999999999999999999999999755211 1111111100000 0000
Q ss_pred ---hhhcC------CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 ---KLVRG------TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ---~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... .......+..+.+++.+||+.||++|| +.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 012233457789999999999999999 999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=260.69 Aligned_cols=227 Identities=18% Similarity=0.156 Sum_probs=171.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------hhhhHHHHhHhhhccccccc-cCCceeeeceeeee------cCceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKL------TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~------~~~~~lV 67 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++ .|+|++++.+.+.. .+..++|
T Consensus 35 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~---------~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 35 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK---------KYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHH---------HHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred CCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHH---------hccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 568899999974 55667777653 234444444 54 69999999999887 4678999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999999864456799999999999999999999999 9999999999999999999999999998754322
Q ss_pred ---cccccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 148 ---FVIDKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 148 ---~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
.....+++.|+|||.+. ...++.++||||||+++|+|++|..||....... .... ....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----------~~~~ 249 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFL----------IPRN 249 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----------HHHS
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHH----------hhcC
Confidence 23446788899999987 4568899999999999999999999996442110 0000 0000
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+...+...+..+.+++.+||+.||.+|| ++|+++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011122233456789999999999999999 999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=260.11 Aligned_cols=238 Identities=17% Similarity=0.182 Sum_probs=174.2
Q ss_pred ccccceeeecc-cCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee--------cCc
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--------TSV 63 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--------~~~ 63 (257)
+.++.||+++. .++..+++|... +.+|++.+. ++.|+|++++.+.+.. .+.
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 28 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ---------LLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHH---------HCCCTTBCCEEEEEEEC--------CE
T ss_pred CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHH---------hccCCCcccHhheeeccccccccCCce
Confidence 57899999997 456677887542 235555555 7789999999999887 346
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+++ +|.+.+.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 8999999975 88888875 456799999999999999999999999 999999999999999999999999999875
Q ss_pred CCC-------CcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh-----
Q 044568 144 PNE-------DFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC----- 210 (257)
Q Consensus 144 ~~~-------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----- 210 (257)
... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||...........+.......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 431 1234467888999999876 457999999999999999999999998652211111111100000
Q ss_pred --hhhhhhhhh---hcCCCCC-HH------HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 --FINRELNKL---VRGTKVD-KK------NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 --~~~~~~~~~---~~~~~~~-~~------~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......... ....... .+ ..+.+.+++.+||+.||++|| ++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000 0000000 00 135688999999999999999 999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=260.34 Aligned_cols=244 Identities=18% Similarity=0.182 Sum_probs=171.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchhhhHHHH-hHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHHHh
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTADIEVL-SVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIF 81 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~ 81 (257)
+.++.||++... +++.+++|........+.. .+...-..+.++.|+||+++.+.+...+..++||||+++++|.+++.
T Consensus 26 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 105 (303)
T 2vwi_A 26 GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK 105 (303)
T ss_dssp --CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHH
T ss_pred ccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHH
Confidence 568899999865 5667788876532111100 01111113447889999999999999999999999999999999996
Q ss_pred cc------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--------
Q 044568 82 CS------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-------- 147 (257)
Q Consensus 82 ~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-------- 147 (257)
.. ....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 182 (303)
T 2vwi_A 106 HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182 (303)
T ss_dssp HHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----------
T ss_pred HHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhh
Confidence 31 345689999999999999999999999 9999999999999999999999999988654321
Q ss_pred cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....+|+.|+|||.+.. ..++.++||||||+++|||++|+.||........ .... ... ...............
T Consensus 183 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~--~~~-~~~~~~~~~~~~~~~ 257 (303)
T 2vwi_A 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLT--LQN-DPPSLETGVQDKEML 257 (303)
T ss_dssp -----CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH--HTS-SCCCTTC-----CCC
T ss_pred hcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHH--hcc-CCCccccccccchhh
Confidence 133467888999999875 4688999999999999999999999975522111 0000 000 000000001111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.||.+|| ++|+++
T Consensus 258 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 33456789999999999999999 999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.94 Aligned_cols=226 Identities=19% Similarity=0.165 Sum_probs=173.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|.+. +.+|++.+. .+.|+||+++.+.+...+..++|||||
T Consensus 48 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK---------LLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 578999999976 44556776543 234555555 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCC--
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNE-- 146 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~-- 146 (257)
++|+|.+.+. ....+++.++..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++.....
T Consensus 119 ~~g~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 119 KGGELFDEII--HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred CCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999987 346799999999999999999999999 9999999999999976 44599999999875433
Q ss_pred CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 147 DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
......+|+.|+|||.+. ..++.++||||+||++|+|++|..||..... .......... . ........
T Consensus 194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~-----~---~~~~~~~~ 261 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKG-----K---YTFDSPEW 261 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-----C---CCCCSGGG
T ss_pred cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-----C---CCCCchhc
Confidence 234557899999999886 4689999999999999999999999975521 1111111100 0 00000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| +.|+++
T Consensus 262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 23456789999999999999999 999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=259.62 Aligned_cols=186 Identities=18% Similarity=0.221 Sum_probs=151.9
Q ss_pred ccccceeeeccc-CCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||++... ++..+++|...- ..|++.+.... ......|.+++.+.+.+...+..++||||++ |
T Consensus 65 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 140 (382)
T 2vx3_A 65 GSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN---KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-Y 140 (382)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHH---HCSSGGGGGBCCEEEEEEETTEEEEEEECCC-C
T ss_pred cCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHH---hcccccceeEEEeeeeeccCCceEEEEecCC-C
Confidence 578999999865 455678886542 23333333111 1113445679999999999999999999996 5
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEeeecccccCCCCccccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKILDFGLAKLPNEDFVIDK 152 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~dfg~~~~~~~~~~~~~ 152 (257)
+|.+++.......+++..+..++.|++.||.|||++ +.+|+||||||+||+++ .++.+||+|||++...........
T Consensus 141 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~ 219 (382)
T 2vx3_A 141 NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219 (382)
T ss_dssp BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSC
T ss_pred CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccccccc
Confidence 999999865556799999999999999999999942 12999999999999995 477899999999987766666778
Q ss_pred CCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 153 RDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 153 ~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 220 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999999999999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.67 Aligned_cols=249 Identities=19% Similarity=0.203 Sum_probs=182.3
Q ss_pred ccccceeeecc-cCCCCCeeeccc--------hhhhHHHHhHhhhcc--ccccccCCceeeeceeeeecC----ceeEEE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS--------WTADIEVLSVAMRGS--KCTRIRGGLLLNVPVRAKLTS----VSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~--------~~~~~~~~~~~~~~~--~~~~~~h~~i~~~~~~~~~~~----~~~lV~ 68 (257)
+.++.||+++. .++..+++|... +.+|++.+....... ......|+|++++.+.+...+ ..++||
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~ 109 (373)
T 1q8y_A 30 GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF 109 (373)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred cCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEE
Confidence 56899999996 456667788654 345555555211100 011234899999999988654 789999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC------CCCceEEeeecccc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD------EFWTAKILDFGLAK 142 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~------~~~~~kl~dfg~~~ 142 (257)
||+ +++|.+++.......+++..+..++.|++.||.|||+++ +++||||||+||+++ ..+.+||+|||++.
T Consensus 110 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~ 186 (373)
T 1q8y_A 110 EVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186 (373)
T ss_dssp CCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred ecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEccccccc
Confidence 999 889999998655677999999999999999999999953 899999999999994 44589999999998
Q ss_pred cCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCCh---hhHHHHHHHHHhhhhhh----
Q 044568 143 LPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKP---EEIILTNWVYKCFINRE---- 215 (257)
Q Consensus 143 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~---- 215 (257)
..........+|+.|+|||.+.+..++.++||||||+++|||++|..||....... ....+..........+.
T Consensus 187 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 266 (373)
T 1q8y_A 187 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 266 (373)
T ss_dssp ETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHh
Confidence 77666666788999999999999999999999999999999999999998553221 11111111100000000
Q ss_pred -------------------------hhh-hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 -------------------------LNK-LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 -------------------------~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... +......+......+.+++.+||+.||.+|| ++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 267 NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred ccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 000 1111235667788999999999999999999 999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=260.48 Aligned_cols=227 Identities=17% Similarity=0.162 Sum_probs=174.7
Q ss_pred ccccceeeecccC-CCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.++.||+++... +..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+++
T Consensus 30 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 30 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILA---------TCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp STTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHh---------cCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 5789999999875 5556676543 233444444 77899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC---CCccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN---EDFVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~---~~~~~ 150 (257)
++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.... .....
T Consensus 101 ~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 101 GAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 999999875 456799999999999999999999999 99999999999999999999999999864311 11233
Q ss_pred ccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 044568 151 DKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKV 225 (257)
Q Consensus 151 ~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
..+++.|+|||.+. ...++.++||||||+++|+|++|..||...... ....... .........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---------~~~~~~~~~ 244 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIA---------KSDPPTLLT 244 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---------HSCCCCCSS
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHh---------ccCCcccCC
Confidence 46788899999983 567889999999999999999999999754211 0110000 000011122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 226 DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 226 ~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+...+..+.+++.+||+.||.+|| +.|+++
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 344567899999999999999999 999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=283.19 Aligned_cols=226 Identities=15% Similarity=0.181 Sum_probs=175.6
Q ss_pred ccccceeeecccCCC----CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.++.||+|....++ .+++|... +.+|++.+. ++.|+||+++.+.+. .+..++|||
T Consensus 401 G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR---------QFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp CSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEe-cCceEEEEE
Confidence 568999999876543 35666543 233444444 788999999999874 567899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
|+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 471 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 471 LCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp CCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred cCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 9999999999975 455799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ---ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 149 ---VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ... ....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i----------~~~-~~~~ 612 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----------ENG-ERLP 612 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----------HHT-CCCC
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----------HcC-CCCC
Confidence 22345667999999998889999999999999999997 99999754211 111100 000 1113
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...++.+.+++.+||+.||.+|| +.|+++.|
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 3445667899999999999999999 99998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=259.52 Aligned_cols=230 Identities=15% Similarity=0.155 Sum_probs=174.8
Q ss_pred ccccceeeecc-cCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEe
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E 69 (257)
+.++.||+++. .++..+++|... +.+|++.+. .+.|+||+++.+.+.. ....++|||
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 40 GGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR---------LFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHH---------TCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred CCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHh---------hcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 56889999996 556677888653 234444444 7889999999998873 447889999
Q ss_pred ecCCCCHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 70 PVRNGSLTDIIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 70 ~~~~gsL~~~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|+++|+|.+++... ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999999742 356799999999999999999999999 9999999999999999999999999987654321
Q ss_pred c------------ccccCCCCccCcccccCCC---CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh
Q 044568 148 F------------VIDKRDKGYMAPECYKRTP---ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI 212 (257)
Q Consensus 148 ~------------~~~~~~~~~~aPE~~~~~~---~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 212 (257)
. ....+|+.|+|||.+.... ++.++||||||+++|||++|+.||........... .
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~------- 258 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA--L------- 258 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH--H-------
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh--H-------
Confidence 1 2335688899999987554 68899999999999999999999963211100000 0
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 213 NRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...... ....+...+..+.+++.+||+.||.+|| ++|+++.|
T Consensus 259 --~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 259 --AVQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --HHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HhhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 000000 0112234457899999999999999999 99998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=257.48 Aligned_cols=227 Identities=19% Similarity=0.207 Sum_probs=171.4
Q ss_pred ccccceeeecccCCC----CCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||+++..... .+++|.... .+|++.+. ++.|+|++++.+.+...+ .++|
T Consensus 29 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH---------SLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSS-CEEE
T ss_pred CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHH---------hCCCCCcccEEEEEccCC-ceee
Confidence 568899999865433 356765432 23333333 778999999999988755 8899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++......
T Consensus 99 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 99 TELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred EecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999999975 345689999999999999999999999 9999999999999999999999999998754332
Q ss_pred c------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 148 F------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....... ....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----------~~~~ 241 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKI----------DKEG 241 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----------HTSC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHH----------HccC
Confidence 2 23345667999999988888999999999999999999 9999975421 1111100 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+...+..+.+++.+||+.||.+|| +.++++.|
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 11123344567899999999999999999 99998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.52 Aligned_cols=236 Identities=17% Similarity=0.114 Sum_probs=173.5
Q ss_pred cccccceeeecccCCCCCeeeccc--------------------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS--------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT- 61 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~--------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~- 61 (257)
.+.++.||++...++..+++|... +.+|++.+. ++.|+||+++.+.+...
T Consensus 32 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN---------HFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp EETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEEEECC
T ss_pred cCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH---------hCCCcCccceeeeEEecc
Confidence 367899999998888889998652 345555555 78899999999998543
Q ss_pred ----CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 62 ----SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 62 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
...++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 35799999997 699999875 556799999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCC--CcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----
Q 044568 138 FGLAKLPNE--DFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC---- 210 (257)
Q Consensus 138 fg~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 210 (257)
||++..... ......+|+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .........
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---QLNKIVEVVGTPK 254 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCC
Confidence 999874332 2244567888999999877 668999999999999999999999997652111 111111000
Q ss_pred ------hhhhhhhhhhcCC----------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 ------FINRELNKLVRGT----------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 ------~~~~~~~~~~~~~----------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+............ .......+.+.+++.+||+.||++|| +.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0001111111100 11122346789999999999999999 999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=253.68 Aligned_cols=223 Identities=17% Similarity=0.139 Sum_probs=172.6
Q ss_pred ccccceeeecccC-CCCCeeeccch-------------hhhHHHHhHhhhccccccccCCceeeeceeee--ecCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW-------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK--LTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~-------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~lV 67 (257)
+.++.||++.... +..+++|.... .+|++.+. ++.|+|++++.+.+. ..+..++|
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR---------RLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHT---------TCCCTTBCCEEEEEECC---CEEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHH---------hcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 5789999999754 45567776542 23333333 788999999999884 45688999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE- 146 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~- 146 (257)
|||++++ |.+.+.......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999876 88888765667899999999999999999999999 999999999999999999999999999875432
Q ss_pred ----CcccccCCCCccCcccccCCC--CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 ----DFVIDKRDKGYMAPECYKRTP--ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ----~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
......+++.|+|||.+.+.. ++.++||||||+++|||++|..||.... ...... .+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~-------------~i~ 226 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFE-------------NIG 226 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHH-------------HHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHH-------------HHh
Confidence 123446788999999987654 3789999999999999999999997542 111111 011
Q ss_pred c-CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 R-GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. ....+......+.+++.+||+.||.+|| ++|+++
T Consensus 227 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 227 KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1123344567889999999999999999 999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=271.53 Aligned_cols=221 Identities=20% Similarity=0.229 Sum_probs=175.4
Q ss_pred ccccceeeecccCC-CCCeeeccc----------------------hhhhHHHHhHhhhccccccccCCceeeeceeeee
Q 044568 4 TKLSNFYRSSFNAR-NSPWISRVS----------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL 60 (257)
Q Consensus 4 ~~~~~~y~~~~~~~-~~~~i~~~~----------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 60 (257)
+.++.||+++...+ ..+++|.+. +.+|++.+. ++.|+||+++.+.+..
T Consensus 47 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK---------SLDHPNIIKLFDVFED 117 (504)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHH---------TCCCTTBCCEEEEEEC
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEEc
Confidence 57899999997654 456776543 234555555 7889999999999999
Q ss_pred cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEee
Q 044568 61 TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW---TAKILD 137 (257)
Q Consensus 61 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~---~~kl~d 137 (257)
.+..++|||||++|+|.+.+. ....+++.++..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999997 346799999999999999999999999 999999999999998765 699999
Q ss_pred ecccccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 138 FGLAKLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 138 fg~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
||++...... .....+|+.|+|||.+. ..++.++||||+|+++|+|++|..||...... .......
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~-------- 260 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKVE-------- 260 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH--------
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--------
Confidence 9998765432 34567899999999986 46899999999999999999999999755211 1111110
Q ss_pred hhhhhcCC-CCC----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGT-KVD----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~-~~~----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... .++ ...++.+.+++.+||+.||.+|| ++|+++
T Consensus 261 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 -----KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 111 12346789999999999999999 999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.10 Aligned_cols=227 Identities=15% Similarity=0.168 Sum_probs=176.6
Q ss_pred ccccceeeecccC-CCCCeeeccch------------------hhhHHHHhHhhhcccccccc-CCceeeeceeeeecCc
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVSW------------------TADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSV 63 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~~------------------~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~ 63 (257)
+.++.||++.... ++.+++|.... .+|++.+. ++. |+|++++.+.+...+.
T Consensus 28 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~---------~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR---------KVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHH---------HHTTCTTBCCEEEEEECSSE
T ss_pred CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHH---------HhcCCCCEeeeeeeeccCCe
Confidence 5688999999754 56677886532 22333333 564 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+++++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+..
T Consensus 99 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999973 46799999999999999999999999 999999999999999999999999999875
Q ss_pred CCC--CcccccCCCCccCccccc------CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 144 PNE--DFVIDKRDKGYMAPECYK------RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 144 ~~~--~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||.... ......... ...
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~-----~~~ 245 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIM-----SGN 245 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-----HTC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHh-----cCC
Confidence 433 224456788999999985 4467899999999999999999999997542 111111100 000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+.......+..+.+++.+||+.||++|| +.|+++
T Consensus 246 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 ---YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000111234567899999999999999999 999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=270.33 Aligned_cols=168 Identities=18% Similarity=0.218 Sum_probs=134.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~l 66 (257)
+.++.||++... +++.+++|.+. +.+|++.+. ++.|+||+++.+++... ...++
T Consensus 64 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN---------RLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp ----CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHH---------hCCCCCCCceEEEEecCCcccCceEEE
Confidence 568999999855 56667888643 234555555 78899999999998543 56899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+. |+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 135 v~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999985 79999997 567799999999999999999999999 999999999999999999999999999976432
Q ss_pred C------------------------------cccccCCCCccCccccc-CCCCCccccchhHHHHHHHHHh
Q 044568 147 D------------------------------FVIDKRDKGYMAPECYK-RTPISVKADVYGYGIVLLETIC 186 (257)
Q Consensus 147 ~------------------------------~~~~~~~~~~~aPE~~~-~~~~~~~~Di~s~G~~l~el~~ 186 (257)
. .....+|+.|+|||++. ...++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 1 23346688899999864 5669999999999999999999
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=267.59 Aligned_cols=236 Identities=15% Similarity=0.128 Sum_probs=177.0
Q ss_pred ccccceeeecccCCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeeecCc------eeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV------SGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~------~~lV~E~~~ 72 (257)
+.++.||+++...++.+++|++. ..+|++.+. .+.|+||+++.+++...+. .++||||++
T Consensus 51 G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~---------~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 51 GSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMR---------IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp ETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHH---------TCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred CCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHH---------hCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 57899999999888888887653 245777766 7889999999999865543 789999998
Q ss_pred CCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEeeecccccCC--CC
Q 044568 73 NGSLTDIIFC--SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAKLPN--ED 147 (257)
Q Consensus 73 ~gsL~~~l~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~dfg~~~~~~--~~ 147 (257)
++ +.+.+.. .....+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||+++... ..
T Consensus 122 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~ 197 (394)
T 4e7w_A 122 ET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197 (394)
T ss_dssp EE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred cc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC
Confidence 64 4444321 1467799999999999999999999999 999999999999998 78899999999987542 33
Q ss_pred cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh---------hhhhh
Q 044568 148 FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI---------NRELN 217 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 217 (257)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+..... .+......... .....
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhChhhh
Confidence 3456778899999998765 58999999999999999999999998653221 11111110000 00000
Q ss_pred -hhhc---CC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 -KLVR---GT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 -~~~~---~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+ +. .++...++.+.+++.+||+.||.+|| +.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 00 11223457899999999999999999 999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.52 Aligned_cols=178 Identities=19% Similarity=0.201 Sum_probs=139.8
Q ss_pred ccccceeeeccc---CCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEeec
Q 044568 4 TKLSNFYRSSFN---ARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~---~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+||+++.+.+.. ....++||||+
T Consensus 32 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR---------ELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp ----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHH---------HCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred cCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHH---------hcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 578999999865 46677888654 346666666 7889999999999954 67889999999
Q ss_pred CCCCHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEeeecc
Q 044568 72 RNGSLTDIIFCS-------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM----DEFWTAKILDFGL 140 (257)
Q Consensus 72 ~~gsL~~~l~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~----~~~~~~kl~dfg~ 140 (257)
. |+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 103 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp S-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred C-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 7 5888887521 223599999999999999999999999 99999999999999 6778999999999
Q ss_pred cccCCCC------cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcC
Q 044568 141 AKLPNED------FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEID 194 (257)
Q Consensus 141 ~~~~~~~------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~ 194 (257)
+...... .....+|+.|+|||.+.+. .++.++|||||||++|||++|..||...
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 8754422 2345778999999999874 4899999999999999999999999755
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=264.18 Aligned_cols=236 Identities=18% Similarity=0.128 Sum_probs=176.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeeec----------------
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT---------------- 61 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~---------------- 61 (257)
+.++.||++.. .+++.+++|... ..+|++.+. .+.|+||+++.+.+...
T Consensus 18 G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~---------~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 18 GSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMK---------VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp C-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHT---------TCCCTTBCCEEEEEEEC----------------
T ss_pred ccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHH---------HcCCCCccchhheeeecCccccccccccccccc
Confidence 57899999985 566777888643 346776666 78899999999988543
Q ss_pred ----------------------CceeEEEeecCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 044568 62 ----------------------SVSGKIERPVRNGSLTDIIFC--SAERNPYWNQRVRIALDVAKGILYLHDECEPPILH 117 (257)
Q Consensus 62 ----------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 117 (257)
...++||||++ |+|.+.+.. .....+++..+..++.|++.||.|||++ +++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H 164 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICH 164 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEEC
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCcc
Confidence 34789999998 588887753 1567899999999999999999999999 9999
Q ss_pred ccCCCCceeeC-CCCceEEeeecccccCC--CCcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCc
Q 044568 118 CDIKPQNILMD-EFWTAKILDFGLAKLPN--EDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEI 193 (257)
Q Consensus 118 ~dl~~~nil~~-~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~ 193 (257)
|||||+||+++ .++.+||+|||.+.... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999997 68899999999997543 233455778899999998765 489999999999999999999999986
Q ss_pred CCCChhhHHHHHHHHHhhhh--hhhhhhh-----------cCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 194 DASKPEEIILTNWVYKCFIN--RELNKLV-----------RGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... .+.......... ......- ... .++...+..+.+++.+||+.||++|| +.|+++
T Consensus 245 ~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 245 ETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp SSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 52221 111111110000 0000000 000 12333456799999999999999999 999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=261.51 Aligned_cols=225 Identities=16% Similarity=0.165 Sum_probs=157.8
Q ss_pred cccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhcccccccc-CCceeeeceeee--------ecCc
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAK--------LTSV 63 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~--------~~~~ 63 (257)
.+.++.||+++.. ++..+++|... +.+|++.+. ++. |+||+++.+.+. ....
T Consensus 38 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~---------~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 38 EGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK---------KLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp CCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHH---------HHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred cCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHH---------HhccCCChhhccccccccccccccCCce
Confidence 3578999999954 56677888652 223333333 664 999999999884 3445
Q ss_pred eeEEEeecCCCCHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeCCCCceEEeeecc
Q 044568 64 SGKIERPVRNGSLTDIIFCS-AERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMDEFWTAKILDFGL 140 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~~~~~~kl~dfg~ 140 (257)
.++||||+. |+|.+++... ....+++.++..++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 789999996 7999998642 345699999999999999999999999 8 99999999999999999999999999
Q ss_pred cccCCCCc---------------ccccCCCCccCcccc---cCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHH
Q 044568 141 AKLPNEDF---------------VIDKRDKGYMAPECY---KRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEII 202 (257)
Q Consensus 141 ~~~~~~~~---------------~~~~~~~~~~aPE~~---~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~ 202 (257)
+....... ....+|+.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 87644322 134578889999998 45678899999999999999999999996431110
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 203 LTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.. ..... ..........+.+++.+||+.||.+|| +.|+++.|
T Consensus 261 ---~~---------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 261 ---IV---------NGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------------CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ---hh---------cCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00 00000 011122234578899999999999999 99998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=268.66 Aligned_cols=232 Identities=16% Similarity=0.125 Sum_probs=169.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++... +++.+++|.+.- .+|++.+. .+.|+||+++.+.+... ...+
T Consensus 73 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK---------CVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEccCCccccCCeEE
Confidence 578999999754 456678887541 23333333 77899999999998754 3569
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
|||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 144 lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 99999975 67777752 389999999999999999999999 99999999999999999999999999998654
Q ss_pred CC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh---------hh
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI---------NR 214 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~ 214 (257)
.. .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+..... .+......... ..
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHcch
Confidence 32 345678999999999999999999999999999999999999997652211 11111110000 00
Q ss_pred hhhhhhcCC---------------------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRGT---------------------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~~---------------------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
......... .......+.+.+|+.+||+.||++|| ++|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111100 00111256789999999999999999 999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.12 Aligned_cols=233 Identities=15% Similarity=0.157 Sum_probs=160.7
Q ss_pred ccccceeeecc-cCCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeec------Ccee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~ 65 (257)
+.++.||++.. .++..+++|.... .+|++.+. .+.|+||+++.+.+... ...+
T Consensus 40 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 40 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---------HMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp ---CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEecCCccccCCeEE
Confidence 56899999984 4566778887532 23444444 78899999999988654 5679
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+ +++|.+++. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 111 lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 111 LVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 999999 689999985 35799999999999999999999999 99999999999999999999999999998766
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----------hhhh
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC----------FINR 214 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~ 214 (257)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .+....... ....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHTTCCCH
T ss_pred ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhhH
Confidence 55566788999999999887 578999999999999999999999997652211 111111100 0001
Q ss_pred hhhhhhc----CCCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVR----GTKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~----~~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+. ....+ ....+.+.+|+.+||+.||.+|| ++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1111111 00111 12346789999999999999999 999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=264.91 Aligned_cols=236 Identities=17% Similarity=0.130 Sum_probs=175.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------ceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~lV~E~~ 71 (257)
+.++.||+++.. +++.+++|.+. ..+|++.+. +++|+||+++.+++.... ..++||||+
T Consensus 65 G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~---------~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 65 GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR---------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHH---------TCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred CCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHH---------HcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 578999999976 46778888653 245777776 888999999988876432 367899999
Q ss_pred CCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEeeecccccCC--C
Q 044568 72 RNGSLTDIIFC--SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-WTAKILDFGLAKLPN--E 146 (257)
Q Consensus 72 ~~gsL~~~l~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-~~~kl~dfg~~~~~~--~ 146 (257)
++ +|.+.+.. .....+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++... .
T Consensus 136 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 136 PE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp CE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 75 67766642 1467899999999999999999999999 99999999999999954 578999999997543 2
Q ss_pred CcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhhhhhhcC-
Q 044568 147 DFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RELNKLVRG- 222 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~- 222 (257)
......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+.......... ..+......
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhChhh
Confidence 23455788999999998765 6899999999999999999999999865221 1111111110000 011111000
Q ss_pred --C------------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 --T------------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 --~------------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .++...+..+.+|+.+||+.||.+|| +.|+++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 01223457899999999999999999 999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=252.03 Aligned_cols=235 Identities=18% Similarity=0.174 Sum_probs=168.3
Q ss_pred ccccceeeecc-cCCCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++. .+++.+++|..... .+.+.+. ..........|+|++++.+.+...+..++||||++ |+|.+
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 94 (290)
T 3fme_A 18 GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM--DLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDK 94 (290)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHH--HHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHH
T ss_pred CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHH--HHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHH
Confidence 57899999996 45666788866421 1111111 11112347789999999999999999999999997 58888
Q ss_pred HHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccCC
Q 044568 79 IIFCS--AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKRD 154 (257)
Q Consensus 79 ~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 154 (257)
++... ....+++..+..++.|++.||.|||++. +++|+||||+||+++.++.+||+|||++....... ....+|
T Consensus 95 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t 172 (290)
T 3fme_A 95 FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGC 172 (290)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---------------CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCC
Confidence 87532 4577999999999999999999999842 89999999999999999999999999987543322 334688
Q ss_pred CCccCcccc----cCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 155 KGYMAPECY----KRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 155 ~~~~aPE~~----~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
+.|+|||.+ .+..++.++||||+|+++|||++|+.||........ ..... . ....+.......+
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~---------~-~~~~~~~~~~~~~ 240 (290)
T 3fme_A 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQV---------V-EEPSPQLPADKFS 240 (290)
T ss_dssp CCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHHH---------H-HSCCCCCCTTTSC
T ss_pred ccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHHH---------h-ccCCCCcccccCC
Confidence 999999996 455688999999999999999999999975322111 11100 0 0011112223456
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.||++|| ++|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 7799999999999999999 999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=255.73 Aligned_cols=239 Identities=18% Similarity=0.115 Sum_probs=168.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----hhhHHHHhHhhhccccccccCCceeeeceeeeecCc-------eeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV-------SGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~-------~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|...- .++.+.+. .+..+.|+||+++.+++...+. .++||||
T Consensus 34 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 34 GTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ------DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp -----CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHH------HHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHH------HHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 578999999975 466678885421 22222222 2226789999999999876544 7899999
Q ss_pred cCCCCHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeeccCCCCceeeCC-CCceEEeeecccccCC
Q 044568 71 VRNGSLTDIIFC--SAERNPYWNQRVRIALDVAKGILYLH--DECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKLPN 145 (257)
Q Consensus 71 ~~~gsL~~~l~~--~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~~~ 145 (257)
+++ +|.+.+.. .....+++..+..++.|++.||.||| ++ +++||||||+||+++. ++.+||+|||++....
T Consensus 108 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp CSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred ccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 986 55554432 15667899999999999999999999 88 9999999999999996 8899999999997644
Q ss_pred CC--cccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh-hhhhhhhhc
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI-NRELNKLVR 221 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 221 (257)
.. .....+|+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ........... .......+.
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHC
T ss_pred CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCCCHHHHHhcc
Confidence 32 24456788899999987654 8999999999999999999999998652211 11111111000 000000000
Q ss_pred C----------C---------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 G----------T---------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~----------~---------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+ . .........+.+++.+||+.||.+|| +.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 11222467899999999999999999 999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=251.05 Aligned_cols=226 Identities=21% Similarity=0.274 Sum_probs=169.0
Q ss_pred ccccceeeeccc-CCCCCeeeccch--------hhhHHHHhHhhhccccccccCCceeeeceeeee-------------c
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW--------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-------------T 61 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-------------~ 61 (257)
+.++.||+++.. ++..+++|.... .+|++.+. ++.|+|++++.+.+.. .
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~---------~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 17 GAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA---------SLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred CCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHH---------hcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 578999999964 566778886542 33444443 7889999999887754 4
Q ss_pred CceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccc
Q 044568 62 SVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLA 141 (257)
Q Consensus 62 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~ 141 (257)
+..++||||+++|+|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 678999999999999999985 456788899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-----------------cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHH
Q 044568 142 KLPNED-----------------FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203 (257)
Q Consensus 142 ~~~~~~-----------------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~ 203 (257)
...... .....+++.|+|||.+.+. .++.++||||||+++|||++ ||... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~- 236 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVN- 236 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHH-
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHH-
Confidence 754321 1344678889999999865 68999999999999999998 55421 00000
Q ss_pred HHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 204 TNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.... ... ....-+...+...+..+.+++.+||+.||.+|| ++|+++
T Consensus 237 --~~~~-~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 --ILKK-LRS---VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHH-HHS---TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHh-ccc---cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000 000 000111234455567789999999999999999 999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=253.88 Aligned_cols=224 Identities=18% Similarity=0.197 Sum_probs=170.8
Q ss_pred ccccceeeecccCCCCCeeeccch-----------hhhHHHHhHhhhcccccccc--CCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIR--GGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||++...++..+++|.... .+|++.+. ++. |+|++++.+.+...+..++|||
T Consensus 39 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 39 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN---------KLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp CSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHH---------HHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred CCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHH---------hccccCCceEEEEEEeecCCEEEEEEe-
Confidence 578999999988888888886532 33444444 444 5999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF-- 148 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~-- 148 (257)
+.+++|.+++.. ...+++.++..++.|++.||.|||++ +++|+||+|+||++++ +.+||+|||++.......
T Consensus 109 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 557899999984 45789999999999999999999999 9999999999999975 799999999987543322
Q ss_pred ---ccccCCCCccCcccccC-----------CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhh
Q 044568 149 ---VIDKRDKGYMAPECYKR-----------TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINR 214 (257)
Q Consensus 149 ---~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 214 (257)
....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~-------- 252 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAI-------- 252 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHH--------
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--HHHHH--------
Confidence 33467889999999875 4678899999999999999999999975421110 00000
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.........+......+.+++.+||+.||.+|| ++|+++
T Consensus 253 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 000011122333456789999999999999999 999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.75 Aligned_cols=232 Identities=16% Similarity=0.115 Sum_probs=166.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.++.||++... ++..+++|... +.+|++.+. .+.|+||+++.+.+...+ ..+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~---------~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 36 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK---------CVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHH---------hcCCCCccceEEeeccccccccccceE
Confidence 578999999854 45567787653 223333333 778999999999987654 679
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||++ |+|.+.+. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 107 lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 9999997 58988885 2489999999999999999999999 99999999999999999999999999987644
Q ss_pred CC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh---------hhh
Q 044568 146 ED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF---------INR 214 (257)
Q Consensus 146 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~ 214 (257)
.. .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+........ ...
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhh
Confidence 32 244578899999999999899999999999999999999999997652111 1111100000 000
Q ss_pred hhh---------------hhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 215 ELN---------------KLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 215 ~~~---------------~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ...... .........+.+++.+||+.||.+|| ++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 000000 01122367899999999999999999 999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.58 Aligned_cols=174 Identities=18% Similarity=0.235 Sum_probs=142.6
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~l 66 (257)
+.++.||++.... ++.+++|.+. +.+|++.+. +++|+||+++.+.+... +..++
T Consensus 37 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 37 GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN---------RLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHH---------HcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 5688999998654 4557888653 234454444 78899999999998876 57899
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||++ |+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 999996 59999997 556799999999999999999999999 999999999999999999999999999976432
Q ss_pred C-------------------------cccccCCCCccCcccc-cCCCCCccccchhHHHHHHHHHhcCCCCC
Q 044568 147 D-------------------------FVIDKRDKGYMAPECY-KRTPISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 147 ~-------------------------~~~~~~~~~~~aPE~~-~~~~~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
. .....+|+.|+|||.+ ....++.++||||+||++|||++|..||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 2 2455778899999986 45568999999999999999998555443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.71 Aligned_cols=232 Identities=16% Similarity=0.151 Sum_probs=172.1
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCce------e
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS------G 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~------~ 65 (257)
+.++.||++... ++..+++|.... .+|++.+. ++.|+|++++.+.+...+.. +
T Consensus 53 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 53 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK---------HMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHH---------hcCCCCchhhhhheeccCCcccceeEE
Confidence 678999999855 456677876542 23444444 78899999999999877655 9
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+. ++|.+.+. ..+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 124 lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 9999997 68988874 3499999999999999999999999 99999999999999999999999999998766
Q ss_pred CCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh----------h-
Q 044568 146 EDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI----------N- 213 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------~- 213 (257)
.......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........... .
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCcHHHHHHhhhh
Confidence 66666788999999999887 678999999999999999999999997652111 11111100000 0
Q ss_pred ---hhhhhhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 ---RELNKLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ---~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+.... .......+.+.+++.+||+.||++|| ++|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000111111 01122357899999999999999999 999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=256.12 Aligned_cols=218 Identities=19% Similarity=0.222 Sum_probs=175.5
Q ss_pred cccccceeeecc-cCCCCCeeeccc---------------hhhhHHHHhHhhhccccccc--cCCceeeeceeeeecCce
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVS---------------WTADIEVLSVAMRGSKCTRI--RGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~--~h~~i~~~~~~~~~~~~~ 64 (257)
.+.++.||++.. .++..+++|... +.+|++.+. ++ .|+|++++.+.+...+..
T Consensus 53 ~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK---------KVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp SSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHH---------HHCSSSCSBCCEEEEEECSSEE
T ss_pred eCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHH---------hhccCCCCceEEEEEEecCCcE
Confidence 357899999985 455667777643 234555555 44 469999999999999999
Q ss_pred eEEEeecCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEeeecccc
Q 044568 65 GKIERPVRN-GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAK 142 (257)
Q Consensus 65 ~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~dfg~~~ 142 (257)
++|||++.+ ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||+|+||+++ +++.+||+|||++.
T Consensus 124 ~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 999999976 899999973 46789999999999999999999999 999999999999998 77899999999987
Q ss_pred cCCCC-cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 143 LPNED-FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 143 ~~~~~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
..... .....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... .. . .
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~--------------~---~ 257 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI--------------I---R 257 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH--------------H---H
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hh--------------h---c
Confidence 65433 344568889999999887665 688999999999999999999996330 00 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+...++.+.+++.+||+.||++|| ++|+++
T Consensus 258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112233456789999999999999999 999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.92 Aligned_cols=226 Identities=16% Similarity=0.144 Sum_probs=166.4
Q ss_pred ccccceeeecccCCCCCeeeccc------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||.....++..++||... ..+|++.+. ++ .|+||+++.+.+...+..+||||||+ |+|
T Consensus 35 G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~---------~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 35 GAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLR---------ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp CGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHH---------HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHH---------hccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 45565433344567788998753 356666665 55 79999999999999999999999996 699
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----CCceEEeeecccccCCCC----
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----FWTAKILDFGLAKLPNED---- 147 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-----~~~~kl~dfg~~~~~~~~---- 147 (257)
.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+||+++. ...+||+|||++......
T Consensus 105 ~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 105 QEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 999985 444455566789999999999999999 9999999999999943 346889999998765422
Q ss_pred --cccccCCCCccCccccc---CCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 148 --FVIDKRDKGYMAPECYK---RTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~---~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.....+|+.|+|||.+. ...++.++|||||||++|||++ |..||.......... .... ...+
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~~~----~~~~ 248 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGA----CSLD 248 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HTTC----CCCT
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------Hhcc----CCcc
Confidence 23456899999999997 3557789999999999999999 999996442111100 0000 0001
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...........+.+++.+||+.||.+|| ++|+++
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1112334456788999999999999999 999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=253.09 Aligned_cols=221 Identities=19% Similarity=0.201 Sum_probs=170.8
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.++.||++... ++..+++|.... .+|++.+... .....|+||+++.+.+...+..++|
T Consensus 42 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~h~~i~~~~~~~~~~~~~~~v 116 (312)
T 2iwi_A 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV-----GAGGGHPGVIRLLDWFETQEGFMLV 116 (312)
T ss_dssp ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHH-----HSSCCCSSBCCEEEEC-----CEEE
T ss_pred CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhh-----cccCCCCCeeeEEEEEecCCeEEEE
Confidence 578999999864 455677876532 2344444400 0122799999999999999999999
Q ss_pred Eee-cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEeeecccccCC
Q 044568 68 ERP-VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILDFGLAKLPN 145 (257)
Q Consensus 68 ~E~-~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~dfg~~~~~~ 145 (257)
||+ +.+++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++ .++.++|+|||++....
T Consensus 117 ~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~ 191 (312)
T 2iwi_A 117 LERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191 (312)
T ss_dssp EECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence 999 788999999974 45699999999999999999999999 999999999999998 78899999999987544
Q ss_pred C-CcccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 146 E-DFVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 146 ~-~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
. ......++..|+|||.+.+..+ +.++||||||+++|||++|+.||... ... . ....
T Consensus 192 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~--------------~---~~~~ 250 (312)
T 2iwi_A 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEI--------------L---EAEL 250 (312)
T ss_dssp SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH--------------H---HTCC
T ss_pred cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHH--------------h---hhcc
Confidence 3 3345567889999999887665 45899999999999999999999633 000 0 0111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+......+.+++.+||+.||++|| ++|+++
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23344556789999999999999999 999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=258.64 Aligned_cols=236 Identities=19% Similarity=0.219 Sum_probs=174.4
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lV 67 (257)
+.++.||++... ++..+++|... +.+|++.+. ++.|+||+++.+.+... ...++|
T Consensus 38 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 38 GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL---------RFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHH---------HCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred CCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHH---------hcCCCCCccceeEEecCCccccceEEEE
Confidence 578999999865 44557787654 234444444 78899999999988765 368999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||++ |+|.+++.. ..+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 109 ~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 109 QDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99997 599999964 4699999999999999999999999 9999999999999999999999999998765432
Q ss_pred c------ccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhhh
Q 044568 148 F------VIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFIN 213 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~ 213 (257)
. ....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||...........+..... .....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2 334778899999987654 589999999999999999999999976532221111111000 00000
Q ss_pred hhh----hhhhcCCCC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 REL----NKLVRGTKV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ~~~----~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ......... .......+.+++.+||+.||++|| ++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000111 122346789999999999999999 999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.53 Aligned_cols=234 Identities=15% Similarity=0.171 Sum_probs=168.8
Q ss_pred cccccceeeecccC-CCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeee-------------
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK------------- 59 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~------------- 59 (257)
.+.++.||++.... +..+++|.... .+|++.+. ++.|+|++++.+.+.
T Consensus 21 ~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 21 CGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR---------RLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp -----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred cCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHH---------hcCCCCeeEEEEeccccccccccccccc
Confidence 35789999999775 66678886542 33444444 788999999987763
Q ss_pred -ecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEee
Q 044568 60 -LTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFWTAKILD 137 (257)
Q Consensus 60 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~-~~~~~kl~d 137 (257)
..+..++||||++ |+|.+++. ...+++..+..++.|++.||.|||++ +++|+||||+||+++ .++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999997 69999995 45799999999999999999999999 999999999999997 567999999
Q ss_pred ecccccCCCC------cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh
Q 044568 138 FGLAKLPNED------FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC 210 (257)
Q Consensus 138 fg~~~~~~~~------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 210 (257)
||.+...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||....... .........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhc
Confidence 9998754321 233456788999998875 678999999999999999999999998652211 111111000
Q ss_pred --hhhhhhhh------------hhcCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 --FINRELNK------------LVRGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 --~~~~~~~~------------~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........ ...+. ......+..+.+++.+||+.||++|| ++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 00000 01123457799999999999999999 999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.75 Aligned_cols=233 Identities=16% Similarity=0.151 Sum_probs=172.1
Q ss_pred cccccceeeeccc-CCCCCeeeccch-----------hhhHHHHhHhhhccccccccCCceeeeceeeeecCc------e
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSW-----------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV------S 64 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~------~ 64 (257)
.+.++.||++... ++..+++|...- .+|++.+. ++.|+|++++.+.+...+. .
T Consensus 34 ~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK---------HMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp ECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred cCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHH---------hcCCCCcccHhheEecccccccceeE
Confidence 3678999999865 466778886532 23333433 7789999999999887654 4
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
++||||+. |+|.+++. ..+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 105 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99999997 68888874 3499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhh----------hh
Q 044568 145 NEDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCF----------IN 213 (257)
Q Consensus 145 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~ 213 (257)
........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+........ ..
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHHhh
Confidence 655566678999999999876 578999999999999999999999997652111 1111111000 00
Q ss_pred hh----hhhhhcC-----CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 RE----LNKLVRG-----TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ~~----~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ...+... ..........+.+++.+||+.||++|| ++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000000 012234567899999999999999999 999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.30 Aligned_cols=226 Identities=19% Similarity=0.207 Sum_probs=174.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+...+..++||||+
T Consensus 33 G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~---------~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (287)
T 2wei_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK---------KLDHPNIMKLFEILEDSSSFYIVGELY 103 (287)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHH---------hccCCCccEEEEEEeCCCeEEEEEEcc
Confidence 568899999976 56667777643 234555554 788999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEeeecccccCCCC-
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF---WTAKILDFGLAKLPNED- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~---~~~kl~dfg~~~~~~~~- 147 (257)
++++|.+.+.. ...+++.++..++.|++.||.|||++ +++|+||+|+||+++.+ +.+||+|||++......
T Consensus 104 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 104 TGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999999873 45699999999999999999999999 99999999999999754 46999999998754332
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... ........ .... .......
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~-----~~~~---~~~~~~~ 246 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVE-----TGKY---AFDLPQW 246 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH-----HCCC---CCCSGGG
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-----cCCC---CCCchhh
Confidence 233356778999998865 488999999999999999999999975421 11111110 0000 0000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...+..+.+++.+||+.||++|| +.|+++
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23356789999999999999999 999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=262.03 Aligned_cols=228 Identities=17% Similarity=0.185 Sum_probs=165.7
Q ss_pred ccccceeeecccCCCCCeeeccch------hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSW------TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||.....++..+++|.... .+|++.+. ++ .|+||+++.+.+...+..++|||||. |+|
T Consensus 26 G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~---------~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 26 GSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLT---------ESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp CSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHH---------HHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred CCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHH---------hccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 467777655566788899997642 23444433 33 79999999999999999999999996 699
Q ss_pred HHHHhccCCCC-----CCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-------------CceEEeee
Q 044568 77 TDIIFCSAERN-----PYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF-------------WTAKILDF 138 (257)
Q Consensus 77 ~~~l~~~~~~~-----l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~-------------~~~kl~df 138 (257)
.+++....... .++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997532111 12334578999999999999999 99999999999999653 48999999
Q ss_pred cccccCCCCc-------ccccCCCCccCcccccC-------CCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHH
Q 044568 139 GLAKLPNEDF-------VIDKRDKGYMAPECYKR-------TPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIIL 203 (257)
Q Consensus 139 g~~~~~~~~~-------~~~~~~~~~~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~ 203 (257)
|++....... ....+|+.|+|||.+.+ ..++.++|||||||++|||++ |..||........
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---- 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---- 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH----
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH----
Confidence 9988654322 23468999999999975 568899999999999999999 9999965422111
Q ss_pred HHHHHHhhhhhhhhhhhc-CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 204 TNWVYKCFINRELNKLVR-GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+..... ..-. ...........+.+++.+||+.||.+|| +.|+++
T Consensus 249 -~i~~~~~------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NIIRGIF------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHTCC------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhcCCC------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1100000 0000 1122455678899999999999999999 999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=254.06 Aligned_cols=236 Identities=17% Similarity=0.201 Sum_probs=173.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeec-----CceeEE
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT-----SVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lV 67 (257)
+.++.||+++.. ++..+++|... +.+|++.+. ++.|+|++++.+.+... ...++|
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 22 GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK---------HFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHH---------HCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHH---------hCcCCCcCCeeeeecccccCccceEEEE
Confidence 578999999976 45567788654 224444444 78899999999887754 678999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
|||+. |+|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp ECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99997 699999964 5699999999999999999999999 9999999999999999999999999998754322
Q ss_pred c-------------ccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHH----
Q 044568 148 F-------------VIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYK---- 209 (257)
Q Consensus 148 ~-------------~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---- 209 (257)
. ....+|+.|+|||.+.. ..++.++||||||+++|||++|+.||..................
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 22356888999998765 67899999999999999999999999765221110000000000
Q ss_pred ----hhhhhhhhhhhcC----C-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 210 ----CFINRELNKLVRG----T-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 210 ----~~~~~~~~~~~~~----~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
............. . ......+..+.+++.+||+.||++|| ++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000011000 0 01123456789999999999999999 999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=247.55 Aligned_cols=234 Identities=16% Similarity=0.152 Sum_probs=162.9
Q ss_pred ccccceeeeccc-CCCCCeeeccchh----hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT----ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~ 78 (257)
+.++.||+++.. ++..+++|..... ...+.+. .. ......+.|+||+++.+.+...+..++||||+ ++.+..
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~~-~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~ 112 (318)
T 2dyl_A 36 GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM-DL-DVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK 112 (318)
T ss_dssp ----CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHH-HH-HHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHH
T ss_pred cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHH-HH-HHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHH
Confidence 568899999976 5667788876431 1111111 00 01233678999999999999999999999999 456655
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--cccccCCC
Q 044568 79 IIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--FVIDKRDK 155 (257)
Q Consensus 79 ~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 155 (257)
+... ....+++..+..++.|++.||.|||+ + +++|+||+|+||+++.++.+||+|||++...... .....+++
T Consensus 113 l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 188 (318)
T 2dyl_A 113 LKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA 188 (318)
T ss_dssp HHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------------CC
T ss_pred HHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCc
Confidence 5543 45679999999999999999999998 7 8999999999999999999999999998654322 23446788
Q ss_pred CccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 156 GYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 156 ~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
.|+|||.+. ...++.++||||||+++|||++|+.||....... ...... ..............+
T Consensus 189 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLTKV---------LQEEPPLLPGHMGFS 257 (318)
T ss_dssp TTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHH---------HHSCCCCCCSSSCCC
T ss_pred cccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHHHH---------hccCCCCCCccCCCC
Confidence 999999985 4567899999999999999999999997532111 111110 000000001112345
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+.+++.+||+.||.+|| ++|+++
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6789999999999999999 999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=248.38 Aligned_cols=233 Identities=19% Similarity=0.208 Sum_probs=158.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchh---hhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.++.||++... +++.+++|..... ...+...... ......+.|+||+++.+.+...+..++||||+++ +|.++
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~ 110 (327)
T 3aln_A 33 GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKF 110 (327)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHH-HHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHH
T ss_pred CCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHH-HHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHH
Confidence 578999999975 5666788865421 1111111011 1123367899999999999999999999999985 88887
Q ss_pred Hhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc--ccccCC
Q 044568 80 IFC---SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--VIDKRD 154 (257)
Q Consensus 80 l~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 154 (257)
+.. .....+++..+..++.|++.||.|||++. +++|+||+|+||+++.++.+||+|||++....... ....++
T Consensus 111 ~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt 188 (327)
T 3aln_A 111 YKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188 (327)
T ss_dssp HHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------
T ss_pred HHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCC
Confidence 752 13677999999999999999999999952 89999999999999999999999999987543322 333688
Q ss_pred CCccCcccc----cCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC------C
Q 044568 155 KGYMAPECY----KRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT------K 224 (257)
Q Consensus 155 ~~~~aPE~~----~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 224 (257)
+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ......... .
T Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------QLTQVVKGDPPQLSNS 253 (327)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------CCCCCSCCCCCCCC
T ss_pred ccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------HHHHHhcCCCCCCCCc
Confidence 899999998 455688999999999999999999999975421110 000111110 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
........+.+++.+||+.||.+|| +.|+++
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1223457899999999999999999 999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=243.12 Aligned_cols=209 Identities=15% Similarity=0.146 Sum_probs=161.0
Q ss_pred ccccceeeecc-cCCCCCeeeccch----hhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~~~g 74 (257)
+.++.||++.. .++..+++|.... .+|++.+. ....|+|++++.+.+.. ....++||||+++|
T Consensus 29 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~--------~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~ 100 (299)
T 3m2w_A 29 GINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW--------RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 100 (299)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHH--------HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSC
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHH--------HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCC
Confidence 56889999986 4566778887653 44444432 14579999999999887 77889999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCCCCcccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPNEDFVID 151 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~~~~~~~ 151 (257)
+|.+++.......+++.++..++.|++.||.|||++ +++||||||+||+++. ++.++|+|||++....
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------ 171 (299)
T 3m2w_A 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------ 171 (299)
T ss_dssp BHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc------
Confidence 999999875556799999999999999999999999 9999999999999998 7889999999876322
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-C-CCCC---
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-G-TKVD--- 226 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~--- 226 (257)
+..++.++||||||+++|||++|..||......... ......+. . ...+
T Consensus 172 -------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 172 -------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp -------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCCSSCTTCCSSCHHH
T ss_pred -------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HHHHHHHhhccccCCchh
Confidence 234688999999999999999999999754211100 00000000 0 0112
Q ss_pred -HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 -KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 -~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| ++|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22457899999999999999999 999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=266.34 Aligned_cols=234 Identities=15% Similarity=0.175 Sum_probs=175.8
Q ss_pred cccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeee------cCcee
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL------TSVSG 65 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~------~~~~~ 65 (257)
.+.++.||++... ++..+++|... +.+|++.+. ++.|+||+++.+.+.. .+..+
T Consensus 24 ~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~---------~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 24 TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK---------KLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp BCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHH---------HCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred eCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHH---------hCCCCCCCceeeeecccccccCCCeEE
Confidence 3678999999974 46677888643 334555555 7889999999888665 67889
Q ss_pred EEEeecCCCCHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEeeeccc
Q 044568 66 KIERPVRNGSLTDIIFCSA-ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT---AKILDFGLA 141 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~---~kl~dfg~~ 141 (257)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++. ++|+|||.+
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 9999999999999998532 33689999999999999999999999 9999999999999986654 899999998
Q ss_pred ccCCCC--cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh--------h
Q 044568 142 KLPNED--FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC--------F 211 (257)
Q Consensus 142 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------~ 211 (257)
...... .....+++.|+|||.+.+..++.++||||||+++||+++|..||....... .|.... .
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~------~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV------QWHGKVREKSNEHIV 245 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH------HSSTTCC------CC
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh------hhhhhhhcccchhhh
Confidence 764432 244578899999999998899999999999999999999999996431110 000000 0
Q ss_pred hhhh------hhhh-hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 212 INRE------LNKL-VRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 212 ~~~~------~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
.... .... ..+.......++.+.+++.+||+.||++|| ++|++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000 0000 111134556788999999999999999999 98754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.16 Aligned_cols=220 Identities=16% Similarity=0.115 Sum_probs=164.9
Q ss_pred ccccceeeeccc--CCCCCeeeccchhhhHHHH-hHhhhccccccccCCceeeeceeeeecCc-----eeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFN--ARNSPWISRVSWTADIEVL-SVAMRGSKCTRIRGGLLLNVPVRAKLTSV-----SGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~--~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~h~~i~~~~~~~~~~~~-----~~lV~E~~~~gs 75 (257)
+.++.||++... ++..+++|........+.. .+......+.++.|+||+++.+++...+. .+|||||+++++
T Consensus 91 G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~ 170 (681)
T 2pzi_A 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170 (681)
T ss_dssp ETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEE
T ss_pred CCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCc
Confidence 568899999875 4677888865421100000 00011113348899999999999998766 699999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
|.+++.. .+++.++..++.|++.||.|||++ +|+||||||+||+++.+ .+||+|||++...... ....+|+
T Consensus 171 L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-~~~~gt~ 241 (681)
T 2pzi_A 171 LKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-GYLYGTP 241 (681)
T ss_dssp CC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-SCCCCCT
T ss_pred HHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-CccCCCc
Confidence 9998752 799999999999999999999999 99999999999999986 8999999998865443 4557899
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVK 235 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (257)
.|+|||.+.+.. +.++||||||+++|+|++|..||........ ..........+.+.+
T Consensus 242 ~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 242 GFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------PEDDPVLKTYDSYGR 299 (681)
T ss_dssp TTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------CTTCHHHHHCHHHHH
T ss_pred cccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------------cccccccccCHHHHH
Confidence 999999987654 8899999999999999999998864311100 000001122356889
Q ss_pred HHHHcccCCCCCCC-hHHHH
Q 044568 236 VGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 236 l~~~cl~~~p~~RP-~~ei~ 254 (257)
++.+||+.||.+|| +.+.+
T Consensus 300 li~~~l~~dP~~R~~~~~~l 319 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEM 319 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHH
T ss_pred HHhhhccCChhhCCCHHHHH
Confidence 99999999999999 55443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.97 Aligned_cols=169 Identities=15% Similarity=0.130 Sum_probs=135.4
Q ss_pred ceeEEEeecCCCCHHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 63 VSGKIERPVRNGSLTDIIF-----CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
..+++|+++ +++|.+++. ......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEe
Confidence 456777766 579999984 22355678889999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCcccccCCCCccCcccc----------cCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHH
Q 044568 138 FGLAKLPNEDFVIDKRDKGYMAPECY----------KRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV 207 (257)
Q Consensus 138 fg~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 207 (257)
||+++..........+ +.|+|||.+ ....++.++|||||||++|||++|+.||.......
T Consensus 255 FG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~--------- 324 (413)
T 3dzo_A 255 FEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG--------- 324 (413)
T ss_dssp GGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS---------
T ss_pred ccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh---------
Confidence 9998876666566677 899999999 45567889999999999999999999997542111
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 208 YKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.....+... ...++.+.+++.+||+.||++|| +.|+++
T Consensus 325 -------~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 325 -------GSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp -------CSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------hHHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011111111 12346789999999999999999 998864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=228.35 Aligned_cols=207 Identities=13% Similarity=0.049 Sum_probs=154.9
Q ss_pred cccccceeeecccC-CCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
.+.++.||++.... +..+++|.... .+|++. +.++.|+||+++.+.+...+..++|||
T Consensus 41 ~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---------l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 41 GVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR---------LSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp BSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHH---------HHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHH---------HhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 36789999999765 66778886542 222222 337899999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (257)
|+++++|.+++.. . ....++..++.|++.||.|||++ +++||||||+||+++.++.+||++++
T Consensus 112 ~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp CCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred ecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999953 2 45567889999999999999999 99999999999999999999997443
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
|++ +++.++||||||+++|||++|+.||............. . ..... ...........
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~-~~~~~---~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----R-DTAGQ---PIEPADIDRDI 232 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----B-CTTSC---BCCHHHHCTTS
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----H-HhccC---CCChhhcccCC
Confidence 333 36899999999999999999999998653221000000 0 00000 00000112234
Q ss_pred HHHHHHHHHHcccCCCCCCChHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRPMKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP~~ei~~~L 257 (257)
++.+.+++.+||+.||++|-+.|+++.|
T Consensus 233 ~~~l~~li~~~l~~dP~~Rs~~el~~~L 260 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIRSASTLLNLM 260 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCCCHHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccCCHHHHHHHH
Confidence 5678999999999999999877777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=235.88 Aligned_cols=225 Identities=9% Similarity=-0.008 Sum_probs=159.4
Q ss_pred ccccceeeecccCCCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeece----------
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPV---------- 56 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~---------- 56 (257)
+.++.||+++. ++..+++|... +.+|++++.....-.....-.|+|++++.+
T Consensus 31 G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp 109 (336)
T 2vuw_A 31 GVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109 (336)
T ss_dssp ETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCH
T ss_pred cCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcH
Confidence 56899999987 67788888654 345555554111100001113555555444
Q ss_pred -------eeee-------------cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCe
Q 044568 57 -------RAKL-------------TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLH-DECEPPI 115 (257)
Q Consensus 57 -------~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i 115 (257)
.+.. .+..+||||||++|++.+.+. ...+++.++..++.|++.||.||| ++ +|
T Consensus 110 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---~i 183 (336)
T 2vuw_A 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASLAVAEASL---RF 183 (336)
T ss_dssp HHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHHHHHHHHH---CC
T ss_pred HHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHhC---CE
Confidence 4333 678999999999997777774 356899999999999999999999 89 99
Q ss_pred eeccCCCCceeeCCCC--------------------ceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccch
Q 044568 116 LHCDIKPQNILMDEFW--------------------TAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVY 175 (257)
Q Consensus 116 ~h~dl~~~nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 175 (257)
+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||.+.+.. +.++|||
T Consensus 184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~~-~~~~Diw 260 (336)
T 2vuw_A 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGDG-DYQFDIY 260 (336)
T ss_dssp BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCCS-SHHHHHH
T ss_pred eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCCC-ccceehh
Confidence 9999999999999886 8999999999864432 447899999999998766 8999999
Q ss_pred hHHHH-HHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh--hhcCC---CCCHHHHHHHHHHHHHcccCCCCCCC
Q 044568 176 GYGIV-LLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK--LVRGT---KVDKKNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 176 s~G~~-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RP 249 (257)
|++++ .+++++|..||... .|.... ...... ..... .......+.+.+|+.+||+.| .
T Consensus 261 sl~~~~~~~~~~g~~p~~~~----------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----s 324 (336)
T 2vuw_A 261 RLMKKENNNRWGEYHPYSNV----------LWLHYL--TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----S 324 (336)
T ss_dssp HHHHHHHTTCTTSCCTHHHH----------HHHHHH--HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----S
T ss_pred hhhCCCCcccccccCCCcch----------hhhhHH--HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----C
Confidence 98766 78888899998421 110000 000100 00111 123456789999999999965 4
Q ss_pred hHHHH
Q 044568 250 MKCAV 254 (257)
Q Consensus 250 ~~ei~ 254 (257)
++|++
T Consensus 325 a~e~l 329 (336)
T 2vuw_A 325 ATDLL 329 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=225.23 Aligned_cols=148 Identities=15% Similarity=0.100 Sum_probs=110.8
Q ss_pred chhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 044568 26 SWTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGI 104 (257)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l 104 (257)
+|.+|++++. ++ .|+|++++..++.+++..||||||++|++|.++|. ....++.. .++.||+.||
T Consensus 287 ~~~~E~~~l~---------~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL 352 (569)
T 4azs_A 287 ELHNEIKFLT---------QPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSL 352 (569)
T ss_dssp HHHHHHHHHH---------SCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHH
T ss_pred HHHHHHHHHH---------hcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHH
Confidence 3677888777 65 69999999999999999999999999999999998 45566653 5899999999
Q ss_pred HHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccccCCCCccCcccccCCCCCccccchhHHHHH
Q 044568 105 LYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVL 181 (257)
Q Consensus 105 ~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l 181 (257)
.|+|++ ||+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+. +..++|+||+|+..
T Consensus 353 ~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~ 428 (569)
T 4azs_A 353 AALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHP 428 (569)
T ss_dssp HHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------
T ss_pred HHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccch
Confidence 999999 9999999999999999999999999999865432 2445788999999998754 56789999999998
Q ss_pred HHHHhcCCCC
Q 044568 182 LETICCRKNM 191 (257)
Q Consensus 182 ~el~~g~~pf 191 (257)
+++.++..|+
T Consensus 429 ~~l~~~~~~~ 438 (569)
T 4azs_A 429 FNLPQPWSNW 438 (569)
T ss_dssp CCCCTTHHHH
T ss_pred hhhccccchh
Confidence 8776554443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=190.95 Aligned_cols=163 Identities=17% Similarity=0.144 Sum_probs=133.5
Q ss_pred ccccceeeecccCCCCCeeeccc-----------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 66 (257)
+.++.||+++.. +..+++|... +.+|++.+. ++.|+|+++...++...+..+|
T Consensus 347 G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~---------~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 347 GAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLA---------LVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp -CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHH---------HGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHH---------hcCCCCcCceEEEEEeCCccEE
Confidence 578999999544 4455555421 345555555 7889999977777778888999
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
||||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+||+++. .+||+|||+++....
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999999963 568999999999999999 9999999999999998 999999999987655
Q ss_pred Cc----------ccccCCCCccCcccccC--CCCCccccchhHHHHHHHHHhcCCCC
Q 044568 147 DF----------VIDKRDKGYMAPECYKR--TPISVKADVYGYGIVLLETICCRKNM 191 (257)
Q Consensus 147 ~~----------~~~~~~~~~~aPE~~~~--~~~~~~~Di~s~G~~l~el~~g~~pf 191 (257)
.. ....+|+.|+|||++.. ..|+...|+|+..+-..+-+-++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32 24578999999999986 56788899999999888888777766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-20 Score=153.63 Aligned_cols=125 Identities=13% Similarity=0.035 Sum_probs=98.0
Q ss_pred ccccceeeecccCCCCCeeeccc---------------------------hhhhHHHHhHhhhccccccccCCceeeece
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS---------------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPV 56 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 56 (257)
++++.||++...++..+++|... +.+|++.+. ++. | ++++.
T Consensus 101 G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~---------~l~--~-~~v~~ 168 (282)
T 1zar_A 101 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ---------KLQ--G-LAVPK 168 (282)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH---------HTT--T-SSSCC
T ss_pred CCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH---------hcc--C-CCcCe
Confidence 67899999999667788888763 335555554 444 4 66666
Q ss_pred eeeecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEe
Q 044568 57 RAKLTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKIL 136 (257)
Q Consensus 57 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~ 136 (257)
... .+..++||||+++|+|.+ +.. .....++.|++.||.|||++ +++||||||.||+++ ++.+||+
T Consensus 169 ~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 169 VYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred EEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 543 456799999999999999 531 23457999999999999999 999999999999999 8999999
Q ss_pred eecccccCCCCcccccCCCCccCccccc
Q 044568 137 DFGLAKLPNEDFVIDKRDKGYMAPECYK 164 (257)
Q Consensus 137 dfg~~~~~~~~~~~~~~~~~~~aPE~~~ 164 (257)
|||++.. +..+.|||.+.
T Consensus 235 DFG~a~~----------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE----------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE----------TTSTTHHHHHH
T ss_pred ECCCCeE----------CCCCCHHHHHH
Confidence 9999863 23467788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.4e-16 Score=127.95 Aligned_cols=120 Identities=15% Similarity=0.091 Sum_probs=86.9
Q ss_pred cccccceeeecc-cCCCC--Ceeeccc---------------------------------hhhhHHHHhHhhhccccccc
Q 044568 3 CTKLSNFYRSSF-NARNS--PWISRVS---------------------------------WTADIEVLSVAMRGSKCTRI 46 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~--~~i~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~ 46 (257)
.++++.||++.. .++.. +++|... +.+|++.+. ++
T Consensus 57 ~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l 127 (258)
T 1zth_A 57 TGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE---------RA 127 (258)
T ss_dssp ECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH---------HH
T ss_pred ecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH---------HH
Confidence 367899999998 67777 8888521 223333333 44
Q ss_pred cCCceeeeceeeeecCceeEEEeecCC-C----CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeccC
Q 044568 47 RGGLLLNVPVRAKLTSVSGKIERPVRN-G----SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLH-DECEPPILHCDI 120 (257)
Q Consensus 47 ~h~~i~~~~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~dl 120 (257)
.|+++ .++.... .+..+|||||+.+ | +|.+.... .++.++..++.|++.|+.||| +. +++||||
T Consensus 128 ~~~~i-~~p~~~~-~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 128 KEAGV-SVPQPYT-YMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HHTTC-CCCCEEE-EETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred HhCCC-CCCeEEE-cCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 44443 2222222 2467899999942 4 77777542 234567889999999999999 88 9999999
Q ss_pred CCCceeeCCCCceEEeeeccccc
Q 044568 121 KPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 121 ~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
||.|||++. .++|+|||++..
T Consensus 198 kp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEE
T ss_pred CHHHEEEcC--cEEEEECccccc
Confidence 999999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.39 E-value=7e-14 Score=120.98 Aligned_cols=128 Identities=15% Similarity=0.035 Sum_probs=83.8
Q ss_pred cccccceeeecccCCCCCeeeccch--------------------h---hhHHHHhHhhhccccccccCCceeeeceeee
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVSW--------------------T---ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAK 59 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 59 (257)
.+|+|+||++...+++.++||-... . ...+........ .+.++.+. -+.++....
T Consensus 105 ~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~-nL~rL~~~-gv~vp~p~~ 182 (397)
T 4gyi_A 105 VGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA-FMKALYEE-GFPVPEPIA 182 (397)
T ss_dssp ECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH-HHHHHHHT-TCSCCCEEE
T ss_pred eCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH-HHHHHHhc-CCCCCeeee
Confidence 3689999999998999999984221 0 011111100011 22222111 122222222
Q ss_pred ecCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC--------
Q 044568 60 LTSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-------- 131 (257)
Q Consensus 60 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-------- 131 (257)
. ...+|||||++|++|.++... .....++.|++.+|.+||+. |++||||||.|||+++++
T Consensus 183 ~-~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 183 Q-SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp E-ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred c-cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccccccc
Confidence 2 234799999999888776431 23457889999999999999 999999999999998765
Q ss_pred --ceEEeeecccccC
Q 044568 132 --TAKILDFGLAKLP 144 (257)
Q Consensus 132 --~~kl~dfg~~~~~ 144 (257)
.+.++||+-+...
T Consensus 251 ~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 251 TLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECCCTTCEET
T ss_pred ccceEEEEeCCcccC
Confidence 3889999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=4.4e-09 Score=86.18 Aligned_cols=121 Identities=12% Similarity=0.020 Sum_probs=85.4
Q ss_pred ccceeeecccCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 6 LSNFYRSSFNARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
.+.||+.... ++..++|... +.+|.+.+. .+.. +..+-++...+...+..++||||++|.+|
T Consensus 27 ~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~------~l~~--~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 27 PAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMML------WLEG--KLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp SSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHH------HHTT--TSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred CCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHH------HHhc--CCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 4668888754 4667777643 456666666 1111 33344556667777889999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------------
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC--------------------------------------------- 111 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--------------------------------------------- 111 (257)
.+.+. +..+...++.+++.++..||+..
T Consensus 98 ~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 98 SEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 88742 11234578899999999999810
Q ss_pred -----------CCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 112 -----------EPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 112 -----------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
...++|+|+++.||+++++..+.++||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0258999999999999876566799998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.75 E-value=1.7e-08 Score=82.18 Aligned_cols=120 Identities=15% Similarity=0.017 Sum_probs=80.1
Q ss_pred ccceeeecccCCCCCeeeccc------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 6 LSNFYRSSFNARNSPWISRVS------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 6 ~~~~y~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
.+.||+....++...++|... +.+|.+.+.... .. ...+-++.......+..++||||++|.+|.
T Consensus 33 ~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~------~~-~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 33 DAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLA------TT-GVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHH------TT-TCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred CceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHH------hC-CCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 478899887767777777533 356666666211 11 111223455555666789999999998884
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------------------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC------------------------------------------------ 111 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------ 111 (257)
.. . .+ ...++.+++..+..||+..
T Consensus 104 ~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 22 1 11 2356777788888888751
Q ss_pred -------CCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 112 -------EPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 112 -------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
...++|+|+++.||+++++..+.++||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.50 E-value=4.6e-07 Score=77.64 Aligned_cols=127 Identities=13% Similarity=0.059 Sum_probs=85.3
Q ss_pred cccceeeecccCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeec---CceeEEEe
Q 044568 5 KLSNFYRSSFNARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT---SVSGKIER 69 (257)
Q Consensus 5 ~~~~~y~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~---~~~~lV~E 69 (257)
.+..+|+.+..+ ...+++... +.+|.+++..... .+..+.++...+... +..++|||
T Consensus 50 ~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~-------~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 50 QSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAG-------TDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTT-------SSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred ccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhc-------CCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456778877654 445555443 3455555552111 122233444444444 34789999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-------------------------------------- 111 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------- 111 (257)
|++|.++.+.. ...++..+...++.+++..|..||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99988775422 234778888999999999999999731
Q ss_pred -----------------CCCeeeccCCCCceeeCCCCc--eEEeeeccccc
Q 044568 112 -----------------EPPILHCDIKPQNILMDEFWT--AKILDFGLAKL 143 (257)
Q Consensus 112 -----------------~~~i~h~dl~~~nil~~~~~~--~kl~dfg~~~~ 143 (257)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987643 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.31 E-value=6.1e-07 Score=75.10 Aligned_cols=125 Identities=18% Similarity=0.167 Sum_probs=82.5
Q ss_pred ceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 044568 63 VSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC------------------------------- 111 (257)
Q Consensus 63 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------- 111 (257)
..++|||+++|.+|.+... ..++..++..++.+++..+..||+..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred cceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 4578999999988876433 23677788888888888888888610
Q ss_pred ------------------------CCCeeeccCCCCceeeCC--CCceEEeeecccccCCCCcccccCCCCc---cCccc
Q 044568 112 ------------------------EPPILHCDIKPQNILMDE--FWTAKILDFGLAKLPNEDFVIDKRDKGY---MAPEC 162 (257)
Q Consensus 112 ------------------------~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~---~aPE~ 162 (257)
.+.++|+|+++.||++++ ...+.++||+.+......... ...... ..|+.
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEF 244 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHH
Confidence 135799999999999998 556789999887543221100 000000 12221
Q ss_pred ccC-----CC---------CCccccchhHHHHHHHHHhcCCCCC
Q 044568 163 YKR-----TP---------ISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 163 ~~~-----~~---------~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
... +. .....+.|+++.++|.+.+|..+|.
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 100 00 1123689999999999999998873
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0002 Score=58.40 Aligned_cols=122 Identities=13% Similarity=0.092 Sum_probs=77.7
Q ss_pred cceeeecccCCC-CCeeeccc------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHHHH
Q 044568 7 SNFYRSSFNARN-SPWISRVS------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLTDI 79 (257)
Q Consensus 7 ~~~y~~~~~~~~-~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~~~ 79 (257)
+.||+-....+. ..++|... +..|...+.. +.+ .++-| ++...+...+..++|||+++|.++.+.
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~-l~~----~vPVP---~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNW-LTA----FMPLP---TIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHH-HTT----TSCCC---CEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHH-hcc----CCCcC---eEEEEEEECCeEEEEEEeeCCcccccc
Confidence 357877655444 45566533 3455555552 122 22323 334556677889999999999888876
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------------------
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC------------------------------------------------ 111 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------ 111 (257)
... .......+..+++..+.-||+..
T Consensus 111 ~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 111 LEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 542 11233455666666666666531
Q ss_pred -------CCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 112 -------EPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 112 -------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+.++|+|+++.||++++++.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1247899999999999987777799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00085 Score=55.96 Aligned_cols=78 Identities=23% Similarity=0.187 Sum_probs=52.2
Q ss_pred cCceeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------
Q 044568 61 TSVSGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDE------------------------------ 110 (257)
Q Consensus 61 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~------------------------------ 110 (257)
.+..++|||+++|.++.+... ..++..+...++.+++..|..||+.
T Consensus 85 ~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp TSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred CCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 345789999999988876432 1234445555555555555555542
Q ss_pred ---------------------------CCCCeeeccCCCCceeeCC---CCc-eEEeeecccc
Q 044568 111 ---------------------------CEPPILHCDIKPQNILMDE---FWT-AKILDFGLAK 142 (257)
Q Consensus 111 ---------------------------~~~~i~h~dl~~~nil~~~---~~~-~kl~dfg~~~ 142 (257)
..+.++|+|+++.|++++. ++. ..|+||+.+.
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1225699999999999987 345 4899998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0022 Score=50.58 Aligned_cols=105 Identities=9% Similarity=-0.053 Sum_probs=66.6
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccC
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKR 153 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (257)
-||.++|.. .+.++++++++.++.|.+.+|.-.-.+. .-..+=..+..|++..+|.+.+.+ ..+. ..
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------~~ 99 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------AG 99 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------cc
Confidence 489999986 7889999999999999999987663210 111223345677777777776643 1110 11
Q ss_pred CCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCC
Q 044568 154 DKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 154 ~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
...+.|||... ...+.+.=|||+|+++|..+--..|-.
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 23467887763 334677889999999999997555543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0035 Score=53.12 Aligned_cols=30 Identities=27% Similarity=0.533 Sum_probs=25.2
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 378999999999999965457899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.039 Score=46.08 Aligned_cols=30 Identities=33% Similarity=0.365 Sum_probs=25.9
Q ss_pred CeeeccCCCCceeeCCC----CceEEeeeccccc
Q 044568 114 PILHCDIKPQNILMDEF----WTAKILDFGLAKL 143 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~----~~~kl~dfg~~~~ 143 (257)
.++|+|+++.||+++.+ ..+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 79999999999999874 6789999987653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.038 Score=45.23 Aligned_cols=62 Identities=10% Similarity=-0.001 Sum_probs=37.3
Q ss_pred ccccceeeecccCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.++.||+-++.+++.+++|... +..|.+.+...... ..++-|-++ .. +..++||||.+++
T Consensus 26 G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~---~~vpvP~v~------~~-~~~~lv~e~l~~~ 95 (288)
T 3f7w_A 26 SHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRS---FGSPVPQVA------GW-DDRTLAMEWVDER 95 (288)
T ss_dssp ETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCS---TTCCSCCEE------EE-ETTEEEEECCCCC
T ss_pred CCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhh---CCCCcceEE------ec-cCceEEEEeeccc
Confidence 34678999999999988888632 35566666521111 022223222 11 3457899998766
Q ss_pred C
Q 044568 75 S 75 (257)
Q Consensus 75 s 75 (257)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.047 Score=46.87 Aligned_cols=28 Identities=25% Similarity=0.452 Sum_probs=24.3
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+++.||+++.+ .++++||..+.
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 89999999999999876 58899997654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.051 Score=45.35 Aligned_cols=27 Identities=19% Similarity=0.181 Sum_probs=23.4
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 112 EPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 112 ~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
.+.++|+|+.+.|++++.++ +.+.|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 45899999999999999886 8888874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.048 Score=45.40 Aligned_cols=30 Identities=23% Similarity=0.304 Sum_probs=26.5
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 389999999999999877789999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=92.44 E-value=0.32 Score=39.84 Aligned_cols=28 Identities=29% Similarity=0.322 Sum_probs=23.5
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.|++ ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 5899999999999 555678999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.07 E-value=0.14 Score=44.34 Aligned_cols=29 Identities=10% Similarity=0.315 Sum_probs=25.8
Q ss_pred CeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++|+|+++.||+++.++ +.++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 899999999999998775 99999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.97 E-value=1.3 Score=34.67 Aligned_cols=119 Identities=11% Similarity=0.085 Sum_probs=80.0
Q ss_pred cccccCCceeeeceeeeecCceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 044568 43 CTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIK 121 (257)
Q Consensus 43 ~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 121 (257)
+....+++++.. .+...++...+.++.-+++ ++.. +. .++...+++++..|+....++++ -+|--++
T Consensus 39 LL~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~ 106 (215)
T 4ann_A 39 LLEQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA 106 (215)
T ss_dssp GGGSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred HHhccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence 334557777755 3444556666666654433 4444 33 37889999999999987765554 4788899
Q ss_pred CCceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCC
Q 044568 122 PQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 122 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
|.|+.++.++.+++.-.|+... ++|. ..+...=+-.+=+++..+++++..|.
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~--------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNV--------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTT--------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccC--------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999988776321 2332 11222224447788889999988885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.96 E-value=0.14 Score=42.32 Aligned_cols=29 Identities=21% Similarity=0.303 Sum_probs=24.9
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+++|+|+++.||+++++..+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 78999999999999887556899998654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.39 E-value=0.68 Score=38.18 Aligned_cols=27 Identities=30% Similarity=0.265 Sum_probs=23.8
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+++.||+++ + .+.++||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 689999999999998 4 88999998664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=82.38 E-value=0.92 Score=37.93 Aligned_cols=29 Identities=24% Similarity=0.339 Sum_probs=25.9
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.|++++.++.+.++||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 78999999999999977789999997654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=81.07 E-value=0.67 Score=39.10 Aligned_cols=28 Identities=21% Similarity=0.407 Sum_probs=23.4
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.||+++++. +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 689999999999998664 8999997654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.89 E-value=4.5 Score=31.63 Aligned_cols=115 Identities=11% Similarity=0.078 Sum_probs=75.0
Q ss_pred ccCCceeeeceeeeecCceeEEEeecCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeeccCCCC
Q 044568 46 IRGGLLLNVPVRAKLTSVSGKIERPVRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGIL-YLHDECEPPILHCDIKPQ 123 (257)
Q Consensus 46 ~~h~~i~~~~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~-~lh~~~~~~i~h~dl~~~ 123 (257)
..|+.+ -..+-..++...+.++.-+++ ++..+ . .++..++++++..++.... +++ .-+|--++|.
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 345655 222334556666666655444 55533 3 3788999999999888766 554 4478889999
Q ss_pred ceeeCCCCceEEeeecccccCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCC
Q 044568 124 NILMDEFWTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNME 192 (257)
Q Consensus 124 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~ 192 (257)
|+.++.++.+++.-.|+-. -++|.- .+...=+-.+=|++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~--------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE--------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT--------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc--------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999888632 133321 1222223346678888888888775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=80.45 E-value=1.4 Score=38.70 Aligned_cols=15 Identities=33% Similarity=0.698 Sum_probs=14.2
Q ss_pred CeeeccCCCCceeeC
Q 044568 114 PILHCDIKPQNILMD 128 (257)
Q Consensus 114 ~i~h~dl~~~nil~~ 128 (257)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 689999999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 257 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-25 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-24 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-24 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-23 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-22 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-22 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-20 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-20 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-20 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-18 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-18 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-17 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-17 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-16 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-16 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-14 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-14 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-14 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-13 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-12 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-11 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-30
Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
SL + + + + IA A+G+ YLH I+H D+K NI + E
Sbjct: 85 CEGSSLYHHLHIIETKFE-MIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHED 140
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK-----GYMAPECYK---RTPISVKADVYGYGIVLL 182
T KI DFGLA + + + ++ +MAPE + + P S ++DVY +GIVL
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200
Query: 183 ETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242
E + + + + ++II V + +++ +L +KV + + ++ C++
Sbjct: 201 ELMTGQLPYS-NINNRDQII--FMVGRGYLSPDL------SKVRSNCPKAMKRLMAECLK 251
Query: 243 DEPALRP-MKCAVMML 257
+ RP + +
Sbjct: 252 KKRDERPLFPQILASI 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-27
Identities = 42/190 (22%), Positives = 77/190 (40%), Gaps = 21/190 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + ++ +LDV + + YL +H D+ +N+L+ E
Sbjct: 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSED 139
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKN 190
AK+ DFGL K + K + APE + S K+DV+ +GI+L E +
Sbjct: 140 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199
Query: 191 MEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN--LENLVKVGLWCVQDEPALR 248
++++ ++ +G K+D + + +V C + A+R
Sbjct: 200 PY-PRIPLKDVV--------------PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244
Query: 249 P-MKCAVMML 257
P L
Sbjct: 245 PSFLQLREQL 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-27
Identities = 37/188 (19%), Positives = 77/188 (40%), Gaps = 10/188 (5%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL ++ ++++ V KG+ YL ++ I+H D+KP NIL++
Sbjct: 86 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR 141
Query: 131 WTAKILDFGLAKLPNEDFVIDKR-DKGYMAPECYKRTPISVKADVYGYGIVLLETICCR- 188
K+ DFG++ + + YM+PE + T SV++D++ G+ L+E R
Sbjct: 142 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
Query: 189 ----KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDE 244
+ + + + R + + +D + + ++ + V +
Sbjct: 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261
Query: 245 PALRPMKC 252
P P
Sbjct: 262 PPKLPSGV 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-27
Identities = 46/213 (21%), Positives = 74/213 (34%), Gaps = 29/213 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNI 125
+GSL D + +++AL A G+ +LH E +P I H D+K +NI
Sbjct: 83 HEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 126 LMDEFWTAKILDFGLAKLPNEDFVIDKRD-------KGYMAPECY------KRTPISVKA 172
L+ + T I D GLA + K YMAPE K +A
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199
Query: 173 DVYGYGIVLLETICCRKNMEIDASKP---EEIILTNWVYKCFINRELNKLVRGTKVDKKN 229
D+Y G+V E I +++ ++ + + +R ++
Sbjct: 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 230 ----LENLVKVGLWCVQDEPALRP-MKCAVMML 257
L + K+ C A R L
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-27
Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 21/192 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL D + + N+ + +A +A+G+ ++ E +H D++ NIL+ +
Sbjct: 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDT 145
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK----GYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ KI DFGLA+L ++ + + APE ++K+DV+ +GI+L E +
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
+ + PE I Y+ E L ++ C ++ P
Sbjct: 206 HGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-------------EELYQLMRLCWKERPE 252
Query: 247 LRP-MKCAVMML 257
RP +L
Sbjct: 253 DRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 2e-25
Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 25/194 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSL D + + Q V +A +A G+ Y+ +H D++ NIL+ E
Sbjct: 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 149
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK----GYMAPECYKRTPISVKADVYGYGIVLLETIC 186
K+ DFGLA+L ++ ++ + APE ++K+DV+ +GI+L E
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK--VDKKNLENLVKVGLWCVQDE 244
+ E+ L+++ RG + + E+L + C + E
Sbjct: 210 KGRVPY-PGMVNREV--------------LDQVERGYRMPCPPECPESLHDLMCQCWRKE 254
Query: 245 PALRP-MKCAVMML 257
P RP + L
Sbjct: 255 PEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 2e-25
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 25/188 (13%)
Query: 71 VRNGSLTDIIFCSAERNPY--WNQRVRIALDVAKGILYLHD--ECEPPILHCDIKPQNIL 126
G L +I + Y +R+ + + H + +LH D+KP N+
Sbjct: 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 146
Query: 127 MDEFWTAKILDFGLAKLPNEDFVIDKRDK---GYMAPECYKRTPISVKADVYGYGIVLLE 183
+D K+ DFGLA++ N D K YM+PE R + K+D++ G +L E
Sbjct: 147 LDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 206
Query: 184 TICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT--KVDKKNLENLVKVGLWCV 241
A +E+ K+ G ++ + + L ++ +
Sbjct: 207 LCALMPPF--TAFSQKEL--------------AGKIREGKFRRIPYRYSDELNEIITRML 250
Query: 242 QDEPALRP 249
+ RP
Sbjct: 251 NLKDYHRP 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 3e-25
Identities = 40/181 (22%), Positives = 65/181 (35%), Gaps = 18/181 (9%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM-DE 129
+ +G+L + + + KG+ +LH PPI+H D+K NI +
Sbjct: 94 MTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGP 150
Query: 130 FWTAKILDFGLAKLPNEDFVIDKR-DKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
+ KI D GLA L F +MAPE Y+ DVY +G+ +LE
Sbjct: 151 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
Query: 189 KNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALR 248
I R + V+ DK + + ++ C++ R
Sbjct: 210 YPYS------------ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 249 P 249
Sbjct: 258 Y 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 2e-24
Identities = 35/192 (18%), Positives = 76/192 (39%), Gaps = 22/192 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ +G L+D + + + LDV +G + E ++H D+ +N L+ E
Sbjct: 82 MEHGCLSDYLRTQRGLFA-AETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGEN 137
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK----GYMAPECYKRTPISVKADVYGYGIVLLETIC 186
K+ DFG+ + +D + +PE + + S K+DV+ +G+++ E
Sbjct: 138 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
K + S E + + ++ + R + ++ ++ C ++ P
Sbjct: 198 EGKIPYENRSNSEVVEDISTGFRLYKPRLAS-------------THVYQIMNHCWKERPE 244
Query: 247 LRP-MKCAVMML 257
RP + L
Sbjct: 245 DRPAFSRLLRQL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 3e-24
Identities = 38/196 (19%), Positives = 68/196 (34%), Gaps = 28/196 (14%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + E P + + V+ G+ YL + +H D+ +N+L+
Sbjct: 90 AGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNR 145
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVLLET 184
AKI DFGL+K D + APEC S ++DV+ YG+ + E
Sbjct: 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN--LENLVKVGLWCVQ 242
+ + K E++ + +G +++ L + C
Sbjct: 206 LSYGQ-KPYKKMKGPEVM--------------AFIEQGKRMECPPECPPELYALMSDCWI 250
Query: 243 DEPALRP-MKCAVMML 257
+ RP +
Sbjct: 251 YKWEDRPDFLTVEQRM 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (236), Expect = 5e-24
Identities = 32/186 (17%), Positives = 64/186 (34%), Gaps = 25/186 (13%)
Query: 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNIL 126
I G++ + + ++A + Y H ++H DIKP+N+L
Sbjct: 84 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLL 138
Query: 127 MDEFWTAKILDFGLAK-LPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETI 185
+ KI DFG + P+ Y+ PE + K D++ G++ E +
Sbjct: 139 LGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198
Query: 186 CCRKNMEIDASKP--EEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQD 243
+ E + + + I + + F+ L+ ++
Sbjct: 199 VGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS-----------------RLLKH 241
Query: 244 EPALRP 249
P+ RP
Sbjct: 242 NPSQRP 247
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.4 bits (234), Expect = 2e-23
Identities = 44/196 (22%), Positives = 76/196 (38%), Gaps = 26/196 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NGSL + + + Q V + +A G+ YL D +H D+ +NIL++
Sbjct: 109 MENGSLDSFLRQNDGQFT-VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164
Query: 131 WTAKILDFGLAKLPNED--------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLL 182
K+ DFGL++ +D + K + APE + + +DV+ YGIV+
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224
Query: 183 ETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242
E + + D + + I Y+ + L ++ L C Q
Sbjct: 225 EVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP-------------SALHQLMLDCWQ 271
Query: 243 DEPALRP-MKCAVMML 257
+ RP V L
Sbjct: 272 KDRNHRPKFGQIVNTL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 2e-23
Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 25/195 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+++G L + I NP + L VAKG + +H D+ +N ++DE
Sbjct: 111 MKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEK 166
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK-------GYMAPECYKRTPISVKADVYGYGIVLLE 183
+T K+ DFGLA+ + +K +MA E + + K+DV+ +G++L E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 184 TICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQD 243
+ D + + R L + + + L +V L C
Sbjct: 227 LMTRGAPPYPDVN------TFDITVYLLQGRRLLQ-------PEYCPDPLYEVMLKCWHP 273
Query: 244 EPALRP-MKCAVMML 257
+ +RP V +
Sbjct: 274 KAEMRPSFSELVSRI 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.6 bits (232), Expect = 3e-23
Identities = 39/192 (20%), Positives = 74/192 (38%), Gaps = 25/192 (13%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
G+L D + + + +A ++ + YL + +H D+ +N L+ E
Sbjct: 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHL 153
Query: 133 AKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K+ DFGL++L D K + APE S+K+DV+ +G++L E
Sbjct: 154 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 189 KNM--EIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
+ ID S+ E++ ++ + + E + ++ C Q P+
Sbjct: 214 MSPYPGIDLSQVYELLEKDYRMER---------------PEGCPEKVYELMRACWQWNPS 258
Query: 247 LRP-MKCAVMML 257
RP
Sbjct: 259 DRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 3e-23
Identities = 39/194 (20%), Positives = 77/194 (39%), Gaps = 26/194 (13%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ NG L + + R Q + + DV + + YL LH D+ +N L+++
Sbjct: 81 MANGCLLNYLREMRHRFQ-TQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQ 136
Query: 131 WTAKILDFGLAKLPNED----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
K+ DFGL++ +D V K + PE + S K+D++ +G+++ E
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL--ENLVKVGLWCVQDE 244
K M + E + +G ++ + +L E + + C ++
Sbjct: 197 LGK-MPYERFTNSETA--------------EHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241
Query: 245 PALRP-MKCAVMML 257
RP K + +
Sbjct: 242 ADERPTFKILLSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 3e-23
Identities = 39/192 (20%), Positives = 71/192 (36%), Gaps = 23/192 (11%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
D + Q V + +A G+ YL +H D+ +NIL++
Sbjct: 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV 148
Query: 133 AKILDFGLAKLPNEDFVIDKRDKG------YMAPECYKRTPISVKADVYGYGIVLLETIC 186
K+ DFGL+++ +D G + APE + +DV+ +GIV+ E +
Sbjct: 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 208
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
+ + S E + N ++ + + ++ + C Q E A
Sbjct: 209 YGERPYWELSNHEVMKAINDGFRLPTPMDC-------------PSAIYQLMMQCWQQERA 255
Query: 247 LRP-MKCAVMML 257
RP V +L
Sbjct: 256 RRPKFADIVSIL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 7e-23
Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148
Q + A DVA+G+ YL + +H D+ +NIL+ E + AKI DFGL++
Sbjct: 126 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 149 -VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWV 207
+ + +MA E + + +DV+ YG++L E + + E
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 236
Query: 208 YKCFINRELNKLVRGTKVDKKN--LENLVKVGLWCVQDEPALRP-MKCAVMML 257
KL +G +++K + + + C +++P RP ++ L
Sbjct: 237 ---------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 3e-22
Identities = 39/196 (19%), Positives = 68/196 (34%), Gaps = 29/196 (14%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + R+ + + V+ G+ YL + +H D+ +N+L+
Sbjct: 89 AELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ 143
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVLLET 184
AKI DFGL+K D K + APEC S K+DV+ +G+++ E
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN--LENLVKVGLWCVQ 242
+ K E+ L +G ++ + + C
Sbjct: 204 FSYGQKP-YRGMKGSEV--------------TAMLEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 243 DEPALRP-MKCAVMML 257
+ RP + L
Sbjct: 249 YDVENRPGFAAVELRL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 3e-22
Identities = 40/176 (22%), Positives = 62/176 (35%), Gaps = 25/176 (14%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ + A VAKG+ +L +H D+ +N+L+ KI DFGLA+ D
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 150 IDKRDK-----GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204
R +MAPE ++K+DV+ YGI+L E N
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--- 276
Query: 205 NWVYKCFINRELNKLVRGTKVDKKNL--ENLVKVGLWCVQDEPALRP-MKCAVMML 257
+ G K+D+ E + + C + RP L
Sbjct: 277 -----------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.1 bits (225), Expect = 3e-22
Identities = 38/174 (21%), Positives = 59/174 (33%), Gaps = 22/174 (12%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+++ IA VA G+ YL E +H D+ +N L+ E KI DFGL++
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 150 IDKRDK-----GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204
+M PE + ++DV+ YG+VL E + E
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----- 250
Query: 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
V + + L + C PA RP +L
Sbjct: 251 --VIYYVRDGNILACPENC------PLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (223), Expect = 5e-22
Identities = 41/187 (21%), Positives = 66/187 (35%), Gaps = 24/187 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G++ ++ ER +Q + + YLH + I+H D+K NIL
Sbjct: 91 CAGGAVDAVM-LELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLD 146
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPEC-----YKRTPISVKADVYGYGIVLL 182
K+ DFG++ G +MAPE K P KADV+ GI L+
Sbjct: 147 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 206
Query: 183 ETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242
E P + V E L + ++ N ++ +K C++
Sbjct: 207 EMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRWS-SNFKDFLK---KCLE 254
Query: 243 DEPALRP 249
R
Sbjct: 255 KNVDARW 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (213), Expect = 1e-20
Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 23/183 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ GSLTD++ E Q + + + + +LH ++H DIK NIL+
Sbjct: 99 LAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 152
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
+ K+ DFG + G +MAPE R K D++ GI+ +E I
Sbjct: 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 188 RK-NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
+ + + +I TN + +L+ + R + + C+ +
Sbjct: 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR----------DFLN---RCLDMDVE 259
Query: 247 LRP 249
R
Sbjct: 260 KRG 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 2e-20
Identities = 42/166 (25%), Positives = 62/166 (37%), Gaps = 21/166 (12%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
R + G++YLH I H DIKP+N+L+DE KI DFGLA + +
Sbjct: 102 EPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158
Query: 150 IDKRDK-----GYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIIL 203
+K Y+APE KR + DV+ GIVL + D
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEY 216
Query: 204 TNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249
++W K K+ L+ + + P+ R
Sbjct: 217 SDWKEKKTYLNPWKKI-------DSAPLALLH---KILVENPSARI 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 2e-20
Identities = 38/193 (19%), Positives = 76/193 (39%), Gaps = 27/193 (13%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
G L D + + + + +AKG+ YL + ++H D+ +N+L+
Sbjct: 94 FGCLLDYVREHKDNIG-SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQH 149
Query: 133 AKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGYGIVLLETICC 187
KI DFGLAKL + + G +MA E + ++DV+ YG+ + E +
Sbjct: 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE-LMT 208
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL--ENLVKVGLWCVQDEP 245
+ D EI + L +G ++ + + ++ + + C +
Sbjct: 209 FGSKPYDGIPASEIS--------------SILEKGERLPQPPICTIDVYMIMVKCWMIDA 254
Query: 246 ALRP-MKCAVMML 257
RP + ++
Sbjct: 255 DSRPKFRELIIEF 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.0 bits (210), Expect = 4e-20
Identities = 34/163 (20%), Positives = 55/163 (33%), Gaps = 20/163 (12%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ + +G+ YLH ++H D+K NIL+ E K+ DFG A +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170
Query: 150 IDKRDKGYMAPE---CYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNW 206
+MAPE K DV+ GI +E + + + +
Sbjct: 171 F-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 207 VYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249
+ ++ R N V C+Q P RP
Sbjct: 230 ESPALQSGHWSEYFR----------NFVD---SCLQKIPQDRP 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 6e-20
Identities = 36/174 (20%), Positives = 68/174 (39%), Gaps = 21/174 (12%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL--PNED 147
+ + VAKG+ +L +H D+ +NIL+ KI DFGLA+ + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 148 FVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204
+V+ + +MAPE + ++DV+ YGI L E + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK- 259
Query: 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
+ +E +++ + + + C +P RP K V ++
Sbjct: 260 -------MIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 7e-20
Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 23/194 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
GSL D + R A+ VA+G+ YL +H D+ +N+L+
Sbjct: 92 APLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATR 147
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVLLET 184
KI DFGL + ++ + + APE K S +D + +G+ L E
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDE 244
+ I + + + I++E +L R +++ V + C +
Sbjct: 208 FTYGQEPWIGLNGSQILHK--------IDKEGERLPRPEDCP----QDIYNVMVQCWAHK 255
Query: 245 PALRP-MKCAVMML 257
P RP L
Sbjct: 256 PEDRPTFVALRDFL 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 84.7 bits (209), Expect = 1e-19
Identities = 25/122 (20%), Positives = 51/122 (41%), Gaps = 8/122 (6%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM--D 128
+ G L + + + ++ V V KG+ ++H+ +H D+KP+NI+
Sbjct: 105 MSGGELFEKVADEHNKMS-EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 160
Query: 129 EFWTAKILDFGLAKL--PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
K++DFGL P + + + APE + P+ D++ G++ +
Sbjct: 161 RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220
Query: 187 CR 188
Sbjct: 221 GL 222
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 2e-19
Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 21/174 (12%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ + VAKG+ +L +H D+ +NIL+ E KI DFGLA+ +D
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 150 IDKRDK-----GYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILT 204
++ +MAPE ++++DV+ +G++L E + EE
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247
Query: 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257
R L + R D + + L C EP+ RP V L
Sbjct: 248 ---------RRLKEGTRMRAPD-YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.8 bits (204), Expect = 3e-19
Identities = 33/144 (22%), Positives = 55/144 (38%), Gaps = 5/144 (3%)
Query: 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140
+ A +V L L I++ D+KP+NIL+D+ KI DFG
Sbjct: 94 LLRKSQRFPNPVAKFYAAEVC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150
Query: 141 AKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK--NMEIDASKP 198
AK + Y+APE P + D + +GI++ E +
Sbjct: 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 199 EEIILTNWVYKCFINRELNKLVRG 222
E+I+ + F N ++ L+
Sbjct: 211 EKILNAELRFPPFFNEDVKDLLSR 234
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-18
Identities = 36/192 (18%), Positives = 66/192 (34%), Gaps = 22/192 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
G L + + A ++ + YL +H DI +N+L+
Sbjct: 89 CTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 144
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETIC 186
K+ DFGL++ + + + + K +MAPE + +DV+ +G+ + E +
Sbjct: 145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204
Query: 187 CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPA 246
KP + + N V N E + L + C +P+
Sbjct: 205 HGV-------KPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSLMTKCWAYDPS 251
Query: 247 LRP-MKCAVMML 257
RP L
Sbjct: 252 RRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 2e-18
Identities = 42/207 (20%), Positives = 69/207 (33%), Gaps = 36/207 (17%)
Query: 71 VRNGSLTDIIFC--------------SAERNPYWNQRVRIALDVAKGILYLHDECEPPIL 116
G+L + + + E V A VA+G+ YL +
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCI 157
Query: 117 HCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK-----GYMAPECYKRTPISVK 171
H D+ +N+L+ E KI DFGLA+ + K +MAPE + +
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217
Query: 172 ADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231
+DV+ +G++L E + P + ++K
Sbjct: 218 SDVWSFGVLLWEIFTLGGS-------PYPGVPVEELFKLLKEGHRMDK------PSNCTN 264
Query: 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257
L + C P+ RP K V L
Sbjct: 265 ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.7 bits (196), Expect = 3e-18
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 10/123 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+NG L I + A+ + L I+H D+KP+NIL++E
Sbjct: 90 AKNGELLKYIRKIGSFDETC-----TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK-----GYMAPECYKRTPISVKADVYGYGIVLLETI 185
+I DFG AK+ + + + + Y++PE +D++ G ++ + +
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 186 CCR 188
Sbjct: 205 AGL 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.6 bits (193), Expect = 2e-17
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 12/159 (7%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G L + S A ++ G+ ++H+ +++ D+KP NIL+DE
Sbjct: 89 MNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH 143
Query: 131 WTAKILDFGLAK-LPNEDFVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCR 188
+I D GLA + GYMAPE ++ AD + G +L + +
Sbjct: 144 GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
Query: 189 KNMEIDASKPEEIILTNWVYKCF-----INRELNKLVRG 222
+K + I + + EL L+ G
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 2e-17
Identities = 39/201 (19%), Positives = 75/201 (37%), Gaps = 30/201 (14%)
Query: 71 VRNGSLTDIIFC--------SAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKP 122
+ G L + P ++ +++A ++A G + +H D+
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG---MAYLNANKFVHRDLAA 161
Query: 123 QNILMDEFWTAKILDFGLAKLPNEDFVIDKRDKG-----YMAPECYKRTPISVKADVYGY 177
+N ++ E +T KI DFG+ + E K KG +M+PE K + +DV+ +
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221
Query: 178 GIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVG 237
G+VL E + P + + V + + L + L ++
Sbjct: 222 GVVLWEIATLAEQ-------PYQGLSNEQVLRFVMEGGLLDKPDNC------PDMLFELM 268
Query: 238 LWCVQDEPALRP-MKCAVMML 257
C Q P +RP + +
Sbjct: 269 RMCWQYNPKMRPSFLEIISSI 289
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.8 bits (191), Expect = 3e-17
Identities = 32/184 (17%), Positives = 63/184 (34%), Gaps = 15/184 (8%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G L I ++ + I + + I YLH I H D+KP+N+L
Sbjct: 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSK 147
Query: 131 W---TAKILDFGLAKLPNEDFVIDKRDK--GYMAPECYKRTPISVKADVYGYGIVLLETI 185
K+ DFG AK + Y+APE D++ G+++ +
Sbjct: 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207
Query: 186 CCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEP 245
C + + ++ + + + ++ L++ ++ EP
Sbjct: 208 CGYPPFYSN----HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEP 260
Query: 246 ALRP 249
R
Sbjct: 261 TQRM 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 3e-17
Identities = 38/182 (20%), Positives = 67/182 (36%), Gaps = 23/182 (12%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G L I + + ++ A ++ G+ +L I++ D+K NIL+D+
Sbjct: 85 LNGGDLMYHIQSCHKFD--LSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKD 139
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICC 187
KI DFG+ K G Y+APE + D + +G++L E +
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
Query: 188 RKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPAL 247
+ EE+ + + F R L K ++L+ EP
Sbjct: 200 Q--SPFHGQDEEELFHSIRMDNPFYPRWLE----------KEAKDLLV---KLFVREPEK 244
Query: 248 RP 249
R
Sbjct: 245 RL 246
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 76.6 bits (188), Expect = 7e-17
Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 8/122 (6%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
+ G L D I + + + +G+ ++H E I+H DIKP+NI+ +
Sbjct: 108 LSGGELFDRIAAEDYKMS-EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETK 163
Query: 131 --WTAKILDFGLAKL--PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
+ KI+DFGLA P+E + + APE R P+ D++ G++ +
Sbjct: 164 KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 187 CR 188
Sbjct: 224 GL 225
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 75.1 bits (184), Expect = 1e-16
Identities = 26/126 (20%), Positives = 53/126 (42%), Gaps = 13/126 (10%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
++ G L D + + + + +I + + I LH I+H D+KP+NIL+D+
Sbjct: 92 MKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD 146
Query: 131 WTAKILDFGLAKLPNEDFVIDKR--DKGYMAPECY------KRTPISVKADVYGYGIVLL 182
K+ DFG + + + + Y+APE + D++ G+++
Sbjct: 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206
Query: 183 ETICCR 188
+
Sbjct: 207 TLLAGS 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 72.9 bits (178), Expect = 8e-16
Identities = 33/185 (17%), Positives = 68/185 (36%), Gaps = 22/185 (11%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130
V +L DI+ E + + + D + + + + I+H D+KP NI++
Sbjct: 93 VDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISAT 147
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK------GYMAPECYKRTPISVKADVYGYGIVLLET 184
K++DFG+A+ + + Y++PE + + ++DVY G VL E
Sbjct: 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207
Query: 185 ICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDE 244
+ P + + ++ + +L+ +V +
Sbjct: 208 LTGEPPF--TGDSPVSVAYQHVREDPIPPSARHEGL------SADLDAVVL---KALAKN 256
Query: 245 PALRP 249
P R
Sbjct: 257 PENRY 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 1e-15
Identities = 38/187 (20%), Positives = 60/187 (32%), Gaps = 20/187 (10%)
Query: 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139
I + L +G+ YLH ILH D+KP N+L+DE K+ DFG
Sbjct: 89 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 145
Query: 140 LAKLPNEDFVIDKRDKG---YMAPECYKR-TPISVKADVYGYGIVLLETIC--------- 186
LAK Y APE V D++ G +L E +
Sbjct: 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 187 ----CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQ 242
+ E + EE ++ + + + ++L+ +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265
Query: 243 DEPALRP 249
P R
Sbjct: 266 FNPCARI 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 1e-15
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 5/118 (4%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
+ LT + E + + +G+ +LH ++H D+KPQNIL+
Sbjct: 98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154
Query: 133 AKILDFGLAKLPNEDFVIDKR--DKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
K+ DFGLA++ + + Y APE ++ + D++ G + E +
Sbjct: 155 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (177), Expect = 2e-15
Identities = 29/122 (23%), Positives = 53/122 (43%), Gaps = 8/122 (6%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-- 128
+ + + I SA + V V + + +LH I H DI+P+NI+
Sbjct: 83 ISGLDIFERINTSAFELN-EREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTR 138
Query: 129 EFWTAKILDFGLAKL--PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC 186
T KI++FG A+ P ++F + Y APE ++ +S D++ G ++ +
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 187 CR 188
Sbjct: 199 GI 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 3e-15
Identities = 40/180 (22%), Positives = 63/180 (35%), Gaps = 27/180 (15%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-EFW 131
F + V + + + +LH DIK +NIL+D
Sbjct: 92 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRG 148
Query: 132 TAKILDFGLAKLPNEDFVIDKR-DKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRK 189
K++DFG L + D + Y PE + A V+ GI+L + +C
Sbjct: 149 ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
Query: 190 NMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249
E D EEII ++ ++ E L+R WC+ P+ RP
Sbjct: 209 PFEHD----EEIIRGQVFFRQRVSSECQHLIR-----------------WCLALRPSDRP 247
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.5 bits (169), Expect = 1e-14
Identities = 31/189 (16%), Positives = 59/189 (31%), Gaps = 23/189 (12%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILM---DEF 130
G + +F R + +A + I Y+H + +H D+KP N LM +
Sbjct: 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKG 142
Query: 131 WTAKILDFGLAKLPNEDFVIDKRDK----------GYMAPECYKRTPISVKADVYGYGIV 180
I+DFGLAK + Y + + S + D+ G V
Sbjct: 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202
Query: 181 LLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWC 240
L+ + + + + ++ + L +G + +C
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCKGY---PSEFATYLN---FC 255
Query: 241 VQDEPALRP 249
+P
Sbjct: 256 RSLRFDDKP 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 69.1 bits (168), Expect = 2e-14
Identities = 27/191 (14%), Positives = 53/191 (27%), Gaps = 25/191 (13%)
Query: 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT- 132
G + + R A + + +H E +++ DIKP N L+ +
Sbjct: 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSK 140
Query: 133 ----AKILDFGLAKLPNEDFVIDKRDK----------GYMAPECYKRTPISVKADVYGYG 178
++DFG+ K + YM+ + S + D+ G
Sbjct: 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200
Query: 179 IVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGL 238
V + + + + + + L +L G E K
Sbjct: 201 HVFMYFLRGSLPWQ-GLKAATNKQKYERIGEKKQSTPLRELCAGFP------EEFYKYMH 253
Query: 239 WCVQDEPALRP 249
+ P
Sbjct: 254 YARNLAFDATP 264
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 2e-14
Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWT 132
+ L + SA + +G+ + H +LH D+KPQN+L++
Sbjct: 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGA 140
Query: 133 AKILDFGLAKL---PNEDFVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCR 188
K+ DFGLA+ P + + Y APE S D++ G + E + R
Sbjct: 141 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.1 bits (168), Expect = 3e-14
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 3/99 (3%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
A + YLH +++ D+KP+N+L+D+ ++ DFG AK
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
+APE + D + G+++ E
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 6e-14
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 10/106 (9%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
+ + +G+ Y+H +LH D+KP N+L++ KI DFGLA++ + D
Sbjct: 108 NDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164
Query: 150 IDKR------DKGYMAPEC-YKRTPISVKADVYGYGIVLLETICCR 188
+ Y APE + D++ G +L E + R
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 7e-14
Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 3/106 (2%)
Query: 86 RNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145
R A+ + L +++ DIK +N+++D+ KI DFGL K
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 146 EDFVIDKRDKG---YMAPECYKRTPISVKADVYGYGIVLLETICCR 188
D K G Y+APE + D +G G+V+ E +C R
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 67.0 bits (163), Expect = 1e-13
Identities = 32/121 (26%), Positives = 46/121 (38%), Gaps = 6/121 (4%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE 129
V G L D I E+ Y R+ V + YLHD +DE
Sbjct: 89 VSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDE 145
Query: 130 FWTAKILDFGLAKLPNEDFVIDKR--DKGYMAPECYKRTPISVKADVYGYGIVLLETICC 187
I DFGL+K+ + V+ GY+APE + P S D + G++ +C
Sbjct: 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
Query: 188 R 188
Sbjct: 206 Y 206
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 3e-13
Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 8/123 (6%)
Query: 71 VRNGSLTDIIFCSAERNPY-WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI-LMD 128
V S + + + + Y+H I H DIKPQN+ L
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP 157
Query: 129 EFWTAKILDFGLAKL--PNEDFVIDKRDKGYMAP-ECYKRTPISVKADVYGYGIVLLETI 185
+ K+ DFG AK E V + Y AP + T + DV+ G VL E +
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 186 CCR 188
+
Sbjct: 218 LGQ 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.6 bits (156), Expect = 8e-13
Identities = 25/113 (22%), Positives = 45/113 (39%), Gaps = 7/113 (6%)
Query: 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGL 140
F S + + KG+ + H +LH D+KPQN+L++ K+ +FGL
Sbjct: 91 FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL 147
Query: 141 AKL---PNEDFVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRK 189
A+ P + + Y P+ + S D++ G + E +
Sbjct: 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (157), Expect = 9e-13
Identities = 34/180 (18%), Positives = 63/180 (35%), Gaps = 26/180 (14%)
Query: 90 WNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149
++ + + KG+ Y+H H D+KP N+ ++E KILDFGLA+ + +
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 150 IDKRDKGYMAPECY-KRTPISVKADVYGYGIVLLETICCR-------------KNMEIDA 195
+ Y APE + D++ G ++ E I + + M++
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 196 SKPEEII------LTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP 249
+ P E + K E NL++ + + R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRV 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (153), Expect = 3e-12
Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 9/114 (7%)
Query: 81 FCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTA----KIL 136
F + + + + + G ++ I H D+KP+NI++ + KI+
Sbjct: 103 FLAEKESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 137 DFGLAKL--PNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
DFGLA +F ++APE P+ ++AD++ G++ +
Sbjct: 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 62.6 bits (151), Expect = 4e-12
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 7/108 (6%)
Query: 85 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL- 143
E L + GI Y H + +LH D+KPQN+L++ KI DFGLA+
Sbjct: 94 EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF 150
Query: 144 --PNEDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCR 188
P + + Y AP+ + S D++ G + E +
Sbjct: 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (149), Expect = 1e-11
Identities = 26/105 (24%), Positives = 49/105 (46%), Gaps = 4/105 (3%)
Query: 85 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144
+ + + + +G+ Y+H I+H D+KP N+ ++E KILDFGLA+
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 145 NEDFVIDKRDKGYMAPECY-KRTPISVKADVYGYGIVLLETICCR 188
+++ + Y APE + D++ G ++ E + R
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.6 bits (148), Expect = 1e-11
Identities = 29/117 (24%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE------FW 131
+I R +I+ + G+ Y+H I+H DIKP+N+LM+
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI 169
Query: 132 TAKILDFGLAKLPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
KI D G A +E + + + Y +PE P AD++ ++ E I
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 5e-11
Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 11/117 (9%)
Query: 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139
+ + ++ R+ + G L+ ILH D+K N+L+ K+ DFG
Sbjct: 106 LLSNVLVKFTLSEIKRVMQMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162
Query: 140 LAKLPNEDFVIDKRDK-------GYMAPECY-KRTPISVKADVYGYGIVLLETICCR 188
LA+ + Y PE D++G G ++ E
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.3 bits (132), Expect = 1e-09
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 85 ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144
+ + + + GI +LH I+H D+KP NI++ T KILDFGLA+
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 145 NEDFVIDKRD--KGYMAPECYKRTPISVKADVYGYGIVLLETICCR 188
F++ + Y APE D++ G ++ E + +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 55.2 bits (132), Expect = 1e-09
Identities = 24/122 (19%), Positives = 49/122 (40%), Gaps = 12/122 (9%)
Query: 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD-E 129
V N + + ++ K + Y H I+H D+KP N+++D E
Sbjct: 114 VNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 165
Query: 130 FWTAKILDFGLAKL--PNEDFVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETIC 186
+++D+GLA+ P +++ + + + PE D++ G +L I
Sbjct: 166 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 187 CR 188
+
Sbjct: 226 RK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 4e-09
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 6/100 (6%)
Query: 95 RIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL----PNEDFVI 150
+ + V + +L L + I++ DIK +NIL+D + DFGL+K E
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 151 DKRDKGYMAPECY--KRTPISVKADVYGYGIVLLETICCR 188
YMAP+ + D + G+++ E +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 49.4 bits (117), Expect = 6e-08
Identities = 12/71 (16%), Positives = 25/71 (35%), Gaps = 4/71 (5%)
Query: 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW 131
N L ++I + + + + + I+H D+ N+L+ E
Sbjct: 84 GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE-E 139
Query: 132 TAKILDFGLAK 142
I+DF +
Sbjct: 140 GIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 257 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.24 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=323.37 Aligned_cols=229 Identities=17% Similarity=0.229 Sum_probs=178.8
Q ss_pred cccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.|+.||+|.+.+++.++||.+. |.+|++.+. +++|+||+++.+++...+..++|||||++|
T Consensus 15 ~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~---------~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 15 SGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM---------KLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHH---------hcCCCCcccccceeccCCceEEEEEecCCC
Confidence 467999999999888889998754 455666666 889999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 150 (257)
+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 86 CLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp BHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred cHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 99999976 567799999999999999999999999 99999999999999999999999999987543322 33
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNL 230 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
..+|+.|+|||.+.+..++.++|||||||++|||+|+..||...... ....... ... .....+..++
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i----------~~~-~~~~~p~~~~ 228 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDI----------STG-FRLYKPRLAS 228 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHH----------HHT-CCCCCCTTSC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHH----------Hhc-CCCCCccccC
Confidence 46788999999999999999999999999999999954444322111 1111110 010 0112344556
Q ss_pred HHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 231 ENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 231 ~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.+.+++.+||+.||++|| ++||++.|
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 7899999999999999999 99999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=324.26 Aligned_cols=229 Identities=23% Similarity=0.324 Sum_probs=177.7
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||+|++.. .+++|.+. |.+|++.+. +++|+||+++.+++. .+..+||||||+
T Consensus 19 G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 19 GSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR---------KTRHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp CSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHT---------TCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred CCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHH---------hCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 6799999998754 48888653 234444444 889999999998764 456899999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+|+|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 87 GSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9999999975 556799999999999999999999999 9999999999999999999999999998754322
Q ss_pred cccccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 148 FVIDKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ............+.. ..
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~p~~------~~ 233 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDL------SK 233 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSCCCCG------GG
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCCCcc------hh
Confidence 234578899999999864 358999999999999999999999997542211 111111111111110 12
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...++.+.+++.+||+.||.+|| ++||++.|
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 3445667899999999999999999 99998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-48 Score=325.96 Aligned_cols=227 Identities=19% Similarity=0.244 Sum_probs=173.9
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|+.||+|+....+. +++|... |.+|++.+. +++|+||+++.+++...+..++|||
T Consensus 37 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 37 GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG---------QFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp CSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHH---------hCCCCCCccEEEEEeeCCEEEEEEE
Confidence 6789999999765443 5566532 345555555 8899999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
||++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 108 y~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 108 FMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp CCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999999875 556799999999999999999999999 99999999999999999999999999997543222
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+... +..-
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----~~~~~---------i~~~- 249 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----DVINA---------IEQD- 249 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH---------HHTT-
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----HHHHH---------HHcC-
Confidence 12346778999999999999999999999999999998 89999754211 11110 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.....+.+.++.+.+++.+||+.||++|| ++||++.|
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 01133455678899999999999999999 99998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=317.92 Aligned_cols=222 Identities=17% Similarity=0.177 Sum_probs=184.0
Q ss_pred ccccceeeecccC-CCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+++... +..+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+|||||
T Consensus 17 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS---------HLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH---------hcCCCCCCeEEEEEEECCEEEEEEee
Confidence 6789999999764 5567787643 234444444 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Ccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFV 149 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~ 149 (257)
|++|+|.+++. ....+++.++..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 88 ~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 88 APLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp CTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred cCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 99999999997 446799999999999999999999999 999999999999999999999999999976543 335
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (257)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... .... ...+..
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~-------------i~~~~~~~p~~ 226 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKR-------------ISRVEFTFPDF 226 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH-------------HHTTCCCCCTT
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHH-------------HHcCCCCCCcc
Confidence 56789999999999999999999999999999999999999975421 111111 1111 133445
Q ss_pred HHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.++.+.+++.+||+.||++|| ++|+++
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 567889999999999999999 999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-48 Score=323.80 Aligned_cols=230 Identities=18% Similarity=0.199 Sum_probs=187.2
Q ss_pred cccccceeeecccC-CCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSFNA-RNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~~~-~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.|+.||+|.... +..+|+|.+. +.+|++.+. +++|+||+++.+.+...+..+||||||++
T Consensus 27 ~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 27 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK---------EIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp TTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHH---------HCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHH---------hCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 46799999999765 5568888754 455666666 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----c
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----V 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~ 149 (257)
|+|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 9999999876678899999999999999999999999 99999999999999999999999999998654332 2
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+++.|+|||.+.+..++.++|||||||++|||++|..||....... ....... .- .....+...
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~~~~~i~---------~~-~~~~~~~~~ 241 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE---------KD-YRMERPEGC 241 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---------TT-CCCCCCTTC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---HHHHHHh---------cC-CCCCCCccc
Confidence 2346778999999999999999999999999999999877765332111 1111100 00 011344556
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+.+++.+||+.||++|| ++|+++.|
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 77899999999999999999 99998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=322.59 Aligned_cols=227 Identities=17% Similarity=0.258 Sum_probs=179.7
Q ss_pred cccccceeeecccCCC---CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 3 CTKLSNFYRSSFNARN---SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~---~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
.+.|+.||+|....++ .++||.+. |.+|++.+. +++|+||+++.+.+.. +..+||||
T Consensus 19 ~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 19 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH---------QLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp CCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHH---------HCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred cccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHH---------hCCCCCEeeEeeeecc-CeEEEEEE
Confidence 3679999999865433 36777643 334555554 8899999999998864 56899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
||++|+|.+++.. ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 89 MAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp CCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred eCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 9999999999865 556799999999999999999999999 99999999999999999999999999998654322
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|+.|+|||.+....++.++|||||||++|||+| |+.||....... +... +... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----~~~~---------i~~~-~~ 230 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAF---------IEQG-KR 230 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HHHH---------HHTT-CC
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----HHHH---------HHcC-CC
Confidence 23356788999999998899999999999999999998 999997542111 1100 0000 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...++.+.+++.+||+.||++|| +.+|++.|
T Consensus 231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 134556678899999999999999999 99998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=317.96 Aligned_cols=226 Identities=21% Similarity=0.190 Sum_probs=182.1
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||+++.. +++.+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+||||||+
T Consensus 16 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~---------~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 16 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK---------MLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHH---------TCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHH---------hCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 578999999975 46667888643 345555555 8899999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-----
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED----- 147 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~----- 147 (257)
+|+|.+++. ....+++.++..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999999997 566899999999999999999999999 9999999999999999999999999999854321
Q ss_pred cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....||+.|+|||.+.+..+ +.++||||+||++|||++|+.||......... ...+... .......
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~~~----------~~~~~~~ 229 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEK----------KTYLNPW 229 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHHTT----------CTTSTTG
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHhcC----------CCCCCcc
Confidence 245578999999999988776 57899999999999999999999765332211 1111000 0000112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||++|| ++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23456788999999999999999 999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=320.60 Aligned_cols=228 Identities=21% Similarity=0.339 Sum_probs=182.9
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.|+.||+|.+.++..++||... |.+|++.+. +++|+||+++.+.+. .+..++|||||++|+
T Consensus 24 G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMK---------QLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (272)
T ss_dssp ETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred CCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHH---------hCCCCCEeEEEeeec-cCCeEEEEEeCCCCc
Confidence 67899999999888889998764 345555555 889999999999764 466799999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|.+++.......+++.++..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 99998754555799999999999999999999999 99999999999999999999999999998654322 344
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.+|+.|+|||.+....++.++|||||||++|||+||..||....... ..... +.... ....+...++
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~----------i~~~~-~~~~p~~~~~ 237 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQN----------LERGY-RMVRPDNCPE 237 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----------HHTTC-CCCCCTTCCH
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHH----------HHhcC-CCCCcccChH
Confidence 67788999999998889999999999999999999766654331111 11111 11111 1123455667
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.+++.+||+.||++|| ++||++.|
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 899999999999999999 99998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=318.10 Aligned_cols=226 Identities=18% Similarity=0.144 Sum_probs=183.9
Q ss_pred cccccceeeecc-cCCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
.+.++.||++.. .+++.+++|.+.. .+|++.+. ++.|+||+++.+.+...+..+||||||+
T Consensus 30 ~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR---------ENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp CSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHH---------hCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 367999999985 4566788886543 34444444 8899999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Ccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~ 149 (257)
+|+|.+++.+ ..+++.++..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 101 gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp TCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9999998864 4699999999999999999999999 999999999999999999999999999986432 234
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+.... .........+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~---------~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIA---------TNGTPELQNPEKL 242 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH---------HHCSCCCSSGGGS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHHH---------hCCCCCCCCcccC
Confidence 557899999999999999999999999999999999999999754211 1111100 0111111334455
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+.+++.+||+.||++|| ++|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67899999999999999999 999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=318.65 Aligned_cols=225 Identities=17% Similarity=0.248 Sum_probs=178.8
Q ss_pred ccccceeeecccCCC---CCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARN---SPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~---~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|+.||+|.+..+. .+++|... +.+|++.+. +++|+||+++.+++.. +..+||||
T Consensus 18 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~g~~~~-~~~~lvmE 87 (277)
T d1xbba_ 18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ---------QLDNPYIVRMIGICEA-ESWMLVME 87 (277)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHH---------hCCCCCCceEEEEecc-CCEEEEEE
Confidence 678999999865443 46777643 344555555 8899999999998854 56789999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc-
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF- 148 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~- 148 (257)
||++|+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||+++......
T Consensus 88 ~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 88 MAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cCCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999999998 456799999999999999999999999 99999999999999999999999999997543322
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+... .... ..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~----i~~~------~~ 228 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM----LEKG------ER 228 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTT------CC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHHH----HHcC------CC
Confidence 23467888999999999899999999999999999998 89999754211 11110 0000 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...++.+.+++.+||+.||++|| ++||.+.|
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 134555678899999999999999999 99997654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=313.73 Aligned_cols=228 Identities=17% Similarity=0.217 Sum_probs=187.8
Q ss_pred cccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 3 CTKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
.+.|+.||+|+..++..++||... |.+|++.+. ++.|+||+++.+++...+..++||||+++|
T Consensus 14 ~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~---------~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 14 TGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM---------NLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp EETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHH---------TCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred cCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHH---------hcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 367999999999877788888643 345666555 889999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----cc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 150 (257)
+|.+++.. ....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 85 CLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred cHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 99999875 566789999999999999999999999 99999999999999999999999999987543322 33
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
..+|+.|+|||.+....++.++||||||+++|||+| |+.||...... + .... +... .....+...
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~-~~~~----------i~~~-~~~~~p~~~ 226 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--E-TAEH----------IAQG-LRLYRPHLA 226 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--H-HHHH----------HHTT-CCCCCCTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--H-HHHH----------HHhC-CCCCCcccc
Confidence 467788999999999999999999999999999998 89999755211 1 1110 1110 111334556
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
++.+.+++.+||+.||++|| ++||++.|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 67899999999999999999 99998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=317.02 Aligned_cols=228 Identities=17% Similarity=0.153 Sum_probs=183.1
Q ss_pred cccccceeeeccc-CCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
.+.++.||++... ++..+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+||||||+
T Consensus 22 ~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~---------~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 22 DGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA---------SCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHH---------HCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHH---------hCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3678999999965 45567777643 345666655 7889999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
+|+|.+++.+ ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 93 ~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp TEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 9999999875 456799999999999999999999999 9999999999999999999999999998754322 23
Q ss_pred cccCCCCccCccccc-----CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 150 IDKRDKGYMAPECYK-----RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~-----~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
...||+.|+|||++. ...|+.++|||||||++|||++|+.||....... .+.... ..-.+...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~---------~~~~~~~~ 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIA---------KSEPPTLA 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHH---------HSCCCCCS
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHH---------cCCCCCCC
Confidence 567899999999984 4458899999999999999999999997552221 111110 00011112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+...++.+.+|+.+||+.||++|| ++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3445567899999999999999999 999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=311.18 Aligned_cols=225 Identities=17% Similarity=0.220 Sum_probs=176.4
Q ss_pred ccccceeeecccC-CCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV 67 (257)
+.|+.||++.... +..+++|.+. +.+|++.+. ++.|+||+++.+.+.. ....+||
T Consensus 20 G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK---------GLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH---------hCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 5789999999764 4566777643 234444444 8899999999998865 3467999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCceeeC-CCCceEEeeecccccC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPP--ILHCDIKPQNILMD-EFWTAKILDFGLAKLP 144 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dl~~~nil~~-~~~~~kl~dfg~~~~~ 144 (257)
||||++|+|.+++. ....+++.++..++.|++.||.|||++ + |+||||||+|||++ .++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHh--ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999997 446799999999999999999999999 7 99999999999996 4789999999999864
Q ss_pred CCC-cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC
Q 044568 145 NED-FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT 223 (257)
Q Consensus 145 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... .+.. .+.....+.
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~---------~i~~~~~~~ 232 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYR---------RVTSGVKPA 232 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHH---------HHTTTCCCG
T ss_pred cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHH---------HHHcCCCCc
Confidence 433 355689999999998865 59999999999999999999999997442111 1110 011111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 224 KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 224 ~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..+....+.+.+++.+||+.||++|| ++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22333456789999999999999999 999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=322.62 Aligned_cols=229 Identities=17% Similarity=0.186 Sum_probs=181.0
Q ss_pred ccccceeeecccCCCC------Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFNARNS------PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~------~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.|+.||+|+...... +++|... +.+|++.+. ++ .|+|||++.+.+...+..+|
T Consensus 48 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT---------QLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSCEE
T ss_pred CCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHH---------HhcCCCcEeEEEEEEeeCCeEEE
Confidence 6799999999765443 5565532 234444444 55 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 67 IERPVRNGSLTDIIFCSA---------------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~---------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|||||++|+|.++|.... ...+++.+++.++.|++.||.|||++ +|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence 999999999999997532 13589999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~ 199 (257)
+++.++.+||+|||+++...... ....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999987533222 23456889999999999999999999999999999998 8999976533221
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+..... .-. ....+...++.+.+|+.+||+.||++|| ++||++.|
T Consensus 276 ---~~~~~~---------~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 276 ---FYKLIQ---------NGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp ---HHHHHH---------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHHHHh---------cCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111110 000 1133455667899999999999999999 99999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=314.54 Aligned_cols=228 Identities=19% Similarity=0.273 Sum_probs=177.3
Q ss_pred ccccceeeecccCCC-----CCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARN-----SPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~-----~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+|++..+. .++||... |.+|++.+. +++|+||+++.+++...+..++||
T Consensus 18 G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~---------~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG---------QFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHH---------hcCCCCEeeeeEEEecCCceEEEE
Confidence 578999999987654 35777643 334444444 889999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
|||.+|++.+.+.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 89 EYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp ECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999999998876 667899999999999999999999999 99999999999999999999999999997643221
Q ss_pred ------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 ------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 ------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|+.|+|||.+.+..++.++|||||||++|||++|..||....... . .. .. +.... .
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~-~~-~~---------i~~~~-~ 231 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-E-VM-KA---------INDGF-R 231 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H-HH-HH---------HHTTC-C
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-H-HH-HH---------HhccC-C
Confidence 23456888999999999999999999999999999999777665432111 1 11 10 01111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
...+...+..+.+++.+||+.||++|| ++||++.|
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 134455678899999999999999999 99998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=313.62 Aligned_cols=238 Identities=15% Similarity=0.144 Sum_probs=170.4
Q ss_pred ccccceeeeccc-CCCCCeeeccchh--hhHHHHhHhhhccccccccCCceeeeceeeee--cCceeEEEeecCCCCHHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWT--ADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--TSVSGKIERPVRNGSLTD 78 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lV~E~~~~gsL~~ 78 (257)
+.|+.||+++.. +++.+++|.+... .+.+.-.+...-..+.++.|+||+++.+.+.+ .+..+||||||++|+|.+
T Consensus 15 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~ 94 (269)
T d2java1 15 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS 94 (269)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHH
Confidence 568999999865 5666888875421 11111111111113348899999999998864 456899999999999999
Q ss_pred HHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cccc
Q 044568 79 IIFCS--AERNPYWNQRVRIALDVAKGILYLHDEC--EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FVID 151 (257)
Q Consensus 79 ~l~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~~~ 151 (257)
++... ....+++.++..++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 95 ~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~ 174 (269)
T d2java1 95 VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 174 (269)
T ss_dssp HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----------
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccC
Confidence 99642 3567999999999999999999999971 013999999999999999999999999999865432 2456
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... ..... ....+...++
T Consensus 175 ~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~-----i~~~~------~~~~~~~~s~ 240 (269)
T d2java1 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGK-----IREGK------FRRIPYRYSD 240 (269)
T ss_dssp -CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH-----HHHTC------CCCCCTTSCH
T ss_pred CCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHH-----HHcCC------CCCCCcccCH
Confidence 789999999999999999999999999999999999999975421 111111 01111 1123445567
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+++.+||+.||++|| ++|+++
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 899999999999999999 999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=314.74 Aligned_cols=221 Identities=17% Similarity=0.163 Sum_probs=180.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. +++.+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+|||||
T Consensus 19 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS---------RLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------HCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHH---------HcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 679999999964 56678888654 234444444 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~--- 147 (257)
|++|+|.+++. ..+.+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999987 456799999999999999999999999 9999999999999999999999999999865422
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC-CC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG-TK 224 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 224 (257)
.....||+.|+|||++.+..++.++||||+||++|||++|..||.... ...... ..... ..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~-------------~i~~~~~~ 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQ-------------KIIKLEYD 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH-------------HHHTTCCC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHH-------------HHHcCCCC
Confidence 234578999999999999999999999999999999999999997542 111111 11111 13
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHH
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAV 254 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~ 254 (257)
++....+.+.+|+.+||+.||++|| ++|++
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 3445567789999999999999999 99863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=312.93 Aligned_cols=227 Identities=21% Similarity=0.245 Sum_probs=177.0
Q ss_pred ccccceeeecccCCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~E~~~~gs 75 (257)
+.++.||+|++. +..+++|... +.+|++.+. +++|+||+++.+++.. .+..++||||+++|+
T Consensus 18 G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~---------~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 18 GEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT---------QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp CSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHT---------TCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred CCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 678999999984 6678888764 455666555 8899999999998854 566899999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcccccCCC
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVIDKRDK 155 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (257)
|.+++.......+++..++.++.|++.||.|||++ +++||||+|+||+++.++.+|++|||+++..........++.
T Consensus 88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence 99999754445689999999999999999999999 999999999999999999999999999987666666677888
Q ss_pred CccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.+..++.++||||||+++|||+| |+.||....... +... +..-. ..+.+...++++.
T Consensus 165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----~~~~---------i~~~~-~~~~~~~~~~~~~ 230 (262)
T d1byga_ 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPR---------VEKGY-KMDAPDGCPPAVY 230 (262)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHHH---------HTTTC-CCCCCTTCCHHHH
T ss_pred cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----HHHH---------HHcCC-CCCCCccCCHHHH
Confidence 9999999998999999999999999999998 688776542111 1110 00101 1134555668899
Q ss_pred HHHHHcccCCCCCCC-hHHHHHhC
Q 044568 235 KVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+++.+||+.||.+|| +.|+++.|
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHH
Confidence 999999999999999 99998865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-46 Score=313.15 Aligned_cols=228 Identities=20% Similarity=0.231 Sum_probs=173.7
Q ss_pred cccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
.+.|+.||+++.. +++.+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+||||||
T Consensus 19 ~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~---------~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH---------KIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp SGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHH---------TCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4689999999965 45667888643 345666555 889999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEeeecccccCCCC-
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~dfg~~~~~~~~- 147 (257)
+||+|.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||++. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 90 SGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999997 567899999999999999999999999 999999999999995 5789999999999765332
Q ss_pred -cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 044568 148 -FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVD 226 (257)
Q Consensus 148 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ....... .. ....+....
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~-----~~---~~~~~~~~~ 233 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQIL-----KA---EYEFDSPYW 233 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH-----TT---CCCCCTTTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHh-----cc---CCCCCCccc
Confidence 34567999999999999999999999999999999999999999754211 1111100 00 000111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++.+.+++.+||+.||.+|| ++|+++
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 44567899999999999999999 999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=317.73 Aligned_cols=238 Identities=19% Similarity=0.203 Sum_probs=179.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||++... ++..+++|.+. +.+|++.+ .++.|+||+++.+.+...+..+||||||+
T Consensus 17 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il---------~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 17 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL---------HECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp CSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGG---------GGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHH---------HhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 679999999965 45667787653 22333333 38899999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-Cccc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVI 150 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~ 150 (257)
+|+|.+++.+ ...+++.++..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++..... ....
T Consensus 88 gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 88 GGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp TEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred CCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 9999999973 4579999999999999999999996 6 899999999999999999999999999875322 2345
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh--------------------
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC-------------------- 210 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 210 (257)
..||+.|+|||++.+..|+.++||||+||++|||++|+.||...................
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 689999999999999999999999999999999999999997653322111000000000
Q ss_pred -----h-hhhhhhhhhc---CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 211 -----F-INRELNKLVR---GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 211 -----~-~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .......... +..........+.+++.+||+.||++|| ++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000000000 0011112346789999999999999999 999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=312.88 Aligned_cols=228 Identities=21% Similarity=0.291 Sum_probs=180.8
Q ss_pred ccccceeeecccCCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGS 75 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gs 75 (257)
+.|+.||+|.+.++..++||.+. |.+|++.+. +++|+||+++.+.+. .+..++|||||++|+
T Consensus 28 G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~---------~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 28 GCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK---------KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp CSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHH---------HCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred CCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHH---------hcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 67899999999988889998754 455555555 889999999999885 456789999999999
Q ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc----ccc
Q 044568 76 LTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF----VID 151 (257)
Q Consensus 76 L~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~----~~~ 151 (257)
|..++.......+++.+++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++...... ...
T Consensus 98 l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 98 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred hhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 99999764556799999999999999999999999 99999999999999999999999999987543222 335
Q ss_pred cCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 044568 152 KRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLE 231 (257)
Q Consensus 152 ~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
.+|+.|+|||.+....++.++||||||+++|||++|..||........ .+..+ .... ..+.+...++
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i----------~~~~-~~~~~~~~~~ 241 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV----------ERGY-RMPCPPECPE 241 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----------HTTC-CCCCCTTSCH
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHH----------HhcC-CCCCCcccCH
Confidence 678889999999999999999999999999999997766654321111 11100 0001 1134556678
Q ss_pred HHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 232 NLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 232 ~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+.+++.+||+.||++|| +++|+++|
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 899999999999999999 99998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-46 Score=312.55 Aligned_cols=224 Identities=17% Similarity=0.119 Sum_probs=180.0
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+++.. ++..+|+|.+. +.+|++.+. ++.|+||+++.+.+...+..+|||||
T Consensus 26 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---------~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ---------KLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHT---------TCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHH---------HCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 678999999865 45567888653 234444444 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
|.+|+|..++. ....+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 97 ~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~ 170 (309)
T d1u5ra_ 97 CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANS 170 (309)
T ss_dssp CSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCC
T ss_pred cCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-CCc
Confidence 99999987776 456799999999999999999999999 999999999999999999999999999986543 355
Q ss_pred ccCCCCccCcccccC---CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 151 DKRDKGYMAPECYKR---TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~---~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
..||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... ..+... .....+...+.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i----------~~~~~~~~~~~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI----------AQNESPALQSG 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH----------HHSCCCCCSCT
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHH----------HhCCCCCCCCC
Confidence 689999999999864 45899999999999999999999999754211 111000 00011112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..++.+.+++.+||+.||.+|| ++|+++
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 4567899999999999999999 999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-44 Score=306.63 Aligned_cols=222 Identities=17% Similarity=0.139 Sum_probs=184.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.++.||+++.. ++..+++|.+. +.+|++.+. +++|+||+++.+.+...+..++||||
T Consensus 15 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS---------IVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------SCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH---------hccCcChhheeeeEeeCCeeeeEeee
Confidence 578999999964 46677888754 223444444 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCccc
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFVI 150 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 150 (257)
|+||+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 86 IEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp CCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred cCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 99999999998 566789999999999999999999999 9999999999999999999999999999987777777
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHHH
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKKN 229 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (257)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .... .... ....+...
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~-------------~i~~~~~~~p~~~ 224 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYE-------------KILNAELRFPPFF 224 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH-------------HHHHCCCCCCTTS
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHH-------------HHHcCCCCCCCCC
Confidence 89999999999999999999999999999999999999999754211 1111 1111 11334445
Q ss_pred HHHHHHHHHHcccCCCCCC-----C-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALR-----P-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~R-----P-~~ei~~ 255 (257)
++.+.+++.+||+.||.+| | ++|+++
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 5778999999999999999 5 677654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.2e-45 Score=311.85 Aligned_cols=228 Identities=17% Similarity=0.163 Sum_probs=182.3
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.|+.||+++.. ++..+++|.+.. .+|++.+. +++|+||+++.+.+...+..+||||||++
T Consensus 37 G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 37 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS---------VLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHH---------HTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred CcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 678999999965 566778886542 23444444 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEeeecccccCCCC--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~--~~ 149 (257)
|+|.+++.+ ....+++.++..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++...... ..
T Consensus 108 g~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 108 GELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 999999975 456799999999999999999999999 9999999999999963 578999999999865433 34
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+...... . ...+.......
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~-----~---~~~~~~~~~~~ 252 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSC-----D---WNMDDSAFSGI 252 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-----C---CCSCCGGGGGC
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-----C---CCCCcccccCC
Confidence 56889999999999999999999999999999999999999975421 1111111100 0 00001112234
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.+.+.+|+.+||+.||++|| ++|+++
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 56789999999999999999 999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=303.93 Aligned_cols=226 Identities=15% Similarity=0.191 Sum_probs=170.8
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
+.|+.||+|.+..++. +++|... +.+|++.+. ++.|+||+++.+.+. .+..++|||
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 18 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR---------QFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 6799999998765443 4565543 234444444 889999999999885 577899999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC--
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED-- 147 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~-- 147 (257)
||++|+|.+++.. ....+++.+++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 88 LCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp CCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred eccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999999875 567899999999999999999999999 9999999999999999999999999998764322
Q ss_pred --cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCC
Q 044568 148 --FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTK 224 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ... ....
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i-----~~~------~~~~ 229 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI-----ENG------ERLP 229 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH-----HTT------CCCC
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH-----HcC------CCCC
Confidence 234466788999999999999999999999999999998 888987552211 11100 000 0113
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 225 VDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 225 ~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.+...++.+.+++.+||+.||++|| ++||++.|
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4556678899999999999999999 99998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-44 Score=310.85 Aligned_cols=228 Identities=18% Similarity=0.185 Sum_probs=183.6
Q ss_pred ccccceeeeccc-CCCCCeeeccch---------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW---------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
+.|+.||++... +++.+++|.+.- .+|++++. ++.|+||+++.+.+...+..+||||||++
T Consensus 40 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~---------~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 40 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN---------QLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT---------TCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred CCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 578999999964 567788887542 33444444 88999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEeeecccccCCCC--cc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD--EFWTAKILDFGLAKLPNED--FV 149 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~--~~~~~kl~dfg~~~~~~~~--~~ 149 (257)
|+|.+.+.. ....+++.++..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++...... ..
T Consensus 111 g~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 111 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred ChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 999998864 556799999999999999999999999 999999999999997 5789999999999865433 35
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKN 229 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
...+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ..+.... .. ....+.......
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~-----~~---~~~~~~~~~~~~ 255 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVK-----RC---DWEFDEDAFSSV 255 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH-----HC---CCCCCSSTTTTS
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----hC---CCCCCcccccCC
Confidence 568899999999999999999999999999999999999999754211 1111100 00 000011223345
Q ss_pred HHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 230 LENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 230 ~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
++.+.+|+.+||+.||.+|| ++|+++
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67889999999999999999 999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=305.28 Aligned_cols=227 Identities=17% Similarity=0.196 Sum_probs=181.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc---------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS---------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.|+.||++.. .++..+++|.+. +.+|++.+. ++.|+||+++.+.+...+..+||
T Consensus 21 G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~---------~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK---------EIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH---------HCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHH---------hCCCCCCCcEEEEEEECCEEEEE
Confidence 57899999996 456678887542 356666666 88899999999999999999999
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEeeeccccc
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW----TAKILDFGLAKL 143 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~----~~kl~dfg~~~~ 143 (257)
||||++|+|.+++.. ...+++.++..++.|++.||.|||++ +|+||||||+||+++.++ .+|++|||++..
T Consensus 92 ~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 92 LELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999973 45799999999999999999999999 999999999999998766 499999999876
Q ss_pred CCC--CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PNE--DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ........... ..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~---~~----- 235 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNY---EF----- 235 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCC---CC-----
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCC---CC-----
Confidence 543 234557888999999999989999999999999999999999999755211 11111100000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
+...+...++.+.+++.+||+.||.+|| ++|+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011122346788999999999999999 999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=305.68 Aligned_cols=228 Identities=20% Similarity=0.278 Sum_probs=178.5
Q ss_pred ccccceeeecccCCCC----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeee-cCceeEEE
Q 044568 4 TKLSNFYRSSFNARNS----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-TSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lV~ 68 (257)
+.|+.||+|++..++. +++|... |.+|++.+. +++|+||+++.+.+.. ....++||
T Consensus 38 G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK---------DFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp ETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHH---------TCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHH---------hCCCCCEeEEeEEEEecCCceEEEE
Confidence 5789999999866542 5677643 345555555 8899999999999875 45789999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
|||++|+|.+++.. ....+++.++..++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999986 666788999999999999999999999 99999999999999999999999999997543221
Q ss_pred -------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 149 -------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 149 -------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
....+|+.|+|||.+....++.++||||||+++|||++|..||........ ...... .- .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~i~---------~g-~ 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL---------QG-R 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH---------TT-C
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHHHH---------cC-C
Confidence 234577889999999999999999999999999999998888864422111 001000 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
....+...++.+.+++.+||+.||++|| +.||++.|
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 1123445567899999999999999999 99998864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=303.22 Aligned_cols=227 Identities=19% Similarity=0.202 Sum_probs=173.7
Q ss_pred ccccceeeecccCCC----CCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFNARN----SPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~----~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.|+.||+|++.... .++||... |.+|++.+. +++|+||+++.+.+.. +..++|
T Consensus 19 G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~---------~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH---------SLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH---------HCCCTTBCCEEEEECS-SSCEEE
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHH---------hCCCCCEEEEEEEEee-cchhee
Confidence 679999999875443 34666543 334444444 8899999999999965 567899
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
||||++|++.+.+.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999999999875 456799999999999999999999999 9999999999999999999999999999865433
Q ss_pred c------ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 148 F------VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 148 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. ....++..|+|||.+.+..++.++||||||+++|||+| |..||...... ....... . ...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~----~-----~~~ 232 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKID----K-----EGE 232 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----T-----SCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHH----h-----CCC
Confidence 2 23345678999999999999999999999999999998 89999754111 1111100 0 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.+...+..+.+++.+||+.||++|| ++||.++|
T Consensus 233 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 233 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0123344567899999999999999999 99998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=304.83 Aligned_cols=217 Identities=17% Similarity=0.168 Sum_probs=179.0
Q ss_pred ccccceeeecc-cCCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~ 70 (257)
+.|+.||+++. .++..+++|.+.- .+|++.+. ++.|+||+++...+...+..++||||
T Consensus 16 G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~---------~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ---------NTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH---------SCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH---------hCCCCCEEEEEeeeccccccccceec
Confidence 57899999996 4567778886542 23333333 88999999999999999999999999
Q ss_pred cCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---C
Q 044568 71 VRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---D 147 (257)
Q Consensus 71 ~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~ 147 (257)
|++|+|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 87 ~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 87 ANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999999998 456799999999999999999999999 999999999999999999999999999985432 2
Q ss_pred cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 044568 148 FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDK 227 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ...... ......++.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i------------~~~~~~~p~ 226 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI------------LMEEIRFPR 226 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------HHCCCCCCT
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHH------------hcCCCCCCc
Confidence 34567899999999999999999999999999999999999999865211 111000 111123455
Q ss_pred HHHHHHHHHHHHcccCCCCCCC
Q 044568 228 KNLENLVKVGLWCVQDEPALRP 249 (257)
Q Consensus 228 ~~~~~l~~l~~~cl~~~p~~RP 249 (257)
...+++.+|+.+||+.||.+||
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~ 248 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTST
T ss_pred cCCHHHHHHHHhhccCCchhhc
Confidence 5667889999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=306.49 Aligned_cols=225 Identities=19% Similarity=0.204 Sum_probs=176.7
Q ss_pred ccccceeeecccCCCC-----Ceeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNARNS-----PWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~-----~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+|+....+. +++|... +.+|++.+. +++|+||+++.+++.. +..++++
T Consensus 20 G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~---------~l~HpnIv~l~g~~~~-~~~~~v~ 89 (317)
T d1xkka_ 20 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA---------SVDNPHVCRLLGICLT-STVQLIT 89 (317)
T ss_dssp CSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHH---------HCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHH---------hCCCCCEeeEEEEEec-CCeeEEE
Confidence 6799999999765543 5666532 345555555 8899999999999876 4567889
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF 148 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (257)
||+.+|+|.+.+.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 99999999999876 677899999999999999999999999 99999999999999999999999999998643222
Q ss_pred -----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcC
Q 044568 149 -----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRG 222 (257)
Q Consensus 149 -----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (257)
....+|+.|+|||.+.+..++.++|||||||++|||+| |..||....... +..... ... .
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~~i~---------~~~-~ 231 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILE---------KGE-R 231 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHHHHH---------HTC-C
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH---------cCC-C
Confidence 23357889999999999999999999999999999998 788887542111 111100 000 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 223 TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 223 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
...+..+++.+.+++.+||+.||.+|| +.||++.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 133455667899999999999999999 9999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=307.69 Aligned_cols=229 Identities=15% Similarity=0.150 Sum_probs=180.4
Q ss_pred cccccceeeecc-cCCCCCeeeccc----hhhhHHHHhHhhhccccccccCCceeeeceeeee----cCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVS----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL----TSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~~lV~E~~~~ 73 (257)
.+.++.||+++. .+++.+|+|.++ ..+|++.+. ....|+||+++.+.+.+ ....+||||||+|
T Consensus 22 ~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~--------~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 22 LGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW--------RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp ECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHH--------HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred eccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHH--------HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 478999999986 556777888765 345555443 12369999999998875 4678999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEeeecccccCC--CCc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE---FWTAKILDFGLAKLPN--EDF 148 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~---~~~~kl~dfg~~~~~~--~~~ 148 (257)
|+|.++|.......+++.++..++.|++.||.|||++ +|+||||||+|||++. .+.+||+|||+++... ...
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~ 170 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCcc
Confidence 9999999864456899999999999999999999999 9999999999999985 4579999999987543 333
Q ss_pred ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CC-CCC
Q 044568 149 VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GT-KVD 226 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~ 226 (257)
....||+.|+|||.+.+..|+.++||||+||++|+|+||+.||...........+ ...+. .. .++
T Consensus 171 ~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------------~~~i~~~~~~~~ 237 (335)
T d2ozaa1 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------------KTRIRMGQYEFP 237 (335)
T ss_dssp CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCCSCSSSCC
T ss_pred ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-------------HHHHhcCCCCCC
Confidence 5668899999999999889999999999999999999999999765322211000 00000 00 111
Q ss_pred ----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 227 ----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 227 ----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++++.+|+.+||+.||++|| +.|+++
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23457899999999999999999 999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-44 Score=306.59 Aligned_cols=223 Identities=15% Similarity=0.097 Sum_probs=185.3
Q ss_pred cccccceeeeccc-CCCCCeeeccch------------hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEe
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVSW------------TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIER 69 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E 69 (257)
.+.|+.||++... +++.+|+|.+.- .+|++.+. .+.|+||+++.+.+...+..++|||
T Consensus 51 ~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ---------AVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp ECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH---------HcCCCcEeecccccccccccccccc
Confidence 3679999999864 577788886541 23333333 8899999999999999999999999
Q ss_pred ecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCcc
Q 044568 70 PVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDFV 149 (257)
Q Consensus 70 ~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (257)
|+.+|+|.+++. ....+++.+++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 122 ~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 122 YVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999999997 445799999999999999999999999 999999999999999999999999999998777667
Q ss_pred cccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc-CCCCCHH
Q 044568 150 IDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR-GTKVDKK 228 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 228 (257)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ... ....+..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~-------------i~~~~~~~p~~ 260 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEK-------------IVSGKVRFPSH 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH-------------HHHCCCCCCTT
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHH-------------HhcCCCCCCcc
Confidence 7789999999999999999999999999999999999999997542 1111111 111 1123445
Q ss_pred HHHHHHHHHHHcccCCCCCC-----C-hHHHHH
Q 044568 229 NLENLVKVGLWCVQDEPALR-----P-MKCAVM 255 (257)
Q Consensus 229 ~~~~l~~l~~~cl~~~p~~R-----P-~~ei~~ 255 (257)
.++.+.+++.+||+.||.+| | ++|+++
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 56788999999999999999 6 778764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=303.43 Aligned_cols=227 Identities=22% Similarity=0.294 Sum_probs=181.1
Q ss_pred cccccceeeecccCCCC---Ceeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEE
Q 044568 3 CTKLSNFYRSSFNARNS---PWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~~~---~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
++.|+.||+|++..++. ++||+.. +.+|++.+. ++ +|+||+++.+.+...+..++||
T Consensus 20 ~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~---------~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 20 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC---------KLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHT---------TCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHH---------hccCCCCEeeEEEEEecCCeeEEEE
Confidence 46799999999877654 4555532 345555555 66 6999999999999999999999
Q ss_pred eecCCCCHHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 044568 69 RPVRNGSLTDIIFCS--------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAK 134 (257)
Q Consensus 69 E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~k 134 (257)
||+++|+|.++|+.. ....+++.++.+++.|++.||.|+|++ +++||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceE
Confidence 999999999999742 246799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccCCCCc--ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCC-CCCcCCCChhhHHHHHHHHHhh
Q 044568 135 ILDFGLAKLPNEDF--VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRK-NMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 135 l~dfg~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~-pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
|+|||+++...... ....+|..|+|||.+.+..++.++||||||+++|||++|.. ||.... ... +.
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~--~~------- 236 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAE--LY------- 236 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHH--HH-------
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHH--HH-------
Confidence 99999987544332 34457889999999999999999999999999999999765 565331 111 10
Q ss_pred hhhhhhhhhc--CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVR--GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.. ....+...++.+.+|+.+||+.||++|| |+||++.|
T Consensus 237 -----~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 237 -----EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp -----HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 01111 1134455678899999999999999999 99998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=303.60 Aligned_cols=228 Identities=18% Similarity=0.207 Sum_probs=180.1
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.|+.||+|+.. ++..++||.+. |.+|++.+. +++|+|++++.+.+...+..++|
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~---------~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA---------EFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHH---------hcCCCCcccceeeeccCCceEEE
Confidence 679999999864 23456787653 455555555 88999999999999999999999
Q ss_pred EeecCCCCHHHHHhcc----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 044568 68 ERPVRNGSLTDIIFCS----------------------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNI 125 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~ni 125 (257)
|||+++|+|.+++... ....+++.++..++.|++.||.|||++ +++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999999642 123588999999999999999999999 999999999999
Q ss_pred eeCCCCceEEeeecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcC-CCCCcCCCChh
Q 044568 126 LMDEFWTAKILDFGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR-KNMEIDASKPE 199 (257)
Q Consensus 126 l~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~-~pf~~~~~~~~ 199 (257)
|++.++.+||+|||+++..... .....+++.|+|||.+.+..++.++|||||||++|||++|. +||.... ..
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-~~- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-HE- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HH-
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-HH-
Confidence 9999999999999998743222 13446778899999999999999999999999999999986 5665431 11
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 200 EIILTNWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+ ..... .... ....+...++++.+++.+||+.||++|| |.||+++|
T Consensus 250 e-~~~~v-----~~~~------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 250 E-VIYYV-----RDGN------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp H-HHHHH-----HTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HHHHH-----HcCC------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1 11110 0000 1134555667899999999999999999 99998865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=304.16 Aligned_cols=249 Identities=20% Similarity=0.159 Sum_probs=177.9
Q ss_pred ccccceeeecccCCCCCeeeccchhhhHHHHhHhhhccccccccCCceeeeceeeeecC----ceeEEEeecCCCCHHHH
Q 044568 4 TKLSNFYRSSFNARNSPWISRVSWTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS----VSGKIERPVRNGSLTDI 79 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----~~~lV~E~~~~gsL~~~ 79 (257)
+.|+.||+|++ ++..++||.+.....-+...-.... ....+.|+||+++.+.+...+ ..++|||||++|+|.++
T Consensus 14 G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~-~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 91 (303)
T d1vjya_ 14 GRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIY-QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 91 (303)
T ss_dssp CSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHH
T ss_pred CCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHH-HHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHH
Confidence 67899999996 5778999987643322222211111 334678999999999998654 57899999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCceeeCCCCceEEeeecccccCCC-------C
Q 044568 80 IFCSAERNPYWNQRVRIALDVAKGILYLHDEC-----EPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-------D 147 (257)
Q Consensus 80 l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-------~ 147 (257)
+++ ..+++.++..++.|++.||.|+|+.. +.+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 92 l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~ 168 (303)
T d1vjya_ 92 LNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168 (303)
T ss_dssp HHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC-
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceecc
Confidence 974 46999999999999999999999620 12999999999999999999999999999875322 1
Q ss_pred cccccCCCCccCcccccCCC------CCccccchhHHHHHHHHHhcCCCCCcCCCChhh-HHH--HHHHHHhhhhhhhhh
Q 044568 148 FVIDKRDKGYMAPECYKRTP------ISVKADVYGYGIVLLETICCRKNMEIDASKPEE-IIL--TNWVYKCFINRELNK 218 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~~~------~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~-~~~--~~~~~~~~~~~~~~~ 218 (257)
.....||+.|+|||++.... ++.++|||||||++|||+||..||......... ... ...............
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T d1vjya_ 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248 (303)
T ss_dssp ---CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS
T ss_pred ccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcc
Confidence 23457899999999987542 567899999999999999999888643211100 000 000000000001111
Q ss_pred hhcCC----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 219 LVRGT----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 219 ~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..++. ..+.+....+.+++.+||+.||++|| +.||++.|
T Consensus 249 ~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 11111 12344567899999999999999999 99998865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-43 Score=305.35 Aligned_cols=234 Identities=16% Similarity=0.120 Sum_probs=180.9
Q ss_pred ccccceeeeccc-CCCCCeeeccchhh----h--HHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSWTA----D--IEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSL 76 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~~~----~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL 76 (257)
+.++.||+++.. ++..+|+|.+.-.. . .........-..+..+.|+||+++.+.+...+..+||||||++|+|
T Consensus 15 G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L 94 (364)
T d1omwa3 15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 94 (364)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcH
Confidence 679999999965 56778888754211 0 0011100001133477899999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC-CcccccCCC
Q 044568 77 TDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE-DFVIDKRDK 155 (257)
Q Consensus 77 ~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~ 155 (257)
.++|. ....+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..... ......||+
T Consensus 95 ~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~ 169 (364)
T d1omwa3 95 HYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169 (364)
T ss_dssp HHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCG
T ss_pred HHHHH--hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCccccccccc
Confidence 99997 456789999999999999999999999 999999999999999999999999999885443 335567999
Q ss_pred CccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 156 GYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 156 ~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
.|+|||.+.. ..++.++|||||||++|||++|+.||.......... +.. .........+...++.+.
T Consensus 170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR-----------MTLTMAVELPDSFSPELR 237 (364)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHH-----------HSSSCCCCCCSSSCHHHH
T ss_pred ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH-----------hcccCCCCCCCCCCHHHH
Confidence 9999999975 468999999999999999999999998653322110 000 001111233445567899
Q ss_pred HHHHHcccCCCCCCC-h-----HHHH
Q 044568 235 KVGLWCVQDEPALRP-M-----KCAV 254 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~-----~ei~ 254 (257)
+++.+||+.||++|| + +|++
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil 263 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVK 263 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHH
Confidence 999999999999999 5 5664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-43 Score=295.46 Aligned_cols=227 Identities=15% Similarity=0.175 Sum_probs=179.7
Q ss_pred ccccceeeeccc-CCCCCeeeccc------------------hhhhHHHHhHhhhcccccccc-CCceeeeceeeeecCc
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------------------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKLTSV 63 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------------------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~ 63 (257)
+.++.||+++.. +++.+++|.+. +.+|++.+. ++. |+||+++.+++...+.
T Consensus 14 G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~---------~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR---------KVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHH---------HHTTCTTBCCEEEEEECSSE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHH---------HhcCCCCeEEEEeecccCcc
Confidence 468899999964 56677787642 233444444 776 9999999999999999
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.+||||||++|+|.++|. ....+++.+++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 85 ~~ivmE~~~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcCCCchHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999997 445799999999999999999999999 999999999999999999999999999986
Q ss_pred CCCC--cccccCCCCccCccccc------CCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 144 PNED--FVIDKRDKGYMAPECYK------RTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 144 ~~~~--~~~~~~~~~~~aPE~~~------~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
.... .....||+.|.|||.+. ...++.++||||+||++|||++|+.||...... ...... ....
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~~i-----~~~~ 231 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMI-----MSGN 231 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH-----HHTC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHHHH-----HhCC
Confidence 5432 34557889999999985 234688999999999999999999999755211 111111 1111
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .+.......++++.+++.+||+.||++|| ++|+++
T Consensus 232 ~~---~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 YQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 01122234567899999999999999999 999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=299.25 Aligned_cols=235 Identities=20% Similarity=0.195 Sum_probs=176.2
Q ss_pred ccccceeeecccCCC--------CCeeeccch---hhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFNARN--------SPWISRVSW---TADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~--------~~~i~~~~~---~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.|+.||+++....+ .+++|...- .++.+.+ ..... .+.++ +|+||+++.+.+...+..++|||||
T Consensus 24 G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~-~~e~~-~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~ 101 (299)
T d1fgka_ 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL-ISEME-MMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101 (299)
T ss_dssp ----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHH-HHHHH-HHHHHCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred cCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHH-HHHHH-HHHHhcCCCeEEecccccccCCeEEEEEEcc
Confidence 578999999875554 356776532 1111111 01111 22244 7999999999999999999999999
Q ss_pred CCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 72 RNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 72 ~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
++|+|.++|.... ...+++.+++.++.|++.||.|||++ +++||||||+|||++.++.+||+|
T Consensus 102 ~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~d 178 (299)
T d1fgka_ 102 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178 (299)
T ss_dssp TTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEecc
Confidence 9999999997432 24689999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCC-----cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHh-cCCCCCcCCCChhhHHHHHHHHHhh
Q 044568 138 FGLAKLPNED-----FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETIC-CRKNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 138 fg~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
||++...... .....+++.|+|||.+.++.|+.++||||||+++|||++ |..||..... .... ..
T Consensus 179 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~~~-~~----- 249 (299)
T d1fgka_ 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELF-KL----- 249 (299)
T ss_dssp TTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH-HH-----
T ss_pred chhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HHHH-HH-----
Confidence 9998753322 234567788999999999999999999999999999998 6888864411 1111 10
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
+.... ....+...++.+.+|+.+||+.||++|| +.||++.|
T Consensus 250 ----i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 250 ----LKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp ----HHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----HHcCC-CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 11100 1133445567899999999999999999 99999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.2e-44 Score=296.08 Aligned_cols=228 Identities=16% Similarity=0.211 Sum_probs=172.9
Q ss_pred ccccceeeecc-cCCCCCeeeccc------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCc----eeE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV----SGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~----~~l 66 (257)
+.++.||+++. .+++.+++|.+. +.+|++.+. ++.|+||+++.+.+...+. .+|
T Consensus 18 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~---------~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA---------ALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHH---------TCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH---------hcCCCCCCcccceeeeccCCCceEEE
Confidence 67899999985 456678888653 233444444 8899999999999887553 789
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
|||||++|+|.+++. ....+++.+++.++.|++.||.|||++ +|+||||||+||+++.++..+++|||.+.....
T Consensus 89 vmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999999997 456799999999999999999999999 999999999999999999999999998764322
Q ss_pred C------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 147 D------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 147 ~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
. .....||+.|+|||.+.+..++.++||||+||++|||+||+.||...... .... .. ... ...
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~-~~----~~~----~~~ 232 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAY-QH----VRE----DPI 232 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-HH----HHC----CCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHH-HH----Hhc----CCC
Confidence 2 24457899999999999989999999999999999999999999754211 1110 00 000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC--hHHHHHh
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP--MKCAVMM 256 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--~~ei~~~ 256 (257)
.+.......++.+.+++.+||+.||.+|| ++|+++.
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 01112233457899999999999999999 6777654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=299.90 Aligned_cols=231 Identities=17% Similarity=0.139 Sum_probs=180.7
Q ss_pred ccccceeeeccc-CCCCCeeeccch-----hhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVSW-----TADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.|+.||+++.. +++.+++|.+.- ....+.......- ....+.|+||+++.+.+...+..+||||||++|+|.
T Consensus 13 G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~-l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~ 91 (320)
T d1xjda_ 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91 (320)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHH-HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHH-HHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHH
Confidence 578999999965 456668887642 1111111111000 112578999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---CcccccCC
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DFVIDKRD 154 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~ 154 (257)
+++. ....+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.... ......||
T Consensus 92 ~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt 166 (320)
T d1xjda_ 92 YHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 166 (320)
T ss_dssp HHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred HHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCC
Confidence 9997 456789999999999999999999999 999999999999999999999999999875432 23456789
Q ss_pred CCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHH
Q 044568 155 KGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGTKVDKKNLENLV 234 (257)
Q Consensus 155 ~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (257)
+.|+|||.+.+..++.++||||+||++|||++|+.||.+... ....... ......++...++.+.
T Consensus 167 ~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i------------~~~~~~~p~~~s~~~~ 231 (320)
T d1xjda_ 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSI------------RMDNPFYPRWLEKEAK 231 (320)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HHCCCCCCTTSCHHHH
T ss_pred CCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHH------------HcCCCCCCccCCHHHH
Confidence 999999999999999999999999999999999999975521 1111110 0111233445567799
Q ss_pred HHHHHcccCCCCCCC-hH-HHHH
Q 044568 235 KVGLWCVQDEPALRP-MK-CAVM 255 (257)
Q Consensus 235 ~l~~~cl~~~p~~RP-~~-ei~~ 255 (257)
+|+.+||+.||.+|| +. |+++
T Consensus 232 dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHhcccCCCCCcCHHHHHHh
Confidence 999999999999999 85 6653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=297.17 Aligned_cols=223 Identities=17% Similarity=0.185 Sum_probs=180.9
Q ss_pred ccccceeeeccc-CCCCCeeeccc--------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS--------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNG 74 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~g 74 (257)
+.|+.||++... ++..+++|.+. +.+|++.+. .++|+||+++.+.+...+..+||||||+||
T Consensus 16 G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~---------~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN---------IARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHH---------HSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred CCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHH---------hCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 579999999865 45567888654 335555554 888999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEeeecccccCCCC--ccc
Q 044568 75 SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE--FWTAKILDFGLAKLPNED--FVI 150 (257)
Q Consensus 75 sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~--~~~~kl~dfg~~~~~~~~--~~~ 150 (257)
+|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++. ...+|++|||++...... ...
T Consensus 87 ~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 87 DIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp BHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999975 445799999999999999999999999 9999999999999984 458999999998764432 355
Q ss_pred ccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhcCC-CCCH--
Q 044568 151 DKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVRGT-KVDK-- 227 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 227 (257)
..+++.|+|||.+.+..++.++||||+||++|+|++|..||...... ..... ..... .++.
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~-------------i~~~~~~~~~~~ 226 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIEN-------------IMNAEYTFDEEA 226 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH-------------HHHTCCCCCHHH
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHH-------------HHhCCCCCChhh
Confidence 57889999999999999999999999999999999999999765211 11111 11111 1111
Q ss_pred --HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 228 --KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 228 --~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..++.+.+|+.+||+.||++|| ++|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2346788999999999999999 999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=295.71 Aligned_cols=237 Identities=18% Similarity=0.169 Sum_probs=168.6
Q ss_pred cccccceeeecccCC------CCCeeeccch---hhhHHHHhHhhhcccccc-ccCCceeeeceeeeec-CceeEEEeec
Q 044568 3 CTKLSNFYRSSFNAR------NSPWISRVSW---TADIEVLSVAMRGSKCTR-IRGGLLLNVPVRAKLT-SVSGKIERPV 71 (257)
Q Consensus 3 ~~~~~~~y~~~~~~~------~~~~i~~~~~---~~~~~~~~~~~~~~~~~~-~~h~~i~~~~~~~~~~-~~~~lV~E~~ 71 (257)
.+.|+.||+|+.... ..+++|.+.. ..+.+.+. .... .+.+ ..|+|++.+.+.+... ...++|||||
T Consensus 23 ~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~-~e~~-~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~ 100 (299)
T d1ywna1 23 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELK-ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 100 (299)
T ss_dssp ECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHH-HHHH-HHHHHCCCTTBCCEEEEECSTTSCCEEEEECC
T ss_pred ecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHH-HHHH-HHHhhcCCCeEEEeeeeeccCCCeEEEEEEec
Confidence 468999999986443 3467776542 11111111 0001 1113 3588999998887654 4689999999
Q ss_pred CCCCHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEee
Q 044568 72 RNGSLTDIIFCSA--------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILD 137 (257)
Q Consensus 72 ~~gsL~~~l~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~d 137 (257)
++|+|.+++.... ...+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 101 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~D 177 (299)
T d1ywna1 101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 177 (299)
T ss_dssp TTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEcc
Confidence 9999999997421 24589999999999999999999999 999999999999999999999999
Q ss_pred ecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcC-CCCCcCCCChhhHHHHHHHHHhh
Q 044568 138 FGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR-KNMEIDASKPEEIILTNWVYKCF 211 (257)
Q Consensus 138 fg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~ 211 (257)
||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|. .||........ +....
T Consensus 178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---~~~~~---- 250 (299)
T d1ywna1 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRL---- 250 (299)
T ss_dssp ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---HHHHH----
T ss_pred CcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----
Confidence 99997543221 3346788999999999999999999999999999999865 56764422221 11100
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 212 INRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
.... ....+...++.+.+++.+||+.||++|| ++|+++.|
T Consensus 251 -----~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 251 -----KEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp -----HHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----hcCC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 0100 1133445667899999999999999999 99999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=293.70 Aligned_cols=235 Identities=19% Similarity=0.137 Sum_probs=178.8
Q ss_pred ccccceeeecccC-CCCCeeeccc--------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEE
Q 044568 4 TKLSNFYRSSFNA-RNSPWISRVS--------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIE 68 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~ 68 (257)
+.|+.||+++... ++.+|+|.+. +.+|++.+. ++.|+||+++.+.+...+..+|||
T Consensus 9 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~---------~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ---------ELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH---------HCCCTTBCCEEEEECCTTCCEEEE
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHH---------hCCCCCEeEEEeeeccCCceeehh
Confidence 5789999999755 5667888654 234555555 888999999999999999999999
Q ss_pred eecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC-
Q 044568 69 RPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 69 E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~- 147 (257)
||+.++++..+.. ....+++.++..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 80 E~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 80 DFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp ECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9999877776664 567799999999999999999999999 9999999999999999999999999999764432
Q ss_pred --cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhhhhhhc-
Q 044568 148 --FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--RELNKLVR- 221 (257)
Q Consensus 148 --~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 221 (257)
.....+|+.|+|||.+... .++.++||||+||++|||++|..||...... ..+.......... ........
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhcc
Confidence 2345689999999998755 5799999999999999999999999755211 1111111110000 00000000
Q ss_pred -------CC-CC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 -------GT-KV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 -------~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .. .....+.+.+|+.+||+.||++|| ++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00 112346789999999999999999 999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=296.47 Aligned_cols=226 Identities=19% Similarity=0.262 Sum_probs=180.6
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKI 67 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV 67 (257)
+.|+.||+|.+. .+..+|||.+. |.+|++.+. ++.|+||+++.+.+...+..++|
T Consensus 31 G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~---------~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK---------EFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGG---------GCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHH---------HcCCCCEeeeeeEEecCCceeEE
Confidence 679999999864 24567888765 234444444 88999999999999999999999
Q ss_pred EeecCCCCHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeec
Q 044568 68 ERPVRNGSLTDIIFCS--------AERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFG 139 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg 139 (257)
||||++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++++||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999998642 224578999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcC-CCCCcCCCChhhHHHHHHHHHhhhh
Q 044568 140 LAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCR-KNMEIDASKPEEIILTNWVYKCFIN 213 (257)
Q Consensus 140 ~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 213 (257)
+++...... ....+|+.|+|||.+.+..++.++||||||+++|||+||. .||...... ...
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~---------- 245 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL---------- 245 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH----------
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH----------
Confidence 987543322 3335678899999999999999999999999999999985 666533111 001
Q ss_pred hhhhhhhcCC--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 214 RELNKLVRGT--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 214 ~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..+.++. ..+...++.+.+++.+||+.||.+|| ++||++.|
T Consensus 246 ---~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 246 ---RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111111 23455667899999999999999999 99999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=296.07 Aligned_cols=229 Identities=19% Similarity=0.235 Sum_probs=177.7
Q ss_pred ccccceeeeccc------CCCCCeeeccc----------hhhhHHHHhHhhhccccccc-cCCceeeeceeeeecCceeE
Q 044568 4 TKLSNFYRSSFN------ARNSPWISRVS----------WTADIEVLSVAMRGSKCTRI-RGGLLLNVPVRAKLTSVSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~~------~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 66 (257)
+.|+.||+|++. ++..+++|.+. +.+|++.+. ++ .|+||+++.+.+...+..+|
T Consensus 34 G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~---------~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS---------YLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHH---------HHCCCTTBCCEEEEECSSSSCEE
T ss_pred cCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHH---------hccCCCCEEEEEEEEeeCCEEEE
Confidence 679999999753 33356777653 223333333 45 59999999999999999999
Q ss_pred EEeecCCCCHHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 044568 67 IERPVRNGSLTDIIFCSA----------------ERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEF 130 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~ 130 (257)
|||||++|+|.++++... ...+++.++..++.|++.|+.|||++ +++||||||+||+++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence 999999999999997532 23589999999999999999999999 99999999999999999
Q ss_pred CceEEeeecccccCCCCc-----ccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhc-CCCCCcCCCChhhHHHH
Q 044568 131 WTAKILDFGLAKLPNEDF-----VIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICC-RKNMEIDASKPEEIILT 204 (257)
Q Consensus 131 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g-~~pf~~~~~~~~~~~~~ 204 (257)
+.++++|||.++...... ....+|+.|+|||.+.+..++.++||||||+++|||+|+ .+||........ +.
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---~~ 258 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY 258 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence 999999999998654322 234667889999999999999999999999999999995 555544322211 11
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 205 NWVYKCFINRELNKLVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
..... -. ....+...++.+.+|+.+||+.||++|| |+||+++|
T Consensus 259 ~~i~~---------~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 259 KMIKE---------GF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHH---------TC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhc---------CC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11110 01 1123344567899999999999999999 99999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=288.29 Aligned_cols=217 Identities=20% Similarity=0.224 Sum_probs=176.0
Q ss_pred ccccceeeeccc-CCCCCeeeccc---------------hhhhHHHHhHhhhccccccc--cCCceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS---------------WTADIEVLSVAMRGSKCTRI--RGGLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~~~~--~h~~i~~~~~~~~~~~~~~ 65 (257)
+.|+.||++... ++..+++|.+. +.+|++.+. ++ .|+||+++.+.+...+..+
T Consensus 15 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~---------~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK---------KVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHH---------HHCSSSCSBCCEEEEEECSSEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHH---------HhccCCCCccEEEEEEeeCCeEE
Confidence 578999999965 56677888643 345666665 33 4999999999999999999
Q ss_pred EEEeecCC-CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEeeeccccc
Q 044568 66 KIERPVRN-GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-FWTAKILDFGLAKL 143 (257)
Q Consensus 66 lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-~~~~kl~dfg~~~~ 143 (257)
+||||+.+ +++.+++. ....+++.++..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++..
T Consensus 86 lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 99999975 68888887 456799999999999999999999999 9999999999999985 57999999999976
Q ss_pred CCCC-cccccCCCCccCcccccCCCC-CccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhhc
Q 044568 144 PNED-FVIDKRDKGYMAPECYKRTPI-SVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLVR 221 (257)
Q Consensus 144 ~~~~-~~~~~~~~~~~aPE~~~~~~~-~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
.... .....||+.|+|||.+.+..+ +.++||||+||++|||++|+.||... ..+. -.
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~i~-----------------~~ 219 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEII-----------------RG 219 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHH-----------------HC
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hHHh-----------------hc
Confidence 4433 355678999999999987765 57789999999999999999999643 1000 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 GTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...++...++++.+++.+||+.||++|| ++|+++
T Consensus 220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1122334457789999999999999999 999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=287.07 Aligned_cols=239 Identities=17% Similarity=0.142 Sum_probs=177.9
Q ss_pred ccccceeeecccC-CC-CCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee-----cCcee
Q 044568 4 TKLSNFYRSSFNA-RN-SPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL-----TSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~~-~~-~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~~~~ 65 (257)
+.++.||++.... ++ .+|+|.+. +.+|++.+. .+....|+||+++.+.+.. ....+
T Consensus 18 G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~------~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR------HLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHH------HHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHH------HHhhcCCCCcceeeeeecccccccCceEE
Confidence 5689999998643 33 46787642 234555554 3335679999999988753 34778
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
++|||+.+|++...... ....+++..++.++.|++.||.|||++ +|+||||||+|||++..+.+|++|||++....
T Consensus 92 ~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167 (305)
T ss_dssp EEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence 99999988776655443 677899999999999999999999999 99999999999999999999999999987543
Q ss_pred C--CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh--h-----
Q 044568 146 E--DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE--L----- 216 (257)
Q Consensus 146 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~----- 216 (257)
. ......||+.|+|||.+.+.+|+.++||||+||++|||++|+.||...... ..+............ +
T Consensus 168 ~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 168 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGSCTTCS
T ss_pred ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCchhccccccc
Confidence 3 235668899999999999999999999999999999999999999755211 111111111000000 0
Q ss_pred ---hhhhcCC-----CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 217 ---NKLVRGT-----KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 217 ---~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
....... .......+.+.+|+.+||+.||++|| ++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 12223456788999999999999999 999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=285.61 Aligned_cols=236 Identities=16% Similarity=0.139 Sum_probs=178.0
Q ss_pred ccccceeeecc-cCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.++.||+++. .+++.+|+|.+. +.+|++++. ++.|+||+++.+.+...+..++||||+
T Consensus 13 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~---------~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 13 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK---------ELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHT---------TCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH---------hCCCCcEEEeccccccccceeEEEeec
Confidence 57999999996 456778888753 234555555 888999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC---Cc
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE---DF 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~---~~ 148 (257)
.+ ++.+.+.......+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+|++|||.++.... ..
T Consensus 84 ~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 84 HQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp SE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred CC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 75 555555543677899999999999999999999999 999999999999999999999999999875432 23
Q ss_pred ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-h----hhhhhhc-
Q 044568 149 VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN-R----ELNKLVR- 221 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~- 221 (257)
....+|+.|+|||.+.... ++.++||||+||++|+|++|+.||...... ..+.......... . ......+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhcccccccccc
Confidence 4557899999999987765 478999999999999999999999754211 1111111000000 0 0000000
Q ss_pred -----CC-CC-----CHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 222 -----GT-KV-----DKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 222 -----~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. .. .....+.+.+++.+||+.||++|| ++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 112236789999999999999999 999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-41 Score=283.77 Aligned_cols=235 Identities=17% Similarity=0.143 Sum_probs=178.6
Q ss_pred ccccceeeecccCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecC
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVR 72 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~ 72 (257)
+.|+.||+++..+++.+|+|... +.+|++.+. ++.|+||+++.+.+...+..+++|||+.
T Consensus 13 G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~---------~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 13 GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK---------ELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp ETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG---------GCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH---------hCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 57899999999888999998753 234454554 8899999999999999999999999998
Q ss_pred CCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC---cc
Q 044568 73 NGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED---FV 149 (257)
Q Consensus 73 ~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~---~~ 149 (257)
++.+..+.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.+...... ..
T Consensus 84 ~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 84 QDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 777666665 567899999999999999999999999 9999999999999999999999999998754332 24
Q ss_pred cccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-----hhhhhhh---
Q 044568 150 IDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN-----RELNKLV--- 220 (257)
Q Consensus 150 ~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--- 220 (257)
...+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ....+........ .......
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 44678889999998765 4689999999999999999999999754211 1111111000000 0000000
Q ss_pred ---cC------CCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 ---RG------TKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ---~~------~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ........+.+.+++.+||+.||++|| ++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 011223346789999999999999999 999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=273.44 Aligned_cols=234 Identities=16% Similarity=0.121 Sum_probs=172.5
Q ss_pred cccccceeeeccc-CCCCCeeeccc-------hhhhHHHHhHhhhccccccccCCcee-eeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRGGLLL-NVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h~~i~-~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.|+.||+|+.. +++.+|+|... +..|++.+. .+.|++++ .+...+...+..++||||++
T Consensus 17 ~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~---------~l~~~~~i~~~~~~~~~~~~~~ivme~~~- 86 (299)
T d1ckia_ 17 SGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK---------MMQGGVGIPTIRWCGAEGDYNVMVMELLG- 86 (299)
T ss_dssp ECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHH---------HSTTSTTCCCEEEEEEETTEEEEEEECCC-
T ss_pred eCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHH---------HccCCCcccEEEEEEecCCEEEEEEEEcC-
Confidence 3679999999864 46677787532 345555555 66666655 44556677888999999994
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEeeecccccCCCC---
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMD---EFWTAKILDFGLAKLPNED--- 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~---~~~~~kl~dfg~~~~~~~~--- 147 (257)
|++.+.+.. ....+++.++..++.|++.||+|||++ +|+||||||+||++. .+..++++|||+++.....
T Consensus 87 ~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred Cchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 577777654 567899999999999999999999999 999999999999875 3557999999999864322
Q ss_pred -------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhhh
Q 044568 148 -------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKLV 220 (257)
Q Consensus 148 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (257)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+....... ...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 238 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE--- 238 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHH---
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Chh---
Confidence 134478999999999999999999999999999999999999998654333222222211111100 011
Q ss_pred cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHhC
Q 044568 221 RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMML 257 (257)
Q Consensus 221 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~L 257 (257)
......++.+.+++..||+.+|++|| ++++.+.|
T Consensus 239 ---~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l 273 (299)
T d1ckia_ 239 ---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273 (299)
T ss_dssp ---HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred ---HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 11223456789999999999999999 99887643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-39 Score=269.79 Aligned_cols=233 Identities=14% Similarity=0.056 Sum_probs=178.9
Q ss_pred cccccceeeeccc-CCCCCeeeccc-------hhhhHHHHhHhhhccccccccC-CceeeeceeeeecCceeEEEeecCC
Q 044568 3 CTKLSNFYRSSFN-ARNSPWISRVS-------WTADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLTSVSGKIERPVRN 73 (257)
Q Consensus 3 ~~~~~~~y~~~~~-~~~~~~i~~~~-------~~~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~~~~~lV~E~~~~ 73 (257)
.+.|+.||+++.. +++.+|+|... +.+|++.+. .+.| ++++.+...+......++||||+ +
T Consensus 15 ~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~---------~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK---------LLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp ECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHH---------HTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred cCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHH---------HhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 3679999999965 45567887543 344555444 4434 78888999999999999999999 6
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----CCceEEeeecccccCCCC-
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDE-----FWTAKILDFGLAKLPNED- 147 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~-----~~~~kl~dfg~~~~~~~~- 147 (257)
++|.+++.. ....++..++..++.|++.||.|||++ +|+||||||+||+++. .+.+||+|||+++.....
T Consensus 85 ~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 85 PSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 899999875 566799999999999999999999999 9999999999999974 568999999999754321
Q ss_pred ---------cccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhh
Q 044568 148 ---------FVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNK 218 (257)
Q Consensus 148 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (257)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||................... .......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChHH
Confidence 133468999999999999999999999999999999999999998654443322222111111 0111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHHh
Q 044568 219 LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVMM 256 (257)
Q Consensus 219 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~~ 256 (257)
+. ...++++.+++..||+.+|++|| .+.+.+.
T Consensus 240 l~------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 240 LC------AGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HT------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hc------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11 22346789999999999999999 8887664
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=278.95 Aligned_cols=233 Identities=15% Similarity=0.132 Sum_probs=176.3
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC------cee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS------VSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------~~~ 65 (257)
+.|+.||++... +++.+|+|.+. +.+|++.+. ++.|+|++++.+++...+ ..+
T Consensus 29 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~---------~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK---------HMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH---------HCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHH---------hcCCCCeeEEEEEeccCccccccceEE
Confidence 678999999964 56778888754 234444444 888999999999988655 569
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+ +++|..++. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 100 lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 999999 568888875 35799999999999999999999999 99999999999999999999999999999887
Q ss_pred CCcccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHh----------hhh-
Q 044568 146 EDFVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKC----------FIN- 213 (257)
Q Consensus 146 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~- 213 (257)
.......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+....... ...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcHHHHhhhcch
Confidence 777788899999999998764 46899999999999999999999997552111 111111000 000
Q ss_pred --hhhhhhhcCC------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 --RELNKLVRGT------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 --~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.......... .......+.+.+|+.+||+.||.+|| ++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000011100 11223346788999999999999999 999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=271.53 Aligned_cols=236 Identities=16% Similarity=0.142 Sum_probs=172.7
Q ss_pred ccccceeeecc-cCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee--------cCc
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL--------TSV 63 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--------~~~ 63 (257)
+.|+.||+++. .+++.+|||.+. +.+|++++. ++.|+|++++.+.+.. ...
T Consensus 21 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~---------~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 21 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ---------LLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHH---------HCCCTTBCCEEEEEEC----------C
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHH---------HhcCCCccceEeeeecccccccccCce
Confidence 57899999996 467778888643 345666666 8899999999988755 346
Q ss_pred eeEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeeccccc
Q 044568 64 SGKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKL 143 (257)
Q Consensus 64 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~ 143 (257)
.++||||+.++.+..... ....++..+++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 92 ~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 789999998776665544 567799999999999999999999999 999999999999999999999999999865
Q ss_pred CCCC-------cccccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhh
Q 044568 144 PNED-------FVIDKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRE 215 (257)
Q Consensus 144 ~~~~-------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 215 (257)
.... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................. .....
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~ 244 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG--SITPE 244 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC--CCCTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC--CCChh
Confidence 4321 1334688999999998765 689999999999999999999999975421111111111100 00000
Q ss_pred hhhhh---------c---CCCCCH-------HHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 LNKLV---------R---GTKVDK-------KNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 ~~~~~---------~---~~~~~~-------~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... . ...... ...+.+.+|+.+||+.||++|| ++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000 0 000000 1134677899999999999999 999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=277.89 Aligned_cols=237 Identities=17% Similarity=0.129 Sum_probs=174.6
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----hhhhHHHHhHhhhccccccccCCceeeeceeeeec------CceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLT------SVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~------~~~~lV~E~~ 71 (257)
+.|+.||+++.. +++.+|||.+. ..+|++.+. ++.|+|++++.+++... ...+||||||
T Consensus 31 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~---------~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 31 GSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR---------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHH---------HCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred CcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHH---------hcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 568999999975 46667887643 357777776 78899999999988643 2468999999
Q ss_pred CCCCHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCC--CC
Q 044568 72 RNGSLTDIIF-CSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPN--ED 147 (257)
Q Consensus 72 ~~gsL~~~l~-~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~--~~ 147 (257)
++|.+..... ......+++.+++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++.... ..
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 8654333332 11567899999999999999999999999 999999999999999764 89999999987543 33
Q ss_pred cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhh--hhhhhhhhcC--
Q 044568 148 FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFI--NRELNKLVRG-- 222 (257)
Q Consensus 148 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-- 222 (257)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+......... ...+......
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCC---
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCCChHHhhhhhccchh
Confidence 355678899999998775 468999999999999999999999997552211 11111100000 0000000000
Q ss_pred -----C--------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 223 -----T--------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 223 -----~--------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
. .......+.+.+|+.+||+.||++|| ++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 11223456789999999999999999 999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=273.63 Aligned_cols=227 Identities=16% Similarity=0.104 Sum_probs=179.4
Q ss_pred ccccceeeeccc----CCCCCeeeccc-------------hhhhHHHHhHhhhccccccccC-CceeeeceeeeecCcee
Q 044568 4 TKLSNFYRSSFN----ARNSPWISRVS-------------WTADIEVLSVAMRGSKCTRIRG-GLLLNVPVRAKLTSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~----~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~~~~~h-~~i~~~~~~~~~~~~~~ 65 (257)
+.++.||+++.. +++.+|+|.+. +.+|++.+. +++| +||+++.+.+......+
T Consensus 35 G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~---------~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE---------HIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHH---------HHHTCTTBCCEEEEEEETTEEE
T ss_pred CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHH---------hccCCCeEEEeeeeeccCCcee
Confidence 578999999742 35567887532 457777777 7777 79999999999999999
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+||||+.+|+|.+++. ....+++..+..++.|++.|+.|+|++ +++||||||+||+++.++.+||+|||+++...
T Consensus 106 ~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999998 455678899999999999999999999 99999999999999999999999999987543
Q ss_pred CCc----ccccCCCCccCcccccCC--CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhhhhhhhh
Q 044568 146 EDF----VIDKRDKGYMAPECYKRT--PISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFINRELNKL 219 (257)
Q Consensus 146 ~~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (257)
... ....+++.|++||.+... .++.++||||+||++|||++|+.||...........+... ..
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-----------~~ 249 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-----------IL 249 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----------HH
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-----------cc
Confidence 322 445788899999999765 3678999999999999999999999866433321111110 01
Q ss_pred hcCCCCCHHHHHHHHHHHHHcccCCCCCCC-h-----HHHHH
Q 044568 220 VRGTKVDKKNLENLVKVGLWCVQDEPALRP-M-----KCAVM 255 (257)
Q Consensus 220 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~-----~ei~~ 255 (257)
......+....+.+.+++.+||+.||.+|| + +|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111234455678899999999999999998 4 56653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=272.55 Aligned_cols=235 Identities=17% Similarity=0.203 Sum_probs=170.9
Q ss_pred cccccceeeecc-cCCCCCeeeccc----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCc----eeEE
Q 044568 3 CTKLSNFYRSSF-NARNSPWISRVS----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSV----SGKI 67 (257)
Q Consensus 3 ~~~~~~~y~~~~-~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~----~~lV 67 (257)
.+.|+.||++.. .++..+|+|.+. +.+|++.+. .+.|+|++++.+.+...+. .+++
T Consensus 18 ~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~---------~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL---------RFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp ---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHH---------HCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHH---------HcCCCCCCcEEEEEeeccccccceEEE
Confidence 367899999985 566777888764 234555555 8889999999999876542 3445
Q ss_pred EeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCC
Q 044568 68 ERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNED 147 (257)
Q Consensus 68 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~ 147 (257)
+||+.+|+|.+++.. ..+++.+++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 89 ~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 566778999999963 4699999999999999999999999 9999999999999999999999999998754322
Q ss_pred ------cccccCCCCccCcccccC-CCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh-------
Q 044568 148 ------FVIDKRDKGYMAPECYKR-TPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN------- 213 (257)
Q Consensus 148 ------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 213 (257)
.....+|+.|+|||.+.. ..++.++||||+||++|||++|+.||........ ...........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhhhh
Confidence 244567889999999854 4578999999999999999999999975521111 00000000000
Q ss_pred ---hhhhh-h--hcC-CCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 214 ---RELNK-L--VRG-TKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 214 ---~~~~~-~--~~~-~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... . ... ...+ ......+.+++.+||+.||.+|| ++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 000 0111 11235688999999999999999 999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=267.11 Aligned_cols=236 Identities=14% Similarity=0.100 Sum_probs=179.1
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeec
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPV 71 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~ 71 (257)
+.||.||+++.. +++.+|+|.+. +.+|++.+. .++|+|++++...+...+..++|+|++
T Consensus 13 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~---------~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK---------ELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT---------TCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHH---------hcCcCCEEeeccccccccceeEEeeec
Confidence 579999999965 55567888643 235555555 889999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCCCc---
Q 044568 72 RNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNEDF--- 148 (257)
Q Consensus 72 ~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~~~--- 148 (257)
.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+.......
T Consensus 84 ~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 84 DQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp SEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred cccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9999988887 667889999999999999999999999 99999999999999999999999999998654332
Q ss_pred ccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHHHhhhh--hhh---hhhh--
Q 044568 149 VIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVYKCFIN--REL---NKLV-- 220 (257)
Q Consensus 149 ~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~-- 220 (257)
....++..|.|||.+.... ++.++||||+||++|||++|+.||.......+. ........... ... ....
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhcccc
Confidence 3345567789999987665 689999999999999999999998543222111 11111000000 000 0000
Q ss_pred ----------cCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 221 ----------RGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 221 ----------~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..........+.+.+|+.+||+.||++|| ++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00012233446788999999999999999 999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-38 Score=267.04 Aligned_cols=235 Identities=14% Similarity=0.203 Sum_probs=173.5
Q ss_pred ccccceeeeccc-CCCCCeeeccc------hhhhHHHHhHhhhcccccccc-CCceeeeceeeee--cCceeEEEeecCC
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS------WTADIEVLSVAMRGSKCTRIR-GGLLLNVPVRAKL--TSVSGKIERPVRN 73 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~------~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~--~~~~~lV~E~~~~ 73 (257)
+.|+.||+++.. +++.+|+|.+. +.+|++++. .+. |+||+++.+.+.. ....++|||||.+
T Consensus 46 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~---------~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 46 GKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE---------NLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHH---------HHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred CcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHH---------hccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 578999999964 56667887633 456666665 553 9999999998874 4568999999999
Q ss_pred CCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEeeecccccCCC--Cccc
Q 044568 74 GSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFW-TAKILDFGLAKLPNE--DFVI 150 (257)
Q Consensus 74 gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~-~~kl~dfg~~~~~~~--~~~~ 150 (257)
++|.++. +.+++.+++.++.|++.||.|||++ +|+||||||+|||++.++ .+|++|||++..... ....
T Consensus 117 ~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~ 188 (328)
T d3bqca1 117 TDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188 (328)
T ss_dssp CBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCS
T ss_pred CcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCcccc
Confidence 9998764 3599999999999999999999999 999999999999998654 689999999975432 3455
Q ss_pred ccCCCCccCcccccCC-CCCccccchhHHHHHHHHHhcCCCCCcCCCChhhH-HHHHHH---------HHhh--hhhhhh
Q 044568 151 DKRDKGYMAPECYKRT-PISVKADVYGYGIVLLETICCRKNMEIDASKPEEI-ILTNWV---------YKCF--INRELN 217 (257)
Q Consensus 151 ~~~~~~~~aPE~~~~~-~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~---------~~~~--~~~~~~ 217 (257)
..+|+.|+|||.+.+. .++.++||||+||++||+++|+.||.......... ...... .... ......
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 6788899999998765 47999999999999999999999997553222111 000000 0000 000000
Q ss_pred hhhcCC-----------CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRGT-----------KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~~-----------~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
...... .......+++.+|+.+||+.||++|| ++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 11122346789999999999999999 999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=268.69 Aligned_cols=237 Identities=15% Similarity=0.155 Sum_probs=174.2
Q ss_pred ccccceeeecc-cCCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeeecC-----ceeE
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTS-----VSGK 66 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~l 66 (257)
+.||.||++.. .++..+|+|.+. +.+|++++. ++.|+|++++.+.+.... ..++
T Consensus 29 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~---------~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---------HMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHH---------hcCCCCeeeEEEEEeeccccccCceEE
Confidence 67999999985 567778898753 234555555 889999999999887433 3466
Q ss_pred EEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCCC
Q 044568 67 IERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPNE 146 (257)
Q Consensus 67 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~~ 146 (257)
+|||+.+|+|.+++. ...+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||.+.....
T Consensus 100 i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence 778888999999995 45799999999999999999999999 999999999999999999999999999987766
Q ss_pred CcccccCCCCccCcccccCCC-CCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH-------Hhhhhhhhhh
Q 044568 147 DFVIDKRDKGYMAPECYKRTP-ISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY-------KCFINRELNK 218 (257)
Q Consensus 147 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 218 (257)
......+++.|+|||...+.. ++.++||||+||++|+|++|+.||.+.........+..... ..........
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 667777888899999877654 68999999999999999999999976522111111110000 0000000000
Q ss_pred hh----cCCCCC-----HHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 219 LV----RGTKVD-----KKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 219 ~~----~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
.. ...... ....+.+.+|+.+||+.||++|| ++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 000111 12346788999999999999999 999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=266.34 Aligned_cols=235 Identities=16% Similarity=0.104 Sum_probs=165.8
Q ss_pred ccccceeeeccc-CCCCCeeeccc-----------hhhhHHHHhHhhhccccccccCCceeeeceeeee------cCcee
Q 044568 4 TKLSNFYRSSFN-ARNSPWISRVS-----------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKL------TSVSG 65 (257)
Q Consensus 4 ~~~~~~y~~~~~-~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~------~~~~~ 65 (257)
+.|+.||++... ++..+|+|.+. +.+|++++. ++.|+||+++.+.+.. ..+.|
T Consensus 28 G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~---------~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK---------CVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHH---------HCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHH---------hcCCCCeeEEEEEEecccccccCceeE
Confidence 578999999965 57778888754 234444444 7789999999999864 36889
Q ss_pred EEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccCC
Q 044568 66 KIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLPN 145 (257)
Q Consensus 66 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~~ 145 (257)
+|||||.++ +.+.+. ..+++.+++.++.|++.||.|||++ ||+||||||+|||++.++.++++|||+++...
T Consensus 99 iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 999999765 445543 3589999999999999999999999 99999999999999999999999999877543
Q ss_pred C--CcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhhHHHHHHHH------Hhhhhhhhh
Q 044568 146 E--DFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEEIILTNWVY------KCFINRELN 217 (257)
Q Consensus 146 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~------~~~~~~~~~ 217 (257)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||................. .........
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3 23455788999999999999999999999999999999999999975521111000000000 000000000
Q ss_pred hhhcC-------------------C--CCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 218 KLVRG-------------------T--KVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 218 ~~~~~-------------------~--~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
..... . .......+.+.+|+.+||+.||++|| ++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0 11223457889999999999999999 999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-33 Score=238.30 Aligned_cols=249 Identities=19% Similarity=0.154 Sum_probs=175.0
Q ss_pred ccccceeeecc-cCCCCCeeeccc--------hhhhHHHHhHhhhc--cccccccCCceeeeceeeeec--CceeEEEee
Q 044568 4 TKLSNFYRSSF-NARNSPWISRVS--------WTADIEVLSVAMRG--SKCTRIRGGLLLNVPVRAKLT--SVSGKIERP 70 (257)
Q Consensus 4 ~~~~~~y~~~~-~~~~~~~i~~~~--------~~~~~~~~~~~~~~--~~~~~~~h~~i~~~~~~~~~~--~~~~lV~E~ 70 (257)
+.||.||+++. .+++.+|||.+. +.+|++.+....+. .......|+|++++...+... ...++++++
T Consensus 24 G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~ 103 (362)
T d1q8ya_ 24 GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF 103 (362)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeee
Confidence 56899999996 457778888654 24455555422211 012234688999999887653 455667776
Q ss_pred cCCC-CHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCC------ceEEeeecccc
Q 044568 71 VRNG-SLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHD-ECEPPILHCDIKPQNILMDEFW------TAKILDFGLAK 142 (257)
Q Consensus 71 ~~~g-sL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~~~nil~~~~~------~~kl~dfg~~~ 142 (257)
+..+ +............+++..+..++.|++.|+.|||+ . ||+||||||+|||++.++ .++++|||.+.
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~ 180 (362)
T d1q8ya_ 104 EVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180 (362)
T ss_dssp CCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred cccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeeccccc
Confidence 6544 44444444467788999999999999999999998 6 999999999999997654 38999999998
Q ss_pred cCCCCcccccCCCCccCcccccCCCCCccccchhHHHHHHHHHhcCCCCCcCCCChhh---HHHHHHHHHhhhh-hh---
Q 044568 143 LPNEDFVIDKRDKGYMAPECYKRTPISVKADVYGYGIVLLETICCRKNMEIDASKPEE---IILTNWVYKCFIN-RE--- 215 (257)
Q Consensus 143 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~-~~--- 215 (257)
..........+|+.|+|||.+....++.++|+||+||+++||++|+.||......... ..+.......... ..
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~ 260 (362)
T d1q8ya_ 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 260 (362)
T ss_dssp ETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhh
Confidence 7777777778999999999999999999999999999999999999999754221110 0111110000000 00
Q ss_pred -------------------------hhh-hhcCCCCCHHHHHHHHHHHHHcccCCCCCCC-hHHHHH
Q 044568 216 -------------------------LNK-LVRGTKVDKKNLENLVKVGLWCVQDEPALRP-MKCAVM 255 (257)
Q Consensus 216 -------------------------~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-~~ei~~ 255 (257)
... ............+.+.+|+.+||+.||.+|| ++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 261 NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0011134566778999999999999999999 999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.73 E-value=1.2e-19 Score=141.39 Aligned_cols=152 Identities=11% Similarity=-0.014 Sum_probs=100.2
Q ss_pred ccccceeeecccCCCCCeeeccc-------------------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCce
Q 044568 4 TKLSNFYRSSFNARNSPWISRVS-------------------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVS 64 (257)
Q Consensus 4 ~~~~~~y~~~~~~~~~~~i~~~~-------------------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 64 (257)
++++.||+++..+++.+++|... +..+.......... .+.++.|.++...... ...
T Consensus 11 G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~v~~~~~~----~~~ 85 (191)
T d1zara2 11 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQGLAVPKVYAW----EGN 85 (191)
T ss_dssp CSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTTTSSSCCEEEE----ETT
T ss_pred CcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHH-HHHHccCCCcceEEEe----cCC
Confidence 68999999998888999998422 11111111111111 3346667666544322 234
Q ss_pred eEEEeecCCCCHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEeeecccccC
Q 044568 65 GKIERPVRNGSLTDIIFCSAERNPYWNQRVRIALDVAKGILYLHDECEPPILHCDIKPQNILMDEFWTAKILDFGLAKLP 144 (257)
Q Consensus 65 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~~~ 144 (257)
++||||++++.+.+ ++......++.|++.|+.|||++ +++||||||+|||++++ .++++|||.+...
T Consensus 86 ~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~ 152 (191)
T d1zara2 86 AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152 (191)
T ss_dssp EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccC
Confidence 79999998765543 33345678999999999999999 99999999999999975 6899999988754
Q ss_pred CCCcccccCCCCccCc------ccccCCCCCccccchhHHH
Q 044568 145 NEDFVIDKRDKGYMAP------ECYKRTPISVKADVYGYGI 179 (257)
Q Consensus 145 ~~~~~~~~~~~~~~aP------E~~~~~~~~~~~Di~s~G~ 179 (257)
...... .|... +. ....|+.++|+||..-
T Consensus 153 ~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 153 GEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp TSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred CCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 332211 01110 11 1245678899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.58 E-value=9.9e-05 Score=57.91 Aligned_cols=120 Identities=13% Similarity=0.104 Sum_probs=72.6
Q ss_pred cceeeecccCCCCCeeeccc---------hhhhHHHHhHhhhccccccccCCceeeeceeeeecCceeEEEeecCCCCHH
Q 044568 7 SNFYRSSFNARNSPWISRVS---------WTADIEVLSVAMRGSKCTRIRGGLLLNVPVRAKLTSVSGKIERPVRNGSLT 77 (257)
Q Consensus 7 ~~~y~~~~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lV~E~~~~gsL~ 77 (257)
+.||+.+. ++...++|... ..+|.+.+.. +.+ .++-| ++.......+..++|||+.+|.++.
T Consensus 28 ~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~-l~~----~vpvP---~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 28 AKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLW-LEG----KLPVP---KVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp SEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHH-HTT----TSCCC---CEEEEEEETTEEEEEEECCSSEEHH
T ss_pred CcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHH-Hhc----cCCCC---cEEEEEecCCceEEEEEeccccccc
Confidence 57888764 33344555432 2445555442 112 22233 2334455677889999999988886
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------------
Q 044568 78 DIIFCSAERNPYWNQRVRIALDVAKGILYLHDEC---------------------------------------------- 111 (257)
Q Consensus 78 ~~l~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------------- 111 (257)
+.... . .....++.+++..+..||+..
T Consensus 99 ~~~~~--~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 99 EEYED--E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp HHTTT--C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred ccccc--c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 65431 1 112334555555555565431
Q ss_pred ----------CCCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 112 ----------EPPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 112 ----------~~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
...++|+|+.+.||+++++....++||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247899999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.25 E-value=0.00046 Score=53.60 Aligned_cols=29 Identities=21% Similarity=0.223 Sum_probs=24.8
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+.+.||+++++..+.++||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999987667899998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.59 E-value=0.035 Score=45.75 Aligned_cols=28 Identities=25% Similarity=0.452 Sum_probs=24.5
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.++|+|+++.||+++++ .++++||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 68999999999999876 58999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.45 E-value=0.3 Score=38.61 Aligned_cols=28 Identities=29% Similarity=0.271 Sum_probs=22.8
Q ss_pred CCeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 113 PPILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 113 ~~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
.+++|+|+.+.||+++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 378999999999999754 4578998664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.24 E-value=0.026 Score=44.82 Aligned_cols=29 Identities=21% Similarity=0.303 Sum_probs=25.9
Q ss_pred CeeeccCCCCceeeCCCCceEEeeecccc
Q 044568 114 PILHCDIKPQNILMDEFWTAKILDFGLAK 142 (257)
Q Consensus 114 ~i~h~dl~~~nil~~~~~~~kl~dfg~~~ 142 (257)
+++|+|+.+.|++++++....++||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988777899998763
|